10328216	ADP	Fritz G	Rho GTPases are over-expressed in human tumors.	International journal of cancer	1999	171
10381378	ADP	Frye RA	Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity.	Biochemical and biophysical research communications	1999	207
11385575	ADP	Perraud AL	ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology.	Nature	2001	218
11817589	ADP	Gergely P Jr	Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus.	Arthritis and rheumatism	2002	82
12237774	ADP	Fritz G	Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters.	British journal of cancer	2002	102
12716823	ADP	Ceriello A	New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy.	Diabetes care	2003	121
15087504	ADP	Hashimoto S	Requirement for Arf6 in breast cancer invasive activities.	Proceedings of the National Academy of Sciences of the United States of America	2004	82
15654602	ADP	Anello M	Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients.	Diabetologia	2005	72
16418332	ADP	Hideshima T	Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells.	Blood	2006	124
17334651	ADP	Boushel R	Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle.	Diabetologia	2007	118
17351150	ADP	Mogensen M	Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes.	Diabetes	2007	114
17456799	ADP	Yamamoto H	Sirtuin functions in health and disease.	Molecular endocrinology	2007	98
18812468	ADP	Eltzschig HK	Central role of Sp1-regulated CD39 in hypoxia/ischemia protection.	Blood	2009	73
18996916	ADP	Ferland RJ	Disruption of neural progenitors along the ventricular and subventricular zones in periventricular heterotopia.	Human molecular genetics	2009	53
19822647	ADP	Paruchuri S	Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor.	The Journal of experimental medicine	2009	69
20125064	ADP	Park KS	Trophic molecules derived from human mesenchymal stem cells enhance survival, function, and angiogenesis of isolated islets after transplantation.	Transplantation	2010	53
20473311	ADP	Shoubridge C	Mutations in the guanine nucleotide exchange factor gene IQSEC2 cause nonsyndromic intellectual disability.	Nature genetics	2010	41
21356345	ADP	Ba X	Signaling mechanism of poly(ADP-ribose) polymerase-1 (PARP-1) in inflammatory diseases.	The American journal of pathology	2011	38
21781245	ADP	Nieswandt B	Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke.	Journal of thrombosis and haemostasis 	2011	42
21825135	ADP	Sannerud R	ADP ribosylation factor 6 (ARF6) controls amyloid precursor protein (APP) processing by mediating the endosomal sorting of BACE1.	Proceedings of the National Academy of Sciences of the United States of America	2011	70
22022533	ADP	Egan K	Platelet adhesion and degranulation induce pro-survival and pro-angiogenic signalling in ovarian cancer cells.	PloS one	2011	38
22262760	ADP	Santo L	Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma.	Blood	2012	107
22363216	ADP	Stafa K	GTPase activity and neuronal toxicity of Parkinson's disease-associated LRRK2 is regulated by ArfGAP1.	PLoS genetics	2012	43
23022210	ADP	Di Vizio D	Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease.	The American journal of pathology	2012	67
23102217	ADP	Hardie DG	AMP-activated protein kinase: a target for drugs both ancient and modern.	Chemistry & biology	2012	99
23143332	ADP	Zhu W	Interleukin receptor activates a MYD88-ARNO-ARF6 cascade to disrupt vascular stability.	Nature	2012	40
23144924	ADP	Bao R	Inhibition of tankyrases induces Axin stabilization and blocks Wnt signalling in breast cancer cells.	PloS one	2012	39
23230278	ADP	Tauro BJ	Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids.	Molecular & cellular proteomics 	2013	75
23423489	ADP	Plummer R	A phase II study of the potent PARP inhibitor, Rucaparib (PF-01367338, AG014699), with temozolomide in patients with metastatic melanoma demonstrating evidence of chemopotentiation.	Cancer chemotherapy and pharmacology	2013	32
23471966	ADP	Maldonado EN	Voltage-dependent anion channels modulate mitochondrial metabolism in cancer cells: regulation by free tubulin and erastin.	The Journal of biological chemistry	2013	36
23535599	ADP	Burnaevskiy N	Proteolytic elimination of N-myristoyl modifications by the Shigella virulence factor IpaJ.	Nature	2013	35
23604120	ADP	Roth M	Sorting out functions of sirtuins in cancer.	Oncogene	2014	67
24438746	ADP	Kugel S	Chromatin and beyond: the multitasking roles for SIRT6.	Trends in biochemical sciences	2014	56
24569222	ADP	Zhao Y	Crosstalk between ubiquitin and other post-translational modifications on chromatin during double-strand break repair.	Trends in cell biology	2014	21
24958846	ADP	Canault M	Human CalDAG-GEFI gene (RASGRP2) mutation affects platelet function and causes severe bleeding.	The Journal of experimental medicine	2014	22
25043379	ADP	Vyas S	Family-wide analysis of poly(ADP-ribose) polymerase activity.	Nature communications	2014	60
25244928	ADP	Bruntz RC	Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer.	Pharmacological reviews	2014	28
25253741	ADP	Eades G	lincRNA-RoR and miR-145 regulate invasion in triple-negative breast cancer via targeting ARF6.	Molecular cancer research 	2015	38
25821842	ADP	Moore CS	P2Y12 expression and function in alternatively activated human microglia.	Neurolog	2015	19
25881554	ADP	Martire S	PARP-1 involvement in neurodegeneration: A focus on Alzheimer's and Parkinson's diseases.	Mechanisms of ageing and development	2015	20
26091342	ADP	Barkauskaite E	Structures and Mechanisms of Enzymes Employed in the Synthesis and Degradation of PARP-Dependent Protein ADP-Ribosylation.	Molecular cell	2015	33
26091343	ADP	Bai P	Biology of Poly(ADP-Ribose) Polymerases: The Factotums of Cell Maintenance.	Molecular cell	2015	32
26277545	ADP	Israelsen WJ	Pyruvate kinase: Function, regulation and role in cancer.	Seminars in cell & developmental biology	2015	34
26824338	ADP	Zakraoui O	Lebein, a snake venom disintegrin, suppresses human colon cancer cells proliferation and tumor-induced angiogenesis through cell cycle arrest, apoptosis induction and inhibition of VEGF expression.	Molecular carcinogenesis	2017	7
26865365	ADP	Radons J	The human HSP70 family of chaperones: where do we stand?	Cell stress & chaperones	2016	26
26873625	ADP	Bamburg JR	Actin dynamics and cofilin-actin rods in alzheimer disease.	Cytoskeleton	2016	13
27064283	ADP	Haemmerle M	FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal.	The Journal of clinical investigation	2016	12
27067600	ADP	Gibbs-Seymour I	HPF1/C4orf27 Is a PARP-1-Interacting Protein that Regulates PARP-1 ADP-Ribosylation Activity.	Molecular cell	2016	16
27321181	ADP	Di Virgilio F	Extracellular purines, purinergic receptors and tumor growth.	Oncogene	2017	14
27497945	ADP	Hurst S	Mitochondrial Ca2+ and regulation of the permeability transition pore.	Journal of bioenergetics and biomembranes	2017	14
27780585	ADP	Menzies RI	Purinergic signaling in kidney disease.	Kidney international	2017	11
28002403	ADP	Hoch NC	XRCC1 mutation is associated with PARP1 hyperactivation and cerebellar ataxia.	Nature	2017	12
28190768	ADP	Bonfiglio JJ	Serine ADP-Ribosylation Depends on HPF1.	Molecular cell	2017	11
28334607	ADP	Essuman K	The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD+ Cleavage Activity that Promotes Pathological Axonal Degeneration.	Neuron	2017	7
9053458	Adenosine triphosphate	Ferrari D	Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin.	The Journal of experimental medicine	1997	108
9157970	Adenosine triphosphate	Eguchi Y	Intracellular ATP levels determine cell death fate by apoptosis or necrosis.	Cancer research	1997	166
9233643	Adenosine triphosphate	Ferrari D	Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages.	Journal of immunology	1997	152
9351836	Adenosine triphosphate	Evans E	Mechanism of open complex and dual incision formation by human nucleotide excision repair factors.	The EMBO journal	1997	145
9815080	Adenosine triphosphate	Sprague RS	Deformation-induced ATP release from red blood cells requires CFTR activity.	The American journal of physiology	1998	105
10369688	Adenosine triphosphate	Masutani C	Xeroderma pigmentosum variant (XP-V) correcting protein from HeLa cells has a thymine dimer bypass DNA polymerase activity.	The EMBO journal	1999	121
10393078	Adenosine triphosphate	Crompton M	The mitochondrial permeability transition pore and its role in cell death.	The Biochemical journal	1999	421
10438458	Adenosine triphosphate	Boulares AH	Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells.	The Journal of biological chemistry	1999	154
10508238	Adenosine triphosphate	Lipton P	Ischemic cell death in brain neurons.	Physiological reviews	1999	461
10562547	Adenosine triphosphate	Szalai G	Apoptosis driven by IP(3)-linked mitochondrial calcium signals.	The EMBO journal	1999	120
11054482	Adenosine triphosphate	White BC	Brain ischemia and reperfusion: molecular mechanisms of neuronal injury.	Journal of the neurological sciences	2000	112
11264476	Adenosine triphosphate	Linden J	Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection.	Annual review of pharmacology and toxicology	2001	171
11385574	Adenosine triphosphate	Nadler MJ	LTRPC7 is a Mg.ATP-regulated divalent cation channel required for cell viability.	Nature	2001	234
11739410	Adenosine triphosphate	Madesh M	VDAC-dependent permeabilization of the outer mitochondrial membrane by superoxide induces rapid and massive cytochrome c release.	The Journal of cell biology	2001	114
11751413	Adenosine triphosphate	Moulder SL	Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo.	Cancer research	2001	99
12194824	Adenosine triphosphate	Horman S	Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis.	Current biology 	2002	119
12202460	Adenosine triphosphate	Chiang JY	Bile acid regulation of gene expression: roles of nuclear hormone receptors.	Endocrine reviews	2002	93
12438266	Adenosine triphosphate	Cuezva JM	The bioenergetic signature of cancer: a marker of tumor progression.	Cancer research	2002	96
12808136	Adenosine triphosphate	Stump CS	Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts.	Proceedings of the National Academy of Sciences of the United States of America	2003	106
12845153	Adenosine triphosphate	Brown GC	Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria.	Molecular neurobiology	2003	81
14517806	Adenosine triphosphate	Jaeschke H	Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury.	Gastroenterology	2003	124
14612543	Adenosine triphosphate	Hasmann M	FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis.	Cancer research	2003	157
14722619	Adenosine triphosphate	Scott JW	CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations.	The Journal of clinical investigation	2004	228
14749273	Adenosine triphosphate	Duchen MR	Roles of mitochondria in health and disease.	Diabetes	2004	75
14769489	Adenosine triphosphate	Veech RL	The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism.	Prostaglandins, leukotrienes, and essential fatty acids	2004	142
14962470	Adenosine triphosphate	Halestrap AP	Mitochondrial permeability transition pore opening during myocardial reperfusion--a target for cardioprotection.	Cardiovascular research	2004	217
15044640	Adenosine triphosphate	Shulenin S	ABCA3 gene mutations in newborns with fatal surfactant deficiency.	The New England journal of medicine	2004	135
15192144	Adenosine triphosphate	Andrei C	Phospholipases C and A2 control lysosome-mediated IL-1 beta secretion: Implications for inflammatory processes.	Proceedings of the National Academy of Sciences of the United States of America	2004	105
15236194	Adenosine triphosphate	Tamborini E	A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient.	Gastroenterology	2004	70
15269217	Adenosine triphosphate	Wahrle SE	ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE.	The Journal of biological chemistry	2004	114
15456405	Adenosine triphosphate	Barnett SF	Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors.	The Biochemical journal	2005	132
15543203	Adenosine triphosphate	de Kok JB	Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes.	Laboratory investigation; a journal of technical methods and pathology	2005	148
15559249	Adenosine triphosphate	Meijer L	Pharmacological inhibitors of glycogen synthase kinase 3.	Trends in pharmacological sciences	2004	136
15695406	Adenosine triphosphate	Xu RH	Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia.	Cancer research	2005	181
15705904	Adenosine triphosphate	Smith JA	Identification of the first specific inhibitor of p90 ribosomal S6 kinase (RSK) reveals an unexpected role for RSK in cancer cell proliferation.	Cancer research	2005	104
15706348	Adenosine triphosphate	Kasper D	Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration.	The EMBO journal	2005	71
15829498	Adenosine triphosphate	Zareparsi S	Toll-like receptor 4 variant D299G is associated with susceptibility to age-related macular degeneration.	Human molecular genetics	2005	74
15831501	Adenosine triphosphate	David DC	Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice.	The Journal of biological chemistry	2005	81
15841208	Adenosine triphosphate	Timmins JM	Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I.	The Journal of clinical investigation	2005	149
15894266	Adenosine triphosphate	Plescia J	Rational design of shepherdin, a novel anticancer agent.	Cancer cell	2005	67
15899824	Adenosine triphosphate	Frank NY	ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma.	Cancer research	2005	139
15899831	Adenosine triphosphate	Wedge SR	AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer.	Cancer research	2005	165
15937340	Adenosine triphosphate	Bali P	Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors.	The Journal of biological chemistry	2005	238
15944221	Adenosine triphosphate	Pellegatti P	A novel recombinant plasma membrane-targeted luciferase reveals a new pathway for ATP secretion.	Molecular biology of the cell	2005	69
15998811	Adenosine triphosphate	Dannenberg JH	mSin3A corepressor regulates diverse transcriptional networks governing normal and neoplastic growth and survival.	Genes & development	2005	86
16007257	Adenosine triphosphate	Mahapatra NR	Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog.	The Journal of clinical investigation	2005	89
16024622	Adenosine triphosphate	Patrawala L	Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic.	Cancer research	2005	281
16098463	Adenosine triphosphate	Moeller BJ	Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity.	Cancer cell	2005	111
16207713	Adenosine triphosphate	Koldamova R	Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice.	The Journal of biological chemistry	2005	95
16226706	Adenosine triphosphate	Hatzivassiliou G	ATP citrate lyase inhibition can suppress tumor cell growth.	Cancer cell	2005	252
16230075	Adenosine triphosphate	Fiorucci S	Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs.	Gastroenterology	2005	81
16239320	Adenosine triphosphate	Haraguchi N	Characterization of a side population of cancer cells from human gastrointestinal system.	Stem cells	2006	170
16275737	Adenosine triphosphate	Ignoul S	CBS domains: structure, function, and pathology in human proteins.	American journal of physiology. Cell physiology	2005	90
16357216	Adenosine triphosphate	Maniataki E	A human, ATP-independent, RISC assembly machine fueled by pre-miRNA.	Genes & development	2005	142
16378731	Adenosine triphosphate	Sultana R	Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach.	Neurobiology of disease	2006	90
16512913	Adenosine triphosphate	Yiangou Y	COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord.	BMC neurology	2006	115
16547218	Adenosine triphosphate	Ferrari D	The P2X7 receptor: a key player in IL-1 processing and release.	Journal of immunology	2006	285
16685256	Adenosine triphosphate	Kanmogne GD	HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis.	Journal of cerebral blood flow and metabolism 	2007	81
16787253	Adenosine triphosphate	Shoshan-Barmatz V	The voltage-dependent anion channel (VDAC): function in intracellular signalling, cell life and cell death.	Current pharmaceutical design	2006	80
16842198	Adenosine triphosphate	Pérez-Tomás R	Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.	Current medicinal chemistry	2006	100
16862155	Adenosine triphosphate	Wong CW	Connexin37 protects against atherosclerosis by regulating monocyte adhesion.	Nature medicine	2006	77
16880519	Adenosine triphosphate	Griswold IJ	Kinase domain mutants of Bcr-Abl exhibit altered transformation potency, kinase activity, and substrate utilization, irrespective of sensitivity to imatinib.	Molecular and cellular biology	2006	62
16892090	Adenosine triphosphate	Mathupala SP	Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria.	Oncogene	2006	166
16935882	Adenosine triphosphate	Fuller-Pace FV	DExD/H box RNA helicases: multifunctional proteins with important roles in transcriptional regulation.	Nucleic acids research	2006	127
16946104	Adenosine triphosphate	Braselmann S	R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation.	The Journal of pharmacology and experimental therapeutics	2006	111
17062895	Adenosine triphosphate	Vandenabeele P	Caspase inhibitors promote alternative cell death pathways.	Science's STKE 	2006	79
17076584	Adenosine triphosphate	Mujawar Z	Human immunodeficiency virus impairs reverse cholesterol transport from macrophages.	PLoS biology	2006	117
17110937	Adenosine triphosphate	Vanakker OM	Pseudoxanthoma elasticum-like phenotype with cutis laxa and multiple coagulation factor deficiency represents a separate genetic entity.	The Journal of investigative dermatology	2007	59
17158952	Adenosine triphosphate	Pelicano H	Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism.	The Journal of cell biology	2006	126
17215403	Adenosine triphosphate	Baloh RH	Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations.	The Journal of neuroscience 	2007	105
17275978	Adenosine triphosphate	Moffett JR	N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.	Progress in neurobiology	2007	272
17307971	Adenosine triphosphate	Towler MC	AMP-activated protein kinase in metabolic control and insulin signaling.	Circulation research	2007	317
17318448	Adenosine triphosphate	Kuo MT	The roles of copper transporters in cisplatin resistance.	Cancer metastasis reviews	2007	67
17322922	Adenosine triphosphate	Lou H	Targeted therapy for cancer stem cells: the patched pathway and ABC transporters.	Oncogene	2007	62
17332438	Adenosine triphosphate	Arad M	AMP-activated protein kinase in the heart: role during health and disease.	Circulation research	2007	92
17353295	Adenosine triphosphate	Wajchenberg BL	beta-cell failure in diabetes and preservation by clinical treatment.	Endocrine reviews	2007	147
17360912	Adenosine triphosphate	Thies E	Missorting of tau in neurons causes degeneration of synapses that can be rescued by the kinase MARK2/Par-1.	The Journal of neuroscience 	2007	85
17404808	Adenosine triphosphate	Alrefai WA	Bile acid transporters: structure, function, regulation and pathophysiological implications.	Pharmaceutical research	2007	68
17483355	Adenosine triphosphate	Zou HY	An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms.	Cancer research	2007	171
17485642	Adenosine triphosphate	Di Fonzo A	ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease.	Neurology	2007	64
17510412	Adenosine triphosphate	Ho MM	Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells.	Cancer research	2007	281
17510466	Adenosine triphosphate	Mulya A	Minimal lipidation of pre-beta HDL by ABCA1 results in reduced ability to interact with ABCA1.	Arteriosclerosis, thrombosis, and vascular biology	2007	57
17519960	Adenosine triphosphate	Brendel C	Imatinib mesylate and nilotinib (AMN107) exhibit high-affinity interaction with ABCG2 on primitive hematopoietic stem cells.	Leukemia	2007	55
17524805	Adenosine triphosphate	Boucher RC	Cystic fibrosis: a disease of vulnerability to airway surface dehydration.	Trends in molecular medicine	2007	59
17531189	Adenosine triphosphate	La Fontaine S	Trafficking of the copper-ATPases, ATP7A and ATP7B: role in copper homeostasis.	Archives of biochemistry and biophysics	2007	69
17692395	Adenosine triphosphate	Di Virgilio F	Liaisons dangereuses: P2X(7) and the inflammasome.	Trends in pharmacological sciences	2007	149
17728465	Adenosine triphosphate	Matute C	P2X(7) receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis.	The Journal of neuroscience 	2007	80
17911267	Adenosine triphosphate	Zhou J	Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance.	Proceedings of the National Academy of Sciences of the United States of America	2007	193
17936707	Adenosine triphosphate	Li X	SIRT1 deacetylates and positively regulates the nuclear receptor LXR.	Molecular cell	2007	204
17938633	Adenosine triphosphate	Klempan TA	Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression.	Molecular psychiatry	2009	69
17942911	Adenosine triphosphate	Pyrko P	The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas.	Cancer research	2007	125
18006487	Adenosine triphosphate	Gustafsson AB	Heart mitochondria: gates of life and death.	Cardiovascular research	2008	95
18006696	Adenosine triphosphate	Chen L	SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma.	Blood	2008	103
18083779	Adenosine triphosphate	De La Fuente R	Small-molecule screen identifies inhibitors of a human intestinal calcium-activated chloride channel.	Molecular pharmacology	2008	65
18202014	Adenosine triphosphate	Clem B	Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth.	Molecular cancer therapeutics	2008	85
18222991	Adenosine triphosphate	Zanna C	OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion.	Brain 	2008	80
18301398	Adenosine triphosphate	Murphy R	Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes.	Nature clinical practice. Endocrinology & metabolism	2008	95
18319074	Adenosine triphosphate	Lagier-Tourenne C	ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiency.	American journal of human genetics	2008	75
18325775	Adenosine triphosphate	Reed T	Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease.	Neurobiology of disease	2008	66
18336669	Adenosine triphosphate	Lu SC	S-Adenosylmethionine in cell growth, apoptosis and liver cancer.	Journal of gastroenterology and hepatology	2008	50
18339875	Adenosine triphosphate	Roberts WG	Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271.	Cancer research	2008	123
18393293	Adenosine triphosphate	Komuta M	Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin.	Hepatology	2008	74
18395287	Adenosine triphosphate	Ouyang X	Fructose consumption as a risk factor for non-alcoholic fatty liver disease.	Journal of hepatology	2008	150
18408761	Adenosine triphosphate	Li D	BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models.	Oncogene	2008	282
18458094	Adenosine triphosphate	Shadel GS	Expression and maintenance of mitochondrial DNA: new insights into human disease pathology.	The American journal of pathology	2008	53
18559531	Adenosine triphosphate	Yang Y	Role of acetylation and extracellular location of heat shock protein 90alpha in tumor cell invasion.	Cancer research	2008	73
18623623	Adenosine triphosphate	Liegl B	Heterogeneity of kinase inhibitor resistance mechanisms in GIST.	The Journal of pathology	2008	80
18624356	Adenosine triphosphate	Franchi L	The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1beta secretion but dispensable for adjuvant activity.	European journal of immunology	2008	133
18680391	Adenosine triphosphate	Huang D	Isolation and identification of cancer stem-like cells in esophageal carcinoma cell lines.	Stem cells and development	2009	48
18752326	Adenosine triphosphate	Ma KL	Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice.	Hepatology	2008	59
18816186	Adenosine triphosphate	Orellana JA	Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration.	Antioxidants & redox signaling	2009	60
18829547	Adenosine triphosphate	Dai CL	Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.	Cancer research	2008	95
18829551	Adenosine triphosphate	Clark EL	The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancer.	Cancer research	2008	58
18922930	Adenosine triphosphate	Migita T	ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer.	Cancer research	2008	78
19008857	Adenosine triphosphate	Nishida M	P2Y6 receptor-Galpha12/13 signalling in cardiomyocytes triggers pressure overload-induced cardiac fibrosis.	The EMBO journal	2008	54
19050078	Adenosine triphosphate	Wang X	Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins.	Proceedings of the National Academy of Sciences of the United States of America	2008	232
19094056	Adenosine triphosphate	Dauchy S	ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier.	Journal of neurochemistry	2008	53
19118021	Adenosine triphosphate	Chiche J	Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH.	Cancer research	2009	121
19206551	Adenosine triphosphate	Xia T	Cationic polystyrene nanosphere toxicity depends on cell-specific endocytic and mitochondrial injury pathways.	ACS nano	2008	108
19251738	Adenosine triphosphate	Schnetz MP	Genomic distribution of CHD7 on chromatin tracks H3K4 methylation patterns.	Genome research	2009	87
19270741	Adenosine triphosphate	Gegg ME	Silencing of PINK1 expression affects mitochondrial DNA and oxidative phosphorylation in dopaminergic cells.	PloS one	2009	60
19383919	Adenosine triphosphate	Dong X	Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP.	Cancer research	2009	56
19442513	Adenosine triphosphate	Yoo AS	ATP-dependent chromatin remodeling in neural development.	Current opinion in neurobiology	2009	51
19450601	Adenosine triphosphate	Mandapathil M	Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression.	Journal of immunological methods	2009	53
19515901	Adenosine triphosphate	Guilbert A	Evidence that TRPM7 is required for breast cancer cell proliferation.	American journal of physiology. Cell physiology	2009	53
19523516	Adenosine triphosphate	Serenó L	A novel GSK-3beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo.	Neurobiology of disease	2009	69
19546216	Adenosine triphosphate	Lutz AK	Loss of parkin or PINK1 function increases Drp1-dependent mitochondrial fragmentation.	The Journal of biological chemistry	2009	133
19593530	Adenosine triphosphate	Kostenko S	Heat shock protein 27 phosphorylation: kinases, phosphatases, functions and pathology.	Cellular and molecular life sciences 	2009	89
19598259	Adenosine triphosphate	Hong SP	CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells.	International journal of cancer	2009	80
19651622	Adenosine triphosphate	Pan C	Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics.	Molecular & cellular proteomics 	2009	65
19666625	Adenosine triphosphate	Peng W	Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury.	Proceedings of the National Academy of Sciences of the United States of America	2009	128
19693011	Adenosine triphosphate	Schafer ZT	Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment.	Nature	2009	234
19711346	Adenosine triphosphate	Zhu Z	Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma.	International journal of cancer	2010	106
19717510	Adenosine triphosphate	Muñoz-Planillo R	A critical role for hemolysins and bacterial lipoproteins in Staphylococcus aureus-induced activation of the Nlrp3 inflammasome.	Journal of immunology	2009	111
19737566	Adenosine triphosphate	Lin JE	The hormone receptor GUCY2C suppresses intestinal tumor formation by inhibiting AKT signaling.	Gastroenterology	2010	40
19753307	Adenosine triphosphate	Chen Y	Oxygen consumption can regulate the growth of tumors, a new perspective on the Warburg effect.	PloS one	2009	55
19782152	Adenosine triphosphate	Menendez JA	Fine-tuning the lipogenic/lipolytic balance to optimize the metabolic requirements of cancer cell growth: molecular mechanisms and therapeutic perspectives.	Biochimica et biophysica acta	2010	43
19789351	Adenosine triphosphate	Wang X	Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI/SNF chromatin remodeling complex.	Cancer research	2009	53
19825957	Adenosine triphosphate	Mandapathil M	Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer.	Clinical cancer research 	2009	56
19843643	Adenosine triphosphate	Furuta M	miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma.	Carcinogenesis	2010	176
19858205	Adenosine triphosphate	Mandapathil M	Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells.	The Journal of biological chemistry	2010	111
19892975	Adenosine triphosphate	Cartier N	Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy.	Science	2009	382
19939921	Adenosine triphosphate	Chambers JW	Glutamine metabolism is essential for human cytomegalovirus infection.	Journal of virology	2010	59
20020268	Adenosine triphosphate	Hinson JA	Mechanisms of acetaminophen-induced liver necrosis.	Handbook of experimental pharmacology	2010	131
20032281	Adenosine triphosphate	Hernández-Alvarez MI	Subjects with early-onset type 2 diabetes show defective activation of the skeletal muscle PGC-1{alpha}/Mitofusin-2 regulatory pathway in response to physical activity.	Diabetes care	2010	48
20038799	Adenosine triphosphate	Samudio I	Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction.	The Journal of clinical investigation	2010	138
20049710	Adenosine triphosphate	Morais VA	Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function.	EMBO molecular medicine	2009	93
20068177	Adenosine triphosphate	Yu K	Beyond rapalog therapy: preclinical pharmacology and antitumor activity of WYE-125132, an ATP-competitive and specific inhibitor of mTORC1 and mTORC2.	Cancer research	2010	58
20086177	Adenosine triphosphate	Aymeric L	Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity.	Cancer research	2010	79
20087650	Adenosine triphosphate	Martin FT	Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT).	Breast cancer research and treatment	2010	59
20101004	Adenosine triphosphate	Hartz AM	Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease.	Molecular pharmacology	2010	66
20103563	Adenosine triphosphate	Klaassen CD	Xenobiotic, bile acid, and cholesterol transporters: function and regulation.	Pharmacological reviews	2010	166
20130576	Adenosine triphosphate	Hatzivassiliou G	RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.	Nature	2010	402
20130644	Adenosine triphosphate	Russo I	Plasmepsin V licenses Plasmodium proteins for export into the host erythrocyte.	Nature	2010	68
20133848	Adenosine triphosphate	Le A	Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression.	Proceedings of the National Academy of Sciences of the United States of America	2010	276
20148667	Adenosine triphosphate	Baines CP	The cardiac mitochondrion: nexus of stress.	Annual review of physiology	2010	51
20167368	Adenosine triphosphate	Szydlowska K	Calcium, ischemia and excitotoxicity.	Cell calcium	2010	126
20173201	Adenosine triphosphate	Agard NJ	Inflammatory stimuli regulate caspase substrate profiles.	Molecular & cellular proteomics 	2010	45
20215500	Adenosine triphosphate	Ben Sahra I	Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells.	Cancer research	2010	133
20352044	Adenosine triphosphate	Cox LE	Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS).	PloS one	2010	57
20360943	Adenosine triphosphate	Gandhirajan RK	Small molecule inhibitors of Wnt/beta-catenin/lef-1 signaling induces apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo.	Neoplasia	2010	45
20381449	Adenosine triphosphate	Mathupala SP	The pivotal roles of mitochondria in cancer: Warburg and beyond and encouraging prospects for effective therapies.	Biochimica et biophysica acta	2010	46
20386866	Adenosine triphosphate	Ost A	Attenuated mTOR signaling and enhanced autophagy in adipocytes from obese patients with type 2 diabetes.	Molecular medicine	2010	65
20413686	Adenosine triphosphate	Rawat R	Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle.	The American journal of pathology	2010	45
20428236	Adenosine triphosphate	Wang L	Abundant lipid and protein components of drusen.	PloS one	2010	84
20442200	Adenosine triphosphate	Yang XR	High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma.	Gut	2010	73
20453110	Adenosine triphosphate	Adinolfi E	Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor.	FASEB journal 	2010	42
20484018	Adenosine triphosphate	Munshi N	ARQ 197, a novel and selective inhibitor of the human c-Met receptor tyrosine kinase with antitumor activity.	Molecular cancer therapeutics	2010	93
20538613	Adenosine triphosphate	Sánchez-Cenizo L	Up-regulation of the ATPase inhibitory factor 1 (IF1) of the mitochondrial H+-ATP synthase in human tumors mediates the metabolic shift of cancer cells to a Warburg phenotype.	The Journal of biological chemistry	2010	52
20538956	Adenosine triphosphate	Carré JE	Survival in critical illness is associated with early activation of mitochondrial biogenesis.	American journal of respiratory and critical care medicine	2010	77
20562527	Adenosine triphosphate	Migneco G	Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: evidence for stromal-epithelial metabolic coupling.	Cell cycle	2010	58
20571029	Adenosine triphosphate	Xiao D	Phenethyl isothiocyanate inhibits oxidative phosphorylation to trigger reactive oxygen species-mediated death of human prostate cancer cells.	The Journal of biological chemistry	2010	51
20585624	Adenosine triphosphate	Ashrafian H	A mutation in the mitochondrial fission gene Dnm1l leads to cardiomyopathy.	PLoS genetics	2010	46
20593179	Adenosine triphosphate	Xi H	2-Deoxy-D-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion.	Cancer chemotherapy and pharmacology	2011	46
20595235	Adenosine triphosphate	Igal RA	Stearoyl-CoA desaturase-1: a novel key player in the mechanisms of cell proliferation, programmed cell death and transformation to cancer.	Carcinogenesis	2010	68
20655326	Adenosine triphosphate	Mammucari C	Signaling pathways in mitochondrial dysfunction and aging.	Mechanisms of ageing and development	2010	67
20658967	Adenosine triphosphate	Halestrap AP	A pore way to die: the role of mitochondria in reperfusion injury and cardioprotection.	Biochemical Society transactions	2010	79
20667897	Adenosine triphosphate	Kefas B	Pyruvate kinase M2 is a target of the tumor-suppressive microRNA-326 and regulates the survival of glioma cells.	Neuro-oncology	2010	57
20669327	Adenosine triphosphate	Paisán-Ruiz C	Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations.	Movement disorders 	2010	52
20671266	Adenosine triphosphate	Park JT	Notch3 overexpression is related to the recurrence of ovarian cancer and confers resistance to carboplatin.	The American journal of pathology	2010	44
20682644	Adenosine triphosphate	Singh A	Expression of ABCG2 (BCRP) is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype.	Molecular cancer therapeutics	2010	43
20819940	Adenosine triphosphate	Tang D	Endogenous HMGB1 regulates autophagy.	The Journal of cell biology	2010	236
20838378	Adenosine triphosphate	Piñeiro R	The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation.	Oncogene	2011	48
20847263	Adenosine triphosphate	Vander Heiden MG	Evidence for an alternative glycolytic pathway in rapidly proliferating cells.	Science	2010	207
20935265	Adenosine triphosphate	Calcagno AM	Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.	Journal of the National Cancer Institute	2010	76
21085683	Adenosine triphosphate	Awad O	High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibition.	PloS one	2010	54
21092862	Adenosine triphosphate	Birdsong WT	Sensing muscle ischemia: coincident detection of acid and ATP via interplay of two ion channels.	Neuron	2010	58
21132003	Adenosine triphosphate	Morris MR	Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma.	Oncogene	2011	56
21145355	Adenosine triphosphate	Reddy PH	Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases.	Brain research reviews	2011	76
21160028	Adenosine triphosphate	Brooks C	Fragmented mitochondria are sensitized to Bax insertion and activation during apoptosis.	American journal of physiology. Cell physiology	2011	48
21205825	Adenosine triphosphate	Copsel S	Multidrug resistance protein 4 (MRP4/ABCC4) regulates cAMP cellular levels and controls human leukemia cell proliferation and differentiation.	The Journal of biological chemistry	2011	35
21212411	Adenosine triphosphate	Frank NY	VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth.	Cancer research	2011	51
21216854	Adenosine triphosphate	Schmid AI	Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes.	Diabetes care	2011	39
21240260	Adenosine triphosphate	Itzhaki I	Modelling the long QT syndrome with induced pluripotent stem cells.	Nature	2011	294
21250988	Adenosine triphosphate	Matute C	Glutamate and ATP signalling in white matter pathology.	Journal of anatomy	2011	39
21278237	Adenosine triphosphate	Kim TH	NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1α.	Cancer research	2011	65
21304474	Adenosine triphosphate	Navab M	HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms.	Nature reviews. Cardiology	2011	129
21326199	Adenosine triphosphate	Clausen T	HTRA proteases: regulated proteolysis in protein quality control.	Nature reviews. Molecular cell biology	2011	96
21331075	Adenosine triphosphate	Evangelisti C	Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia.	Leukemia	2011	37
21383285	Adenosine triphosphate	Yap TA	Phase I trial of a selective c-MET inhibitor ARQ 197 incorporating proof of mechanism pharmacodynamic studies.	Journal of clinical oncology 	2011	73
21396365	Adenosine triphosphate	Alexander A	The role of LKB1 and AMPK in cellular responses to stress and damage.	FEBS letters	2011	46
21441104	Adenosine triphosphate	Hu J	Mutation that blocks ATP binding creates a pseudokinase stabilizing the scaffolding function of kinase suppressor of Ras, CRAF and BRAF.	Proceedings of the National Academy of Sciences of the United States of America	2011	42
21480217	Adenosine triphosphate	Kryczek I	Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells.	International journal of cancer	2012	78
21481196	Adenosine triphosphate	Kinnamon SC	Taste receptor signalling - from tongues to lungs.	Acta physiologica	2012	38
21531766	Adenosine triphosphate	Jeon HM	ID4 imparts chemoresistance and cancer stemness to glioma cells by derepressing miR-9*-mediated suppression of SOX2.	Cancer research	2011	54
21555003	Adenosine triphosphate	Russell RG	Bisphosphonates: the first 40 years.	Bone	2011	112
21576264	Adenosine triphosphate	Zaugg K	Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress.	Genes & development	2011	123
21625222	Adenosine triphosphate	Singh RR	ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma.	Oncogene	2011	51
21637292	Adenosine triphosphate	Geering B	Peculiarities of cell death mechanisms in neutrophils.	Cell death and differentiation	2011	65
21647434	Adenosine triphosphate	Pramanik KC	Role of mitochondrial electron transport chain complexes in capsaicin mediated oxidative stress leading to apoptosis in pancreatic cancer cells.	PloS one	2011	39
21677139	Adenosine triphosphate	Clayton A	Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production.	Journal of immunology	2011	91
21684291	Adenosine triphosphate	Liu W	Cross talk between activation of microglia and astrocytes in pathological conditions in the central nervous system.	Life sciences	2011	55
21709020	Adenosine triphosphate	Avivar-Valderas A	PERK integrates autophagy and oxidative stress responses to promote survival during extracellular matrix detachment.	Molecular and cellular biology	2011	71
21715610	Adenosine triphosphate	Eugenin EA	Human immunodeficiency virus infection of human astrocytes disrupts blood-brain barrier integrity by a gap junction-dependent mechanism.	The Journal of neuroscience 	2011	74
21734725	Adenosine triphosphate	Saxena M	Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters.	Cell death & disease	2011	56
21873242	Adenosine triphosphate	Aung T	Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3.	Proceedings of the National Academy of Sciences of the United States of America	2011	41
21885853	Adenosine triphosphate	Ramirez CM	MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1.	Arteriosclerosis, thrombosis, and vascular biology	2011	62
21900605	Adenosine triphosphate	Vlashi E	Metabolic state of glioma stem cells and nontumorigenic cells.	Proceedings of the National Academy of Sciences of the United States of America	2011	113
21948564	Adenosine triphosphate	Bitarte N	MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells.	Stem cells	2011	70
21969607	Adenosine triphosphate	Fan J	Tyrosine phosphorylation of lactate dehydrogenase A is important for NADH/NAD(+) redox homeostasis in cancer cells.	Molecular and cellular biology	2011	37
22003197	Adenosine triphosphate	Hoegen T	The NLRP3 inflammasome contributes to brain injury in pneumococcal meningitis and is activated through ATP-dependent lysosomal cathepsin B release.	Journal of immunology	2011	46
22052357	Adenosine triphosphate	Menendez JA	mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: a roadmap from energy metabolism to stem cell renewal and aging.	Cell cycle	2011	58
22072639	Adenosine triphosphate	Bresler SC	Differential inhibitor sensitivity of anaplastic lymphoma kinase variants found in neuroblastoma.	Science translational medicine	2011	70
22072942	Adenosine triphosphate	Chen SD	Roles of oxidative stress, apoptosis, PGC-1α and mitochondrial biogenesis in cerebral ischemia.	International journal of molecular sciences	2011	49
22077634	Adenosine triphosphate	Sheng B	Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease.	Journal of neurochemistry	2012	66
22084398	Adenosine triphosphate	Zhou Y	Intracellular ATP levels are a pivotal determinant of chemoresistance in colon cancer cells.	Cancer research	2012	59
22085932	Adenosine triphosphate	Zhang J	UCP2 regulates energy metabolism and differentiation potential of human pluripotent stem cells.	The EMBO journal	2011	135
22101433	Adenosine triphosphate	Metallo CM	Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia.	Nature	2011	435
22113612	Adenosine triphosphate	Poulikakos PI	RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E).	Nature	2011	385
22154776	Adenosine triphosphate	Finn AV	Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques.	Journal of the American College of Cardiology	2012	54
22170153	Adenosine triphosphate	Mai S	Autophagy proteins LC3B, ATG5 and ATG12 participate in quality control after mitochondrial damage and influence lifespan.	Autophagy	2012	42
22195962	Adenosine triphosphate	Hitosugi T	Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism.	Molecular cell	2011	72
22198378	Adenosine triphosphate	Gusdon AM	ATP13A2 regulates mitochondrial bioenergetics through macroautophagy.	Neurobiology of disease	2012	39
22248732	Adenosine triphosphate	Natarajan K	Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.	Biochemical pharmacology	2012	80
22266115	Adenosine triphosphate	Zaytseva YY	Inhibition of fatty acid synthase attenuates CD44-associated signaling and reduces metastasis in colorectal cancer.	Cancer research	2012	35
22295065	Adenosine triphosphate	Segovia J	TLR2/MyD88/NF-κB pathway, reactive oxygen species, potassium efflux activates NLRP3/ASC inflammasome during respiratory syncytial virus infection.	PloS one	2012	72
22342343	Adenosine triphosphate	Formentini L	The mitochondrial ATPase inhibitory factor 1 triggers a ROS-mediated retrograde prosurvival and proliferative response.	Molecular cell	2012	48
22360810	Adenosine triphosphate	Filipp FV	Reverse TCA cycle flux through isocitrate dehydrogenases 1 and 2 is required for lipogenesis in hypoxic melanoma cells.	Pigment cell & melanoma research	2012	52
22367541	Adenosine triphosphate	Hsieh AC	The translational landscape of mTOR signalling steers cancer initiation and metastasis.	Nature	2012	343
22388936	Adenosine triphosphate	Bras J	Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis.	Human molecular genetics	2012	48
22415665	Adenosine triphosphate	Hoque R	Sterile inflammatory response in acute pancreatitis.	Pancreas	2012	34
22446165	Adenosine triphosphate	Chowdhury SK	The role of aberrant mitochondrial bioenergetics in diabetic neuropathy.	Neurobiology of disease	2013	37
22447075	Adenosine triphosphate	Sorge RE	Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity.	Nature medicine	2012	75
22449631	Adenosine triphosphate	Garrido C	The small heat shock proteins family: the long forgotten chaperones.	The international journal of biochemistry & cell biology	2012	48
22460906	Adenosine triphosphate	Liu L	Deregulated MYC expression induces dependence upon AMPK-related kinase 5.	Nature	2012	83
22483867	Adenosine triphosphate	Kemp S	X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects.	Biochimica et biophysica acta	2012	42
22505653	Adenosine triphosphate	Adinolfi E	Expression of P2X7 receptor increases in vivo tumor growth.	Cancer research	2012	67
22525272	Adenosine triphosphate	Galavotti S	The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells.	Oncogene	2013	55
22532167	Adenosine triphosphate	Huang X	An NQO1 substrate with potent antitumor activity that selectively kills by PARP1-induced programmed necrosis.	Cancer research	2012	34
22544529	Adenosine triphosphate	Franke H	Pathophysiology of astroglial purinergic signalling.	Purinergic signalling	2012	34
22556413	Adenosine triphosphate	Khan MJ	Inhibition of autophagy rescues palmitic acid-induced necroptosis of endothelial cells.	The Journal of biological chemistry	2012	37
22613083	Adenosine triphosphate	Trang T	Brain-derived neurotrophic factor from microglia: a molecular substrate for neuropathic pain.	Neuron glia biology	2011	43
22647602	Adenosine triphosphate	Dehay B	Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration.	Proceedings of the National Academy of Sciences of the United States of America	2012	63
22722202	Adenosine triphosphate	Banerji S	Sequence analysis of mutations and translocations across breast cancer subtypes.	Nature	2012	352
22739839	Adenosine triphosphate	Pandi-Perumal SR	Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.	Neurotoxicity research	2013	33
22750655	Adenosine triphosphate	Sorci-Thomas MG	Nascent high density lipoproteins formed by ABCA1 resemble lipid rafts and are structurally organized by three apoA-I monomers.	Journal of lipid research	2012	45
22761435	Adenosine triphosphate	Marino ML	Autophagy is a protective mechanism for human melanoma cells under acidic stress.	The Journal of biological chemistry	2012	40
22771709	Adenosine triphosphate	Dahl G	Pannexin: from discovery to bedside in 11±4 years?	Brain research	2012	43
22787121	Adenosine triphosphate	Zaidi N	ATP-citrate lyase: a key player in cancer metabolism.	Cancer research	2012	68
22797058	Adenosine triphosphate	Chau WK	c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin-ATP-binding cassette G2 signaling.	Oncogene	2013	53
22878108	Adenosine triphosphate	Kalogeris T	Cell biology of ischemia/reperfusion injury.	International review of cell and molecular biology	2012	142
22886304	Adenosine triphosphate	Carracedo A	A metabolic prosurvival role for PML in breast cancer.	The Journal of clinical investigation	2012	65
22892528	Adenosine triphosphate	Onat OE	Missense mutation in the ATPase, aminophospholipid transporter protein ATP8A2 is associated with cerebellar atrophy and quadrupedal locomotion.	European journal of human genetics 	2013	30
22926141	Adenosine triphosphate	Manczak M	Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer's disease.	Human molecular genetics	2012	37
22948162	Adenosine triphosphate	Juliana C	Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation.	The Journal of biological chemistry	2012	116
23049731	Adenosine triphosphate	Lodola F	Store-operated Ca2+ entry is remodelled and controls in vitro angiogenesis in endothelial progenitor cells isolated from tumoral patients.	PloS one	2012	37
23051977	Adenosine triphosphate	Coen PM	Skeletal muscle mitochondrial energetics are associated with maximal aerobic capacity and walking speed in older adults.	The journals of gerontology. Series A, Biological sciences and medical sciences	2013	62
23071355	Adenosine triphosphate	Teicher BA	Targeting cancer metabolism.	Clinical cancer research 	2012	34
23090120	Adenosine triphosphate	Di Virgilio F	Purines, purinergic receptors, and cancer.	Cancer research	2012	69
23112875	Adenosine triphosphate	Lanaspa MA	Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver.	PloS one	2012	43
23128392	Adenosine triphosphate	Zhao J	Mitochondrial dynamics regulates migration and invasion of breast cancer cells.	Oncogene	2013	102
23129651	Adenosine triphosphate	Lin CS	Mouse mtDNA mutant model of Leber hereditary optic neuropathy.	Proceedings of the National Academy of Sciences of the United States of America	2012	42
23151605	Adenosine triphosphate	Krysko DV	Immunogenic cell death and DAMPs in cancer therapy.	Nature reviews. Cancer	2012	210
23177194	Adenosine triphosphate	Miyata Y	Cysteine reactivity distinguishes redox sensing by the heat-inducible and constitutive forms of heat shock protein 70.	Chemistry & biology	2012	31
23199317	Adenosine triphosphate	Regateiro FS	CD73 and adenosine generation in the creation of regulatory microenvironments.	Clinical and experimental immunology	2013	32
23235493	Adenosine triphosphate	Sánchez-Lozada LG	Uric acid-induced endothelial dysfunction is associated with mitochondrial alterations and decreased intracellular ATP concentrations.	Nephron. Experimental nephrology	2012	37
23239881	Adenosine triphosphate	Tan B	Pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD+ biosynthesis, in human cancer cells: metabolic basis and potential clinical implications.	The Journal of biological chemistry	2013	44
23251084	Adenosine triphosphate	Naujokat C	Salinomycin as a drug for targeting human cancer stem cells.	Journal of biomedicine & biotechnology	2012	64
23271701	Adenosine triphosphate	Mills KH	The role of inflammasome-derived IL-1 in driving IL-17 responses.	Journal of leukocyte biology	2013	41
23313576	Adenosine triphosphate	Calì T	Enhanced parkin levels favor ER-mitochondria crosstalk and guarantee Ca(2+) transfer to sustain cell bioenergetics.	Biochimica et biophysica acta	2013	37
23355908	Adenosine triphosphate	Shain AH	The spectrum of SWI/SNF mutations, ubiquitous in human cancers.	PloS one	2013	101
23365660	Adenosine triphosphate	Kenney MC	Mitochondrial DNA variants mediate energy production and expression levels for CFH, C3 and EFEMP1 genes: implications for age-related macular degeneration.	PloS one	2013	27
23371930	Adenosine triphosphate	Xiong Q	Functional consequences of human induced pluripotent stem cell therapy: myocardial ATP turnover rate in the in vivo swine heart with postinfarction remodeling.	Circulation	2013	32
23410520	Adenosine triphosphate	Cindrova-Davies T	Reduced cystathionine γ-lyase and increased miR-21 expression are associated with increased vascular resistance in growth-restricted pregnancies: hydrogen sulfide as a placental vasodilator.	The American journal of pathology	2013	28
23436801	Adenosine triphosphate	Liu Q	Characterization of Torin2, an ATP-competitive inhibitor of mTOR, ATM, and ATR.	Cancer research	2013	33
23453623	Adenosine triphosphate	Dong C	Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer.	Cancer cell	2013	149
23460667	Adenosine triphosphate	Golebiewska A	Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells.	Brain 	2013	28
23477399	Adenosine triphosphate	Lai RC	Mesenchymal stem cell exosome ameliorates reperfusion injury through proteomic complementation.	Regenerative medicine	2013	28
23483818	Adenosine triphosphate	Basaranoglu M	From fatty liver to fibrosis: a tale of "second hit".	World journal of gastroenterology	2013	39
23498975	Adenosine triphosphate	Bartolome F	Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels.	Neuron	2013	38
23523468	Adenosine triphosphate	Gonzalvez F	Barth syndrome: cellular compensation of mitochondrial dysfunction and apoptosis inhibition due to changes in cardiolipin remodeling linked to tafazzin (TAZ) gene mutation.	Biochimica et biophysica acta	2013	34
23562078	Adenosine triphosphate	Sene A	Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration.	Cell metabolism	2013	56
23589839	Adenosine triphosphate	Nieminen AI	Myc-induced AMPK-phospho p53 pathway activates Bak to sensitize mitochondrial apoptosis.	Proceedings of the National Academy of Sciences of the United States of America	2013	32
23603840	Adenosine triphosphate	Hall A	Dysfunctional oxidative phosphorylation makes malignant melanoma cells addicted to glycolysis driven by the (V600E)BRAF oncogene.	Oncotarget	2013	43
23639289	Adenosine triphosphate	Jangamreddy JR	Salinomycin induces activation of autophagy, mitophagy and affects mitochondrial polarity: differences between primary and cancer cells.	Biochimica et biophysica acta	2013	28
23665396	Adenosine triphosphate	Tseng AH	SIRT3 deacetylates FOXO3 to protect mitochondria against oxidative damage.	Free radical biology & medicine	2013	51
23699655	Adenosine triphosphate	Guertin AD	Preclinical evaluation of the WEE1 inhibitor MK-1775 as single-agent anticancer therapy.	Molecular cancer therapeutics	2013	43
23716663	Adenosine triphosphate	Jiang D	Letm1, the mitochondrial Ca2+/H+ antiporter, is essential for normal glucose metabolism and alters brain function in Wolf-Hirschhorn syndrome.	Proceedings of the National Academy of Sciences of the United States of America	2013	26
23764003	Adenosine triphosphate	Roesch A	Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells.	Cancer cell	2013	124
23764021	Adenosine triphosphate	Cheng G	Mitochondria-targeted vitamin E analogs inhibit breast cancer cell energy metabolism and promote cell death.	BMC cancer	2013	26
23782937	Adenosine triphosphate	Yu XH	Foam cells in atherosclerosis.	Clinica chimica acta; international journal of clinical chemistry	2013	55
23785148	Adenosine triphosphate	Staahl BT	Kinetic analysis of npBAF to nBAF switching reveals exchange of SS18 with CREST and integration with neural developmental pathways.	The Journal of neuroscience 	2013	28
23792284	Adenosine triphosphate	Ji RR	Glia and pain: is chronic pain a gliopathy?	Pain	2013	154
23800749	Adenosine triphosphate	Garg AD	ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death.	Autophagy	2013	46
23844554	Adenosine triphosphate	Fox EM	Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation.	Breast cancer research 	2013	27
23883585	Adenosine triphosphate	Bey EA	Catalase abrogates β-lapachone-induced PARP1 hyperactivation-directed programmed necrosis in NQO1-positive breast cancers.	Molecular cancer therapeutics	2013	27
23886165	Adenosine triphosphate	Jin J	miRNA-218 inhibits osteosarcoma cell migration and invasion by down-regulating of TIAM1, MMP2 and MMP9.	Asian Pacific journal of cancer prevention 	2013	27
23932781	Adenosine triphosphate	Lin R	Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth.	Molecular cell	2013	47
23945235	Adenosine triphosphate	Byers DE	Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease.	The Journal of clinical investigation	2013	57
23953109	Adenosine triphosphate	Hertz NT	A neo-substrate that amplifies catalytic activity of parkinson's-disease-related kinase PINK1.	Cell	2013	42
23967283	Adenosine triphosphate	Yang Y	Metabolic reprogramming for producing energy and reducing power in fumarate hydratase null cells from hereditary leiomyomatosis renal cell carcinoma.	PloS one	2013	27
24021215	Adenosine triphosphate	Stacy AE	Molecular pharmacology of ABCG2 and its role in chemoresistance.	Molecular pharmacology	2013	42
24025713	Adenosine triphosphate	Chini CC	Targeting of NAD metabolism in pancreatic cancer cells: potential novel therapy for pancreatic tumors.	Clinical cancer research 	2014	24
24037090	Adenosine triphosphate	Ko A	Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling.	Cell death and differentiation	2014	54
24050699	Adenosine triphosphate	Cole SP	Targeting multidrug resistance protein 1 (MRP1, ABCC1): past, present, and future.	Annual review of pharmacology and toxicology	2014	30
24096870	Adenosine triphosphate	Liu PP	Metabolic regulation of cancer cell side population by glucose through activation of the Akt pathway.	Cell death and differentiation	2014	48
24097981	Adenosine triphosphate	Quazi F	Differential phospholipid substrates and directional transport by ATP-binding cassette proteins ABCA1, ABCA7, and ABCA4 and disease-causing mutants.	The Journal of biological chemistry	2013	32
24117156	Adenosine triphosphate	Bubici C	JNK signalling in cancer: in need of new, smarter therapeutic targets.	British journal of pharmacology	2014	32
24134926	Adenosine triphosphate	Vigetti D	Metabolic control of hyaluronan synthases.	Matrix biology 	2014	21
24144321	Adenosine triphosphate	Križaj D	From mechanosensitivity to inflammatory responses: new players in the pathology of glaucoma.	Current eye research	2014	40
24186207	Adenosine triphosphate	Tennakoon JB	Androgens regulate prostate cancer cell growth via an AMPK-PGC-1α-mediated metabolic switch.	Oncogene	2014	45
24211491	Adenosine triphosphate	Tahara T	Colorectal carcinomas with CpG island methylator phenotype 1 frequently contain mutations in chromatin regulators.	Gastroenterology	2014	23
24236104	Adenosine triphosphate	Bhattacharyya S	Cystathionine beta-synthase (CBS) contributes to advanced ovarian cancer progression and drug resistance.	PloS one	2013	37
24253024	Adenosine triphosphate	Buontempo F	Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling.	Leukemia	2014	23
24270265	Adenosine triphosphate	Goncharov DA	Mammalian target of rapamycin complex 2 (mTORC2) coordinates pulmonary artery smooth muscle cell metabolism, proliferation, and survival in pulmonary arterial hypertension.	Circulation	2014	38
24277820	Adenosine triphosphate	Jansen RS	ABCC6 prevents ectopic mineralization seen in pseudoxanthoma elasticum by inducing cellular nucleotide release.	Proceedings of the National Academy of Sciences of the United States of America	2013	37
24332968	Adenosine triphosphate	Tornovsky-Babeay S	Type 2 diabetes and congenital hyperinsulinism cause DNA double-strand breaks and p53 activity in β cells.	Cell metabolism	2014	32
24337569	Adenosine triphosphate	Lai L	A role for peroxisome proliferator-activated receptor γ coactivator 1 (PGC-1) in the regulation of cardiac mitochondrial phospholipid biosynthesis.	The Journal of biological chemistry	2014	20
24398940	Adenosine triphosphate	de Rivero Vaccari JP	Activation and regulation of cellular inflammasomes: gaps in our knowledge for central nervous system injury.	Journal of cerebral blood flow and metabolism 	2014	42
24399447	Adenosine triphosphate	Mourier A	Loss of LRPPRC causes ATP synthase deficiency.	Human molecular genetics	2014	30
24403227	Adenosine triphosphate	Ellinghaus P	BAY 87-2243, a highly potent and selective inhibitor of hypoxia-induced gene activation has antitumor activities by inhibition of mitochondrial complex I.	Cancer medicine	2013	27
24407029	Adenosine triphosphate	Hewing B	Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice.	Arteriosclerosis, thrombosis, and vascular biology	2014	26
24416410	Adenosine triphosphate	Rose S	Oxidative stress induces mitochondrial dysfunction in a subset of autism lymphoblastoid cell lines in a well-matched case control cohort.	PloS one	2014	31
24457989	Adenosine triphosphate	Koilkonda RD	Safety and effects of the vector for the Leber hereditary optic neuropathy gene therapy clinical trial.	JAMA ophthalmology	2014	26
24464187	Adenosine triphosphate	Huang Y	An abundant dysfunctional apolipoprotein A1 in human atheroma.	Nature medicine	2014	55
24474669	Adenosine triphosphate	Garcia PD	Pan-PIM kinase inhibition provides a novel therapy for treating hematologic cancers.	Clinical cancer research 	2014	27
24481950	Adenosine triphosphate	Allahverdian S	Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis.	Circulation	2014	62
24508027	Adenosine triphosphate	Wong N	PKM2 contributes to cancer metabolism.	Cancer letters	2015	42
24568860	Adenosine triphosphate	Tan W	Role of mitochondria in mutant SOD1 linked amyotrophic lateral sclerosis.	Biochimica et biophysica acta	2014	23
24585446	Adenosine triphosphate	Zhu B	Genetic variants in the SWI/SNF complex and smoking collaborate to modify the risk of pancreatic cancer in a Chinese population.	Molecular carcinogenesis	2015	18
24619111	Adenosine triphosphate	Götzl JK	Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis.	Acta neuropathologica	2014	38
24656405	Adenosine triphosphate	Kitambi SS	RETRACTED: Vulnerability of glioblastoma cells to catastrophic vacuolization and death induced by a small molecule.	Cell	2014	45
24669934	Adenosine triphosphate	Lindoso RS	Extracellular vesicles released from mesenchymal stromal cells modulate miRNA in renal tubular cells and inhibit ATP depletion injury.	Stem cells and development	2014	24
24677093	Adenosine triphosphate	Rehman G	Role of AMP-activated protein kinase in cancer therapy.	Archiv der Pharmazie	2014	24
24703697	Adenosine triphosphate	Prentice KJ	The furan fatty acid metabolite CMPF is elevated in diabetes and induces β cell dysfunction.	Cell metabolism	2014	29
24705351	Adenosine triphosphate	Zhai B	Inhibition of Akt reverses the acquired resistance to sorafenib by switching protective autophagy to autophagic cell death in hepatocellular carcinoma.	Molecular cancer therapeutics	2014	45
24713656	Adenosine triphosphate	Amato KR	Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLC.	The Journal of clinical investigation	2014	21
24727893	Adenosine triphosphate	Bonora M	Molecular mechanisms of cell death: central implication of ATP synthase in mitochondrial permeability transition.	Oncogene	2015	39
24736023	Adenosine triphosphate	Arend RC	Inhibition of Wnt/β-catenin pathway by niclosamide: a therapeutic target for ovarian cancer.	Gynecologic oncology	2014	38
24746669	Adenosine triphosphate	Wang Z	Cyclin B1/Cdk1 coordinates mitochondrial respiration for cell-cycle G2/M progression.	Developmental cell	2014	37
24768297	Adenosine triphosphate	Liang H	PTENα, a PTEN isoform translated through alternative initiation, regulates mitochondrial function and energy metabolism.	Cell metabolism	2014	45
24770881	Adenosine triphosphate	Nelson PT	ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology.	Acta neuropathologica	2014	23
24777293	Adenosine triphosphate	Shi L	miR-145 inhibits migration and invasion of glioma stem cells by targeting ABCG2.	Neuromolecular medicine	2014	24
24787293	Adenosine triphosphate	Martinez-Outschoorn U	Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.	Seminars in oncology	2014	40
24813252	Adenosine triphosphate	Wang G	Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies.	Nature medicine	2014	139
24837364	Adenosine triphosphate	Zhou JZ	Differential impact of adenosine nucleotides released by osteocytes on breast cancer growth and bone metastasis.	Oncogene	2015	15
24849361	Adenosine triphosphate	Boehm-Cagan A	Reversal of apoE4-driven brain pathology and behavioral deficits by bexarotene.	The Journal of neuroscience 	2014	37
24874432	Adenosine triphosphate	Takahashi K	Involvement of extracellular vesicle long noncoding RNA (linc-VLDLR) in tumor cell responses to chemotherapy.	Molecular cancer research 	2014	29
24875192	Adenosine triphosphate	Pearce D	Collecting duct principal cell transport processes and their regulation.	Clinical journal of the American Society of Nephrology 	2015	36
24901049	Adenosine triphosphate	Li JX	The B-Raf(V600E) inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury.	Cell death & disease	2014	34
24949970	Adenosine triphosphate	Soleimanpour SA	The diabetes susceptibility gene Clec16a regulates mitophagy.	Cell	2014	34
24958102	Adenosine triphosphate	Wang Y	Long noncoding RNA MRUL promotes ABCB1 expression in multidrug-resistant gastric cancer cell sublines.	Molecular and cellular biology	2014	29
24998913	Adenosine triphosphate	Lee JV	Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation.	Cell metabolism	2014	82
25017063	Adenosine triphosphate	Quirós PM	ATP-dependent Lon protease controls tumor bioenergetics by reprogramming mitochondrial activity.	Cell reports	2014	31
25026296	Adenosine triphosphate	Wang Z	MicroRNA-25 regulates chemoresistance-associated autophagy in breast cancer cells, a process modulated by the natural autophagy inducer isoliquiritigenin.	Oncotarget	2014	61
25030174	Adenosine triphosphate	Ksander BR	ABCB5 is a limbal stem cell gene required for corneal development and repair.	Nature	2014	48
25043816	Adenosine triphosphate	Petruzzelli M	A switch from white to brown fat increases energy expenditure in cancer-associated cachexia.	Cell metabolism	2014	83
25119037	Adenosine triphosphate	Van Nostrand JL	Inappropriate p53 activation during development induces features of CHARGE syndrome.	Nature	2014	33
25119045	Adenosine triphosphate	Han P	A long noncoding RNA protects the heart from pathological hypertrophy.	Nature	2014	97
25136135	Adenosine triphosphate	Nguyen TT	Loss of Miro1-directed mitochondrial movement results in a novel murine model for neuron disease.	Proceedings of the National Academy of Sciences of the United States of America	2014	36
25151301	Adenosine triphosphate	Sanderson J	Purines in the eye: recent evidence for the physiological and pathological role of purines in the RPE, retinal neurons, astrocytes, Müller cells, lens, trabecular meshwork, cornea and lacrimal gland.	Experimental eye research	2014	23
25152236	Adenosine triphosphate	Ozden O	SIRT3 deacetylates and increases pyruvate dehydrogenase activity in cancer cells.	Free radical biology & medicine	2014	32
25156912	Adenosine triphosphate	Zhang X	GOLPH3 promotes glioblastoma cell migration and invasion via the mTOR-YB1 pathway in vitro.	Molecular carcinogenesis	2015	16
25188341	Adenosine triphosphate	Beecham GW	Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias.	PLoS genetics	2014	54
25223574	Adenosine triphosphate	Sperlágh B	P2X7 receptor: an emerging target in central nervous system diseases.	Trends in pharmacological sciences	2014	48
25236865	Adenosine triphosphate	Mao Q	Role of the breast cancer resistance protein (BCRP/ABCG2) in drug transport--an update.	The AAPS journal	2015	45
25241037	Adenosine triphosphate	LeBleu VS	PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis.	Nature cell biology	2014	167
25262208	Adenosine triphosphate	Miranda-Lorenzo I	Intracellular autofluorescence: a biomarker for epithelial cancer stem cells.	Nature methods	2014	36
25281745	Adenosine triphosphate	Cole SP	Multidrug resistance protein 1 (MRP1, ABCC1), a "multitasking" ATP-binding cassette (ABC) transporter.	The Journal of biological chemistry	2014	24
25315773	Adenosine triphosphate	Takatsu H	Phospholipid flippase activities and substrate specificities of human type IV P-type ATPases localized to the plasma membrane.	The Journal of biological chemistry	2014	23
25326666	Adenosine triphosphate	Ronan B	A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy.	Nature chemical biology	2014	56
25404738	Adenosine triphosphate	Liu TF	Sequential actions of SIRT1-RELB-SIRT3 coordinate nuclear-mitochondrial communication during immunometabolic adaptation to acute inflammation and sepsis.	The Journal of biological chemistry	2015	31
25415869	Adenosine triphosphate	Rudolph J	Inhibitors of p21-activated kinases (PAKs).	Journal of medicinal chemistry	2015	18
25437566	Adenosine triphosphate	Brehme M	A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease.	Cell reports	2014	69
25447846	Adenosine triphosphate	Maléth J	Alcohol disrupts levels and function of the cystic fibrosis transmembrane conductance regulator to promote development of pancreatitis.	Gastroenterology	2015	23
25465468	Adenosine triphosphate	Song BJ	Mitochondrial dysfunction and tissue injury by alcohol, high fat, nonalcoholic substances and pathological conditions through post-translational protein modifications.	Redox biology	2014	20
25524771	Adenosine triphosphate	Meiler S	MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2015	19
25556000	Adenosine triphosphate	Bakthisaran R	Small heat shock proteins: Role in cellular functions and pathology.	Biochimica et biophysica acta	2015	44
25590809	Adenosine triphosphate	Moore Z	NAMPT inhibition sensitizes pancreatic adenocarcinoma cells to tumor-selective, PAR-independent metabolic catastrophe and cell death induced by β-lapachone.	Cell death & disease	2015	18
25607458	Adenosine triphosphate	Blagih J	The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo.	Immunity	2015	77
25628390	Adenosine triphosphate	Huang Q	Thioredoxin-2 inhibits mitochondrial reactive oxygen species generation and apoptosis stress kinase-1 activity to maintain cardiac function.	Circulation	2015	28
25730877	Adenosine triphosphate	Carta S	Cell stress increases ATP release in NLRP3 inflammasome-mediated autoinflammatory diseases, resulting in cytokine imbalance.	Proceedings of the National Academy of Sciences of the United States of America	2015	18
25733882	Adenosine triphosphate	Zou HY	PF-06463922 is a potent and selective next-generation ROS1/ALK inhibitor capable of blocking crizotinib-resistant ROS1 mutations.	Proceedings of the National Academy of Sciences of the United States of America	2015	28
25821004	Adenosine triphosphate	Hassanein M	Targeting SLC1a5-mediated glutamine dependence in non-small cell lung cancer.	International journal of cancer	2015	22
25828268	Adenosine triphosphate	Wiegman CH	Oxidative stress-induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease.	The Journal of allergy and clinical immunology	2015	41
25840885	Adenosine triphosphate	Zhang YK	Multidrug Resistance Proteins (MRPs) and Cancer Therapy.	The AAPS journal	2015	24
25840982	Adenosine triphosphate	Sadok A	Rho kinase inhibitors block melanoma cell migration and inhibit metastasis.	Cancer research	2015	19
25867026	Adenosine triphosphate	Sesen J	Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response.	PloS one	2015	25
25867072	Adenosine triphosphate	He K	mTOR inhibitors induce apoptosis in colon cancer cells via CHOP-dependent DR5 induction on 4E-BP1 dephosphorylation.	Oncogene	2016	20
25904599	Adenosine triphosphate	Zhang H	Functional analysis and transcriptomic profiling of iPSC-derived macrophages and their application in modeling Mendelian disease.	Circulation research	2015	18
25915845	Adenosine triphosphate	Helmke C	The role of Plk3 in oncogenesis.	Oncogene	2016	10
25941621	Adenosine triphosphate	Kepp O	Consensus guidelines for the detection of immunogenic cell death.	Oncoimmunology	2014	114
26005855	Adenosine triphosphate	Mascanfroni ID	Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α.	Nature medicine	2015	68
26027935	Adenosine triphosphate	Cullen SP	Diverse Activators of the NLRP3 Inflammasome Promote IL-1β Secretion by Triggering Necrosis.	Cell reports	2015	33
26062441	Adenosine triphosphate	Wang J	Lactate dehydrogenase A negatively regulated by miRNAs promotes aerobic glycolysis and is increased in colorectal cancer.	Oncotarget	2015	24
26159692	Adenosine triphosphate	Dibble CC	Regulation of mTORC1 by PI3K signaling.	Trends in cell biology	2015	103
26168216	Adenosine triphosphate	Wang S	P2Y₂ and Gq/G₁₁ control blood pressure by mediating endothelial mechanotransduction.	The Journal of clinical investigation	2015	21
26177051	Adenosine triphosphate	Leontieva OV	Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program).	Oncotarget	2015	25
26183239	Adenosine triphosphate	Kawamukai M	Biosynthesis of coenzyme Q in eukaryotes.	Bioscience, biotechnology, and biochemistry	2016	13
26190651	Adenosine triphosphate	Fu X	2-Hydroxyglutarate Inhibits ATP Synthase and mTOR Signaling.	Cell metabolism	2015	21
26214738	Adenosine triphosphate	Senyilmaz D	Regulation of mitochondrial morphology and function by stearoylation of TFR1.	Nature	2015	20
26269525	Adenosine triphosphate	Bockaert J	mTOR in Brain Physiology and Pathologies.	Physiological reviews	2015	25
26311743	Adenosine triphosphate	Heerma van Voss MR	Identification of the DEAD box RNA helicase DDX3 as a therapeutic target in colorectal cancer.	Oncotarget	2015	18
26358751	Adenosine triphosphate	Guichard SM	AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly Effective in ER+ Breast Cancer When Administered Using Intermittent or Continuous Schedules.	Molecular cancer therapeutics	2015	15
26389676	Adenosine triphosphate	Ferdaoussi M	Isocitrate-to-SENP1 signaling amplifies insulin secretion and rescues dysfunctional β cells.	The Journal of clinical investigation	2015	24
26418144	Adenosine triphosphate	Lee S	Regulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung Disease.	American journal of respiratory cell and molecular biology	2016	12
26433470	Adenosine triphosphate	Azimi I	Altered purinergic receptor-Ca²⁺ signaling associated with hypoxia-induced epithelial-mesenchymal transition in breast cancer cells.	Molecular oncology	2016	13
26436840	Adenosine triphosphate	Poepsel S	Determinants of amyloid fibril degradation by the PDZ protease HTRA1.	Nature chemical biology	2015	19
26501192	Adenosine triphosphate	Wagschal A	Genome-wide identification of microRNAs regulating cholesterol and triglyceride homeostasis.	Nature medicine	2015	36
26519060	Adenosine triphosphate	Zhai L	Molecular Pathways: Targeting IDO1 and Other Tryptophan Dioxygenases for Cancer Immunotherapy.	Clinical cancer research 	2015	24
26549853	Adenosine triphosphate	Engel T	ATPergic signalling during seizures and epilepsy.	Neuropharmacology	2016	11
26607222	Adenosine triphosphate	Giannuzzo A	The P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells.	Molecular cancer	2015	16
26654173	Adenosine triphosphate	Zuccolo E	Constitutive Store-Operated Ca(2+) Entry Leads to Enhanced Nitric Oxide Production and Proliferation in Infantile Hemangioma-Derived Endothelial Colony-Forming Cells.	Stem cells and development	2016	11
26691987	Adenosine triphosphate	Okosun J	Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma.	Nature genetics	2016	16
26744319	Adenosine triphosphate	Wang MD	HBx regulates fatty acid oxidation to promote hepatocellular carcinoma survival during metabolic stress.	Oncotarget	2016	11
26777405	Adenosine triphosphate	Jain S	ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure.	Cell	2016	79
26804906	Adenosine triphosphate	Franco J	Metabolic Reprogramming of Pancreatic Cancer Mediated by CDK4/6 Inhibition Elicits Unique Vulnerabilities.	Cell reports	2016	11
26836503	Adenosine triphosphate	Kadoch C	PRC2 and SWI/SNF Chromatin Remodeling Complexes in Health and Disease.	Biochemistry	2016	10
26860875	Adenosine triphosphate	Migdalska-Richards A	The relationship between glucocerebrosidase mutations and Parkinson disease.	Journal of neurochemistry	2016	15
26876430	Adenosine triphosphate	García-Bermúdez J	The ATPase Inhibitory Factor 1 (IF1): A master regulator of energy metabolism and of cell survival.	Biochimica et biophysica acta	2016	12
26892966	Adenosine triphosphate	Sorci-Thomas MG	Microdomains, Inflammation, and Atherosclerosis.	Circulation research	2016	18
26923594	Adenosine triphosphate	Park JH	Fatty Acid Oxidation-Driven Src Links Mitochondrial Energy Reprogramming and Oncogenic Properties in Triple-Negative Breast Cancer.	Cell reports	2016	18
27038735	Adenosine triphosphate	Zhang Y	Liraglutide protects cardiac microvascular endothelial cells against hypoxia/reoxygenation injury through the suppression of the SR-Ca(2+)-XO-ROS axis via activation of the GLP-1R/PI3K/Akt/survivin pathways.	Free radical biology & medicine	2016	15
27117941	Adenosine triphosphate	Kleszczyński K	Melatonin enhances mitochondrial ATP synthesis, reduces reactive oxygen species formation, and mediates translocation of the nuclear erythroid 2-related factor 2 resulting in activation of phase-2 antioxidant enzymes (γ-GCS, HO-1, NQO1) in ultraviolet radiation-treated normal human epidermal keratinocytes (NHEK).	Journal of pineal research	2016	12
27180306	Adenosine triphosphate	Fletcher JI	ABC transporters as mediators of drug resistance and contributors to cancer cell biology.	Drug resistance updates 	2016	13
27219534	Adenosine triphosphate	Bhattacharya A	The microglial ATP-gated ion channel P2X7 as a CNS drug target.	Glia	2016	17
27230643	Adenosine triphosphate	Shah MS	Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes.	Circulation research	2016	24
27250110	Adenosine triphosphate	Gao M	Sensitization of multidrug-resistant malignant cells by liposomes co-encapsulating doxorubicin and chloroquine through autophagic inhibition.	Journal of liposome research	2017	6
27254664	Adenosine triphosphate	Ali YO	NMNAT2:HSP90 Complex Mediates Proteostasis in Proteinopathies.	PLoS biology	2016	13
27269284	Adenosine triphosphate	Li X	Nucleosome disassembly during human non-homologous end joining followed by concerted HIRA- and CAF-1-dependent reassembly.	eLife	2016	17
27344270	Adenosine triphosphate	Fiorillo M	Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs).	Aging	2016	13
27350397	Adenosine triphosphate	Daulatzai MA	Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.	Journal of neuroscience research	2017	14
27385336	Adenosine triphosphate	Cunniff B	AMPK activity regulates trafficking of mitochondria to the leading edge during cell migration and matrix invasion.	Molecular biology of the cell	2016	11
27413115	Adenosine triphosphate	Hodges C	The Many Roles of BAF (mSWI/SNF) and PBAF Complexes in Cancer.	Cold Spring Harbor perspectives in medicine	2016	16
27489254	Adenosine triphosphate	Lee CF	Normalization of NAD+ Redox Balance as a Therapy for Heart Failure.	Circulation	2016	17
27599716	Adenosine triphosphate	Kim DI	Aβ-Induced Drp1 phosphorylation through Akt activation promotes excessive mitochondrial fission leading to neuronal apoptosis.	Biochimica et biophysica acta	2016	11
27693323	Adenosine triphosphate	Shouval DS	Interleukin 1β Mediates Intestinal Inflammation in Mice and Patients With Interleukin 10 Receptor Deficiency.	Gastroenterology	2016	10
27748766	Adenosine triphosphate	Yang C	Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence.	Oncogene	2017	8
27879251	Adenosine triphosphate	Milewicz DM	Altered Smooth Muscle Cell Force Generation as a Driver of Thoracic Aortic Aneurysms and Dissections.	Arteriosclerosis, thrombosis, and vascular biology	2017	10
27941796	Adenosine triphosphate	Kadoch C	Dynamics of BAF-Polycomb complex opposition on heterochromatin in normal and oncogenic states.	Nature genetics	2017	16
27967234	Adenosine triphosphate	Yee M	Alternative Progenitor Lineages Regenerate the Adult Lung Depleted of Alveolar Epithelial Type 2 Cells.	American journal of respiratory cell and molecular biology	2017	5
28060726	Adenosine triphosphate	Ogawa M	Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity.	Oncotarget	2017	11
28093236	Adenosine triphosphate	Faas MM	Extracellular ATP and adenosine: The Yin and Yang in immune responses?	Molecular aspects of medicine	2017	7
28131082	Adenosine triphosphate	Rovira-Llopis S	Mitochondrial dynamics in type 2 diabetes: Pathophysiological implications.	Redox biology	2017	7
28192788	Adenosine triphosphate	Chan LN	Metabolic gatekeeper function of B-lymphoid transcription factors.	Nature	2017	10
28223517	Adenosine triphosphate	Rohde JA	Heart failure drug changes the mechanoenzymology of the cardiac myosin powerstroke.	Proceedings of the National Academy of Sciences of the United States of America	2017	6
28234357	Adenosine triphosphate	Garg AD	Pathogen response-like recruitment and activation of neutrophils by sterile immunogenic dying cells drives neutrophil-mediated residual cell killing.	Cell death and differentiation	2017	11
28333713	Adenosine triphosphate	Aryal B	MicroRNAs and lipid metabolism.	Current opinion in lipidology	2017	5
28337542	Adenosine triphosphate	Paillusson S	α-Synuclein binds to the ER-mitochondria tethering protein VAPB to disrupt Ca2+ homeostasis and mitochondrial ATP production.	Acta neuropathologica	2017	9
28360422	Adenosine triphosphate	Weyand CM	Immunometabolism in early and late stages of rheumatoid arthritis.	Nature reviews. Rheumatology	2017	6
28802038	Adenosine triphosphate	Ulland TK	TREM2 Maintains Microglial Metabolic Fitness in Alzheimer's Disease.	Cell	2017	15
9808620	Guanosine triphosphate	Kiyokawa E	Activation of Rac1 by a Crk SH3-binding protein, DOCK180.	Genes & development	1998	116
10639096	Guanosine triphosphate	Somlyo AP	Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II.	The Journal of physiology	2000	222
10835631	Guanosine triphosphate	Ménasché G	Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome.	Nature genetics	2000	183
10871853	Guanosine triphosphate	Schnelzer A	Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b.	Oncogene	2000	120
17079465	Guanosine triphosphate	Kurayoshi M	Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion.	Cancer research	2006	134
17200152	Guanosine triphosphate	West AB	Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity.	Human molecular genetics	2007	201
17409395	Guanosine triphosphate	Wang H	PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition.	Cancer research	2007	78
17468766	Guanosine triphosphate	Carè A	MicroRNA-133 controls cardiac hypertrophy.	Nature medicine	2007	498
17517660	Guanosine triphosphate	Oliveira JB	NRAS mutation causes a human autoimmune lymphoproliferative syndrome.	Proceedings of the National Academy of Sciences of the United States of America	2007	57
17597763	Guanosine triphosphate	Sato T	The Rab8 GTPase regulates apical protein localization in intestinal cells.	Nature	2007	111
17706965	Guanosine triphosphate	Guo L	The Parkinson's disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity.	Experimental cell research	2007	81
18344980	Guanosine triphosphate	Lim KH	Tumour maintenance is mediated by eNOS.	Nature	2008	104
19252414	Guanosine triphosphate	Koorstra JB	The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target.	Cancer biology & therapy	2009	55
19570025	Guanosine triphosphate	Greggio E	Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions.	ASN neuro	2009	107
19856314	Guanosine triphosphate	Pandey M	Promoter demethylation and chromatin remodeling by green tea polyphenols leads to re-expression of GSTP1 in human prostate cancer cells.	International journal of cancer	2010	49
20157015	Guanosine triphosphate	Yu-Wai-Man P	Multi-system neurological disease is common in patients with OPA1 mutations.	Brain 	2010	81
20357086	Guanosine triphosphate	Bruce EA	The Rab11 pathway is required for influenza A virus budding and filament formation.	Journal of virology	2010	63
20460433	Guanosine triphosphate	Nethe M	Focal-adhesion targeting links caveolin-1 to a Rac1-degradation pathway.	Journal of cell science	2010	43
20484105	Guanosine triphosphate	Hendrix A	Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis.	Journal of the National Cancer Institute	2010	59
20570890	Guanosine triphosphate	Janakiraman M	Genomic and biological characterization of exon 4 KRAS mutations in human cancer.	Cancer research	2010	98
20951941	Guanosine triphosphate	Melo SA	A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells.	Cancer cell	2010	101
21220294	Guanosine triphosphate	Byrnes LJ	Structural basis for the nucleotide-dependent dimerization of the large G protein atlastin-1/SPG3A.	Proceedings of the National Academy of Sciences of the United States of America	2011	61
21307188	Guanosine triphosphate	Amorim MJ	A Rab11- and microtubule-dependent mechanism for cytoplasmic transport of influenza A virus viral RNA.	Journal of virology	2011	65
21491416	Guanosine triphosphate	Chen MY	Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy.	Cancer	2011	38
21515363	Guanosine triphosphate	Stengel K	Cdc42 in oncogenic transformation, invasion, and tumorigenesis.	Cellular signalling	2011	53
21536732	Guanosine triphosphate	Finch AJ	Uncoupling of GTP hydrolysis from eIF6 release on the ribosome causes Shwachman-Diamond syndrome.	Genes & development	2011	66
21706022	Guanosine triphosphate	Dambournet D	Rab35 GTPase and OCRL phosphatase remodel lipids and F-actin for successful cytokinesis.	Nature cell biology	2011	73
22220215	Guanosine triphosphate	Carcamo WC	Induction of cytoplasmic rods and rings structures by inhibition of the CTP and GTP synthetic pathway in mammalian cells.	PloS one	2011	37
22228096	Guanosine triphosphate	Wang X	LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1.	Human molecular genetics	2012	94
22745122	Guanosine triphosphate	Gawlowski T	Modulation of dynamin-related protein 1 (DRP1) function by increased O-linked-β-N-acetylglucosamine modification (O-GlcNAc) in cardiac myocytes.	The Journal of biological chemistry	2012	47
23867502	Guanosine triphosphate	Gee HY	ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling.	The Journal of clinical investigation	2013	54
23993195	Guanosine triphosphate	Nakamura K	De Novo mutations in GNAO1, encoding a Gαo subunit of heterotrimeric G proteins, cause epileptic encephalopathy.	American journal of human genetics	2013	27
24256730	Guanosine triphosphate	Ostrem JM	K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.	Nature	2013	221
24413737	Guanosine triphosphate	Sakata-Yanagimoto M	Somatic RHOA mutation in angioimmunoblastic T cell lymphoma.	Nature genetics	2014	88
24431073	Guanosine triphosphate	Cheng Y	XPO1 (CRM1) inhibition represses STAT3 activation to drive a survivin-dependent oncogenic switch in triple-negative breast cancer.	Molecular cancer therapeutics	2014	31
24481780	Guanosine triphosphate	Deb G	Epigenetic induction of tissue inhibitor of matrix metalloproteinase-3 by green tea polyphenols in breast cancer cells.	Molecular carcinogenesis	2015	16
25446900	Guanosine triphosphate	Thomas JD	Rab1A is an mTORC1 activator and a colorectal oncogene.	Cancer cell	2014	56
25961457	Guanosine triphosphate	Gee HY	KANK deficiency leads to podocyte dysfunction and nephrotic syndrome.	The Journal of clinical investigation	2015	36
26067754	Guanosine triphosphate	Kollareddy M	Regulation of nucleotide metabolism by mutant p53 contributes to its gain-of-function activities.	Nature communications	2015	20
26604000	Guanosine triphosphate	Vanstone JR	DNM1L-related mitochondrial fission defect presenting as refractory epilepsy.	European journal of human genetics 	2016	14
26873344	Guanosine triphosphate	Nussinov R	K-Ras4B/calmodulin/PI3Kα: A promising new adenocarcinoma-specific drug target?	Expert opinion on therapeutic targets	2016	11
27181209	Guanosine triphosphate	Bianchi-Smiraglia A	Microphthalmia-associated transcription factor suppresses invasion by reducing intracellular GTP pools.	Oncogene	2017	6
27617292	Guanosine triphosphate	Yang M	A C9ORF72/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagy.	Science advances	2016	22
27820802	Guanosine triphosphate	Spencer-Smith R	Inhibition of RAS function through targeting an allosteric regulatory site.	Nature chemical biology	2017	16
16966688	Dacarbazine	Bedikian AY	Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group.	Journal of clinical oncology 	2006	126
18281670	Dacarbazine	Testori A	Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study Group.	Journal of clinical oncology 	2008	71
18809613	Dacarbazine	Dudley ME	Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens.	Journal of clinical oncology 	2008	417
19001327	Dacarbazine	Atkins MB	Phase III trial comparing concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, and interferon alfa-2b with cisplatin, vinblastine, and dacarbazine alone in patients with metastatic malignant melanoma (E3695): a trial coordinated by the Eastern Cooperative Oncology Group.	Journal of clinical oncology 	2008	63
19704068	Dacarbazine	Engert A	Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.	Journal of clinical oncology 	2009	49
19884534	Dacarbazine	Senzer NN	Phase II clinical trial of a granulocyte-macrophage colony-stimulating factor-encoding, second-generation oncolytic herpesvirus in patients with unresectable metastatic melanoma.	Journal of clinical oncology 	2009	162
22972589	Dacarbazine	Patel SP	Clinical responses to selumetinib (AZD6244; ARRY-142886)-based combination therapy stratified by gene mutations in patients with metastatic melanoma.	Cancer	2013	29
23735514	Dacarbazine	Robert C	Selumetinib plus dacarbazine versus placebo plus dacarbazine as first-line treatment for BRAF-mutant metastatic melanoma: a phase 2 double-blind randomised study.	The Lancet. Oncology	2013	38
23833299	Dacarbazine	Nathanson KL	Tumor genetic analyses of patients with metastatic melanoma treated with the BRAF inhibitor dabrafenib (GSK2118436).	Clinical cancer research 	2013	40
24077405	Dacarbazine	Phan GQ	Adoptive cell transfer for patients with metastatic melanoma: the potential and promise of cancer immunotherapy.	Cancer control 	2013	25
24581497	Dacarbazine	Pencheva N	Broad-spectrum therapeutic suppression of metastatic melanoma through nuclear hormone receptor activation.	Cell	2014	27
24582505	Dacarbazine	Larkin J	Vemurafenib in patients with BRAF(V600) mutated metastatic melanoma: an open-label, multicentre, safety study.	The Lancet. Oncology	2014	33
25096067	Dacarbazine	Kim G	FDA approval summary: vemurafenib for treatment of unresectable or metastatic melanoma with the BRAFV600E mutation.	Clinical cancer research 	2014	21
25542447	Dacarbazine	Paraiso KH	Ligand-independent EPHA2 signaling drives the adoption of a targeted therapy-mediated metastatic melanoma phenotype.	Cancer discovery	2015	20
25795410	Dacarbazine	Weber JS	Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.	The Lancet. Oncology	2015	332
26115796	Dacarbazine	Ribas A	Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial.	The Lancet. Oncology	2015	208
27069074	Dacarbazine	Press OW	US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816.	Journal of clinical oncology 	2016	16
28284557	Dacarbazine	Dummer R	Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial.	The Lancet. Oncology	2017	17
8675659	Iron	Watson AD	Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.	The Journal of clinical investigation	1995	137
8721615	Iron	Berliner JA	The role of oxidized lipoproteins in atherogenesis.	Free radical biology & medicine	1996	126
9180083	Iron	Babcock M	Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin.	Science	1997	178
9493273	Iron	Rabinowitz YS	Keratoconus.	Survey of ophthalmology	1998	375
10353251	Iron	Maxwell PH	The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.	Nature	1999	1093
10573511	Iron	Angulo P	Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.	Hepatology	1999	237
10756000	Iron	Ribes JA	Zygomycetes in human disease.	Clinical microbiology reviews	2000	214
11175786	Iron	Puccio H	Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits.	Nature genetics	2001	159
11438811	Iron	Curtis AR	Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease.	Nature genetics	2001	92
11731783	Iron	Bulte JW	Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells.	Nature biotechnology	2001	178
12130498	Iron	Jeney V	Pro-oxidant and cytotoxic effects of circulating heme.	Blood	2002	121
12393428	Iron	Weinstein DA	Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease.	Blood	2002	109
12510040	Iron	Hayflick SJ	Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome.	The New England journal of medicine	2003	88
12512031	Iron	Ruhl CE	Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States.	Gastroenterology	2003	120
14668457	Iron	Kolodgie FD	Intraplaque hemorrhage and progression of coronary atheroma.	The New England journal of medicine	2003	195
14744237	Iron	Caro AA	Oxidative stress, toxicology, and pharmacology of CYP2E1.	Annual review of pharmacology and toxicology	2004	93
14757427	Iron	Pietrangelo A	The ferroportin disease.	Blood cells, molecules & diseases	2004	76
15100158	Iron	Arbab AS	Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI.	Blood	2004	137
15124018	Iron	Nemeth E	IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin.	The Journal of clinical investigation	2004	477
15625418	Iron	Hill ID	Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.	Journal of pediatric gastroenterology and nutrition	2005	145
15925276	Iron	Abraham NG	Heme oxygenase and the cardiovascular-renal system.	Free radical biology & medicine	2005	89
16075058	Iron	Niederkofler V	Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload.	The Journal of clinical investigation	2005	125
16075059	Iron	Huang FW	A mouse model of juvenile hemochromatosis.	The Journal of clinical investigation	2005	119
16113265	Iron	Hissen AH	The Aspergillus fumigatus siderophore biosynthetic gene sidA, encoding L-ornithine N5-oxygenase, is required for virulence.	Infection and immunity	2005	77
16508012	Iron	O'Donnell KA	Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis.	Molecular and cellular biology	2006	65
16775460	Iron	Schmidt-Ott KM	Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia.	Current opinion in nephrology and hypertension	2006	62
16848710	Iron	Nemeth E	Regulation of iron metabolism by hepcidin.	Annual review of nutrition	2006	144
16919418	Iron	Al-Mahdawi S	GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology.	Genomics	2006	76
16946298	Iron	Verga Falzacappa MV	STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation.	Blood	2007	144
16952548	Iron	Bekri S	Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH.	Gastroenterology	2006	92
17101452	Iron	Rouault TA	Brain iron metabolism.	Seminars in pediatric neurology	2006	62
17101781	Iron	Pan Y	Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro.	Molecular and cellular biology	2007	101
17127365	Iron	Mancuso C	Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders.	Frontiers in bioscience 	2007	70
17261733	Iron	Hua Y	Brain injury after intracerebral hemorrhage: the role of thrombin and iron.	Stroke	2007	63
17475779	Iron	De Domenico I	The molecular mechanism of hepcidin-mediated ferroportin down-regulation.	Molecular biology of the cell	2007	114
17485548	Iron	Camaschella C	The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload.	Blood	2007	89
17540841	Iron	Lin L	Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4.	Blood	2007	77
17607367	Iron	Martineau AR	Neutrophil-mediated innate immune resistance to mycobacteria.	The Journal of clinical investigation	2007	100
17623039	Iron	Uversky VN	Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation.	Journal of neurochemistry	2007	134
17699374	Iron	Wish JB	Assessing iron status: beyond serum ferritin and transferrin saturation.	Clinical journal of the American Society of Nephrology 	2006	65
17822372	Iron	Jozkowicz A	Heme oxygenase-1 in tumors: is it a false friend?	Antioxidants & redox signaling	2007	83
18202189	Iron	Malik I	Disrupted membrane homeostasis and accumulation of ubiquitinated proteins in a mouse model of infantile neuroaxonal dystrophy caused by PLA2G6 mutations.	The American journal of pathology	2008	56
18305254	Iron	Shinzawa K	Neuroaxonal dystrophy caused by group VIA phospholipase A2 deficiency in mice: a model of human neurodegenerative disease.	The Journal of neuroscience 	2008	61
18324353	Iron	Hatcher H	Curcumin: from ancient medicine to current clinical trials.	Cellular and molecular life sciences 	2008	250
18326817	Iron	Xia Y	Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin.	Blood	2008	81
18355723	Iron	Yang WS	Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells.	Chemistry & biology	2008	78
18443312	Iron	McNeill A	T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation.	Neurology	2008	52
18570303	Iron	Paisan-Ruiz C	Characterization of PLA2G6 as a locus for dystonia-parkinsonism.	Annals of neurology	2009	75
18576916	Iron	Loboda A	Heme oxygenase-1 and the vascular bed: from molecular mechanisms to therapeutic opportunities.	Antioxidants & redox signaling	2008	66
18760763	Iron	Whatley SD	C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload.	American journal of human genetics	2008	51
18799783	Iron	Gregory A	Neurodegeneration associated with genetic defects in phospholipase A(2).	Neurology	2008	63
18817553	Iron	Modell B	Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance.	Journal of cardiovascular magnetic resonance 	2008	93
18981035	Iron	Gregory A	Clinical and genetic delineation of neurodegeneration with brain iron accumulation.	Journal of medical genetics	2009	63
19134195	Iron	Apopa PL	Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling.	Particle and fibre toxicology	2009	47
19234114	Iron	De Domenico I	Hepcidin-induced internalization of ferroportin requires binding and cooperative interaction with Jak2.	Proceedings of the National Academy of Sciences of the United States of America	2009	47
19234137	Iron	Boyle JJ	Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype.	The American journal of pathology	2009	62
19362144	Iron	Morse D	Heme oxygenase-1, a critical arbitrator of cell death pathways in lung injury and disease.	Free radical biology & medicine	2009	51
19412178	Iron	Guernsey DL	Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia.	Nature genetics	2009	60
19414861	Iron	Tanno T	Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells.	Blood	2009	109
19457088	Iron	Schipper HM	Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement.	Journal of neurochemistry	2009	59
19467991	Iron	Connor JR	Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome.	Brain 	2009	59
19540040	Iron	Bolignano D	Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene.	Cancer letters	2010	47
19805308	Iron	Huang ML	Elucidation of the mechanism of mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant.	Proceedings of the National Academy of Sciences of the United States of America	2009	52
19937043	Iron	Schrag M	Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study.	Acta neuropathologica	2010	57
20062075	Iron	Yamaguchi K	Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes.	Oncogene	2010	42
20194272	Iron	Skinner AC	Multiple markers of inflammation and weight status: cross-sectional analyses throughout childhood.	Pediatrics	2010	52
20378845	Iron	Nagy E	Red cells, hemoglobin, heme, iron, and atherogenesis.	Arteriosclerosis, thrombosis, and vascular biology	2010	57
20436681	Iron	Favaro E	MicroRNA-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU.	PloS one	2010	100
20481466	Iron	Ye H	Human iron-sulfur cluster assembly, cellular iron homeostasis, and disease.	Biochemistry	2010	70
20484814	Iron	Liu M	The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice.	The Journal of clinical investigation	2010	42
20542038	Iron	Pietrangelo A	Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment.	Gastroenterology	2010	87
20550936	Iron	Devireddy LR	A mammalian siderophore synthesized by an enzyme with a bacterial homolog involved in enterobactin production.	Cell	2010	85
20580464	Iron	Sierra-Filardi E	Heme Oxygenase-1 expression in M-CSF-polarized M2 macrophages contributes to LPS-induced IL-10 release.	Immunobiology	2010	54
20619503	Iron	Paisán-Ruiz C	Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations.	Neurobiology of aging	2012	42
20686179	Iron	Pinnix ZK	Ferroportin and iron regulation in breast cancer progression and prognosis.	Science translational medicine	2010	83
20698697	Iron	Wang J	The complex role of multivalency in nanoparticles targeting the transferrin receptor for cancer therapies.	Journal of the American Chemical Society	2010	57
20728697	Iron	Sawyer DB	Mechanisms of anthracycline cardiac injury: can we identify strategies for cardioprotection?	Progress in cardiovascular diseases	2010	44
20736190	Iron	Péran P	Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature.	Brain 	2010	90
21315377	Iron	Koeppen AH	Friedreich's ataxia: pathology, pathogenesis, and molecular genetics.	Journal of the neurological sciences	2011	86
21363917	Iron	Torti SV	Ironing out cancer.	Cancer research	2011	37
21427356	Iron	Josson S	β2-microglobulin induces epithelial to mesenchymal transition and confers cancer lethality and bone metastasis in human cancer cells.	Cancer research	2011	44
21576334	Iron	Bachman MA	Klebsiella pneumoniae yersiniabactin promotes respiratory tract infection through evasion of lipocalin 2.	Infection and immunity	2011	57
21768301	Iron	Ginzburg Y	β-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism.	Blood	2011	53
21801864	Iron	Lee DC	miR-210 targets iron-sulfur cluster scaffold homologue in human trophoblast cell lines: siderosis of interstitial trophoblasts as a novel pathology of preterm preeclampsia and small-for-gestational-age pregnancies.	The American journal of pathology	2011	35
21907923	Iron	Tong WH	The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels.	Cancer cell	2011	56
21953442	Iron	Kowdley KV	Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease.	Hepatology	2012	75
21981780	Iron	Hartig MB	Absence of an orphan mitochondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation.	American journal of human genetics	2011	36
21992109	Iron	Grochot-Przeczek A	Haem oxygenase-1: non-canonical roles in physiology and pathology.	Clinical science	2012	46
22021369	Iron	Hod EA	Transfusion of human volunteers with older, stored red blood cells produces extravascular hemolysis and circulating non-transferrin-bound iron.	Blood	2011	71
22032835	Iron	Munksgaard PS	The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations.	Gynecologic oncology	2012	35
22052915	Iron	Boyle JJ	Activating transcription factor 1 directs Mhem atheroprotective macrophages through coordinated iron handling and foam cell protection.	Circulation research	2012	34
22323289	Iron	Sheftel AD	The human mitochondrial ISCA1, ISCA2, and IBA57 proteins are required for 4Fe-4S protein maturation.	Molecular biology of the cell	2012	34
22424293	Iron	Merlot AM	Novel chelators for cancer treatment: where are we now?	Antioxidants & redox signaling	2013	31
22440905	Iron	Zager RA	Plasma and urinary heme oxygenase-1 in AKI.	Journal of the American Society of Nephrology 	2012	33
22462691	Iron	Kovacevic Z	The iron-regulated metastasis suppressor NDRG1 targets NEDD4L, PTEN, and SMAD4 and inhibits the PI3K and Ras signaling pathways.	Antioxidants & redox signaling	2013	38
22706697	Iron	Fan K	Magnetoferritin nanoparticles for targeting and visualizing tumour tissues.	Nature nanotechnology	2012	40
22719876	Iron	Kawaguchi T	Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese.	PloS one	2012	50
22728873	Iron	D'Alessio F	The hemochromatosis proteins HFE, TfR2, and HJV form a membrane-associated protein complex for hepcidin regulation.	Journal of hepatology	2012	43
22826563	Iron	Visconte V	SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes.	Blood	2012	55
23064436	Iron	Hauser DN	Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism.	Neurobiology of disease	2013	56
23074173	Iron	Lui GY	The iron chelator, deferasirox, as a novel strategy for cancer treatment: oral activity against human lung tumor xenografts and molecular mechanism of action.	Molecular pharmacology	2013	28
23136396	Iron	Hick A	Neurons and cardiomyocytes derived from induced pluripotent stem cells as a model for mitochondrial defects in Friedreich's ataxia.	Disease models & mechanisms	2013	43
23176820	Iron	Haack TB	Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, X-linked dominant form of NBIA.	American journal of human genetics	2012	66
23302230	Iron	Alkins R	Focused ultrasound delivers targeted immune cells to metastatic brain tumors.	Cancer research	2013	37
23334592	Iron	Koeppen AH	Friedreich ataxia: neuropathology revised.	Journal of neuropathology and experimental neurology	2013	38
23349391	Iron	Schwoebel F	The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys.	Blood	2013	36
23474058	Iron	Boeve BF	Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder.	Sleep medicine	2013	41
23843466	Iron	Blazejewska AI	Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI.	Neurology	2013	26
23853581	Iron	Leal SM Jr	Targeting iron acquisition blocks infection with the fungal pathogens Aspergillus fumigatus and Fusarium oxysporum.	PLoS pathogens	2013	30
23859340	Iron	Pastore A	Frataxin: a protein in search for a function.	Journal of neurochemistry	2013	36
23908332	Iron	Kloner RA	Current state of clinical translation of cardioprotective agents for acute myocardial infarction.	Circulation research	2013	30
23959881	Iron	Sohn YS	NAF-1 and mitoNEET are central to human breast cancer proliferation by maintaining mitochondrial homeostasis and promoting tumor growth.	Proceedings of the National Academy of Sciences of the United States of America	2013	33
24269900	Iron	Fang BA	Molecular functions of the iron-regulated metastasis suppressor, NDRG1, and its potential as a molecular target for cancer therapy.	Biochimica et biophysica acta	2014	27
24334290	Iron	Baker PR 2nd	Variant non ketotic hyperglycinemia is caused by mutations in LIAS, BOLA3 and the novel gene GLRX5.	Brain 	2014	24
24462711	Iron	Stehling O	Mitochondrial iron-sulfur protein biogenesis and human disease.	Biochimie	2014	53
24532803	Iron	Sahni S	The metastasis suppressor, N-myc downstream-regulated gene 1 (NDRG1), inhibits stress-induced autophagy in cancer cells.	The Journal of biological chemistry	2014	21
24622774	Iron	Schuh C	Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models.	Acta neuropathologica	2014	20
24705334	Iron	Perdomini M	Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich's ataxia.	Nature medicine	2014	32
24904118	Iron	Wu XG	HFE interacts with the BMP type I receptor ALK3 to regulate hepcidin expression.	Blood	2014	21
25241054	Iron	Naito Y	Heme oxygenase-1 and anti-inflammatory M2 macrophages.	Archives of biochemistry and biophysics	2014	33
25267626	Iron	Guo P	ICAM-1 as a molecular target for triple negative breast cancer.	Proceedings of the National Academy of Sciences of the United States of America	2014	27
25394715	Iron	Bulycheva E	Myelodysplasia is in the niche: novel concepts and emerging therapies.	Leukemia	2015	15
25527668	Iron	Karakochuk CD	Genetic hemoglobin disorders rather than iron deficiency are a major predictor of hemoglobin concentration in women of reproductive age in rural prey Veng, Cambodia.	The Journal of nutrition	2015	18
25728673	Iron	Sun X	HSPB1 as a novel regulator of ferroptotic cancer cell death.	Oncogene	2015	25
25825391	Iron	White K	Genetic and hypoxic alterations of the microRNA-210-ISCU1/2 axis promote iron-sulfur deficiency and pulmonary hypertension.	EMBO molecular medicine	2015	22
25858146	Iron	Tesfay L	Hepcidin regulation in prostate and its disruption in prostate cancer.	Cancer research	2015	20
26125440	Iron	Lui GY	Targeting cancer by binding iron: Dissecting cellular signaling pathways.	Oncotarget	2015	18
26291319	Iron	Michels K	Hepcidin and Host Defense against Infectious Diseases.	PLoS pathogens	2015	19
26385212	Iron	de Swart L	Second international round robin for the quantification of serum non-transferrin-bound iron and labile plasma iron in patients with iron-overload disorders.	Haematologica	2016	11
26403645	Iron	Sun X	Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells.	Hepatology	2016	34
26471505	Iron	Pavlides M	Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease.	Journal of hepatology	2016	14
26675351	Iron	Vinchi F	Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.	Blood	2016	27
26700815	Iron	Flavahan WA	Insulator dysfunction and oncogene activation in IDH mutant gliomas.	Nature	2016	130
26894396	Iron	Zhang Z	Microglial Polarization and Inflammatory Mediators After Intracerebral Hemorrhage.	Molecular neurobiology	2017	16
26988023	Iron	Kabe Y	Haem-dependent dimerization of PGRMC1/Sigma-2 receptor facilitates cancer proliferation and chemoresistance.	Nature communications	2016	16
27296779	Iron	Lowe VJ	An autoradiographic evaluation of AV-1451 Tau PET in dementia.	Acta neuropathologica communications	2016	57
27887750	Iron	Webster AC	Chronic Kidney Disease.	Lancet	2017	16
28060743	Iron	González N	2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications.	Oncotarget	2017	5
28185035	Iron	McGowan JV	Anthracycline Chemotherapy and Cardiotoxicity.	Cardiovascular drugs and therapy	2017	12
28319068	Iron	Basuli D	Iron addiction: a novel therapeutic target in ovarian cancer.	Oncogene	2017	5
10225978	Tartaric acid	Kotake S	IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis.	The Journal of clinical investigation	1999	357
18535913	Tartaric acid	Zhau HE	Epithelial to mesenchymal transition (EMT) in human prostate cancer: lessons learned from ARCaP model.	Clinical & experimental metastasis	2008	63
21217755	Tartaric acid	Briggs TA	Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature.	Nature genetics	2011	49
24733914	Tartaric acid	Chen W	Arthritogenic alphaviral infection perturbs osteoblast function and triggers pathologic bone loss.	Proceedings of the National Academy of Sciences of the United States of America	2014	22
25503693	Tartaric acid	Xu W	The systemic delivery of an oncolytic adenovirus expressing decorin inhibits bone metastasis in a mouse model of human prostate cancer.	Gene therapy	2015	18
9861036	Gamma-Aminobutyric acid	Impagnatiello F	A decrease of reelin expression as a putative vulnerability factor in schizophrenia.	Proceedings of the National Academy of Sciences of the United States of America	1998	165
11814263	Gamma-Aminobutyric acid	Blatt GJ	Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study.	Journal of autism and developmental disorders	2001	86
12867516	Gamma-Aminobutyric acid	Hashimoto T	Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia.	The Journal of neuroscience 	2003	302
14960621	Gamma-Aminobutyric acid	Merali Z	Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region.	The Journal of neuroscience 	2004	81
15263907	Gamma-Aminobutyric acid	Harrison PJ	Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence.	Molecular psychiatry	2005	529
16427029	Gamma-Aminobutyric acid	Rujescu D	A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities.	Biological psychiatry	2006	64
16709666	Gamma-Aminobutyric acid	Palma E	Anomalous levels of Cl- transporters in the hippocampal subiculum from temporal lobe epilepsy patients make GABA excitatory.	Proceedings of the National Academy of Sciences of the United States of America	2006	64
16759710	Gamma-Aminobutyric acid	Akbarian S	Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders.	Brain research reviews	2006	128
17224405	Gamma-Aminobutyric acid	Kuramoto N	Phospho-dependent functional modulation of GABA(B) receptors by the metabolic sensor AMP-dependent protein kinase.	Neuron	2007	62
17235515	Gamma-Aminobutyric acid	Yip J	Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism: pathophysiological implications.	Acta neuropathologica	2007	77
17379385	Gamma-Aminobutyric acid	Zuccato C	Role of brain-derived neurotrophic factor in Huntington's disease.	Progress in neurobiology	2007	123
17471287	Gamma-Aminobutyric acid	Hashimoto T	Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia.	Molecular psychiatry	2008	178
17511618	Gamma-Aminobutyric acid	Rajkowska G	Gliogenesis and glial pathology in depression.	CNS & neurological disorders drug targets	2007	130
17553960	Gamma-Aminobutyric acid	Benes FM	Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars.	Proceedings of the National Academy of Sciences of the United States of America	2007	152
17765749	Gamma-Aminobutyric acid	Dudek FE	Epileptogenesis in the dentate gyrus: a critical perspective.	Progress in brain research	2007	84
17767149	Gamma-Aminobutyric acid	Straub RE	Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression.	Molecular psychiatry	2007	98
17855601	Gamma-Aminobutyric acid	Huberfeld G	Perturbed chloride homeostasis and GABAergic signaling in human temporal lobe epilepsy.	The Journal of neuroscience 	2007	154
17965125	Gamma-Aminobutyric acid	Bayatti N	A molecular neuroanatomical study of the developing human neocortex from 8 to 17 postconceptional weeks revealing the early differentiation of the subplate and subventricular zone.	Cerebral cortex	2008	56
18184780	Gamma-Aminobutyric acid	Terunuma M	Deficits in phosphorylation of GABA(A) receptors by intimately associated protein kinase C activity underlie compromised synaptic inhibition during status epilepticus.	The Journal of neuroscience 	2008	57
18483561	Gamma-Aminobutyric acid	Marc RE	Extreme retinal remodeling triggered by light damage: implications for age related macular degeneration.	Molecular vision	2008	75
18830410	Gamma-Aminobutyric acid	Loerch PM	Evolution of the aging brain transcriptome and synaptic regulation.	PloS one	2008	95
19321177	Gamma-Aminobutyric acid	Thompson M	Decreased glutamic acid decarboxylase(67) mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders.	Journal of psychiatric research	2009	50
19549685	Gamma-Aminobutyric acid	Betin VM	Caspase cleavage of Atg4D stimulates GABARAP-L1 processing and triggers mitochondrial targeting and apoptosis.	Journal of cell science	2009	70
19701204	Gamma-Aminobutyric acid	Zhou YD	Arrested maturation of excitatory synapses in autosomal dominant lateral temporal lobe epilepsy.	Nature medicine	2009	54
19951690	Gamma-Aminobutyric acid	Sun B	Imbalance between GABAergic and Glutamatergic Transmission Impairs Adult Neurogenesis in an Animal Model of Alzheimer's Disease.	Cell stem cell	2009	52
20614802	Gamma-Aminobutyric acid	Nikolaus S	Cortical GABA, striatal dopamine and midbrain serotonin as the key players in compulsive and anxiety disorders--results from in vivo imaging studies.	Reviews in the neurosciences	2010	52
20888417	Gamma-Aminobutyric acid	Massone S	17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease.	Neurobiology of disease	2011	46
21232602	Gamma-Aminobutyric acid	Tripp A	Reduced somatostatin in subgenual anterior cingulate cortex in major depression.	Neurobiology of disease	2011	39
21315745	Gamma-Aminobutyric acid	Powell SB	Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia.	Neuropharmacology	2012	46
21632647	Gamma-Aminobutyric acid	Curley AA	Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features.	The American journal of psychiatry	2011	92
21657944	Gamma-Aminobutyric acid	Alfonso-Loeches S	Molecular and behavioral aspects of the actions of alcohol on the adult and developing brain.	Critical reviews in clinical laboratory sciences	2011	54
21677653	Gamma-Aminobutyric acid	Glausier JR	Selective pyramidal cell reduction of GABA(A) receptor α1 subunit messenger RNA expression in schizophrenia.	Neuropsychopharmacology 	2011	36
21708249	Gamma-Aminobutyric acid	Zou X	Inhalation anesthetic-induced neuronal damage in the developing rhesus monkey.	Neurotoxicology and teratology	2011	43
21795557	Gamma-Aminobutyric acid	Hyde TM	Expression of GABA signaling molecules KCC2, NKCC1, and GAD1 in cortical development and schizophrenia.	The Journal of neuroscience 	2011	80
21856318	Gamma-Aminobutyric acid	Berretta S	Extracellular matrix abnormalities in schizophrenia.	Neuropharmacology	2012	34
21901839	Gamma-Aminobutyric acid	Blatt GJ	Alterations in GABAergic biomarkers in the autism brain: research findings and clinical implications.	Anatomical record	2011	43
21901840	Gamma-Aminobutyric acid	Fatemi SH	Metabotropic glutamate receptor 5 upregulation in children with autism is associated with underexpression of both Fragile X mental retardation protein and GABAA receptor beta 3 in adults with autism.	Anatomical record	2011	37
22626542	Gamma-Aminobutyric acid	Waite A	The dystrophin-glycoprotein complex in brain development and disease.	Trends in neurosciences	2012	36
22938092	Gamma-Aminobutyric acid	Kulak A	Redox dysregulation in the pathophysiology of schizophrenia and bipolar disorder: insights from animal models.	Antioxidants & redox signaling	2013	26
22983435	Gamma-Aminobutyric acid	Volk DW	Deficits in transcriptional regulators of cortical parvalbumin neurons in schizophrenia.	The American journal of psychiatry	2012	59
22993294	Gamma-Aminobutyric acid	Berry-Kravis EM	Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial.	Science translational medicine	2012	103
23049970	Gamma-Aminobutyric acid	Gelman BB	The National NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment.	PloS one	2012	55
23128924	Gamma-Aminobutyric acid	Tripp A	Brain-derived neurotrophic factor signaling and subgenual anterior cingulate cortex dysfunction in major depressive disorder.	The American journal of psychiatry	2012	55
23143228	Gamma-Aminobutyric acid	Brockington A	Unravelling the enigma of selective vulnerability in neurodegeneration: motor neurons resistant to degeneration in ALS show distinct gene expression characteristics and decreased susceptibility to excitotoxicity.	Acta neuropathologica	2013	27
23604284	Gamma-Aminobutyric acid	Liu Y	Medial ganglionic eminence-like cells derived from human embryonic stem cells correct learning and memory deficits.	Nature biotechnology	2013	59
23642365	Gamma-Aminobutyric acid	Maroof AM	Directed differentiation and functional maturation of cortical interneurons from human embryonic stem cells.	Cell stem cell	2013	153
23735822	Gamma-Aminobutyric acid	Lang UE	Molecular mechanisms of depression: perspectives on new treatment strategies.	Cellular physiology and biochemistry 	2013	43
24139641	Gamma-Aminobutyric acid	Kahle KT	Modulation of neuronal activity by phosphorylation of the K-Cl cotransporter KCC2.	Trends in neurosciences	2013	46
24149188	Gamma-Aminobutyric acid	Felipo V	Hepatic encephalopathy: effects of liver failure on brain function.	Nature reviews. Neuroscience	2013	39
24217255	Gamma-Aminobutyric acid	Glausier JR	Altered parvalbumin basket cell inputs in the dorsolateral prefrontal cortex of schizophrenia subjects.	Molecular psychiatry	2014	39
24395782	Gamma-Aminobutyric acid	Neman J	Human breast cancer metastases to the brain display GABAergic properties in the neural niche.	Proceedings of the National Academy of Sciences of the United States of America	2014	41
24650500	Gamma-Aminobutyric acid	Lewis DA	Inhibitory neurons in human cortical circuits: substrate for cognitive dysfunction in schizophrenia.	Current opinion in neurobiology	2014	41
24650502	Gamma-Aminobutyric acid	Kaila K	GABA actions and ionic plasticity in epilepsy.	Current opinion in neurobiology	2014	30
24923909	Gamma-Aminobutyric acid	Wu Z	Tonic inhibition in dentate gyrus impairs long-term potentiation and memory in an Alzheimer's corrected disease model.	Nature communications	2014	27
25486982	Gamma-Aminobutyric acid	Gold PW	The organization of the stress system and its dysregulation in depressive illness.	Molecular psychiatry	2015	55
26186191	Gamma-Aminobutyric acid	Mariani J	FOXG1-Dependent Dysregulation of GABA/Glutamate Neuron Differentiation in Autism Spectrum Disorders.	Cell	2015	105
26780170	Gamma-Aminobutyric acid	Kim HK	Neuropathological relationship between major depression and dementia: A hypothetical model and review.	Progress in neuro-psychopharmacology & biological psychiatry	2016	10
26869529	Gamma-Aminobutyric acid	Jarius S	Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.	Multiple sclerosis	2016	14
9165306	Heme	Markesbery WR	Oxidative stress hypothesis in Alzheimer's disease.	Free radical biology & medicine	1997	272
15932948	Heme	Brunori M	Neuroglobin, nitric oxide, and oxygen: functional pathways and conformational changes.	Proceedings of the National Academy of Sciences of the United States of America	2005	65
17194590	Heme	Dunn LL	Iron uptake and metabolism in the new millennium.	Trends in cell biology	2007	60
17363558	Heme	Liby K	The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate in A/J mice.	Cancer research	2007	62
17467679	Heme	Buhaescu I	Mevalonate pathway: a review of clinical and therapeutical implications.	Clinical biochemistry	2007	74
17544386	Heme	Peluffo G	Biochemistry of protein tyrosine nitration in cardiovascular pathology.	Cardiovascular research	2007	56
18195184	Heme	Dulak J	Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis.	Circulation	2008	75
18331199	Heme	Davies MJ	Mammalian heme peroxidases: from molecular mechanisms to health implications.	Antioxidants & redox signaling	2008	83
18769149	Heme	Kim HP	Autophagic proteins regulate cigarette smoke-induced apoptosis: protective role of heme oxygenase-1.	Autophagy	2008	74
19622015	Heme	van der Veen BS	Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease.	Antioxidants & redox signaling	2009	60
20495089	Heme	Richardson DR	Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol.	Proceedings of the National Academy of Sciences of the United States of America	2010	100
20600583	Heme	Batarseh A	Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states.	Molecular and cellular endocrinology	2010	63
21088618	Heme	Radhakrishnan N	Human heme oxygenase-1 deficiency presenting with hemolysis, nephritis, and asplenia.	Journal of pediatric hematology/oncology	2011	42
21091076	Heme	Wu ML	A central role of heme oxygenase-1 in cardiovascular protection.	Antioxidants & redox signaling	2011	39
21444764	Heme	Sheikh SZ	An anti-inflammatory role for carbon monoxide and heme oxygenase-1 in chronic Th2-mediated murine colitis.	Journal of immunology	2011	39
21745276	Heme	Jaeschke H	Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity.	Liver international 	2012	88
22513881	Heme	Lastres-Becker I	α-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease.	Human molecular genetics	2012	39
23055342	Heme	Tsai JR	High expression of heme oxygenase-1 is associated with tumor invasiveness and poor clinical outcome in non-small cell lung cancer patients.	Cellular oncology	2012	31
23092325	Heme	Tibullo D	Nuclear translocation of heme oxygenase-1 confers resistance to imatinib in chronic myeloid leukemia cells.	Current pharmaceutical design	2013	27
23100518	Heme	Cunnington AJ	Prolonged neutrophil dysfunction after Plasmodium falciparum malaria is related to hemolysis and heme oxygenase-1 induction.	Journal of immunology	2012	36
23475203	Heme	Li F	Human PXR modulates hepatotoxicity associated with rifampicin and isoniazid co-therapy.	Nature medicine	2013	29
23642066	Heme	Stagg J	Mechanisms of immune modulation by mesenchymal stromal cells and clinical translation.	Current molecular medicine	2013	42
24121491	Heme	Wegiel B	Carbon monoxide expedites metabolic exhaustion to inhibit tumor growth.	Cancer research	2013	35
24277722	Heme	Lastres-Becker I	Fractalkine activates NRF2/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis.	Brain 	2014	24
24386930	Heme	Laurindo FR	Nox NADPH oxidases and the endoplasmic reticulum.	Antioxidants & redox signaling	2014	23
24743738	Heme	Kang KA	Epigenetic modification of Nrf2 in 5-fluorouracil-resistant colon cancer cells: involvement of TET-dependent DNA demethylation.	Cell death & disease	2014	22
25062272	Heme	Nisimoto Y	Nox4: a hydrogen peroxide-generating oxygen sensor.	Biochemistry	2014	55
25827830	Heme	Camus SM	Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease.	Blood	2015	32
26011640	Heme	Schallner N	Microglia regulate blood clearance in subarachnoid hemorrhage by heme oxygenase-1.	The Journal of clinical investigation	2015	20
26011642	Heme	Dey S	ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasis.	The Journal of clinical investigation	2015	41
26024535	Heme	Deng R	Oxidative stress markers induced by hyperosmolarity in primary human corneal epithelial cells.	PloS one	2015	17
26269531	Heme	Hughes R	Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy.	Cancer research	2015	30
9922383	Cyclic AMP	Pilewski JM	Role of CFTR in airway disease.	Physiological reviews	1999	113
11967539	Cyclic AMP	Mantamadiotis T	Disruption of CREB function in brain leads to neurodegeneration.	Nature genetics	2002	174
12706957	Cyclic AMP	Manji HK	Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression.	Biological psychiatry	2003	88
14668433	Cyclic AMP	Coakley RD	Abnormal surface liquid pH regulation by cultured cystic fibrosis bronchial epithelium.	Proceedings of the National Academy of Sciences of the United States of America	2003	81
14746512	Cyclic AMP	Chao J	Molecular neurobiology of drug addiction.	Annual review of medicine	2004	86
14999077	Cyclic AMP	Spires TL	Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism.	The Journal of neuroscience 	2004	76
15374886	Cyclic AMP	Cullere X	Regulation of vascular endothelial barrier function by Epac, a cAMP-activated exchange factor for Rap GTPase.	Blood	2005	132
15717292	Cyclic AMP	Abdolmaleky HM	Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report.	American journal of medical genetics. Part B, Neuropsychiatric genetics 	2005	117
15731352	Cyclic AMP	Lee YH	Regulation of coactivator complex assembly and function by protein arginine methylation and demethylimination.	Proceedings of the National Academy of Sciences of the United States of America	2005	76
15746443	Cyclic AMP	Pathak A	Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1.	Circulation research	2005	76
15899904	Cyclic AMP	Shao J	Prostaglandin E2 Stimulates the beta-catenin/T cell factor-dependent transcription in colon cancer.	The Journal of biological chemistry	2005	69
16177794	Cyclic AMP	Dodge-Kafka KL	The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways.	Nature	2005	192
16319189	Cyclic AMP	Yamaguchi T	Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells.	Journal of the American Society of Nephrology 	2006	78
16740699	Cyclic AMP	Ho SM	Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4.	Cancer research	2006	235
16767104	Cyclic AMP	Horvath A	A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia.	Nature genetics	2006	93
16844790	Cyclic AMP	Liggett SB	A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure.	Proceedings of the National Academy of Sciences of the United States of America	2006	116
16928806	Cyclic AMP	Smith LA	Development of polycystic kidney disease in juvenile cystic kidney mice: insights into pathogenesis, ciliary abnormalities, and common features with human disease.	Journal of the American Society of Nephrology 	2006	63
17018604	Cyclic AMP	Dumaz N	In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signaling.	Cancer research	2006	97
17197073	Cyclic AMP	Slominski A	Differential expression of HPA axis homolog in the skin.	Molecular and cellular endocrinology	2007	65
17241267	Cyclic AMP	Wang JZ	Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.	The European journal of neuroscience	2007	115
17306374	Cyclic AMP	Doyle ME	Mechanisms of action of glucagon-like peptide 1 in the pancreas.	Pharmacology & therapeutics	2007	129
17344407	Cyclic AMP	Zhang Z	Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion.	The Journal of neuroscience 	2007	57
17353197	Cyclic AMP	Sastry KS	Epinephrine protects cancer cells from apoptosis via activation of cAMP-dependent protein kinase and BAD phosphorylation.	The Journal of biological chemistry	2007	55
17493609	Cyclic AMP	Birukova AA	Prostaglandins PGE(2) and PGI(2) promote endothelial barrier enhancement via PKA- and Epac1/Rap1-dependent Rac activation.	Experimental cell research	2007	83
17612487	Cyclic AMP	Dohi T	Compartmentalized phosphorylation of IAP by protein kinase A regulates cytoprotection.	Molecular cell	2007	56
17630319	Cyclic AMP	Hodge S	Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease.	American journal of respiratory cell and molecular biology	2007	83
17686866	Cyclic AMP	Medigeshi GR	West Nile virus infection activates the unfolded protein response, leading to CHOP induction and apoptosis.	Journal of virology	2007	85
17952119	Cyclic AMP	Yin X	A potential dichotomous role of ATF3, an adaptive-response gene, in cancer development.	Oncogene	2008	71
18064650	Cyclic AMP	Birukova AA	Epac/Rap and PKA are novel mechanisms of ANP-induced Rac-mediated pulmonary endothelial barrier protection.	Journal of cellular physiology	2008	52
18188154	Cyclic AMP	Richter W	Signaling from beta1- and beta2-adrenergic receptors is defined by differential interactions with PDE4.	The EMBO journal	2008	53
18272904	Cyclic AMP	Horvath A	Mutation in PDE8B, a cyclic AMP-specific phosphodiesterase in adrenal hyperplasia.	The New England journal of medicine	2008	55
18323524	Cyclic AMP	Métrich M	Epac mediates beta-adrenergic receptor-induced cardiomyocyte hypertrophy.	Circulation research	2008	68
18636076	Cyclic AMP	Sarkar S	Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies.	Cell death and differentiation	2009	134
18689544	Cyclic AMP	Arnold J	Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation.	Blood	2008	80
19151200	Cyclic AMP	Noyan-Ashraf MH	GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice.	Diabetes	2009	116
19164583	Cyclic AMP	Li Y	GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism.	Proceedings of the National Academy of Sciences of the United States of America	2009	109
19190754	Cyclic AMP	Slominski AT	Sequential metabolism of 7-dehydrocholesterol to steroidal 5,7-dienes in adrenal glands and its biological implication in the skin.	PloS one	2009	47
19386608	Cyclic AMP	Yanagida K	Identification and characterization of a novel lysophosphatidic acid receptor, p2y5/LPA6.	The Journal of biological chemistry	2009	61
19654912	Cyclic AMP	Bouskine A	Low doses of bisphenol A promote human seminoma cell proliferation by activating PKA and PKG via a membrane G-protein-coupled estrogen receptor.	Environmental health perspectives	2009	47
20050849	Cyclic AMP	Schafer PH	Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis.	British journal of pharmacology	2010	46
20068138	Cyclic AMP	Arakawa M	Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4.	Diabetes	2010	102
20081107	Cyclic AMP	Rajkumar R	Genomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertension.	American journal of physiology. Heart and circulatory physiology	2010	57
20168088	Cyclic AMP	Carloni S	Activation of autophagy and Akt/CREB signaling play an equivalent role in the neuroprotective effect of rapamycin in neonatal hypoxia-ischemia.	Autophagy	2010	54
20234090	Cyclic AMP	Kang S	p90 ribosomal S6 kinase 2 promotes invasion and metastasis of human head and neck squamous cell carcinoma cells.	The Journal of clinical investigation	2010	48
20373471	Cyclic AMP	Janssen DG	A psychoneuroimmunological review on cytokines involved in antidepressant treatment response.	Human psychopharmacology	2010	47
20424515	Cyclic AMP	Zhang D	β2-adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NFκB and AP-1.	Cancer biology & therapy	2010	45
20448207	Cyclic AMP	Oeseburg H	Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A.	Arteriosclerosis, thrombosis, and vascular biology	2010	61
20514020	Cyclic AMP	Rzymski T	Regulation of autophagy by ATF4 in response to severe hypoxia.	Oncogene	2010	89
20624818	Cyclic AMP	Laneve P	A minicircuitry involving REST and CREB controls miR-9-2 expression during human neuronal differentiation.	Nucleic acids research	2010	51
20810711	Cyclic AMP	Pedram A	Estrogen receptor-beta prevents cardiac fibrosis.	Molecular endocrinology	2010	43
20833281	Cyclic AMP	Selvi BR	Tuning acetylation levels with HAT activators: therapeutic strategy in neurodegenerative diseases.	Biochimica et biophysica acta	2010	41
21149712	Cyclic AMP	Caccamo A	CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer's disease.	Proceedings of the National Academy of Sciences of the United States of America	2010	60
21220306	Cyclic AMP	Franco AT	Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice.	Proceedings of the National Academy of Sciences of the United States of America	2011	52
21354433	Cyclic AMP	Cheng SB	Retrograde transport of the transmembrane estrogen receptor, G-protein-coupled-receptor-30 (GPR30/GPER) from the plasma membrane towards the nucleus.	Steroids	2011	40
21490598	Cyclic AMP	Brennand KJ	Modelling schizophrenia using human induced pluripotent stem cells.	Nature	2011	374
21796118	Cyclic AMP	Wang M	Neuronal basis of age-related working memory decline.	Nature	2011	98
21868695	Cyclic AMP	Katare R	Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132.	Circulation research	2011	91
22048463	Cyclic AMP	Funk AJ	Abnormal activity of the MAPK- and cAMP-associated signaling pathways in frontal cortical areas in postmortem brain in schizophrenia.	Neuropsychopharmacology 	2012	33
22049059	Cyclic AMP	Hsieh TH	Phthalates induce proliferation and invasiveness of estrogen receptor-negative breast cancer through the AhR/HDAC6/c-Myc signaling pathway.	FASEB journal 	2012	37
22178870	Cyclic AMP	Fatima A	In vitro modeling of ryanodine receptor 2 dysfunction using human induced pluripotent stem cells.	Cellular physiology and biochemistry 	2011	63
22179319	Cyclic AMP	Jiang M	Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets.	Nature medicine	2011	91
22241478	Cyclic AMP	Zhou B	Interactions between β-catenin and transforming growth factor-β signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP).	The Journal of biological chemistry	2012	71
22247037	Cyclic AMP	Bhattacharyya N	Mechanism of FGF23 processing in fibrous dysplasia.	Journal of bone and mineral research 	2012	30
22266668	Cyclic AMP	Gier B	Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model.	Diabetes	2012	49
22269949	Cyclic AMP	Chen W	Berardinelli-seip congenital lipodystrophy 2/seipin is a cell-autonomous regulator of lipolysis essential for adipocyte differentiation.	Molecular and cellular biology	2012	31
22285928	Cyclic AMP	Yang C	Long non-coding RNA UCA1 regulated cell cycle distribution via CREB through PI3-K dependent pathway in bladder carcinoma cells.	Gene	2012	60
22325466	Cyclic AMP	Kong WQ	MicroRNA-182 targets cAMP-responsive element-binding protein 1 and suppresses cell growth in human gastric adenocarcinoma.	The FEBS journal	2012	33
22403610	Cyclic AMP	Zhang S	ROR1 is expressed in human breast cancer and associated with enhanced tumor-cell growth.	PloS one	2012	75
22576212	Cyclic AMP	Subbaramaiah K	Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women.	Cancer discovery	2012	72
22685290	Cyclic AMP	Du Y	Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18.	The Journal of biological chemistry	2012	112
22710715	Cyclic AMP	Park MH	p21-Activated kinase 4 promotes prostate cancer progression through CREB.	Oncogene	2013	29
22778400	Cyclic AMP	Narasimamurthy R	Circadian clock protein cryptochrome regulates the expression of proinflammatory cytokines.	Proceedings of the National Academy of Sciences of the United States of America	2012	75
22951447	Cyclic AMP	Kreda SM	CFTR, mucins, and mucus obstruction in cystic fibrosis.	Cold Spring Harbor perspectives in medicine	2012	39
23019365	Cyclic AMP	Tan X	cAMP response element-binding protein promotes gliomagenesis by modulating the expression of oncogenic microRNA-23a.	Proceedings of the National Academy of Sciences of the United States of America	2012	33
23045699	Cyclic AMP	Guo C	Global identification of MLL2-targeted loci reveals MLL2's role in diverse signaling pathways.	Proceedings of the National Academy of Sciences of the United States of America	2012	34
23159879	Cyclic AMP	Lee G	Large-scale screening using familial dysautonomia induced pluripotent stem cells identifies compounds that rescue IKBKAP expression.	Nature biotechnology	2012	66
23268191	Cyclic AMP	Marsden WN	Synaptic plasticity in depression: molecular, cellular and functional correlates.	Progress in neuro-psychopharmacology & biological psychiatry	2013	38
23296467	Cyclic AMP	Luo J	Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival.	The Journal of experimental medicine	2013	39
23497056	Cyclic AMP	Suh HS	Insulin-like growth factor 1 and 2 (IGF1, IGF2) expression in human microglia: differential regulation by inflammatory mediators.	Journal of neuroinflammation	2013	40
23558954	Cyclic AMP	Dominguez CL	Diacylglycerol kinase α is a critical signaling node and novel therapeutic target in glioblastoma and other cancers.	Cancer discovery	2013	27
23589561	Cyclic AMP	Jiang DS	Role of interferon regulatory factor 4 in the regulation of pathological cardiac hypertrophy.	Hypertension	2013	29
23663782	Cyclic AMP	Csibi A	The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4.	Cell	2013	122
23979134	Cyclic AMP	Yang Z	MicroRNA-433 inhibits liver cancer cell migration by repressing the protein expression and function of cAMP response element-binding protein.	The Journal of biological chemistry	2013	29
24145604	Cyclic AMP	Chen ML	Resveratrol attenuates vascular endothelial inflammation by inducing autophagy through the cAMP signaling pathway.	Autophagy	2013	36
24315439	Cyclic AMP	Schwank G	Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients.	Cell stem cell	2013	203
24375753	Cyclic AMP	Diggs-Andrews KA	Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.	Annals of neurology	2014	23
24418614	Cyclic AMP	Coffey EE	Lysosomal alkalization and dysfunction in human fibroblasts with the Alzheimer's disease-linked presenilin 1 A246E mutation can be reversed with cAMP.	Neuroscience	2014	26
24667640	Cyclic AMP	Koga T	CaMK4-dependent activation of AKT/mTOR and CREM-α underlies autoimmunity-associated Th17 imbalance.	The Journal of clinical investigation	2014	30
24855271	Cyclic AMP	Sato Y	Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome.	Science	2014	37
25022529	Cyclic AMP	Grantham JJ	Rationale for early treatment of polycystic kidney disease.	Pediatric nephrology	2015	16
25043713	Cyclic AMP	Lopez-Sanchez I	GIV/Girdin is a central hub for profibrogenic signalling networks during liver fibrosis.	Nature communications	2014	28
25122662	Cyclic AMP	Xu L	Genomic analysis of fibrolamellar hepatocellular carcinoma.	Human molecular genetics	2015	16
25150496	Cyclic AMP	He X	The G protein α subunit Gαs is a tumor suppressor in Sonic hedgehog-driven medulloblastoma.	Nature medicine	2014	32
25159073	Cyclic AMP	Heckman PR	Phosphodiesterase inhibitors as a target for cognition enhancement in aging and Alzheimer's disease: a translational overview.	Current pharmaceutical design	2015	21
25320361	Cyclic AMP	Weed DT	Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma.	Clinical cancer research 	2015	35
25381027	Cyclic AMP	Collawn JF	CFTR and lung homeostasis.	American journal of physiology. Lung cellular and molecular physiology	2014	23
25511446	Cyclic AMP	Kamat PK	Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.	Molecular neurobiology	2016	15
25513961	Cyclic AMP	Maßberg D	Monoterpene (-)-citronellal affects hepatocarcinoma cell signaling via an olfactory receptor.	Archives of biochemistry and biophysics	2015	17
25565142	Cyclic AMP	Modali SD	Epigenetic regulation of the lncRNA MEG3 and its target c-MET in pancreatic neuroendocrine tumors.	Molecular endocrinology	2015	25
25601083	Cyclic AMP	Sanyal A	A novel link between Fic (filamentation induced by cAMP)-mediated adenylylation/AMPylation and the unfolded protein response.	The Journal of biological chemistry	2015	19
25654762	Cyclic AMP	Baron L	The NLRP3 inflammasome is activated by nanoparticles through ATP, ADP and adenosine.	Cell death & disease	2015	20
25768345	Cyclic AMP	Lorton D	Molecular mechanisms underlying β-adrenergic receptor-mediated cross-talk between sympathetic neurons and immune cells.	International journal of molecular sciences	2015	17
25878251	Cyclic AMP	Zhao P	Neutrophil Elastase Activates Protease-activated Receptor-2 (PAR2) and Transient Receptor Potential Vanilloid 4 (TRPV4) to Cause Inflammation and Pain.	The Journal of biological chemistry	2015	19
25937398	Cyclic AMP	Kreutzmann JC	Sleep deprivation and hippocampal vulnerability: changes in neuronal plasticity, neurogenesis and cognitive function.	Neuroscience	2015	19
26095046	Cyclic AMP	Wu H	Epigenetic Regulation of Phosphodiesterases 2A and 3A Underlies Compromised β-Adrenergic Signaling in an iPSC Model of Dilated Cardiomyopathy.	Cell stem cell	2015	27
26099526	Cyclic AMP	Xu MJ	Fat-Specific Protein 27/CIDEC Promotes Development of Alcoholic Steatohepatitis in Mice and Humans.	Gastroenterology	2015	23
26336032	Cyclic AMP	Widdicombe JH	Airway Gland Structure and Function.	Physiological reviews	2015	18
26632666	Cyclic AMP	Duan S	PTEN deficiency reprogrammes human neural stem cells towards a glioblastoma stem cell-like phenotype.	Nature communications	2015	18
27140397	Cyclic AMP	Chen Z	cAMP/CREB-regulated LINC00473 marks LKB1-inactivated lung cancer and mediates tumor growth.	The Journal of clinical investigation	2016	16
27144433	Cyclic AMP	Cheng HL	Nobiletin inhibits human osteosarcoma cells metastasis by blocking ERK and JNK-mediated MMPs expression.	Oncotarget	2016	12
27648837	Cyclic AMP	Hong Z	MicroRNA-138 and MicroRNA-25 Down-regulate Mitochondrial Calcium Uniporter, Causing the Pulmonary Arterial Hypertension Cancer Phenotype.	American journal of respiratory and critical care medicine	2017	10
27692610	Cyclic AMP	Guo C	Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome.	Immunity	2016	17
27721408	Cyclic AMP	Yu T	Cytoplasmic GPER translocation in cancer-associated fibroblasts mediates cAMP/PKA/CREB/glycolytic axis to confer tumor cells with multidrug resistance.	Oncogene	2017	5
27770549	Cyclic AMP	Zhang L	Long noncoding RNA MEG3 induces cholestatic liver injury by interaction with PTBP1 to facilitate shp mRNA decay.	Hepatology	2017	12
28132808	Cyclic AMP	Maus M	Store-Operated Ca2+ Entry Controls Induction of Lipolysis and the Transcriptional Reprogramming to Lipid Metabolism.	Cell metabolism	2017	10
28242433	Cyclic AMP	Havekes R	The tired hippocampus: the molecular impact of sleep deprivation on hippocampal function.	Current opinion in neurobiology	2017	7
11602621	Serotonin	Eddahibi S	Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension.	The Journal of clinical investigation	2001	101
14559886	Serotonin	Hesketh PJ	The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 Study Group.	Journal of clinical oncology 	2003	102
14642974	Serotonin	Meltzer HY	Serotonin receptors: their key role in drugs to treat schizophrenia.	Progress in neuro-psychopharmacology & biological psychiatry	2003	112
15194174	Serotonin	Humbert M	Cellular and molecular pathobiology of pulmonary arterial hypertension.	Journal of the American College of Cardiology	2004	293
15880108	Serotonin	Pezawas L	5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression.	Nature neuroscience	2005	505
15887161	Serotonin	Modlin IM	Current status of gastrointestinal carcinoids.	Gastroenterology	2005	117
16444258	Serotonin	Binstadt BA	Particularities of the vasculature can promote the organ specificity of autoimmune attack.	Nature immunology	2006	65
16530463	Serotonin	Hariri AR	Genetics of emotional regulation: the role of the serotonin transporter in neural function.	Trends in cognitive sciences	2006	202
17919129	Serotonin	Pardo CA	The neurobiology of autism.	Brain pathology	2007	123
17956909	Serotonin	Kish SJ	Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease.	Brain 	2008	72
18164737	Serotonin	Kaye W	Neurobiology of anorexia and bulimia nervosa.	Physiology & behavior	2008	83
18185497	Serotonin	Yang RJ	Variation in mouse basolateral amygdala volume is associated with differences in stress reactivity and fear learning.	Neuropsychopharmacology 	2008	52
18347599	Serotonin	Pezawas L	Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression.	Molecular psychiatry	2008	73
18639564	Serotonin	Le François B	Transcriptional regulation at a HTR1A polymorphism associated with mental illness.	Neuropharmacology	2008	55
18801471	Serotonin	Raison CL	Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression.	Biological psychiatry	2009	100
19358877	Serotonin	Savitz JB	Imaging phenotypes of major depressive disorder: genetic correlates.	Neuroscience	2009	69
19373443	Serotonin	Capela JP	Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview.	Molecular neurobiology	2009	48
19555855	Serotonin	Morrell NW	Cellular and molecular basis of pulmonary arterial hypertension.	Journal of the American College of Cardiology	2009	191
19606083	Serotonin	Boldrini M	Antidepressants increase neural progenitor cells in the human hippocampus.	Neuropsychopharmacology 	2009	165
19933774	Serotonin	Marek GJ	Glutamatergic (N-methyl-D-aspartate receptor) hypofrontality in schizophrenia: too little juice or a miswired brain?	Molecular pharmacology	2010	43
20147891	Serotonin	Frodl T	Childhood stress, serotonin transporter gene and brain structures in major depression.	Neuropsychopharmacology 	2010	42
20231323	Serotonin	Caspi A	Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits.	The American journal of psychiatry	2010	365
20385997	Serotonin	Dezentjé VO	Effect of concomitant CYP2D6 inhibitor use and tamoxifen adherence on breast cancer recurrence in early-stage breast cancer.	Journal of clinical oncology 	2010	45
21550210	Serotonin	Abdolmaleky HM	Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder.	Schizophrenia research	2011	41
21868504	Serotonin	Ciuclan L	A novel murine model of severe pulmonary arterial hypertension.	American journal of respiratory and critical care medicine	2011	61
22652019	Serotonin	Boldrini M	Hippocampal angiogenesis and progenitor cell proliferation are increased with antidepressant use in major depression.	Biological psychiatry	2012	64
22894052	Serotonin	Slominski AT	Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system.	Advances in anatomy, embryology, and cell biology	2012	158
23303074	Serotonin	Boldrini M	Hippocampal granule neuron number and dentate gyrus volume in antidepressant-treated and untreated major depression.	Neuropsychopharmacology 	2013	50
23401542	Serotonin	Mineur YS	Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety- and depression-like behavior.	Proceedings of the National Academy of Sciences of the United States of America	2013	56
24184687	Serotonin	Myint AM	Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis.	Progress in neuro-psychopharmacology & biological psychiatry	2014	25
24316398	Serotonin	El-Salhy M	Abnormal rectal endocrine cells in patients with irritable bowel syndrome.	Regulatory peptides	2014	23
24757112	Serotonin	Halliday GM	The neurobiological basis of cognitive impairment in Parkinson's disease.	Movement disorders 	2014	43
25739765	Serotonin	Schumacher SM	Paroxetine-mediated GRK2 inhibition reverses cardiac dysfunction and remodeling after myocardial infarction.	Science translational medicine	2015	26
25772380	Serotonin	Tremblay L	Selective dysfunction of basal ganglia subterritories: From movement to behavioral disorders.	Movement disorders 	2015	24
25974703	Serotonin	Hicks JK	Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.	Clinical pharmacology and therapeutics	2015	63
26096838	Serotonin	Daniel SE	Stress Modulation of Opposing Circuits in the Bed Nucleus of the Stria Terminalis.	Neuropsychopharmacology 	2016	29
7641194	Prostaglandin E2	Sano H	Expression of cyclooxygenase-1 and -2 in human colorectal cancer.	Cancer research	1995	183
9892207	Prostaglandin E2	Zimmermann KC	Cyclooxygenase-2 expression in human esophageal carcinoma.	Cancer research	1999	100
15207461	Prostaglandin E2	Meinel L	The inflammatory responses to silk films in vitro and in vivo.	Biomaterials	2005	100
16081203	Prostaglandin E2	Block ML	Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism.	Progress in neurobiology	2005	315
16319132	Prostaglandin E2	Kawamori T	Sphingosine kinase 1 is up-regulated in colon carcinogenesis.	FASEB journal 	2006	75
17606437	Prostaglandin E2	Prevosto C	Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction.	Haematologica	2007	86
18261936	Prostaglandin E2	Lago R	A new player in cartilage homeostasis: adiponectin induces nitric oxide synthase type II and pro-inflammatory cytokines in chondrocytes.	Osteoarthritis and cartilage	2008	51
19887554	Prostaglandin E2	Qamri Z	Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.	Molecular cancer therapeutics	2009	48
20945369	Prostaglandin E2	Wang J	Toll-like receptors expressed by dermal fibroblasts contribute to hypertrophic scarring.	Journal of cellular physiology	2011	36
21846384	Prostaglandin E2	Rao JS	Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in brain of HIV-1 transgenic rats.	Journal of neuroinflammation	2011	36
22182446	Prostaglandin E2	Li T	Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO.	Cancer letters	2012	37
22465232	Prostaglandin E2	Whiteside TL	What are regulatory T cells (Treg) regulating in cancer and why?	Seminars in cancer biology	2012	55
22641101	Prostaglandin E2	Xin X	Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model.	Laboratory investigation; a journal of technical methods and pathology	2012	34
23401547	Prostaglandin E2	Jiang J	Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation.	Proceedings of the National Academy of Sciences of the United States of America	2013	44
23515290	Prostaglandin E2	Vo BT	TGF-β effects on prostate cancer cell migration and invasion are mediated by PGE2 through activation of PI3K/AKT/mTOR pathway.	Endocrinology	2013	40
23935251	Prostaglandin E2	More SV	Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's disease.	Mediators of inflammation	2013	44
24213679	Prostaglandin E2	Whiteside TL	Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression?	Cancer immunology, immunotherapy 	2014	43
24431222	Prostaglandin E2	Ahmad T	Miro1 regulates intercellular mitochondrial transport & enhances mesenchymal stem cell rescue efficacy.	The EMBO journal	2014	62
24682451	Prostaglandin E2	Goolaerts A	Conditioned media from mesenchymal stromal cells restore sodium transport and preserve epithelial permeability in an in vitro model of acute alveolar injury.	American journal of physiology. Lung cellular and molecular physiology	2014	23
24793239	Prostaglandin E2	Motz GT	Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors.	Nature medicine	2014	80
25420066	Prostaglandin E2	Wainger BJ	Modeling pain in vitro using nociceptor neurons reprogrammed from fibroblasts.	Nature neuroscience	2015	32
25954974	Prostaglandin E2	Liu X	Berberine Inhibits Invasion and Metastasis of Colorectal Cancer Cells via COX-2/PGE2 Mediated JAK2/STAT3 Signaling Pathway.	PloS one	2015	21
26435067	Prostaglandin E2	Wang D	The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus.	Cellular & molecular immunology	2017	13
26573797	Prostaglandin E2	Wang X	p53: Protection against Tumor Growth beyond Effects on Cell Cycle and Apoptosis.	Cancer research	2015	25
26606969	Prostaglandin E2	Headland SE	Neutrophil-derived microvesicles enter cartilage and protect the joint in inflammatory arthritis.	Science translational medicine	2015	22
26801617	Prostaglandin E2	Martinez-Useros J	Obesity and colorectal cancer: molecular features of adipose tissue.	Journal of translational medicine	2016	24
27074574	Prostaglandin E2	Guillem-Llobat P	Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells.	Oncotarget	2016	18
27215396	Prostaglandin E2	Reinartz S	A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome.	Genome biology	2016	11
27464306	Prostaglandin E2	Maione F	Anti-inflammatory and analgesic activity of carnosol and carnosic acid in vivo and in vitro and in silico analysis of their target interactions.	British journal of pharmacology	2017	6
28237856	Prostaglandin E2	Khan NM	Wogonin, a plant derived small molecule, exerts potent anti-inflammatory and chondroprotective effects through the activation of ROS/ERK/Nrf2 signaling pathways in human Osteoarthritis chondrocytes.	Free radical biology & medicine	2017	10
11554766	Adenosine monophosphate	Imamura K	Cell cycle regulation via p53 phosphorylation by a 5'-AMP activated protein kinase activator, 5-aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line.	Biochemical and biophysical research communications	2001	110
11827995	Adenosine monophosphate	Arad M	Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy.	The Journal of clinical investigation	2002	103
14511394	Adenosine monophosphate	Hawley SA	Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade.	Journal of biology	2003	485
15358229	Adenosine monophosphate	Xiang X	AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms.	Biochemical and biophysical research communications	2004	75
15673802	Adenosine monophosphate	Arad M	Glycogen storage diseases presenting as hypertrophic cardiomyopathy.	The New England journal of medicine	2005	90
16380484	Adenosine monophosphate	Kukidome D	Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells.	Diabetes	2006	140
16397245	Adenosine monophosphate	Han S	Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.	Cancer research	2006	63
16678125	Adenosine monophosphate	Dieudonne MN	Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells.	Biochemical and biophysical research communications	2006	70
16805776	Adenosine monophosphate	Moncada S	Nitric oxide, cell bioenergetics and neurodegeneration.	Journal of neurochemistry	2006	98
16873412	Adenosine monophosphate	Dreyer HC	Resistance exercise increases AMPK activity and reduces 4E-BP1 phosphorylation and protein synthesis in human skeletal muscle.	The Journal of physiology	2006	130
16885382	Adenosine monophosphate	Xu Y	Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins.	Cancer research	2006	104
17522440	Adenosine monophosphate	Sultana R	Proteomics analysis of the Alzheimer's disease hippocampal proteome.	Journal of Alzheimer's disease 	2007	66
18006825	Adenosine monophosphate	Dowling RJ	Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells.	Cancer research	2007	269
18167336	Adenosine monophosphate	Hallstrom TC	An E2F1-dependent gene expression program that determines the balance between proliferation and cell death.	Cancer cell	2008	93
18227155	Adenosine monophosphate	Hezel AF	Pancreatic LKB1 deletion leads to acinar polarity defects and cystic neoplasms.	Molecular and cellular biology	2008	66
18387000	Adenosine monophosphate	Huang X	Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice.	The Biochemical journal	2008	133
18403135	Adenosine monophosphate	Hasumi H	Identification and characterization of a novel folliculin-interacting protein FNIP2.	Gene	2008	63
19106626	Adenosine monophosphate	Vazquez-Martin A	The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells.	Cell cycle	2009	74
19138981	Adenosine monophosphate	Zakikhani M	The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase.	Cancer prevention research	2008	80
19261992	Adenosine monophosphate	Shibata R	Adiponectin and cardiovascular disease.	Circulation journal 	2009	53
19372545	Adenosine monophosphate	Park HU	AMP-activated protein kinase promotes human prostate cancer cell growth and survival.	Molecular cancer therapeutics	2009	56
19468337	Adenosine monophosphate	Dzeja P	Adenylate kinase and AMP signaling networks: metabolic monitoring, signal communication and body energy sensing.	International journal of molecular sciences	2009	59
19483724	Adenosine monophosphate	Taliaferro-Smith L	LKB1 is required for adiponectin-mediated modulation of AMPK-S6K axis and inhibition of migration and invasion of breast cancer cells.	Oncogene	2009	47
19549896	Adenosine monophosphate	Racanelli AC	Therapeutics by cytotoxic metabolite accumulation: pemetrexed causes ZMP accumulation, AMPK activation, and mammalian target of rapamycin inhibition.	Cancer research	2009	59
19679549	Adenosine monophosphate	Kisfalvi K	Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth.	Cancer research	2009	109
19710915	Adenosine monophosphate	Scaglia N	Inhibition of stearoylCoA desaturase-1 inactivates acetyl-CoA carboxylase and impairs proliferation in cancer cells: role of AMPK.	PloS one	2009	49
20209079	Adenosine monophosphate	Soscia SJ	The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide.	PloS one	2010	162
20388847	Adenosine monophosphate	Rozengurt E	Crosstalk between insulin/insulin-like growth factor-1 receptors and G protein-coupled receptor signaling systems: a novel target for the antidiabetic drug metformin in pancreatic cancer.	Clinical cancer research 	2010	80
20530718	Adenosine monophosphate	Fritz V	Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice.	Molecular cancer therapeutics	2010	45
20637208	Adenosine monophosphate	Saxena NK	Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma.	Gastroenterology	2010	45
20810185	Adenosine monophosphate	Rautou PE	Autophagy in liver diseases.	Journal of hepatology	2010	99
20878915	Adenosine monophosphate	Budanov AV	Stressin' Sestrins take an aging fight.	EMBO molecular medicine	2010	58
20880848	Adenosine monophosphate	Zhang WB	Activation of AMP-activated protein kinase by temozolomide contributes to apoptosis in glioblastoma cells via p53 activation and mTORC1 inhibition.	The Journal of biological chemistry	2010	43
20957377	Adenosine monophosphate	Vingtdeux V	AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies.	Acta neuropathologica	2011	54
20972457	Adenosine monophosphate	El Mjiyad N	Sugar-free approaches to cancer cell killing.	Oncogene	2011	58
20980833	Adenosine monophosphate	Vucicevic L	Compound C induces protective autophagy in cancer cells through AMPK inhibition-independent blockade of Akt/mTOR pathway.	Autophagy	2011	44
21074987	Adenosine monophosphate	Brahimi-Horn MC	Hypoxia and energetic tumour metabolism.	Current opinion in genetics & development	2011	68
21098087	Adenosine monophosphate	Frigo DE	CaM kinase kinase beta-mediated activation of the growth regulatory kinase AMPK is required for androgen-dependent migration of prostate cancer cells.	Cancer research	2011	39
21147110	Adenosine monophosphate	Calvisi DF	Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.	Gastroenterology	2011	98
21195169	Adenosine monophosphate	Chen L	Cadmium induction of reactive oxygen species activates the mTOR pathway, leading to neuronal cell death.	Free radical biology & medicine	2011	42
21262823	Adenosine monophosphate	Takiar V	Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis.	Proceedings of the National Academy of Sciences of the United States of America	2011	51
21540236	Adenosine monophosphate	Ben Sahra I	Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1.	Cancer research	2011	162
21567395	Adenosine monophosphate	Lim JY	AMP-activated protein kinase inhibits TGF-β-induced fibrogenic responses of hepatic stellate cells by targeting transcriptional coactivator p300.	Journal of cellular physiology	2012	33
21613612	Adenosine monophosphate	Pirkmajer S	Serum starvation: caveat emptor.	American journal of physiology. Cell physiology	2011	39
21623793	Adenosine monophosphate	Salminen A	AMP-activated protein kinase: a potential player in Alzheimer's disease.	Journal of neurochemistry	2011	46
21768291	Adenosine monophosphate	Ju TC	Nuclear translocation of AMPK-alpha1 potentiates striatal neurodegeneration in Huntington's disease.	The Journal of cell biology	2011	51
21980456	Adenosine monophosphate	Wang Q	Activation of AMP-activated protein kinase is required for berberine-induced reduction of atherosclerosis in mice: the role of uncoupling protein 2.	PloS one	2011	36
22001850	Adenosine monophosphate	Wu SB	AMPK-mediated increase of glycolysis as an adaptive response to oxidative stress in human cells: implication of the cell survival in mitochondrial diseases.	Biochimica et biophysica acta	2012	33
22048125	Adenosine monophosphate	Son SM	Aβ-induced formation of autophagosomes is mediated by RAGE-CaMKKβ-AMPK signaling.	Neurobiology of aging	2012	32
22049153	Adenosine monophosphate	Young LE	The mRNA stability factor HuR inhibits microRNA-16 targeting of COX-2.	Molecular cancer research 	2012	61
22120676	Adenosine monophosphate	Kim HS	Berberine-induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression.	Biochemical pharmacology	2012	34
22323564	Adenosine monophosphate	Xu XJ	Insulin sensitive and resistant obesity in humans: AMPK activity, oxidative stress, and depot-specific changes in gene expression in adipose tissue.	Journal of lipid research	2012	45
22341444	Adenosine monophosphate	Raimundo N	Mitochondrial stress engages E2F1 apoptotic signaling to cause deafness.	Cell	2012	58
22363791	Adenosine monophosphate	Sanli T	Sestrin2 modulates AMPK subunit expression and its response to ionizing radiation in breast cancer cells.	PloS one	2012	38
22378068	Adenosine monophosphate	Shi WY	Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy.	Cell death & disease	2012	56
22576211	Adenosine monophosphate	Martin MJ	Metformin accelerates the growth of BRAF V600E-driven melanoma by upregulating VEGF-A.	Cancer discovery	2012	36
22722266	Adenosine monophosphate	Salem AF	Two-compartment tumor metabolism: autophagy in the tumor microenvironment and oxidative mitochondrial metabolism (OXPHOS) in cancer cells.	Cell cycle	2012	43
22728651	Adenosine monophosphate	Lee CW	AMPK promotes p53 acetylation via phosphorylation and inactivation of SIRT1 in liver cancer cells.	Cancer research	2012	54
22750049	Adenosine monophosphate	O'Neill HM	AMPK regulation of fatty acid metabolism and mitochondrial biogenesis: implications for obesity.	Molecular and cellular endocrinology	2013	45
22929303	Adenosine monophosphate	Ogura Y	Therapeutic impact of follistatin-like 1 on myocardial ischemic injury in preclinical models.	Circulation	2012	36
22975376	Adenosine monophosphate	Chae YC	Control of tumor bioenergetics and survival stress signaling by mitochondrial HSP90s.	Cancer cell	2012	30
23160380	Adenosine monophosphate	Avivar-Valderas A	Regulation of autophagy during ECM detachment is linked to a selective inhibition of mTORC1 by PERK.	Oncogene	2013	30
23169238	Adenosine monophosphate	Huang H	Hepatitis C virus inhibits AKT-tuberous sclerosis complex (TSC), the mechanistic target of rapamycin (MTOR) pathway, through endoplasmic reticulum stress to induce autophagy.	Autophagy	2013	36
23186644	Adenosine monophosphate	Noyan-Ashraf MH	A glucagon-like peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesity.	Circulation	2013	49
23197693	Adenosine monophosphate	Sato A	Glioma-initiating cell elimination by metformin activation of FOXO3 via AMPK.	Stem cells translational medicine	2012	40
23278683	Adenosine monophosphate	Tacar O	Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems.	The Journal of pharmacy and pharmacology	2013	184
23325217	Adenosine monophosphate	O'Neill LA	Metabolism of inflammation limited by AMPK and pseudo-starvation.	Nature	2013	255
23562077	Adenosine monophosphate	Mansuy-Aubert V	Imbalance between neutrophil elastase and its inhibitor α1-antitrypsin in obesity alters insulin sensitivity, inflammation, and energy expenditure.	Cell metabolism	2013	39
23567191	Adenosine monophosphate	Chaturvedi RK	Mitochondrial diseases of the brain.	Free radical biology & medicine	2013	64
23587167	Adenosine monophosphate	Hardie DG	LKB1 and AMPK and the cancer-metabolism link - ten years after.	BMC biology	2013	81
23632475	Adenosine monophosphate	Storozhuk Y	Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK.	British journal of cancer	2013	58
23688501	Adenosine monophosphate	Sid B	Role of AMPK activation in oxidative cell damage: Implications for alcohol-induced liver disease.	Biochemical pharmacology	2013	31
23696823	Adenosine monophosphate	Endo H	Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis.	PloS one	2013	39
23712032	Adenosine monophosphate	Chen MB	Activation of AMP-activated protein kinase (AMPK) mediates plumbagin-induced apoptosis and growth inhibition in cultured human colon cancer cells.	Cellular signalling	2013	28
23899558	Adenosine monophosphate	Chen MB	MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.	Cellular signalling	2014	35
23932046	Adenosine monophosphate	Palomer X	An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.	International journal of cardiology	2013	35
23942093	Adenosine monophosphate	Zheng L	Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.	Clinical cancer research 	2013	43
24055102	Adenosine monophosphate	Lee JH	Sestrins orchestrate cellular metabolism to attenuate aging.	Cell metabolism	2013	61
24080159	Adenosine monophosphate	She C	Activation of AMPK protects against hydrogen peroxide-induced osteoblast apoptosis through autophagy induction and NADPH maintenance: new implications for osteonecrosis treatment?	Cellular signalling	2014	22
24095280	Adenosine monophosphate	Shen CH	Phosphorylation of BRAF by AMPK impairs BRAF-KSR1 association and cell proliferation.	Molecular cell	2013	29
24096736	Adenosine monophosphate	Qu C	Metformin reverses multidrug resistance and epithelial-mesenchymal transition (EMT) via activating AMP-activated protein kinase (AMPK) in human breast cancer cells.	Molecular and cellular biochemistry	2014	29
24100703	Adenosine monophosphate	Sanli T	AMP-activated protein kinase (AMPK) beyond metabolism: a novel genomic stress sensor participating in the DNA damage response pathway.	Cancer biology & therapy	2014	45
24338509	Adenosine monophosphate	Hadad SM	Effects of metformin on breast cancer cell proliferation, the AMPK pathway and the cell cycle.	Clinical & translational oncology 	2014	23
24366076	Adenosine monophosphate	Xu X	Macrophage migration inhibitory factor deletion exacerbates pressure overload-induced cardiac hypertrophy through mitigating autophagy.	Hypertension	2014	21
24419061	Adenosine monophosphate	Liu X	The AMPK inhibitor compound C is a potent AMPK-independent antiglioma agent.	Molecular cancer therapeutics	2014	43
24419232	Adenosine monophosphate	Dallaglio K	Paradoxic effects of metformin on endothelial cells and angiogenesis.	Carcinogenesis	2014	26
24651621	Adenosine monophosphate	Zhang Y	Cartilage-specific deletion of mTOR upregulates autophagy and protects mice from osteoarthritis.	Annals of the rheumatic diseases	2015	45
24662833	Adenosine monophosphate	Nguyen HG	Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model.	Oncogene	2014	34
24726383	Adenosine monophosphate	Burkewitz K	AMPK at the nexus of energetics and aging.	Cell metabolism	2014	48
24768874	Adenosine monophosphate	Kataoka Y	Omentin prevents myocardial ischemic injury through AMP-activated protein kinase- and Akt-dependent mechanisms.	Journal of the American College of Cardiology	2014	21
24813208	Adenosine monophosphate	Ablasser A	TREX1 deficiency triggers cell-autonomous immunity in a cGAS-dependent manner.	Journal of immunology	2014	30
24847102	Adenosine monophosphate	Gano LB	Ketogenic diets, mitochondria, and neurological diseases.	Journal of lipid research	2014	26
25047736	Adenosine monophosphate	Jin X	Delphinidin-3-glucoside protects human umbilical vein endothelial cells against oxidized low-density lipoprotein-induced injury by autophagy upregulation via the AMPK/SIRT1 signaling pathway.	Molecular nutrition & food research	2014	25
25241895	Adenosine monophosphate	Vincent EE	Differential effects of AMPK agonists on cell growth and metabolism.	Oncogene	2015	36
25417601	Adenosine monophosphate	Schuler KM	Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer.	Cancer medicine	2015	24
25449221	Adenosine monophosphate	Ambalavanan N	Integrated genomic analyses in bronchopulmonary dysplasia.	The Journal of pediatrics	2015	18
25548474	Adenosine monophosphate	Ceni E	Pathogenesis of alcoholic liver disease: role of oxidative metabolism.	World journal of gastroenterology	2014	34
25609923	Adenosine monophosphate	Yuan CX	Inhibition of mitotic Aurora kinase A by alisertib induces apoptosis and autophagy of human gastric cancer AGS and NCI-N78 cells.	Drug design, development and therapy	2015	16
25632225	Adenosine monophosphate	Wang F	Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.	Drug design, development and therapy	2015	15
25730670	Adenosine monophosphate	Xie Q	Mitochondrial control by DRP1 in brain tumor initiating cells.	Nature neuroscience	2015	49
25834399	Adenosine monophosphate	Zhou ZW	Induction of apoptosis and autophagy via sirtuin1- and PI3K/Akt/mTOR-mediated pathways by plumbagin in human prostate cancer cells.	Drug design, development and therapy	2015	21
25849721	Adenosine monophosphate	Dowling RJ	Changes in insulin receptor signaling underlie neoadjuvant metformin administration in breast cancer: a prospective window of opportunity neoadjuvant study.	Breast cancer research 	2015	17
25862373	Adenosine monophosphate	Kato H	Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor.	Biochemical and biophysical research communications	2015	17
25940306	Adenosine monophosphate	O'Brien AJ	Salicylate activates AMPK and synergizes with metformin to reduce the survival of prostate and lung cancer cells ex vivo through inhibition of de novo lipogenesis.	The Biochemical journal	2015	17
26116623	Adenosine monophosphate	Chen MB	C6 ceramide dramatically increases vincristine sensitivity both in vivo and in vitro, involving AMP-activated protein kinase-p53 signaling.	Carcinogenesis	2015	19
26202455	Adenosine monophosphate	Hung CH	Quercetin is a potent anti-atherosclerotic compound by activation of SIRT1 signaling under oxLDL stimulation.	Molecular nutrition & food research	2015	17
26223300	Adenosine monophosphate	Cai H	Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice.	Science translational medicine	2015	23
26271666	Adenosine monophosphate	Hu X	Compound 13, an α1-selective small molecule activator of AMPK, potently inhibits melanoma cell proliferation.	Tumour biology 	2016	10
26431379	Adenosine monophosphate	Yu Z	Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo.	Oncotarget	2015	22
26440282	Adenosine monophosphate	Saito Y	AMPK Protects Leukemia-Initiating Cells in Myeloid Leukemias from Metabolic Stress in the Bone Marrow.	Cell stem cell	2015	25
26565381	Adenosine monophosphate	Farago AF	Durable Clinical Response to Entrectinib in NTRK1-Rearranged Non-Small Cell Lung Cancer.	Journal of thoracic oncology 	2015	19
26625127	Adenosine monophosphate	Griss T	Metformin Antagonizes Cancer Cell Proliferation by Suppressing Mitochondrial-Dependent Biosynthesis.	PLoS biology	2015	32
26655904	Adenosine monophosphate	Joshi S	The Genomic Landscape of Renal Oncocytoma Identifies a Metabolic Barrier to Tumorigenesis.	Cell reports	2015	17
26678338	Adenosine monophosphate	von Eyss B	A MYC-Driven Change in Mitochondrial Dynamics Limits YAP/TAZ Function in Mammary Epithelial Cells and Breast Cancer.	Cancer cell	2015	23
26708719	Adenosine monophosphate	Cubero FJ	Combined Activities of JNK1 and JNK2 in Hepatocytes Protect Against Toxic Liver Injury.	Gastroenterology	2016	13
26772531	Adenosine monophosphate	Daskalopoulos EP	AMPK in cardiac fibrosis and repair: Actions beyond metabolic regulation.	Journal of molecular and cellular cardiology	2016	10
26784987	Adenosine monophosphate	Sullivan K	Identification of a Small Molecule Inhibitor of RAD52 by Structure-Based Selection.	PloS one	2016	11
26811496	Adenosine monophosphate	Law BY	Hernandezine, a novel AMPK activator induces autophagic cell death in drug-resistant cancers.	Oncotarget	2016	17
26999735	Adenosine monophosphate	Liu X	LncRNA NBR2 engages a metabolic checkpoint by regulating AMPK under energy stress.	Nature cell biology	2016	33
27001618	Adenosine monophosphate	Shah SA	Novel osmotin inhibits SREBP2 via the AdipoR1/AMPK/SIRT1 pathway to improve Alzheimer's disease neuropathological deficits.	Molecular psychiatry	2017	10
27057473	Adenosine monophosphate	Figueiró F	Phenotypic and functional characteristics of CD39high human regulatory B cells (Breg).	Oncoimmunology	2016	11
27381825	Adenosine monophosphate	Shi X	Sestrin2, as a negative feedback regulator of mTOR, provides neuroprotection by activation AMPK phosphorylation in neonatal hypoxic-ischemic encephalopathy in rat pups.	Journal of cerebral blood flow and metabolism 	2017	7
27416781	Adenosine monophosphate	Jeon SM	Regulation and function of AMPK in physiology and diseases.	Experimental & molecular medicine	2016	30
27418629	Adenosine monophosphate	Cameron AR	Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status.	Circulation research	2016	20
28099841	Adenosine monophosphate	Momcilovic M	Targeted Inhibition of EGFR and Glutaminase Induces Metabolic Crisis in EGFR Mutant Lung Cancer.	Cell reports	2017	10
28137967	Adenosine monophosphate	Zhang ZH	Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.	The Journal of neuroscience 	2017	7
28197628	Adenosine monophosphate	Chang CH	Resveratrol-induced autophagy and apoptosis in cisplatin-resistant human oral cancer CAR cells: A key role of AMPK and Akt/mTOR signaling.	International journal of oncology	2017	6
28552616	Adenosine monophosphate	Li X	Nucleus-Translocated ACSS2 Promotes Gene Transcription for Lysosomal Biogenesis and Autophagy.	Molecular cell	2017	6
11672522	NAD	Luo J	Negative control of p53 by Sir2alpha promotes cell survival under stress.	Cell	2001	654
12006491	NAD	Langley E	Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence.	The EMBO journal	2002	237
12618962	NAD	van der Walt JM	Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease.	American journal of human genetics	2003	142
12736687	NAD	Anderson RM	Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae.	Nature	2003	238
15684044	NAD	Kuzmichev A	Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation.	Proceedings of the National Academy of Sciences of the United States of America	2005	139
16207712	NAD	Pillai JB	Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2alpha deacetylase activity.	The Journal of biological chemistry	2005	123
16751189	NAD	Qin W	Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction.	The Journal of biological chemistry	2006	163
17889652	NAD	Yang H	Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival.	Cell	2007	302
18235502	NAD	Zhao W	Negative regulation of the deacetylase SIRT1 by DBC1.	Nature	2008	191
18364004	NAD	Katz JB	Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape.	Immunological reviews	2008	106
18414679	NAD	Firestein R	The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth.	PloS one	2008	200
18607376	NAD	Palmieri L	Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1.	Molecular psychiatry	2010	49
19060927	NAD	Lara E	Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect.	Oncogene	2009	69
19433578	NAD	Kabra N	SirT1 is an inhibitor of proliferation and tumor formation in colon cancer.	The Journal of biological chemistry	2009	46
20644332	NAD	Kao CL	Resveratrol protects human endothelium from H(2)O(2)-induced oxidative stress and senescence via SirT1 activation.	Journal of atherosclerosis and thrombosis	2010	54
21300765	NAD	Végran F	Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-κB/IL-8 pathway that drives tumor angiogenesis.	Cancer research	2011	120
21397863	NAD	Finley LW	SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization.	Cancer cell	2011	221
21920899	NAD	Elangovan S	SIRT1 is essential for oncogenic signaling by estrogen/estrogen receptor α in breast cancer.	Cancer research	2011	37
22146883	NAD	Chen HC	SIRT1 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma and its expression predicts poor prognosis.	Annals of surgical oncology	2012	41
22179316	NAD	Jeong H	Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway.	Nature medicine	2011	91
22340598	NAD	Li L	Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib.	Cancer cell	2012	121
22546858	NAD	Yao H	SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice.	The Journal of clinical investigation	2012	92
22589701	NAD	Lu W	Novel role of NOX in supporting aerobic glycolysis in cancer cells with mitochondrial dysfunction and as a potential target for cancer therapy.	PLoS biology	2012	33
22682224	NAD	Cantó C	The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity.	Cell metabolism	2012	200
23056490	NAD	Latifi A	Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors.	PloS one	2012	51
23417962	NAD	Donmez G	SIRT1 and SIRT2: emerging targets in neurodegeneration.	EMBO molecular medicine	2013	58
24184811	NAD	Li Y	Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21.	Gastroenterology	2014	44
24439680	NAD	Hubbard BP	Small molecule SIRT1 activators for the treatment of aging and age-related diseases.	Trends in pharmacological sciences	2014	89
25028121	NAD	Pal R	Src-dependent impairment of autophagy by oxidative stress in a mouse model of Duchenne muscular dystrophy.	Nature communications	2014	44
25280219	NAD	Li L	SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human FLT3-ITD acute myeloid leukemia stem cells.	Cell stem cell	2014	30
26788256	NAD	Santos L	Potential Modulation of Sirtuins by Oxidative Stress.	Oxidative medicine and cellular longevity	2016	11
26959057	NAD	Buhrmann C	Sirt1 Is Required for Resveratrol-Mediated Chemopreventive Effects in Colorectal Cancer Cells.	Nutrients	2016	13
28143522	NAD	Drew DA	ASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trial.	Trials	2017	6
28223550	NAD	Bonuccelli G	NADH autofluorescence, a new metabolic biomarker for cancer stem cells: Identification of Vitamin C and CAPE as natural products targeting "stemness".	Oncotarget	2017	8
8358726	Cytarabine	Kaufmann SH	Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis.	Cancer research	1993	281
10653870	Cytarabine	Kantarjian HM	Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia.	Journal of clinical oncology 	2000	103
10815900	Cytarabine	Tamm I	Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias.	Clinical cancer research 	2000	129
12200686	Cytarabine	Konopleva M	Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins.	Leukemia	2002	102
12702506	Cytarabine	Xu Q	Survival of acute myeloid leukemia cells requires PI3 kinase activation.	Blood	2003	111
15687234	Cytarabine	Guzman ML	The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells.	Blood	2005	163
18000167	Cytarabine	Lange BJ	Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group.	Blood	2008	77
18200035	Cytarabine	Zhang W	Sorafenib induces apoptosis of AML cells via Bim-mediated activation of the intrinsic apoptotic pathway.	Leukemia	2008	61
19194470	Cytarabine	Flotho C	The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells.	Leukemia	2009	67
20212254	Cytarabine	Ravandi F	Phase I/II study of combination therapy with sorafenib, idarubicin, and cytarabine in younger patients with acute myeloid leukemia.	Journal of clinical oncology 	2010	100
20215516	Cytarabine	Jin Y	Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species.	Cancer research	2010	92
20451454	Cytarabine	Rubnitz JE	Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial.	The Lancet. Oncology	2010	94
20528872	Cytarabine	Romaguera JE	Ten-year follow-up after intense chemoimmunotherapy with Rituximab-HyperCVAD alternating with Rituximab-high dose methotrexate/cytarabine (R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma.	British journal of haematology	2010	46
20660832	Cytarabine	Gisselbrecht C	Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era.	Journal of clinical oncology 	2010	159
20841507	Cytarabine	Schwind S	BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.	Blood	2010	41
20876803	Cytarabine	Chiarini F	Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against T-cell acute lymphoblastic leukemia.	Cancer research	2010	56
21175313	Cytarabine	Preudhomme C	Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia.	The New England journal of medicine	2010	61
21233840	Cytarabine	Cristóbal I	PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect.	Leukemia	2011	46
21947824	Cytarabine	Thieblemont C	The germinal center/activated B-cell subclassification has a prognostic impact for response to salvage therapy in relapsed/refractory diffuse large B-cell lymphoma: a bio-CORAL study.	Journal of clinical oncology 	2011	44
22753902	Cytarabine	Mendler JH	RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures.	Journal of clinical oncology 	2012	51
23249862	Cytarabine	Herrmann H	Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML.	Oncotarget	2012	45
23321257	Cytarabine	Jourdan E	Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia.	Blood	2013	39
23526416	Cytarabine	Estey EH	Acute myeloid leukemia: 2013 update on risk-stratification and management.	American journal of hematology	2013	70
23676502	Cytarabine	Chen Y	CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia.	The Journal of clinical investigation	2013	49
24708856	Cytarabine	Palma CA	MicroRNA-155 as an inducer of apoptosis and cell differentiation in Acute Myeloid Leukaemia.	Molecular cancer	2014	27
24872388	Cytarabine	Weng H	Inhibition of miR-17 and miR-20a by oridonin triggers apoptosis and reverses chemoresistance by derepressing BIM-S.	Cancer research	2014	23
24943107	Cytarabine	Oki Y	Double hit lymphoma: the MD Anderson Cancer Center clinical experience.	British journal of haematology	2014	31
25710880	Cytarabine	Mussai F	Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target.	Blood	2015	17
26738796	Cytarabine	Singh N	Early memory phenotypes drive T cell proliferation in patients with pediatric malignancies.	Science translational medicine	2016	18
26968357	Cytarabine	Garcia-Manero G	Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial.	The Lancet. Oncology	2016	12
27103402	Cytarabine	Niu X	Binding of Released Bim to Mcl-1 is a Mechanism of Intrinsic Resistance to ABT-199 which can be Overcome by Combination with Daunorubicin or Cytarabine in AML Cells.	Clinical cancer research 	2016	11
27941792	Cytarabine	Göllner S	Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia.	Nature medicine	2017	11
28416471	Cytarabine	Farge T	Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism.	Cancer discovery	2017	7
17710231	Uridine 5'-diphosphate	Ichikawa S	A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis.	The Journal of clinical investigation	2007	104
17906960	Uridine 5'-diphosphate	Marchetti P	The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients.	Diabetologia	2007	110
18701722	Uridine 5'-diphosphate	Lau KS	N-Glycans in cancer progression.	Glycobiology	2008	109
23223517	Uridine 5'-diphosphate	Hardwick RN	Altered UDP-glucuronosyltransferase and sulfotransferase expression and function during progressive stages of human nonalcoholic fatty liver disease.	Drug metabolism and disposition	2013	25
23592772	Uridine 5'-diphosphate	Ma Z	Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.	The Journal of biological chemistry	2013	54
24630721	Uridine 5'-diphosphate	Wang ZV	Spliced X-box binding protein 1 couples the unfolded protein response to hexosamine biosynthetic pathway.	Cell	2014	55
24759912	Uridine 5'-diphosphate	Yuzwa SA	O-GlcNAc and neurodegeneration: biochemical mechanisms and potential roles in Alzheimer's disease and beyond.	Chemical Society reviews	2014	25
24870236	Uridine 5'-diphosphate	Zahreddine HA	The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation.	Nature	2014	43
24931394	Uridine 5'-diphosphate	Stray-Pedersen A	PGM3 mutations cause a congenital disorder of glycosylation with severe immunodeficiency and skeletal dysplasia.	American journal of human genetics	2014	21
25002140	Uridine 5'-diphosphate	Nishino I	GNE myopathy: current update and future therapy.	Journal of neurology, neurosurgery, and psychiatry	2015	21
25233931	Uridine 5'-diphosphate	Murphy SE	Nicotine N-glucuronidation relative to N-oxidation and C-oxidation and UGT2B10 genotype in five ethnic/racial groups.	Carcinogenesis	2014	36
25422324	Uridine 5'-diphosphate	Wu Q	Decreased expression of hepatocyte nuclear factor 4α (Hnf4α)/microRNA-122 (miR-122) axis in hepatitis B virus-associated hepatocellular carcinoma enhances potential oncogenic GALNT10 protein activity.	The Journal of biological chemistry	2015	15
25657018	Uridine 5'-diphosphate	Wikoff WR	Metabolomic markers of altered nucleotide metabolism in early stage adenocarcinoma.	Cancer prevention research	2015	16
26092931	Uridine 5'-diphosphate	Nabi IR	The galectin lattice at a glance.	Journal of cell science	2015	37
26417955	Uridine 5'-diphosphate	Gammal RS	Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing.	Clinical pharmacology and therapeutics	2016	20
26503631	Uridine 5'-diphosphate	Roy HK	Spectral biomarkers for chemoprevention of colonic neoplasia: a placebo-controlled double-blinded trial with aspirin.	Gut	2017	8
27130732	Uridine 5'-diphosphate	Praissman JL	The functional O-mannose glycan on α-dystroglycan contains a phospho-ribitol primed for matriglycan addition.	eLife	2016	17
11499871	4,4'-Methylenedianiline	Yoneda T	A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro.	Journal of bone and mineral research 	2001	129
11805321	4,4'-Methylenedianiline	Kang DC	mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties.	Proceedings of the National Academy of Sciences of the United States of America	2002	166
12359858	4,4'-Methylenedianiline	Wang F	Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts.	Journal of the National Cancer Institute	2002	112
14518029	4,4'-Methylenedianiline	van Bokhoven A	Molecular characterization of human prostate carcinoma cell lines.	The Prostate	2003	146
15313925	4,4'-Methylenedianiline	Osta WA	EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy.	Cancer research	2004	98
15599396	4,4'-Methylenedianiline	Boucharaba A	Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer.	The Journal of clinical investigation	2004	103
17018625	4,4'-Methylenedianiline	Cai W	In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin alpha v beta 3.	Cancer research	2006	70
17145894	4,4'-Methylenedianiline	Wang Y	Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice.	Cancer research	2006	69
17179479	4,4'-Methylenedianiline	Phillips TM	The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation.	Journal of the National Cancer Institute	2006	416
17332325	4,4'-Methylenedianiline	Cheng GZ	Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel.	Cancer research	2007	170
17339367	4,4'-Methylenedianiline	Pledgie-Tracy A	Sulforaphane induces cell type-specific apoptosis in human breast cancer cell lines.	Molecular cancer therapeutics	2007	72
17483326	4,4'-Methylenedianiline	Hiraga T	Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.	Cancer research	2007	70
17671502	4,4'-Methylenedianiline	Tomlins SA	Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.	Nature	2007	285
18089802	4,4'-Methylenedianiline	Olmeda D	SNAI1 is required for tumor growth and lymph node metastasis of human breast carcinoma MDA-MB-231 cells.	Cancer research	2007	61
18182989	4,4'-Methylenedianiline	Grossmann ME	Effects of adiponectin on breast cancer cell growth and signaling.	British journal of cancer	2008	55
18353781	4,4'-Methylenedianiline	Cheng GZ	Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function.	The Journal of biological chemistry	2008	83
18504431	4,4'-Methylenedianiline	Bhaumik D	Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells.	Oncogene	2008	192
18681906	4,4'-Methylenedianiline	Croker AK	High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability.	Journal of cellular and molecular medicine	2009	139
18794155	4,4'-Methylenedianiline	Stan SD	Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo.	Cancer research	2008	68
18829534	4,4'-Methylenedianiline	Pratap J	Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells.	Cancer research	2008	65
19011242	4,4'-Methylenedianiline	Chen M	Integrin alpha6beta4 controls the expression of genes associated with cell motility, invasion, and metastasis, including S100A4/metastasin.	The Journal of biological chemistry	2009	56
19067525	4,4'-Methylenedianiline	Wang L	Improving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers.	Molecular pharmaceutics	2009	47
19158675	4,4'-Methylenedianiline	Hornung V	AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC.	Nature	2009	609
19190326	4,4'-Methylenedianiline	Hurst DR	Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis.	Cancer research	2009	146
19238171	4,4'-Methylenedianiline	Wu H	Suppression of cell growth and invasion by miR-205 in breast cancer.	Cell research	2009	117
19243594	4,4'-Methylenedianiline	Eiseler T	Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion.	Breast cancer research 	2009	58
19276163	4,4'-Methylenedianiline	McGovern UB	Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer.	Molecular cancer therapeutics	2009	49
19435893	4,4'-Methylenedianiline	Miller TW	Loss of Phosphatase and Tensin homologue deleted on chromosome 10 engages ErbB3 and insulin-like growth factor-I receptor signaling to promote antiestrogen resistance in breast cancer.	Cancer research	2009	57
19509223	4,4'-Methylenedianiline	Zhang H	Dual activity lysophosphatidic acid receptor pan-antagonist/autotaxin inhibitor reduces breast cancer cell migration in vitro and causes tumor regression in vivo.	Cancer research	2009	45
19546228	4,4'-Methylenedianiline	Jo M	Reversibility of epithelial-mesenchymal transition (EMT) induced in breast cancer cells by activation of urokinase receptor-dependent cell signaling.	The Journal of biological chemistry	2009	55
19620789	4,4'-Methylenedianiline	Besch R	Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells.	The Journal of clinical investigation	2009	100
19720836	4,4'-Methylenedianiline	Lu X	Chemokine (C-C motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone.	The Journal of biological chemistry	2009	67
19767768	4,4'-Methylenedianiline	Shao R	YKL-40, a secreted glycoprotein, promotes tumor angiogenesis.	Oncogene	2009	81
20145128	4,4'-Methylenedianiline	Ward CS	Noninvasive detection of target modulation following phosphatidylinositol 3-kinase inhibition using hyperpolarized 13C magnetic resonance spectroscopy.	Cancer research	2010	66
20179208	4,4'-Methylenedianiline	Zhong Z	Cyclin D1/cyclin-dependent kinase 4 interacts with filamin A and affects the migration and invasion potential of breast cancer cells.	Cancer research	2010	47
20188164	4,4'-Methylenedianiline	Banerjee A	HIV proteins (gp120 and Tat) and methamphetamine in oxidative stress-induced damage in the brain: potential role of the thiol antioxidant N-acetylcysteine amide.	Free radical biology & medicine	2010	42
20406981	4,4'-Methylenedianiline	Bhutia SK	Mechanism of autophagy to apoptosis switch triggered in prostate cancer cells by antitumor cytokine melanoma differentiation-associated gene 7/interleukin-24.	Cancer research	2010	53
20460522	4,4'-Methylenedianiline	Nimmagadda S	Molecular imaging of CXCR4 receptor expression in human cancer xenografts with 64CuAMD3100 positron emission tomography.	Cancer research	2010	45
20580095	4,4'-Methylenedianiline	Miguel-Hidalgo JJ	Glial and glutamatergic markers in depression, alcoholism, and their comorbidity.	Journal of affective disorders	2010	46
20843787	4,4'-Methylenedianiline	Bourguignon LY	Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.	The Journal of biological chemistry	2010	57
21189326	4,4'-Methylenedianiline	Johnson RW	TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling.	Cancer research	2011	57
21242971	4,4'-Methylenedianiline	Yu F	Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion.	Oncogene	2011	120
21245912	4,4'-Methylenedianiline	Nasirudeen AM	RIG-I, MDA5 and TLR3 synergistically play an important role in restriction of dengue virus infection.	PLoS neglected tropical diseases	2011	71
21389093	4,4'-Methylenedianiline	Ahmad A	Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells.	Cancer research	2011	52
21701558	4,4'-Methylenedianiline	Robinson JL	Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1.	The EMBO journal	2011	73
23620807	4,4'-Methylenedianiline	Duan J	Toxic effect of silica nanoparticles on endothelial cells through DNA damage response via Chk1-dependent G2/M checkpoint.	PloS one	2013	26
23869629	4,4'-Methylenedianiline	Miricescu D	Salivary biomarkers: relationship between oxidative stress and alveolar bone loss in chronic periodontitis.	Acta odontologica Scandinavica	2014	20
24444438	4,4'-Methylenedianiline	Guo C	Hydrogen sulfide protected gastric epithelial cell from ischemia/reperfusion injury by Keap1 s-sulfhydration, MAPK dependent anti-apoptosis and NF-κB dependent anti-inflammation pathway.	European journal of pharmacology	2014	25
2981404	Calcium	McCord JM	Oxygen-derived free radicals in postischemic tissue injury.	The New England journal of medicine	1985	445
7519131	Calcium	Otto CM	Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies.	Circulation	1994	190
7568023	Calcium	Rimm DL	Alpha 1(E)-catenin is an actin-binding and -bundling protein mediating the attachment of F-actin to the membrane adhesion complex.	Proceedings of the National Academy of Sciences of the United States of America	1995	203
8988170	Calcium	Zhuchenko O	Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel.	Nature genetics	1997	188
8996247	Calcium	Aiuti A	The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood.	The Journal of experimental medicine	1997	243
9050881	Calcium	Bleul CC	The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes.	Proceedings of the National Academy of Sciences of the United States of America	1997	308
9458167	Calcium	Griffin WS	Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression.	Brain pathology	1998	126
9568714	Calcium	Molkentin JD	A calcineurin-dependent transcriptional pathway for cardiac hypertrophy.	Cell	1998	578
10545506	Calcium	Nieman MT	N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression.	The Journal of cell biology	1999	187
10564536	Calcium	Mizejewski GJ	Role of integrins in cancer: survey of expression patterns.	Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine	1999	107
10572077	Calcium	Burger JA	Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells.	Blood	1999	113
10639159	Calcium	Miyamoto MI	Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure.	Proceedings of the National Academy of Sciences of the United States of America	2000	102
10681545	Calcium	Wang HY	beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology.	The Journal of biological chemistry	2000	152
10684258	Calcium	Hazan RB	Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis.	The Journal of cell biology	2000	195
10704437	Calcium	Pinton P	Reduced loading of intracellular Ca(2+) stores and downregulation of capacitative Ca(2+) influx in Bcl-2-overexpressing cells.	The Journal of cell biology	2000	117
10769208	Calcium	Nusrat A	Tight junctions are membrane microdomains.	Journal of cell science	2000	109
10852816	Calcium	Liu Y	Human junction adhesion molecule regulates tight junction resealing in epithelia.	Journal of cell science	2000	130
10947989	Calcium	McQuibban GA	Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3.	Science	2000	162
11030334	Calcium	Okamura H	Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity.	Molecular cell	2000	150
11063054	Calcium	Lewén A	Free radical pathways in CNS injury.	Journal of neurotrauma	2000	122
11157710	Calcium	Laitinen PJ	Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia.	Circulation	2001	116
11159936	Calcium	Tiso N	Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2).	Human molecular genetics	2001	111
11245677	Calcium	Wolf JA	Traumatic axonal injury induces calcium influx modulated by tetrodotoxin-sensitive sodium channels.	The Journal of neuroscience 	2001	89
11481452	Calcium	Gong G	Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B.	Proceedings of the National Academy of Sciences of the United States of America	2001	159
11585349	Calcium	Dempster DW	Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study.	Journal of bone and mineral research 	2001	88
11726533	Calcium	Deluca HF	Vitamin D: its role and uses in immunology.	FASEB journal 	2001	138
11742876	Calcium	Dhore CR	Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques.	Arteriosclerosis, thrombosis, and vascular biology	2001	121
11917091	Calcium	Blake DJ	Function and genetics of dystrophin and dystrophin-related proteins in muscle.	Physiological reviews	2002	254
11955958	Calcium	Zhang ZJ	A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia.	Schizophrenia research	2002	98
11967535	Calcium	Sehnert AJ	Cardiac troponin T is essential in sarcomere assembly and cardiac contractility.	Nature genetics	2002	175
12015988	Calcium	Launay P	TRPM4 is a Ca2+-activated nonselective cation channel mediating cell membrane depolarization.	Cell	2002	146
12107827	Calcium	Nickoloff BJ	Jagged-1 mediated activation of notch signaling induces complete maturation of human keratinocytes through NF-kappaB and PPARgamma.	Cell death and differentiation	2002	88
12172548	Calcium	Robitaille J	Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy.	Nature genetics	2002	106
12351684	Calcium	Heinlein CA	The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions.	Molecular endocrinology	2002	97
12372661	Calcium	Beasley CL	Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins.	Biological psychiatry	2002	101
12490194	Calcium	Wharton KA Jr	Runnin' with the Dvl: proteins that associate with Dsh/Dvl and their significance to Wnt signal transduction.	Developmental biology	2003	92
12509415	Calcium	Mandic A	Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling.	The Journal of biological chemistry	2003	89
12571597	Calcium	Mohler PJ	Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death.	Nature	2003	232
12610310	Calcium	Schmitt JP	Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban.	Science	2003	154
12626353	Calcium	Phillips RJ	The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases.	American journal of respiratory and critical care medicine	2003	111
12645009	Calcium	Rothermundt M	S100B in brain damage and neurodegeneration.	Microscopy research and technique	2003	82
12708612	Calcium	Weber LW	Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model.	Critical reviews in toxicology	2003	208
12728191	Calcium	Mattson MP	Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders.	Neuromolecular medicine	2003	90
12897203	Calcium	Schafer C	The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification.	The Journal of clinical investigation	2003	143
14528017	Calcium	Ivanov AI	Endocytosis of epithelial apical junctional proteins by a clathrin-mediated pathway into a unique storage compartment.	Molecular biology of the cell	2004	126
14644193	Calcium	Kuwana T	Bcl-2-family proteins and the role of mitochondria in apoptosis.	Current opinion in cell biology	2003	122
14667502	Calcium	Liang H	Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue.	Cancer cell	2003	92
14976002	Calcium	Ceriello A	Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited.	Arteriosclerosis, thrombosis, and vascular biology	2004	198
14988389	Calcium	Larsson T	Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis.	Endocrinology	2004	118
14993287	Calcium	Glading A	Epidermal growth factor activates m-calpain (calpain II), at least in part, by extracellular signal-regulated kinase-mediated phosphorylation.	Molecular and cellular biology	2004	81
15010700	Calcium	Bassik MC	Phosphorylation of BCL-2 regulates ER Ca2+ homeostasis and apoptosis.	The EMBO journal	2004	86
15070697	Calcium	Moreaux J	BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone.	Blood	2004	115
15148385	Calcium	Craner MJ	Molecular changes in neurons in multiple sclerosis: altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na+/Ca2+ exchanger.	Proceedings of the National Academy of Sciences of the United States of America	2004	94
15193035	Calcium	Raghupathi R	Cell death mechanisms following traumatic brain injury.	Brain pathology	2004	111
15234332	Calcium	Wong K	Neuropathology provides clues to the pathophysiology of Gaucher disease.	Molecular genetics and metabolism	2004	92
15284207	Calcium	Bai X	Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders.	Endocrinology	2004	74
15454629	Calcium	Ji RR	Cell signaling and the genesis of neuropathic pain.	Science's STKE 	2004	79
15550671	Calcium	Launay P	TRPM4 regulates calcium oscillations after T cell activation.	Science	2004	77
15735754	Calcium	Kremenevskaja N	Wnt-5a has tumor suppressor activity in thyroid carcinoma.	Oncogene	2005	78
15765134	Calcium	Dorn GW 2nd	Protein kinase cascades in the regulation of cardiac hypertrophy.	The Journal of clinical investigation	2005	183
15800060	Calcium	Ivanov AI	Differential roles for actin polymerization and a myosin II motor in assembly of the epithelial apical junctional complex.	Molecular biology of the cell	2005	91
15827134	Calcium	Moreaux J	The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature.	Blood	2005	67
15863612	Calcium	Splawski I	Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations.	Proceedings of the National Academy of Sciences of the United States of America	2005	171
15879332	Calcium	Schrader J	Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES).	Stroke	2005	67
15912889	Calcium	Bazan NG	Neuroprotectin D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress.	Brain pathology	2005	68
15914466	Calcium	Hawkins BT	The blood-brain barrier/neurovascular unit in health and disease.	Pharmacological reviews	2005	508
16025100	Calcium	Garg V	Mutations in NOTCH1 cause aortic valve disease.	Nature	2005	323
16025101	Calcium	Yasuda S	Dystrophic heart failure blocked by membrane sealant poloxamer.	Nature	2005	92
16093311	Calcium	Noh KM	Blockade of calcium-permeable AMPA receptors protects hippocampal neurons against global ischemia-induced death.	Proceedings of the National Academy of Sciences of the United States of America	2005	69
16131542	Calcium	Kalanithi PS	Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome.	Proceedings of the National Academy of Sciences of the United States of America	2005	142
16306347	Calcium	Cnop M	Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities.	Diabetes	2005	320
16332727	Calcium	Abdelrahim M	3,3'-diindolylmethane (DIM) and its derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5.	Carcinogenesis	2006	63
16484498	Calcium	Shalizi A	A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation.	Science	2006	190
16565258	Calcium	Nauli SM	Loss of polycystin-1 in human cyst-lining epithelia leads to ciliary dysfunction.	Journal of the American Society of Nephrology 	2006	83
16597347	Calcium	Chang B	The nob2 mouse, a null mutation in Cacna1f: anatomical and functional abnormalities in the outer retina and their consequences on ganglion cell visual responses.	Visual neuroscience	2006	81
16738244	Calcium	Deshpande A	Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons.	The Journal of neuroscience 	2006	119
16767219	Calcium	Backs J	CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy.	The Journal of clinical investigation	2006	155
16846592	Calcium	Gebhardt C	S100A8 and S100A9 in inflammation and cancer.	Biochemical pharmacology	2006	180
16885372	Calcium	Walser TC	Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer.	Cancer research	2006	64
16902413	Calcium	Witt CC	Nebulin regulates thin filament length, contractility, and Z-disk structure in vivo.	The EMBO journal	2006	82
16950166	Calcium	Festjens N	Necrosis, a well-orchestrated form of cell demise: signalling cascades, important mediators and concomitant immune response.	Biochimica et biophysica acta	2006	155
16971498	Calcium	Chen Q	Modulation of electron transport protects cardiac mitochondria and decreases myocardial injury during ischemia and reperfusion.	American journal of physiology. Cell physiology	2007	86
16978865	Calcium	Vig M	CRACM1 multimers form the ion-selective pore of the CRAC channel.	Current biology 	2006	234
17095733	Calcium	Johnson RC	Vascular calcification: pathobiological mechanisms and clinical implications.	Circulation research	2006	152
17098490	Calcium	Asagiri M	The molecular understanding of osteoclast differentiation.	Bone	2007	235
17167110	Calcium	Möller CC	Induction of TRPC6 channel in acquired forms of proteinuric kidney disease.	Journal of the American Society of Nephrology 	2007	88
17261713	Calcium	Bano D	Ca2+ signals and neuronal death in brain ischemia.	Stroke	2007	56
17293345	Calcium	Gwack Y	Biochemical and functional characterization of Orai proteins.	The Journal of biological chemistry	2007	151
17328689	Calcium	Mattson MP	Calcium and neurodegeneration.	Aging cell	2007	168
17360908	Calcium	Shankar GM	Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway.	The Journal of neuroscience 	2007	469
17409416	Calcium	Kang HG	E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase.	Cancer research	2007	62
17428836	Calcium	Gerido DA	Aberrant hemichannel properties of Cx26 mutations causing skin disease and deafness.	American journal of physiology. Cell physiology	2007	56
17492052	Calcium	Bergmeier W	Mice lacking the signaling molecule CalDAG-GEFI represent a model for leukocyte adhesion deficiency type III.	The Journal of clinical investigation	2007	66
17548474	Calcium	Rahmani M	The kinase inhibitor sorafenib induces cell death through a process involving induction of endoplasmic reticulum stress.	Molecular and cellular biology	2007	76
17570692	Calcium	Carman CV	Transcellular diapedesis is initiated by invasive podosomes.	Immunity	2007	150
17592133	Calcium	Hybiske K	Mechanisms of host cell exit by the intracellular bacterium Chlamydia.	Proceedings of the National Academy of Sciences of the United States of America	2007	148
17599072	Calcium	Foell D	Mechanisms of disease: a 'DAMP' view of inflammatory arthritis.	Nature clinical practice. Rheumatology	2007	80
17724466	Calcium	Wendt MK	Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells.	Oncogene	2008	54
17726019	Calcium	Leclerc E	S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains.	The Journal of biological chemistry	2007	56
17898169	Calcium	Woodruff PG	Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids.	Proceedings of the National Academy of Sciences of the United States of America	2007	197
17984303	Calcium	Tsung A	HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling.	The Journal of experimental medicine	2007	176
17986870	Calcium	Ding WX	Sorting, recognition and activation of the misfolded protein degradation pathways through macroautophagy and the proteasome.	Autophagy	2008	109
18039135	Calcium	Novack DV	The osteoclast: friend or foe?	Annual review of pathology	2008	98
18048764	Calcium	Eizirik DL	The role for endoplasmic reticulum stress in diabetes mellitus.	Endocrine reviews	2008	306
18056286	Calcium	Trian T	Bronchial smooth muscle remodeling involves calcium-dependent enhanced mitochondrial biogenesis in asthma.	The Journal of experimental medicine	2007	73
18059270	Calcium	Vig M	Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of store-operated calcium release-activated calcium channels.	Nature immunology	2008	162
18096457	Calcium	Roschger P	Bone mineralization density distribution in health and disease.	Bone	2008	96
18190912	Calcium	He J	Increased MCP-1 and microglia in various regions of the human alcoholic brain.	Experimental neurology	2008	146
18272392	Calcium	Gómez-Ramos A	Extracellular tau promotes intracellular calcium increase through M1 and M3 muscarinic receptors in neuronal cells.	Molecular and cellular neurosciences	2008	58
18287530	Calcium	Fujita H	Tight junction proteins claudin-2 and -12 are critical for vitamin D-dependent Ca2+ absorption between enterocytes.	Molecular biology of the cell	2008	64
18469813	Calcium	Dibbens LM	X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment.	Nature genetics	2008	72
18478527	Calcium	Wojda U	Calcium ions in neuronal degeneration.	IUBMB life	2008	64
18515009	Calcium	Reid DM	Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group.	Cancer treatment reviews	2008	51
18559892	Calcium	Cunha DA	Initiation and execution of lipotoxic ER stress in pancreatic beta-cells.	Journal of cell science	2008	157
18591664	Calcium	Ueda K	Syntrophin mutation associated with long QT syndrome through activation of the nNOS-SCN5A macromolecular complex.	Proceedings of the National Academy of Sciences of the United States of America	2008	115
18606998	Calcium	Cha SK	Removal of sialic acid involving Klotho causes cell-surface retention of TRPV5 channel via binding to galectin-1.	Proceedings of the National Academy of Sciences of the United States of America	2008	130
18675468	Calcium	Bezprozvanny I	Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease.	Trends in neurosciences	2008	233
18684981	Calcium	Sakai A	Identification of IL-18 and Th17 cells in salivary glands of patients with Sjögren's syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18.	Journal of immunology	2008	64
18777097	Calcium	Chang-Chen KJ	Beta-cell failure as a complication of diabetes.	Reviews in endocrine & metabolic disorders	2008	50
18801384	Calcium	Holick MF	The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action.	Molecular aspects of medicine	2008	61
18801879	Calcium	Piton A	Mutations in the calcium-related gene IL1RAPL1 are associated with autism.	Human molecular genetics	2008	56
18803808	Calcium	Yamasaki N	Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders.	Molecular brain	2008	100
18832659	Calcium	Braun A	Orai1 (CRACM1) is the platelet SOC channel and essential for pathological thrombus formation.	Blood	2009	53
18838561	Calcium	Shroff RC	Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis.	Circulation	2008	96
18951640	Calcium	Bossy-Wetzel E	Mutant huntingtin and mitochondrial dysfunction.	Trends in neurosciences	2008	66
19036954	Calcium	Kim HJ	Human immunodeficiency virus protein Tat induces synapse loss via a reversible process that is distinct from cell death.	The Journal of neuroscience 	2008	54
19036964	Calcium	Chen X	Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 3.	The Journal of neuroscience 	2008	62
19098100	Calcium	Saotome M	Bidirectional Ca2+-dependent control of mitochondrial dynamics by the Miro GTPase.	Proceedings of the National Academy of Sciences of the United States of America	2008	156
19122847	Calcium	Delpón E	Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome.	Circulation. Arrhythmia and electrophysiology	2008	93
19139381	Calcium	Pokreisz P	Ventricular phosphodiesterase-5 expression is increased in patients with advanced heart failure and contributes to adverse ventricular remodeling after myocardial infarction in mice.	Circulation	2009	61
19164547	Calcium	Malhotra A	Role of calcium-independent phospholipase A2 in the pathogenesis of Barth syndrome.	Proceedings of the National Academy of Sciences of the United States of America	2009	55
19166511	Calcium	Marongiu R	Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux.	Journal of neurochemistry	2009	48
19177135	Calcium	Chien AJ	A Wnt survival guide: from flies to human disease.	The Journal of investigative dermatology	2009	143
19185847	Calcium	Yang S	Orai1 and STIM1 are critical for breast tumor cell migration and metastasis.	Cancer cell	2009	165
19197364	Calcium	Dowling JJ	Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy.	PLoS genetics	2009	82
19236889	Calcium	Siu ER	Cadmium-induced testicular injury.	Toxicology and applied pharmacology	2009	59
19265110	Calcium	Arechiga AF	Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling.	Journal of immunology	2009	72
19276362	Calcium	Pelicano H	Mitochondrial dysfunction and reactive oxygen species imbalance promote breast cancer cell motility through a CXCL14-mediated mechanism.	Cancer research	2009	48
19293237	Calcium	Mahad DJ	Mitochondrial changes within axons in multiple sclerosis.	Brain 	2009	82
19342367	Calcium	Maru DM	MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus.	The American journal of pathology	2009	51
19379710	Calcium	Baranwal S	Molecular mechanisms controlling E-cadherin expression in breast cancer.	Biochemical and biophysical research communications	2009	52
19394359	Calcium	Reddy PH	Mitochondrial structural and functional dynamics in Huntington's disease.	Brain research reviews	2009	45
19433061	Calcium	Kawasaki T	A minimal regulatory domain in the C terminus of STIM1 binds to and activates ORAI1 CRAC channels.	Biochemical and biophysical research communications	2009	96
19491390	Calcium	Quiroga MP	B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406.	Blood	2009	79
19556521	Calcium	Liu Q	Protein kinase C{alpha}, but not PKC{beta} or PKC{gamma}, regulates contractility and heart failure susceptibility: implications for ruboxistaurin as a novel therapeutic approach.	Circulation research	2009	51
19561614	Calcium	Chen K	Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cell-stimulating programs in basophils.	Nature immunology	2009	87
19594303	Calcium	Priemel M	Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients.	Journal of bone and mineral research 	2010	65
19616093	Calcium	Du H	Mitochondrial permeability transition pore in Alzheimer's disease: cyclophilin D and amyloid beta.	Biochimica et biophysica acta	2010	43
19620505	Calcium	Croce K	Myeloid-related protein-8/14 is critical for the biological response to vascular injury.	Circulation	2009	66
19631259	Calcium	Rossi D	Astrocytic dysfunction: insights on the role in neurodegeneration.	Brain research bulletin	2009	59
19667085	Calcium	Nasser MW	Differential activation and regulation of CXCR1 and CXCR2 by CXCL8 monomer and dimer.	Journal of immunology	2009	56
19667145	Calcium	Köstner K	The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature.	Anticancer research	2009	77
19715758	Calcium	Gibson GE	Cause and consequence: mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases.	Biochimica et biophysica acta	2010	64
19805772	Calcium	Helfand M	Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force.	Annals of internal medicine	2009	63
19819884	Calcium	Cantero-Recasens G	The asthma-associated ORMDL3 gene product regulates endoplasmic reticulum-mediated calcium signaling and cellular stress.	Human molecular genetics	2010	70
19826129	Calcium	Heng DY	Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study.	Journal of clinical oncology 	2009	268
19828810	Calcium	Abdul HM	Cognitive decline in Alzheimer's disease is associated with selective changes in calcineurin/NFAT signaling.	The Journal of neuroscience 	2009	77
19841182	Calcium	Luangsay S	Mouse ChemR23 is expressed in dendritic cell subsets and macrophages, and mediates an anti-inflammatory activity of chemerin in a lung disease model.	Journal of immunology	2009	53
19874198	Calcium	Bone HG	Odanacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone density.	Journal of bone and mineral research 	2010	48
19883649	Calcium	Waghray M	Interleukin-1beta promotes gastric atrophy through suppression of Sonic Hedgehog.	Gastroenterology	2010	44
19913545	Calcium	Minamino T	ER stress in cardiovascular disease.	Journal of molecular and cellular cardiology	2010	85
19938015	Calcium	Garraway IP	Human prostate sphere-forming cells represent a subset of basal epithelial cells capable of glandular regeneration in vivo.	The Prostate	2010	63
19961855	Calcium	Koitabashi N	Cyclic GMP/PKG-dependent inhibition of TRPC6 channel activity and expression negatively regulates cardiomyocyte NFAT activation Novel mechanism of cardiac stress modulation by PDE5 inhibition.	Journal of molecular and cellular cardiology	2010	50
20032460	Calcium	Zhao WQ	Inhibition of calcineurin-mediated endocytosis and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors prevents amyloid beta oligomer-induced synaptic disruption.	The Journal of biological chemistry	2010	49
20037587	Calcium	Deng HX	Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4.	Nature genetics	2010	54
20042720	Calcium	Wang W	Fluid shear stress stimulates phosphorylation-dependent nuclear export of HDAC5 and mediates expression of KLF2 and eNOS.	Blood	2010	56
20059346	Calcium	Whitcomb DC	Genetic aspects of pancreatitis.	Annual review of medicine	2010	46
20074572	Calcium	Cheng X	Mucolipins: Intracellular TRPML1-3 channels.	FEBS letters	2010	65
20075334	Calcium	Du J	TRPM7-mediated Ca2+ signals confer fibrogenesis in human atrial fibrillation.	Circulation research	2010	70
20080610	Calcium	Di L	Inhibition of the K+ channel KCa3.1 ameliorates T cell-mediated colitis.	Proceedings of the National Academy of Sciences of the United States of America	2010	44
20086172	Calcium	Ariazi EA	The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells.	Cancer research	2010	54
20096397	Calcium	Bolduc V	Recessive mutations in the putative calcium-activated chloride channel Anoctamin 5 cause proximal LGMD2L and distal MMD3 muscular dystrophies.	American journal of human genetics	2010	45
20129495	Calcium	Saatman KE	Calpain as a therapeutic target in traumatic brain injury.	Neurotherapeutics 	2010	65
20144708	Calcium	Liu J	The sodium pump and cardiotonic steroids-induced signal transduction protein kinases and calcium-signaling microdomain in regulation of transporter trafficking.	Biochimica et biophysica acta	2010	41
20164348	Calcium	Wu HY	Amyloid beta induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation.	The Journal of neuroscience 	2010	134
20189884	Calcium	Feske S	Immunodeficiency due to mutations in ORAI1 and STIM1.	Clinical immunology	2010	49
20346437	Calcium	Zhong H	Integrating pathway analysis and genetics of gene expression for genome-wide association studies.	American journal of human genetics	2010	127
20354226	Calcium	Vandenabeele P	The role of the kinases RIP1 and RIP3 in TNF-induced necrosis.	Science signaling	2010	148
20385539	Calcium	Chu CT	A pivotal role for PINK1 and autophagy in mitochondrial quality control: implications for Parkinson disease.	Human molecular genetics	2010	52
20390225	Calcium	Connor DE	The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib.	Thrombosis and haemostasis	2010	59
20405009	Calcium	Gómez Ravetti M	Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.	PloS one	2010	41
20415633	Calcium	Woo TU	Gamma oscillation deficits and the onset and early progression of schizophrenia.	Harvard review of psychiatry	2010	44
20484626	Calcium	Emmanouilidou E	Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival.	The Journal of neuroscience 	2010	262
20554944	Calcium	Ding X	Essential role of TRPC6 channels in G2/M phase transition and development of human glioma.	Journal of the National Cancer Institute	2010	46
20657034	Calcium	Patil S	Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma.	Annals of oncology 	2011	40
20702634	Calcium	McKenna DJ	MicroRNA 203 expression in keratinocytes is dependent on regulation of p53 levels by E6.	Journal of virology	2010	41
20723845	Calcium	Durr A	Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond.	The Lancet. Neurology	2010	94
20731583	Calcium	Wang S	Influenza virus-cytokine-protease cycle in the pathogenesis of vascular hyperpermeability in severe influenza.	The Journal of infectious diseases	2010	40
20839240	Calcium	Wilmshurst JM	RYR1 mutations are a common cause of congenital myopathies with central nuclei.	Annals of neurology	2010	59
20861820	Calcium	Wesseling-Perry K	Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism.	Kidney international	2011	48
20971854	Calcium	Maezawa I	Amyloid-beta protein oligomer at low nanomolar concentrations activates microglia and induces microglial neurotoxicity.	The Journal of biological chemistry	2011	60
20978119	Calcium	He BC	Tetrandrine inhibits Wnt/β-catenin signaling and suppresses tumor growth of human colorectal cancer.	Molecular pharmacology	2011	44
21068725	Calcium	Guzman JN	Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1.	Nature	2010	176
21118718	Calcium	Wallace DP	Cyclic AMP-mediated cyst expansion.	Biochimica et biophysica acta	2011	43
21122809	Calcium	Rodriguez D	Integrating stress signals at the endoplasmic reticulum: The BCL-2 protein family rheostat.	Biochimica et biophysica acta	2011	43
21145844	Calcium	Malhi H	Endoplasmic reticulum stress in liver disease.	Journal of hepatology	2011	244
21160030	Calcium	Slominski AT	20-Hydroxyvitamin D2 is a noncalcemic analog of vitamin D with potent antiproliferative and prodifferentiation activities in normal and malignant cells.	American journal of physiology. Cell physiology	2011	57
21192095	Calcium	de Groot J	Glutamate and the biology of gliomas.	Glia	2011	55
21193740	Calcium	Boström KI	Activation of vascular bone morphogenetic protein signaling in diabetes mellitus.	Circulation research	2011	57
21215707	Calcium	Arozarena I	Oncogenic BRAF induces melanoma cell invasion by downregulating the cGMP-specific phosphodiesterase PDE5A.	Cancer cell	2011	67
21216834	Calcium	Landstrom AP	Junctophilin-2 expression silencing causes cardiocyte hypertrophy and abnormal intracellular calcium-handling.	Circulation. Heart failure	2011	40
21266974	Calcium	Proctor MJ	An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study.	British journal of cancer	2011	71
21282332	Calcium	Kirchhof P	PITX2c is expressed in the adult left atrium, and reducing Pitx2c expression promotes atrial fibrillation inducibility and complex changes in gene expression.	Circulation. Cardiovascular genetics	2011	68
21300876	Calcium	Maul-Pavicic A	ORAI1-mediated calcium influx is required for human cytotoxic lymphocyte degranulation and target cell lysis.	Proceedings of the National Academy of Sciences of the United States of America	2011	53
21307850	Calcium	Yazawa M	Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome.	Nature	2011	218
21311022	Calcium	Choi M	K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.	Science	2011	173
21353695	Calcium	Fizazi K	Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study.	Lancet	2011	308
21408028	Calcium	Crossman DJ	Changes in the organization of excitation-contraction coupling structures in failing human heart.	PloS one	2011	52
21408177	Calcium	Wang SF	Early T cell signalling is reversibly altered in PD-1+ T lymphocytes infiltrating human tumors.	PloS one	2011	36
21421840	Calcium	Charles ED	Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset.	Blood	2011	50
21444679	Calcium	Jamieson NB	Tissue biomarkers for prognosis in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis.	Clinical cancer research 	2011	36
21454719	Calcium	Cunningham J	Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options.	Clinical journal of the American Society of Nephrology 	2011	58
21481794	Calcium	Chen J	CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3.	Cancer cell	2011	114
21485744	Calcium	Wolkowitz OM	Of sound mind and body: depression, disease, and accelerated aging.	Dialogues in clinical neuroscience	2011	56
21531043	Calcium	Bruno AM	Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease.	Neurobiology of aging	2012	32
21572519	Calcium	Zheng L	Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer.	PloS one	2011	62
21602788	Calcium	Massie CE	The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis.	The EMBO journal	2011	156
21622563	Calcium	Zhou H	Novel mechanism of anti-apoptotic function of 78-kDa glucose-regulated protein (GRP78): endocrine resistance factor in breast cancer, through release of B-cell lymphoma 2 (BCL-2) from BCL-2-interacting killer (BIK).	The Journal of biological chemistry	2011	39
21659653	Calcium	Jahnen-Dechent W	Fetuin-A regulation of calcified matrix metabolism.	Circulation research	2011	61
21684273	Calcium	Vogt SD	Retinal pigment epithelial expression of complement regulator CD46 is altered early in the course of geographic atrophy.	Experimental eye research	2011	39
21685359	Calcium	Sack U	Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.	Journal of the National Cancer Institute	2011	50
21740229	Calcium	Su SC	Cyclin-dependent kinases in brain development and disease.	Annual review of cell and developmental biology	2011	101
21752263	Calcium	Chang BY	The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells.	Arthritis research & therapy	2011	50
21763243	Calcium	Engel MA	TRPA1 and substance P mediate colitis in mice.	Gastroenterology	2011	51
21775626	Calcium	Ward HH	A conserved signal and GTPase complex are required for the ciliary transport of polycystin-1.	Molecular biology of the cell	2011	44
21775667	Calcium	Pleger ST	Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model.	Science translational medicine	2011	54
21792295	Calcium	Kones R	Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.	Drug design, development and therapy	2011	42
21799901	Calcium	Li X	Comparative mRNA and microRNA expression profiling of three genitourinary cancers reveals common hallmarks and cancer-specific molecular events.	PloS one	2011	37
21844361	Calcium	Qu J	S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by beta-amyloid peptide.	Proceedings of the National Academy of Sciences of the United States of America	2011	45
21876174	Calcium	Chen YF	Calcium store sensor stromal-interaction molecule 1-dependent signaling plays an important role in cervical cancer growth, migration, and angiogenesis.	Proceedings of the National Academy of Sciences of the United States of America	2011	85
21883880	Calcium	Aleman MM	Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability.	Journal of thrombosis and haemostasis 	2011	38
21884755	Calcium	Surmeier DJ	The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease.	Neuroscience	2011	48
21889421	Calcium	Medina DL	Transcriptional activation of lysosomal exocytosis promotes cellular clearance.	Developmental cell	2011	136
21903638	Calcium	De A	Wnt/Ca2+ signaling pathway: a brief overview.	Acta biochimica et biophysica Sinica	2011	63
22014436	Calcium	Vekrellis K	Pathological roles of α-synuclein in neurological disorders.	The Lancet. Neurology	2011	72
22035880	Calcium	Thiel J	Genetic CD21 deficiency is associated with hypogammaglobulinemia.	The Journal of allergy and clinical immunology	2012	36
22079671	Calcium	Marzec M	GRP94: An HSP90-like protein specialized for protein folding and quality control in the endoplasmic reticulum.	Biochimica et biophysica acta	2012	68
22109080	Calcium	Mishra SK	S100A4 calcium-binding protein is key player in tumor progression and metastasis: preclinical and clinical evidence.	Cancer metastasis reviews	2012	36
22110751	Calcium	Acharya A	Inhibitory role of Notch1 in calcific aortic valve disease.	PloS one	2011	41
22115958	Calcium	Yeung BH	Evolution and roles of stanniocalcin.	Molecular and cellular endocrinology	2012	36
22129055	Calcium	Feske S	Immunodeficiency due to defects in store-operated calcium entry.	Annals of the New York Academy of Sciences	2011	42
22131369	Calcium	De Vos KJ	VAPB interacts with the mitochondrial protein PTPIP51 to regulate calcium homeostasis.	Human molecular genetics	2012	73
22140091	Calcium	Tang ZZ	Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel.	Human molecular genetics	2012	50
22145907	Calcium	Michetti F	The S100B protein in biological fluids: more than a lifelong biomarker of brain distress.	Journal of neurochemistry	2012	31
22186024	Calcium	Ramonet D	PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity.	Human molecular genetics	2012	40
22190180	Calcium	Fuchs S	Antiviral and regulatory T cell immunity in a patient with stromal interaction molecule 1 deficiency.	Journal of immunology	2012	46
22307057	Calcium	Foster TC	Dissecting the age-related decline on spatial learning and memory tasks in rodent models: N-methyl-D-aspartate receptors and voltage-dependent Ca2+ channels in senescent synaptic plasticity.	Progress in neurobiology	2012	47
22315453	Calcium	Oki K	Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis.	Endocrinology	2012	37
22349828	Calcium	Trerotola M	Upregulation of Trop-2 quantitatively stimulates human cancer growth.	Oncogene	2013	26
22421513	Calcium	Quarles LD	Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease.	Experimental cell research	2012	48
22422768	Calcium	Roux-Buisson N	Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human.	Human molecular genetics	2012	51
22442078	Calcium	Misko AL	Mitofusin2 mutations disrupt axonal mitochondrial positioning and promote axon degeneration.	The Journal of neuroscience 	2012	39
22444631	Calcium	Gross O	Inflammasome activators induce interleukin-1α secretion via distinct pathways with differential requirement for the protease function of caspase-1.	Immunity	2012	131
22446186	Calcium	Selvaraj S	Neurotoxin-induced ER stress in mouse dopaminergic neurons involves downregulation of TRPC1 and inhibition of AKT/mTOR signaling.	The Journal of clinical investigation	2012	42
22516444	Calcium	Dweck MR	Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.	Journal of the American College of Cardiology	2012	55
22564524	Calcium	Duvvuri U	TMEM16A induces MAPK and contributes directly to tumorigenesis and cancer progression.	Cancer research	2012	80
22641815	Calcium	Liu J	Signaling defects in iPSC-derived fragile X premutation neurons.	Human molecular genetics	2012	48
22647055	Calcium	Zhao H	Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice.	BMC gastroenterology	2012	41
22733215	Calcium	Venetucci L	Inherited calcium channelopathies in the pathophysiology of arrhythmias.	Nature reviews. Cardiology	2012	45
22789936	Calcium	Sillesen H	Carotid plaque burden as a measure of subclinical atherosclerosis: comparison with other tests for subclinical arterial disease in the High Risk Plaque BioImage study.	JACC. Cardiovascular imaging	2012	37
22802447	Calcium	Parker H	Requirements for NADPH oxidase and myeloperoxidase in neutrophil extracellular trap formation differ depending on the stimulus.	Journal of leukocyte biology	2012	85
22810731	Calcium	Marcinkiewicz J	Taurine and inflammatory diseases.	Amino acids	2014	37
22820791	Calcium	Subramanian S	Arterial inflammation in patients with HIV.	JAMA	2012	141
22858544	Calcium	Lee SH	Phosphatidylserine exposure during apoptosis reflects bidirectional trafficking between plasma membrane and cytoplasm.	Cell death and differentiation	2013	26
22892566	Calcium	Area-Gomez E	Upregulated function of mitochondria-associated ER membranes in Alzheimer disease.	The EMBO journal	2012	99
22895189	Calcium	Timmann C	Genome-wide association study indicates two novel resistance loci for severe malaria.	Nature	2012	55
22905134	Calcium	Nassini R	Transient receptor potential ankyrin 1 channel localized to non-neuronal airway cells promotes non-neurogenic inflammation.	PloS one	2012	48
22915123	Calcium	Oulès B	Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease.	The Journal of neuroscience 	2012	45
22962621	Calcium	Kujala K	Cell model of catecholaminergic polymorphic ventricular tachycardia reveals early and delayed afterdepolarizations.	PloS one	2012	41
23007404	Calcium	Cortese-Krott MM	Human red blood cells at work: identification and visualization of erythrocytic eNOS activity in health and disease.	Blood	2012	32
23039869	Calcium	Chami L	BACE1 is at the crossroad of a toxic vicious cycle involving cellular stress and β-amyloid production in Alzheimer's disease.	Molecular neurodegeneration	2012	38
23052215	Calcium	Shaw PJ	Molecular regulation of CRAC channels and their role in lymphocyte function.	Cellular and molecular life sciences 	2013	29
23112146	Calcium	Harraz MM	MicroRNA-223 is neuroprotective by targeting glutamate receptors.	Proceedings of the National Academy of Sciences of the United States of America	2012	46
23139242	Calcium	Singh R	iPS cell modeling of Best disease: insights into the pathophysiology of an inherited macular degeneration.	Human molecular genetics	2013	75
23140368	Calcium	Hou J	Claudins and the kidney.	Annual review of physiology	2013	41
23169676	Calcium	Girgis CM	The roles of vitamin D in skeletal muscle: form, function, and metabolism.	Endocrine reviews	2013	62
23186989	Calcium	Mizwicki MT	1α,25-dihydroxyvitamin D3 and resolvin D1 retune the balance between amyloid-β phagocytosis and inflammation in Alzheimer's disease patients.	Journal of Alzheimer's disease 	2013	28
23187130	Calcium	Alevy YG	IL-13-induced airway mucus production is attenuated by MAPK13 inhibition.	The Journal of clinical investigation	2012	46
23213054	Calcium	Kuhne MR	BMS-936564/MDX-1338: a fully human anti-CXCR4 antibody induces apoptosis in vitro and shows antitumor activity in vivo in hematologic malignancies.	Clinical cancer research 	2013	55
23229924	Calcium	Louvet L	Magnesium prevents phosphate-induced calcification in human aortic vascular smooth muscle cells.	Nephrology, dialysis, transplantation 	2013	28
23246404	Calcium	Marchi S	Downregulation of the mitochondrial calcium uniporter by cancer-related miR-25.	Current biology 	2013	48
23281406	Calcium	McNally EM	Genetic mutations and mechanisms in dilated cardiomyopathy.	The Journal of clinical investigation	2013	87
23281409	Calcium	Marks AR	Calcium cycling proteins and heart failure: mechanisms and therapeutics.	The Journal of clinical investigation	2013	85
23313911	Calcium	Krey JF	Timothy syndrome is associated with activity-dependent dendritic retraction in rodent and human neurons.	Nature neuroscience	2013	79
23328481	Calcium	Ryu S	Suppression of miRNA-708 by polycomb group promotes metastases by calcium-induced cell migration.	Cancer cell	2013	34
23332920	Calcium	Böhm J	Constitutive activation of the calcium sensor STIM1 causes tubular-aggregate myopathy.	American journal of human genetics	2013	34
23343770	Calcium	Bonora M	Role of the c subunit of the FO ATP synthase in mitochondrial permeability transition.	Cell cycle	2013	100
23354045	Calcium	Kim C	Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs.	Nature	2013	108
23362240	Calcium	Beck D	Vemurafenib potently induces endoplasmic reticulum stress-mediated apoptosis in BRAFV600E melanoma cells.	Science signaling	2013	30
23413890	Calcium	Brini M	The plasma membrane calcium pump in health and disease.	The FEBS journal	2013	26
23431153	Calcium	Britschgi A	Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling.	Proceedings of the National Academy of Sciences of the United States of America	2013	69
23438480	Calcium	Rüb U	Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7.	Progress in neurobiology	2013	45
23447037	Calcium	Mhaske PV	The human Cx26-D50A and Cx26-A88V mutations causing keratitis-ichthyosis-deafness syndrome display increased hemichannel activity.	American journal of physiology. Cell physiology	2013	26
23467346	Calcium	Robison AJ	Behavioral and structural responses to chronic cocaine require a feedforward loop involving ΔFosB and calcium/calmodulin-dependent protein kinase II in the nucleus accumbens shell.	The Journal of neuroscience 	2013	52
23469922	Calcium	Rajkowska G	Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue.	Current drug targets	2013	65
23511024	Calcium	Bergmeier W	Emerging roles of store-operated Ca²⁺ entry through STIM and ORAI proteins in immunity, hemostasis and cancer.	Channels	2013	26
23516275	Calcium	Lek A	Calpains, cleaved mini-dysferlinC72, and L-type channels underpin calcium-dependent muscle membrane repair.	The Journal of neuroscience 	2013	30
23582339	Calcium	DuBoff B	Why size matters - balancing mitochondrial dynamics in Alzheimer's disease.	Trends in neurosciences	2013	32
23594099	Calcium	Chen YF	Remodeling of calcium signaling in tumor progression.	Journal of biomedical science	2013	47
23597567	Calcium	Zhao W	1B50-1, a mAb raised against recurrent tumor cells, targets liver tumor-initiating cells by binding to the calcium channel α2δ1 subunit.	Cancer cell	2013	27
23616621	Calcium	New SE	Macrophage-derived matrix vesicles: an alternative novel mechanism for microcalcification in atherosclerotic plaques.	Circulation research	2013	67
23620518	Calcium	Hedskog L	Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer's disease and related models.	Proceedings of the National Academy of Sciences of the United States of America	2013	66
23684427	Calcium	Zhang XH	Ca2+ signaling in human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM) from normal and catecholaminergic polymorphic ventricular tachycardia (CPVT)-afflicted subjects.	Cell calcium	2013	29
23686305	Calcium	Davis FM	Induction of epithelial-mesenchymal transition (EMT) in breast cancer cells is calcium signal dependent.	Oncogene	2014	54
23687099	Calcium	Neeland IJ	Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults.	Obesity	2013	55
23698771	Calcium	Bogdanova A	Calcium in red blood cells-a perilous balance.	International journal of molecular sciences	2013	26
23726674	Calcium	Chen Y	Temporomandibular joint pain: a critical role for Trpv4 in the trigeminal ganglion.	Pain	2013	29
23733696	Calcium	Tidball JG	Mechanisms of muscle injury, repair, and regeneration.	Comprehensive Physiology	2011	39
23774819	Calcium	Kuro-o M	Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism.	Nature reviews. Nephrology	2013	31
23802516	Calcium	Nesbit MA	Mutations affecting G-protein subunit α11 in hypercalcemia and hypocalcemia.	The New England journal of medicine	2013	52
23829673	Calcium	Bezprozvanny I	The synaptic maintenance problem: membrane recycling, Ca2+ homeostasis and late onset degeneration.	Molecular neurodegeneration	2013	33
23860259	Calcium	Wang S	Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis.	Biochimica et biophysica acta	2013	41
23871436	Calcium	Tan MS	Bridging integrator 1 (BIN1): form, function, and Alzheimer's disease.	Trends in molecular medicine	2013	27
23913003	Calcium	Keller A	Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice.	Nature genetics	2013	43
23921556	Calcium	Muñoz JP	Mfn2 modulates the UPR and mitochondrial function via repression of PERK.	The EMBO journal	2013	42
23929777	Calcium	Moore C	UVB radiation generates sunburn pain and affects skin by activating epidermal TRPV4 ion channels and triggering endothelin-1 signaling.	Proceedings of the National Academy of Sciences of the United States of America	2013	36
23943781	Calcium	Zotova E	Inflammatory components in human Alzheimer's disease and after active amyloid-β42 immunization.	Brain 	2013	42
24046081	Calcium	Jantzie LL	Developmental expression of N-methyl-D-aspartate (NMDA) receptor subunits in human white and gray matter: potential mechanism of increased vulnerability in the immature brain.	Cerebral cortex	2015	20
24054868	Calcium	Chen R	Cav1.3 channel α1D protein is overexpressed and modulates androgen receptor transactivation in prostate cancers.	Urologic oncology	2014	22
24055979	Calcium	Rao VK	Mitochondrial permeability transition pore is a potential drug target for neurodegeneration.	Biochimica et biophysica acta	2014	30
24094650	Calcium	Wilson SR	The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch.	Cell	2013	81
24113177	Calcium	Di Pasquale E	CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia.	Cell death & disease	2013	31
24180474	Calcium	Konior A	NADPH oxidases in vascular pathology.	Antioxidants & redox signaling	2014	52
24284821	Calcium	Andrukhova O	Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice.	Molecular endocrinology	2014	31
24316057	Calcium	Vance JE	MAM (mitochondria-associated membranes) in mammalian cells: lipids and beyond.	Biochimica et biophysica acta	2014	90
24336167	Calcium	Logan CV	Loss-of-function mutations in MICU1 cause a brain and muscle disorder linked to primary alterations in mitochondrial calcium signaling.	Nature genetics	2014	60
24366263	Calcium	Marchi S	The mitochondrial calcium uniporter complex: molecular components, structure and physiopathological implications.	The Journal of physiology	2014	45
24370480	Calcium	Baker JV	Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohort.	AIDS	2014	38
24371120	Calcium	Gouspillou G	Increased sensitivity to mitochondrial permeability transition and myonuclear translocation of endonuclease G in atrophied muscle of physically active older humans.	FASEB journal 	2014	35
24395921	Calcium	Tao Y	Pitx2, an atrial fibrillation predisposition gene, directly regulates ion transport and intercalated disc genes.	Circulation. Cardiovascular genetics	2014	23
24401693	Calcium	Duan L	Stem cell derived basal forebrain cholinergic neurons from Alzheimer's disease patients are more susceptible to cell death.	Molecular neurodegeneration	2014	30
24472175	Calcium	Stanisz H	Inverse regulation of melanoma growth and migration by Orai1/STIM2-dependent calcium entry.	Pigment cell & melanoma research	2014	22
24531552	Calcium	Lee RJ	Bitter and sweet taste receptors regulate human upper respiratory innate immunity.	The Journal of clinical investigation	2014	74
24586273	Calcium	Hartfield EM	Physiological characterisation of human iPS-derived dopaminergic neurons.	PloS one	2014	36
24599954	Calcium	Bill A	Small molecule-facilitated degradation of ANO1 protein: a new targeting approach for anticancer therapeutics.	The Journal of biological chemistry	2014	21
24668259	Calcium	Kestenbaum B	Fibroblast growth factor-23 and cardiovascular disease in the general population: the Multi-Ethnic Study of Atherosclerosis.	Circulation. Heart failure	2014	23
24671417	Calcium	Birsa N	Lysine 27 ubiquitination of the mitochondrial transport protein Miro is dependent on serine 65 of the Parkin ubiquitin ligase.	The Journal of biological chemistry	2014	36
24691204	Calcium	Longenecker CT	Soluble CD14 is independently associated with coronary calcification and extent of subclinical vascular disease in treated HIV infection.	AIDS	2014	48
24691441	Calcium	Wang Y	Platelet-derived S100 family member myeloid-related protein-14 regulates thrombosis.	The Journal of clinical investigation	2014	24
24733928	Calcium	Heinecke JL	Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression.	Proceedings of the National Academy of Sciences of the United States of America	2014	34
24735830	Calcium	Yang X	Tri-iodo-l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells.	Journal of molecular and cellular cardiology	2014	55
24751540	Calcium	Eisner V	Mitochondrial fusion is frequent in skeletal muscle and supports excitation-contraction coupling.	The Journal of cell biology	2014	33
24766647	Calcium	Ekström EJ	WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells.	Molecular cancer	2014	37
24768714	Calcium	Akl H	A dual role for the anti-apoptotic Bcl-2 protein in cancer: mitochondria versus endoplasmic reticulum.	Biochimica et biophysica acta	2014	28
24781336	Calcium	Zhai X	Abnormal expression of EMT-related proteins, S100A4, vimentin and E-cadherin, is correlated with clinicopathological features and prognosis in HCC.	Medical oncology	2014	29
24806074	Calcium	Jaiswal JK	S100A11 is required for efficient plasma membrane repair and survival of invasive cancer cells.	Nature communications	2014	26
24858659	Calcium	Torres-Platas SG	Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides.	Brain, behavior, and immunity	2014	51
24905578	Calcium	Schöndorf DC	iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calcium homeostasis.	Nature communications	2014	71
24928681	Calcium	Montaigne D	Myocardial contractile dysfunction is associated with impaired mitochondrial function and dynamics in type 2 diabetic but not in obese patients.	Circulation	2014	33
24934288	Calcium	Dragicevic E	Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons.	Brain 	2014	25
24997452	Calcium	Varga ZV	Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy.	Biochimica et biophysica acta	2015	38
25023795	Calcium	Eberhardt M	H2S and NO cooperatively regulate vascular tone by activating a neuroendocrine HNO-TRPA1-CGRP signalling pathway.	Nature communications	2014	51
25116795	Calcium	Chen HM	Transcripts involved in calcium signaling and telencephalic neuronal fate are altered in induced pluripotent stem cells from bipolar disorder patients.	Translational psychiatry	2014	35
25216637	Calcium	Cheng X	The intracellular Ca²⁺ channel MCOLN1 is required for sarcolemma repair to prevent muscular dystrophy.	Nature medicine	2014	29
25239387	Calcium	Gilon P	Calcium signaling in pancreatic β-cells in health and in Type 2 diabetes.	Cell calcium	2014	23
25308530	Calcium	D'Aurizio F	Is vitamin D a player or not in the pathophysiology of autoimmune thyroid diseases?	Autoimmunity reviews	2015	18
25311085	Calcium	Li JT	Nuclear factor of activated T cells 5 maintained by Hotair suppression of miR-568 upregulates S100 calcium binding protein A4 to promote breast cancer metastasis.	Breast cancer research 	2014	23
25328135	Calcium	Bai XL	Myocyte enhancer factor 2C regulation of hepatocellular carcinoma via vascular endothelial growth factor and Wnt/β-catenin signaling.	Oncogene	2015	19
25398718	Calcium	Kelly JJ	Mechanisms linking connexin mutations to human diseases.	Cell and tissue research	2015	24
25403839	Calcium	Yoshimizu T	Functional implications of a psychiatric risk variant within CACNA1C in induced human neurons.	Molecular psychiatry	2015	31
25422446	Calcium	Lu S	A calcium-dependent protease as a potential therapeutic target for Wolfram syndrome.	Proceedings of the National Academy of Sciences of the United States of America	2014	23
25453953	Calcium	Pati F	Ornamenting 3D printed scaffolds with cell-laid extracellular matrix for bone tissue regeneration.	Biomaterials	2015	18
25478815	Calcium	Van Laar VS	Glutamate excitotoxicity in neurons triggers mitochondrial and endoplasmic reticulum accumulation of Parkin, and, in the presence of N-acetyl cysteine, mitophagy.	Neurobiology of disease	2015	18
25528431	Calcium	Pugliese G	The dark and bright side of atherosclerotic calcification.	Atherosclerosis	2015	19
25541060	Calcium	Wang W	Mitofusin-2 triggers mitochondria Ca2+ influx from the endoplasmic reticulum to induce apoptosis in hepatocellular carcinoma cells.	Cancer letters	2015	17
25543971	Calcium	Ho CY	Diltiazem treatment for pre-clinical hypertrophic cardiomyopathy sarcomere mutation carriers: a pilot randomized trial to modify disease expression.	JACC. Heart failure	2015	22
25556685	Calcium	Hoeijmakers JG	Painful peripheral neuropathy and sodium channel mutations.	Neuroscience letters	2015	17
25561520	Calcium	Myrick LK	Independent role for presynaptic FMRP revealed by an FMR1 missense mutation associated with intellectual disability and seizures.	Proceedings of the National Academy of Sciences of the United States of America	2015	34
25565209	Calcium	Paupe V	CCDC90A (MCUR1) is a cytochrome c oxidase assembly factor and not a regulator of the mitochondrial calcium uniporter.	Cell metabolism	2015	22
25587051	Calcium	Weisenberger DJ	Association of the colorectal CpG island methylator phenotype with molecular features, risk factors, and family history.	Cancer epidemiology, biomarkers & prevention 	2015	18
25601362	Calcium	Berretta S	Losing the sugar coating: potential impact of perineuronal net abnormalities on interneurons in schizophrenia.	Schizophrenia research	2015	24
25624484	Calcium	Giorgi C	p53 at the endoplasmic reticulum regulates apoptosis in a Ca2+-dependent manner.	Proceedings of the National Academy of Sciences of the United States of America	2015	46
25632041	Calcium	Smith SA	Dysfunction in the βII spectrin-dependent cytoskeleton underlies human arrhythmia.	Circulation	2015	19
25642965	Calcium	West AP	Mitochondrial DNA stress primes the antiviral innate immune response.	Nature	2015	120
25661091	Calcium	Thornton C	Role of mitochondria in apoptotic and necroptotic cell death in the developing brain.	Clinica chimica acta; international journal of clinical chemistry	2015	15
25711438	Calcium	Kapustin AN	Vascular smooth muscle cell calcification is mediated by regulated exosome secretion.	Circulation research	2015	51
25758716	Calcium	Kumari S	Actin foci facilitate activation of the phospholipase C-γ in primary T lymphocytes via the WASP pathway.	eLife	2015	34
25772239	Calcium	Vassallo I	WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1.	Oncogene	2016	23
25801675	Calcium	Zhang Y	MicroRNA-26a prevents endothelial cell apoptosis by directly targeting TRPC6 in the setting of atherosclerosis.	Scientific reports	2015	23
25835438	Calcium	Puri R	Impact of statins on serial coronary calcification during atheroma progression and regression.	Journal of the American College of Cardiology	2015	34
25838312	Calcium	Leslie CC	Cytosolic phospholipase A₂: physiological function and role in disease.	Journal of lipid research	2015	26
25842288	Calcium	Mathieu AL	PRKDC mutations associated with immunodeficiency, granuloma, and autoimmune regulator-dependent autoimmunity.	The Journal of allergy and clinical immunology	2015	15
25907736	Calcium	Scholl UI	Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism.	eLife	2015	25
25916871	Calcium	Schlieper G	Vascular calcification in chronic kidney disease: an update.	Nephrology, dialysis, transplantation 	2016	11
25925688	Calcium	Keyzer CA	Calcification Propensity and Survival among Renal Transplant Recipients.	Journal of the American Society of Nephrology 	2016	11
25966694	Calcium	Santulli G	Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging.	Current molecular pharmacology	2015	49
26055713	Calcium	Zackular JP	Nutritional Immunity: S100 Proteins at the Host-Pathogen Interface.	The Journal of biological chemistry	2015	19
26072287	Calcium	Déliot N	Plasma membrane calcium channels in cancer: Alterations and consequences for cell proliferation and migration.	Biochimica et biophysica acta	2015	20
26076170	Calcium	Korvatska O	R47H Variant of TREM2 Associated With Alzheimer Disease in a Large Late-Onset Family: Clinical, Genetic, and Neuropathological Study.	JAMA neurology	2015	17
26178670	Calcium	Fetahu IS	miR-135b- and miR-146b-dependent silencing of calcium-sensing receptor expression in colorectal tumors.	International journal of cancer	2016	11
26240369	Calcium	Nishimoto K	Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands.	Proceedings of the National Academy of Sciences of the United States of America	2015	32
26286145	Calcium	Walker DG	Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains.	Alzheimer's research & therapy	2015	30
26335399	Calcium	Vannini F	The dual role of iNOS in cancer.	Redox biology	2015	29
26362469	Calcium	Zamponi GW	The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential.	Pharmacological reviews	2015	72
26404261	Calcium	Temraz S	Dual Inhibition of MEK and PI3K Pathway in KRAS and BRAF Mutated Colorectal Cancers.	International journal of molecular sciences	2015	16
26449662	Calcium	Pietra D	Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms.	Leukemia	2016	21
26457758	Calcium	Waning DL	Excess TGF-β mediates muscle weakness associated with bone metastases in mice.	Nature medicine	2015	41
26469693	Calcium	Lacruz RS	Diseases caused by mutations in ORAI1 and STIM1.	Annals of the New York Academy of Sciences	2015	32
26482279	Calcium	Motzer RJ	Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial.	The Lancet. Oncology	2015	72
26488271	Calcium	Cook DP	Cystic Fibrosis Transmembrane Conductance Regulator in Sarcoplasmic Reticulum of Airway Smooth Muscle. Implications for Airway Contractility.	American journal of respiratory and critical care medicine	2016	13
26538029	Calcium	Morciano G	Mcl-1 involvement in mitochondrial dynamics is associated with apoptotic cell death.	Molecular biology of the cell	2016	16
26589592	Calcium	Johnson VE	SNTF immunostaining reveals previously undetected axonal pathology in traumatic brain injury.	Acta neuropathologica	2016	16
26663395	Calcium	Yan Z	Rab11a Mediates Vascular Endothelial-Cadherin Recycling and Controls Endothelial Barrier Function.	Arteriosclerosis, thrombosis, and vascular biology	2016	10
26772784	Calcium	Bittremieux M	ER functions of oncogenes and tumor suppressors: Modulators of intracellular Ca(2+) signaling.	Biochimica et biophysica acta	2016	20
26826102	Calcium	Oaks AW	Cc2d1a Loss of Function Disrupts Functional and Morphological Development in Forebrain Neurons Leading to Cognitive and Social Deficits.	Cerebral cortex	2017	8
26862948	Calcium	Mvunta DH	Overexpression of SIRT1 is Associated With Poor Outcomes in Patients With Ovarian Carcinoma.	Applied immunohistochemistry & molecular morphology 	2017	7
26899994	Calcium	Li X	miR-155 acts as an anti-inflammatory factor in atherosclerosis-associated foam cell formation by repressing calcium-regulated heat stable protein 1.	Scientific reports	2016	14
27007844	Calcium	Wells MF	Thalamic reticular impairment underlies attention deficit in Ptchd1(Y/-) mice.	Nature	2016	16
27028912	Calcium	Hodis HN	Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol.	The New England journal of medicine	2016	31
27055401	Calcium	Sakallı Çetin E	Selenium potentiates the anticancer effect of cisplatin against oxidative stress and calcium ion signaling-induced intracellular toxicity in MCF-7 breast cancer cells: involvement of the TRPV1 channel.	Journal of receptor and signal transduction research	2017	5
27097283	Calcium	Dafinca R	C9orf72 Hexanucleotide Expansions Are Associated with Altered Endoplasmic Reticulum Calcium Homeostasis and Stress Granule Formation in Induced Pluripotent Stem Cell-Derived Neurons from Patients with Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.	Stem cells	2016	22
27138568	Calcium	Tosatto A	The mitochondrial calcium uniporter regulates breast cancer progression via HIF-1α.	EMBO molecular medicine	2016	18
27190210	Calcium	Corradi J	Understanding the Bases of Function and Modulation of α7 Nicotinic Receptors: Implications for Drug Discovery.	Molecular pharmacology	2016	10
27211800	Calcium	Rozpedek W	The Role of the PERK/eIF2α/ATF4/CHOP Signaling Pathway in Tumor Progression During Endoplasmic Reticulum Stress.	Current molecular medicine	2016	13
27509850	Calcium	Chailangkarn T	A human neurodevelopmental model for Williams syndrome.	Nature	2016	15
27514990	Calcium	Balez R	Neuroprotective effects of apigenin against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer's disease.	Scientific reports	2016	11
27590583	Calcium	Surmeier DJ	Calcium and Parkinson's disease.	Biochemical and biophysical research communications	2017	12
27662816	Calcium	Wimalawansa SJ	Associations of vitamin D with insulin resistance, obesity, type 2 diabetes, and metabolic syndrome.	The Journal of steroid biochemistry and molecular biology	2018	5
27845201	Calcium	Tarantini S	Impaired neurovascular coupling in aging and Alzheimer's disease: Contribution of astrocyte dysfunction and endothelial impairment to cognitive decline.	Experimental gerontology	2017	13
27984724	Calcium	Ang YS	Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis.	Cell	2016	16
28069694	Calcium	Gao L	Myocardial Tissue Engineering With Cells Derived From Human-Induced Pluripotent Stem Cells and a Native-Like, High-Resolution, 3-Dimensionally Printed Scaffold.	Circulation research	2017	10
28132687	Calcium	Riessland M	Neurocalcin Delta Suppression Protects against Spinal Muscular Atrophy in Humans and across Species by Restoring Impaired Endocytosis.	American journal of human genetics	2017	6
28137840	Calcium	Zeng Q	Interleukin-37 suppresses the osteogenic responses of human aortic valve interstitial cells in vitro and alleviates valve lesions in mice.	Proceedings of the National Academy of Sciences of the United States of America	2017	12
28213158	Calcium	Whitworth AJ	PINK1/Parkin mitophagy and neurodegeneration-what do we really know in vivo?	Current opinion in genetics & development	2017	10
28388412	Calcium	Gong YN	ESCRT-III Acts Downstream of MLKL to Regulate Necroptotic Cell Death and Its Consequences.	Cell	2017	22
28445465	Calcium	Birey F	Assembly of functionally integrated human forebrain spheroids.	Nature	2017	28
28574339	Calcium	Kenny EF	Diverse stimuli engage different neutrophil extracellular trap pathways.	eLife	2017	13
15814656	Epigallocatechin gallate	Shimizu M	(-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells.	Clinical cancer research 	2005	69
16918500	Epigallocatechin gallate	Nam NH	Naturally occurring NF-kappaB inhibitors.	Mini reviews in medicinal chemistry	2006	60
17998943	Epigallocatechin gallate	Siddiqui IA	Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis.	Oncogene	2008	56
19190249	Epigallocatechin gallate	Golden EB	Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors.	Blood	2009	49
20015867	Epigallocatechin gallate	Balasubramanian S	The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival.	Carcinogenesis	2010	42
21209038	Epigallocatechin gallate	Nandakumar V	(-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells.	Carcinogenesis	2011	69
21796625	Epigallocatechin gallate	Tang SN	Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics.	International journal of cancer	2012	50
21798853	Epigallocatechin gallate	Choudhury SR	(-)-Epigallocatechin-3-gallate and DZNep reduce polycomb protein level via a proteasome-dependent mechanism in skin cancer cells.	Carcinogenesis	2011	41
21965273	Epigallocatechin gallate	Wang H	Green tea polyphenol EGCG suppresses lung cancer cell growth through upregulating miR-210 expression caused by stabilizing HIF-1α.	Carcinogenesis	2011	45
23201840	Epigallocatechin gallate	Du GJ	Epigallocatechin Gallate (EGCG) is the most effective cancer chemopreventive polyphenol in green tea.	Nutrients	2012	33
24518414	Epigallocatechin gallate	Saldanha SN	Molecular mechanisms for inhibition of colon cancer cells by combined epigenetic-modulating epigallocatechin gallate and sodium butyrate.	Experimental cell research	2014	22
25865775	Epigallocatechin gallate	Casey SC	Cancer prevention and therapy through the modulation of the tumor microenvironment.	Seminars in cancer biology	2015	27
26930714	Epigallocatechin gallate	Toden S	Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer.	Oncotarget	2016	14
26933999	Epigallocatechin gallate	Yu CC	Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.	Oncotarget	2016	15
27200496	Epigallocatechin gallate	Yuan CH	Epigallocatechin gallate sensitizes cisplatin-resistant oral cancer CAR cell apoptosis and autophagy through stimulating AKT/STAT3 pathway and suppressing multidrug resistance 1 signaling.	Environmental toxicology	2017	10
9425011	Glutathione	Keller JN	Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction.	The Journal of neuroscience 	1998	123
10485474	Glutathione	McMenamin ME	Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage.	Cancer research	1999	141
10562656	Glutathione	Winkler BS	Oxidative damage and age-related macular degeneration.	Molecular vision	1999	144
12177198	Glutathione	Sherer TB	An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage.	The Journal of neuroscience 	2002	123
12676598	Glutathione	Li N	Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage.	Environmental health perspectives	2003	257
12923074	Glutathione	Jauslin ML	Mitochondria-targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants.	FASEB journal 	2003	83
14556645	Glutathione	Videla LA	Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients.	Clinical science	2004	78
14616092	Glutathione	Levonen AL	Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products.	The Biochemical journal	2004	145
15032713	Glutathione	Swanson RA	Astrocyte influences on ischemic neuronal death.	Current molecular medicine	2004	95
15764812	Glutathione	Singh SV	Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species.	The Journal of biological chemistry	2005	94
15790984	Glutathione	Drost EM	Oxidative stress and airway inflammation in severe exacerbations of COPD.	Thorax	2005	77
16103712	Glutathione	Luqmani YA	Mechanisms of drug resistance in cancer chemotherapy.	Medical principles and practice 	2005	72
16127462	Glutathione	Vikramadithyan RK	Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice.	The Journal of clinical investigation	2005	68
16573358	Glutathione	Finaud J	Oxidative stress : relationship with exercise and training.	Sports medicine	2006	60
16816350	Glutathione	Rahman I	Oxidative stress and redox regulation of lung inflammation in COPD.	The European respiratory journal	2006	171
16959615	Glutathione	Trachootham D	Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate.	Cancer cell	2006	294
17062156	Glutathione	Kode A	Differential effects of cigarette smoke on oxidative stress and proinflammatory cytokine release in primary human airway epithelial cells and in a variety of transformed alveolar epithelial cells.	Respiratory research	2006	76
17075858	Glutathione	Aigner T	Large-scale gene expression profiling reveals major pathogenetic pathways of cartilage degeneration in osteoarthritis.	Arthritis and rheumatism	2006	98
17329258	Glutathione	Peskin AV	The high reactivity of peroxiredoxin 2 with H(2)O(2) is not reflected in its reaction with other oxidants and thiol reagents.	The Journal of biological chemistry	2007	106
17640917	Glutathione	Lu J	Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide.	Proceedings of the National Academy of Sciences of the United States of America	2007	94
17804715	Glutathione	Yu YP	Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis.	Cancer research	2007	60
18072094	Glutathione	Bonomini F	Atherosclerosis and oxidative stress.	Histology and histopathology	2008	62
18367735	Glutathione	Levine S	Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans.	The New England journal of medicine	2008	201
18372916	Glutathione	Frohlich DA	The role of Nrf2 in increased reactive oxygen species and DNA damage in prostate tumorigenesis.	Oncogene	2008	58
18567819	Glutathione	Boden G	Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals.	Diabetes	2008	119
18572023	Glutathione	Pi J	Arsenic-induced malignant transformation of human keratinocytes: involvement of Nrf2.	Free radical biology & medicine	2008	53
18574029	Glutathione	Trachootham D	Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism.	Blood	2008	57
18588971	Glutathione	Sorolla MA	Proteomic and oxidative stress analysis in human brain samples of Huntington disease.	Free radical biology & medicine	2008	57
18664505	Glutathione	Peng DF	DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma.	Gut	2009	54
18762024	Glutathione	Seiler A	Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death.	Cell metabolism	2008	140
18831679	Glutathione	Berthoud VM	Oxidative stress, lens gap junctions, and cataracts.	Antioxidants & redox signaling	2009	55
19074031	Glutathione	Vargas MR	Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis.	The Journal of neuroscience 	2008	131
19417020	Glutathione	Homma S	Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer.	Clinical cancer research 	2009	96
19484125	Glutathione	Yang L	Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription.	PloS one	2009	51
19654295	Glutathione	Yodkeeree S	Zerumbone enhances TRAIL-induced apoptosis through the induction of death receptors in human colon cancer cells: Evidence for an essential role of reactive oxygen species.	Cancer research	2009	45
19660542	Glutathione	Lin PW	Lactobacillus rhamnosus blocks inflammatory signaling in vivo via reactive oxygen species generation.	Free radical biology & medicine	2009	54
19748514	Glutathione	Fuller S	Activated astroglia during chronic inflammation in Alzheimer's disease--do they neglect their neurosupportive roles?	Mutation research	2010	50
20124447	Glutathione	Zhang P	Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth.	Molecular cancer therapeutics	2010	112
20126446	Glutathione	Qin Z	Upregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stress.	PLoS pathogens	2010	53
20228251	Glutathione	Lee M	Depletion of GSH in glial cells induces neurotoxicity: relevance to aging and degenerative neurological diseases.	FASEB journal 	2010	41
20357106	Glutathione	Li X	Aberrant Rab11-dependent trafficking of the neuronal glutamate transporter EAAC1 causes oxidative stress and cell death in Huntington's disease.	The Journal of neuroscience 	2010	56
20417696	Glutathione	Kantrowitz JT	N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia?	Brain research bulletin	2010	118
20506400	Glutathione	Guo F	Granulin-epithelin precursor binds directly to ADAMTS-7 and ADAMTS-12 and inhibits their degradation of cartilage oligomeric matrix protein.	Arthritis and rheumatism	2010	43
20709907	Glutathione	Sangokoya C	microRNA miR-144 modulates oxidative stress tolerance and associates with anemia severity in sickle cell disease.	Blood	2010	76
20855962	Glutathione	Martinez-Outschoorn UE	Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment.	Cell cycle	2010	136
20939847	Glutathione	Chandrasekharan B	Colonic motor dysfunction in human diabetes is associated with enteric neuronal loss and increased oxidative stress.	Neurogastroenterology and motility 	2011	38
21041533	Glutathione	Lamb GD	Acute effects of reactive oxygen and nitrogen species on the contractile function of skeletal muscle.	The Journal of physiology	2011	40
21071633	Glutathione	Indran IR	hTERT overexpression alleviates intracellular ROS production, improves mitochondrial function, and inhibits ROS-mediated apoptosis in cancer cells.	Cancer research	2011	49
21156786	Glutathione	Pathi SS	GT-094, a NO-NSAID, inhibits colon cancer cell growth by activation of a reactive oxygen species-microRNA-27a: ZBTB10-specificity protein pathway.	Molecular cancer research 	2011	39
21289278	Glutathione	Reitman ZJ	Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome.	Proceedings of the National Academy of Sciences of the United States of America	2011	164
21317550	Glutathione	McCoy MK	DJ-1 regulation of mitochondrial function and autophagy through oxidative stress.	Autophagy	2011	44
21397861	Glutathione	Ishimoto T	CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth.	Cancer cell	2011	212
21402146	Glutathione	Tang X	Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs.	Free radical biology & medicine	2011	47
21686173	Glutathione	Fernández-Sánchez A	Inflammation, oxidative stress, and obesity.	International journal of molecular sciences	2011	117
21750178	Glutathione	Lovejoy DB	Antitumor activity of metal-chelating compound Dp44mT is mediated by formation of a redox-active copper complex that accumulates in lysosomes.	Cancer research	2011	44
21985599	Glutathione	Marra M	Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview.	Journal of translational medicine	2011	46
22015945	Glutathione	Pope WB	Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy.	Journal of neuro-oncology	2012	62
22117045	Glutathione	Yin L	Inhibition of the MUC1-C oncoprotein induces multiple myeloma cell death by down-regulating TIGAR expression and depleting NADPH.	Blood	2012	33
22361232	Glutathione	Collins LM	Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease.	Neuropharmacology	2012	32
22854025	Glutathione	Galluzzi L	Prognostic impact of vitamin B6 metabolism in lung cancer.	Cell reports	2012	38
23123197	Glutathione	Wei PC	Loss of the oxidative stress sensor NPGPx compromises GRP78 chaperone activity and induces systemic disease.	Molecular cell	2012	33
23242140	Glutathione	Maddocks OD	Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells.	Nature	2013	159
23334333	Glutathione	Nagano O	Redox regulation in stem-like cancer cells by CD44 variant isoforms.	Oncogene	2013	62
23535601	Glutathione	Son J	Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway.	Nature	2013	342
23747014	Glutathione	Sullivan LB	The proto-oncometabolite fumarate binds glutathione to amplify ROS-dependent signaling.	Molecular cell	2013	66
23752353	Glutathione	Yang L	Fucoidan derived from Undaria pinnatifida induces apoptosis in human hepatocellular carcinoma SMMC-7721 cells via the ROS-mediated mitochondrial pathway.	Marine drugs	2013	25
23849856	Glutathione	Winterbourn CC	The biological chemistry of hydrogen peroxide.	Methods in enzymology	2013	39
23863625	Glutathione	Guo S	Inactivation of specific β cell transcription factors in type 2 diabetes.	The Journal of clinical investigation	2013	114
23872024	Glutathione	Shearn CT	Increased carbonylation of the lipid phosphatase PTEN contributes to Akt2 activation in a murine model of early alcohol-induced steatosis.	Free radical biology & medicine	2013	25
24031087	Glutathione	Dey P	Insight into the mechanisms of action of estrogen receptor β in the breast, prostate, colon, and CNS.	Journal of molecular endocrinology	2013	26
24089526	Glutathione	Pei S	Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cells.	The Journal of biological chemistry	2013	40
24100461	Glutathione	Perl A	Oxidative stress in the pathology and treatment of systemic lupus erythematosus.	Nature reviews. Rheumatology	2013	47
24186494	Glutathione	Xu Z	NRF2 plays a protective role in diabetic retinopathy in mice.	Diabetologia	2014	31
24292713	Glutathione	Glasauer A	Targeting SOD1 reduces experimental non–small-cell lung cancer.	The Journal of clinical investigation	2014	31
24334253	Glutathione	Evans MK	Mn porphyrin in combination with ascorbate acts as a pro-oxidant and mediates caspase-independent cancer cell death.	Free radical biology & medicine	2014	21
24505477	Glutathione	Ren W	Serum amino acids profile and the beneficial effects of L-arginine or L-glutamine supplementation in dextran sulfate sodium colitis.	PloS one	2014	24
24516043	Glutathione	Drayton RM	Reduced expression of miRNA-27a modulates cisplatin resistance in bladder cancer by targeting the cystine/glutamate exchanger SLC7A11.	Clinical cancer research 	2014	33
24523301	Glutathione	Gross MI	Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer.	Molecular cancer therapeutics	2014	113
24637114	Glutathione	Pekovic-Vaughan V	The circadian clock regulates rhythmic activation of the NRF2/glutathione-mediated antioxidant defense pathway to modulate pulmonary fibrosis.	Genes & development	2014	44
24692350	Glutathione	Bhattacharyya A	Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases.	Physiological reviews	2014	99
24714342	Glutathione	Karamichos D	In vitro model suggests oxidative stress involved in keratoconus disease.	Scientific reports	2014	23
24905542	Glutathione	Xie Y	Mechanisms of acetaminophen-induced cell death in primary human hepatocytes.	Toxicology and applied pharmacology	2014	48
25002527	Glutathione	Ye P	Nrf2- and ATF4-dependent upregulation of xCT modulates the sensitivity of T24 bladder carcinoma cells to proteasome inhibition.	Molecular and cellular biology	2014	24
25006124	Glutathione	Tessoulin B	PRIMA-1Met induces myeloma cell death independent of p53 by impairing the GSH/ROS balance.	Blood	2014	26
25244505	Glutathione	Li H	Vascular oxidative stress, nitric oxide and atherosclerosis.	Atherosclerosis	2014	76
25283382	Glutathione	Shi J	Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation.	Tumour biology 	2015	22
25524627	Glutathione	Li J	Synthetic lethality of combined glutaminase and Hsp90 inhibition in mTORC1-driven tumor cells.	Proceedings of the National Academy of Sciences of the United States of America	2015	17
25607840	Glutathione	Sellers K	Pyruvate carboxylase is critical for non-small-cell lung cancer proliferation.	The Journal of clinical investigation	2015	84
25793315	Glutathione	Sun L	cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions.	Cell research	2015	20
25834400	Glutathione	Pan ST	Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells.	Drug design, development and therapy	2015	18
25952651	Glutathione	Wettersten HI	Grade-Dependent Metabolic Reprogramming in Kidney Cancer Revealed by Combined Proteomics and Metabolomics Analysis.	Cancer research	2015	30
25985305	Glutathione	Checconi P	Redox proteomics of the inflammatory secretome identifies a common set of redoxins and other glutathionylated proteins released in inflammation, influenza virus infection and oxidative stress.	PloS one	2015	15
26019222	Glutathione	Robert SM	SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma.	Science translational medicine	2015	19
26233704	Glutathione	Espinosa-Diez C	Antioxidant responses and cellular adjustments to oxidative stress.	Redox biology	2015	77
26482881	Glutathione	DeNicola GM	NRF2 regulates serine biosynthesis in non-small cell lung cancer.	Nature genetics	2015	70
26491296	Glutathione	Gurunathan S	Reduced graphene oxide-silver nanoparticle nanocomposite: a potential anticancer nanotherapy.	International journal of nanomedicine	2015	17
26541605	Glutathione	Yun J	Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH.	Science	2015	73
26564470	Glutathione	Deas E	Alpha-Synuclein Oligomers Interact with Metal Ions to Induce Oxidative Stress and Neuronal Death in Parkinson's Disease.	Antioxidants & redox signaling	2016	23
26669865	Glutathione	Emir UE	Noninvasive Quantification of 2-Hydroxyglutarate in Human Gliomas with IDH1 and IDH2 Mutations.	Cancer research	2016	19
26754582	Glutathione	Vilhardt F	Microglia antioxidant systems and redox signalling.	British journal of pharmacology	2017	6
26772193	Glutathione	Rossi M	Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial.	Clinical journal of the American Society of Nephrology 	2016	13
27055559	Glutathione	Shitara K	Dose-escalation study for the targeting of CD44v+ cancer stem cells by sulfasalazine in patients with advanced gastric cancer (EPOC1205).	Gastric cancer 	2017	11
27133165	Glutathione	Wang W	Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer.	Cell	2016	23
27193186	Glutathione	Zheng ZG	The Essential Role of H19 Contributing to Cisplatin Resistance by Regulating Glutathione Metabolism in High-Grade Serous Ovarian Cancer.	Scientific reports	2016	15
27245224	Glutathione	Peiró C	Inflammation, glucose, and vascular cell damage: the role of the pentose phosphate pathway.	Cardiovascular diabetology	2016	11
27477511	Glutathione	Chio IIC	NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer.	Cell	2016	29
27878243	Glutathione	Häggblad Sahlberg S	Different functions of AKT1 and AKT2 in molecular pathways, cell migration and metabolism in colon cancer cells.	International journal of oncology	2017	6
28007895	Glutathione	Semenza GL	Hypoxia-inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype.	The EMBO journal	2017	12
28017891	Glutathione	Xie Y	Self-immolative nanoparticles for simultaneous delivery of microRNA and targeting of polyamine metabolism in combination cancer therapy.	Journal of controlled release 	2017	7
1279431	Oxygen	Shweiki D	Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.	Nature	1992	672
8058797	Oxygen	Borchelt DR	Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity.	Proceedings of the National Academy of Sciences of the United States of America	1994	124
8790408	Oxygen	Lebovitz RM	Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice.	Proceedings of the National Academy of Sciences of the United States of America	1996	226
8876227	Oxygen	MacMillan-Crow LA	Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts.	Proceedings of the National Academy of Sciences of the United States of America	1996	126
8958220	Oxygen	Rajagopalan S	Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability.	The Journal of clinical investigation	1996	170
8986723	Oxygen	Coxon A	A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation.	Immunity	1996	167
9192621	Oxygen	Shim H	c-Myc transactivation of LDH-A: implications for tumor metabolism and growth.	Proceedings of the National Academy of Sciences of the United States of America	1997	249
9633809	Oxygen	Hall ED	Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS.	Glia	1998	124
9704769	Oxygen	Sacks GP	Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis.	American journal of obstetrics and gynecology	1998	146
10385613	Oxygen	Bouloumie A	Leptin induces oxidative stress in human endothelial cells.	FASEB journal 	1999	107
10386999	Oxygen	Huang X	The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction.	Biochemistry	1999	143
10398599	Oxygen	Dawson DW	Pigment epithelium-derived factor: a potent inhibitor of angiogenesis.	Science	1999	303
10430608	Oxygen	Frantz S	Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium.	The Journal of clinical investigation	1999	114
10545952	Oxygen	Papadopoulou LC	Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene.	Nature genetics	1999	101
10581086	Oxygen	Jones MK	Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing.	Nature medicine	1999	105
10640274	Oxygen	Ravi R	Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.	Genes & development	2000	226
10891486	Oxygen	Vande Velde C	BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore.	Molecular and cellular biology	2000	149
10910033	Oxygen	Hussain SP	Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease.	Cancer research	2000	102
10924851	Oxygen	Janssen-Heininger YM	Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB.	Free radical biology & medicine	2000	103
11283670	Oxygen	Kim MS	Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes.	Nature medicine	2001	145
11304501	Oxygen	Dzau VJ	Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis.	Hypertension	2001	96
11461977	Oxygen	Lauderback CM	The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42.	Journal of neurochemistry	2001	95
11487050	Oxygen	Nunomura A	Oxidative damage is the earliest event in Alzheimer disease.	Journal of neuropathology and experimental neurology	2001	359
11507045	Oxygen	Fukumura D	Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo.	Cancer research	2001	91
11566918	Oxygen	London GM	Arterial wave reflections and survival in end-stage renal failure.	Hypertension	2001	112
11719508	Oxygen	Colavitti R	Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR.	The Journal of biological chemistry	2002	89
11729749	Oxygen	Kmieć Z	Cooperation of liver cells in health and disease.	Advances in anatomy, embryology, and cell biology	2001	103
11734454	Oxygen	Bhatt AJ	Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia.	American journal of respiratory and critical care medicine	2001	122
12042811	Oxygen	Xu J	Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease.	Nature medicine	2002	150
12086861	Oxygen	Maranchie JK	The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma.	Cancer cell	2002	130
12147534	Oxygen	Ballinger SW	Mitochondrial integrity and function in atherogenesis.	Circulation	2002	104
12176889	Oxygen	Dekker RJ	Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Krüppel-like factor (KLF2).	Blood	2002	160
12209156	Oxygen	Kaelin WG Jr	Molecular basis of the VHL hereditary cancer syndrome.	Nature reviews. Cancer	2002	193
12354300	Oxygen	Castegna A	Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71.	Journal of neurochemistry	2002	110
12414515	Oxygen	Muller DN	Immunosuppressive treatment protects against angiotensin II-induced renal damage.	The American journal of pathology	2002	87
12621155	Oxygen	Sun Y	Neuroglobin protects the brain from experimental stroke in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2003	93
12663857	Oxygen	Calvillo L	Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling.	Proceedings of the National Academy of Sciences of the United States of America	2003	88
12821241	Oxygen	Heymes C	Increased myocardial NADPH oxidase activity in human heart failure.	Journal of the American College of Cardiology	2003	119
12821677	Oxygen	Ling YH	Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells.	The Journal of biological chemistry	2003	101
12840067	Oxygen	Danet GH	Expansion of human SCID-repopulating cells under hypoxic conditions.	The Journal of clinical investigation	2003	81
12855411	Oxygen	Lassègue B	Vascular NAD(P)H oxidases: specific features, expression, and regulation.	American journal of physiology. Regulatory, integrative and comparative physiology	2003	201
12858170	Oxygen	Mattiasson G	Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma.	Nature medicine	2003	111
12885586	Oxygen	Fattman CL	Extracellular superoxide dismutase in biology and medicine.	Free radical biology & medicine	2003	104
14604834	Oxygen	Delafontaine P	Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels.	Arteriosclerosis, thrombosis, and vascular biology	2004	100
14610616	Oxygen	Hileman EO	Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity.	Cancer chemotherapy and pharmacology	2004	72
14644195	Oxygen	Bossy-Wetzel E	Mitochondrial fission in apoptosis, neurodegeneration and aging.	Current opinion in cell biology	2003	106
14699081	Oxygen	Kim JY	BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1alpha.	The Journal of experimental medicine	2004	81
14713953	Oxygen	Miyauchi H	Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway.	The EMBO journal	2004	82
14766366	Oxygen	Diegelmann RF	Wound healing: an overview of acute, fibrotic and delayed healing.	Frontiers in bioscience 	2004	287
14985465	Oxygen	Zimmer M	Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL-/- tumors.	Molecular cancer research 	2004	82
15073152	Oxygen	Pesah Y	Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress.	Development	2004	133
15104534	Oxygen	Marxsen JH	Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.	The Biochemical journal	2004	80
15126346	Oxygen	Xie Y	Deficiencies in mouse Myh and Ogg1 result in tumor predisposition and G to T mutations in codon 12 of the K-ras oncogene in lung tumors.	Cancer research	2004	73
15173093	Oxygen	Pei XY	Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors.	Clinical cancer research 	2004	102
15217919	Oxygen	Nian M	Inflammatory cytokines and postmyocardial infarction remodeling.	Circulation research	2004	197
15279799	Oxygen	Barzilai A	DNA damage responses to oxidative stress.	DNA repair	2004	111
15297389	Oxygen	De Larco JE	The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8.	Clinical cancer research 	2004	72
15389790	Oxygen	Lim SD	Increased Nox1 and hydrogen peroxide in prostate cancer.	The Prostate	2005	85
15502868	Oxygen	Martinat C	Sensitivity to oxidative stress in DJ-1-deficient dopamine neurons: an ES- derived cell model of primary Parkinsonism.	PLoS biology	2004	81
15509579	Oxygen	Umeda N	Mitochondria-specific RNA-modifying enzymes responsible for the biosynthesis of the wobble base in mitochondrial tRNAs. Implications for the molecular pathogenesis of human mitochondrial diseases.	The Journal of biological chemistry	2005	72
15509775	Oxygen	Fribley A	Proteasome inhibitor PS-341 induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells.	Molecular and cellular biology	2004	145
15555528	Oxygen	SanGiovanni JP	The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina.	Progress in retinal and eye research	2005	126
15589366	Oxygen	Horbinski C	Kinase signaling cascades in the mitochondrion: a matter of life or death.	Free radical biology & medicine	2005	77
15647368	Oxygen	Petros JA	mtDNA mutations increase tumorigenicity in prostate cancer.	Proceedings of the National Academy of Sciences of the United States of America	2005	249
15647377	Oxygen	John GB	The mitochondrial inner membrane protein mitofilin controls cristae morphology.	Molecular biology of the cell	2005	113
15738989	Oxygen	Krauss S	The mitochondrial uncoupling-protein homologues.	Nature reviews. Molecular cell biology	2005	145
15820197	Oxygen	Brandes RP	Endothelial aging.	Cardiovascular research	2005	123
15857893	Oxygen	Waghray M	Hydrogen peroxide is a diffusible paracrine signal for the induction of epithelial cell death by activated myofibroblasts.	FASEB journal 	2005	78
15879174	Oxygen	Schriner SE	Extension of murine life span by overexpression of catalase targeted to mitochondria.	Science	2005	458
15882775	Oxygen	Chong ZZ	Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease.	Progress in neurobiology	2005	149
15922663	Oxygen	Mayadas TN	Neutrophil beta2 integrins: moderators of life or death decisions.	Trends in immunology	2005	68
15964800	Oxygen	Dai Y	Blockade of histone deacetylase inhibitor-induced RelA/p65 acetylation and NF-kappaB activation potentiates apoptosis in leukemia cells through a process mediated by oxidative damage, XIAP downregulation, and c-Jun N-terminal kinase 1 activation.	Molecular and cellular biology	2005	70
15978720	Oxygen	Sarkar D	Molecular mechanisms of aging-associated inflammation.	Cancer letters	2006	79
15994299	Oxygen	Kawahara T	Point mutations in the proline-rich region of p22phox are dominant inhibitors of Nox1- and Nox2-dependent reactive oxygen generation.	The Journal of biological chemistry	2005	71
16009356	Oxygen	Cai H	Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences.	Cardiovascular research	2005	143
16101524	Oxygen	Korhonen R	Nitric oxide production and signaling in inflammation.	Current drug targets. Inflammation and allergy	2005	99
16155123	Oxygen	Yang Y	Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling.	Proceedings of the National Academy of Sciences of the United States of America	2005	108
16163384	Oxygen	Achanta G	Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol gamma.	The EMBO journal	2005	99
16166634	Oxygen	Storz P	Protein kinase D mediates mitochondrion-to-nucleus signaling and detoxification from mitochondrial reactive oxygen species.	Molecular and cellular biology	2005	82
16179589	Oxygen	Cucoranu I	NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts.	Circulation research	2005	225
16210396	Oxygen	Caspersen C	Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease.	FASEB journal 	2005	208
16254208	Oxygen	Hemdahl AL	Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction.	Arteriosclerosis, thrombosis, and vascular biology	2006	66
16291837	Oxygen	Nangaku M	Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure.	Journal of the American Society of Nephrology 	2006	207
16294028	Oxygen	Desouki MM	Cross talk between mitochondria and superoxide generating NADPH oxidase in breast and ovarian tumors.	Cancer biology & therapy	2005	66
16373444	Oxygen	O'Leary VB	Exercise-induced reversal of insulin resistance in obese elderly is associated with reduced visceral fat.	Journal of applied physiology	2006	62
16394109	Oxygen	Galkina E	Leukocyte recruitment and vascular injury in diabetic nephropathy.	Journal of the American Society of Nephrology 	2006	73
16417408	Oxygen	Chi JT	Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers.	PLoS medicine	2006	195
16456579	Oxygen	Papa S	The NF-kappaB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease.	Cell death and differentiation	2006	70
16473887	Oxygen	Neumann J	Microglia provide neuroprotection after ischemia.	FASEB journal 	2006	73
16532036	Oxygen	Mochizuki T	Inhibition of NADPH oxidase 4 activates apoptosis via the AKT/apoptosis signal-regulating kinase 1 pathway in pancreatic cancer PANC-1 cells.	Oncogene	2006	75
16565714	Oxygen	Bosco DA	Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization.	Nature chemical biology	2006	67
16585181	Oxygen	Esteban MA	Regulation of E-cadherin expression by VHL and hypoxia-inducible factor.	Cancer research	2006	85
16636067	Oxygen	Cheng G	Nox1-dependent reactive oxygen generation is regulated by Rac1.	The Journal of biological chemistry	2006	86
16642001	Oxygen	Erler JT	Lysyl oxidase is essential for hypoxia-induced metastasis.	Nature	2006	431
16648488	Oxygen	Connolly E	Hypoxia inhibits protein synthesis through a 4E-BP1 and elongation factor 2 kinase pathway controlled by mTOR and uncoupled in breast cancer cells.	Molecular and cellular biology	2006	65
16678181	Oxygen	Hunt NH	Immunopathogenesis of cerebral malaria.	International journal for parasitology	2006	84
16687579	Oxygen	Jaeschke H	Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions.	American journal of physiology. Gastrointestinal and liver physiology	2006	124
16707454	Oxygen	Chajès V	Acetyl-CoA carboxylase alpha is essential to breast cancer cell survival.	Cancer research	2006	78
16724053	Oxygen	Shaw RJ	Ras, PI(3)K and mTOR signalling controls tumour cell growth.	Nature	2006	571
16724055	Oxygen	Pouysségur J	Hypoxia signalling in cancer and approaches to enforce tumour regression.	Nature	2006	405
16754882	Oxygen	Basile JR	Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis.	Proceedings of the National Academy of Sciences of the United States of America	2006	75
16771662	Oxygen	Cave AC	NADPH oxidases in cardiovascular health and disease.	Antioxidants & redox signaling	2006	164
16861899	Oxygen	Fels DR	The PERK/eIF2alpha/ATF4 module of the UPR in hypoxia resistance and tumor growth.	Cancer biology & therapy	2006	91
16870827	Oxygen	Mehta PK	Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system.	American journal of physiology. Cell physiology	2007	439
16894049	Oxygen	Goldin A	Advanced glycation end products: sparking the development of diabetic vascular injury.	Circulation	2006	336
16923312	Oxygen	Albano E	Alcohol, oxidative stress and free radical damage.	The Proceedings of the Nutrition Society	2006	97
17034340	Oxygen	Frangogiannis NG	The mechanistic basis of infarct healing.	Antioxidants & redox signaling	2006	66
17084552	Oxygen	Blazek ER	Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia.	International journal of radiation oncology, biology, physics	2007	60
17116235	Oxygen	Lambert MP	Monoclonal antibodies that target pathological assemblies of Abeta.	Journal of neurochemistry	2007	109
17160708	Oxygen	Wu WS	The signaling mechanism of ROS in tumor progression.	Cancer metastasis reviews	2006	175
17182618	Oxygen	Koivunen P	Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF.	The Journal of biological chemistry	2007	124
17220275	Oxygen	Yan Q	The hypoxia-inducible factor 2alpha N-terminal and C-terminal transactivation domains cooperate to promote renal tumorigenesis in vivo.	Molecular and cellular biology	2007	62
17222355	Oxygen	Hebert C	High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma.	Molecular cancer	2007	122
17222916	Oxygen	Heneka MT	Inflammatory processes in Alzheimer's disease.	Journal of neuroimmunology	2007	171
17234762	Oxygen	Kim YJ	Human prx1 gene is a target of Nrf2 and is up-regulated by hypoxia/reoxygenation: implication to tumor biology.	Cancer research	2007	65
17237347	Oxygen	Bedard K	The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology.	Physiological reviews	2007	1434
17250680	Oxygen	Haorah J	Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction.	Journal of neurochemistry	2007	79
17255293	Oxygen	Kaelin WG Jr	The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma.	Clinical cancer research 	2007	88
17292829	Oxygen	Dolado I	p38alpha MAP kinase as a sensor of reactive oxygen species in tumorigenesis.	Cancer cell	2007	115
17311546	Oxygen	Maiese K	Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus.	Current neurovascular research	2007	62
17329180	Oxygen	Takemura G	Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management.	Progress in cardiovascular diseases	2007	127
17360382	Oxygen	Chin BY	Hypoxia-inducible factor 1alpha stabilization by carbon monoxide results in cytoprotective preconditioning.	Proceedings of the National Academy of Sciences of the United States of America	2007	62
17369289	Oxygen	Sturrock A	Nox4 mediates TGF-beta1-induced retinoblastoma protein phosphorylation, proliferation, and hypertrophy in human airway smooth muscle cells.	American journal of physiology. Lung cellular and molecular physiology	2007	58
17404109	Oxygen	Puri N	c-Met is a potentially new therapeutic target for treatment of human melanoma.	Clinical cancer research 	2007	63
17440056	Oxygen	Alexandre J	Novel action of paclitaxel against cancer cells: bystander effect mediated by reactive oxygen species.	Cancer research	2007	82
17482542	Oxygen	Keith B	Hypoxia-inducible factors, stem cells, and cancer.	Cell	2007	333
17494630	Oxygen	Schoner W	Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth.	American journal of physiology. Cell physiology	2007	123
17513612	Oxygen	Han W	Shikonin circumvents cancer drug resistance by induction of a necroptotic death.	Molecular cancer therapeutics	2007	78
17545622	Oxygen	De Milito A	Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species.	Cancer research	2007	67
17557118	Oxygen	Peyssonnaux C	Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs).	The Journal of clinical investigation	2007	161
17567756	Oxygen	Lofqvist C	IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth.	Proceedings of the National Academy of Sciences of the United States of America	2007	69
17584843	Oxygen	Newsholme P	Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity.	The Journal of physiology	2007	114
17585072	Oxygen	Mittal M	Hypoxia-dependent regulation of nonphagocytic NADPH oxidase subunit NOX4 in the pulmonary vasculature.	Circulation research	2007	124
17603752	Oxygen	Liao D	Hypoxia: a key regulator of angiogenesis in cancer.	Cancer metastasis reviews	2007	177
17643088	Oxygen	Jain RK	Angiogenesis in brain tumours.	Nature reviews. Neuroscience	2007	335
17786216	Oxygen	Matouk IJ	The H19 non-coding RNA is essential for human tumor growth.	PloS one	2007	185
17873906	Oxygen	Gort EH	The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2alpha.	Oncogene	2008	51
17875751	Oxygen	Talmadge JE	Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy.	Clinical cancer research 	2007	82
17893868	Oxygen	Federico A	Chronic inflammation and oxidative stress in human carcinogenesis.	International journal of cancer	2007	165
17914462	Oxygen	Kumar A	Commensal bacteria modulate cullin-dependent signaling via generation of reactive oxygen species.	The EMBO journal	2007	74
17916722	Oxygen	Semenza GL	Life with oxygen.	Science	2007	169
17924549	Oxygen	Luo HR	Constitutive neutrophil apoptosis: mechanisms and regulation.	American journal of hematology	2008	77
17967865	Oxygen	Guzy RD	Loss of the SdhB, but Not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis.	Molecular and cellular biology	2008	113
18006827	Oxygen	Xia C	Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor.	Cancer research	2007	122
18032788	Oxygen	Chen Y	Mitochondrial electron-transport-chain inhibitors of complexes I and II induce autophagic cell death mediated by reactive oxygen species.	Journal of cell science	2007	130
18059169	Oxygen	Azad MB	Hypoxia induces autophagic cell death in apoptosis-competent cells through a mechanism involving BNIP3.	Autophagy	2008	93
18160646	Oxygen	Boettiger CA	Immediate reward bias in humans: fronto-parietal networks and a role for the catechol-O-methyltransferase 158(Val/Val) genotype.	The Journal of neuroscience 	2007	109
18192505	Oxygen	Sallmyr A	Internal tandem duplication of FLT3 (FLT3/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML.	Blood	2008	79
18193093	Oxygen	Courtois-Cox S	Many roads lead to oncogene-induced senescence.	Oncogene	2008	115
18218341	Oxygen	Reddy PH	Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease.	Trends in molecular medicine	2008	185
18222169	Oxygen	Suzuki C	Participation of autophagy in renal ischemia/reperfusion injury.	Biochemical and biophysical research communications	2008	57
18245082	Oxygen	Devi L	Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain.	The Journal of biological chemistry	2008	198
18259200	Oxygen	Loor G	Role of hypoxia-inducible factor in cell survival during myocardial ischemia-reperfusion.	Cell death and differentiation	2008	63
18259201	Oxygen	Weidemann A	Biology of HIF-1alpha.	Cell death and differentiation	2008	173
18264786	Oxygen	Legg JA	Slits and Roundabouts in cancer, tumour angiogenesis and endothelial cell migration.	Angiogenesis	2008	54
18281474	Oxygen	Furuta E	Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1.	Cancer research	2008	91
18325636	Oxygen	Fleisher AS	Cerebral perfusion and oxygenation differences in Alzheimer's disease risk.	Neurobiology of aging	2009	66
18339858	Oxygen	Kumar B	Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype.	Cancer research	2008	157
18374622	Oxygen	Andersson-Sjöland A	Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis.	The international journal of biochemistry & cell biology	2008	115
18394557	Oxygen	Duran A	The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis.	Cancer cell	2008	181
18395093	Oxygen	Horiguchi N	Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury.	Gastroenterology	2008	70
18511948	Oxygen	Fagerholm R	NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer.	Nature genetics	2008	78
18524993	Oxygen	Sallmyr A	Up-regulation of WRN and DNA ligase IIIalpha in chronic myeloid leukemia: consequences for the repair of DNA double-strand breaks.	Blood	2008	57
18536919	Oxygen	El-Benna J	Priming of the neutrophil NADPH oxidase activation: role of p47phox phosphorylation and NOX2 mobilization to the plasma membrane.	Seminars in immunopathology	2008	89
18541534	Oxygen	McFate T	Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells.	The Journal of biological chemistry	2008	96
18547751	Oxygen	Hsin YH	The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells.	Toxicology letters	2008	87
18577586	Oxygen	Cassel SL	The Nalp3 inflammasome is essential for the development of silicosis.	Proceedings of the National Academy of Sciences of the United States of America	2008	278
18616529	Oxygen	Fujii S	Autophagy is activated in pancreatic cancer cells and correlates with poor patient outcome.	Cancer science	2008	65
18620057	Oxygen	Frangogiannis NG	The immune system and cardiac repair.	Pharmacological research	2008	163
18635960	Oxygen	Yang MH	TWIST activation by hypoxia inducible factor-1 (HIF-1): implications in metastasis and development.	Cell cycle	2008	80
18784066	Oxygen	Ruiz-Romero C	Mitochondrial dysregulation of osteoarthritic human articular chondrocytes analyzed by proteomics: a decrease in mitochondrial superoxide dismutase points to a redox imbalance.	Molecular & cellular proteomics 	2009	57
18791199	Oxygen	Cannito S	Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells.	Carcinogenesis	2008	91
18795165	Oxygen	Pacurari M	Raw single-wall carbon nanotubes induce oxidative stress and activate MAPKs, AP-1, NF-kappaB, and Akt in normal and malignant human mesothelial cells.	Environmental health perspectives	2008	57
18801366	Oxygen	Lim SO	Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.	Gastroenterology	2008	80
18831567	Oxygen	Carlson C	Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species.	The journal of physical chemistry. B	2008	154
18838554	Oxygen	Degtyarev M	Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents.	The Journal of cell biology	2008	157
18924608	Oxygen	Bedogni B	Notch1 is an effector of Akt and hypoxia in melanoma development.	The Journal of clinical investigation	2008	72
18979503	Oxygen	Tonissen KF	Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy.	Molecular nutrition & food research	2009	48
19011099	Oxygen	Breckwoldt MO	Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidase.	Proceedings of the National Academy of Sciences of the United States of America	2008	78
19018762	Oxygen	Toyokuni S	Role of iron in carcinogenesis: cancer as a ferrotoxic disease.	Cancer science	2009	75
19023330	Oxygen	Moisoi N	Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response.	Cell death and differentiation	2009	47
19033663	Oxygen	Sonveaux P	Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice.	The Journal of clinical investigation	2008	332
19047340	Oxygen	Hori M	Oxidative stress and left ventricular remodelling after myocardial infarction.	Cardiovascular research	2009	95
19059306	Oxygen	Garrido AM	NADPH oxidases and angiotensin II receptor signaling.	Molecular and cellular endocrinology	2009	99
19098000	Oxygen	Harada H	The Akt/mTOR pathway assures the synthesis of HIF-1alpha protein in a glucose- and reoxygenation-dependent manner in irradiated tumors.	The Journal of biological chemistry	2009	48
19106412	Oxygen	Sanson M	Oxidized low-density lipoproteins trigger endoplasmic reticulum stress in vascular cells: prevention by oxygen-regulated protein 150 expression.	Circulation research	2009	51
19115482	Oxygen	Rodríguez-Hernández A	Coenzyme Q deficiency triggers mitochondria degradation by mitophagy.	Autophagy	2009	61
19131383	Oxygen	de-Wahl Granelli A	Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39,821 newborns.	BMJ	2009	48
19139406	Oxygen	Gruhne B	The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species.	Proceedings of the National Academy of Sciences of the United States of America	2009	73
19149564	Oxygen	Potenza MA	Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets.	Current medicinal chemistry	2009	66
19158125	Oxygen	Seymour JM	Ultrasound measurement of rectus femoris cross-sectional area and the relationship with quadriceps strength in COPD.	Thorax	2009	49
19190247	Oxygen	Lucas DM	The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo.	Blood	2009	55
19265035	Oxygen	Rane S	Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes.	Circulation research	2009	186
19265148	Oxygen	Yang CS	NADPH oxidase 2 interaction with TLR2 is required for efficient innate immune responses to mycobacteria via cathelicidin expression.	Journal of immunology	2009	49
19276355	Oxygen	Yamaura M	NADPH oxidase 4 contributes to transformation phenotype of melanoma cells by regulating G2-M cell cycle progression.	Cancer research	2009	58
19285945	Oxygen	Gandhi S	PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death.	Molecular cell	2009	170
19309263	Oxygen	Sorce S	NOX enzymes in the central nervous system: from signaling to disease.	Antioxidants & redox signaling	2009	122
19364912	Oxygen	Semenza GL	Regulation of oxygen homeostasis by hypoxia-inducible factor 1.	Physiology	2009	222
19372578	Oxygen	McCord AM	Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro.	Molecular cancer research 	2009	70
19383922	Oxygen	Kopetz S	Synergistic activity of the SRC family kinase inhibitor dasatinib and oxaliplatin in colon carcinoma cells is mediated by oxidative stress.	Cancer research	2009	48
19413947	Oxygen	Lebedeva MA	Loss of p53 causes mitochondrial DNA depletion and altered mitochondrial reactive oxygen species homeostasis.	Biochimica et biophysica acta	2009	62
19417078	Oxygen	Zingaretti MC	The presence of UCP1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue.	FASEB journal 	2009	198
19433855	Oxygen	Wallace KL	NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-gamma and CXCR3 chemokines.	Blood	2009	48
19447517	Oxygen	Baffy G	Kupffer cells in non-alcoholic fatty liver disease: the emerging view.	Journal of hepatology	2009	107
19459851	Oxygen	Kizaka-Kondoh S	Significance of nitroimidazole compounds and hypoxia-inducible factor-1 for imaging tumor hypoxia.	Cancer science	2009	46
19460403	Oxygen	Porter KE	Cardiac fibroblasts: at the heart of myocardial remodeling.	Pharmacology & therapeutics	2009	243
19470762	Oxygen	Sudarshan S	Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1alpha stabilization by glucose-dependent generation of reactive oxygen species.	Molecular and cellular biology	2009	78
19479945	Oxygen	Ruan K	Role of hypoxia in the hallmarks of human cancer.	Journal of cellular biochemistry	2009	96
19493276	Oxygen	Kamata T	Roles of Nox1 and other Nox isoforms in cancer development.	Cancer science	2009	49
19494350	Oxygen	Semenza GL	Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis.	Blood	2009	55
19520972	Oxygen	Eisenhardt SU	Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques.	Circulation research	2009	55
19524513	Oxygen	Cho YS	Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.	Cell	2009	543
19539034	Oxygen	Fleisher AS	Resting-state BOLD networks versus task-associated functional MRI for distinguishing Alzheimer's disease risk groups.	NeuroImage	2009	83
19607894	Oxygen	Foldbjerg R	PVP-coated silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and necrosis in THP-1 monocytes.	Toxicology letters	2009	76
19652871	Oxygen	Schuett H	How much is too much? Interleukin-6 and its signalling in atherosclerosis.	Thrombosis and haemostasis	2009	55
19654589	Oxygen	Ramirez SH	Methamphetamine disrupts blood-brain barrier function by induction of oxidative stress in brain endothelial cells.	Journal of cerebral blood flow and metabolism 	2009	59
19686841	Oxygen	Kahle PJ	DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders.	Free radical biology & medicine	2009	79
19701206	Oxygen	Hecker L	NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury.	Nature medicine	2009	238
19706526	Oxygen	Bertout JA	HIF2alpha inhibition promotes p53 pathway activity, tumor cell death, and radiation responses.	Proceedings of the National Academy of Sciences of the United States of America	2009	59
19711453	Oxygen	Kawamoto A	Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial.	Stem cells	2009	51
19718046	Oxygen	Soeda A	Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha.	Oncogene	2009	169
19731042	Oxygen	Henkel JS	Microglia in ALS: the good, the bad, and the resting.	Journal of neuroimmune pharmacology 	2009	95
19747980	Oxygen	Booij JC	The dynamic nature of Bruch's membrane.	Progress in retinal and eye research	2010	77
19756672	Oxygen	Muthusamy V	The UV response of the skin: a review of the MAPK, NFkappaB and TNFalpha signal transduction pathways.	Archives of dermatological research	2010	41
19786027	Oxygen	Xue J	Prolyl hydroxylase-3 is down-regulated in colorectal cancer cells and inhibits IKKbeta independent of hydroxylase activity.	Gastroenterology	2010	42
19789382	Oxygen	Vollmar B	The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair.	Physiological reviews	2009	72
19800967	Oxygen	Liu RM	Oxidative stress and glutathione in TGF-beta-mediated fibrogenesis.	Free radical biology & medicine	2010	73
19801454	Oxygen	Zhou G	Hypoxia-induced alveolar epithelial-mesenchymal transition requires mitochondrial ROS and hypoxia-inducible factor 1.	American journal of physiology. Lung cellular and molecular physiology	2009	62
19824815	Oxygen	Whitsett JA	Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease.	Annual review of medicine	2010	78
19844232	Oxygen	Lundgren K	Hypoxia, Snail and incomplete epithelial-mesenchymal transition in breast cancer.	British journal of cancer	2009	47
19858293	Oxygen	Krieg AJ	Regulation of the histone demethylase JMJD1A by hypoxia-inducible factor 1 alpha enhances hypoxic gene expression and tumor growth.	Molecular and cellular biology	2010	110
19893619	Oxygen	Lei Z	Regulation of HIF-1alpha and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration.	PloS one	2009	72
19910640	Oxygen	Lassègue B	NADPH oxidases: functions and pathologies in the vasculature.	Arteriosclerosis, thrombosis, and vascular biology	2010	180
19919699	Oxygen	Lakhan SE	Inflammatory mechanisms in ischemic stroke: therapeutic approaches.	Journal of translational medicine	2009	196
19920251	Oxygen	Hitosugi T	Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth.	Science signaling	2009	221
19929412	Oxygen	Dewhirst MW	Relationships between cycling hypoxia, HIF-1, angiogenesis and oxidative stress.	Radiation research	2009	69
19942623	Oxygen	Mukhopadhyay P	CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes.	Cardiovascular research	2010	42
20010808	Oxygen	David CJ	HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer.	Nature	2010	284
20010815	Oxygen	Campaner S	Cdk2 suppresses cellular senescence induced by the c-myc oncogene.	Nature cell biology	2010	83
20015196	Oxygen	Chiche J	Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer.	Journal of cellular and molecular medicine	2010	115
20026663	Oxygen	Yin F	Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice.	The Journal of experimental medicine	2010	137
20038740	Oxygen	De Angelis A	Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function.	Circulation	2010	70
20040868	Oxygen	Wang M	Arterial aging: a journey into subclinical arterial disease.	Current opinion in nephrology and hypertension	2010	51
20057496	Oxygen	Zhang D	Disease and the brain's dark energy.	Nature reviews. Neurology	2010	251
20140248	Oxygen	Xin H	Increasing tPA activity in astrocytes induced by multipotent mesenchymal stromal cells facilitate neurite outgrowth after stroke in the mouse.	PloS one	2010	42
20150287	Oxygen	Curtis JM	Downregulation of adipose glutathione S-transferase A4 leads to increased protein carbonylation, oxidative stress, and mitochondrial dysfunction.	Diabetes	2010	69
20164424	Oxygen	Denny MF	A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs.	Journal of immunology	2010	125
20169192	Oxygen	Coppé JP	A human-like senescence-associated secretory phenotype is conserved in mouse cells dependent on physiological oxygen.	PloS one	2010	118
20179104	Oxygen	Mai S	Decreased expression of Drp1 and Fis1 mediates mitochondrial elongation in senescent cells and enhances resistance to oxidative stress through PINK1.	Journal of cell science	2010	49
20186336	Oxygen	Krebiehl G	Reduced basal autophagy and impaired mitochondrial dynamics due to loss of Parkinson's disease-associated protein DJ-1.	PloS one	2010	88
20194303	Oxygen	Gloviczki ML	Preserved oxygenation despite reduced blood flow in poststenotic kidneys in human atherosclerotic renal artery stenosis.	Hypertension	2010	47
20197461	Oxygen	Xu Y	CD44 attenuates activation of the hippo signaling pathway and is a prime therapeutic target for glioblastoma.	Cancer research	2010	59
20306310	Oxygen	Sun AY	Resveratrol as a therapeutic agent for neurodegenerative diseases.	Molecular neurobiology	2010	49
20309962	Oxygen	Pistollato F	Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma.	Stem cells	2010	66
20357180	Oxygen	Gottlieb RA	Autophagy in health and disease. 5. Mitophagy as a way of life.	American journal of physiology. Cell physiology	2010	77
20424957	Oxygen	Briones AM	Oxidative stress and hypertension: current concepts.	Current hypertension reports	2010	66
20453876	Oxygen	Bobrovnikova-Marjon E	PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage.	Oncogene	2010	78
20462866	Oxygen	Becker BF	Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential.	Cardiovascular research	2010	62
20463368	Oxygen	Michelakis ED	Metabolic modulation of glioblastoma with dichloroacetate.	Science translational medicine	2010	201
20489163	Oxygen	Fleissner F	Short communication: asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease through a microRNA-21-dependent mechanism.	Circulation research	2010	41
20495074	Oxygen	Meissner F	Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease.	Blood	2010	81
20513808	Oxygen	Reitman ZJ	Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism.	Journal of the National Cancer Institute	2010	110
20517715	Oxygen	Imtiyaz HZ	Hypoxia-inducible factors as essential regulators of inflammation.	Current topics in microbiology and immunology	2010	75
20520707	Oxygen	Sendoel A	HIF-1 antagonizes p53-mediated apoptosis through a secreted neuronal tyrosinase.	Nature	2010	57
20523116	Oxygen	Graham KA	NADPH oxidase 4 is an oncoprotein localized to mitochondria.	Cancer biology & therapy	2010	64
20530669	Oxygen	Jiang T	High levels of Nrf2 determine chemoresistance in type II endometrial cancer.	Cancer research	2010	80
20535745	Oxygen	Toullec A	Oxidative stress promotes myofibroblast differentiation and tumour spreading.	EMBO molecular medicine	2010	74
20555359	Oxygen	Pyne NJ	Sphingosine 1-phosphate and cancer.	Nature reviews. Cancer	2010	257
20573959	Oxygen	Ding WX	Nix is critical to two distinct phases of mitophagy, reactive oxygen species-mediated autophagy induction and Parkin-ubiquitin-p62-mediated mitochondrial priming.	The Journal of biological chemistry	2010	167
20574517	Oxygen	Venkataraman S	MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence.	PloS one	2010	55
20581868	Oxygen	Bartkova J	Replication stress and oxidative damage contribute to aberrant constitutive activation of DNA damage signalling in human gliomas.	Oncogene	2010	56
20609355	Oxygen	Jeanne M	PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3.	Cancer cell	2010	68
20622120	Oxygen	Lu X	PPAR{gamma} regulates hypoxia-induced Nox4 expression in human pulmonary artery smooth muscle cells through NF-{kappa}B.	American journal of physiology. Lung cellular and molecular physiology	2010	59
20632195	Oxygen	Heneka MT	Neuroinflammatory processes in Alzheimer's disease.	Journal of neural transmission	2010	92
20660313	Oxygen	Mazumdar J	HIF-2alpha deletion promotes Kras-driven lung tumor development.	Proceedings of the National Academy of Sciences of the United States of America	2010	52
20665378	Oxygen	Rosmorduc O	Hypoxia: a link between fibrogenesis, angiogenesis, and carcinogenesis in liver disease.	Seminars in liver disease	2010	52
20671264	Oxygen	Bar EE	Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres.	The American journal of pathology	2010	93
20685750	Oxygen	Amara N	NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFbeta1-induced fibroblast differentiation into myofibroblasts.	Thorax	2010	73
20715845	Oxygen	Gianni D	A novel and specific NADPH oxidase-1 (Nox1) small-molecule inhibitor blocks the formation of functional invadopodia in human colon cancer cells.	ACS chemical biology	2010	51
20718759	Oxygen	Elmarakby AA	Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy.	Cardiovascular therapeutics	2012	65
20818739	Oxygen	Abu-Amara M	Liver ischemia/reperfusion injury: processes in inflammatory networks--a review.	Liver transplantation 	2010	59
20861671	Oxygen	Lisanti MP	Understanding the "lethal" drivers of tumor-stroma co-evolution: emerging role(s) for hypoxia, oxidative stress and autophagy/mitophagy in the tumor micro-environment.	Cancer biology & therapy	2010	66
20880500	Oxygen	Lull ME	Microglial activation and chronic neurodegeneration.	Neurotherapeutics 	2010	124
20889127	Oxygen	Eichner LJ	miR-378(∗) mediates metabolic shift in breast cancer cells via the PGC-1β/ERRγ transcriptional pathway.	Cell metabolism	2010	80
20923773	Oxygen	Luanpitpong S	Regulation of lung cancer cell migration and invasion by reactive oxygen species and caveolin-1.	The Journal of biological chemistry	2010	41
20939709	Oxygen	Lee FS	The HIF pathway and erythrocytosis.	Annual review of pathology	2011	48
20943885	Oxygen	Giordano C	Oestrogens ameliorate mitochondrial dysfunction in Leber's hereditary optic neuropathy.	Brain 	2011	42
20962028	Oxygen	Lu X	Hypoxia and hypoxia-inducible factors: master regulators of metastasis.	Clinical cancer research 	2010	161
20965425	Oxygen	Wellen KE	Cellular metabolic stress: considering how cells respond to nutrient excess.	Molecular cell	2010	99
20965426	Oxygen	Haigis MC	The aging stress response.	Molecular cell	2010	133
21050132	Oxygen	Cook-Mills JM	Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants.	Antioxidants & redox signaling	2011	70
21074607	Oxygen	Martin-Garrido A	NADPH oxidase 4 mediates TGF-β-induced smooth muscle α-actin via p38MAPK and serum response factor.	Free radical biology & medicine	2011	38
21098019	Oxygen	Lin W	HIV and HCV cooperatively promote hepatic fibrogenesis via induction of reactive oxygen species and NFkappaB.	The Journal of biological chemistry	2011	39
21124315	Oxygen	Zhou R	A role for mitochondria in NLRP3 inflammasome activation.	Nature	2011	887
21127501	Oxygen	Hjelmeland AB	Acidic stress promotes a glioma stem cell phenotype.	Cell death and differentiation	2011	92
21144973	Oxygen	Rajesh M	Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.	Journal of the American College of Cardiology	2010	61
21215757	Oxygen	Maejima Y	Regulation of myocardial growth and death by NADPH oxidase.	Journal of molecular and cellular cardiology	2011	49
21224240	Oxygen	Powers SK	Reactive oxygen and nitrogen species as intracellular signals in skeletal muscle.	The Journal of physiology	2011	56
21235356	Oxygen	Giannoni E	Cancer associated fibroblasts exploit reactive oxygen species through a proinflammatory signature leading to epithelial mesenchymal transition and stemness.	Antioxidants & redox signaling	2011	50
21245297	Oxygen	Hess A	Blockade of TNF-α rapidly inhibits pain responses in the central nervous system.	Proceedings of the National Academy of Sciences of the United States of America	2011	59
21300795	Oxygen	Kim MJ	Involvement of autophagy in oncogenic K-Ras-induced malignant cell transformation.	The Journal of biological chemistry	2011	76
21307839	Oxygen	Barnes JL	Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases.	Kidney international	2011	108
21317538	Oxygen	Walmsley SR	Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice.	The Journal of clinical investigation	2011	42
21320885	Oxygen	Jackson MJ	Age-related changes in skeletal muscle reactive oxygen species generation and adaptive responses to reactive oxygen species.	The Journal of physiology	2011	35
21350183	Oxygen	Chiang DJ	Obesity, diabetes mellitus, and liver fibrosis.	American journal of physiology. Gastrointestinal and liver physiology	2011	42
21391892	Oxygen	Carnesecchi S	A key role for NOX4 in epithelial cell death during development of lung fibrosis.	Antioxidants & redox signaling	2011	79
21421804	Oxygen	Raina D	Dependence on the MUC1-C oncoprotein in non-small cell lung cancer cells.	Molecular cancer therapeutics	2011	62
21441382	Oxygen	Lee SJ	Carbon monoxide activates autophagy via mitochondrial reactive oxygen species formation.	American journal of respiratory cell and molecular biology	2011	45
21466972	Oxygen	Rohwer N	Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.	Drug resistance updates 	2011	95
21507901	Oxygen	Hulsmans M	MicroRNAs regulating oxidative stress and inflammation in relation to obesity and atherosclerosis.	FASEB journal 	2011	60
21512133	Oxygen	Koh MY	The hypoxia-associated factor switches cells from HIF-1α- to HIF-2α-dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasion.	Cancer research	2011	65
21525939	Oxygen	Donadelli M	Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism.	Cell death & disease	2011	45
21530747	Oxygen	Ullman TA	Intestinal inflammation and cancer.	Gastroenterology	2011	212
21555567	Oxygen	Shaw AT	Selective killing of K-ras mutant cancer cells by small molecule inducers of oxidative stress.	Proceedings of the National Academy of Sciences of the United States of America	2011	56
21566064	Oxygen	Shrivastava A	Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy.	Molecular cancer therapeutics	2011	51
21567162	Oxygen	Shao L	Reactive oxygen species and hematopoietic stem cell senescence.	International journal of hematology	2011	39
21571904	Oxygen	Lennon FE	Role of hyaluronan and hyaluronan-binding proteins in lung pathobiology.	American journal of physiology. Lung cellular and molecular physiology	2011	36
21593862	Oxygen	Carmeliet P	Molecular mechanisms and clinical applications of angiogenesis.	Nature	2011	923
21606348	Oxygen	Billia F	PTEN-inducible kinase 1 (PINK1)/Park6 is indispensable for normal heart function.	Proceedings of the National Academy of Sciences of the United States of America	2011	78
21637285	Oxygen	Martin SK	The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma.	Leukemia	2011	44
21664270	Oxygen	Wagner BA	The rate of oxygen utilization by cells.	Free radical biology & medicine	2011	50
21671682	Oxygen	Lippert AR	Reaction-based fluorescent probes for selective imaging of hydrogen sulfide in living cells.	Journal of the American Chemical Society	2011	63
21692241	Oxygen	Pike LS	Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells.	Biochimica et biophysica acta	2011	80
21700219	Oxygen	Lv L	Acetylation targets the M2 isoform of pyruvate kinase for degradation through chaperone-mediated autophagy and promotes tumor growth.	Molecular cell	2011	134
21702944	Oxygen	Gu J	Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice.	Critical care	2011	37
21712087	Oxygen	Fraser PA	The role of free radical generation in increasing cerebrovascular permeability.	Free radical biology & medicine	2011	37
21712406	Oxygen	Raychaudhuri P	FoxM1: a master regulator of tumor metastasis.	Cancer research	2011	78
21712410	Oxygen	Mathieu J	HIF induces human embryonic stem cell markers in cancer cells.	Cancer research	2011	146
21717292	Oxygen	Purohit V	Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia.	Molecular neurobiology	2011	51
21742796	Oxygen	Goel S	Normalization of the vasculature for treatment of cancer and other diseases.	Physiological reviews	2011	317
21763418	Oxygen	Xie CM	Bufalin induces autophagy-mediated cell death in human colon cancer cells through reactive oxygen species generation and JNK activation.	Free radical biology & medicine	2011	48
21771249	Oxygen	Sriram S	Modulation of reactive oxygen species in skeletal muscle by myostatin is mediated through NF-κB.	Aging cell	2011	37
21782234	Oxygen	Szot CS	3D in vitro bioengineered tumors based on collagen I hydrogels.	Biomaterials	2011	47
21785006	Oxygen	Semenza GL	Regulation of metabolism by hypoxia-inducible factor 1.	Cold Spring Harbor symposia on quantitative biology	2011	91
21836617	Oxygen	Heddleston JM	Hypoxia-induced mixed-lineage leukemia 1 regulates glioma stem cell tumorigenic potential.	Cell death and differentiation	2012	41
21853114	Oxygen	Hahm ER	Withaferin A-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species.	PloS one	2011	52
21856739	Oxygen	Ostman A	Regulation of protein tyrosine phosphatases by reversible oxidation.	Journal of biochemistry	2011	70
21876558	Oxygen	Hu Y	K-ras(G12V) transformation leads to mitochondrial dysfunction and a metabolic switch from oxidative phosphorylation to glycolysis.	Cell research	2012	66
21878340	Oxygen	Darley-Usmar VM	Protein O-linked β-N-acetylglucosamine: a novel effector of cardiomyocyte metabolism and function.	Journal of molecular and cellular cardiology	2012	31
21878644	Oxygen	Achuthan S	Drug-induced senescence generates chemoresistant stemlike cells with low reactive oxygen species.	The Journal of biological chemistry	2011	47
21890786	Oxygen	Curcio CA	The oil spill in ageing Bruch membrane.	The British journal of ophthalmology	2011	82
21911939	Oxygen	Vogt G	In vitro differentiation of human macrophages with enhanced antimycobacterial activity.	The Journal of clinical investigation	2011	40
21916837	Oxygen	Arden GB	Hypoxia and oxidative stress in the causation of diabetic retinopathy.	Current diabetes reviews	2011	38
21931738	Oxygen	Zotev V	Self-regulation of amygdala activation using real-time FMRI neurofeedback.	PloS one	2011	55
21940680	Oxygen	Xiang M	Hemorrhagic shock activation of NLRP3 inflammasome in lung endothelial cells.	Journal of immunology	2011	49
21945098	Oxygen	Schneider L	Differentiation of SH-SY5Y cells to a neuronal phenotype changes cellular bioenergetics and the response to oxidative stress.	Free radical biology & medicine	2011	36
21951851	Oxygen	Li ZY	Mitochondrial ROS generation for regulation of autophagic pathways in cancer.	Biochemical and biophysical research communications	2011	58
21969016	Oxygen	Chen J	Wnt signaling mediates pathological vascular growth in proliferative retinopathy.	Circulation	2011	36
21984483	Oxygen	Jing Y	Cadmium increases HIF-1 and VEGF expression through ROS, ERK, and AKT signaling pathways and induces malignant transformation of human bronchial epithelial cells.	Toxicological sciences 	2012	42
22011623	Oxygen	Gong K	Shikonin, a Chinese plant-derived naphthoquinone, induces apoptosis in hepatocellular carcinoma cells through reactive oxygen species: A potential new treatment for hepatocellular carcinoma.	Free radical biology & medicine	2011	36
22052977	Oxygen	Anastasiou D	Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses.	Science	2011	261
22064655	Oxygen	Huang WC	Activation of androgen receptor, lipogenesis, and oxidative stress converged by SREBP-1 is responsible for regulating growth and progression of prostate cancer cells.	Molecular cancer research 	2012	51
22065079	Oxygen	Carbone M	Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma.	Clinical cancer research 	2012	50
22079466	Oxygen	Piao LS	CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma.	Cancer letters	2012	53
22084410	Oxygen	Swarup V	Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor κB-mediated pathogenic pathways.	The Journal of experimental medicine	2011	61
22084445	Oxygen	Hirschhaeuser F	Lactate: a metabolic key player in cancer.	Cancer research	2011	158
22094256	Oxygen	Anders L	A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells.	Cancer cell	2011	109
22098189	Oxygen	Choi DH	NADPH oxidase 1-mediated oxidative stress leads to dopamine neuron death in Parkinson's disease.	Antioxidants & redox signaling	2012	39
22147463	Oxygen	Sasaki H	Autophagy modulates osteoarthritis-related gene expression in human chondrocytes.	Arthritis and rheumatism	2012	45
22147748	Oxygen	Meng F	Molecular and cellular pharmacology of the hypoxia-activated prodrug TH-302.	Molecular cancer therapeutics	2012	51
22193987	Oxygen	Garg AD	Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin.	Cancer immunology, immunotherapy 	2012	48
22223731	Oxygen	Derwall M	Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2012	51
22225988	Oxygen	Schwab LP	Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer.	Breast cancer research 	2012	48
22240163	Oxygen	Qin L	NADPH oxidase and reactive oxygen species contribute to alcohol-induced microglial activation and neurodegeneration.	Journal of neuroinflammation	2012	76
22278288	Oxygen	Menu P	ER stress activates the NLRP3 inflammasome via an UPR-independent pathway.	Cell death & disease	2012	73
22281437	Oxygen	Lozy F	Autophagy and cancer cell metabolism.	Seminars in cell & developmental biology	2012	54
22284662	Oxygen	López J	Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance.	BMC cancer	2012	44
22293762	Oxygen	Konisti S	Hypoxia--a key regulator of angiogenesis and inflammation in rheumatoid arthritis.	Nature reviews. Rheumatology	2012	57
22300081	Oxygen	Ahluwalia A	Critical role of hypoxia sensor--HIF-1α in VEGF gene activation. Implications for angiogenesis and tissue injury healing.	Current medicinal chemistry	2012	37
22313689	Oxygen	Hegde ML	Oxidative genome damage and its repair: implications in aging and neurodegenerative diseases.	Mechanisms of ageing and development	2012	38
22331464	Oxygen	Ma J	PALB2 interacts with KEAP1 to promote NRF2 nuclear accumulation and function.	Molecular and cellular biology	2012	37
22344686	Oxygen	Chau BN	MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways.	Science translational medicine	2012	130
22354151	Oxygen	del Zoppo GJ	Microglial cell activation is a source of metalloproteinase generation during hemorrhagic transformation.	Journal of cerebral blood flow and metabolism 	2012	37
22363487	Oxygen	Du R	Hypoxia-induced down-regulation of microRNA-34a promotes EMT by targeting the Notch signaling pathway in tubular epithelial cells.	PloS one	2012	49
22366799	Oxygen	Fischer MT	NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury.	Brain 	2012	87
22367679	Oxygen	Kaur C	Roles of activated microglia in hypoxia induced neuroinflammation in the developing brain and the retina.	Journal of neuroimmune pharmacology 	2013	29
22388960	Oxygen	Wu LJ	The voltage-gated proton channel Hv1 enhances brain damage from ischemic stroke.	Nature neuroscience	2012	60
22411871	Oxygen	Nieborowska-Skorska M	Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors.	Blood	2012	32
22411934	Oxygen	Salminen A	Inflammaging: disturbed interplay between autophagy and inflammasomes.	Aging	2012	79
22443458	Oxygen	Dikalov SI	Angiotensin II-induced production of mitochondrial reactive oxygen species: potential mechanisms and relevance for cardiovascular disease.	Antioxidants & redox signaling	2013	40
22448145	Oxygen	Bayat V	Mutations in the mitochondrial methionyl-tRNA synthetase cause a neurodegenerative phenotype in flies and a recessive ataxia (ARSAL) in humans.	PLoS biology	2012	60
22458843	Oxygen	Zhu P	Angiopoietin-like 4: a decade of research.	Bioscience reports	2012	43
22461640	Oxygen	Munson JM	Anti-invasive adjuvant therapy with imipramine blue enhances chemotherapeutic efficacy against glioma.	Science translational medicine	2012	37
22502743	Oxygen	Weaver JR	Integration of pro-inflammatory cytokines, 12-lipoxygenase and NOX-1 in pancreatic islet beta cell dysfunction.	Molecular and cellular endocrinology	2012	33
22522114	Oxygen	Kotsakis A	Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples.	Journal of immunological methods	2012	51
22525300	Oxygen	Shay JE	Hypoxia-inducible factors: crosstalk between inflammation and metabolism.	Seminars in cell & developmental biology	2012	32
22530599	Oxygen	Nguyen Dinh Cat A	Angiotensin II, NADPH oxidase, and redox signaling in the vasculature.	Antioxidants & redox signaling	2013	55
22533670	Oxygen	Giralt A	SIRT3, a pivotal actor in mitochondrial functions: metabolism, cell death and aging.	The Biochemical journal	2012	50
22549002	Oxygen	Barone E	Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairment.	Free radical biology & medicine	2012	32
22562464	Oxygen	Luo Z	The Nedd8-activating enzyme inhibitor MLN4924 induces autophagy and apoptosis to suppress liver cancer cell growth.	Cancer research	2012	68
22581365	Oxygen	Surace MJ	Targeting microglia-mediated neurotoxicity: the potential of NOX2 inhibitors.	Cellular and molecular life sciences 	2012	32
22595400	Oxygen	Scoditti E	Mediterranean diet polyphenols reduce inflammatory angiogenesis through MMP-9 and COX-2 inhibition in human vascular endothelial cells: a potentially protective mechanism in atherosclerotic vascular disease and cancer.	Archives of biochemistry and biophysics	2012	49
22596262	Oxygen	Thomas GM	Extracellular DNA traps are associated with the pathogenesis of TRALI in humans and mice.	Blood	2012	49
22618020	Oxygen	Jiang JX	Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo.	Free radical biology & medicine	2012	73
22632748	Oxygen	Vendramini-Costa DB	Molecular link mechanisms between inflammation and cancer.	Current pharmaceutical design	2012	101
22642602	Oxygen	Liang D	The hypoxic microenvironment upgrades stem-like properties of ovarian cancer cells.	BMC cancer	2012	36
22693349	Oxygen	Paneni F	Gene silencing of the mitochondrial adaptor p66(Shc) suppresses vascular hyperglycemic memory in diabetes.	Circulation research	2012	38
22701472	Oxygen	Arcidiacono B	Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms.	Experimental diabetes research	2012	74
22717232	Oxygen	Hussain S	Cerium dioxide nanoparticles induce apoptosis and autophagy in human peripheral blood monocytes.	ACS nano	2012	34
22764206	Oxygen	Cooper O	Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease.	Science translational medicine	2012	116
22770242	Oxygen	Anguera MC	Molecular signatures of human induced pluripotent stem cells highlight sex differences and cancer genes.	Cell stem cell	2012	41
22787113	Oxygen	Maron BA	Aldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension.	Circulation	2012	38
22796521	Oxygen	Chiba T	Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation.	Gastroenterology	2012	79
22801492	Oxygen	Montagner M	SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors.	Nature	2012	65
22811423	Oxygen	Prabhakar NR	Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2.	Physiological reviews	2012	126
22871044	Oxygen	Vernon PJ	Eat-me: autophagy, phagocytosis, and reactive oxygen species signaling.	Antioxidants & redox signaling	2013	33
22874567	Oxygen	Chen G	Autophagy is a protective response to ethanol neurotoxicity.	Autophagy	2012	44
22897481	Oxygen	Sheng SL	Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma.	The FEBS journal	2012	42
22899010	Oxygen	Janiszewska M	Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells.	Genes & development	2012	68
22917578	Oxygen	Frank M	Mitophagy is triggered by mild oxidative stress in a mitochondrial fission dependent manner.	Biochimica et biophysica acta	2012	90
22927446	Oxygen	Gong K	Autophagy-related gene 7 (ATG7) and reactive oxygen species/extracellular signal-regulated kinase regulate tetrandrine-induced autophagy in human hepatocellular carcinoma.	The Journal of biological chemistry	2012	33
22959024	Oxygen	Bailey KM	Targeting the metabolic microenvironment of tumors.	Advances in pharmacology	2012	35
22962263	Oxygen	Noman MZ	Hypoxia-inducible miR-210 regulates the susceptibility of tumor cells to lysis by cytotoxic T cells.	Cancer research	2012	38
22979952	Oxygen	White MG	FKBP5 and emotional neglect interact to predict individual differences in amygdala reactivity.	Genes, brain, and behavior	2012	41
22986741	Oxygen	Jerby L	Metabolic associations of reduced proliferation and oxidative stress in advanced breast cancer.	Cancer research	2012	31
22988108	Oxygen	Clambey ET	Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa.	Proceedings of the National Academy of Sciences of the United States of America	2012	103
23001918	Oxygen	Lecker SH	Expression of the irisin precursor FNDC5 in skeletal muscle correlates with aerobic exercise performance in patients with heart failure.	Circulation. Heart failure	2012	37
23003569	Oxygen	Cheng G	Mitochondria in traumatic brain injury and mitochondrial-targeted multipotential therapeutic strategies.	British journal of pharmacology	2012	39
23018917	Oxygen	Hurdman J	Pulmonary hypertension in COPD: results from the ASPIRE registry.	The European respiratory journal	2013	30
23022011	Oxygen	Khan SR	Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations.	The Journal of urology	2013	37
23041058	Oxygen	Lee JH	Dietary phytochemicals and cancer prevention: Nrf2 signaling, epigenetics, and cell death mechanisms in blocking cancer initiation and progression.	Pharmacology & therapeutics	2013	34
23063463	Oxygen	Samarakoon R	TGF-β signaling in tissue fibrosis: redox controls, target genes and therapeutic opportunities.	Cellular signalling	2013	80
23071357	Oxygen	Tamada M	Pyruvate kinase M2: multiple faces for conferring benefits on cancer cells.	Clinical cancer research 	2012	47
23079083	Oxygen	Selimovic D	Bortezomib/proteasome inhibitor triggers both apoptosis and autophagy-dependent pathways in melanoma cells.	Cellular signalling	2013	35
23103253	Oxygen	Elorza A	HIF2α acts as an mTORC1 activator through the amino acid carrier SLC7A5.	Molecular cell	2012	33
23115158	Oxygen	Li S	Overexpression of isocitrate dehydrogenase mutant proteins renders glioma cells more sensitive to radiation.	Neuro-oncology	2013	38
23177934	Oxygen	Favaro E	Glucose utilization via glycogen phosphorylase sustains proliferation and prevents premature senescence in cancer cells.	Cell metabolism	2012	64
23181475	Oxygen	Hansell P	Determinants of kidney oxygen consumption and their relationship to tissue oxygen tension in diabetes and hypertension.	Clinical and experimental pharmacology & physiology	2013	28
23220211	Oxygen	Wu M	The effect of interstitial pressure on tumor growth: coupling with the blood and lymphatic vascular systems.	Journal of theoretical biology	2013	39
23220288	Oxygen	Prosser BL	X-ROS signaling in the heart and skeletal muscle: stretch-dependent local ROS regulates Ca²⁺i.	Journal of molecular and cellular cardiology	2013	28
23239023	Oxygen	Qi X	A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity.	Journal of cell science	2013	68
23248151	Oxygen	Sun B	Bone morphogenetic protein-4 mediates cardiac hypertrophy, apoptosis, and fibrosis in experimentally pathological cardiac hypertrophy.	Hypertension	2013	28
23297826	Oxygen	Agani F	Oxygen-independent regulation of HIF-1: novel involvement of PI3K/AKT/mTOR pathway in cancer.	Current cancer drug targets	2013	40
23299965	Oxygen	Milara J	Epithelial to mesenchymal transition is increased in patients with COPD and induced by cigarette smoke.	Thorax	2013	42
23301832	Oxygen	Mimeault M	Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells.	Journal of cellular and molecular medicine	2013	60
23303309	Oxygen	Watson J	Oxidants, antioxidants and the current incurability of metastatic cancers.	Open biology	2013	86
23318445	Oxygen	Kumari U	Evidence of mitochondrial dysfunction and impaired ROS detoxifying machinery in Fanconi anemia cells.	Oncogene	2014	26
23322784	Oxygen	van Sorge NM	Methicillin-resistant Staphylococcus aureus bacterial nitric-oxide synthase affects antibiotic sensitivity and skin abscess development.	The Journal of biological chemistry	2013	32
23323860	Oxygen	Padgett LE	The role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis.	Annals of the New York Academy of Sciences	2013	61
23325087	Oxygen	Watanabe H	p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase.	Kidney international	2013	35
23326372	Oxygen	Singhapol C	Mitochondrial telomerase protects cancer cells from nuclear DNA damage and apoptosis.	PloS one	2013	30
23333149	Oxygen	Lagadinou ED	BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells.	Cell stem cell	2013	142
23347351	Oxygen	Liu G	Molecular basis of asbestos-induced lung disease.	Annual review of pathology	2013	32
23378588	Oxygen	Gasparre G	Relevance of mitochondrial genetics and metabolism in cancer development.	Cold Spring Harbor perspectives in biology	2013	30
23391506	Oxygen	Li H	Stress response of glioblastoma cells mediated by miR-17-5p targeting PTEN and the passenger strand miR-17-3p targeting MDM2.	Oncotarget	2012	42
23392169	Oxygen	Luo H	PTEN-regulated AKT/FoxO3a/Bim signaling contributes to reactive oxygen species-mediated apoptosis in selenite-treated colorectal cancer cells.	Cell death & disease	2013	35
23425123	Oxygen	Laddha NC	Vitiligo: interplay between oxidative stress and immune system.	Experimental dermatology	2013	26
23475579	Oxygen	Das TP	Induction of reactive oxygen species generation inhibits epithelial-mesenchymal transition and promotes growth arrest in prostate cancer cells.	Molecular carcinogenesis	2014	23
23485523	Oxygen	Hernández-Gea V	Endoplasmic reticulum stress induces fibrogenic activity in hepatic stellate cells through autophagy.	Journal of hepatology	2013	40
23508104	Oxygen	Kim KH	Matricellular protein CCN1 promotes regression of liver fibrosis through induction of cellular senescence in hepatic myofibroblasts.	Molecular and cellular biology	2013	59
23514110	Oxygen	Kozieł R	Mitochondrial respiratory chain complex I is inactivated by NADPH oxidase Nox4.	The Biochemical journal	2013	32
23519123	Oxygen	Jin M	Regulation of cytochrome P450 2e1 expression by ethanol: role of oxidative stress-mediated pkc/jnk/sp1 pathway.	Cell death & disease	2013	37
23524583	Oxygen	Zhang S	Generation of cancer stem-like cells through the formation of polyploid giant cancer cells.	Oncogene	2014	58
23533664	Oxygen	Luo H	Resveratrol induces premature senescence in lung cancer cells via ROS-mediated DNA damage.	PloS one	2013	33
23547621	Oxygen	Cornelius C	Traumatic brain injury: oxidative stress and neuroprotection.	Antioxidants & redox signaling	2013	46
23553816	Oxygen	Folmes CD	Disease-causing mitochondrial heteroplasmy segregated within induced pluripotent stem cell clones derived from a patient with MELAS.	Stem cells	2013	33
23564668	Oxygen	Gray SP	NADPH oxidase 1 plays a key role in diabetes mellitus-accelerated atherosclerosis.	Circulation	2013	86
23589885	Oxygen	Kucharzewska P	Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development.	Proceedings of the National Academy of Sciences of the United States of America	2013	148
23619421	Oxygen	Davies PF	The atherosusceptible endothelium: endothelial phenotypes in complex haemodynamic shear stress regions in vivo.	Cardiovascular research	2013	53
23633453	Oxygen	Nawrocki ST	Disrupting protein NEDDylation with MLN4924 is a novel strategy to target cisplatin resistance in ovarian cancer.	Clinical cancer research 	2013	32
23634225	Oxygen	Freeman D	Alpha-synuclein induces lysosomal rupture and cathepsin dependent reactive oxygen species following endocytosis.	PloS one	2013	39
23640890	Oxygen	Tan Q	Erythrocytosis and pulmonary hypertension in a mouse model of human HIF2A gain of function mutation.	The Journal of biological chemistry	2013	29
23642249	Oxygen	Infanger DW	Engineered culture models for studies of tumor-microenvironment interactions.	Annual review of biomedical engineering	2013	28
23699409	Oxygen	Young RM	Dysregulated mTORC1 renders cells critically dependent on desaturated lipids for survival under tumor-like stress.	Genes & development	2013	54
23704228	Oxygen	Cohen-Cymberknoh M	Airway inflammation in cystic fibrosis: molecular mechanisms and clinical implications.	Thorax	2013	34
23734789	Oxygen	Qu G	Graphene oxide induces toll-like receptor 4 (TLR4)-dependent necrosis in macrophages.	ACS nano	2013	35
23740244	Oxygen	Arora S	An undesired effect of chemotherapy: gemcitabine promotes pancreatic cancer cell invasiveness through reactive oxygen species-dependent, nuclear factor κB- and hypoxia-inducible factor 1α-mediated up-regulation of CXCR4.	The Journal of biological chemistry	2013	44
23760662	Oxygen	Huang A	Increased CD14(+)HLA-DR (-/low) myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients.	Cancer immunology, immunotherapy 	2013	40
23770291	Oxygen	Kauppinen A	Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders.	Cellular signalling	2013	88
23774812	Oxygen	Brown NJ	Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis.	Nature reviews. Nephrology	2013	33
23782686	Oxygen	Hellström A	Retinopathy of prematurity.	Lancet	2013	75
23783559	Oxygen	Niranjan R	The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson's disease: focus on astrocytes.	Molecular neurobiology	2014	33
23792436	Oxygen	Dudek J	Cardiolipin deficiency affects respiratory chain function and organization in an induced pluripotent stem cell model of Barth syndrome.	Stem cell research	2013	29
23792563	Oxygen	Cancer Genome Atlas Research Network.	Comprehensive molecular characterization of clear cell renal cell carcinoma.	Nature	2013	637
23795962	Oxygen	Lerner C	Reduced mammalian target of rapamycin activity facilitates mitochondrial retrograde signaling and increases life span in normal human fibroblasts.	Aging cell	2013	26
23820265	Oxygen	Gañán-Gómez I	Oncogenic functions of the transcription factor Nrf2.	Free radical biology & medicine	2013	47
23828498	Oxygen	Markowitz J	Myeloid-derived suppressor cells in breast cancer.	Breast cancer research and treatment	2013	32
23840916	Oxygen	García-Escudero V	Deconstructing mitochondrial dysfunction in Alzheimer disease.	Oxidative medicine and cellular longevity	2013	28
23841076	Oxygen	Shin S	The omega-3 polyunsaturated fatty acid DHA induces simultaneous apoptosis and autophagy via mitochondrial ROS-mediated Akt-mTOR signaling in prostate cancer cells expressing mutant p53.	BioMed research international	2013	29
23841983	Oxygen	Yu E	Mitochondrial DNA damage can promote atherosclerosis independently of reactive oxygen species through effects on smooth muscle cells and monocytes and correlates with higher-risk plaques in humans.	Circulation	2013	34
23851032	Oxygen	El Assar M	Oxidative stress and vascular inflammation in aging.	Free radical biology & medicine	2013	64
23860500	Oxygen	Xue X	Endothelial PAS domain protein 1 activates the inflammatory response in the intestinal epithelium to promote colitis in mice.	Gastroenterology	2013	48
23880293	Oxygen	Cheng X	Regulation of the Nrf2 antioxidant pathway by microRNAs: New players in micromanaging redox homeostasis.	Free radical biology & medicine	2013	43
23915129	Oxygen	Dashdorj A	Mitochondria-targeted antioxidant MitoQ ameliorates experimental mouse colitis by suppressing NLRP3 inflammasome-mediated inflammatory cytokines.	BMC medicine	2013	37
23936814	Oxygen	Gurunathan S	Cytotoxicity of biologically synthesized silver nanoparticles in MDA-MB-231 human breast cancer cells.	BioMed research international	2013	30
23939310	Oxygen	Poynton RA	Peroxiredoxins as biomarkers of oxidative stress.	Biochimica et biophysica acta	2014	32
23947803	Oxygen	De Francesco EM	HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs).	Breast cancer research 	2013	35
23954133	Oxygen	Iyer SS	Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation.	Immunity	2013	114
23970124	Oxygen	Sedeek M	NADPH oxidases, reactive oxygen species, and the kidney: friend and foe.	Journal of the American Society of Nephrology 	2013	48
23975169	Oxygen	Magenta A	Oxidative stress and microRNAs in vascular diseases.	International journal of molecular sciences	2013	40
23977848	Oxygen	Jarman ER	An inhibitor of NADPH oxidase-4 attenuates established pulmonary fibrosis in a rodent disease model.	American journal of respiratory cell and molecular biology	2014	24
23984879	Oxygen	Ishibashi Y	Advanced glycation end products evoke endothelial cell damage by stimulating soluble dipeptidyl peptidase-4 production and its interaction with mannose 6-phosphate/insulin-like growth factor II receptor.	Cardiovascular diabetology	2013	35
23993194	Oxygen	Gai X	Mutations in FBXL4, encoding a mitochondrial protein, cause early-onset mitochondrial encephalomyopathy.	American journal of human genetics	2013	29
23999440	Oxygen	Semenza GL	HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations.	The Journal of clinical investigation	2013	246
24008734	Oxygen	Fann DY	Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke.	Cell death & disease	2013	46
24025640	Oxygen	Jiang T	Nrf2 suppresses lupus nephritis through inhibition of oxidative injury and the NF-κB-mediated inflammatory response.	Kidney international	2014	25
24040957	Oxygen	Paik YH	Role of NADPH oxidases in liver fibrosis.	Antioxidants & redox signaling	2014	43
24045183	Oxygen	Mujcic H	Hypoxic activation of the PERK/eIF2α arm of the unfolded protein response promotes metastasis through induction of LAMP3.	Clinical cancer research 	2013	27
24056969	Oxygen	Hara H	Mitochondrial fragmentation in cigarette smoke-induced bronchial epithelial cell senescence.	American journal of physiology. Lung cellular and molecular physiology	2013	27
24076634	Oxygen	Doedens AL	Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen.	Nature immunology	2013	105
24080946	Oxygen	Stankov MV	Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy.	Leukemia	2014	21
24084631	Oxygen	Chauhan VP	Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels.	Nature communications	2013	116
24084731	Oxygen	Daffu G	Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond.	International journal of molecular sciences	2013	37
24097820	Oxygen	Zhang Y	Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance.	Cancer research	2013	43
24113184	Oxygen	Shah A	HIV gp120- and methamphetamine-mediated oxidative stress induces astrocyte apoptosis via cytochrome P450 2E1.	Cell death & disease	2013	25
24121277	Oxygen	Venere M	Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells.	Cell death and differentiation	2014	37
24133204	Oxygen	Kang T	MicroRNA-27 (miR-27) targets prohibitin and impairs adipocyte differentiation and mitochondrial function in human adipose-derived stem cells.	The Journal of biological chemistry	2013	33
24180381	Oxygen	Karbach S	eNOS uncoupling in cardiovascular diseases--the role of oxidative stress and inflammation.	Current pharmaceutical design	2014	41
24185179	Oxygen	Sato A	Pivotal role for ROS activation of p38 MAPK in the control of differentiation and tumor-initiating capacity of glioma-initiating cells.	Stem cell research	2014	26
24200652	Oxygen	Kenney MC	Molecular and bioenergetic differences between cells with African versus European inherited mitochondrial DNA haplogroups: implications for population susceptibility to diseases.	Biochimica et biophysica acta	2014	34
24204632	Oxygen	Lonardo E	Metformin targets the metabolic achilles heel of human pancreatic cancer stem cells.	PloS one	2013	47
24240701	Oxygen	Shin DH	SIRT1 and AMPK mediate hypoxia-induced resistance of non-small cell lung cancers to cisplatin and doxorubicin.	Cancer research	2014	20
24280585	Oxygen	Li YC	Plumbagin induces apoptotic and autophagic cell death through inhibition of the PI3K/Akt/mTOR pathway in human non-small cell lung cancer cells.	Cancer letters	2014	36
24281743	Oxygen	Jickling GC	Hemorrhagic transformation after ischemic stroke in animals and humans.	Journal of cerebral blood flow and metabolism 	2014	49
24318116	Oxygen	Williams AE	The mercurial nature of neutrophils: still an enigma in ARDS?	American journal of physiology. Lung cellular and molecular physiology	2014	52
24356959	Oxygen	van der Burgh R	Defects in mitochondrial clearance predispose human monocytes to interleukin-1β hypersecretion.	The Journal of biological chemistry	2014	27
24362892	Oxygen	Taylor PR	Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORγt and dectin-2.	Nature immunology	2014	104
24381719	Oxygen	Popa-Wagner A	ROS and brain diseases: the good, the bad, and the ugly.	Oxidative medicine and cellular longevity	2013	29
24382987	Oxygen	Ohnishi S	DNA damage in inflammation-related carcinogenesis and cancer stem cells.	Oxidative medicine and cellular longevity	2013	29
24418575	Oxygen	Mehla K	MUC1: a novel metabolic master regulator.	Biochimica et biophysica acta	2014	21
24435707	Oxygen	Cho KH	A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.	The Prostate	2014	21
24436432	Oxygen	Pillai VB	Regulation of Akt signaling by sirtuins: its implication in cardiac hypertrophy and aging.	Circulation research	2014	38
24438903	Oxygen	Bura A	Phase I trial: the use of autologous cultured adipose-derived stroma/stem cells to treat patients with non-revascularizable critical limb ischemia.	Cytotherapy	2014	47
24455696	Oxygen	Hsieh HL	Role of redox signaling in neuroinflammation and neurodegenerative diseases.	BioMed research international	2013	59
24462787	Oxygen	Huynh K	Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways.	Pharmacology & therapeutics	2014	72
24465942	Oxygen	Ahn HJ	Targeting cancer cells with reactive oxygen and nitrogen species generated by atmospheric-pressure air plasma.	PloS one	2014	36
24466275	Oxygen	Liu AM	miR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma.	PloS one	2014	26
24469051	Oxygen	Yin M	Selective killing of lung cancer cells by miRNA-506 molecule through inhibiting NF-κB p65 to evoke reactive oxygen species generation and p53 activation.	Oncogene	2015	20
24477002	Oxygen	Sayin VI	Antioxidants accelerate lung cancer progression in mice.	Science translational medicine	2014	136
24509161	Oxygen	Crosas-Molist E	The NADPH oxidase NOX4 inhibits hepatocyte proliferation and liver cancer progression.	Free radical biology & medicine	2014	20
24515801	Oxygen	Lee SO	The orphan nuclear receptor NR4A1 (Nur77) regulates oxidative and endoplasmic reticulum stress in pancreatic cancer cells.	Molecular cancer research 	2014	21
24522549	Oxygen	Gaki GS	Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's disease.	Neuromolecular medicine	2014	22
24569087	Oxygen	Brocato J	Molecular responses to hypoxia-inducible factor 1α and beyond.	Molecular pharmacology	2014	23
24574503	Oxygen	McNeill A	Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells.	Brain 	2014	39
24578389	Oxygen	Virdis A	Tumour necrosis factor-alpha participates on the endothelin-1/nitric oxide imbalance in small arteries from obese patients: role of perivascular adipose tissue.	European heart journal	2015	17
24583638	Oxygen	Ogrunc M	Oncogene-induced reactive oxygen species fuel hyperproliferation and DNA damage response activation.	Cell death and differentiation	2014	46
24610934	Oxygen	Aravamudan B	Cigarette smoke-induced mitochondrial fragmentation and dysfunction in human airway smooth muscle.	American journal of physiology. Lung cellular and molecular physiology	2014	32
24626392	Oxygen	Bowers NL	Immune suppression by neutrophils in HIV-1 infection: role of PD-L1/PD-1 pathway.	PLoS pathogens	2014	42
24634660	Oxygen	Riabov V	Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis.	Frontiers in physiology	2014	61
24663091	Oxygen	Frangogiannis NG	The inflammatory response in myocardial injury, repair, and remodelling.	Nature reviews. Cardiology	2014	115
24675724	Oxygen	Tian FJ	Elevated microRNA-155 promotes foam cell formation by targeting HBP1 in atherogenesis.	Cardiovascular research	2014	24
24695224	Oxygen	Gad H	MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool.	Nature	2014	83
24718857	Oxygen	Hecker L	Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance.	Science translational medicine	2014	111
24732804	Oxygen	Jutooru I	Mechanism of action of phenethylisothiocyanate and other reactive oxygen species-inducing anticancer agents.	Molecular and cellular biology	2014	25
24732809	Oxygen	Lu J	The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism.	Cancer letters	2015	49
24743516	Oxygen	Sousa CM	The complex landscape of pancreatic cancer metabolism.	Carcinogenesis	2014	22
24779584	Oxygen	Hazeldine J	Impaired neutrophil extracellular trap formation: a novel defect in the innate immune system of aged individuals.	Aging cell	2014	28
24786789	Oxygen	Xu Y	Oxidative stress activates SIRT2 to deacetylate and stimulate phosphoglycerate mutase.	Cancer research	2014	23
24791940	Oxygen	Cortez MA	Therapeutic delivery of miR-200c enhances radiosensitivity in lung cancer.	Molecular therapy 	2014	38
24808022	Oxygen	Nelson MD	PDE5 inhibition alleviates functional muscle ischemia in boys with Duchenne muscular dystrophy.	Neurology	2014	25
24825347	Oxygen	Pate KT	Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer.	The EMBO journal	2014	76
24832602	Oxygen	Park EJ	β-Lapachone induces programmed necrosis through the RIP1-PARP-AIF-dependent pathway in human hepatocellular carcinoma SK-Hep1 cells.	Cell death & disease	2014	26
24836575	Oxygen	Schwab L	Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage.	Nature medicine	2014	30
24865512	Oxygen	Abdul-Muneer PM	Interactions of oxidative stress and neurovascular inflammation in the pathogenesis of traumatic brain injury.	Molecular neurobiology	2015	36
24875536	Oxygen	Zhang L	Inhibition of cathepsin S induces autophagy and apoptosis in human glioblastoma cell lines through ROS-mediated PI3K/AKT/mTOR/p70S6K and JNK signaling pathways.	Toxicology letters	2014	28
24885398	Oxygen	Renganathan A	GAS5 long non-coding RNA in malignant pleural mesothelioma.	Molecular cancer	2014	21
24901008	Oxygen	Landskron G	Chronic inflammation and cytokines in the tumor microenvironment.	Journal of immunology research	2014	178
24916152	Oxygen	Deffert C	Phagocyte NADPH oxidase, chronic granulomatous disease and mycobacterial infections.	Cellular microbiology	2014	26
24941215	Oxygen	Lohmann P	The airway microbiome of intubated premature infants: characteristics and changes that predict the development of bronchopulmonary dysplasia.	Pediatric research	2014	22
24953182	Oxygen	Paul MK	Dynamic changes in intracellular ROS levels regulate airway basal stem cell homeostasis through Nrf2-dependent Notch signaling.	Cell stem cell	2014	52
24988374	Oxygen	Jaffer OA	Mitochondrial-targeted antioxidant therapy decreases transforming growth factor-β-mediated collagen production in a murine asthma model.	American journal of respiratory cell and molecular biology	2015	20
25023700	Oxygen	Patel A	MutT Homolog 1 (MTH1) maintains multiple KRAS-driven pro-malignant pathways.	Oncogene	2015	20
25024378	Oxygen	Behnen M	Immobilized immune complexes induce neutrophil extracellular trap release by human neutrophil granulocytes via FcγRIIIB and Mac-1.	Journal of immunology	2014	27
25034944	Oxygen	Chen C	Role of astroglia in Down's syndrome revealed by patient-derived human-induced pluripotent stem cells.	Nature communications	2014	43
25078148	Oxygen	Marcos-Ramiro B	TNF-induced endothelial barrier disruption: beyond actin and Rho.	Thrombosis and haemostasis	2014	22
25091898	Oxygen	Bordt EA	NADPH oxidase- and mitochondria-derived reactive oxygen species in proinflammatory microglial activation: a bipartisan affair?	Free radical biology & medicine	2014	23
25117006	Oxygen	Pastorek J	Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use.	Seminars in cancer biology	2015	28
25129147	Oxygen	Lorenzo FR	A genetic mechanism for Tibetan high-altitude adaptation.	Nature genetics	2014	64
25143940	Oxygen	Wu J	The role of oxidative stress and inflammation in cardiovascular aging.	BioMed research international	2014	27
25186948	Oxygen	Ye J	Serine catabolism regulates mitochondrial redox control during hypoxia.	Cancer discovery	2014	58
25200065	Oxygen	Zhang D	Twist1 expression induced by sunitinib accelerates tumor cell vasculogenic mimicry by increasing the population of CD133+ cells in triple-negative breast cancer.	Molecular cancer	2014	25
25201986	Oxygen	Duque-Correa MA	Macrophage arginase-1 controls bacterial growth and pathology in hypoxic tuberculosis granulomas.	Proceedings of the National Academy of Sciences of the United States of America	2014	29
25238263	Oxygen	Chen MF	IL-6-stimulated CD11b+ CD14+ HLA-DR- myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus.	Oncotarget	2014	23
25242319	Oxygen	Huang	HIF-1-mediated suppression of acyl-CoA dehydrogenases and fatty acid oxidation is critical for cancer progression.	Cell reports	2014	39
25253673	Oxygen	Ebert AD	Characterization of the molecular mechanisms underlying increased ischemic damage in the aldehyde dehydrogenase 2 genetic polymorphism using a human induced pluripotent stem cell model system.	Science translational medicine	2014	27
25263450	Oxygen	Lincet H	How do glycolytic enzymes favour cancer cell proliferation by nonmetabolic functions?	Oncogene	2015	26
25294812	Oxygen	Zhou H	Ciclopirox induces autophagy through reactive oxygen species-mediated activation of JNK signaling pathway.	Oncotarget	2014	22
25301052	Oxygen	Ma X	Lin28/let-7 axis regulates aerobic glycolysis and cancer progression via PDK1.	Nature communications	2014	26
25313054	Oxygen	Yu J	Inflammasome activation leads to Caspase-1-dependent mitochondrial damage and block of mitophagy.	Proceedings of the National Academy of Sciences of the United States of America	2014	45
25341036	Oxygen	Huang H	Mcl-1 promotes lung cancer cell migration by directly interacting with VDAC to increase mitochondrial Ca2+ uptake and reactive oxygen species generation.	Cell death & disease	2014	23
25351418	Oxygen	van den Beucken T	Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER.	Nature communications	2014	43
25355928	Oxygen	Javeed N	Pancreatic Cancer-Derived Exosomes Cause Paraneoplastic β-cell Dysfunction.	Clinical cancer research 	2015	16
25383540	Oxygen	Zuo W	p63(+)Krt5(+) distal airway stem cells are essential for lung regeneration.	Nature	2015	78
25406339	Oxygen	Kawakami T	Deficient Autophagy Results in Mitochondrial Dysfunction and FSGS.	Journal of the American Society of Nephrology 	2015	27
25409149	Oxygen	Venkatanarayan A	IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo.	Nature	2015	29
25416158	Oxygen	Harischandra DS	α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson's disease.	Toxicological sciences 	2015	22
25440060	Oxygen	Walter KM	Hif-2α promotes degradation of mammalian peroxisomes by selective autophagy.	Cell metabolism	2014	20
25466887	Oxygen	Guan H	Epoxyeicosanoids suppress osteoclastogenesis and prevent ovariectomy-induced bone loss.	FASEB journal 	2015	15
25484094	Oxygen	Mitter SK	Dysregulated autophagy in the RPE is associated with increased susceptibility to oxidative stress and AMD.	Autophagy	2014	51
25497091	Oxygen	Baek G	MCT4 defines a glycolytic subtype of pancreatic cancer with poor prognosis and unique metabolic dependencies.	Cell reports	2014	25
25497209	Oxygen	Diakopoulos KN	Impaired autophagy induces chronic atrophic pancreatitis in mice via sex- and nutrition-dependent processes.	Gastroenterology	2015	21
25521078	Oxygen	Olagnier D	Cellular oxidative stress response controls the antiviral and apoptotic programs in dengue virus-infected dendritic cells.	PLoS pathogens	2014	36
25535359	Oxygen	Amelio I	TAp73 opposes tumor angiogenesis by promoting hypoxia-inducible factor 1α degradation.	Proceedings of the National Academy of Sciences of the United States of America	2015	26
25541259	Oxygen	Mizuno T	Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species.	Gynecologic oncology	2015	24
25542180	Oxygen	Obre E	Emerging concepts in bioenergetics and cancer research: metabolic flexibility, coupling, symbiosis, switch, oxidative tumors, metabolic remodeling, signaling and bioenergetic therapy.	The international journal of biochemistry & cell biology	2015	27
25581126	Oxygen	Sun B	NADPH Oxidase-Dependent NLRP3 Inflammasome Activation and its Important Role in Lung Fibrosis by Multiwalled Carbon Nanotubes.	Small	2015	30
25583481	Oxygen	Bartesaghi S	Inhibition of oxidative metabolism leads to p53 genetic inactivation and transformation in neural stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2015	15
25584894	Oxygen	Schug ZT	Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress.	Cancer cell	2015	82
25589557	Oxygen	Zhao QD	NADPH oxidase 4 induces cardiac fibrosis and hypertrophy through activating Akt/mTOR and NFκB signaling pathways.	Circulation	2015	19
25590811	Oxygen	Singer E	Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma.	Cell death & disease	2015	18
25592377	Oxygen	Liu X	NADPH oxidase 1-dependent ROS is crucial for TLR4 signaling to promote tumor metastasis of non-small cell lung cancer.	Tumour biology 	2015	16
25622857	Oxygen	Wang F	Activation of the NF-κB pathway as a mechanism of alcohol enhanced progression and metastasis of human hepatocellular carcinoma.	Molecular cancer	2015	16
25670081	Oxygen	Jin L	Glutamate dehydrogenase 1 signals through antioxidant glutathione peroxidase 1 to regulate redox homeostasis and tumor growth.	Cancer cell	2015	37
25693838	Oxygen	Wang Q	Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development.	The Journal of pathology	2015	44
25704383	Oxygen	Span PN	Biology of hypoxia.	Seminars in nuclear medicine	2015	16
25714022	Oxygen	Zou P	ROS generation mediates the anti-cancer effects of WZ35 via activating JNK and ER stress apoptotic pathways in gastric cancer.	Oncotarget	2015	20
25714760	Oxygen	Ito S	PARK2-mediated mitophagy is involved in regulation of HBEC senescence in COPD pathogenesis.	Autophagy	2015	27
25762540	Oxygen	Dudek-Perić AM	Antitumor immunity triggered by melphalan is potentiated by melanoma cell surface-associated calreticulin.	Cancer research	2015	20
25767287	Oxygen	McMaster WG	Inflammation, immunity, and hypertensive end-organ damage.	Circulation research	2015	83
25779952	Oxygen	Vellinga TT	SIRT1/PGC1α-Dependent Increase in Oxidative Phosphorylation Supports Chemotherapy Resistance of Colon Cancer.	Clinical cancer research 	2015	20
25782072	Oxygen	Zeng H	High-fat diet induces cardiac remodelling and dysfunction: assessment of the role played by SIRT3 loss.	Journal of cellular and molecular medicine	2015	17
25791797	Oxygen	van Tellingen O	Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.	Drug resistance updates 	2015	44
25799988	Oxygen	Jiang L	Ferroptosis as a p53-mediated activity during tumour suppression.	Nature	2015	117
25814684	Oxygen	Eelen G	Endothelial cell metabolism in normal and diseased vasculature.	Circulation research	2015	52
25829424	Oxygen	Qiu B	HIF2α-Dependent Lipid Storage Promotes Endoplasmic Reticulum Homeostasis in Clear-Cell Renal Cell Carcinoma.	Cancer discovery	2015	32
25834699	Oxygen	Fischer R	Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF.	Oxidative medicine and cellular longevity	2015	42
25855294	Oxygen	Kim D	SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance.	Nature	2015	54
25879282	Oxygen	Elliott EI	Initiation and perpetuation of NLRP3 inflammasome activation and assembly.	Immunological reviews	2015	42
25892225	Oxygen	Lee DC	A lactate-induced response to hypoxia.	Cell	2015	37
25904646	Oxygen	Raaz U	Segmental aortic stiffening contributes to experimental abdominal aortic aneurysm development.	Circulation	2015	15
25945836	Oxygen	Lucarelli G	Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma.	Oncotarget	2015	23
25981581	Oxygen	Hao W	Licochalcone A-induced human gastric cancer BGC-823 cells apoptosis by regulating ROS-mediated MAPKs and PI3K/AKT signaling pathways.	Scientific reports	2015	16
26028023	Oxygen	Chen CC	The matricellular protein CCN1 suppresses hepatocarcinogenesis by inhibiting compensatory proliferation.	Oncogene	2016	14
26078812	Oxygen	Krstić J	Transforming Growth Factor-Beta and Oxidative Stress Interplay: Implications in Tumorigenesis and Cancer Progression.	Oxidative medicine and cellular longevity	2015	22
26080835	Oxygen	Cottini F	Synthetic Lethal Approaches Exploiting DNA Damage in Aggressive Myeloma.	Cancer discovery	2015	22
26096935	Oxygen	Latina A	ΔNp63 targets cytoglobin to inhibit oxidative stress-induced apoptosis in keratinocytes and lung cancer.	Oncogene	2016	12
26184557	Oxygen	Klotz LO	Redox regulation of FoxO transcription factors.	Redox biology	2015	45
26210446	Oxygen	O'Neill S	Genetic disorders coupled to ROS deficiency.	Redox biology	2015	19
26212717	Oxygen	Intlekofer AM	Hypoxia Induces Production of L-2-Hydroxyglutarate.	Cell metabolism	2015	53
26257063	Oxygen	Yang WH	Imipramine blue halts head and neck cancer invasion through promoting F-box and leucine-rich repeat protein 14-mediated Twist1 degradation.	Oncogene	2016	10
26284484	Oxygen	Moffett A	Co-evolution of NK receptors and HLA ligands in humans is driven by reproduction.	Immunological reviews	2015	19
26317471	Oxygen	Arpaia N	A Distinct Function of Regulatory T Cells in Tissue Protection.	Cell	2015	81
26319899	Oxygen	Xu X	Aldehyde dehydrogenases and cancer stem cells.	Cancer letters	2015	19
26335400	Oxygen	Richter K	Redox-fibrosis: Impact of TGFβ1 on ROS generators, mediators and functional consequences.	Redox biology	2015	25
26341399	Oxygen	Bronner DN	Endoplasmic Reticulum Stress Activates the Inflammasome via NLRP3- and Caspase-2-Driven Mitochondrial Damage.	Immunity	2015	36
26387536	Oxygen	Blanco FF	The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells.	Oncogene	2016	19
26454217	Oxygen	Yeh PS	Honokiol induces autophagy of neuroblastoma cells through activating the PI3K/Akt/mTOR and endoplasmic reticular stress/ERK1/2 signaling pathways and suppressing cell migration.	Cancer letters	2016	14
26477888	Oxygen	Dumont LJ	CO2 -dependent metabolic modulation in red blood cells stored under anaerobic conditions.	Transfusion	2016	10
26501191	Oxygen	Huang L	Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids.	Nature medicine	2015	39
26516076	Oxygen	Broekgaarden M	Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies.	Cancer metastasis reviews	2015	18
26598532	Oxygen	Erapaneedi R	A novel family of fluorescent hypoxia sensors reveal strong heterogeneity in tumor hypoxia at the cellular level.	The EMBO journal	2016	13
26627594	Oxygen	Qian P	The Dlk1-Gtl2 Locus Preserves LT-HSC Function by Inhibiting the PI3K-mTOR Pathway to Restrict Mitochondrial Metabolism.	Cell stem cell	2016	19
26631723	Oxygen	Yu W	Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies.	The Journal of biological chemistry	2016	12
26654980	Oxygen	Marazita MC	Oxidative stress-induced premature senescence dysregulates VEGF and CFH expression in retinal pigment epithelial cells: Implications for Age-related Macular Degeneration.	Redox biology	2016	13
26676145	Oxygen	Allen DG	Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy.	Physiological reviews	2016	21
26682001	Oxygen	Ryoo IG	Redox Modulating NRF2: A Potential Mediator of Cancer Stem Cell Resistance.	Oxidative medicine and cellular longevity	2016	12
26703470	Oxygen	Laukka T	Fumarate and Succinate Regulate Expression of Hypoxia-inducible Genes via TET Enzymes.	The Journal of biological chemistry	2016	22
26705059	Oxygen	Russo I	Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities.	Journal of molecular and cellular cardiology	2016	22
26711459	Oxygen	Love S	Cerebrovascular disease in ageing and Alzheimer's disease.	Acta neuropathologica	2016	21
26711691	Oxygen	Portal-Núñez S	Oxidative stress, autophagy, epigenetic changes and regulation by miRNAs as potential therapeutic targets in osteoarthritis.	Biochemical pharmacology	2016	12
26715682	Oxygen	Gray SP	Reactive Oxygen Species Can Provide Atheroprotection via NOX4-Dependent Inhibition of Inflammation and Vascular Remodeling.	Arteriosclerosis, thrombosis, and vascular biology	2016	25
26734996	Oxygen	Capello M	Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest.	Oncotarget	2016	11
26735018	Oxygen	Lee SB	An ID2-dependent mechanism for VHL inactivation in cancer.	Nature	2016	18
26772155	Oxygen	Gu S	ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction underlie apoptosis induced by resveratrol and arsenic trioxide in A549 cells.	Chemico-biological interactions	2016	15
26791157	Oxygen	Blaser H	TNF and ROS Crosstalk in Inflammation.	Trends in cell biology	2016	32
26801746	Oxygen	Ai Z	Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism.	Cancer letters	2016	11
26804739	Oxygen	Subramani R	Nimbolide inhibits pancreatic cancer growth and metastasis through ROS-mediated apoptosis and inhibition of epithelial-to-mesenchymal transition.	Scientific reports	2016	17
26839313	Oxygen	Zielonka J	Mitigation of NADPH Oxidase 2 Activity as a Strategy to Inhibit Peroxynitrite Formation.	The Journal of biological chemistry	2016	12
26848183	Oxygen	Ruiz PA	Titanium dioxide nanoparticles exacerbate DSS-induced colitis: role of the NLRP3 inflammasome.	Gut	2017	8
26871664	Oxygen	Ince C	THE ENDOTHELIUM IN SEPSIS.	Shock	2016	19
26878598	Oxygen	Greenshields AL	Contribution of reactive oxygen species to ovarian cancer cell growth arrest and killing by the anti-malarial drug artesunate.	Molecular carcinogenesis	2017	9
26894974	Oxygen	Syu JP	Nrf2 is the key to chemotherapy resistance in MCF7 breast cancer cells under hypoxia.	Oncotarget	2016	11
26907999	Oxygen	Dingjan I	Lipid peroxidation causes endosomal antigen release for cross-presentation.	Scientific reports	2016	11
26918353	Oxygen	Yu L	The sweet trap in tumors: aerobic glycolysis and potential targets for therapy.	Oncotarget	2016	15
26926996	Oxygen	Shirai T	The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease.	The Journal of experimental medicine	2016	34
26934227	Oxygen	Ma C	NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis.	Nature	2016	37
26940009	Oxygen	Dai W	Class III-specific HDAC inhibitor Tenovin-6 induces apoptosis, suppresses migration and eliminates cancer stem cells in uveal melanoma.	Scientific reports	2016	11
26942675	Oxygen	Li X	Mitochondria-Translocated PGK1 Functions as a Protein Kinase to Coordinate Glycolysis and the TCA Cycle in Tumorigenesis.	Molecular cell	2016	19
26947075	Oxygen	Liou GY	Mutant KRas-Induced Mitochondrial Oxidative Stress in Acinar Cells Upregulates EGFR Signaling to Drive Formation of Pancreatic Precancerous Lesions.	Cell reports	2016	17
26972897	Oxygen	Ilekis JV	Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.	American journal of obstetrics and gynecology	2016	17
26982722	Oxygen	Ravindran R	The amino acid sensor GCN2 controls gut inflammation by inhibiting inflammasome activation.	Nature	2016	27
26990160	Oxygen	Sreekumar PG	The Mitochondrial-Derived Peptide Humanin Protects RPE Cells From Oxidative Stress, Senescence, and Mitochondrial Dysfunction.	Investigative ophthalmology & visual science	2016	13
26999719	Oxygen	Atienzar-Aroca S	Oxidative stress in retinal pigment epithelium cells increases exosome secretion and promotes angiogenesis in endothelial cells.	Journal of cellular and molecular medicine	2016	15
27001847	Oxygen	Zhang C	Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m⁶A-demethylation of NANOG mRNA.	Proceedings of the National Academy of Sciences of the United States of America	2016	42
27003603	Oxygen	Wörmann SM	Loss of P53 Function Activates JAK2-STAT3 Signaling to Promote Pancreatic Tumor Growth, Stroma Modification, and Gemcitabine Resistance in Mice and Is Associated With Patient Survival.	Gastroenterology	2016	17
27009267	Oxygen	Yang Z	Restoring oxidant signaling suppresses proarthritogenic T cell effector functions in rheumatoid arthritis.	Science translational medicine	2016	20
27036091	Oxygen	Thieblemont N	Human neutrophils in auto-immunity.	Seminars in immunology	2016	13
27042933	Oxygen	Kaur A	sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance.	Nature	2016	34
27049945	Oxygen	Jiang L	Reductive carboxylation supports redox homeostasis during anchorage-independent growth.	Nature	2016	56
27050287	Oxygen	Winterbourn CC	Reactive Oxygen Species and Neutrophil Function.	Annual review of biochemistry	2016	21
27075628	Oxygen	Ribas V	Skeletal muscle action of estrogen receptor α is critical for the maintenance of mitochondrial function and metabolic homeostasis in females.	Science translational medicine	2016	15
27127546	Oxygen	Minutoli L	ROS-Mediated NLRP3 Inflammasome Activation in Brain, Heart, Kidney, and Testis Ischemia/Reperfusion Injury.	Oxidative medicine and cellular longevity	2016	17
27136895	Oxygen	Fiorillo M	Repurposing atovaquone: targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells.	Oncotarget	2016	17
27157131	Oxygen	Chan TK	House dust mite-induced asthma causes oxidative damage and DNA double-strand breaks in the lungs.	The Journal of allergy and clinical immunology	2016	11
27179829	Oxygen	Molina AJ	Skeletal Muscle Mitochondrial Content, Oxidative Capacity, and Mfn2 Expression Are Reduced in Older Patients With Heart Failure and Preserved Ejection Fraction and Are Related to Exercise Intolerance.	JACC. Heart failure	2016	14
27225300	Oxygen	Fearon U	Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis.	Nature reviews. Rheumatology	2016	11
27279371	Oxygen	Kobayashi K	Involvement of PARK2-Mediated Mitophagy in Idiopathic Pulmonary Fibrosis Pathogenesis.	Journal of immunology	2016	13
27368101	Oxygen	Briggs KJ	Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine.	Cell	2016	20
27443527	Oxygen	Roberts RF	Defending the mitochondria: The pathways of mitophagy and mitochondrial-derived vesicles.	The international journal of biochemistry & cell biology	2016	14
27484637	Oxygen	Prieto-Domínguez N	Melatonin-induced increase in sensitivity of human hepatocellular carcinoma cells to sorafenib is associated with reactive oxygen species production and mitophagy.	Journal of pineal research	2016	11
27588494	Oxygen	Diedrich JD	Bone marrow adipocytes promote the Warburg phenotype in metastatic prostate tumors via HIF-1α activation.	Oncotarget	2016	11
27669541	Oxygen	Khan NM	Sucrose, But Not Glucose, Blocks IL1-β-Induced Inflammatory Response in Human Chondrocytes by Inducing Autophagy via AKT/mTOR Pathway.	Journal of cellular biochemistry	2017	9
27679493	Oxygen	Li M	MicroRNA-223 ameliorates alcoholic liver injury by inhibiting the IL-6-p47phox-oxidative stress pathway in neutrophils.	Gut	2017	17
27698118	Oxygen	Ou Y	Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses.	Proceedings of the National Academy of Sciences of the United States of America	2016	15
27732568	Oxygen	Akamata K	SIRT3 is attenuated in systemic sclerosis skin and lungs, and its pharmacologic activation mitigates organ fibrosis.	Oncotarget	2016	13
27815257	Oxygen	Bindu S	SIRT3 blocks myofibroblast differentiation and pulmonary fibrosis by preventing mitochondrial DNA damage.	American journal of physiology. Lung cellular and molecular physiology	2017	6
27826011	Oxygen	Qiu YY	Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy.	Pharmacological research	2016	11
27865851	Oxygen	Zhang QS	Pathological α-synuclein exacerbates the progression of Parkinson's disease through microglial activation.	Toxicology letters	2017	9
27899487	Oxygen	Qi H	Glomerular Endothelial Mitochondrial Dysfunction Is Essential and Characteristic of Diabetic Kidney Disease Susceptibility.	Diabetes	2017	7
27932512	Oxygen	Jin JK	ATF6 Decreases Myocardial Ischemia/Reperfusion Damage and Links ER Stress and Oxidative Stress Signaling Pathways in the Heart.	Circulation research	2017	8
28049732	Oxygen	Bernard K	NADPH Oxidase 4 (Nox4) Suppresses Mitochondrial Biogenesis and Bioenergetics in Lung Fibroblasts via a Nuclear Factor Erythroid-derived 2-like 2 (Nrf2)-dependent Pathway.	The Journal of biological chemistry	2017	7
28063379	Oxygen	Maciejczyk M	Oxidative stress, mitochondrial abnormalities and antioxidant defense in Ataxia-telangiectasia, Bloom syndrome and Nijmegen breakage syndrome.	Redox biology	2017	8
28089725	Oxygen	Zhenyukh O	High concentration of branched-chain amino acids promotes oxidative stress, inflammation and migration of human peripheral blood mononuclear cells via mTORC1 activation.	Free radical biology & medicine	2017	7
28108279	Oxygen	Wenzel P	Redox regulation of cardiovascular inflammation - Immunomodulatory function of mitochondrial and Nox-derived reactive oxygen and nitrogen species.	Free radical biology & medicine	2017	8
28126520	Oxygen	Kietzmann T	Metabolic zonation of the liver: The oxygen gradient revisited.	Redox biology	2017	12
28137309	Oxygen	Lee SY	Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.	Molecular cancer	2017	11
28209797	Oxygen	Förstermann U	Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis.	Circulation research	2017	25
28279976	Oxygen	Yang SJ	Regulation of hypoxia responses by flavin adenine dinucleotide-dependent modulation of HIF-1α protein stability.	The EMBO journal	2017	6
28306514	Oxygen	Gupta A	PARK2 Depletion Connects Energy and Oxidative Stress to PI3K/Akt Activation via PTEN S-Nitrosylation.	Molecular cell	2017	7
28396419	Oxygen	Rand AA	Cyclooxygenase-derived proangiogenic metabolites of epoxyeicosatrienoic acids.	Proceedings of the National Academy of Sciences of the United States of America	2017	6
9506738	Dexamethasone	Fried SK	Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid.	The Journal of clinical endocrinology and metabolism	1998	288
10648003	Dexamethasone	Buechler C	Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli.	Journal of leukocyte biology	2000	137
10877829	Dexamethasone	Puddicombe SM	Involvement of the epidermal growth factor receptor in epithelial repair in asthma.	FASEB journal 	2000	113
11049970	Dexamethasone	Hideshima T	Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy.	Blood	2000	133
11306489	Dexamethasone	Hideshima T	The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells.	Cancer research	2001	315
11753617	Dexamethasone	Gupta D	Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications.	Leukemia	2001	98
12036884	Dexamethasone	Mitsiades N	Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications.	Blood	2002	103
12070027	Dexamethasone	Derenne S	Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-x(L) is an essential survival protein of human myeloma cells.	Blood	2002	97
12082286	Dexamethasone	Fernandes JC	The role of cytokines in osteoarthritis pathophysiology.	Biorheology	2002	191
12173037	Dexamethasone	Mitsiades CS	Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications.	Oncogene	2002	110
12495931	Dexamethasone	Hellings PW	Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma.	American journal of respiratory cell and molecular biology	2003	109
12944327	Dexamethasone	Raison CL	When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders.	The American journal of psychiatry	2003	207
14500688	Dexamethasone	Bharti AC	Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells.	Journal of immunology	2003	119
14638850	Dexamethasone	Rich JN	Phase II trial of gefitinib in recurrent glioblastoma.	Journal of clinical oncology 	2004	134
14996737	Dexamethasone	Wu W	Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells.	Cancer research	2004	87
15070700	Dexamethasone	Bharti AC	Nuclear factor-kappaB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis.	Blood	2004	82
15251979	Dexamethasone	Pui CH	Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital.	Blood	2004	107
15890265	Dexamethasone	Morsczeck C	Isolation of precursor cells (PCs) from human dental follicle of wisdom teeth.	Matrix biology 	2005	121
16728695	Dexamethasone	Catley L	Aggresome induction by proteasome inhibitor bortezomib and alpha-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells.	Blood	2006	92
16740717	Dexamethasone	Maiso P	The histone deacetylase inhibitor LBH589 is a potent antimyeloma agent that overcomes drug resistance.	Cancer research	2006	61
16885367	Dexamethasone	Baughn LB	A novel orally active small molecule potently induces G1 arrest in primary myeloma cells and prevents tumor growth by specific inhibition of cyclin-dependent kinase 4/6.	Cancer research	2006	64
17016430	Dexamethasone	Chauhan D	A novel Bcl-2/Bcl-X(L)/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma.	Oncogene	2007	60
17182612	Dexamethasone	Shindou H	A single enzyme catalyzes both platelet-activating factor production and membrane biogenesis of inflammatory cells. Cloning and characterization of acetyl-CoA:LYSO-PAF acetyltransferase.	The Journal of biological chemistry	2007	64
17236958	Dexamethasone	Gonzalez J	Effect of bevacizumab on radiation necrosis of the brain.	International journal of radiation oncology, biology, physics	2007	67
17591945	Dexamethasone	Kuhn DJ	Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma.	Blood	2007	166
18172311	Dexamethasone	Matsui W	Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance.	Cancer research	2008	174
18438858	Dexamethasone	Mueller MB	Functional characterization of hypertrophy in chondrogenesis of human mesenchymal stem cells.	Arthritis and rheumatism	2008	86
18492738	Dexamethasone	Bhavsar P	Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma.	Thorax	2008	66
19181644	Dexamethasone	Lust JA	Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component.	Mayo Clinic proceedings	2009	61
19470933	Dexamethasone	Attard G	Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancer.	Journal of clinical oncology 	2009	152
19509164	Dexamethasone	Ikeda H	The monoclonal antibody nBT062 conjugated to cytotoxic Maytansinoids has selective cytotoxicity against CD138-positive multiple myeloma cells in vitro and in vivo.	Clinical cancer research 	2009	52
19584292	Dexamethasone	McMillin DW	Antimyeloma activity of the orally bioavailable dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235.	Cancer research	2009	46
19762485	Dexamethasone	Kurtova AV	Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance.	Blood	2009	89
19801525	Dexamethasone	Préfontaine D	Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells.	Journal of immunology	2009	117
20107188	Dexamethasone	Dufton N	Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation.	Journal of immunology	2010	78
20179016	Dexamethasone	Gustafson MP	Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone.	Neuro-oncology	2010	50
20200450	Dexamethasone	Bonapace L	Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance.	The Journal of clinical investigation	2010	100
21098398	Dexamethasone	Chen SS	Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLL.	Blood	2011	35
21257720	Dexamethasone	Ritchie JP	SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axis.	Clinical cancer research 	2011	60
21803855	Dexamethasone	Hoellenriegel J	The phosphoinositide 3'-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia.	Blood	2011	151
21907973	Dexamethasone	Touma C	FK506 binding protein 5 shapes stress responsiveness: modulation of neuroendocrine reactivity and coping behavior.	Biological psychiatry	2011	48
21990393	Dexamethasone	Yamaguchi M	Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.	Journal of clinical oncology 	2011	68
22055018	Dexamethasone	Wikgren M	Short telomeres in depression and the general population are associated with a hypocortisolemic state.	Biological psychiatry	2012	42
22215599	Dexamethasone	Bozinovski S	Serum amyloid A opposes lipoxin A₄ to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease.	Proceedings of the National Academy of Sciences of the United States of America	2012	52
22606276	Dexamethasone	Sutherland ER	Cluster analysis of obesity and asthma phenotypes.	PloS one	2012	41
22740309	Dexamethasone	Melief J	Phenotyping primary human microglia: tight regulation of LPS responsiveness.	Glia	2012	34
22891284	Dexamethasone	Yin Z	Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells.	Journal of immunology	2012	39
22919026	Dexamethasone	Kwong YL	SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group.	Blood	2012	54
22975377	Dexamethasone	Chauhan D	A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance.	Cancer cell	2012	100
22996336	Dexamethasone	Zheng Y	PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma.	Leukemia	2013	30
23105009	Dexamethasone	Clark R	Comparative genomic and proteomic analysis of cytoskeletal changes in dexamethasone-treated trabecular meshwork cells.	Molecular & cellular proteomics 	2013	29
23289374	Dexamethasone	Zou J	Notch1 is required for hypoxia-induced proliferation, invasion and chemoresistance of T-cell acute lymphoblastic leukemia cells.	Journal of hematology & oncology	2013	27
23658244	Dexamethasone	Aboody KS	Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies.	Science translational medicine	2013	60
23683514	Dexamethasone	Nanzer AM	Enhanced production of IL-17A in patients with severe asthma is inhibited by 1α,25-dihydroxyvitamin D3 in a glucocorticoid-independent fashion.	The Journal of allergy and clinical immunology	2013	40
23944957	Dexamethasone	Perry MM	Airway smooth muscle hyperproliferation is regulated by microRNA-221 in severe asthma.	American journal of respiratory cell and molecular biology	2014	36
24030633	Dexamethasone	Saha MN	PRIMA-1Met/APR-246 displays high antitumor activity in multiple myeloma by induction of p73 and Noxa.	Molecular cancer therapeutics	2013	26
24194604	Dexamethasone	Paakinaho V	SUMOylation regulates the chromatin occupancy and anti-proliferative gene programs of glucocorticoid receptor.	Nucleic acids research	2014	22
24319254	Dexamethasone	Tian Z	A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance.	Blood	2014	65
24335104	Dexamethasone	Mulligan G	Mutation of NRAS but not KRAS significantly reduces myeloma sensitivity to single-agent bortezomib therapy.	Blood	2014	23
24606108	Dexamethasone	New MI	Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma.	The Journal of clinical endocrinology and metabolism	2014	29
24615402	Dexamethasone	Isikbay M	Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer.	Hormones & cancer	2014	36
24926665	Dexamethasone	Himes BE	RNA-Seq transcriptome profiling identifies CRISPLD2 as a glucocorticoid responsive gene that modulates cytokine function in airway smooth muscle cells.	PloS one	2014	26
25042748	Dexamethasone	Irvin C	Increased frequency of dual-positive TH2/TH17 cells in bronchoalveolar lavage fluid characterizes a population of patients with severe asthma.	The Journal of allergy and clinical immunology	2014	39
25064128	Dexamethasone	Gibbs J	An epithelial circadian clock controls pulmonary inflammation and glucocorticoid action.	Nature medicine	2014	55
25232177	Dexamethasone	Carreira S	Tumor clone dynamics in lethal prostate cancer.	Science translational medicine	2014	82
25415285	Dexamethasone	Szmania S	Ex vivo-expanded natural killer cells demonstrate robust proliferation in vivo in high-risk relapsed multiple myeloma patients.	Journal of immunotherapy	2015	31
25573908	Dexamethasone	Kopp JB	Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical Trial.	Journal of the American Society of Nephrology 	2015	26
25710470	Dexamethasone	Alexander T	The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus.	Annals of the rheumatic diseases	2015	23
25772594	Dexamethasone	Chambers ES	Distinct endotypes of steroid-resistant asthma characterized by IL-17A(high) and IFN-γ(high) immunophenotypes: Potential benefits of calcitriol.	The Journal of allergy and clinical immunology	2015	17
25888260	Dexamethasone	Surace L	Complement is a central mediator of radiotherapy-induced tumor-specific immunity and clinical response.	Immunity	2015	24
25999435	Dexamethasone	Benson DM Jr	A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma.	Clinical cancer research 	2015	30
26272769	Dexamethasone	Rapoport BL	Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of cisplatin-based highly emetogenic chemotherapy in patients with cancer: two randomised, active-controlled, double-blind, phase 3 trials.	The Lancet. Oncology	2015	17
26423795	Dexamethasone	Sarantopoulos J	Phase I Study of the Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (TAK-924/MLN4924) in Patients with Advanced Solid Tumors.	Clinical cancer research 	2016	20
26565896	Dexamethasone	Rajkumar SV	Myeloma today: Disease definitions and treatment advances.	American journal of hematology	2016	14
26842680	Dexamethasone	Muller L	Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets.	Scientific reports	2016	27
27314535	Dexamethasone	Jia Y	IL-13+ Type 2 Innate Lymphoid Cells Correlate with Asthma Control Status and Treatment Response.	American journal of respiratory cell and molecular biology	2016	12
28053023	Dexamethasone	Vogl DT	Ricolinostat, the First Selective Histone Deacetylase 6 Inhibitor, in Combination with Bortezomib and Dexamethasone for Relapsed or Refractory Multiple Myeloma.	Clinical cancer research 	2017	6
28196531	Dexamethasone	Kiessling S	Enhancing circadian clock function in cancer cells inhibits tumor growth.	BMC biology	2017	8
28461396	Dexamethasone	Badros A	Pembrolizumab, pomalidomide, and low-dose dexamethasone for relapsed/refractory multiple myeloma.	Blood	2017	12
9815541	Folic acid	Silver DA	Prostate-specific membrane antigen expression in normal and malignant human tissues.	Clinical cancer research 	1997	179
11156248	Folic acid	Sirotnak FM	Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase.	Clinical cancer research 	2000	98
12810640	Folic acid	van Engeland M	Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer.	Cancer research	2003	79
12860938	Folic acid	Vogelzang NJ	Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.	Journal of clinical oncology 	2003	413
16401840	Folic acid	Gurol ME	Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy.	Neurology	2006	123
17096326	Folic acid	Slattery ML	Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer.	International journal of cancer	2007	87
18222534	Folic acid	Kalli KR	Folate receptor alpha as a tumor target in epithelial ovarian cancer.	Gynecologic oncology	2008	72
20686660	Folic acid	Christensen BC	Breast cancer DNA methylation profiles are associated with tumor size and alcohol and folate intake.	PLoS genetics	2010	59
20802351	Folic acid	Hainsworth JD	A phase II, open-label, randomized study to assess the efficacy and safety of AZD6244 (ARRY-142886) versus pemetrexed in patients with non-small cell lung cancer who have failed one or two prior chemotherapeutic regimens.	Journal of thoracic oncology 	2010	48
21622715	Folic acid	Bareford MD	Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cells.	Cancer research	2011	40
21926976	Folic acid	van Dam GM	Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results.	Nature medicine	2011	352
22281794	Folic acid	Zafarana G	Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy.	Cancer	2012	31
23794259	Folic acid	Franchina T	Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non-small cell lung cancer.	Journal of cellular physiology	2014	26
24028341	Folic acid	Zhang Z	Folate receptor α associated with triple-negative breast cancer and poor prognosis.	Archives of pathology & laboratory medicine	2014	21
24451681	Folic acid	Nilsson R	Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer.	Nature communications	2014	73
24556396	Folic acid	Birkinshaw RW	MAITs, MR1 and vitamin B metabolites.	Current opinion in immunology	2014	36
24798476	Folic acid	Zhong Y	Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapy.	Biomacromolecules	2014	25
25579803	Folic acid	Gustavsson B	A review of the evolution of systemic chemotherapy in the management of colorectal cancer.	Clinical colorectal cancer	2015	40
25816016	Folic acid	Necela BM	Folate receptor-α (FOLR1) expression and function in triple negative tumors.	PloS one	2015	15
26418287	Folic acid	Nilsson E	Epigenetic Alterations in Human Liver From Subjects With Type 2 Diabetes in Parallel With Reduced Folate Levels.	The Journal of clinical endocrinology and metabolism	2015	19
26449608	Folic acid	Craciun FL	RNA Sequencing Identifies Novel Translational Biomarkers of Kidney Fibrosis.	Journal of the American Society of Nephrology 	2016	10
26595060	Folic acid	Kurosaki A	Serum folate receptor alpha as a biomarker for ovarian cancer: Implications for diagnosis, prognosis and predicting its local tumor expression.	International journal of cancer	2016	11
27015562	Folic acid	Booth L	Pemetrexed + Sorafenib lethality is increased by inhibition of ERBB1/2/3-PI3K-NFκB compensatory survival signaling.	Oncotarget	2016	10
27280394	Folic acid	Samanta D	PHGDH Expression Is Required for Mitochondrial Redox Homeostasis, Breast Cancer Stem Cell Maintenance, and Lung Metastasis.	Cancer research	2016	12
27306792	Folic acid	Hoogstins CE	A Novel Tumor-Specific Agent for Intraoperative Near-Infrared Fluorescence Imaging: A Translational Study in Healthy Volunteers and Patients with Ovarian Cancer.	Clinical cancer research 	2016	18
28236692	Folic acid	Gawde KA	Synthesis and characterization of folate decorated albumin bio-conjugate nanoparticles loaded with a synthetic curcumin difluorinated analogue.	Journal of colloid and interface science	2017	7
11016644	Vorinostat	Butler LM	Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo.	Cancer research	2000	143
12189205	Vorinostat	Butler LM	The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin.	Proceedings of the National Academy of Sciences of the United States of America	2002	128
15596714	Vorinostat	Shao Y	Apoptotic and autophagic cell death induced by histone deacetylase inhibitors.	Proceedings of the National Academy of Sciences of the United States of America	2004	169
17363733	Vorinostat	Carew JS	Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance.	Blood	2007	183
17962618	Vorinostat	Mann BS	FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma.	The oncologist	2007	260
18413790	Vorinostat	Fournel M	MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo.	Molecular cancer therapeutics	2008	75
19671864	Vorinostat	Badros A	Phase I study of vorinostat in combination with bortezomib for relapsed and refractory multiple myeloma.	Clinical cancer research 	2009	69
20427703	Vorinostat	Leshchenko VV	Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma.	Blood	2010	51
21084276	Vorinostat	Lopez G	Autophagic survival in resistance to histone deacetylase inhibitors: novel strategies to treat malignant peripheral nerve sheath tumors.	Cancer research	2011	35
21637290	Vorinostat	Li D	SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis.	Cell death and differentiation	2011	77
21653597	Vorinostat	Singh MM	Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors.	Neuro-oncology	2011	38
21660961	Vorinostat	Bruzzese F	HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT.	Journal of cellular physiology	2011	43
21909380	Vorinostat	Nalls D	Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells.	PloS one	2011	67
21926171	Vorinostat	Eades G	miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells.	The Journal of biological chemistry	2011	62
22002311	Vorinostat	Zhang X	Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas.	Oncogene	2012	46
22038994	Vorinostat	Landreville S	Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.	Clinical cancer research 	2012	66
22461695	Vorinostat	Yang D	Decitabine and vorinostat cooperate to sensitize colon carcinoma cells to Fas ligand-induced apoptosis in vitro and tumor suppression in vivo.	Journal of immunology	2012	30
23382048	Vorinostat	Nakagawa T	EGFR-TKI resistance due to BIM polymorphism can be circumvented in combination with HDAC inhibition.	Cancer research	2013	44
23449455	Vorinostat	Bolden JE	HDAC inhibitors induce tumor-cell-selective pro-apoptotic transcriptional responses.	Cell death & disease	2013	49
24991835	Vorinostat	Mahalingam D	Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors.	Autophagy	2014	68
25142817	Vorinostat	Montalban-Bravo G	Novel drugs for older patients with acute myeloid leukemia.	Leukemia	2015	20
26136424	Vorinostat	Paschall AV	H3K9 Trimethylation Silences Fas Expression To Confer Colon Carcinoma Immune Escape and 5-Fluorouracil Chemoresistance.	Journal of immunology	2015	17
27582487	Vorinostat	Min HY	Essential Role of DNA Methyltransferase 1-mediated Transcription of Insulin-like Growth Factor 2 in Resistance to Histone Deacetylase Inhibitors.	Clinical cancer research 	2017	5
28193631	Vorinostat	Pipalia NH	Histone deacetylase inhibitors correct the cholesterol storage defect in most Niemann-Pick C1 mutant cells.	Journal of lipid research	2017	6
11041445	Vitamin D3	Slominski A	Neuroendocrinology of the skin.	Endocrine reviews	2000	152
16402404	Vitamin D3	Sadeghi K	Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns.	European journal of immunology	2006	104
17122772	Vitamin D3	O'Brien CA	A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.	Nature	2007	1111
18368131	Vitamin D3	Zbytek B	20-Hydroxyvitamin D3, a product of vitamin D3 hydroxylation by cytochrome P450scc, stimulates keratinocyte differentiation.	The Journal of investigative dermatology	2008	62
19068548	Vitamin D3	Nijnik A	The roles of cathelicidin LL-37 in immune defences and novel clinical applications.	Current opinion in hematology	2009	73
19188585	Vitamin D3	Zhang Z	Thymic stromal lymphopoietin overproduced by keratinocytes in mouse skin aggravates experimental asthma.	Proceedings of the National Academy of Sciences of the United States of America	2009	51
19433889	Vitamin D3	Masoumi A	1alpha,25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer's disease patients.	Journal of Alzheimer's disease 	2009	47
19543524	Vitamin D3	Janjetovic Z	20-Hydroxycholecalciferol, product of vitamin D3 hydroxylation by P450scc, decreases NF-kappaB activity by increasing IkappaB alpha levels in human keratinocytes.	PloS one	2009	55
19796194	Vitamin D3	Aceves SS	Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids.	Allergy	2010	60
19850138	Vitamin D3	Rosas HD	Altered white matter microstructure in the corpus callosum in Huntington's disease: implications for cortical "disconnection".	NeuroImage	2010	59
20360850	Vitamin D3	Slominski AT	Products of vitamin D3 or 7-dehydrocholesterol metabolism by cytochrome P450scc show anti-leukemia effects, having low or absent calcemic activity.	PloS one	2010	66
20413890	Vitamin D3	Agholme L	An in vitro model for neuroscience: differentiation of SH-SY5Y cells into cells with morphological and biochemical characteristics of mature neurons.	Journal of Alzheimer's disease 	2010	42
20678967	Vitamin D3	Hardy OT	Body mass index-independent inflammation in omental adipose tissue associated with insulin resistance in morbid obesity.	Surgery for obesity and related diseases 	2011	45
21123584	Vitamin D3	Tripathi RB	NG2 glia generate new oligodendrocytes but few astrocytes in a murine experimental autoimmune encephalomyelitis model of demyelinating disease.	The Journal of neuroscience 	2010	69
22095230	Vitamin D3	Janjetovic Z	High basal NF-κB activity in nonpigmented melanoma cells is associated with an enhanced sensitivity to vitamin D3 derivatives.	British journal of cancer	2011	43
22446628	Vitamin D3	Everitt AR	IFITM3 restricts the morbidity and mortality associated with influenza.	Nature	2012	208
22753133	Vitamin D3	Barchetta I	Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus.	Hepatology	2012	47
23869782	Vitamin D3	Slominski AT	Cytochromes p450 and skin cancer: role of local endocrine pathways.	Anti-cancer agents in medicinal chemistry	2014	37
24477043	Vitamin D3	Daly RM	Protein-enriched diet, with the use of lean red meat, combined with progressive resistance training enhances lean tissue mass and muscle strength and reduces circulating IL-6 concentrations in elderly women: a cluster randomized controlled trial.	The American journal of clinical nutrition	2014	29
24529992	Vitamin D3	Bikle DD	Vitamin D metabolism, mechanism of action, and clinical applications.	Chemistry & biology	2014	75
25617667	Vitamin D3	Slominski AT	Novel non-calcemic secosteroids that are produced by human epidermal keratinocytes protect against solar radiation.	The Journal of steroid biochemistry and molecular biology	2015	20
11096166	Methotrexate	Lipsky PE	Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.	The New England journal of medicine	2000	468
12171485	Methotrexate	MacMillan ML	Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems.	Biology of blood and marrow transplantation 	2002	88
15818697	Methotrexate	Smolen JS	Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study.	Arthritis and rheumatism	2005	81
16230674	Methotrexate	Fisher RI	New treatment options have changed the survival of patients with follicular lymphoma.	Journal of clinical oncology 	2005	69
17393394	Methotrexate	Curtis JR	Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists.	Arthritis and rheumatism	2007	60
18754698	Methotrexate	Chou AJ	Therapy for osteosarcoma: where do we go from here?	Paediatric drugs	2008	67
19088023	Methotrexate	Song B	miR-192 Regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit.	Clinical cancer research 	2008	61
19630828	Methotrexate	Ridker PM	Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT).	Journal of thrombosis and haemostasis 	2009	75
19734943	Methotrexate	Song B	Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells.	Oncogene	2009	125
20039405	Methotrexate	Hetland ML	Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry.	Arthritis and rheumatism	2010	84
20113825	Methotrexate	Gianni L	Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort.	Lancet	2010	184
20154586	Methotrexate	Dojcinov SD	EBV positive mucocutaneous ulcer--a study of 26 cases associated with various sources of immunosuppression.	The American journal of surgical pathology	2010	43
20224986	Methotrexate	Liu T	Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1.	Molecular and cellular biochemistry	2010	43
20404278	Methotrexate	Hoarau JJ	Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response.	Journal of immunology	2010	121
20433742	Methotrexate	Song B	Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells.	Molecular cancer	2010	73
20685255	Methotrexate	Wolff D	Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease.	Biology of blood and marrow transplantation 	2011	38
20943624	Methotrexate	Vermorken JB	Optimal treatment for recurrent/metastatic head and neck cancer.	Annals of oncology 	2010	58
21501481	Methotrexate	Kao KJ	Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization.	BMC cancer	2011	81
21917518	Methotrexate	Di Leo A	HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data.	The Lancet. Oncology	2011	36
22045784	Methotrexate	Chan CC	Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium.	The oncologist	2011	47
22102692	Methotrexate	Huang J	HMGB1 promotes drug resistance in osteosarcoma.	Cancer research	2012	84
22151962	Methotrexate	West NR	Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer.	Breast cancer research 	2011	92
22301993	Methotrexate	Huang J	Targeting HMGB1-mediated autophagy as a novel therapeutic strategy for osteosarcoma.	Autophagy	2012	33
22665540	Methotrexate	Ebb D	Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression: a report from the children's oncology group.	Journal of clinical oncology 	2012	46
23291185	Methotrexate	Ma Y	Inhibition of the Wnt-β-catenin and Notch signaling pathways sensitizes osteosarcoma cells to chemotherapy.	Biochemical and biophysical research communications	2013	28
23341518	Methotrexate	Loi S	Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98.	Journal of clinical oncology 	2013	227
23490655	Methotrexate	Harbeck N	Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients.	European journal of cancer	2013	28
23792190	Methotrexate	Sáez-Ayala M	Directed phenotype switching as an effective antimelanoma strategy.	Cancer cell	2013	30
24443618	Methotrexate	Prat A	Research-based PAM50 subtype predictor identifies higher responses and improved survival outcomes in HER2-positive breast cancer in the NOAH study.	Clinical cancer research 	2014	33
24525232	Methotrexate	Choi W	Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy.	Cancer cell	2014	181
24821881	Methotrexate	Plimack ER	Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicity.	Journal of clinical oncology 	2014	23
24821883	Methotrexate	Choueiri TK	Neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin with pegfilgrastim support in muscle-invasive urothelial cancer: pathologic, radiologic, and biomarker correlates.	Journal of clinical oncology 	2014	21
25498218	Methotrexate	Sternberg CN	Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial.	The Lancet. Oncology	2015	32
25498219	Methotrexate	Grignani G	Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial.	The Lancet. Oncology	2015	34
25892145	Methotrexate	Machiels JP	Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial.	The Lancet. Oncology	2015	46
27025861	Methotrexate	Deng Y	The Inflammatory Response in Psoriasis: a Comprehensive Review.	Clinical reviews in allergy & immunology	2016	25
27211551	Methotrexate	Pasquier E	Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study.	EBioMedicine	2016	12
27324280	Methotrexate	Piperno-Neumann S	Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial.	The Lancet. Oncology	2016	12
28199814	Methotrexate	Taylor PC	Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis.	The New England journal of medicine	2017	14
8651649	L-Methionine	Parchi P	Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease.	Annals of neurology	1996	139
10443888	L-Methionine	Parchi P	Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects.	Annals of neurology	1999	224
15302196	L-Methionine	Peden AH	Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient.	Lancet	2004	147
15728811	L-Methionine	Kobayashi S	EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.	The New England journal of medicine	2005	914
16517609	L-Methionine	Choi J	Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases.	The Journal of biological chemistry	2006	115
16818862	L-Methionine	Ho BC	Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.	Archives of general psychiatry	2006	64
17085664	L-Methionine	Balak MN	Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor-mutant lung adenocarcinomas with acquired resistance to kinase inhibitors.	Clinical cancer research 	2006	213
17093497	L-Methionine	Boutet A	Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney.	The EMBO journal	2006	99
17607709	L-Methionine	Benvenuti S	The MET receptor tyrosine kinase in invasion and metastasis.	Journal of cellular physiology	2007	81
18077431	L-Methionine	Beroukhim R	Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma.	Proceedings of the National Academy of Sciences of the United States of America	2007	422
18376396	L-Methionine	Gregory PA	The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.	Nature cell biology	2008	1244
18379349	L-Methionine	Beau-Faller M	MET gene copy number in non-small cell lung cancer: molecular analysis in a targeted tyrosine kinase inhibitor naïve cohort.	Journal of thoracic oncology 	2008	64
18600305	L-Methionine	Wells A	E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas.	Clinical & experimental metastasis	2008	85
19119140	L-Methionine	Li ZZ	Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase.	The Journal of biological chemistry	2009	112
19577569	L-Methionine	Syn WK	Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease.	Gastroenterology	2009	86
20070383	L-Methionine	Peden A	Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia.	Haemophilia 	2010	43
20496415	L-Methionine	Christopher-Stine L	A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy.	Arthritis and rheumatism	2010	59
20695009	L-Methionine	Zou WQ	Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein.	Annals of neurology	2010	49
20805998	L-Methionine	Kong D	Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells.	PloS one	2010	132
20852131	L-Methionine	Ashworth TD	Deletion-based mechanisms of Notch1 activation in T-ALL: key roles for RAG recombinase and a conserved internal translational start site in Notch1.	Blood	2010	42
20955337	L-Methionine	Frielingsdorf H	Variant brain-derived neurotrophic factor Val66Met endophenotypes: implications for posttraumatic stress disorder.	Annals of the New York Academy of Sciences	2010	45
20978355	L-Methionine	Berres ML	Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice.	The Journal of clinical investigation	2010	46
21445238	L-Methionine	Padilla D	Sheep and goat BSE propagate more efficiently than cattle BSE in human PrP transgenic mice.	PLoS pathogens	2011	38
21521745	L-Methionine	Tworkoski K	Phosphoproteomic screen identifies potential therapeutic targets in melanoma.	Molecular cancer research 	2011	37
21577214	L-Methionine	Gerritsen L	BDNF Val66Met genotype modulates the effect of childhood adversity on subgenual anterior cingulate cortex volume in healthy subjects.	Molecular psychiatry	2012	33
21665936	L-Methionine	Armstrong AJ	Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers.	Molecular cancer research 	2011	172
21727254	L-Methionine	Lyoo IK	The neurobiological role of the dorsolateral prefrontal cortex in recovery from trauma. Longitudinal brain imaging study among survivors of the South Korean subway disaster.	Archives of general psychiatry	2011	35
21840990	L-Methionine	Iozzo RV	Decorin antagonizes IGF receptor I (IGF-IR) function by interfering with IGF-IR activity and attenuating downstream signaling.	The Journal of biological chemistry	2011	52
21878621	L-Methionine	Teng YW	Deletion of betaine-homocysteine S-methyltransferase in mice perturbs choline and 1-carbon metabolism, resulting in fatty liver and hepatocellular carcinomas.	The Journal of biological chemistry	2011	51
22031526	L-Methionine	Peden AH	Sensitive and specific detection of sporadic Creutzfeldt-Jakob disease brain prion protein using real-time quaking-induced conversion.	The Journal of general virology	2012	35
22389872	L-Methionine	Catenacci DV	Durable complete response of metastatic gastric cancer with anti-Met therapy followed by resistance at recurrence.	Cancer discovery	2011	39
22580601	L-Methionine	Muller PA	Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion.	Oncogene	2013	57
22763439	L-Methionine	Straussman R	Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion.	Nature	2012	461
23110189	L-Methionine	Hall KT	Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome.	PloS one	2012	38
23241961	L-Methionine	Yang H	MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma.	The Journal of clinical investigation	2013	35
23431330	L-Methionine	Pavon-Eternod M	Overexpression of initiator methionine tRNA leads to global reprogramming of tRNA expression and increased proliferation in human epithelial cells.	RNA	2013	31
23455543	L-Methionine	Ulanovskaya OA	NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink.	Nature chemical biology	2013	62
23916847	L-Methionine	Murphy SK	Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease.	Gastroenterology	2013	52
23959575	L-Methionine	Hammerich L	Chemokine receptor CCR6-dependent accumulation of γδ T cells in injured liver restricts hepatic inflammation and fibrosis.	Hepatology	2014	33
24129059	L-Methionine	Gill ON	Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey.	BMJ	2013	47
24222941	L-Methionine	Dongiovanni P	PNPLA3 I148M polymorphism and progressive liver disease.	World journal of gastroenterology	2013	32
24699458	L-Methionine	Watts JC	Evidence that bank vole PrP is a universal acceptor for prions.	PLoS pathogens	2014	23
24743734	L-Methionine	González-Rodríguez A	Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD.	Cell death & disease	2014	60
24902765	L-Methionine	Coombes JD	Osteopontin neutralisation abrogates the liver progenitor cell response and fibrogenesis in mice.	Gut	2015	17
25525250	L-Methionine	Funato K	Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation.	Science	2014	60
25533952	L-Methionine	Brestoff JR	Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity.	Nature	2015	129
25671304	L-Methionine	Lamb R	Targeting tumor-initiating cells: eliminating anabolic cancer stem cells with inhibitors of protein synthesis or by mimicking caloric restriction.	Oncotarget	2015	19
26201023	L-Methionine	Afonso MB	Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis.	Clinical science	2015	18
27229140	L-Methionine	Fang D	The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas.	Science	2016	20
28167322	L-Methionine	Mridha AR	NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.	Journal of hepatology	2017	12
28263309	L-Methionine	Mohammad F	EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas.	Nature medicine	2017	17
9710447	Deoxyuridine triphosphate	Barber AJ	Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin.	The Journal of clinical investigation	1998	280
10446814	Deoxyuridine triphosphate	Hotchkiss RS	Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction.	Critical care medicine	1999	270
11254533	Deoxyuridine triphosphate	Kasahara Y	Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema.	American journal of respiratory and critical care medicine	2001	167
12414525	Deoxyuridine triphosphate	Albertine KH	Fas and fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome.	The American journal of pathology	2002	84
12427055	Deoxyuridine triphosphate	Dunaief JL	The role of apoptosis in age-related macular degeneration.	Archives of ophthalmology	2002	158
14769747	Deoxyuridine triphosphate	Yokohori N	Increased levels of cell death and proliferation in alveolar wall cells in patients with pulmonary emphysema.	Chest	2004	74
15831805	Deoxyuridine triphosphate	Schrijvers DM	Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2005	93
16079129	Deoxyuridine triphosphate	Petit A	Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations.	The Journal of biological chemistry	2005	86
16083712	Deoxyuridine triphosphate	Heller F	Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution.	Gastroenterology	2005	242
16473959	Deoxyuridine triphosphate	Berry MF	Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance.	American journal of physiology. Heart and circulatory physiology	2006	165
17526595	Deoxyuridine triphosphate	Masri FA	Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension.	American journal of physiology. Lung cellular and molecular physiology	2007	109
19208360	Deoxyuridine triphosphate	Dominguez M	Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis.	Gastroenterology	2009	71
19509158	Deoxyuridine triphosphate	Li J	MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor.	Clinical cancer research 	2009	102
19955044	Deoxyuridine triphosphate	Cash H	Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.	The Journal of rheumatology	2010	43
20145154	Deoxyuridine triphosphate	Kaneda H	FOXQ1 is overexpressed in colorectal cancer and enhances tumorigenicity and tumor growth.	Cancer research	2010	53
20847286	Deoxyuridine triphosphate	Jurkunas UV	Evidence of oxidative stress in the pathogenesis of fuchs endothelial corneal dystrophy.	The American journal of pathology	2010	62
20956938	Deoxyuridine triphosphate	Dunn EF	Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab.	Oncogene	2011	40
21325072	Deoxyuridine triphosphate	Song L	Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K/Akt/NF-κB pathway in human non-small cell lung cancer.	Clinical cancer research 	2011	50
21884573	Deoxyuridine triphosphate	Huang C	β1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib.	Breast cancer research 	2011	58
22264502	Deoxyuridine triphosphate	Cui Z	The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor.	Urologic oncology	2013	48
22933030	Deoxyuridine triphosphate	Niraula S	Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study.	Breast cancer research and treatment	2012	66
24270264	Deoxyuridine triphosphate	Meloche J	Role for DNA damage signaling in pulmonary arterial hypertension.	Circulation	2014	34
27335459	Deoxyuridine triphosphate	Hrecka K	HIV-1 and HIV-2 exhibit divergent interactions with HLTF and UNG2 DNA repair proteins.	Proceedings of the National Academy of Sciences of the United States of America	2016	11
28245344	Deoxyuridine triphosphate	Ribeiro S	Inter- and intra-laboratory standardization of TUNEL assay for assessment of sperm DNA fragmentation.	Andrology	2017	17
2644532	Progesterone	Fisher B	A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors.	The New England journal of medicine	1989	154
3458212	Progesterone	Berthois Y	Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture.	Proceedings of the National Academy of Sciences of the United States of America	1986	165
8405201	Progesterone	Pike MC	Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk.	Epidemiologic reviews	1993	171
9371488	Progesterone	Clarke RB	Dissociation between steroid receptor expression and cell proliferation in the human breast.	Cancer research	1997	160
9504686	Progesterone	Allred DC	Prognostic and predictive factors in breast cancer by immunohistochemical analysis.	Modern pathology 	1998	420
11140706	Progesterone	Camp RL	Validation of tissue microarray technology in breast carcinoma.	Laboratory investigation; a journal of technical methods and pathology	2000	121
11545730	Progesterone	Boonyaratanakornkit V	Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases.	Molecular cell	2001	140
11559718	Progesterone	Ellis MJ	Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial.	Journal of clinical oncology 	2001	104
11719442	Progesterone	Hayward SW	Malignant transformation in a nontumorigenic human prostatic epithelial cell line.	Cancer research	2001	105
11733374	Progesterone	Torhorst J	Tissue microarrays for rapid linking of molecular changes to clinical endpoints.	The American journal of pathology	2001	88
11745677	Progesterone	Piek JM	Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.	The Journal of pathology	2001	142
11792709	Progesterone	Yang F	Linking beta-catenin to androgen-signaling pathway.	The Journal of biological chemistry	2002	101
11981002	Progesterone	Lakhani SR	The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.	Journal of clinical oncology 	2002	177
12373602	Progesterone	Boyd NF	The association of breast mitogens with mammographic densities.	British journal of cancer	2002	85
12529347	Progesterone	Konecny G	Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer.	Journal of the National Cancer Institute	2003	91
12627523	Progesterone	Bos R	Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.	Cancer	2003	141
12743151	Progesterone	Bardou VJ	Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases.	Journal of clinical oncology 	2003	122
12824206	Progesterone	Li CI	Relationship between long durations and different regimens of hormone therapy and risk of breast cancer.	JAMA	2003	77
14578209	Progesterone	Lin EY	Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases.	The American journal of pathology	2003	356
15084238	Progesterone	Arpino G	Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome.	Breast cancer research 	2004	115
15169792	Progesterone	Nevalainen MT	Signal transducer and activator of transcription-5 activation and breast cancer prognosis.	Journal of clinical oncology 	2004	71
15221988	Progesterone	Giordano SH	Breast carcinoma in men: a population-based study.	Cancer	2004	114
15455388	Progesterone	Lengyel E	C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu.	International journal of cancer	2005	88
15475452	Progesterone	Colleoni M	Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment.	Clinical cancer research 	2004	73
15545664	Progesterone	Winer EP	American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.	Journal of clinical oncology 	2005	146
15574759	Progesterone	Al-Kuraya K	Prognostic relevance of gene amplifications and coamplifications in breast cancer.	Cancer research	2004	82
15641021	Progesterone	Simpson PT	Molecular evolution of breast cancer.	The Journal of pathology	2005	99
15668482	Progesterone	Lukanova A	Endogenous hormones and ovarian cancer: epidemiology and current hypotheses.	Cancer epidemiology, biomarkers & prevention 	2005	74
15746036	Progesterone	Takahashi Y	Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.	Clinical cancer research 	2005	89
15753463	Progesterone	Gutierrez MC	Molecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase.	Journal of clinical oncology 	2005	129
15762276	Progesterone	Nadji M	Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5,993 breast cancers.	American journal of clinical pathology	2005	70
15805248	Progesterone	Saal LH	PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma.	Cancer research	2005	258
15897552	Progesterone	Mamounas EP	Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28.	Journal of clinical oncology 	2005	110
15987800	Progesterone	Hallmann R	Expression and function of laminins in the embryonic and mature vasculature.	Physiological reviews	2005	112
16000569	Progesterone	De Laurentiis M	A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer.	Clinical cancer research 	2005	76
16006439	Progesterone	Skinner MK	Regulation of primordial follicle assembly and development.	Human reproduction update	2005	80
16019138	Progesterone	Chen DC	Serum adiponectin and leptin levels in Taiwanese breast cancer patients.	Cancer letters	2006	86
16103053	Progesterone	Iorio MV	MicroRNA gene expression deregulation in human breast cancer.	Cancer research	2005	1201
16126938	Progesterone	Mulholland DJ	Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know?	Endocrine reviews	2005	129
16175185	Progesterone	Li CI	Clinical characteristics of different histologic types of breast cancer.	British journal of cancer	2005	73
16299229	Progesterone	Willipinski-Stapelfeldt B	Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells.	Clinical cancer research 	2005	81
16357129	Progesterone	Mehra R	Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis.	Cancer research	2005	84
16397211	Progesterone	Fiegl H	Breast cancer DNA methylation profiles in cancer cells and tumor stroma: association with HER-2/neu status in primary breast cancer.	Cancer research	2006	65
16489069	Progesterone	Olivier M	The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.	Clinical cancer research 	2006	126
16491124	Progesterone	Doane AS	An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen.	Oncogene	2006	154
16611412	Progesterone	Ghebeh H	The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors.	Neoplasia	2006	142
16648502	Progesterone	Wapnir IL	Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials.	Journal of clinical oncology 	2006	71
16757721	Progesterone	Carey LA	Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.	JAMA	2006	1027
16951137	Progesterone	Amend K	Breast cancer in African-American women: differences in tumor biology from European-American women.	Cancer research	2006	67
17085646	Progesterone	Filardo EJ	Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression.	Clinical cancer research 	2006	101
17113977	Progesterone	Russo J	The role of estrogen in the initiation of breast cancer.	The Journal of steroid biochemistry and molecular biology	2006	82
17116942	Progesterone	Haffty BG	Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer.	Journal of clinical oncology 	2006	226
17239243	Progesterone	Dunnwald LK	Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients.	Breast cancer research 	2007	158
17261184	Progesterone	Chavey C	Oestrogen receptor negative breast cancers exhibit high cytokine content.	Breast cancer research 	2007	86
17308128	Progesterone	Albanito L	G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.	Cancer research	2007	140
17329194	Progesterone	Cleator S	Triple-negative breast cancer: therapeutic options.	The Lancet. Oncology	2007	211
17332353	Progesterone	Huang F	Identification of candidate molecular markers predicting sensitivity in solid tumors to dasatinib: rationale for patient selection.	Cancer research	2007	105
17334350	Progesterone	Rodriguez-Pinilla SM	Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer.	Modern pathology 	2007	64
17403429	Progesterone	Smith HO	GPR30: a novel indicator of poor survival for endometrial carcinoma.	American journal of obstetrics and gynecology	2007	77
17409397	Progesterone	Pick E	High HSP90 expression is associated with decreased survival in breast cancer.	Cancer research	2007	78
17512856	Progesterone	LHRH-agonists in Early Breast Cancer Overview group.	Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials.	Lancet	2007	61
17515606	Progesterone	Lee KY	Bmp2 is critical for the murine uterine decidual response.	Molecular and cellular biology	2007	95
17652280	Progesterone	Glass AG	Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.	Journal of the National Cancer Institute	2007	99
17671124	Progesterone	Badve S	FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.	Clinical cancer research 	2007	69
17671126	Progesterone	Dent R	Triple-negative breast cancer: clinical features and patterns of recurrence.	Clinical cancer research 	2007	767
17679725	Progesterone	Viale G	Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.	Journal of clinical oncology 	2007	80
17910759	Progesterone	Kreike B	Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas.	Breast cancer research 	2007	171
17954709	Progesterone	Harris L	American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.	Journal of clinical oncology 	2007	496
18037158	Progesterone	Tomsová M	Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma.	Gynecologic oncology	2008	64
18048329	Progesterone	Gupta GP	ID genes mediate tumor reinitiation during breast cancer lung metastasis.	Proceedings of the National Academy of Sciences of the United States of America	2007	91
18089790	Progesterone	Sempere LF	Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer.	Cancer research	2007	212
18227529	Progesterone	Dowsett M	Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trial.	Journal of clinical oncology 	2008	84
18250347	Progesterone	Liedtke C	Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.	Journal of clinical oncology 	2008	473
18285604	Progesterone	Kyndi M	Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.	Journal of clinical oncology 	2008	89
18316557	Progesterone	Cheang MC	Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype.	Clinical cancer research 	2008	318
18324472	Progesterone	Lund MJ	Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA.	Breast cancer research and treatment	2009	114
18374402	Progesterone	Brinton RD	Progesterone receptors: form and function in brain.	Frontiers in neuroendocrinology	2008	126
18381931	Progesterone	Wu JM	Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases.	Clinical cancer research 	2008	68
18386815	Progesterone	Davies MP	Expression and splicing of the unfolded protein response gene XBP-1 are significantly associated with clinical outcome of endocrine-treated breast cancer.	International journal of cancer	2008	53
18391223	Progesterone	Horwitz KB	Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts.	Proceedings of the National Academy of Sciences of the United States of America	2008	62
18413639	Progesterone	Nguyen PL	Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.	Journal of clinical oncology 	2008	162
18451146	Progesterone	Yang XH	CD151 accelerates breast cancer by regulating alpha 6 integrin function, signaling, and molecular organization.	Cancer research	2008	63
18487567	Progesterone	Badve SS	Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory.	Journal of clinical oncology 	2008	60
18543098	Progesterone	Dent R	Pattern of metastatic spread in triple-negative breast cancer.	Breast cancer research and treatment	2009	88
18559090	Progesterone	Honeth G	The CD44+/CD24- phenotype is enriched in basal-like breast tumors.	Breast cancer research 	2008	186
18612148	Progesterone	Anders CK	Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression.	Journal of clinical oncology 	2008	159
18669459	Progesterone	Honma N	Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy.	Journal of clinical oncology 	2008	58
18698041	Progesterone	Shaaban AM	Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients.	Clinical cancer research 	2008	63
18779615	Progesterone	Atchley DP	Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer.	Journal of clinical oncology 	2008	113
19188147	Progesterone	Beck AH	The macrophage colony-stimulating factor 1 response signature in breast carcinoma.	Clinical cancer research 	2009	59
19204205	Progesterone	Hugh J	Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial.	Journal of clinical oncology 	2009	111
19317994	Progesterone	Gnerlich JL	Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease.	Journal of the American College of Surgeons	2009	69
19318481	Progesterone	Rakha EA	Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes.	Clinical cancer research 	2009	132
19320967	Progesterone	Stead LA	Triple-negative breast cancers are increased in black women regardless of age or body mass index.	Breast cancer research 	2009	81
19380449	Progesterone	Baselga J	Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer.	Journal of clinical oncology 	2009	148
19380452	Progesterone	Penault-Llorca F	Ki67 expression and docetaxel efficacy in patients with estrogen receptor-positive breast cancer.	Journal of clinical oncology 	2009	50
19385968	Progesterone	Morimoto K	Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression.	Cancer science	2009	59
19411448	Progesterone	Witkiewicz AK	An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers.	The American journal of pathology	2009	116
19436038	Progesterone	Cheang MC	Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.	Journal of the National Cancer Institute	2009	447
19440038	Progesterone	Liu B	Metformin induces unique biological and molecular responses in triple negative breast cancer cells.	Cell cycle	2009	123
19567422	Progesterone	Milne RL	Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042.	Journal of the National Cancer Institute	2009	52
19574486	Progesterone	Onitilo AA	Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival.	Clinical medicine & research	2009	165
19596646	Progesterone	Anders CK	Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer.	Clinical breast cancer	2009	118
19596702	Progesterone	Liedtke C	Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer.	Annals of oncology 	2009	71
19638585	Progesterone	Peters AA	Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer.	Cancer research	2009	79
19664291	Progesterone	Fehm T	Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells.	Breast cancer research 	2009	61
19687332	Progesterone	Ellard SL	Randomized phase II study comparing two schedules of everolimus in patients with recurrent/metastatic breast cancer: NCIC Clinical Trials Group IND.163.	Journal of clinical oncology 	2009	60
19764994	Progesterone	Parise CA	Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.	The breast journal	2009	73
19775602	Progesterone	Dawson SJ	Triple negative breast cancers: clinical and prognostic implications.	European journal of cancer	2009	61
19826037	Progesterone	Maillot G	Widespread estrogen-dependent repression of micrornas involved in breast tumor cell growth.	Cancer research	2009	92
19858088	Progesterone	Aitken SJ	Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases.	Annals of oncology 	2010	43
19887463	Progesterone	Park S	Expression of androgen receptors in primary breast cancer.	Annals of oncology 	2010	71
19898421	Progesterone	Niemeier LA	Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation.	Modern pathology 	2010	81
19994911	Progesterone	Giskeødegård GF	Multivariate modeling and prediction of breast cancer prognostic factors using MR metabolomics.	Journal of proteome research	2010	43
20060649	Progesterone	Bosch A	Triple-negative breast cancer: molecular features, pathogenesis, treatment and current lines of research.	Cancer treatment reviews	2010	62
20082448	Progesterone	Rimawi MF	Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes.	Cancer	2010	52
20104427	Progesterone	Bulun SE	Estrogen receptor-beta, estrogen receptor-alpha, and progesterone resistance in endometriosis.	Seminars in reproductive medicine	2010	48
20179196	Progesterone	Turner N	FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer.	Cancer research	2010	139
20194857	Progesterone	Voduc KD	Breast cancer subtypes and the risk of local and regional relapse.	Journal of clinical oncology 	2010	247
20332136	Progesterone	Cancello G	Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer.	Annals of oncology 	2010	41
20404251	Progesterone	Hammond ME	American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.	Journal of clinical oncology 	2010	560
20427430	Progesterone	Kerlikowske K	Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis.	Journal of the National Cancer Institute	2010	84
20537966	Progesterone	Podo F	Triple-negative breast cancer: present challenges and new perspectives.	Molecular oncology	2010	70
20569503	Progesterone	Creighton CJ	Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer.	Breast cancer research 	2010	78
20586616	Progesterone	Hammond ME	American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version).	Archives of pathology & laboratory medicine	2010	150
20629078	Progesterone	Stark A	African ancestry and higher prevalence of triple-negative breast cancer: findings from an international study.	Cancer	2010	54
20647302	Progesterone	Weigel MT	Current and emerging biomarkers in breast cancer: prognosis and prediction.	Endocrine-related cancer	2010	99
20663194	Progesterone	Tuominen VJ	ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67.	Breast cancer research 	2010	142
20664514	Progesterone	Ismail-Khan R	A review of triple-negative breast cancer.	Cancer control 	2010	42
20665103	Progesterone	Kabos P	Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers.	Breast cancer research and treatment	2011	45
20679727	Progesterone	Jiang Z	Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status.	The Journal of clinical investigation	2010	58
20798217	Progesterone	Hastak K	Synergistic chemosensitivity of triple-negative breast cancer cell lines to poly(ADP-Ribose) polymerase inhibition, gemcitabine, and cisplatin.	Cancer research	2010	47
20837693	Progesterone	Nielsen TO	A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer.	Clinical cancer research 	2010	187
20861225	Progesterone	Toft DJ	Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies.	Molecular endocrinology	2011	40
20863372	Progesterone	Hoefnagel LD	Receptor conversion in distant breast cancer metastases.	Breast cancer research 	2010	52
20881962	Progesterone	Schramek D	Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer.	Nature	2010	138
20946665	Progesterone	Yau C	A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer.	Breast cancer research 	2010	52
21057787	Progesterone	Groheux D	Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer.	European journal of nuclear medicine and molecular imaging	2011	41
21059212	Progesterone	Thompson AM	Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS).	Breast cancer research 	2010	63
21067385	Progesterone	Foulkes WD	Triple-negative breast cancer.	The New England journal of medicine	2010	625
21191117	Progesterone	Yang XR	Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies.	Journal of the National Cancer Institute	2011	223
21278435	Progesterone	Hudis CA	Triple-negative breast cancer: an unmet medical need.	The oncologist	2011	171
21324165	Progesterone	Soini Y	Transcription factors zeb1, twist and snai1 in breast carcinoma.	BMC cancer	2011	37
21356373	Progesterone	Conklin MW	Aligned collagen is a prognostic signature for survival in human breast carcinoma.	The American journal of pathology	2011	217
21363912	Progesterone	Hill VK	Genome-wide DNA methylation profiling of CpG islands in breast cancer identifies novel genes associated with tumorigenicity.	Cancer research	2011	47
21369698	Progesterone	Catchpole S	PLU-1/JARID1B/KDM5B is required for embryonic survival and contributes to cell proliferation in the mammary gland and in ER+ breast cancer cells.	International journal of oncology	2011	45
21387260	Progesterone	Lara-Medina F	Triple-negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity.	Cancer	2011	47
21472708	Progesterone	Anders CK	The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases.	Cancer	2011	35
21483002	Progesterone	Mahmoud SM	Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer.	Journal of clinical oncology 	2011	287
21490305	Progesterone	Gonzalez-Angulo AM	PI3K pathway mutations and PTEN levels in primary and metastatic breast cancer.	Molecular cancer therapeutics	2011	76
21502402	Progesterone	Hong J	Phosphorylation of serine 68 of Twist1 by MAPKs stabilizes Twist1 protein and promotes breast cancer cell invasiveness.	Cancer research	2011	62
21552212	Progesterone	Collins LC	Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study.	Modern pathology 	2011	49
21605893	Progesterone	Aktas B	Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients.	Gynecologic oncology	2011	37
21670451	Progesterone	Abdulkarim BS	Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy.	Journal of clinical oncology 	2011	57
21677874	Progesterone	Davison Z	Insulin-like growth factor-dependent proliferation and survival of triple-negative breast cancer cells: implications for therapy.	Neoplasia	2011	50
21795664	Progesterone	Yaghjyan L	Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics.	Journal of the National Cancer Institute	2011	50
21802721	Progesterone	Early Breast Cancer Trialists' Collaborative Group (EBCTCG).	Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.	Lancet	2011	412
21825015	Progesterone	Fackler MJ	Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence.	Cancer research	2011	72
21830014	Progesterone	Tamimi RM	Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer.	Breast cancer research and treatment	2012	59
21846820	Progesterone	Palmer JR	Parity and lactation in relation to estrogen receptor negative breast cancer in African American women.	Cancer epidemiology, biomarkers & prevention 	2011	57
21852249	Progesterone	Figueroa JD	Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium.	Human molecular genetics	2011	41
21859480	Progesterone	Li J	A nation-wide multicenter 10-year (1999-2008) retrospective clinical epidemiological study of female breast cancer in China.	BMC cancer	2011	50
21870331	Progesterone	Pinheiro C	GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression.	Histology and histopathology	2011	52
21900114	Progesterone	Arvold ND	Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy.	Journal of clinical oncology 	2011	67
21914172	Progesterone	Sihto H	Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study.	Breast cancer research 	2011	50
21969591	Progesterone	Haughian JM	Maintenance of hormone responsiveness in luminal breast cancers by suppression of Notch.	Proceedings of the National Academy of Sciences of the United States of America	2012	42
22028449	Progesterone	Hammes SR	Minireview: Recent advances in extranuclear steroid receptor actions.	Endocrinology	2011	50
22031096	Progesterone	Dougall WC	Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis.	Clinical cancer research 	2012	48
22144499	Progesterone	Mavaddat N	Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).	Cancer epidemiology, biomarkers & prevention 	2012	80
22178456	Progesterone	Amir E	Tissue confirmation of disease recurrence in breast cancer patients: pooled analysis of multi-centre, multi-disciplinary prospective studies.	Cancer treatment reviews	2012	35
22189713	Progesterone	Deng XS	Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers.	Cell cycle	2012	51
22264274	Progesterone	Chan SR	STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas.	Breast cancer research 	2012	56
22270867	Progesterone	Krzeslak A	Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers.	Pathology oncology research 	2012	39
22331459	Progesterone	Stevens KN	19p13.1 is a triple-negative-specific breast cancer susceptibility locus.	Cancer research	2012	50
22367781	Progesterone	Rao R	Combination of pan-histone deacetylase inhibitor and autophagy inhibitor exerts superior efficacy against triple-negative human breast cancer cells.	Molecular cancer therapeutics	2012	40
22496457	Progesterone	Palafox M	RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis.	Cancer research	2012	44
22544643	Progesterone	Lin NU	Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network.	Cancer	2012	64
22562122	Progesterone	Niraula S	Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis.	Breast cancer research and treatment	2012	36
22613095	Progesterone	Tate CR	Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat.	Breast cancer research 	2012	55
22614657	Progesterone	Hartman AR	Prevalence of BRCA mutations in an unselected population of triple-negative breast cancer.	Cancer	2012	40
22677156	Progesterone	Lucci A	Circulating tumour cells in non-metastatic breast cancer: a prospective study.	The Lancet. Oncology	2012	103
22689798	Progesterone	Chlebowski RT	Diabetes, metformin, and breast cancer in postmenopausal women.	Journal of clinical oncology 	2012	49
22698676	Progesterone	Mercier I	Caveolin-1 and accelerated host aging in the breast tumor microenvironment: chemoprevention with rapamycin, an mTOR inhibitor and anti-aging drug.	The American journal of pathology	2012	68
22711706	Progesterone	Chia SK	A 50-gene intrinsic subtype classifier for prognosis and prediction of benefit from adjuvant tamoxifen.	Clinical cancer research 	2012	55
22751119	Progesterone	Cittelly DM	Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4.	Oncogene	2013	41
22773826	Progesterone	Clarke CA	Age-specific incidence of breast cancer subtypes: understanding the black-white crossover.	Journal of the National Cancer Institute	2012	61
22817698	Progesterone	Byrski T	Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer.	Breast cancer research 	2012	41
22821401	Progesterone	Kabos P	Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures.	Breast cancer research and treatment	2012	40
22824040	Progesterone	Medrek C	The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients.	BMC cancer	2012	113
22847191	Progesterone	Liu Y	MicroRNA-10b targets E-cadherin and modulates breast cancer metastasis.	Medical science monitor 	2012	35
22878371	Progesterone	Mohammed ZM	The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer.	British journal of cancer	2012	33
23035882	Progesterone	Bastien RR	PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers.	BMC medical genomics	2012	75
23088337	Progesterone	Franken B	Circulating tumor cells, disease recurrence and survival in newly diagnosed breast cancer.	Breast cancer research 	2012	36
23139210	Progesterone	McCleland ML	An integrated genomic screen identifies LDHB as an essential gene for triple-negative breast cancer.	Cancer research	2012	33
23171949	Progesterone	Craig DW	Genome and transcriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnerabilities.	Molecular cancer therapeutics	2013	56
23233704	Progesterone	Prat A	Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer.	Journal of clinical oncology 	2013	98
23242585	Progesterone	Ma CX	A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer.	Breast cancer research and treatment	2013	29
23251644	Progesterone	Budczies J	Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization.	PloS one	2012	159
23303565	Progesterone	Kim JJ	Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer.	Endocrine reviews	2013	86
23319610	Progesterone	Ferraro DA	Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR.	Proceedings of the National Academy of Sciences of the United States of America	2013	33
23354099	Progesterone	Huijbregts RP	Hormonal contraception and HIV-1 infection: medroxyprogesterone acetate suppresses innate and adaptive immune mechanisms.	Endocrinology	2013	33
23358903	Progesterone	Bayraktar S	Molecularly targeted therapies for metastatic triple-negative breast cancer.	Breast cancer research and treatment	2013	35
23412770	Progesterone	Karihtala P	Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype.	Breast cancer research and treatment	2013	27
23436342	Progesterone	De Los Santos JF	Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017.	Cancer	2013	27
23436929	Progesterone	O'Toole SA	Therapeutic targets in triple negative breast cancer.	Journal of clinical pathology	2013	42
23629941	Progesterone	Pellatt AJ	Telomere length, telomere-related genes, and breast cancer risk: the breast cancer health disparities study.	Genes, chromosomes & cancer	2013	33
23737486	Progesterone	Zhang X	A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models.	Cancer research	2013	94
23748853	Progesterone	Eichelser C	Deregulated serum concentrations of circulating cell-free microRNAs miR-17, miR-34a, miR-155, and miR-373 in human breast cancer development and progression.	Clinical chemistry	2013	41
23845225	Progesterone	Sieh W	Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study.	The Lancet. Oncology	2013	66
23902874	Progesterone	Johnston SR	Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial.	The Lancet. Oncology	2013	34
23920327	Progesterone	Engebraaten O	Triple-negative breast cancer and the need for new therapeutic targets.	The American journal of pathology	2013	34
23929266	Progesterone	Thike AA	Loss of androgen receptor expression predicts early recurrence in triple-negative and basal-like breast cancer.	Modern pathology 	2014	22
23939688	Progesterone	Piva R	From microRNA functions to microRNA therapeutics: novel targets and novel drugs in breast cancer research and treatment (Review).	International journal of oncology	2013	31
23965901	Progesterone	Gucalp A	Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast Cancer.	Clinical cancer research 	2013	104
23993780	Progesterone	Rivenbark AG	Molecular and cellular heterogeneity in breast cancer: challenges for personalized medicine.	The American journal of pathology	2013	31
24188089	Progesterone	Bertrand KA	Mammographic density and risk of breast cancer by age and tumor characteristics.	Breast cancer research 	2013	34
24188694	Progesterone	Bilir B	Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells.	Journal of translational medicine	2013	29
24265601	Progesterone	Jones A	Role of DNA methylation and epigenetic silencing of HAND2 in endometrial cancer development.	PLoS medicine	2013	27
24269135	Progesterone	Aurilio G	A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases.	European journal of cancer	2014	30
24353241	Progesterone	Park SH	Correlations between apparent diffusion coefficient values of invasive ductal carcinoma and pathologic factors on diffusion-weighted MRI at 3.0 Tesla.	Journal of magnetic resonance imaging 	2015	17
24439313	Progesterone	Aebi S	Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial.	The Lancet. Oncology	2014	23
24463450	Progesterone	Santagata S	Taxonomy of breast cancer based on normal cell phenotype predicts outcome.	The Journal of clinical investigation	2014	60
24469035	Progesterone	Daniel AR	Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes.	Oncogene	2015	32
24477977	Progesterone	Anderson KN	Reproductive risk factors and breast cancer subtypes: a review of the literature.	Breast cancer research and treatment	2014	57
24521995	Progesterone	Sweeney C	Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics.	Cancer epidemiology, biomarkers & prevention 	2014	30
24569463	Progesterone	Yoshida T	Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.	British journal of cancer	2014	48
24603652	Progesterone	Dyson MT	Genome-wide DNA methylation analysis predicts an epigenetic switch for GATA factor expression in endometriosis.	PLoS genetics	2014	24
24670641	Progesterone	Chen X	XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway.	Nature	2014	137
24721646	Progesterone	Chittaranjan S	Autophagy inhibition augments the anticancer effects of epirubicin treatment in anthracycline-sensitive and -resistant triple-negative breast cancer.	Clinical cancer research 	2014	24
24722644	Progesterone	Soussan M	Relationship between tumor heterogeneity measured on FDG-PET/CT and pathological prognostic factors in invasive breast cancer.	PloS one	2014	33
24799465	Progesterone	Giordano SH	Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline.	Journal of clinical oncology 	2014	52
24967588	Progesterone	Ferrari N	Expression of RUNX1 correlates with poor patient prognosis in triple negative breast cancer.	PloS one	2014	23
25173780	Progesterone	van Waarde A	Potential applications for sigma receptor ligands in cancer diagnosis and therapy.	Biochimica et biophysica acta	2015	16
25277734	Progesterone	Sabatier R	Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization.	Molecular cancer	2014	20
25333260	Progesterone	Eichelser C	Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients.	Oncotarget	2014	40
25495193	Progesterone	Cao MD	Metabolic characterization of triple negative breast cancer.	BMC cancer	2014	26
25663687	Progesterone	Nyante SJ	Prognostic significance of mammographic density change after initiation of tamoxifen for ER-positive breast cancer.	Journal of the National Cancer Institute	2015	16
25682074	Progesterone	Wong-Brown MW	Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer.	Breast cancer research and treatment	2015	18
25707740	Progesterone	Fournier T	Review: hCGs: different sources of production, different glycoforms and functions.	Placenta	2015	17
25726524	Progesterone	Rincón R	PP2A inhibition determines poor outcome and doxorubicin resistance in early breast cancer and its activation shows promising therapeutic effects.	Oncotarget	2015	18
25740979	Progesterone	Goodwin PJ	Effect of metformin vs placebo on and metabolic factors in NCIC CTG MA.32.	Journal of the National Cancer Institute	2015	17
25762479	Progesterone	Abduljabbar R	Clinical and biological significance of glucocorticoid receptor (GR) expression in breast cancer.	Breast cancer research and treatment	2015	19
25847929	Progesterone	Telli ML	Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105.	Journal of clinical oncology 	2015	35
25895611	Progesterone	Zardavas D	Clinical management of breast cancer heterogeneity.	Nature reviews. Clinical oncology	2015	44
25922306	Progesterone	Yang Q	The Mechanism and Function of Epigenetics in Uterine Leiomyoma Development.	Reproductive sciences	2016	15
26040322	Progesterone	Huo CW	High mammographic density is associated with an increase in stromal collagen and immune cells within the mammary epithelium.	Breast cancer research 	2015	24
26045046	Progesterone	Goodwin CM	Myeloid cell leukemia-1 is an important apoptotic survival factor in triple-negative breast cancer.	Cell death and differentiation	2015	25
26053034	Progesterone	Hait NC	The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer.	Oncogenesis	2015	23
26153859	Progesterone	Mohammed H	Progesterone receptor modulates ERα action in breast cancer.	Nature	2015	78
26181262	Progesterone	Santa-Maria CA	Changing Treatment Paradigms in Metastatic Breast Cancer: Lessons Learned.	JAMA oncology	2015	17
26195705	Progesterone	Van Poznak C	Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline.	Journal of clinical oncology 	2015	37
26201402	Progesterone	Barton VN	Androgen Receptor Biology in Triple Negative Breast Cancer: a Case for Classification as AR+ or Quadruple Negative Disease.	Hormones & cancer	2015	17
26211827	Progesterone	Early Breast Cancer Trialists' Collaborative Group (EBCTCG).	Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.	Lancet	2015	65
26227106	Progesterone	Leventhal JR	Nonchimeric HLA-Identical Renal Transplant Tolerance: Regulatory Immunophenotypic/Genomic Biomarkers.	American journal of transplantation 	2016	11
26266985	Progesterone	Van Keymeulen A	Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity.	Nature	2015	51
26341644	Progesterone	Kumar P	An overview of triple-negative breast cancer.	Archives of gynecology and obstetrics	2016	19
26563128	Progesterone	Ma CX	A Phase I Trial of BKM120 (Buparlisib) in Combination with Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive Metastatic Breast Cancer.	Clinical cancer research 	2016	17
26617202	Progesterone	Takashima T	Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial.	The Lancet. Oncology	2016	11
26683709	Progesterone	Jiang T	Prognostic value of high EZH2 expression in patients with different types of cancer: a systematic review with meta-analysis.	Oncotarget	2016	14
26765445	Progesterone	Dai ZJ	Association Between Single Nucleotide Polymorphisms in DNA Polymerase Kappa Gene and Breast Cancer Risk in Chinese Han Population: A STROBE-Compliant Observational Study.	Medicine	2016	11
26769139	Progesterone	Thompson E	The immune microenvironment of breast ductal carcinoma in situ.	Modern pathology 	2016	13
26822398	Progesterone	Harbeck N	Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): an open-label, randomised, phase 3 trial.	The Lancet. Oncology	2016	12
26855592	Progesterone	Xu H	Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosis.	OncoTargets and therapy	2016	15
26858339	Progesterone	Harris LN	Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline.	Journal of clinical oncology 	2016	73
26868521	Progesterone	Kasimir-Bauer S	Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy.	Breast cancer research 	2016	16
26874901	Progesterone	Chan A	Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.	The Lancet. Oncology	2016	26
26909695	Progesterone	Rostami R	Brain metastasis in breast cancer: a comprehensive literature review.	Journal of neuro-oncology	2016	13
26926676	Progesterone	Gluz O	West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment.	Journal of clinical oncology 	2016	21
27052658	Progesterone	Bonnefoi H	A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1).	Annals of oncology 	2016	12
27144536	Progesterone	Li H	MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays.	Radiology	2016	20
27171498	Progesterone	Chen X	Suppression of SPIN1-mediated PI3K-Akt pathway by miR-489 increases chemosensitivity in breast cancer.	The Journal of pathology	2016	12
27179402	Progesterone	Gianni L	5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial.	The Lancet. Oncology	2016	21
27191888	Progesterone	Huang NS	Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 (MALAT1) interacts with estrogen receptor and predicted poor survival in breast cancer.	Oncotarget	2016	17
27322743	Progesterone	Nolan E	RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers.	Nature medicine	2016	23
27388585	Progesterone	Millis SZ	Landscape of Phosphatidylinositol-3-Kinase Pathway Alterations Across 19 784 Diverse Solid Tumors.	JAMA oncology	2016	15
27725895	Progesterone	Hon JD	Breast cancer molecular subtypes: from TNBC to QNBC.	American journal of cancer research	2016	11
27765921	Progesterone	Yao H	Triple-negative breast cancer: is there a treatment on the horizon?	Oncotarget	2017	8
27908454	Progesterone	Robertson JFR	Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial.	Lancet	2016	16
27935867	Progesterone	Vázquez R	The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus.	Oncotarget	2017	5
27974799	Progesterone	Hosseini H	Early dissemination seeds metastasis in breast cancer.	Nature	2016	34
28030809	Progesterone	McDaniel JM	Genomic regulation of invasion by STAT3 in triple negative breast cancer.	Oncotarget	2017	6
28052940	Progesterone	Busch EL	Endometrial Cancer Risk Factors, Hormone Receptors, and Mortality Prediction.	Cancer epidemiology, biomarkers & prevention 	2017	6
28108260	Progesterone	Maiti A	Metastatic triple-negative breast cancer is dependent on SphKs/S1P signaling for growth and survival.	Cellular signalling	2017	11
28108967	Progesterone	Inoue M	Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer.	Breast cancer	2017	5
28259011	Progesterone	Duffy MJ	Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM).	European journal of cancer	2017	12
28356971	Progesterone	Luo Y	Elevated microRNA-125b levels predict a worse prognosis in HER2-positive breast cancer patients.	Oncology letters	2017	5
28412963	Progesterone	Knutson TP	Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs.	Journal of hematology & oncology	2017	6
14504078	Trimethylamine	Hans CP	Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.	Blood	2004	543
19001334	Trimethylamine	Chia S	Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers.	Journal of clinical oncology 	2008	57
22611154	Trimethylamine	Fuchs TA	Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies.	Blood	2012	35
22919003	Trimethylamine	Davies KD	Identifying and targeting ROS1 gene fusions in non-small cell lung cancer.	Clinical cancer research 	2012	77
23018874	Trimethylamine	Yoshimoto M	PTEN losses exhibit heterogeneity in multifocal prostatic adenocarcinoma and are associated with higher Gleason grade.	Modern pathology 	2013	25
24217091	Trimethylamine	Velcheti V	Programmed death ligand-1 expression in non-small cell lung cancer.	Laboratory investigation; a journal of technical methods and pathology	2014	175
26584136	Trimethylamine	Collins HL	L-Carnitine intake and high trimethylamine N-oxide plasma levels correlate with low aortic lesions in ApoE(-/-) transgenic mice expressing CETP.	Atherosclerosis	2016	13
8617770	Ceramide (d18:1/12:0)	Chinnaiyan AM	FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis.	The Journal of biological chemistry	1996	112
8706124	Ceramide (d18:1/12:0)	Santana P	Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis.	Cell	1996	121
8968075	Ceramide (d18:1/12:0)	Hakomori S	Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.	Cancer research	1996	174
9271409	Ceramide (d18:1/12:0)	Mosser DD	Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis.	Molecular and cellular biology	1997	140
11595837	Ceramide (d18:1/12:0)	Mandlekar S	Mechanisms of tamoxifen-induced apoptosis.	Apoptosis 	2001	89
11801602	Ceramide (d18:1/12:0)	Chalfant CE	De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1.	The Journal of biological chemistry	2002	92
14755730	Ceramide (d18:1/12:0)	Haughey NJ	Perturbation of sphingolipid metabolism and ceramide production in HIV-dementia.	Annals of neurology	2004	92
14970312	Ceramide (d18:1/12:0)	Cutler RG	Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease.	Proceedings of the National Academy of Sciences of the United States of America	2004	223
15205343	Ceramide (d18:1/12:0)	Daido S	Pivotal role of the cell death factor BNIP3 in ceramide-induced autophagic cell death in malignant glioma cells.	Cancer research	2004	112
15469822	Ceramide (d18:1/12:0)	Szabadkai G	Drp-1-dependent division of the mitochondrial network blocks intraorganellar Ca2+ waves and protects against Ca2+-mediated apoptosis.	Molecular cell	2004	135
16415355	Ceramide (d18:1/12:0)	Lavieu G	Regulation of autophagy by sphingosine kinase 1 and its role in cell survival during nutrient starvation.	The Journal of biological chemistry	2006	82
16571143	Ceramide (d18:1/12:0)	Demedts IK	Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema.	Respiratory research	2006	108
16616335	Ceramide (d18:1/12:0)	Carracedo A	The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells.	Cancer cell	2006	75
16818650	Ceramide (d18:1/12:0)	Carracedo A	Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes.	Cancer research	2006	64
17090686	Ceramide (d18:1/12:0)	Oskouian B	Sphingosine-1-phosphate lyase potentiates apoptosis via p53- and p38-dependent pathways and is down-regulated in colon cancer.	Proceedings of the National Academy of Sciences of the United States of America	2006	76
17303574	Ceramide (d18:1/12:0)	Baran Y	Alterations of ceramide/sphingosine 1-phosphate rheostat involved in the regulation of resistance to imatinib-induced apoptosis in K562 human chronic myeloid leukemia cells.	The Journal of biological chemistry	2007	58
17620421	Ceramide (d18:1/12:0)	Kolak M	Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity.	Diabetes	2007	79
18058224	Ceramide (d18:1/12:0)	Ruckhäberle E	Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer.	Breast cancer research and treatment	2008	95
18166162	Ceramide (d18:1/12:0)	Patra SK	Dissecting lipid raft facilitated cell signaling pathways in cancer.	Biochimica et biophysica acta	2008	89
19029119	Ceramide (d18:1/12:0)	Pattingre S	Role of JNK1-dependent Bcl-2 phosphorylation in ceramide-induced macroautophagy.	The Journal of biological chemistry	2009	89
19217411	Ceramide (d18:1/12:0)	Roy SS	Bad targets the permeability transition pore independent of Bax or Bak to switch between Ca2+-dependent cell survival and death.	Molecular cell	2009	52
19425170	Ceramide (d18:1/12:0)	Salazar M	Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells.	The Journal of clinical investigation	2009	173
19608407	Ceramide (d18:1/12:0)	Lopez PH	Gangliosides in cell recognition and membrane protein regulation.	Current opinion in structural biology	2009	62
19723703	Ceramide (d18:1/12:0)	Senkal CE	Antiapoptotic roles of ceramide-synthase-6-generated C16-ceramide via selective regulation of the ATF6/CHOP arm of ER-stress-response pathways.	FASEB journal 	2010	88
19777393	Ceramide (d18:1/12:0)	de la Monte SM	Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.	Current opinion in investigational drugs	2009	47
20061445	Ceramide (d18:1/12:0)	French KJ	Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2.	The Journal of pharmacology and experimental therapeutics	2010	94
20530211	Ceramide (d18:1/12:0)	Tam C	Exocytosis of acid sphingomyelinase by wounded cells promotes endocytosis and plasma membrane repair.	The Journal of cell biology	2010	84
20712405	Ceramide (d18:1/12:0)	Tanida I	Autophagosome formation and molecular mechanism of autophagy.	Antioxidants & redox signaling	2011	111
20861373	Ceramide (d18:1/12:0)	Jana A	Fibrillar amyloid-beta-activated human astroglia kill primary human neurons via neutral sphingomyelinase: implications for Alzheimer's disease.	The Journal of neuroscience 	2010	48
21994399	Ceramide (d18:1/12:0)	Geekiyanage H	MicroRNA-137/181c regulates serine palmitoyltransferase and in turn amyloid β, novel targets in sporadic Alzheimer's disease.	The Journal of neuroscience 	2011	59
22258513	Ceramide (d18:1/12:0)	Filippov V	Increased ceramide in brains with Alzheimer's and other neurodegenerative diseases.	Journal of Alzheimer's disease 	2012	33
22532571	Ceramide (d18:1/12:0)	Wang G	Astrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4): potential mechanism of apoptosis induction in Alzheimer disease (AD).	The Journal of biological chemistry	2012	73
22577490	Ceramide (d18:1/12:0)	Longato L	Insulin resistance, ceramide accumulation, and endoplasmic reticulum stress in human chronic alcohol-related liver disease.	Oxidative medicine and cellular longevity	2012	36
22619219	Ceramide (d18:1/12:0)	Takahashi T	Role of sulfatide in normal and pathological cells and tissues.	Journal of lipid research	2012	37
23180565	Ceramide (d18:1/12:0)	Saddoughi SA	Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis.	EMBO molecular medicine	2013	75
23290776	Ceramide (d18:1/12:0)	Saddoughi SA	Diverse functions of ceramide in cancer cell death and proliferation.	Advances in cancer research	2013	32
23290781	Ceramide (d18:1/12:0)	Heffernan-Stroud LA	Sphingosine kinase 1 in cancer.	Advances in cancer research	2013	29
23332916	Ceramide (d18:1/12:0)	Martin E	Loss of function of glucocerebrosidase GBA2 is responsible for motor neuron defects in hereditary spastic paraplegia.	American journal of human genetics	2013	32
23550081	Ceramide (d18:1/12:0)	Hocking S	Adiposity and insulin resistance in humans: the role of the different tissue and cellular lipid depots.	Endocrine reviews	2013	33
23615526	Ceramide (d18:1/12:0)	Schneider G	Bioactive lipids S1P and C1P are prometastatic factors in human rhabdomyosarcoma, and their tissue levels increase in response to radio/chemotherapy.	Molecular cancer research 	2013	25
23638983	Ceramide (d18:1/12:0)	Neubauer HA	Roles, regulation and inhibitors of sphingosine kinase 2.	The FEBS journal	2013	40
23926298	Ceramide (d18:1/12:0)	Oaks JJ	Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies.	Blood	2013	31
24091326	Ceramide (d18:1/12:0)	Cheng JC	Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse.	The Journal of clinical investigation	2013	29
24092747	Ceramide (d18:1/12:0)	Camont L	Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities.	Arteriosclerosis, thrombosis, and vascular biology	2013	36
24477431	Ceramide (d18:1/12:0)	Murphy KE	Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease.	Brain 	2014	69
24632610	Ceramide (d18:1/12:0)	Edmond V	Downregulation of ceramide synthase-6 during epithelial-to-mesenchymal transition reduces plasma membrane fluidity and cancer cell motility.	Oncogene	2015	16
25295788	Ceramide (d18:1/12:0)	Turpin SM	Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance.	Cell metabolism	2014	80
25303541	Ceramide (d18:1/12:0)	Booth L	PDE5 inhibitors enhance celecoxib killing in multiple tumor types.	Journal of cellular physiology	2015	17
26071354	Ceramide (d18:1/12:0)	Chen MB	MicroRNA-101 down-regulates sphingosine kinase 1 in colorectal cancer cells.	Biochemical and biophysical research communications	2015	28
26621917	Ceramide (d18:1/12:0)	Kakazu E	Hepatocytes release ceramide-enriched pro-inflammatory extracellular vesicles in an IRE1α-dependent manner.	Journal of lipid research	2016	18
26625315	Ceramide (d18:1/12:0)	Ramos-Torres Á	The pepper's natural ingredient capsaicin induces autophagy blockage in prostate cancer cells.	Oncotarget	2016	11
26670557	Ceramide (d18:1/12:0)	Jiang C	Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction.	Nature communications	2015	37
26676316	Ceramide (d18:1/12:0)	Chakravarthy H	Role of Acid Sphingomyelinase in Shifting the Balance Between Proinflammatory and Reparative Bone Marrow Cells in Diabetic Retinopathy.	Stem cells	2016	10
26780287	Ceramide (d18:1/12:0)	Luukkonen PK	Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease.	Journal of hepatology	2016	20
27771292	Ceramide (d18:1/12:0)	Coant N	Ceramidases, roles in sphingolipid metabolism and in health and disease.	Advances in biological regulation	2017	6
28009749	Ceramide (d18:1/12:0)	Hoehn RS	Acid Sphingomyelinase Inhibition in Stored Erythrocytes Reduces Transfusion-Associated Lung Inflammation.	Annals of surgery	2017	9
11389051	Dihydrotestosterone	Gregory CW	A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy.	Cancer research	2001	158
14760063	Dihydrotestosterone	Mohler JL	The androgen axis in recurrent prostate cancer.	Clinical cancer research 	2004	217
18676866	Dihydrotestosterone	Locke JA	Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer.	Cancer research	2008	226
19289629	Dihydrotestosterone	Mendiratta P	Genomic strategy for targeting therapy in castration-resistant prostate cancer.	Journal of clinical oncology 	2009	44
19901020	Dihydrotestosterone	Zhu ML	Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells.	FASEB journal 	2010	64
20086173	Dihydrotestosterone	Hofland J	Evidence of limited contributions for intratumoral steroidogenesis in prostate cancer.	Cancer research	2010	58
20945501	Dihydrotestosterone	Waltering KK	Androgen regulation of micro-RNAs in prostate cancer.	The Prostate	2011	47
21620560	Dihydrotestosterone	Nicholson TM	Androgens and estrogens in benign prostatic hyperplasia: past, present and future.	Differentiation; research in biological diversity	2011	45
23704919	Dihydrotestosterone	Gao L	Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulation.	PloS one	2013	35
23993097	Dihydrotestosterone	Chang KH	A gain-of-function mutation in DHT synthesis in castration-resistant prostate cancer.	Cell	2013	80
24451109	Dihydrotestosterone	Cochrane DR	Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide.	Breast cancer research 	2014	60
25311217	Dihydrotestosterone	Taplin ME	Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant study.	Journal of clinical oncology 	2014	32
25512207	Dihydrotestosterone	Azad AA	Targeting heat shock proteins in metastatic castration-resistant prostate cancer.	Nature reviews. Urology	2015	17
26030522	Dihydrotestosterone	Li Z	Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer.	Nature	2015	44
26342199	Dihydrotestosterone	Kawahara T	ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression.	Oncotarget	2015	18
27893717	Dihydrotestosterone	Feng J	Androgen and AR contribute to breast cancer development and metastasis: an insight of mechanisms.	Oncogene	2017	6
10329646	L-Leucine	Inohara N	Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB.	The Journal of biological chemistry	1999	149
10531035	L-Leucine	Cenciarelli C	Identification of a family of human F-box proteins.	Current biology 	1999	112
10880512	L-Leucine	Inohara N	An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways.	The Journal of biological chemistry	2000	134
11058605	L-Leucine	Inohara N	Human Nod1 confers responsiveness to bacterial lipopolysaccharides.	The Journal of biological chemistry	2001	92
11087742	L-Leucine	Ogura Y	Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB.	The Journal of biological chemistry	2001	294
11120765	L-Leucine	Chatila TA	JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome.	The Journal of clinical investigation	2000	199
11292372	L-Leucine	Knudson CB	Cartilage proteoglycans.	Seminars in cell & developmental biology	2001	91
11991887	L-Leucine	Thomas AQ	Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred.	American journal of respiratory and critical care medicine	2002	155
12078479	L-Leucine	Rock KL	Protein degradation and the generation of MHC class I-presented peptides.	Advances in immunology	2002	89
12102052	L-Leucine	Corsi A	Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues.	Journal of bone and mineral research 	2002	92
12721295	L-Leucine	Sreenath T	Dentin sialophosphoprotein knockout mouse teeth display widened predentin zone and develop defective dentin mineralization similar to human dentinogenesis imperfecta type III.	The Journal of biological chemistry	2003	117
12766759	L-Leucine	Inohara N	NODs: intracellular proteins involved in inflammation and apoptosis.	Nature reviews. Immunology	2003	203
12789278	L-Leucine	Widlund HR	Microphthalamia-associated transcription factor: a critical regulator of pigment cell development and survival.	Oncogene	2003	79
14559776	L-Leucine	Burnett B	The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity.	Human molecular genetics	2003	100
14560001	L-Leucine	Pauleau AL	Role of nod2 in the response of macrophages to toll-like receptor agonists.	Molecular and cellular biology	2003	76
15044951	L-Leucine	Tanabe T	Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition.	The EMBO journal	2004	95
15541309	L-Leucine	Zimprich A	Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.	Neuron	2004	622
15680457	L-Leucine	Gilks WP	A common LRRK2 mutation in idiopathic Parkinson's disease.	Lancet	2005	161
15952891	L-Leucine	Inohara	NOD-LRR proteins: role in host-microbial interactions and inflammatory disease.	Annual review of biochemistry	2005	253
16011459	L-Leucine	Kilberg MS	Nutritional control of gene expression: how mammalian cells respond to amino acid limitation.	Annual review of nutrition	2005	70
16321986	L-Leucine	Gloeckner CJ	The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity.	Human molecular genetics	2006	136
16352719	L-Leucine	Smith WW	Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration.	Proceedings of the National Academy of Sciences of the United States of America	2005	120
16407133	L-Leucine	Satou Y	HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells.	Proceedings of the National Academy of Sciences of the United States of America	2006	191
16437584	L-Leucine	Giasson BI	Biochemical and pathological characterization of Lrrk2.	Annals of neurology	2006	68
16510280	L-Leucine	Strieter RM	Cancer CXC chemokine networks and tumour angiogenesis.	European journal of cancer	2006	104
16705038	L-Leucine	Politi K	Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors.	Genes & development	2006	130
17114044	L-Leucine	MacLeod D	The familial Parkinsonism gene LRRK2 regulates neurite process morphology.	Neuron	2006	223
17280616	L-Leucine	Lin ML	Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family.	Breast cancer research 	2007	55
17463046	L-Leucine	Roos S	Mammalian target of rapamycin in the human placenta regulates leucine transport and is down-regulated in restricted fetal growth.	The Journal of physiology	2007	72
17559673	L-Leucine	DeHart JL	HIV-1 Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system.	Virology journal	2007	77
17667961	L-Leucine	Francks C	LRRTM1 on chromosome 2p12 is a maternally suppressed gene that is associated paternally with handedness and schizophrenia.	Molecular psychiatry	2007	87
17722061	L-Leucine	Nakano I	Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells.	Journal of neuroscience research	2008	64
18079489	L-Leucine	Kelsen SG	Cigarette smoke induces an unfolded protein response in the human lung: a proteomic approach.	American journal of respiratory cell and molecular biology	2008	58
18093566	L-Leucine	Schapira AH	Mitochondria in the aetiology and pathogenesis of Parkinson's disease.	The Lancet. Neurology	2008	205
18182054	L-Leucine	Plowey ED	Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells.	Journal of neurochemistry	2008	186
18214993	L-Leucine	Gandhi PN	The Roc domain of leucine-rich repeat kinase 2 is sufficient for interaction with microtubules.	Journal of neuroscience research	2008	62
18258746	L-Leucine	Liu Z	A Drosophila model for LRRK2-linked parkinsonism.	Proceedings of the National Academy of Sciences of the United States of America	2008	89
18362948	L-Leucine	Ting JP	NLRs at the intersection of cell death and immunity.	Nature reviews. Immunology	2008	140
18367607	L-Leucine	de Rivero Vaccari JP	A molecular platform in neurons regulates inflammation after spinal cord injury.	The Journal of neuroscience 	2008	84
18688028	L-Leucine	Goldoni S	An antimetastatic role for decorin in breast cancer.	The American journal of pathology	2008	52
18798267	L-Leucine	Goldoni S	Tumor microenvironment: Modulation by decorin and related molecules harboring leucine-rich tandem motifs.	International journal of cancer	2008	69
18827171	L-Leucine	Drummond MJ	Aging differentially affects human skeletal muscle microRNA expression at rest and after an anabolic stimulus of resistance exercise and essential amino acids.	American journal of physiology. Endocrinology and metabolism	2008	55
19167516	L-Leucine	Vesely PW	Translational regulation mechanisms of AP-1 proteins.	Mutation research	2009	51
19176810	L-Leucine	Ho CC	The Parkinson disease protein leucine-rich repeat kinase 2 transduces death signals via Fas-associated protein with death domain and caspase-8 in a cellular model of neurodegeneration.	The Journal of neuroscience 	2009	52
19433454	L-Leucine	Goldoni S	Decorin is a novel antagonistic ligand of the Met receptor.	The Journal of cell biology	2009	86
19545277	L-Leucine	Gillardon F	Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability--a point of convergence in parkinsonian neurodegeneration?	Journal of neurochemistry	2009	78
20090955	L-Leucine	Kumar A	The Parkinson's disease associated LRRK2 exhibits weaker in vitro phosphorylation of 4E-BP compared to autophosphorylation.	PloS one	2010	42
20420952	L-Leucine	Todaro M	Colon cancer stem cells: promise of targeted therapy.	Gastroenterology	2010	110
20584763	L-Leucine	Lech M	Quantitative expression of RIG-like helicase, NOD-like receptor and inflammasome-related mRNAs in humans and mice.	International immunology	2010	44
20671708	L-Leucine	Gehrke S	Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression.	Nature	2010	140
20713600	L-Leucine	Cherra SJ 3rd	Regulation of the autophagy protein LC3 by phosphorylation.	The Journal of cell biology	2010	88
20974860	L-Leucine	Buraschi S	Decorin antagonizes Met receptor activity and down-regulates {beta}-catenin and Myc levels.	The Journal of biological chemistry	2010	53
21088684	L-Leucine	Cookson MR	The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease.	Nature reviews. Neuroscience	2010	141
21125339	L-Leucine	Takahashi H	Significance of Lgr5(+ve) cancer stem cells in the colon and rectum.	Annals of surgical oncology	2011	41
21159966	L-Leucine	Lee S	LRRK2 kinase regulates synaptic morphology through distinct substrates at the presynaptic and postsynaptic compartments of the Drosophila neuromuscular junction.	The Journal of neuroscience 	2010	50
21168496	L-Leucine	Winner B	Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice.	Neurobiology of disease	2011	54
21245324	L-Leucine	Denoble AE	Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation.	Proceedings of the National Academy of Sciences of the United States of America	2011	42
21248115	L-Leucine	Dusonchet J	A rat model of progressive nigral neurodegeneration induced by the Parkinson's disease-associated G2019S mutation in LRRK2.	The Journal of neuroscience 	2011	45
21362567	L-Leucine	Nguyen HN	LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress.	Cell stem cell	2011	194
21378983	L-Leucine	Deng X	Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2.	Nature chemical biology	2011	121
21454543	L-Leucine	Chan D	Rac1 protein rescues neurite retraction caused by G2019S leucine-rich repeat kinase 2 (LRRK2).	The Journal of biological chemistry	2011	45
21494637	L-Leucine	Ramonet D	Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2.	PloS one	2011	103
21552986	L-Leucine	Hakimi M	Parkinson's disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures.	Journal of neural transmission	2011	50
21745188	L-Leucine	Hanke ML	Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential.	Clinical science	2011	82
21750348	L-Leucine	Beezhold K	miR-190-mediated downregulation of PHLPP contributes to arsenic-induced Akt activation and carcinogenesis.	Toxicological sciences 	2011	40
21829496	L-Leucine	Walker F	LGR5 is a negative regulator of tumourigenicity, antagonizes Wnt signalling and regulates cell adhesion in colorectal cancer cell lines.	PloS one	2011	39
22194599	L-Leucine	Neill T	Decorin antagonizes the angiogenic network: concurrent inhibition of Met, hypoxia inducible factor 1α, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3.	The Journal of biological chemistry	2012	49
22260996	L-Leucine	Baghy K	Decorin-TGFβ axis in hepatic fibrosis and cirrhosis.	The journal of histochemistry and cytochemistry 	2012	33
22261194	L-Leucine	Barallobre-Barreiro J	Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.	Circulation	2012	50
22382496	L-Leucine	Lynch J	MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathway.	Carcinogenesis	2012	42
22407749	L-Leucine	Sánchez-Danés A	Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease.	EMBO molecular medicine	2012	117
22539006	L-Leucine	Chen CY	(G2019S) LRRK2 activates MKK4-JNK pathway and causes degeneration of SN dopaminergic neurons in a transgenic mouse model of PD.	Cell death and differentiation	2012	30
22734070	L-Leucine	Payne EM	L-Leucine improves the anemia and developmental defects associated with Diamond-Blackfan anemia and del(5q) MDS by activating the mTOR pathway.	Blood	2012	45
22735579	L-Leucine	Neill T	Decorin: a guardian from the matrix.	The American journal of pathology	2012	76
22948661	L-Leucine	Wang W	PTPN14 is required for the density-dependent control of YAP1.	Genes & development	2012	49
23029096	L-Leucine	Buraschi S	Decorin protein core affects the global gene expression profile of the tumor microenvironment in a triple-negative orthotopic breast carcinoma xenograft model.	PloS one	2012	37
23122589	L-Leucine	Kott E	Loss-of-function mutations in LRRC6, a gene essential for proper axonemal assembly of inner and outer dynein arms, cause primary ciliary dyskinesia.	American journal of human genetics	2012	50
23125283	L-Leucine	Cho HJ	MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein.	Human molecular genetics	2013	40
23283305	L-Leucine	Chung S	Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer.	Oncotarget	2012	40
23349017	L-Leucine	Al-Kharusi MR	LGR5 promotes survival in human colorectal adenoma cells and is upregulated by PGE2: implications for targeting adenoma stem cells with NSAIDs.	Carcinogenesis	2013	26
23471228	L-Leucine	Shimabukuro M	Epicardial adipose tissue volume and adipocytokine imbalance are strongly linked to human coronary atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2013	25
23580333	L-Leucine	Dehay B	Lysosomal impairment in Parkinson's disease.	Movement disorders 	2013	58
23592611	L-Leucine	Di Virgilio F	The therapeutic potential of modifying inflammasomes and NOD-like receptors.	Pharmacological reviews	2013	29
23645676	L-Leucine	Krokowski D	A self-defeating anabolic program leads to β-cell apoptosis in endoplasmic reticulum stress-induced diabetes via regulation of amino acid flux.	The Journal of biological chemistry	2013	35
23681442	L-Leucine	Tedeschi A	The DLK signalling pathway--a double-edged sword in neural development and regeneration.	EMBO reports	2013	32
23741301	L-Leucine	Itsumura N	Compound heterozygous mutations in SLC30A2/ZnT2 results in low milk zinc concentrations: a novel mechanism for zinc deficiency in a breast-fed infant.	PloS one	2013	27
23787991	L-Leucine	Murphy TL	Specificity through cooperation: BATF-IRF interactions control immune-regulatory networks.	Nature reviews. Immunology	2013	68
23846336	L-Leucine	Liao WT	microRNA-224 promotes cell proliferation and tumor growth in human colorectal cancer by repressing PHLPP1 and PHLPP2.	Clinical cancer research 	2013	37
23975430	L-Leucine	Roy SS	Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer.	Oncogene	2014	29
23979718	L-Leucine	Huntwork-Rodriguez S	JNK-mediated phosphorylation of DLK suppresses its ubiquitination to promote neuronal apoptosis.	The Journal of cell biology	2013	43
24014241	L-Leucine	Willems L	Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia.	Blood	2013	56
24052624	L-Leucine	Wang Q	Targeting amino acid transport in metastatic castration-resistant prostate cancer: effects on cell cycle, cell growth, and tumor development.	Journal of the National Cancer Institute	2013	31
24282287	L-Leucine	Hirsch D	LGR5 positivity defines stem-like cells in colorectal cancer.	Carcinogenesis	2014	44
24403142	L-Leucine	Skibinski G	Mutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodies.	The Journal of neuroscience 	2014	39
24410877	L-Leucine	Ihle MA	Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations.	BMC cancer	2014	52
24441039	L-Leucine	Satoyoshi R	Asporin activates coordinated invasion of scirrhous gastric cancer and cancer-associated fibroblasts.	Oncogene	2015	18
24477476	L-Leucine	Martina JA	Novel roles for the MiTF/TFE family of transcription factors in organelle biogenesis, nutrient sensing, and energy homeostasis.	Cellular and molecular life sciences 	2014	28
24480070	L-Leucine	Moreth K	Biglycan-triggered TLR-2- and TLR-4-signaling exacerbates the pathophysiology of ischemic acute kidney injury.	Matrix biology 	2014	24
24531984	L-Leucine	Wang Q	Targeting glutamine transport to suppress melanoma cell growth.	International journal of cancer	2014	45
24681892	L-Leucine	Hu L	Biglycan enhances gastric cancer invasion by activating FAK signaling pathway.	Oncotarget	2014	23
24682598	L-Leucine	Schapansky J	Membrane recruitment of endogenous LRRK2 precedes its potent regulation of autophagy.	Human molecular genetics	2014	29
24703948	L-Leucine	Wang P	Both decreased and increased SRPK1 levels promote cancer by interfering with PHLPP-mediated dephosphorylation of Akt.	Molecular cell	2014	21
24885567	L-Leucine	Du T	Maternal embryonic leucine zipper kinase enhances gastric cancer progression via the FAK/Paxillin pathway.	Molecular cancer	2014	21
25080504	L-Leucine	Gómez-Suaga P	LRRK2 delays degradative receptor trafficking by impeding late endosomal budding through decreasing Rab7 activity.	Human molecular genetics	2014	30
25231743	L-Leucine	Mets E	MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia.	Leukemia	2015	22
25251388	L-Leucine	Martin I	LRRK2 pathobiology in Parkinson's disease.	Journal of neurochemistry	2014	28
25284317	L-Leucine	Schapansky J	The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's disease.	Neuroscience	2015	24
25401511	L-Leucine	Kalia LV	Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease.	JAMA neurology	2015	25
25458917	L-Leucine	Moon EJ	Dual roles of NRF2 in tumor prevention and progression: possible implications in cancer treatment.	Free radical biology & medicine	2015	25
25520363	L-Leucine	Van Aelst LN	Osteoglycin prevents cardiac dilatation and dysfunction after myocardial infarction through infarct collagen strengthening.	Circulation research	2015	15
25733449	L-Leucine	Rahman SA	Molecular mechanisms of congenital hyperinsulinism.	Journal of molecular endocrinology	2015	17
25753223	L-Leucine	Friedman AD	C/EBPα in normal and malignant myelopoiesis.	International journal of hematology	2015	17
25757399	L-Leucine	Ryan BJ	Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease.	Trends in biochemical sciences	2015	66
26078453	L-Leucine	Daher JP	Leucine-rich Repeat Kinase 2 (LRRK2) Pharmacological Inhibition Abates α-Synuclein Gene-induced Neurodegeneration.	The Journal of biological chemistry	2015	21
26101198	L-Leucine	Kumaran R	Pathways to Parkinsonism Redux: convergent pathobiological mechanisms in genetics of Parkinson's disease.	Human molecular genetics	2015	20
26251043	L-Leucine	Henry AG	Pathogenic LRRK2 mutations, through increased kinase activity, produce enlarged lysosomes with reduced degradative capacity and increase ATP13A2 expression.	Human molecular genetics	2015	17
26522384	L-Leucine	Neill T	Decorin as a multivalent therapeutic agent against cancer.	Advanced drug delivery reviews	2016	12
26719418	L-Leucine	Holland SM	Palmitoylation controls DLK localization, interactions and activity to ensure effective axonal injury signaling.	Proceedings of the National Academy of Sciences of the United States of America	2016	11
26760997	L-Leucine	Wang Y	NLRP3 Upregulation in Retinal Pigment Epithelium in Age-Related Macular Degeneration.	International journal of molecular sciences	2016	10
26789255	L-Leucine	Martinez-Zapien D	Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53.	Nature	2016	19
26856989	L-Leucine	Zhang J	LRG1 modulates epithelial-mesenchymal transition and angiogenesis in colorectal cancer via HIF-1α activation.	Journal of experimental & clinical cancer research 	2016	23
27295191	L-Leucine	Maishi N	Tumour endothelial cells in high metastatic tumours promote metastasis via epigenetic dysregulation of biglycan.	Scientific reports	2016	11
27477328	L-Leucine	Chen HH	Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells.	The Journal of allergy and clinical immunology	2017	7
27669650	L-Leucine	He Y	Mechanism and Regulation of NLRP3 Inflammasome Activation.	Trends in biochemical sciences	2016	50
27693454	L-Leucine	Gubbiotti MA	Decorin interacting network: A comprehensive analysis of decorin-binding partners and their versatile functions.	Matrix biology 	2016	13
28093447	L-Leucine	Karki R	Inflammasomes and Cancer.	Cancer immunology research	2017	12
28111074	L-Leucine	Huang YA	ApoE2, ApoE3, and ApoE4 Differentially Stimulate APP Transcription and Aβ Secretion.	Cell	2017	16
28214016	L-Leucine	Kohler RS	MELK expression in ovarian cancer correlates with poor outcome and its inhibition by OTSSP167 abrogates proliferation and viability of ovarian cancer cells.	Gynecologic oncology	2017	6
28358093	L-Leucine	de Sousa e Melo F	A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer.	Nature	2017	30
28436964	L-Leucine	Zhang Y	SWELL1 is a regulator of adipocyte size, insulin signalling and glucose homeostasis.	Nature cell biology	2017	6
15710622	Sphing-4-enine-1-phosphate	Finigan JH	Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation.	The Journal of biological chemistry	2005	135
16106218	Sphing-4-enine-1-phosphate	Van Brocklyn JR	Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines.	Journal of neuropathology and experimental neurology	2005	108
16194537	Sphing-4-enine-1-phosphate	Sarkar S	Sphingosine kinase 1 is required for migration, proliferation and survival of MCF-7 human breast cancer cells.	FEBS letters	2005	73
16397235	Sphing-4-enine-1-phosphate	LaMontagne K	Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization.	Cancer research	2006	76
16855590	Sphing-4-enine-1-phosphate	Carlson CM	Kruppel-like factor 2 regulates thymocyte and T-cell migration.	Nature	2006	187
17974990	Sphing-4-enine-1-phosphate	Sankala HM	Involvement of sphingosine kinase 2 in p53-independent induction of p21 by the chemotherapeutic drug doxorubicin.	Cancer research	2007	60
18815359	Sphing-4-enine-1-phosphate	Snider AJ	A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis.	FASEB journal 	2009	69
18824518	Sphing-4-enine-1-phosphate	Kawamori T	Role for sphingosine kinase 1 in colon carcinogenesis.	FASEB journal 	2009	86
19723667	Sphing-4-enine-1-phosphate	Kapitonov D	Targeting sphingosine kinase 1 inhibits Akt signaling, induces apoptosis, and suppresses growth of human glioblastoma cells and xenografts.	Cancer research	2009	63
19814729	Sphing-4-enine-1-phosphate	Brinkmann V	FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system.	British journal of pharmacology	2009	96
20081052	Sphing-4-enine-1-phosphate	Shea BS	Prolonged exposure to sphingosine 1-phosphate receptor-1 agonists exacerbates vascular leak, fibrosis, and mortality after lung injury.	American journal of respiratory cell and molecular biology	2010	45
20413685	Sphing-4-enine-1-phosphate	Miron VE	Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices.	The American journal of pathology	2010	54
22098666	Sphing-4-enine-1-phosphate	Bao M	Sphingosine kinase 1 promotes tumour cell migration and invasion via the S1P/EDG1 axis in hepatocellular carcinoma.	Liver international 	2012	32
22298596	Sphing-4-enine-1-phosphate	Nagahashi M	Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis.	Cancer research	2012	90
22986288	Sphing-4-enine-1-phosphate	Xiang SY	Lysophospholipid receptor activation of RhoA and lipid signaling pathways.	Biochimica et biophysica acta	2013	29
23723450	Sphing-4-enine-1-phosphate	Zhang G	Critical role of sphingosine-1-phosphate receptor 2 (S1PR2) in acute vascular inflammation.	Blood	2013	26
23861887	Sphing-4-enine-1-phosphate	Rex K	Sphingosine kinase activity is not required for tumor cell viability.	PloS one	2013	26
24464131	Sphing-4-enine-1-phosphate	Harikumar KB	K63-linked polyubiquitination of transcription factor IRF1 is essential for IL-1-induced production of chemokines CXCL10 and CCL5.	Nature immunology	2014	35
24516383	Sphing-4-enine-1-phosphate	Petersen J	The major cellular sterol regulatory pathway is required for Andes virus infection.	PLoS pathogens	2014	21
25347472	Sphing-4-enine-1-phosphate	Degagné E	Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated microRNAs.	The Journal of clinical investigation	2014	34
25624457	Sphing-4-enine-1-phosphate	Mackay LK	Cutting edge: CD69 interference with sphingosine-1-phosphate receptor function regulates peripheral T cell retention.	Journal of immunology	2015	56
26268607	Sphing-4-enine-1-phosphate	Galvani S	HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation.	Science signaling	2015	34
26715391	Sphing-4-enine-1-phosphate	Hunter SF	The Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple Sclerosis.	CNS drugs	2016	11
26857281	Sphing-4-enine-1-phosphate	Li J	Overexpression of SphK1 enhances cell proliferation and invasion in triple-negative breast cancer via the PI3K/AKT signaling pathway.	Tumour biology 	2016	12
27879252	Sphing-4-enine-1-phosphate	Ruiz M	High-Density Lipoprotein-Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1.	Arteriosclerosis, thrombosis, and vascular biology	2017	7
27956387	Sphing-4-enine-1-phosphate	Powell JA	Targeting sphingosine kinase 1 induces MCL1-dependent cell death in acute myeloid leukemia.	Blood	2017	5
28052056	Sphing-4-enine-1-phosphate	van der Weyden L	Genome-wide in vivo screen identifies novel host regulators of metastatic colonization.	Nature	2017	19
28420720	Sphing-4-enine-1-phosphate	Britten CD	A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors.	Clinical cancer research 	2017	8
8209258	L-Alanine	Gurney ME	Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.	Science	1994	813
9819447	L-Alanine	Davis GL	Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.	The New England journal of medicine	1998	153
10210705	L-Alanine	Kenny-Walsh E	Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group.	The New England journal of medicine	1999	147
10323868	L-Alanine	Montagnoli A	Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation.	Genes & development	1999	151
10567572	L-Alanine	Yamamoto K	BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M.	Molecular and cellular biology	1999	194
10764647	L-Alanine	Li M	Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model.	Science	2000	102
11438497	L-Alanine	Dixon JB	Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese.	Gastroenterology	2001	185
12186883	L-Alanine	Fodor E	A single amino acid mutation in the PA subunit of the influenza virus RNA polymerase inhibits endonucleolytic cleavage of capped RNAs.	Journal of virology	2002	106
12606734	L-Alanine	Hadziyannis SJ	Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.	The New England journal of medicine	2003	134
12774006	L-Alanine	Mofrad P	Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values.	Hepatology	2003	184
12897283	L-Alanine	van den Hout HM	The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature.	Pediatrics	2003	90
14512888	L-Alanine	Neuschwander-Tetri BA	Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone.	Hepatology	2003	101
14960526	L-Alanine	Hickman IJ	Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life.	Gut	2004	73
15034571	L-Alanine	Kieran D	Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice.	Nature medicine	2004	99
15639293	L-Alanine	Janssen HL	Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial.	Lancet	2005	165
15760475	L-Alanine	Guettouche T	Analysis of phosphorylation of human heat shock factor 1 in cells experiencing a stress.	BMC biochemistry	2005	90
15834418	L-Alanine	Chen L	Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease.	Nature neuroscience	2005	162
15842582	L-Alanine	Bugianesi E	A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.	The American journal of gastroenterology	2005	111
15879138	L-Alanine	Hart ML	Gastrointestinal ischemia-reperfusion injury is lectin complement pathway dependent without involving C1q.	Journal of immunology	2005	66
16139227	L-Alanine	Enomoto A	Akt/PKB regulates actin organization and cell motility via Girdin/APE.	Developmental cell	2005	128
16446383	L-Alanine	Radomska HS	Block of C/EBP alpha function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations.	The Journal of experimental medicine	2006	64
16611886	L-Alanine	Schweiger MR	Bromodomain protein 4 mediates the papillomavirus E2 transcriptional activation function.	Journal of virology	2006	69
16785532	L-Alanine	Teeling JL	The biological activity of human CD20 monoclonal antibodies is linked to unique epitopes on CD20.	Journal of immunology	2006	127
17087951	L-Alanine	Hadziyannis SJ	Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years.	Gastroenterology	2006	150
17214506	L-Alanine	Abdulla MH	Schistosomiasis mansoni: novel chemotherapy using a cysteine protease inhibitor.	PLoS medicine	2007	74
17439526	L-Alanine	Coco B	Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases.	Journal of viral hepatitis	2007	114
17918180	L-Alanine	Fraser M	Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function.	International journal of cancer	2008	51
18079403	L-Alanine	Egloff S	Serine-7 of the RNA polymerase II CTD is specifically required for snRNA gene expression.	Science	2007	117
18081738	L-Alanine	Jarrar MH	Adipokines and cytokines in non-alcoholic fatty liver disease.	Alimentary pharmacology & therapeutics	2008	74
18095306	L-Alanine	Arena U	Acute viral hepatitis increases liver stiffness values measured by transient elastography.	Hepatology	2008	114
18178617	L-Alanine	Gorbatyuk OS	The phosphorylation state of Ser-129 in human alpha-synuclein determines neurodegeneration in a rat model of Parkinson disease.	Proceedings of the National Academy of Sciences of the United States of America	2008	81
18390575	L-Alanine	Harrison SA	Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.	Gut	2008	97
18400849	L-Alanine	Keck ZY	Definition of a conserved immunodominant domain on hepatitis C virus E2 glycoprotein by neutralizing human monoclonal antibodies.	Journal of virology	2008	58
18571548	L-Alanine	Tremoulet AH	Resistance to intravenous immunoglobulin in children with Kawasaki disease.	The Journal of pediatrics	2008	64
18673426	L-Alanine	Chan HL	Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B.	Journal of viral hepatitis	2009	70
18690212	L-Alanine	Qi HH	Prolyl 4-hydroxylation regulates Argonaute 2 stability.	Nature	2008	78
18752331	L-Alanine	Fracanzani AL	Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.	Hepatology	2008	105
19013463	L-Alanine	Patton HM	Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis.	Gastroenterology	2008	53
19276368	L-Alanine	Chen RQ	CDC25B mediates rapamycin-induced oncogenic responses in cancer cells.	Cancer research	2009	46
19302977	L-Alanine	Li T	MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells.	Biochemical and biophysical research communications	2009	95
19524579	L-Alanine	Kotronen A	Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors.	Gastroenterology	2009	77
19585618	L-Alanine	Feldstein AE	Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study.	Hepatology	2009	128
19842207	L-Alanine	Zhang JY	Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B.	Hepatology	2010	95
19877169	L-Alanine	Ratziu V	Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial.	Hepatology	2010	56
19931264	L-Alanine	Valenti L	HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.	Gastroenterology	2010	50
20159111	L-Alanine	Nikopoulos K	Next-generation sequencing of a 40 Mb linkage interval reveals TSPAN12 mutations in patients with familial exudative vitreoretinopathy.	American journal of human genetics	2010	67
20648474	L-Alanine	Valenti L	I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease.	Hepatology	2010	61
20648476	L-Alanine	Neuschwander-Tetri BA	Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease.	Hepatology	2010	98
20708005	L-Alanine	Chalasani N	Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease.	Gastroenterology	2010	76
20858492	L-Alanine	Williams CD	Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.	Gastroenterology	2011	398
21208101	L-Alanine	O'Shaughnessy J	Iniparib plus chemotherapy in metastatic triple-negative breast cancer.	The New England journal of medicine	2011	196
21254163	L-Alanine	Zhang Z	Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients.	Hepatology	2011	45
21319195	L-Alanine	Valenti L	Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C.	Hepatology	2011	65
21319198	L-Alanine	Brunt EM	Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings.	Hepatology	2011	138
21321221	L-Alanine	Keunen O	Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma.	Proceedings of the National Academy of Sciences of the United States of America	2011	185
21688282	L-Alanine	Bhala N	The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.	Hepatology	2011	88
21937277	L-Alanine	Schöffski P	Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes.	The Lancet. Oncology	2011	44
21971536	L-Alanine	Rizzo L	Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C.	The American journal of gastroenterology	2011	40
21985374	L-Alanine	Tang Y	Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease.	Clinical and experimental immunology	2011	47
21987488	L-Alanine	Bambha K	Ethnicity and nonalcoholic fatty liver disease.	Hepatology	2012	40
22066022	L-Alanine	Bihrer V	Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma.	PloS one	2011	48
22137580	L-Alanine	Egloff S	Ser7 phosphorylation of the CTD recruits the RPAP2 Ser5 phosphatase to snRNA genes.	Molecular cell	2012	38
22183689	L-Alanine	Lomonaco R	Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease.	Hepatology	2012	56
22266604	L-Alanine	Antoine DJ	Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity.	Journal of hepatology	2012	116
22537612	L-Alanine	Kornek M	Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis.	Gastroenterology	2012	33
22700995	L-Alanine	Kindler HL	A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer.	Annals of oncology 	2012	55
22707395	L-Alanine	Bedossa P	Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients.	Hepatology	2012	55
22894884	L-Alanine	Di Giacomo AM	Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial.	The Lancet. Oncology	2012	53
23060426	L-Alanine	Stein EA	Apolipoprotein B synthesis inhibition with mipomersen in heterozygous familial hypercholesterolemia: results of a randomized, double-blind, placebo-controlled trial to assess efficacy and safety as add-on therapy in patients with coronary artery disease.	Circulation	2012	42
23197664	L-Alanine	Shi M	Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients.	Stem cells translational medicine	2012	38
23416328	L-Alanine	Hernaez R	Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey.	Clinical gastroenterology and hepatology 	2013	30
23535911	L-Alanine	Kitamoto T	Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan.	Human genetics	2013	39
23575478	L-Alanine	Jimeno A	Phase I study of the Hedgehog pathway inhibitor IPI-926 in adult patients with solid tumors.	Clinical cancer research 	2013	40
23592832	L-Alanine	Holmberg SD	Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort.	Clinical infectious diseases 	2013	30
23633921	L-Alanine	Khan AP	The role of sarcosine metabolism in prostate cancer progression.	Neoplasia	2013	34
23696515	L-Alanine	Noureddin M	Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials.	Hepatology	2013	65
23703931	L-Alanine	Noureddin M	Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: a longitudinal analysis.	Hepatology	2013	36
23761443	L-Alanine	Bélanger K	Binding of RNA by APOBEC3G controls deamination-independent restriction of retroviruses.	Nucleic acids research	2013	26
23763360	L-Alanine	Verma S	Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).	Liver international 	2013	34
23853598	L-Alanine	Serra-Moreno R	Tetherin/BST-2 antagonism by Nef depends on a direct physical interaction between Nef and tetherin, and on clathrin-mediated endocytosis.	PLoS pathogens	2013	27
23928932	L-Alanine	Venkatesh SK	Magnetic resonance elastography for the detection and staging of liver fibrosis in chronic hepatitis B.	European radiology	2014	35
24069390	L-Alanine	Kennedy KM	Catabolism of exogenous lactate reveals it as a legitimate metabolic substrate in breast cancer.	PloS one	2013	36
24086778	L-Alanine	Huy NT	Factors associated with dengue shock syndrome: a systematic review and meta-analysis.	PLoS neglected tropical diseases	2013	38
24123097	L-Alanine	Wong GL	On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir.	Hepatology	2014	26
24316260	L-Alanine	Lambert JE	Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease.	Gastroenterology	2014	78
24352239	L-Alanine	Tessarz P	Glutamine methylation in histone H2A is an RNA-polymerase-I-dedicated modification.	Nature	2014	40
24411639	L-Alanine	Reck M	Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial.	The Lancet. Oncology	2014	129
24436062	L-Alanine	Konerman MA	Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: prospective analysis of 435 liver biopsy pairs.	Hepatology	2014	23
24448638	L-Alanine	Sausville E	Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors.	Cancer chemotherapy and pharmacology	2014	31
24569542	L-Alanine	Chiu S	Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials.	European journal of clinical nutrition	2014	34
24582567	L-Alanine	Chachay VS	Resveratrol does not benefit patients with nonalcoholic fatty liver disease.	Clinical gastroenterology and hepatology 	2014	36
24583798	L-Alanine	Papadopoulos KP	Phase I safety, pharmacokinetic, and pharmacodynamic study of SAR245409 (XL765), a novel, orally administered PI3K/mTOR inhibitor in patients with advanced solid tumors.	Clinical cancer research 	2014	22
24615778	L-Alanine	Kahl BS	A phase 1 study of the PI3Kδ inhibitor idelalisib in patients with relapsed/refractory mantle cell lymphoma (MCL).	Blood	2014	36
24893048	L-Alanine	Shi Y	MR elastography for the assessment of hepatic fibrosis in patients with chronic hepatitis B infection: does histologic necroinflammation influence the measurement of hepatic stiffness?	Radiology	2014	20
24919570	L-Alanine	Shiwarski DJ	To "grow" or "go": TMEM16A expression as a switch between tumor growth and metastasis in SCCHN.	Clinical cancer research 	2014	24
24973316	L-Alanine	Pirola CJ	Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis.	Gut	2015	68
25145475	L-Alanine	Maximos M	The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.	Hepatology	2015	20
25251399	L-Alanine	Dongiovanni P	Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease.	Hepatology	2015	52
25311610	L-Alanine	Faghihzadeh F	Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease.	Nutrition research	2014	30
25398948	L-Alanine	Yamakawa M	Characterization of the dipeptide repeat protein in the molecular pathogenesis of c9FTD/ALS.	Human molecular genetics	2015	32
25601341	L-Alanine	Ryan CJ	Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study.	The Lancet. Oncology	2015	109
25695221	L-Alanine	Ichihara E	Phase II trial of gefitinib in combination with bevacizumab as first-line therapy for advanced non-small cell lung cancer with activating EGFR gene mutations: the Okayama Lung Cancer Study Group Trial 1001.	Journal of thoracic oncology 	2015	20
25754348	L-Alanine	Khozin S	FDA approval: ceritinib for the treatment of metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer.	Clinical cancer research 	2015	24
25873639	L-Alanine	Kwok R	Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study.	Gut	2016	18
25882986	L-Alanine	Pignata S	Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trial.	The Lancet. Oncology	2015	17
25981818	L-Alanine	Li J	Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial.	The Lancet. Oncology	2015	57
26311725	L-Alanine	Schlumberger M	A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer.	Clinical cancer research 	2016	15
26352813	L-Alanine	Burton BK	A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency.	The New England journal of medicine	2015	19
26409216	L-Alanine	Liang HW	Hepatitis B virus-human chimeric transcript HBx-LINE1 promotes hepatic injury via sequestering cellular microRNA-122.	Journal of hepatology	2016	13
26455325	L-Alanine	van Geldermalsen M	ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer.	Oncogene	2016	46
26553503	L-Alanine	Fox JM	Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress.	Cell	2015	17
26650570	L-Alanine	Wilson CG	Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice.	Endocrinology	2016	17
26677985	L-Alanine	Imajo K	Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.	Gastroenterology	2016	30
26714945	L-Alanine	Sun JJ	Postoperative Adjuvant Transcatheter Arterial Chemoembolization After R0 Hepatectomy Improves Outcomes of Patients Who have Hepatocellular Carcinoma with Microvascular Invasion.	Annals of surgical oncology	2016	15
26809794	L-Alanine	Mullins FM	The inactivation domain of STIM1 is functionally coupled with the Orai1 pore to enable Ca2+-dependent inactivation.	The Journal of general physiology	2016	11
26858122	L-Alanine	Antonia S	Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study.	The Lancet. Oncology	2016	75
26858343	L-Alanine	Wieser V	Reversal of murine alcoholic steatohepatitis by pepducin-based functional blockade of interleukin-8 receptors.	Gut	2017	9
26919392	L-Alanine	Klemann C	Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.	Clinical and experimental immunology	2016	12
26973324	L-Alanine	Kim DW	Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial.	The Lancet. Oncology	2016	70
26980062	L-Alanine	Kazandjian D	FDA Approval of Gefitinib for the Treatment of Patients with Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer.	Clinical cancer research 	2016	16
27002799	L-Alanine	Nelson JE	Vitamin D Deficiency Is Associated With Increased Risk of Non-alcoholic Steatohepatitis in Adults With Non-alcoholic Fatty Liver Disease: Possible Role for MAPK and NF-κB?	The American journal of gastroenterology	2016	15
27022112	L-Alanine	Urata Y	Randomized Phase III Study Comparing Gefitinib With Erlotinib in Patients With Previously Treated Advanced Lung Adenocarcinoma: WJOG 5108L.	Journal of clinical oncology 	2016	13
27075625	L-Alanine	Wang H	NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis.	Science translational medicine	2016	21
27081703	L-Alanine	Yang Z	MARCKS contributes to stromal cancer-associated fibroblast activation and facilitates ovarian cancer metastasis.	Oncotarget	2016	11
27247226	L-Alanine	Seiwert TY	Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial.	The Lancet. Oncology	2016	106
27265347	L-Alanine	Uesaka K	Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01).	Lancet	2016	23
27480103	L-Alanine	Ascierto PA	Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial.	The Lancet. Oncology	2016	27
27670892	L-Alanine	Masuishi T	Regorafenib Versus Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: A Retrospective Comparison.	Clinical colorectal cancer	2017	9
27725647	L-Alanine	McPherson S	Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis.	The American journal of gastroenterology	2017	8
27825636	L-Alanine	Drilon A	Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial.	The Lancet. Oncology	2016	31
27908594	L-Alanine	Swisher EM	Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial.	The Lancet. Oncology	2017	48
27908641	L-Alanine	Clark AJ	Free Energy Perturbation Calculation of Relative Binding Free Energy between Broadly Neutralizing Antibodies and the gp120 Glycoprotein of HIV-1.	Journal of molecular biology	2017	6
27995906	L-Alanine	Kwo PY	ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.	The American journal of gastroenterology	2017	8
28264872	L-Alanine	Kristeleit R	A Phase I-II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline BRCA1/2-Mutated Ovarian Carcinoma or Other Solid Tumors.	Clinical cancer research 	2017	8
28576675	L-Alanine	Baselga J	Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial.	The Lancet. Oncology	2017	10
28602779	L-Alanine	Shaw AT	Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial.	The Lancet. Oncology	2017	18
12084879	Silver	Thal DR	Phases of A beta-deposition in the human brain and its relevance for the development of AD.	Neurology	2002	463
12122208	Silver	Lo Bianco C	alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.	Proceedings of the National Academy of Sciences of the United States of America	2002	113
14981520	Silver	Windpassinger C	Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome.	Nature genetics	2004	73
15753419	Silver	Bennett DA	Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.	Neurology	2005	177
15851731	Silver	Braak H	Cognitive status correlates with neuropathologic stage in Parkinson disease.	Neurology	2005	82
17159101	Silver	Arvanitakis Z	Diabetes is related to cerebral infarction but not to AD pathology in older persons.	Neurology	2006	91
18566444	Silver	Adams S	Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant.	Journal of immunology	2008	75
18802081	Silver	Kurowska-Stolarska M	IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4.	Journal of immunology	2008	139
19273758	Silver	Tapiola T	Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.	Archives of neurology	2009	157
19557866	Silver	Kok E	Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age.	Annals of neurology	2009	85
20064793	Silver	Samberg ME	Evaluation of silver nanoparticle toxicity in skin in vivo and keratinocytes in vitro.	Environmental health perspectives	2010	63
20363604	Silver	Curtsinger JM	Inflammatory cytokines as a third signal for T cell activation.	Current opinion in immunology	2010	126
20483789	Silver	Herbert DR	Arginase I suppresses IL-12/IL-23p40-driven intestinal inflammation during acute schistosomiasis.	Journal of immunology	2010	51
20604817	Silver	Kostin S	Myocardial telocytes: a specific new cellular entity.	Journal of cellular and molecular medicine	2010	43
21270408	Silver	Jones DC	HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding.	Journal of immunology	2011	38
21357266	Silver	Ansari NA	IL-27 and IL-21 are associated with T cell IL-10 responses in human visceral leishmaniasis.	Journal of immunology	2011	57
21813772	Silver	Laggner U	Identification of a novel proinflammatory human skin-homing Vγ9Vδ2 T cell subset with a potential role in psoriasis.	Journal of immunology	2011	70
22069374	Silver	Palendira U	Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP.	PLoS biology	2011	38
22222640	Silver	Rüschoff J	HER2 testing in gastric cancer: a practical approach.	Modern pathology 	2012	90
22461703	Silver	Garg G	Type 1 diabetes-associated IL2RA variation lowers IL-2 signaling and contributes to diminished CD4+CD25+ regulatory T cell function.	Journal of immunology	2012	49
23658459	Silver	André F	Targeting FGFR with dovitinib (TKI258): preclinical and clinical data in breast cancer.	Clinical cancer research 	2013	65
23788757	Silver	Sheng WQ	HER2 status in gastric cancers: a retrospective analysis from four Chinese representative clinical centers and assessment of its prognostic significance.	Annals of oncology 	2013	25
23836404	Silver	Shulman JM	Genetic susceptibility for Alzheimer disease neuritic plaque pathology.	JAMA neurology	2013	38
24879338	Silver	Seo AN	HER2 status in colorectal cancer: its clinical significance and the relationship between HER2 gene amplification and expression.	PloS one	2014	23
25307057	Silver	Choi SH	A three-dimensional human neural cell culture model of Alzheimer's disease.	Nature	2014	143
25951829	Silver	Azzi S	A prospective study validating a clinical scoring system and demonstrating phenotypical-genotypical correlations in Silver-Russell syndrome.	Journal of medical genetics	2015	19
27585961	Silver	Wakeling EL	Diagnosis and management of Silver-Russell syndrome: first international consensus statement.	Nature reviews. Endocrinology	2017	10
15914560	Fludarabine	Beyer M	Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine.	Blood	2005	108
16543464	Fludarabine	Kojima K	Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia.	Blood	2006	71
18003888	Fludarabine	Chaudhuri A	STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier.	Blood	2008	57
18836097	Fludarabine	Balakrishnan K	AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistance.	Blood	2009	60
19549911	Fludarabine	Buchner M	Spleen tyrosine kinase is overexpressed and represents a potential therapeutic target in chronic lymphocytic leukemia.	Cancer research	2009	62
20085940	Fludarabine	Rubnitz JE	NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia.	Journal of clinical oncology 	2010	129
20335218	Fludarabine	Buchner M	Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia.	Blood	2010	62
20719934	Fludarabine	Hong JJ	Successful treatment of melanoma brain metastases with adoptive cell therapy.	Clinical cancer research 	2010	47
21402714	Fludarabine	Amrein PC	Phase II study of dasatinib in relapsed or refractory chronic lymphocytic leukemia.	Clinical cancer research 	2011	41
21791425	Fludarabine	Curti A	Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients.	Blood	2011	81
21844497	Fludarabine	Fischer K	Bendamustine combined with rituximab in patients with relapsed and/or refractory chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group.	Journal of clinical oncology 	2011	75
22039264	Fludarabine	Rossi D	Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness.	Blood	2011	85
22128299	Fludarabine	Tromp JM	Tipping the Noxa/Mcl-1 balance overcomes ABT-737 resistance in chronic lymphocytic leukemia.	Clinical cancer research 	2012	35
22740450	Fludarabine	Mahoney E	ER stress and autophagy: new discoveries in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridol.	Blood	2012	32
23086750	Fludarabine	Oscier DG	The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial.	Blood	2013	52
23530110	Fludarabine	Federico M	R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lymphoma: results of the FOLL05 trial conducted by the Fondazione Italiana Linfomi.	Journal of clinical oncology 	2013	31
23720127	Fludarabine	Hallek M	Chronic lymphocytic leukemia: 2013 update on diagnosis, risk stratification and treatment.	American journal of hematology	2013	38
24277076	Fludarabine	Hoellenriegel J	The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization.	Blood	2014	31
24719405	Fludarabine	Bachanova V	Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein.	Blood	2014	71
24912431	Fludarabine	Cao Y	The WHIM-like CXCR4(S338X) somatic mutation activates AKT and ERK, and promotes resistance to ibrutinib and other agents used in the treatment of Waldenstrom's Macroglobulinemia.	Leukemia	2015	21
25319501	Fludarabine	Lee DW	T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial.	Lancet	2015	367
25908509	Fludarabine	Hallek M	Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment.	American journal of hematology	2015	50
25940712	Fludarabine	Ninomiya S	Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs.	Blood	2015	32
26002963	Fludarabine	Treon SP	How I treat Waldenström macroglobulinemia.	Blood	2015	15
26675346	Fludarabine	Ljungström V	Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations.	Blood	2016	17
26762740	Fludarabine	Ikeda S	PD-L1 Is Upregulated by Simultaneous Amplification of the PD-L1 and JAK2 Genes in Non-Small Cell Lung Cancer.	Journal of thoracic oncology 	2016	16
27111235	Fludarabine	Turtle CJ	CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients.	The Journal of clinical investigation	2016	120
28395880	Fludarabine	Chandran SS	Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study.	The Lancet. Oncology	2017	8
9111344	17a-Ethynylestradiol	Hong H	GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors.	Molecular and cellular biology	1997	125
9199297	17a-Ethynylestradiol	Nakshatri H	Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth.	Molecular and cellular biology	1997	186
9362426	17a-Ethynylestradiol	Coleman RE	Skeletal complications of malignancy.	Cancer	1997	219
9662379	17a-Ethynylestradiol	Kononen J	Tissue microarrays for high-throughput molecular profiling of tumor specimens.	Nature medicine	1998	777
9747868	17a-Ethynylestradiol	Fisher B	Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.	Journal of the National Cancer Institute	1998	717
10080586	17a-Ethynylestradiol	Kuerer HM	Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy.	Journal of clinical oncology 	1999	225
10227624	17a-Ethynylestradiol	Jack CR Jr	Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment.	Neurology	1999	322
10334533	17a-Ethynylestradiol	Harvey JM	Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.	Journal of clinical oncology 	1999	417
10713699	17a-Ethynylestradiol	Cogswell PC	Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3.	Oncogene	2000	126
11016622	17a-Ethynylestradiol	Eads CA	Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma.	Cancer research	2000	102
11181778	17a-Ethynylestradiol	Bos R	Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis.	Journal of the National Cancer Institute	2001	143
11289127	17a-Ethynylestradiol	Roger P	Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors.	Cancer research	2001	92
11438457	17a-Ethynylestradiol	Leav I	Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma.	The American journal of pathology	2001	97
11507038	17a-Ethynylestradiol	Gruvberger S	Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns.	Cancer research	2001	168
11517191	17a-Ethynylestradiol	Lazennec G	ER beta inhibits proliferation and invasion of breast cancer cells.	Endocrinology	2001	101
11751417	17a-Ethynylestradiol	Xie D	Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features.	Cancer research	2001	90
11751582	17a-Ethynylestradiol	Bauer UM	Methylation at arginine 17 of histone H3 is linked to gene activation.	EMBO reports	2002	95
11929836	17a-Ethynylestradiol	Stabile LP	Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen.	Cancer research	2002	104
12060624	17a-Ethynylestradiol	Schindl M	Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer.	Clinical cancer research 	2002	102
12400004	17a-Ethynylestradiol	Real PJ	Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells.	Oncogene	2002	88
12498683	17a-Ethynylestradiol	Daujat S	Crosstalk between CARM1 methylation and CBP acetylation on histone H3.	Current biology 	2002	85
12657462	17a-Ethynylestradiol	Wu C	The function of the protein tyrosine phosphatase SHP-1 in cancer.	Gene	2003	76
12705869	17a-Ethynylestradiol	Fujita N	MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer.	Cell	2003	149
12928347	17a-Ethynylestradiol	Key TJ	Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women.	Journal of the National Cancer Institute	2003	246
14636987	17a-Ethynylestradiol	Nanes MS	Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology.	Gene	2003	83
14729654	17a-Ethynylestradiol	Paruthiyil S	Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest.	Cancer research	2004	147
14871808	17a-Ethynylestradiol	Foulkes WD	The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer.	Cancer research	2004	73
15041722	17a-Ethynylestradiol	Foulkes WD	Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type.	Clinical cancer research 	2004	77
15111773	17a-Ethynylestradiol	Johnson MD	Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifen.	Breast cancer research and treatment	2004	114
15169882	17a-Ethynylestradiol	Louie MC	ACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance.	Molecular and cellular biology	2004	103
15193262	17a-Ethynylestradiol	Michalides R	Tamoxifen resistance by a conformational arrest of the estrogen receptor alpha after PKA activation in breast cancer.	Cancer cell	2004	73
15220474	17a-Ethynylestradiol	Biswas DK	NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis.	Proceedings of the National Academy of Sciences of the United States of America	2004	115
15223047	17a-Ethynylestradiol	Dontu G	Breast cancer, stem/progenitor cells and the estrogen receptor.	Trends in endocrinology and metabolism	2004	95
15310774	17a-Ethynylestradiol	Fink AK	Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor--positive breast cancer.	Journal of clinical oncology 	2004	78
15328174	17a-Ethynylestradiol	Nielsen TO	Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.	Clinical cancer research 	2004	631
15339660	17a-Ethynylestradiol	Cuthbert GL	Histone deimination antagonizes arginine methylation.	Cell	2004	199
15342389	17a-Ethynylestradiol	Kubo M	Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer.	Cancer research	2004	110
15369453	17a-Ethynylestradiol	Bardin A	Loss of ERbeta expression as a common step in estrogen-dependent tumor progression.	Endocrine-related cancer	2004	80
15380517	17a-Ethynylestradiol	Torres-Arzayus MI	High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene.	Cancer cell	2004	148
15534099	17a-Ethynylestradiol	Camp RL	X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization.	Clinical cancer research 	2004	337
15574760	17a-Ethynylestradiol	Loo LW	Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes.	Cancer research	2004	70
15585641	17a-Ethynylestradiol	deGraffenried LA	Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity.	Clinical cancer research 	2004	82
15591335	17a-Ethynylestradiol	Paik S	A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.	The New England journal of medicine	2004	1319
15674344	17a-Ethynylestradiol	Foster KW	Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia.	Oncogene	2005	83
15735034	17a-Ethynylestradiol	Stabile LP	Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects.	Cancer research	2005	86
15883431	17a-Ethynylestradiol	Setchell KD	S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora.	The American journal of clinical nutrition	2005	72
15899795	17a-Ethynylestradiol	Dai H	A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients.	Cancer research	2005	91
16012726	17a-Ethynylestradiol	Tsutsui S	Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density.	Oncology reports	2005	92
16033833	17a-Ethynylestradiol	Lakhani SR	Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype.	Clinical cancer research 	2005	155
16087863	17a-Ethynylestradiol	Laganière J	From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response.	Proceedings of the National Academy of Sciences of the United States of America	2005	133
16115903	17a-Ethynylestradiol	Rouzier R	Breast cancer molecular subtypes respond differently to preoperative chemotherapy.	Clinical cancer research 	2005	370
16172792	17a-Ethynylestradiol	Zhang Z	Quantitation of HDAC1 mRNA expression in invasive carcinoma of the breast*.	Breast cancer research and treatment	2005	71
16239258	17a-Ethynylestradiol	Vivacqua A	The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells.	Molecular endocrinology	2006	104
16317585	17a-Ethynylestradiol	Li SY	PIK3CA mutations in breast cancer are associated with poor outcome.	Breast cancer research and treatment	2006	60
16333030	17a-Ethynylestradiol	Lewis JS	Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation.	Journal of the National Cancer Institute	2005	78
16341146	17a-Ethynylestradiol	Livasy CA	Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.	Modern pathology 	2006	250
16368942	17a-Ethynylestradiol	McCabe A	Automated quantitative analysis (AQUA) of in situ protein expression, antibody concentration, and prognosis.	Journal of the National Cancer Institute	2005	81
16397019	17a-Ethynylestradiol	Diaz N	Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expression.	Clinical cancer research 	2006	81
16469706	17a-Ethynylestradiol	Zhu P	Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway.	Cell	2006	94
16478745	17a-Ethynylestradiol	Sotiriou C	Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis.	Journal of the National Cancer Institute	2006	549
16533778	17a-Ethynylestradiol	Rodríguez-Pinilla SM	Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas.	Clinical cancer research 	2006	73
16603601	17a-Ethynylestradiol	Pestalozzi BC	Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG).	Annals of oncology 	2006	76
16609087	17a-Ethynylestradiol	Berry DA	Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer.	JAMA	2006	145
16626501	17a-Ethynylestradiol	Perreard L	Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay.	Breast cancer research 	2006	62
16682622	17a-Ethynylestradiol	Xia W	A model of acquired autoresistance to a potent ErbB2 tyrosine kinase inhibitor and a therapeutic strategy to prevent its onset in breast cancer.	Proceedings of the National Academy of Sciences of the United States of America	2006	113
16682724	17a-Ethynylestradiol	Linden HM	Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer.	Journal of clinical oncology 	2006	67
16705121	17a-Ethynylestradiol	Holm C	Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients.	Journal of the National Cancer Institute	2006	68
16707433	17a-Ethynylestradiol	Bond GL	MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner.	Cancer research	2006	111
16849584	17a-Ethynylestradiol	Frasor J	Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome.	Cancer research	2006	73
16854453	17a-Ethynylestradiol	McCubrey JA	Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.	Advances in enzyme regulation	2006	168
16931954	17a-Ethynylestradiol	Hicks DG	Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR.	The American journal of surgical pathology	2006	71
16938528	17a-Ethynylestradiol	Kim MJ	Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.	Human pathology	2006	84
16940181	17a-Ethynylestradiol	Hossain A	Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA.	Molecular and cellular biology	2006	171
16954471	17a-Ethynylestradiol	Buyse M	Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer.	Journal of the National Cancer Institute	2006	257
16980581	17a-Ethynylestradiol	Eeckhoute J	A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer.	Genes & development	2006	104
17028294	17a-Ethynylestradiol	Hecht JL	Molecular and pathologic aspects of endometrial carcinogenesis.	Journal of clinical oncology 	2006	94
17135638	17a-Ethynylestradiol	Bates GJ	Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse.	Journal of clinical oncology 	2006	234
17234468	17a-Ethynylestradiol	Livasy CA	Identification of a basal-like subtype of breast ductal carcinoma in situ.	Human pathology	2007	60
17235397	17a-Ethynylestradiol	Amaravadi RK	Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma.	The Journal of clinical investigation	2007	390
17308356	17a-Ethynylestradiol	Zhao H	Phosphoinositide-3-kinase/akt survival signal pathways are implicated in neuronal survival after stroke.	Molecular neurobiology	2006	77
17372279	17a-Ethynylestradiol	Tworoger SS	A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.	Journal of clinical oncology 	2007	68
17401012	17a-Ethynylestradiol	Loi S	Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade.	Journal of clinical oncology 	2007	271
17438091	17a-Ethynylestradiol	Carey LA	The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.	Clinical cancer research 	2007	472
17440086	17a-Ethynylestradiol	Fu Y	GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis.	Cancer research	2007	92
17470737	17a-Ethynylestradiol	Arpino G	Treatment of human epidermal growth factor receptor 2-overexpressing breast cancer xenografts with multiagent HER-targeted therapy.	Journal of the National Cancer Institute	2007	62
17488799	17a-Ethynylestradiol	Rometo AM	Hypertrophy and increased kisspeptin gene expression in the hypothalamic infundibular nucleus of postmenopausal women and ovariectomized monkeys.	The Journal of clinical endocrinology and metabolism	2007	88
17491024	17a-Ethynylestradiol	Armstrong VJ	Wnt/beta-catenin signaling is a component of osteoblastic bone cell early responses to load-bearing and requires estrogen receptor alpha.	The Journal of biological chemistry	2007	95
17502350	17a-Ethynylestradiol	Shi B	Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells.	Molecular and cellular biology	2007	107
17554627	17a-Ethynylestradiol	Bauer M	Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer.	Breast cancer research and treatment	2008	58
17586727	17a-Ethynylestradiol	Sasser AK	Interleukin-6 is a potent growth factor for ER-alpha-positive human breast cancer.	FASEB journal 	2007	70
17620276	17a-Ethynylestradiol	Morris GJ	Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results database.	Cancer	2007	144
17626182	17a-Ethynylestradiol	Liu X	Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer.	Proceedings of the National Academy of Sciences of the United States of America	2007	115
17663798	17a-Ethynylestradiol	Hoadley KA	EGFR associated expression profiles vary with breast tumor subtype.	BMC genomics	2007	104
17872378	17a-Ethynylestradiol	DuSell CD	27-hydroxycholesterol is an endogenous selective estrogen receptor modulator.	Molecular endocrinology	2008	73
17897439	17a-Ethynylestradiol	Schlange T	Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.	Breast cancer research 	2007	75
18006846	17a-Ethynylestradiol	Mertens-Talcott SU	The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells.	Cancer research	2007	152
18071188	17a-Ethynylestradiol	Owusu C	Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer.	Journal of clinical oncology 	2008	77
18172323	17a-Ethynylestradiol	Frietze S	CARM1 regulates estrogen-stimulated breast cancer growth through up-regulation of E2F1.	Cancer research	2008	64
18230721	17a-Ethynylestradiol	Liu S	BRCA1 regulates human mammary stem/progenitor cell fate.	Proceedings of the National Academy of Sciences of the United States of America	2008	157
18240539	17a-Ethynylestradiol	Mundy GR	Osteoporosis and inflammation.	Nutrition reviews	2007	102
18297396	17a-Ethynylestradiol	Lu X	Predicting features of breast cancer with gene expression patterns.	Breast cancer research and treatment	2008	90
18317227	17a-Ethynylestradiol	Soslow RA	Histologic subtypes of ovarian carcinoma: an overview.	International journal of gynecological pathology 	2008	63
18339859	17a-Ethynylestradiol	Cheng AS	Epithelial progeny of estrogen-exposed breast progenitor cells display a cancer-like methylome.	Cancer research	2008	54
18347134	17a-Ethynylestradiol	Sun M	Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells.	Molecular cancer therapeutics	2008	110
18375767	17a-Ethynylestradiol	Tan-Wong SM	Dynamic interactions between the promoter and terminator regions of the mammalian BRCA1 gene.	Proceedings of the National Academy of Sciences of the United States of America	2008	62
18438407	17a-Ethynylestradiol	Stacey SN	Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer.	Nature genetics	2008	219
18443585	17a-Ethynylestradiol	Ben-Porath I	An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors.	Nature genetics	2008	811
18451221	17a-Ethynylestradiol	Ignatiadis M	Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer.	Clinical cancer research 	2008	52
18451222	17a-Ethynylestradiol	Ma XJ	A five-gene molecular grade index and HOXB13:IL17BR are complementary prognostic factors in early stage breast cancer.	Clinical cancer research 	2008	66
18458044	17a-Ethynylestradiol	Pestalozzi BC	Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials.	Journal of clinical oncology 	2008	54
18506688	17a-Ethynylestradiol	Shabo I	Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival.	International journal of cancer	2008	52
18509175	17a-Ethynylestradiol	Azim AA	Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study.	Journal of clinical oncology 	2008	79
18515733	17a-Ethynylestradiol	Ross JS	Commercialized multigene predictors of clinical outcome for breast cancer.	The oncologist	2008	55
18593897	17a-Ethynylestradiol	Kondo N	miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer.	Cancer research	2008	106
18593923	17a-Ethynylestradiol	Rizzo P	Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches.	Cancer research	2008	106
18614256	17a-Ethynylestradiol	Rance NE	Menopause and the human hypothalamus: evidence for the role of kisspeptin/neurokinin B neurons in the regulation of estrogen negative feedback.	Peptides	2009	63
18657504	17a-Ethynylestradiol	Le Romancer M	Regulation of estrogen rapid signaling through arginine methylation by PRMT1.	Molecular cell	2008	76
18662380	17a-Ethynylestradiol	Wirapati P	Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures.	Breast cancer research 	2008	249
18698033	17a-Ethynylestradiol	Desmedt C	Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes.	Clinical cancer research 	2008	235
18714348	17a-Ethynylestradiol	Martin KJ	Prognostic breast cancer signature identified from 3D culture model accurately predicts clinical outcome across independent datasets.	PloS one	2008	90
18755890	17a-Ethynylestradiol	Foekens JA	Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer.	Proceedings of the National Academy of Sciences of the United States of America	2008	132
18787018	17a-Ethynylestradiol	Adams BD	Argonaute-2 expression is regulated by epidermal growth factor receptor and mitogen-activated protein kinase signaling and correlates with a transformed phenotype in breast cancer cells.	Endocrinology	2009	55
18806226	17a-Ethynylestradiol	Dumont N	Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers.	Proceedings of the National Academy of Sciences of the United States of America	2008	81
18821585	17a-Ethynylestradiol	Cirillo D	Leptin signaling in breast cancer: an overview.	Journal of cellular biochemistry	2008	65
18841463	17a-Ethynylestradiol	Tan AR	Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?	Breast cancer research and treatment	2009	48
18974155	17a-Ethynylestradiol	Studebaker AW	Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner.	Cancer research	2008	70
19027010	17a-Ethynylestradiol	Liu WH	MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.	Gastroenterology	2009	65
19079346	17a-Ethynylestradiol	Gonzalez ME	Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1.	Oncogene	2009	75
19112174	17a-Ethynylestradiol	Yamnik RL	S6 kinase 1 regulates estrogen receptor alpha in control of breast cancer cell proliferation.	The Journal of biological chemistry	2009	62
19116762	17a-Ethynylestradiol	Toh Y	The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications.	Clinical & experimental metastasis	2009	67
19147748	17a-Ethynylestradiol	Andre F	Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.	Clinical cancer research 	2009	97
19221498	17a-Ethynylestradiol	Alimova IN	Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro.	Cell cycle	2009	136
19234134	17a-Ethynylestradiol	Sotgia F	Caveolin-1-/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts.	The American journal of pathology	2009	52
19237579	17a-Ethynylestradiol	Yang J	Lipocalin 2 promotes breast cancer progression.	Proceedings of the National Academy of Sciences of the United States of America	2009	85
19244106	17a-Ethynylestradiol	Wu X	The tamoxifen metabolite, endoxifen, is a potent antiestrogen that targets estrogen receptor alpha for degradation in breast cancer cells.	Cancer research	2009	51
19275906	17a-Ethynylestradiol	Solomon MB	Sex differences in psychopathology: of gonads, adrenals and mental illness.	Physiology & behavior	2009	64
19349544	17a-Ethynylestradiol	Anderson SJ	Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer.	Journal of clinical oncology 	2009	63
19421758	17a-Ethynylestradiol	Fang YJ	Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer.	International journal of colorectal disease	2009	47
19428444	17a-Ethynylestradiol	Lebesgue D	Estradiol rescues neurons from global ischemia-induced cell death: multiple cellular pathways of neuroprotection.	Steroids	2009	61
19451693	17a-Ethynylestradiol	Bierie B	Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer.	The Journal of clinical investigation	2009	46
19458043	17a-Ethynylestradiol	Swanton C	Chromosomal instability determines taxane response.	Proceedings of the National Academy of Sciences of the United States of America	2009	80
19483720	17a-Ethynylestradiol	Walter M	Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells.	Oncogene	2009	70
19487384	17a-Ethynylestradiol	Shi L	Expression of ER-{alpha}36, a novel variant of estrogen receptor {alpha}, and resistance to tamoxifen treatment in breast cancer.	Journal of clinical oncology 	2009	52
19498003	17a-Ethynylestradiol	Paulsson J	Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer.	The American journal of pathology	2009	59
19501895	17a-Ethynylestradiol	Smith HO	GPR30 predicts poor survival for ovarian cancer.	Gynecologic oncology	2009	65
19561322	17a-Ethynylestradiol	Calado RT	Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells.	Blood	2009	57
19581928	17a-Ethynylestradiol	Sullivan NJ	Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells.	Oncogene	2009	186
19582160	17a-Ethynylestradiol	Kao J	Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.	PloS one	2009	264
19602591	17a-Ethynylestradiol	Hartman J	Tumor repressive functions of estrogen receptor beta in SW480 colon cancer cells.	Cancer research	2009	52
19671800	17a-Ethynylestradiol	Liu L	Novel mechanism of lapatinib resistance in HER2-positive breast tumor cells: activation of AXL.	Cancer research	2009	128
19706001	17a-Ethynylestradiol	Kjaer M	From mechanical loading to collagen synthesis, structural changes and function in human tendon.	Scandinavian journal of medicine & science in sports	2009	49
19730444	17a-Ethynylestradiol	Spizzo R	miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells.	Cell death and differentiation	2010	85
19738052	17a-Ethynylestradiol	Saetrom P	A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis.	Cancer research	2009	52
19819674	17a-Ethynylestradiol	Fairweather D	Alternatively activated macrophages in infection and autoimmunity.	Journal of autoimmunity	2009	77
19838210	17a-Ethynylestradiol	Hao L	Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells.	Oncogene	2010	43
19874578	17a-Ethynylestradiol	Finn RS	PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro.	Breast cancer research 	2009	228
19911270	17a-Ethynylestradiol	Resetkova E	Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment.	Breast cancer research and treatment	2010	60
20020197	17a-Ethynylestradiol	Györffy B	An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients.	Breast cancer research and treatment	2010	524
20031276	17a-Ethynylestradiol	Rasgon NL	Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease.	Neurobiology of aging	2011	48
20042638	17a-Ethynylestradiol	Lim S	Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology.	Carcinogenesis	2010	129
20065188	17a-Ethynylestradiol	Mamounas EP	Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20.	Journal of clinical oncology 	2010	78
20080637	17a-Ethynylestradiol	Lovén J	MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma.	Proceedings of the National Academy of Sciences of the United States of America	2010	48
20101232	17a-Ethynylestradiol	Ye Y	ERalpha signaling through slug regulates E-cadherin and EMT.	Oncogene	2010	44
20133657	17a-Ethynylestradiol	McPherson SJ	Estrogen receptor-beta activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFalpha mediated.	Proceedings of the National Academy of Sciences of the United States of America	2010	51
20203690	17a-Ethynylestradiol	Chan QK	Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest.	Cell death and differentiation	2010	54
20204595	17a-Ethynylestradiol	Rochefort GY	Osteocyte: the unrecognized side of bone tissue.	Osteoporosis international 	2010	40
20231686	17a-Ethynylestradiol	Staaf J	Identification of subtypes in human epidermal growth factor receptor 2--positive breast cancer reveals a gene signature prognostic of outcome.	Journal of clinical oncology 	2010	58
20339121	17a-Ethynylestradiol	Karamanlidis G	Defective DNA replication impairs mitochondrial biogenesis in human failing hearts.	Circulation research	2010	55
20385358	17a-Ethynylestradiol	Mak P	ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading.	Cancer cell	2010	130
20442245	17a-Ethynylestradiol	Hsu PY	Estrogen-mediated epigenetic repression of large chromosomal regions through DNA looping.	Genome research	2010	41
20459607	17a-Ethynylestradiol	Staaf J	High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer.	Breast cancer research 	2010	52
20501593	17a-Ethynylestradiol	Bernardo GM	FOXA1 is an essential determinant of ERalpha expression and mammary ductal morphogenesis.	Development	2010	71
20501637	17a-Ethynylestradiol	Leung YK	Estrogen receptor beta2 and beta5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion.	Endocrine-related cancer	2010	43
20509143	17a-Ethynylestradiol	Storci G	TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype.	Journal of cellular physiology	2010	41
20519412	17a-Ethynylestradiol	Setchell KD	Equol: history, chemistry, and formation.	The Journal of nutrition	2010	69
20530877	17a-Ethynylestradiol	Miller TW	Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor-positive human breast cancer.	The Journal of clinical investigation	2010	120
20551055	17a-Ethynylestradiol	Madeo A	Nuclear alternate estrogen receptor GPR30 mediates 17beta-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts.	Cancer research	2010	50
20664043	17a-Ethynylestradiol	Reeves GK	Incidence of breast cancer and its subtypes in relation to individual and multiple low-penetrance genetic susceptibility loci.	JAMA	2010	51
20682797	17a-Ethynylestradiol	Yang J	The histone demethylase JMJD2B is regulated by estrogen receptor alpha and hypoxia, and is a key mediator of estrogen induced growth.	Cancer research	2010	50
20697068	17a-Ethynylestradiol	Symmans WF	Genomic index of sensitivity to endocrine therapy for breast cancer.	Journal of clinical oncology 	2010	88
20711231	17a-Ethynylestradiol	Arias-Romero LE	A Rac-Pak signaling pathway is essential for ErbB2-mediated transformation of human breast epithelial cancer cells.	Oncogene	2010	52
20800582	17a-Ethynylestradiol	Rance NE	Neurokinin B and the hypothalamic regulation of reproduction.	Brain research	2010	54
20805453	17a-Ethynylestradiol	Bianchini G	Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancers.	Journal of clinical oncology 	2010	64
20821253	17a-Ethynylestradiol	Grossmann ME	Obesity and breast cancer: status of leptin and adiponectin in pathological processes.	Cancer metastasis reviews	2010	52
20852631	17a-Ethynylestradiol	Antoniou AC	A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population.	Nature genetics	2010	160
20864510	17a-Ethynylestradiol	Kalashnikova EV	ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2.	Cancer research	2010	42
20876186	17a-Ethynylestradiol	Suzuki HI	Emerging complexity of microRNA generation cascades.	Journal of biochemistry	2011	38
20876285	17a-Ethynylestradiol	Cittelly DM	Oncogenic HER2{Delta}16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors.	Carcinogenesis	2010	57
20876420	17a-Ethynylestradiol	Ingle JN	Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors.	Journal of clinical oncology 	2010	75
20935677	17a-Ethynylestradiol	Zhang XT	A positive feedback loop of ER-α36/EGFR promotes malignant growth of ER-negative breast cancer cells.	Oncogene	2011	41
20956553	17a-Ethynylestradiol	Madak-Erdogan Z	Genomic collaboration of estrogen receptor alpha and extracellular signal-regulated kinase 2 in regulating gene and proliferation programs.	Molecular and cellular biology	2011	48
20978187	17a-Ethynylestradiol	de Souza Rocha Simonini P	Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells.	Cancer research	2010	78
20978357	17a-Ethynylestradiol	Glynn SA	Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients.	The Journal of clinical investigation	2010	63
21057539	17a-Ethynylestradiol	Patel JB	Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22.	Oncogene	2011	39
21084273	17a-Ethynylestradiol	Wynendaele J	An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivity.	Cancer research	2010	51
21123450	17a-Ethynylestradiol	Rhodes LV	Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer.	Cancer research	2011	59
21127264	17a-Ethynylestradiol	Fedele CG	Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers.	Proceedings of the National Academy of Sciences of the United States of America	2010	77
21172025	17a-Ethynylestradiol	Cittelly DM	Downregulation of miR-342 is associated with tamoxifen resistant breast tumors.	Molecular cancer	2010	69
21191116	17a-Ethynylestradiol	Iwamoto T	Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer.	Journal of the National Cancer Institute	2011	69
21220480	17a-Ethynylestradiol	Osborne CK	Gefitinib or placebo in combination with tamoxifen in patients with hormone receptor-positive metastatic breast cancer: a randomized phase II study.	Clinical cancer research 	2011	53
21220595	17a-Ethynylestradiol	Loo CE	Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype.	Journal of clinical oncology 	2011	42
21235772	17a-Ethynylestradiol	Grober OM	Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulation.	BMC genomics	2011	49
21289245	17a-Ethynylestradiol	Halder SK	1,25-Dihydroxyvitamin D3 reduces TGF-beta3-induced fibrosis-related gene expression in human uterine leiomyoma cells.	The Journal of clinical endocrinology and metabolism	2011	38
21310761	17a-Ethynylestradiol	Park S	Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers.	Annals of oncology 	2011	43
21372223	17a-Ethynylestradiol	Attard G	New strategies in metastatic prostate cancer: targeting the androgen receptor signaling pathway.	Clinical cancer research 	2011	49
21375733	17a-Ethynylestradiol	Hannafon BN	Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer.	Breast cancer research 	2011	57
21422418	17a-Ethynylestradiol	Desmedt C	Multifactorial approach to predicting resistance to anthracyclines.	Journal of clinical oncology 	2011	46
21445275	17a-Ethynylestradiol	Kawazu M	Histone demethylase JMJD2B functions as a co-factor of estrogen receptor in breast cancer proliferation and mammary gland development.	PloS one	2011	56
21482677	17a-Ethynylestradiol	Meyer DS	Luminal expression of PIK3CA mutant H1047R in the mammary gland induces heterogeneous tumors.	Cancer research	2011	43
21505063	17a-Ethynylestradiol	Sieuwerts AM	mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients.	Clinical cancer research 	2011	65
21553120	17a-Ethynylestradiol	Guttilla IK	Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs.	Breast cancer research and treatment	2012	38
21555689	17a-Ethynylestradiol	Ellis MJ	Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype--ACOSOG Z1031.	Journal of clinical oncology 	2011	96
21666713	17a-Ethynylestradiol	Bergamaschi A	Tamoxifen downregulation of miR-451 increases 14-3-3ζ and promotes breast cancer cell survival and endocrine resistance.	Oncogene	2012	62
21690342	17a-Ethynylestradiol	Jin K	The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway.	Proceedings of the National Academy of Sciences of the United States of America	2012	31
21713035	17a-Ethynylestradiol	Al Saleh S	Estrogen receptor silencing induces epithelial to mesenchymal transition in human breast cancer cells.	PloS one	2011	39
21737487	17a-Ethynylestradiol	Buffa FM	microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer.	Cancer research	2011	115
21738599	17a-Ethynylestradiol	Rothé F	Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer.	PloS one	2011	71
21741601	17a-Ethynylestradiol	Ni M	Targeting androgen receptor in estrogen receptor-negative breast cancer.	Cancer cell	2011	100
21796367	17a-Ethynylestradiol	van Nes JG	Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients.	Breast cancer research and treatment	2012	30
21807638	17a-Ethynylestradiol	Filipits M	A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors.	Clinical cancer research 	2011	96
21868760	17a-Ethynylestradiol	Qian P	Pivotal role of reduced let-7g expression in breast cancer invasion and metastasis.	Cancer research	2011	51
21878914	17a-Ethynylestradiol	Kong SL	Cellular reprogramming by the conjoint action of ERα, FOXA1, and GATA3 to a ligand-inducible growth state.	Molecular systems biology	2011	57
21893191	17a-Ethynylestradiol	Wertheimer E	Rac signaling in breast cancer: a tale of GEFs and GAPs.	Cellular signalling	2012	66
21908496	17a-Ethynylestradiol	Rojo F	Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer.	Annals of oncology 	2012	42
21916582	17a-Ethynylestradiol	Cook KL	Autophagy and endocrine resistance in breast cancer.	Expert review of anticancer therapy	2011	38
21940501	17a-Ethynylestradiol	Keller PJ	Defining the cellular precursors to human breast cancer.	Proceedings of the National Academy of Sciences of the United States of America	2012	84
21983130	17a-Ethynylestradiol	Chen X	Expression of the tumor suppressor miR-206 is associated with cellular proliferative inhibition and impairs invasion in ERα-positive endometrioid adenocarcinoma.	Cancer letters	2012	31
21984977	17a-Ethynylestradiol	Brough R	Functional viability profiles of breast cancer.	Cancer discovery	2011	49
22014575	17a-Ethynylestradiol	Chang CY	The metabolic regulator ERRα, a downstream target of HER2/IGF-1R, as a therapeutic target in breast cancer.	Cancer cell	2011	41
22042860	17a-Ethynylestradiol	Santagata S	High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer.	Proceedings of the National Academy of Sciences of the United States of America	2011	89
22056872	17a-Ethynylestradiol	Vesuna F	Twist contributes to hormone resistance in breast cancer by downregulating estrogen receptor-α.	Oncogene	2012	49
22083089	17a-Ethynylestradiol	Andò S	The multifactorial role of leptin in driving the breast cancer microenvironment.	Nature reviews. Endocrinology	2011	40
22125492	17a-Ethynylestradiol	Magnani L	PBX1 genomic pioneer function drives ERα signaling underlying progression in breast cancer.	PLoS genetics	2011	50
22138582	17a-Ethynylestradiol	Gerhardt J	FOXA1 promotes tumor progression in prostate cancer and represents a novel hallmark of castration-resistant prostate cancer.	The American journal of pathology	2012	32
22151997	17a-Ethynylestradiol	Chimge NO	Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2.	Breast cancer research 	2011	38
22158945	17a-Ethynylestradiol	Nasser MW	S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways.	Cancer research	2012	38
22223266	17a-Ethynylestradiol	Markowski DN	MED12 mutations in uterine fibroids--their relationship to cytogenetic subgroups.	International journal of cancer	2012	38
22231041	17a-Ethynylestradiol	Munster PN	Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer.	Journal of clinical oncology 	2012	33
22257677	17a-Ethynylestradiol	Guttilla IK	ERα, microRNAs, and the epithelial-mesenchymal transition in breast cancer.	Trends in endocrinology and metabolism	2012	31
22262870	17a-Ethynylestradiol	Haibe-Kains B	A three-gene model to robustly identify breast cancer molecular subtypes.	Journal of the National Cancer Institute	2012	86
22282662	17a-Ethynylestradiol	Barone I	Leptin mediates tumor-stromal interactions that promote the invasive growth of breast cancer cells.	Cancer research	2012	30
22301780	17a-Ethynylestradiol	Baumgarten SC	Minireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers.	Molecular endocrinology	2012	46
22391567	17a-Ethynylestradiol	Bernardo GM	FOXA1 represses the molecular phenotype of basal breast cancer cells.	Oncogene	2013	41
22417809	17a-Ethynylestradiol	Zhou C	Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration.	Breast cancer research 	2012	31
22420471	17a-Ethynylestradiol	Liu S	CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer.	Breast cancer research 	2012	82
22430211	17a-Ethynylestradiol	Yeramian A	Endometrial carcinoma: molecular alterations involved in tumor development and progression.	Oncogene	2013	26
22537901	17a-Ethynylestradiol	Tseng LM	CIP2A is a target of bortezomib in human triple negative breast cancer cells.	Breast cancer research 	2012	33
22573715	17a-Ethynylestradiol	Fagan DH	Acquired resistance to tamoxifen is associated with loss of the type I insulin-like growth factor receptor: implications for breast cancer treatment.	Cancer research	2012	45
22632819	17a-Ethynylestradiol	Zhi X	YAP promotes breast cell proliferation and survival partially through stabilizing the KLF5 transcription factor.	The American journal of pathology	2012	33
22660634	17a-Ethynylestradiol	Han SJ	A new isoform of steroid receptor coactivator-1 is crucial for pathogenic progression of endometriosis.	Nature medicine	2012	40
22692575	17a-Ethynylestradiol	Leth-Larsen R	Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis.	Molecular medicine	2012	36
22770227	17a-Ethynylestradiol	Kim J	Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer.	Breast cancer research 	2012	31
22853014	17a-Ethynylestradiol	Mehta RS	Combination anastrozole and fulvestrant in metastatic breast cancer.	The New England journal of medicine	2012	63
22875023	17a-Ethynylestradiol	Ramaswamy B	Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer aberrantly activated by PI3K/AKT pathway.	Cancer research	2012	60
22923429	17a-Ethynylestradiol	Khosla S	Pathogenesis of age-related bone loss in humans.	The journals of gerontology. Series A, Biological sciences and medical sciences	2013	34
23112837	17a-Ethynylestradiol	Castilla MÁ	MicroRNA-200 family modulation in distinct breast cancer phenotypes.	PloS one	2012	34
23136233	17a-Ethynylestradiol	Eiermann W	The 21-gene recurrence score assay impacts adjuvant therapy recommendations for ER-positive, node-negative and node-positive early breast cancer resulting in a risk-adapted change in chemotherapy use.	Annals of oncology 	2013	36
23178278	17a-Ethynylestradiol	Yue W	Estrogen receptor-dependent and independent mechanisms of breast cancer carcinogenesis.	Steroids	2013	45
23283688	17a-Ethynylestradiol	Knickmeyer RC	Common variants in psychiatric risk genes predict brain structure at birth.	Cerebral cortex	2014	38
23319822	17a-Ethynylestradiol	Wik E	Lack of estrogen receptor-α is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma.	Clinical cancer research 	2013	38
23334326	17a-Ethynylestradiol	D'Assoro AB	The mitotic kinase Aurora--a promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERα(+) breast cancer cells.	Oncogene	2014	38
23344024	17a-Ethynylestradiol	García-Becerra R	Mechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, miRNAs and genetically based resistance.	International journal of molecular sciences	2012	59
23379261	17a-Ethynylestradiol	Li Y	Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer.	Molecular cancer	2013	37
23403292	17a-Ethynylestradiol	Mohammed H	Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor.	Cell reports	2013	78
23442322	17a-Ethynylestradiol	Ithimakin S	HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: implications for efficacy of adjuvant trastuzumab.	Cancer research	2013	62
23492819	17a-Ethynylestradiol	Singh B	MicroRNA-93 regulates NRF2 expression and is associated with breast carcinogenesis.	Carcinogenesis	2013	34
23532539	17a-Ethynylestradiol	Dethlefsen C	The role of intratumoral and systemic IL-6 in breast cancer.	Breast cancer research and treatment	2013	67
23535731	17a-Ethynylestradiol	Bojesen SE	Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.	Nature genetics	2013	199
23535733	17a-Ethynylestradiol	Garcia-Closas M	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Nature genetics	2013	173
23536434	17a-Ethynylestradiol	Wardell SE	Bazedoxifene exhibits antiestrogenic activity in animal models of tamoxifen-resistant breast cancer: implications for treatment of advanced disease.	Clinical cancer research 	2013	28
23569315	17a-Ethynylestradiol	Rimawi MF	Multicenter phase II study of neoadjuvant lapatinib and trastuzumab with hormonal therapy and without chemotherapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer: TBCRC 006.	Journal of clinical oncology 	2013	45
23690420	17a-Ethynylestradiol	Hughes KS	Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343.	Journal of clinical oncology 	2013	77
23711559	17a-Ethynylestradiol	Feng S	Role of aryl hydrocarbon receptor in cancer.	Biochimica et biophysica acta	2013	35
23739063	17a-Ethynylestradiol	Loi S	Somatic mutation profiling and associations with prognosis and trastuzumab benefit in early breast cancer.	Journal of the National Cancer Institute	2013	37
23752191	17a-Ethynylestradiol	Li Q	Downregulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer.	Oncogene	2014	53
23791814	17a-Ethynylestradiol	Jiang X	The immune system and inflammation in breast cancer.	Molecular and cellular endocrinology	2014	28
23836010	17a-Ethynylestradiol	Mihály Z	A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer.	Breast cancer research and treatment	2013	53
23845444	17a-Ethynylestradiol	Vaillant F	Targeting BCL-2 with the BH3 mimetic ABT-199 in estrogen receptor-positive breast cancer.	Cancer cell	2013	72
23861811	17a-Ethynylestradiol	Lamb R	Wnt pathway activity in breast cancer sub-types and stem-like cells.	PloS one	2013	41
23872331	17a-Ethynylestradiol	Rance NE	Modulation of body temperature and LH secretion by hypothalamic KNDy (kisspeptin, neurokinin B and dynorphin) neurons: a novel hypothesis on the mechanism of hot flushes.	Frontiers in neuroendocrinology	2013	29
23954741	17a-Ethynylestradiol	Haldosén LA	Estrogen receptor beta in breast cancer.	Molecular and cellular endocrinology	2014	26
23958744	17a-Ethynylestradiol	Howe LR	Molecular pathways: adipose inflammation as a mediator of obesity-associated cancer.	Clinical cancer research 	2013	78
23971832	17a-Ethynylestradiol	Borges S	Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis.	Breast cancer research 	2013	28
24013225	17a-Ethynylestradiol	Zhou ZN	Autocrine HBEGF expression promotes breast cancer intravasation, metastasis and macrophage-independent invasion in vivo.	Oncogene	2014	26
24029245	17a-Ethynylestradiol	Sestak I	Factors predicting late recurrence for estrogen receptor-positive breast cancer.	Journal of the National Cancer Institute	2013	41
24055055	17a-Ethynylestradiol	Li S	Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts.	Cell reports	2013	146
24058649	17a-Ethynylestradiol	Babayan A	Heterogeneity of estrogen receptor expression in circulating tumor cells from metastatic breast cancer patients.	PloS one	2013	29
24060820	17a-Ethynylestradiol	Province MA	CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations.	Clinical pharmacology and therapeutics	2014	37
24077289	17a-Ethynylestradiol	Dey P	Estrogen receptor β upregulates FOXO3a and causes induction of apoptosis through PUMA in prostate cancer.	Oncogene	2014	29
24210818	17a-Ethynylestradiol	Wu Q	27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth.	Cell reports	2013	58
24217577	17a-Ethynylestradiol	Merenbakh-Lamin K	D538G mutation in estrogen receptor-α: A novel mechanism for acquired endocrine resistance in breast cancer.	Cancer research	2013	70
24258260	17a-Ethynylestradiol	Sørensen KP	Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer.	Breast cancer research and treatment	2013	66
24273215	17a-Ethynylestradiol	Vera-Badillo FE	Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis.	Journal of the National Cancer Institute	2014	56
24283290	17a-Ethynylestradiol	Liao XH	Estrogen receptor α mediates proliferation of breast cancer MCF-7 cells via a p21/PCNA/E2F1-dependent pathway.	The FEBS journal	2014	22
24288332	17a-Ethynylestradiol	Nelson ER	27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology.	Science	2013	122
24298069	17a-Ethynylestradiol	Zhang XH	Metastasis dormancy in estrogen receptor-positive breast cancer.	Clinical cancer research 	2013	32
24337597	17a-Ethynylestradiol	Auvinen P	Hyaluronan synthases (HAS1-3) in stromal and malignant cells correlate with breast cancer grade and predict patient survival.	Breast cancer research and treatment	2014	24
24343304	17a-Ethynylestradiol	Palmer JR	A collaborative study of the etiology of breast cancer subtypes in African American women: the AMBER consortium.	Cancer causes & control 	2014	33
24347518	17a-Ethynylestradiol	Gnant M	Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone.	Annals of oncology 	2014	43
24366116	17a-Ethynylestradiol	Vercellini P	Endometriosis: pathogenesis and treatment.	Nature reviews. Endocrinology	2014	57
24369047	17a-Ethynylestradiol	Rocca A	Palbociclib (PD 0332991) : targeting the cell cycle machinery in breast cancer.	Expert opinion on pharmacotherapy	2014	23
24398047	17a-Ethynylestradiol	Jeselsohn R	Emergence of constitutively active estrogen receptor-α mutations in pretreated advanced estrogen receptor-positive breast cancer.	Clinical cancer research 	2014	102
24449868	17a-Ethynylestradiol	Huang B	Differential expression of estrogen receptor α, β1, and β2 in lobular and ductal breast cancer.	Proceedings of the National Academy of Sciences of the United States of America	2014	24
24462521	17a-Ethynylestradiol	Győrffy B	TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancers.	Molecular oncology	2014	20
24469049	17a-Ethynylestradiol	Cyr AR	TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesis.	Oncogene	2015	22
24525122	17a-Ethynylestradiol	Zhao Z	17β-Estradiol treatment inhibits breast cell proliferation, migration and invasion by decreasing MALAT-1 RNA level.	Biochemical and biophysical research communications	2014	26
24620909	17a-Ethynylestradiol	Agner SC	Computerized image analysis for identifying triple-negative breast cancers and differentiating them from other molecular subtypes of breast cancer on dynamic contrast-enhanced MR images: a feasibility study.	Radiology	2014	25
24647569	17a-Ethynylestradiol	Schalper KA	In situ tumor PD-L1 mRNA expression is associated with increased TILs and better outcome in breast carcinomas.	Clinical cancer research 	2014	116
24663045	17a-Ethynylestradiol	Mayer IA	Stand up to cancer phase Ib study of pan-phosphoinositide-3-kinase inhibitor buparlisib with letrozole in estrogen receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer.	Journal of clinical oncology 	2014	49
24718936	17a-Ethynylestradiol	Scaling AL	GPER mediates estrogen-induced signaling and proliferation in human breast epithelial cells and normal and malignant breast.	Hormones & cancer	2014	22
24803582	17a-Ethynylestradiol	Silwal-Pandit L	TP53 mutation spectrum in breast cancer is subtype specific and has distinct prognostic relevance.	Clinical cancer research 	2014	41
24858917	17a-Ethynylestradiol	Ohba K	In vivo and in vitro studies suggest a possible involvement of HPV infection in the early stage of breast carcinogenesis via APOBEC3B induction.	PloS one	2014	26
24876105	17a-Ethynylestradiol	Dinami R	miR-155 drives telomere fragility in human breast cancer by targeting TRF1.	Cancer research	2014	23
24895374	17a-Ethynylestradiol	Rohan TE	Tumor microenvironment of metastasis and risk of distant metastasis of breast cancer.	Journal of the National Cancer Institute	2014	40
24915873	17a-Ethynylestradiol	Ali HR	Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients.	Annals of oncology 	2014	60
24957076	17a-Ethynylestradiol	Fuentes-Mattei E	Effects of obesity on transcriptomic changes and cancer hallmarks in estrogen receptor-positive breast cancer.	Journal of the National Cancer Institute	2014	32
25009010	17a-Ethynylestradiol	De Mattos-Arruda L	Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle.	Annals of oncology 	2014	63
25011475	17a-Ethynylestradiol	Jin UH	The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis.	BMC cancer	2014	22
25013076	17a-Ethynylestradiol	Yu M	Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility.	Science	2014	167
25038752	17a-Ethynylestradiol	Lim WK	Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenoma.	Nature genetics	2014	37
25071141	17a-Ethynylestradiol	Sabine VS	Mutational analysis of PI3K/AKT signaling pathway in tamoxifen exemestane adjuvant multinational pathology study.	Journal of clinical oncology 	2014	23
25091503	17a-Ethynylestradiol	Saladores P	Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancer.	The pharmacogenomics journal	2015	20
25185096	17a-Ethynylestradiol	Partridge AH	Chemotherapy and targeted therapy for women with human epidermal growth factor receptor 2-negative (or unknown) advanced breast cancer: American Society of Clinical Oncology Clinical Practice Guideline.	Journal of clinical oncology 	2014	43
25208879	17a-Ethynylestradiol	Burstein MD	Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer.	Clinical cancer research 	2015	92
25213081	17a-Ethynylestradiol	Bergamaschi A	The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells.	Breast cancer research 	2014	22
25224496	17a-Ethynylestradiol	Palmer JR	Parity, lactation, and breast cancer subtypes in African American women: results from the AMBER Consortium.	Journal of the National Cancer Institute	2014	43
25241899	17a-Ethynylestradiol	Finlay-Schultz J	Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a.	Oncogene	2015	16
25284585	17a-Ethynylestradiol	Dillon LM	P-REX1 creates a positive feedback loop to activate growth factor receptor, PI3K/AKT and MEK/ERK signaling in breast cancer.	Oncogene	2015	19
25307233	17a-Ethynylestradiol	Zhao W	Comprehensive characterization of cancer subtype associated long non-coding RNAs and their clinical implications.	Scientific reports	2014	26
25313140	17a-Ethynylestradiol	Hashim A	RNA sequencing identifies specific PIWI-interacting small non-coding RNA expression patterns in breast cancer.	Oncotarget	2014	28
25339261	17a-Ethynylestradiol	Jordan VC	The new biology of estrogen-induced apoptosis applied to treat and prevent breast cancer.	Endocrine-related cancer	2015	23
25347744	17a-Ethynylestradiol	Mahajan K	ACK1/TNK2 tyrosine kinase: molecular signaling and evolving role in cancers.	Oncogene	2015	21
25361613	17a-Ethynylestradiol	Ibrahim EM	The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis.	Breast cancer research and treatment	2014	33
25361981	17a-Ethynylestradiol	Tobin NP	Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival.	Annals of oncology 	2015	17
25380844	17a-Ethynylestradiol	van Kruchten M	Measuring residual estrogen receptor availability during fulvestrant therapy in patients with metastatic breast cancer.	Cancer discovery	2015	18
25381136	17a-Ethynylestradiol	Twelves C	Efficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studies.	Breast cancer research and treatment	2014	29
25381338	17a-Ethynylestradiol	Paoletti C	Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer.	Clinical cancer research 	2015	20
25388283	17a-Ethynylestradiol	Bailey ST	Loss of estrogen-regulated microRNA expression increases HER2 signaling and is prognostic of poor outcome in luminal breast cancer.	Cancer research	2015	17
25406186	17a-Ethynylestradiol	Patel B	Role of nuclear progesterone receptor isoforms in uterine pathophysiology.	Human reproduction update	2015	16
25488809	17a-Ethynylestradiol	Wade MA	The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer.	Nucleic acids research	2015	18
25489079	17a-Ethynylestradiol	Whitesell L	HSP90 empowers evolution of resistance to hormonal therapy in human breast cancer models.	Proceedings of the National Academy of Sciences of the United States of America	2014	23
25529635	17a-Ethynylestradiol	Glubb DM	Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.	American journal of human genetics	2015	23
25532911	17a-Ethynylestradiol	Meyer MR	G protein-coupled estrogen receptor protects from atherosclerosis.	Scientific reports	2014	22
25538079	17a-Ethynylestradiol	Martz CA	Systematic identification of signaling pathways with potential to confer anticancer drug resistance.	Science signaling	2014	47
25592968	17a-Ethynylestradiol	Fang D	17β-estradiol regulates cell proliferation, colony formation, migration, invasion and promotes apoptosis by upregulating miR-9 and thus degrades MALAT-1 in osteosarcoma cell MG-63 in an estrogen receptor-independent manner.	Biochemical and biophysical research communications	2015	17
25633049	17a-Ethynylestradiol	Vilquin P	MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.	Breast cancer research 	2015	17
25713166	17a-Ethynylestradiol	Ng CK	Breast cancer genomics from microarrays to massively parallel sequencing: paradigms and new insights.	Journal of the National Cancer Institute	2015	21
25720324	17a-Ethynylestradiol	Nawaz S	Beyond immune density: critical role of spatial heterogeneity in estrogen receptor-negative breast cancer.	Modern pathology 	2015	16
25752574	17a-Ethynylestradiol	Franco HL	TNFα signaling exposes latent estrogen receptor binding sites to alter the breast cancer cell transcriptome.	Molecular cell	2015	24
25792301	17a-Ethynylestradiol	Dhillon S	Palbociclib: first global approval.	Drugs	2015	18
25825707	17a-Ethynylestradiol	Tang H	Decreased BECN1 mRNA Expression in Human Breast Cancer is Associated with Estrogen Receptor-Negative Subtypes and Poor Prognosis.	EBioMedicine	2015	22
25855707	17a-Ethynylestradiol	Mavaddat N	Prediction of breast cancer risk based on profiling with common genetic variants.	Journal of the National Cancer Institute	2015	85
25879485	17a-Ethynylestradiol	Lai A	Identification of GDC-0810 (ARN-810), an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) that Demonstrates Robust Activity in Tamoxifen-Resistant Breast Cancer Xenografts.	Journal of medicinal chemistry	2015	29
25892662	17a-Ethynylestradiol	Feitelson MA	Sustained proliferation in cancer: Mechanisms and novel therapeutic targets.	Seminars in cancer biology	2015	24
25964252	17a-Ethynylestradiol	Warner ET	Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors.	Journal of clinical oncology 	2015	25
25979954	17a-Ethynylestradiol	Guttery DS	Noninvasive detection of activating estrogen receptor 1 (ESR1) mutations in estrogen receptor-positive metastatic breast cancer.	Clinical chemistry	2015	27
25990368	17a-Ethynylestradiol	Yuan J	Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.	Breast cancer research 	2015	16
25991817	17a-Ethynylestradiol	Wardell SE	Efficacy of SERD/SERM Hybrid-CDK4/6 Inhibitor Combinations in Models of Endocrine Therapy-Resistant Breast Cancer.	Clinical cancer research 	2015	19
25995301	17a-Ethynylestradiol	Dieci MV	Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials.	Annals of oncology 	2015	23
26033453	17a-Ethynylestradiol	Stückrath I	Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients.	Oncotarget	2015	16
26056290	17a-Ethynylestradiol	den Boon JA	Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling.	Proceedings of the National Academy of Sciences of the United States of America	2015	30
26124144	17a-Ethynylestradiol	Honda S	Sex hormone-dependent tRNA halves enhance cell proliferation in breast and prostate cancers.	Proceedings of the National Academy of Sciences of the United States of America	2015	33
26166704	17a-Ethynylestradiol	Li W	Condensin I and II Complexes License Full Estrogen Receptor α-Dependent Enhancer Activation.	Molecular cell	2015	18
26243145	17a-Ethynylestradiol	Sousa S	Human breast cancer cells educate macrophages toward the M2 activation status.	Breast cancer research 	2015	30
26251289	17a-Ethynylestradiol	Johnston SR	Enhancing Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer: Cotargeting Signaling Pathways.	Journal of the National Cancer Institute	2015	20
26257067	17a-Ethynylestradiol	Merino D	Targeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancer.	Oncogene	2016	14
26261103	17a-Ethynylestradiol	Chu D	ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer Patients.	Clinical cancer research 	2016	32
26286584	17a-Ethynylestradiol	Strong AL	Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers.	Breast cancer research 	2015	20
26311719	17a-Ethynylestradiol	Deng L	MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension.	Circulation research	2015	26
26324739	17a-Ethynylestradiol	Beaver JA	FDA Approval: Palbociclib for the Treatment of Postmenopausal Patients with Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer.	Clinical cancer research 	2015	33
26476745	17a-Ethynylestradiol	Tsuboi M	APOBEC3B high expression status is associated with aggressive phenotype in Japanese breast cancers.	Breast cancer	2016	10
26487756	17a-Ethynylestradiol	Chen X	Estrogen Metabolite 16α-Hydroxyestrone Exacerbates Bone Morphogenetic Protein Receptor Type II-Associated Pulmonary Arterial Hypertension Through MicroRNA-29-Mediated Modulation of Cellular Metabolism.	Circulation	2016	21
26541326	17a-Ethynylestradiol	Baptista MZ	Prognostic significance of PD-L1 and PD-L2 in breast cancer.	Human pathology	2016	27
26586665	17a-Ethynylestradiol	Meeks HD	BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.	Journal of the National Cancer Institute	2016	14
26598746	17a-Ethynylestradiol	Levine MN	Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario.	Journal of clinical oncology 	2016	17
26899533	17a-Ethynylestradiol	Masuda T	Clinical and biological significance of circulating tumor cells in cancer.	Molecular oncology	2016	14
26919573	17a-Ethynylestradiol	Klair JS	A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease.	Hepatology	2016	12
26923330	17a-Ethynylestradiol	Johnson J	Targeting the RB-E2F pathway in breast cancer.	Oncogene	2016	16
26928228	17a-Ethynylestradiol	Dunning AM	Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.	Nature genetics	2016	18
26947176	17a-Ethynylestradiol	Sflomos G	A Preclinical Model for ERα-Positive Breast Cancer Points to the Epithelial Microenvironment as Determinant of Luminal Phenotype and Hormone Response.	Cancer cell	2016	22
26960396	17a-Ethynylestradiol	Piscuoglio S	The Genomic Landscape of Male Breast Cancers.	Clinical cancer research 	2016	16
26995633	17a-Ethynylestradiol	Yang SX	New insights on PI3K/AKT pathway alterations and clinical outcomes in breast cancer.	Cancer treatment reviews	2016	25
27020862	17a-Ethynylestradiol	Weir HM	AZD9496: An Oral Estrogen Receptor Inhibitor That Blocks the Growth of ER-Positive and ESR1-Mutant Breast Tumors in Preclinical Models.	Cancer research	2016	17
27029038	17a-Ethynylestradiol	Micucci C	Current perspectives between metabolic syndrome and cancer.	Oncotarget	2016	13
27059645	17a-Ethynylestradiol	Steelman LS	The therapeutic potential of mTOR inhibitors in breast cancer.	British journal of clinical pharmacology	2016	13
27073890	17a-Ethynylestradiol	Mao Y	The Prognostic Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-Analysis.	PloS one	2016	16
27160528	17a-Ethynylestradiol	Mamtani A	How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study.	Annals of surgical oncology	2016	13
27225691	17a-Ethynylestradiol	Speers C	Maternal Embryonic Leucine Zipper Kinase (MELK) as a Novel Mediator and Biomarker of Radioresistance in Human Breast Cancer.	Clinical cancer research 	2016	13
27226503	17a-Ethynylestradiol	Gradishar W	NCCN Guidelines Update: Breast Cancer.	Journal of the National Comprehensive Cancer Network 	2016	10
27277684	17a-Ethynylestradiol	Singh R	Regulation of alternative splicing of Bcl-x by BC200 contributes to breast cancer pathogenesis.	Cell death & disease	2016	12
27348297	17a-Ethynylestradiol	Gibson WJ	The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis.	Nature genetics	2016	23
27349747	17a-Ethynylestradiol	Finn RS	Efficacy and safety of palbociclib in combination with letrozole as first-line treatment of ER-positive, HER2-negative, advanced breast cancer: expanded analyses of subgroups from the randomized pivotal trial PALOMA-1/TRIO-18.	Breast cancer research 	2016	15
27400969	17a-Ethynylestradiol	Buus R	Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy.	Journal of the National Cancer Institute	2016	14
27513155	17a-Ethynylestradiol	Giuliano AE	Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial.	Annals of surgery	2016	30
27532364	17a-Ethynylestradiol	Chandarlapaty S	Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer: A Secondary Analysis of the BOLERO-2 Clinical Trial.	JAMA oncology	2016	30
27694385	17a-Ethynylestradiol	Svoronos N	Tumor Cell-Independent Estrogen Signaling Drives Disease Progression through Mobilization of Myeloid-Derived Suppressor Cells.	Cancer discovery	2017	12
27748765	17a-Ethynylestradiol	Harrod A	Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer.	Oncogene	2017	8
27879270	17a-Ethynylestradiol	Shibata T	Breast Cancer Resistance to Antiestrogens Is Enhanced by Increased ER Degradation and ERBB2 Expression.	Cancer research	2017	5
27886589	17a-Ethynylestradiol	Angus L	ESR1 mutations: Moving towards guiding treatment decision-making in metastatic breast cancer patients.	Cancer treatment reviews	2017	5
27902959	17a-Ethynylestradiol	Lee GA	Kaempferol, a phytoestrogen, suppressed triclosan-induced epithelial-mesenchymal transition and metastatic-related behaviors of MCF-7 breast cancer cells.	Environmental toxicology and pharmacology	2017	5
27903149	17a-Ethynylestradiol	Jiralerspong S	Obesity and Breast Cancer Prognosis: Evidence, Challenges, and Opportunities.	Journal of clinical oncology 	2016	14
27914795	17a-Ethynylestradiol	Wintrob ZA	Insulin use, adipokine profiles and breast cancer prognosis.	Cytokine	2017	11
27926948	17a-Ethynylestradiol	Priedigkeit N	Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases.	JAMA oncology	2017	9
27939373	17a-Ethynylestradiol	Nault JC	Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.	Gastroenterology	2017	7
27940449	17a-Ethynylestradiol	Page K	Next Generation Sequencing of Circulating Cell-Free DNA for Evaluating Mutations and Gene Amplification in Metastatic Breast Cancer.	Clinical chemistry	2017	6
28045625	17a-Ethynylestradiol	Ellis MJ	Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance).	Journal of clinical oncology 	2017	11
28147342	17a-Ethynylestradiol	McDermott MS	Inhibition of CDK8 mediator kinase suppresses estrogen dependent transcription and the growth of estrogen receptor positive breast cancer.	Oncotarget	2017	5
28249905	17a-Ethynylestradiol	Cejalvo JM	Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer.	Cancer research	2017	9
28249908	17a-Ethynylestradiol	Jansen VM	Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer.	Cancer research	2017	8
28270386	17a-Ethynylestradiol	Iyengar NM	Metabolic Obesity, Adipose Inflammation and Elevated Breast Aromatase in Women with Normal Body Mass Index.	Cancer prevention research	2017	8
28270497	17a-Ethynylestradiol	Ma CX	NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer.	Clinical cancer research 	2017	10
28274582	17a-Ethynylestradiol	Jameera Begam A	Estrogen receptor agonists/antagonists in breast cancer therapy: A critical review.	Bioorganic chemistry	2017	6
11870167	Platinum	Bristow RE	Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis.	Journal of clinical oncology 	2002	270
12409326	Platinum	Scagliotti GV	Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer.	Journal of clinical oncology 	2002	123
12748309	Platinum	Abrams TJ	SU11248 inhibits KIT and platelet-derived growth factor receptor beta in preclinical models of human small cell lung cancer.	Molecular cancer therapeutics	2003	147
15173214	Platinum	Gurubhagavatula S	XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy.	Journal of clinical oncology 	2004	76
15310767	Platinum	Pérez-Soler R	Determinants of tumor response and survival with erlotinib in patients with non--small-cell lung cancer.	Journal of clinical oncology 	2004	157
17229776	Platinum	Bellmunt J	Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy.	Annals of oncology 	2007	69
17290060	Platinum	Dressman HK	An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.	Journal of clinical oncology 	2007	95
17909199	Platinum	Herbst RS	Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancer.	Journal of clinical oncology 	2007	94
18165643	Platinum	Garcia AA	Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia.	Journal of clinical oncology 	2008	135
18235126	Platinum	Socinski MA	Multicenter, phase II trial of sunitinib in previously treated, advanced non-small-cell lung cancer.	Journal of clinical oncology 	2008	84
18263769	Platinum	Ramalingam S	Systemic chemotherapy for advanced non-small cell lung cancer: recent advances and future directions.	The oncologist	2008	80
18264087	Platinum	Sakai W	Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers.	Nature	2008	241
18649131	Platinum	Byrski T	Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients.	Breast cancer research and treatment	2009	76
18836486	Platinum	Baba T	Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells.	Oncogene	2009	126
19027483	Platinum	Kim ES	Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial.	Lancet	2008	278
19332730	Platinum	Natale RB	Vandetanib versus gefitinib in patients with advanced non-small-cell lung cancer: results from a two-part, double-blind, randomized phase ii study.	Journal of clinical oncology 	2009	55
19349352	Platinum	Kuo KT	Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma.	The American journal of pathology	2009	98
19410716	Platinum	Pirker R	Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial.	Lancet	2009	310
19414683	Platinum	Bai H	Epidermal growth factor receptor mutations in plasma DNA samples predict tumor response in Chinese patients with stages IIIB to IV non-small-cell lung cancer.	Journal of clinical oncology 	2009	96
19549709	Platinum	Soria JC	Efficacy of everolimus (RAD001) in patients with advanced NSCLC previously treated with chemotherapy alone or with chemotherapy and EGFR inhibitors.	Annals of oncology 	2009	45
19652055	Platinum	Blumenschein GR Jr	Phase II, multicenter, uncontrolled trial of single-agent sorafenib in patients with relapsed or refractory, advanced non-small-cell lung cancer.	Journal of clinical oncology 	2009	51
19667264	Platinum	Shaw AT	Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK.	Journal of clinical oncology 	2009	422
19805294	Platinum	Bertolini G	Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.	Proceedings of the National Academy of Sciences of the United States of America	2009	248
19917871	Platinum	Azzoli CG	American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer.	Journal of clinical oncology 	2009	145
20103634	Platinum	Galanis E	Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer.	Cancer research	2010	101
20104527	Platinum	Delage B	Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer.	International journal of cancer	2010	65
20150572	Platinum	Reck M	Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL).	Annals of oncology 	2010	138
20164691	Platinum	Isakoff SJ	Triple-negative breast cancer: role of specific chemotherapy agents.	Cancer journal	2010	55
20406929	Platinum	Fong PC	Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval.	Journal of clinical oncology 	2010	223
20534738	Platinum	Solis LM	Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features.	Clinical cancer research 	2010	105
20551945	Platinum	Janku F	Targeted therapy in non-small-cell lung cancer--is it becoming a reality?	Nature reviews. Clinical oncology	2010	63
20581869	Platinum	Cooke SL	Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma.	Oncogene	2010	52
20889728	Platinum	Landen CN Jr	Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer.	Molecular cancer therapeutics	2010	114
21041624	Platinum	Su F	Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer.	Proceedings of the National Academy of Sciences of the United States of America	2010	56
21048039	Platinum	Licitra L	Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study.	Annals of oncology 	2011	58
21216927	Platinum	Rizzo S	Ovarian cancer stem cell-like side populations are enriched following chemotherapy and overexpress EZH2.	Molecular cancer therapeutics	2011	65
21299897	Platinum	Wilken R	Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma.	Molecular cancer	2011	111
21468130	Platinum	Forster MD	Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer.	Nature reviews. Clinical oncology	2011	42
21618587	Platinum	Latifi A	Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile.	Journal of cellular biochemistry	2011	70
21627863	Platinum	Wei J	Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer.	Chinese journal of cancer	2011	50
21676886	Platinum	Konstantinopoulos PA	Keap1 mutations and Nrf2 pathway activation in epithelial ovarian cancer.	Cancer research	2011	61
21709188	Platinum	Norquist B	Secondary somatic mutations restoring BRCA1/2 predict chemotherapy resistance in hereditary ovarian carcinomas.	Journal of clinical oncology 	2011	102
21934105	Platinum	Lowery MA	An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment implications, and future directions.	The oncologist	2011	43
21990299	Platinum	Yang D	Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer.	JAMA	2011	113
22119437	Platinum	Soria JC	EGFR-mutated oncogene-addicted non-small cell lung cancer: current trends and future prospects.	Cancer treatment reviews	2012	37
22131882	Platinum	Stronach EA	DNA-PK mediates AKT activation and apoptosis inhibition in clinically acquired platinum resistance.	Neoplasia	2011	41
22142828	Platinum	Steg AD	Stem cell pathways contribute to clinical chemoresistance in ovarian cancer.	Clinical cancer research 	2012	92
22203755	Platinum	Kaye SB	Phase II, open-label, randomized, multicenter study comparing the efficacy and safety of olaparib, a poly (ADP-ribose) polymerase inhibitor, and pegylated liposomal doxorubicin in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer.	Journal of clinical oncology 	2012	106
22237007	Platinum	Gao W	MiRNA-21: a biomarker predictive for platinum-based adjuvant chemotherapy response in patients with non-small cell lung cancer.	Cancer biology & therapy	2012	33
22278287	Platinum	Ajabnoor GM	Paclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF-7 breast cancer cells.	Cell death & disease	2012	33
22330607	Platinum	Kim A	Therapeutic strategies in epithelial ovarian cancer.	Journal of experimental & clinical cancer research 	2012	67
22330686	Platinum	Postel-Vinay S	The potential of exploiting DNA-repair defects for optimizing lung cancer treatment.	Nature reviews. Clinical oncology	2012	31
22416079	Platinum	Romero I	Minireview: human ovarian cancer: biology, current management, and paths to personalizing therapy.	Endocrinology	2012	76
22452356	Platinum	Ledermann J	Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer.	The New England journal of medicine	2012	239
22473592	Platinum	Seront E	Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers.	Annals of oncology 	2012	33
22593197	Platinum	Berns EM	The changing view of high-grade serous ovarian cancer.	Cancer research	2012	43
22721387	Platinum	Tang Z	The role of mesothelin in tumor progression and targeted therapy.	Anti-cancer agents in medicinal chemistry	2013	27
22897840	Platinum	Marchini S	Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer.	European journal of cancer	2013	43
22965962	Platinum	Ramlau R	Aflibercept and Docetaxel versus Docetaxel alone after platinum failure in patients with advanced or metastatic non-small-cell lung cancer: a randomized, controlled phase III trial.	Journal of clinical oncology 	2012	38
22996961	Platinum	Castellarin M	Clonal evolution of high-grade serous ovarian carcinoma from primary to recurrent disease.	The Journal of pathology	2013	27
23012302	Platinum	André F	Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents.	Annals of oncology 	2012	66
23017820	Platinum	Obermayr E	Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance -- a study of the OVCAD consortium.	Gynecologic oncology	2013	26
23019585	Platinum	McAuliffe SM	Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy.	Proceedings of the National Academy of Sciences of the United States of America	2012	87
23045278	Platinum	van Jaarsveld MT	miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells.	Oncogene	2013	59
23129122	Platinum	Wu YL	Erlotinib as second-line treatment in patients with advanced non-small-cell lung cancer and asymptomatic brain metastases: a phase II study (CTONG-0803).	Annals of oncology 	2013	46
23135908	Platinum	Liu YP	Cisplatin selects for multidrug-resistant CD133+ cells in lung adenocarcinoma by activating Notch signaling.	Cancer research	2013	44
23349823	Platinum	Barr MP	Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature.	PloS one	2013	52
23649446	Platinum	Socinski MA	Treatment of stage IV non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.	Chest	2013	28
23649448	Platinum	Jett JR	Treatment of small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.	Chest	2013	45
23782814	Platinum	Wu YL	Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trial.	The Lancet. Oncology	2013	75
23810788	Platinum	Sandhu SK	The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial.	The Lancet. Oncology	2013	101
23833300	Platinum	Cardarella S	Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer.	Clinical cancer research 	2013	46
23950211	Platinum	Zhang L	miR-153 supports colorectal cancer progression via pleiotropic effects that enhance invasion and chemotherapeutic resistance.	Cancer research	2013	39
24035405	Platinum	Calabrò L	Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial.	The Lancet. Oncology	2013	48
24085845	Platinum	Johnson N	Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance.	Proceedings of the National Academy of Sciences of the United States of America	2013	36
24240112	Platinum	Pennington KP	Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas.	Clinical cancer research 	2014	94
24366758	Platinum	Koizumi W	Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START).	Journal of cancer research and clinical oncology	2014	27
24366937	Platinum	Vergote IB	Randomized phase III study of erlotinib versus observation in patients with no evidence of disease progression after first-line platin-based chemotherapy for ovarian carcinoma: a European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group, and Gynecologic Cancer Intergroup study.	Journal of clinical oncology 	2014	26
24439931	Platinum	Rajan A	Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial.	The Lancet. Oncology	2014	25
24560445	Platinum	Topp MD	Molecular correlates of platinum response in human high-grade serous ovarian cancer patient-derived xenografts.	Molecular oncology	2014	30
24727321	Platinum	Beltran H	Aggressive variants of castration-resistant prostate cancer.	Clinical cancer research 	2014	59
24794243	Platinum	von Minckwitz G	Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial.	The Lancet. Oncology	2014	100
24858042	Platinum	Miow QH	Epithelial-mesenchymal status renders differential responses to cisplatin in ovarian cancer.	Oncogene	2015	26
24886434	Platinum	Abubaker K	Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden.	BMC cancer	2014	23
24933332	Platinum	Garon EB	Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial.	Lancet	2014	158
25015375	Platinum	Kuhlmann JD	ERCC1-positive circulating tumor cells in the blood of ovarian cancer patients as a predictive biomarker for platinum resistance.	Clinical chemistry	2014	20
25069034	Platinum	Sullivan I	Pharmacogenetics of the DNA repair pathways in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.	Cancer letters	2014	22
25072261	Platinum	Golan T	Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers.	British journal of cancer	2014	31
25091798	Platinum	Masterson L	De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: a systematic review and meta-analysis of current clinical trials.	European journal of cancer	2014	39
25154822	Platinum	Ang KK	Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522.	Journal of clinical oncology 	2014	120
25165721	Platinum	Ozkok A	Pathophysiology of cisplatin-induced acute kidney injury.	BioMed research international	2014	54
25216266	Platinum	Meng E	ALDH1A1 maintains ovarian cancer stem cell-like properties by altered regulation of cell cycle checkpoint and DNA repair network signaling.	PloS one	2014	28
25218906	Platinum	Liu JF	Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study.	The Lancet. Oncology	2014	73
25349291	Platinum	Iyengar P	Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer.	Journal of clinical oncology 	2014	35
25359574	Platinum	Lo Iacono M	ATF2 contributes to cisplatin resistance in non-small cell lung cancer and celastrol induces cisplatin resensitization through inhibition of JNK/ATF2 pathway.	International journal of cancer	2015	15
25366685	Platinum	Kaufman B	Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation.	Journal of clinical oncology 	2015	192
25370471	Platinum	Sarker D	First-in-human phase I study of pictilisib (GDC-0941), a potent pan-class I phosphatidylinositol-3-kinase (PI3K) inhibitor, in patients with advanced solid tumors.	Clinical cancer research 	2015	54
25398436	Platinum	Galanis E	Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer.	Cancer research	2015	44
25481791	Platinum	Oza AM	Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial.	The Lancet. Oncology	2015	87
25597412	Platinum	Fujita Y	The clinical relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 network in chemoresistant non-small-cell lung cancer.	Molecular therapy 	2015	28
25636205	Platinum	Groenendijk FH	ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy.	European urology	2016	19
25646366	Platinum	Caplin ME	Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids.	Annals of oncology 	2015	35
25707631	Platinum	Nick AM	A framework for a personalized surgical approach to ovarian cancer.	Nature reviews. Clinical oncology	2015	28
25722381	Platinum	Blumenschein GR Jr	A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)†.	Annals of oncology 	2015	34
25770156	Platinum	Watkins J	Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers.	Cancer discovery	2015	17
25823737	Platinum	Stevanović S	Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells.	Journal of clinical oncology 	2015	61
25847936	Platinum	Isakoff SJ	TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer.	Journal of clinical oncology 	2015	54
25979846	Platinum	Panou V	The established and future biomarkers of malignant pleural mesothelioma.	Cancer treatment reviews	2015	17
26014294	Platinum	Zhou C	BEYOND: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study of First-Line Carboplatin/Paclitaxel Plus Bevacizumab or Placebo in Chinese Patients With Advanced or Recurrent Nonsquamous Non-Small-Cell Lung Cancer.	Journal of clinical oncology 	2015	37
26017449	Platinum	Patch AM	Whole-genome characterization of chemoresistant ovarian cancer.	Nature	2015	158
26119935	Platinum	Ciamporcero E	YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage.	Oncogene	2016	19
26125441	Platinum	Nagaraj AB	Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.	Oncotarget	2015	30
26159065	Platinum	Soria JC	Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR-mutation-positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS): a phase 3 randomised trial.	The Lancet. Oncology	2015	69
26169611	Platinum	Scagliotti G	Phase III Multinational, Randomized, Double-Blind, Placebo-Controlled Study of Tivantinib (ARQ 197) Plus Erlotinib Versus Erlotinib Alone in Previously Treated Patients With Locally Advanced or Metastatic Nonsquamous Non-Small-Cell Lung Cancer.	Journal of clinical oncology 	2015	52
26181256	Platinum	Beltran H	Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.	JAMA oncology	2015	52
26279307	Platinum	He J	Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer.	Scientific reports	2015	48
26317305	Platinum	Phillips T	Development of an automated PD-L1 immunohistochemistry (IHC) assay for non-small cell lung cancer.	Applied immunohistochemistry & molecular morphology 	2015	32
26324367	Platinum	Masters GA	Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.	Journal of clinical oncology 	2015	74
26351341	Platinum	Sacco AG	Current Treatment Options for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.	Journal of clinical oncology 	2015	33
26410730	Platinum	Oing C	Second Line Chemotherapy for Advanced and Metastatic Urothelial Carcinoma: Vinflunine and Beyond-A Comprehensive Review of the Current Literature.	The Journal of urology	2016	10
26463832	Platinum	Konstantinopoulos PA	Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer.	Cancer discovery	2015	39
26511885	Platinum	Alexandrov LB	A mutational signature in gastric cancer suggests therapeutic strategies.	Nature communications	2015	20
26530471	Platinum	Planells-Cases R	Subunit composition of VRAC channels determines substrate specificity and cellular resistance to Pt-based anti-cancer drugs.	The EMBO journal	2015	19
26716514	Platinum	Cheng H	Functional genomics screen identifies YAP1 as a key determinant to enhance treatment sensitivity in lung cancer cells.	Oncotarget	2016	17
26724258	Platinum	Cheng HH	Biallelic Inactivation of BRCA2 in Platinum-sensitive Metastatic Castration-resistant Prostate Cancer.	European urology	2016	11
26745875	Platinum	Mafficini A	BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing.	Oncotarget	2016	11
26823294	Platinum	Schuler M	First-Line Afatinib versus Chemotherapy in Patients with Non-Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain Metastases.	Journal of thoracic oncology 	2016	17
26898616	Platinum	Tan CS	Next-generation epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor -mutant non-small cell lung cancer.	Lung cancer	2016	23
26957554	Platinum	Telli ML	Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer.	Clinical cancer research 	2016	33
26984449	Platinum	Kazandjian D	FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy.	The oncologist	2016	36
27002934	Platinum	Drew Y	Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer.	British journal of cancer	2016	19
27026676	Platinum	Sul J	FDA Approval Summary: Pembrolizumab for the Treatment of Patients With Metastatic Non-Small Cell Lung Cancer Whose Tumors Express Programmed Death-Ligand 1.	The oncologist	2016	24
27041570	Platinum	Özeş AR	NF-κB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer.	Oncogene	2016	19
27074572	Platinum	Zhou M	Comprehensive analysis of lncRNA expression profiles reveals a novel lncRNA signature to discriminate nonequivalent outcomes in patients with ovarian cancer.	Oncotarget	2016	49
27265743	Platinum	Planchard D	A Phase III Study of Durvalumab (MEDI4736) With or Without Tremelimumab for Previously Treated Patients With Advanced NSCLC: Rationale and Protocol Design of the ARCTIC Study.	Clinical lung cancer	2016	21
27283860	Platinum	Planchard D	Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial.	The Lancet. Oncology	2016	43
27432917	Platinum	Crinò L	Multicenter Phase II Study of Whole-Body and Intracranial Activity With Ceritinib in Patients With ALK-Rearranged Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib: Results From ASCEND-2.	Journal of clinical oncology 	2016	38
27502726	Platinum	Olaussen KA	Predictors of chemotherapy efficacy in non-small-cell lung cancer: a challenging landscape.	Annals of oncology 	2016	12
27590317	Platinum	Mateo J	DNA Repair in Prostate Cancer: Biology and Clinical Implications.	European urology	2017	7
27733243	Platinum	Sharma P	Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial.	The Lancet. Oncology	2016	42
27803005	Platinum	Lee SH	Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial.	Annals of oncology 	2017	9
27932068	Platinum	Rudin CM	Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study.	The Lancet. Oncology	2017	23
27937096	Platinum	Spigel DR	Results From the Phase III Randomized Trial of Onartuzumab Plus Erlotinib Versus Erlotinib in Previously Treated Stage IIIB or IV Non-Small-Cell Lung Cancer: METLung.	Journal of clinical oncology 	2017	13
28104537	Platinum	Rangachari D	Correlation between Classic Driver Oncogene Mutations in EGFR, ALK, or ROS1 and 22C3-PD-L1 ≥50% Expression in Lung Adenocarcinoma.	Journal of thoracic oncology 	2017	10
28131785	Platinum	Sharma P	Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial.	The Lancet. Oncology	2017	58
28212060	Platinum	Bellmunt J	Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma.	The New England journal of medicine	2017	70
28221868	Platinum	Lheureux S	Somatic BRCA1/2 Recovery as a Resistance Mechanism After Exceptional Response to Poly (ADP-ribose) Polymerase Inhibition.	Journal of clinical oncology 	2017	8
28328302	Platinum	Bauml J	Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study.	Journal of clinical oncology 	2017	19
28373005	Platinum	Gulley JL	Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial.	The Lancet. Oncology	2017	23
28407528	Platinum	Giroux Leprieur E	Immunotherapy revolutionises non-small-cell lung cancer therapy: Results, perspectives and new challenges.	European journal of cancer	2017	7
28424325	Platinum	Ning YM	FDA Approval Summary: Atezolizumab for the Treatment of Patients with Progressive Advanced Urothelial Carcinoma after Platinum-Containing Chemotherapy.	The oncologist	2017	11
28490518	Platinum	Sen T	CHK1 Inhibition in Small-Cell Lung Cancer Produces Single-Agent Activity in Biomarker-Defined Disease Subsets and Combination Activity with Cisplatin or Olaparib.	Cancer research	2017	9
28754483	Platinum	Pujade-Lauraine E	Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial.	The Lancet. Oncology	2017	14
9809557	Thymidine	Eriksson PS	Neurogenesis in the adult human hippocampus.	Nature medicine	1998	1036
9809561	Thymidine	Shields AF	Imaging proliferation in vivo with F-18FLT and positron emission tomography.	Nature medicine	1998	219
10778957	Thymidine	Salonga D	Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase.	Clinical cancer research 	2000	124
10955814	Thymidine	Ueno T	Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer.	Clinical cancer research 	2000	166
11502704	Thymidine	Morrell NW	Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins.	Circulation	2001	104
12215561	Thymidine	Rasey JS	Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells.	Journal of nuclear medicine 	2002	81
16716759	Thymidine	Braat H	A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease.	Clinical gastroenterology and hepatology 	2006	121
16905462	Thymidine	Kim JH	Systemic armed oncolytic and immunologic therapy for cancer with JX-594, a targeted poxvirus expressing GM-CSF.	Molecular therapy 	2006	86
17227781	Thymidine	Ripka S	WNT5A--target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer.	Carcinogenesis	2007	61
17495131	Thymidine	Yang J	AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo.	Blood	2007	67
18162040	Thymidine	Kirn DH	Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus.	PLoS medicine	2007	83
18455396	Thymidine	Stuart-Harris R	Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients.	Breast	2008	85
18523066	Thymidine	Bading JR	Imaging of cell proliferation: status and prospects.	Journal of nuclear medicine 	2008	63
19119139	Thymidine	Casteel DE	A DNA polymerase-{alpha}{middle dot}primase cofactor with homology to replication protein A-32 regulates DNA replication in mammalian cells.	The Journal of biological chemistry	2009	64
19805493	Thymidine	Palazuelos J	Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity.	Brain 	2009	78
20080668	Thymidine	Pine SR	Microenvironmental modulation of asymmetric cell division in human lung cancer cells.	Proceedings of the National Academy of Sciences of the United States of America	2010	56
20522802	Thymidine	Kajstura J	Cardiomyogenesis in the adult human heart.	Circulation research	2010	105
20530679	Thymidine	Coffelt SB	Angiopoietin-2 regulates gene expression in TIE2-expressing monocytes and augments their inherent proangiogenic functions.	Cancer research	2010	76
21912681	Thymidine	Skalsky RL	Reduced expression of brain-enriched microRNAs in glioblastomas permits targeted regulation of a cell death gene.	PloS one	2011	51
22269649	Thymidine	Cheng F	Protecting against wayward human induced pluripotent stem cells with a suicide gene.	Biomaterials	2012	31
23825958	Thymidine	Hollenbaugh JA	Host factor SAMHD1 restricts DNA viruses in non-dividing myeloid cells.	PLoS pathogens	2013	41
23850491	Thymidine	Westphal M	Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial.	The Lancet. Oncology	2013	33
24275137	Thymidine	Deng J	Targeting miR-21 enhances the sensitivity of human colon cancer HT-29 cells to chemoradiotherapy in vitro.	Biochemical and biophysical research communications	2014	26
24917306	Thymidine	Mitsuhashi A	Effects of metformin on endometrial cancer cell growth in vivo: a preoperative prospective trial.	Cancer	2014	24
27110680	Thymidine	Pacold ME	A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate.	Nature chemical biology	2016	31
1279432	L-Tyrosine	Plate KH	Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.	Nature	1992	346
1359541	L-Tyrosine	Guy CT	Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.	Proceedings of the National Academy of Sciences of the United States of America	1992	334
7724599	L-Tyrosine	Kaipainen A	Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.	Proceedings of the National Academy of Sciences of the United States of America	1995	260
7842013	L-Tyrosine	Kaplitt MG	Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain.	Nature genetics	1994	169
8052651	L-Tyrosine	Nishikawa R	A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.	Proceedings of the National Academy of Sciences of the United States of America	1994	242
8099202	L-Tyrosine	Mulligan LM	Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.	Nature	1993	188
8628398	L-Tyrosine	Meydan N	Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor.	Nature	1996	153
8640565	L-Tyrosine	Wilson JM	Striatal dopamine nerve terminal markers in human, chronic methamphetamine users.	Nature medicine	1996	160
9006938	L-Tyrosine	Huang HS	The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling.	The Journal of biological chemistry	1997	173
9403702	L-Tyrosine	Petit AM	Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.	The American journal of pathology	1997	120
9438854	L-Tyrosine	Hirota S	Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.	Science	1998	720
9472046	L-Tyrosine	Klemke RL	CAS/Crk coupling serves as a "molecular switch" for induction of cell migration.	The Journal of cell biology	1998	177
9504046	L-Tyrosine	Riese DJ 2nd	Specificity within the EGF family/ErbB receptor family signaling network.	BioEssays 	1998	132
9763511	L-Tyrosine	Lee G	Tau interacts with src-family non-receptor tyrosine kinases.	Journal of cell science	1998	108
9831867	L-Tyrosine	Ross JS	The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy.	Stem cells	1998	110
10223227	L-Tyrosine	Nakajima M	The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas.	Cancer	1999	119
10371505	L-Tyrosine	Sethi T	Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo.	Nature medicine	1999	134
10404636	L-Tyrosine	Wells A	EGF receptor.	The international journal of biochemistry & cell biology	1999	192
10611246	L-Tyrosine	Lee RJ	Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway.	Molecular and cellular biology	2000	96
10699153	L-Tyrosine	Kim S	Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases.	Pharmacological reviews	2000	156
10699960	L-Tyrosine	Grimberg A	Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis.	Journal of cellular physiology	2000	91
10815932	L-Tyrosine	Ciardiello F	Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor.	Clinical cancer research 	2000	110
10851045	L-Tyrosine	Bromberg J	The role of STATs in transcriptional control and their impact on cellular function.	Oncogene	2000	273
10934142	L-Tyrosine	Lawrence B	TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors.	The American journal of pathology	2000	108
11062131	L-Tyrosine	Giasson BI	Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.	Science	2000	280
11062461	L-Tyrosine	Gal A	Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa.	Nature genetics	2000	180
11090077	L-Tyrosine	Mizuki M	Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways.	Blood	2000	106
11146556	L-Tyrosine	Ogawa K	The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization.	Oncogene	2000	96
11213830	L-Tyrosine	Miettinen M	Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis.	Virchows Archiv 	2001	258
11280802	L-Tyrosine	Zelinski DP	EphA2 overexpression causes tumorigenesis of mammary epithelial cells.	Cancer research	2001	129
11282421	L-Tyrosine	Cross MJ	FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition.	Trends in pharmacological sciences	2001	163
11287972	L-Tyrosine	Druker BJ	Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.	The New England journal of medicine	2001	756
11287973	L-Tyrosine	Druker BJ	Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.	The New England journal of medicine	2001	398
11416160	L-Tyrosine	Hendrix MJ	Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry.	Proceedings of the National Academy of Sciences of the United States of America	2001	101
11420660	L-Tyrosine	Garcia R	Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells.	Oncogene	2001	173
11526490	L-Tyrosine	Tuveson DA	STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications.	Oncogene	2001	105
11585753	L-Tyrosine	Moasser MM	The tyrosine kinase inhibitor ZD1839 ("Iressa") inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells.	Cancer research	2001	91
11598267	L-Tyrosine	Saha S	A phosphatase associated with metastasis of colorectal cancer.	Science	2001	149
11719439	L-Tyrosine	Rubin BP	KIT activation is a ubiquitous feature of gastrointestinal stromal tumors.	Cancer research	2001	155
11741095	L-Tyrosine	Matsumoto T	VEGF receptor signal transduction.	Science's STKE 	2001	116
11756186	L-Tyrosine	Kelly LM	FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model.	Blood	2002	101
11756187	L-Tyrosine	Graham SM	Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro.	Blood	2002	276
11923443	L-Tyrosine	Kirik D	Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system.	The Journal of neuroscience 	2002	159
12010785	L-Tyrosine	Levis M	A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo.	Blood	2002	90
12093746	L-Tyrosine	Levanon D	The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons.	The EMBO journal	2002	121
12094370	L-Tyrosine	Fletcher CD	Diagnosis of gastrointestinal stromal tumors: A consensus approach.	Human pathology	2002	519
12094371	L-Tyrosine	Dematteo RP	Clinical management of gastrointestinal stromal tumors: before and after STI-571.	Human pathology	2002	86
12124177	L-Tyrosine	Sattler M	Critical role for Gab2 in transformation by BCR/ABL.	Cancer cell	2002	93
12130516	L-Tyrosine	Roche-Lestienne C	Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment.	Blood	2002	99
12181401	L-Tyrosine	Demetri GD	Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.	The New England journal of medicine	2002	692
12204532	L-Tyrosine	Shah NP	Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia.	Cancer cell	2002	391
12204533	L-Tyrosine	Agus DB	Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth.	Cancer cell	2002	203
12213723	L-Tyrosine	Schoppmann SF	Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis.	The American journal of pathology	2002	183
12370822	L-Tyrosine	Niu G	Roles of activated Src and Stat3 signaling in melanoma tumor cell growth.	Oncogene	2002	99
12398893	L-Tyrosine	Hiratsuka S	MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis.	Cancer cell	2002	185
12409327	L-Tyrosine	Baselga J	Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types.	Journal of clinical oncology 	2002	108
12424067	L-Tyrosine	Joensuu H	Management of malignant gastrointestinal stromal tumours.	The Lancet. Oncology	2002	85
12467226	L-Tyrosine	Rusnak DW	The effects of the novel, reversible epidermal growth factor receptor/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo.	Molecular cancer therapeutics	2001	141
12499271	L-Tyrosine	Carlomagno F	ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases.	Cancer research	2002	115
12502502	L-Tyrosine	Buteau J	Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor.	Diabetes	2003	97
12505989	L-Tyrosine	Storz P	Protein kinase D mediates a stress-induced NF-kappaB activation and survival pathway.	The EMBO journal	2003	109
12509383	L-Tyrosine	Donato NJ	BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571.	Blood	2003	153
12510148	L-Tyrosine	Brodie C	Regulation of cell apoptosis by protein kinase c delta.	Apoptosis 	2003	113
12522257	L-Tyrosine	Heinrich MC	PDGFRA activating mutations in gastrointestinal stromal tumors.	Science	2003	401
12576334	L-Tyrosine	Bhatia R	Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment.	Blood	2003	121
12601150	L-Tyrosine	Kirik D	Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease.	Proceedings of the National Academy of Sciences of the United States of America	2003	89
12663862	L-Tyrosine	Mareel M	Clinical, cellular, and molecular aspects of cancer invasion.	Physiological reviews	2003	94
12743152	L-Tyrosine	Cohen EE	Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck.	Journal of clinical oncology 	2003	99
12765939	L-Tyrosine	Bouzakri K	Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes.	Diabetes	2003	82
12782602	L-Tyrosine	Sriuranpong V	Epidermal growth factor receptor-independent constitutive activation of STAT3 in head and neck squamous cell carcinoma is mediated by the autocrine/paracrine stimulation of the interleukin 6/gp130 cytokine system.	Cancer research	2003	88
12824187	L-Tyrosine	Buchanan FG	Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor.	The Journal of biological chemistry	2003	106
12841864	L-Tyrosine	Hirohashi S	Cell adhesion system and human cancer morphogenesis.	Cancer science	2003	84
12853564	L-Tyrosine	Holbro T	The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation.	Proceedings of the National Academy of Sciences of the United States of America	2003	299
12860957	L-Tyrosine	Mendelsohn J	Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer.	Journal of clinical oncology 	2003	193
12884908	L-Tyrosine	Ma PC	c-Met: structure, functions and potential for therapeutic inhibition.	Cancer metastasis reviews	2003	120
12884910	L-Tyrosine	Summy JM	Src family kinases in tumor progression and metastasis.	Cancer metastasis reviews	2003	243
12887919	L-Tyrosine	Seo DW	TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism.	Cell	2003	127
12897328	L-Tyrosine	Ross JS	The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy.	The oncologist	2003	96
12912764	L-Tyrosine	Dwivedi Y	Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects.	Archives of general psychiatry	2003	187
12949711	L-Tyrosine	Hirota S	Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors.	Gastroenterology	2003	112
14517187	L-Tyrosine	Morgan B	Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: results from two phase I studies.	Journal of clinical oncology 	2003	105
14559814	L-Tyrosine	Ma PC	c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.	Cancer research	2003	131
14701768	L-Tyrosine	Soulieres D	Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck.	Journal of clinical oncology 	2004	152
14712221	L-Tyrosine	Fernandis AZ	Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells.	Oncogene	2004	70
14726387	L-Tyrosine	Smith BD	Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia.	Blood	2004	137
14739340	L-Tyrosine	Seton-Rogers SE	Cooperation of the ErbB2 receptor and transforming growth factor beta in induction of migration and invasion in mammary epithelial cells.	Proceedings of the National Academy of Sciences of the United States of America	2004	92
14755679	L-Tyrosine	Taplin ME	Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence.	Journal of cellular biochemistry	2004	96
14963045	L-Tyrosine	Higashi H	Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation.	The Journal of biological chemistry	2004	79
14988838	L-Tyrosine	Shintani Y	Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance.	Gastroenterology	2004	133
14999081	L-Tyrosine	Lee G	Phosphorylation of tau by fyn: implications for Alzheimer's disease.	The Journal of neuroscience 	2004	95
15024053	L-Tyrosine	Storz P	Protein kinase Cdelta selectively regulates protein kinase D-dependent activation of NF-kappaB in oxidative stress signaling.	Molecular and cellular biology	2004	87
15050914	L-Tyrosine	Mitsiades CS	Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors.	Cancer cell	2004	124
15126356	L-Tyrosine	Hutchinson JN	Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion.	Cancer research	2004	81
15240681	L-Tyrosine	Chemnitz JM	SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation.	Journal of immunology	2004	240
15249664	L-Tyrosine	Dechow TN	Requirement of matrix metalloproteinase-9 for the transformation of human mammary epithelial cells by Stat3-C.	Proceedings of the National Academy of Sciences of the United States of America	2004	73
15284455	L-Tyrosine	Sordella R	Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways.	Science	2004	355
15329723	L-Tyrosine	Douma S	Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB.	Nature	2004	163
15365079	L-Tyrosine	Corless CL	Biology of gastrointestinal stromal tumors.	Journal of clinical oncology 	2004	179
15385631	L-Tyrosine	Austin CD	Endocytosis and sorting of ErbB2 and the site of action of cancer therapeutics trastuzumab and geldanamycin.	Molecular biology of the cell	2004	120
15492241	L-Tyrosine	Tracy S	Gefitinib induces apoptosis in the EGFRL858R non-small-cell lung cancer cell line H3255.	Cancer research	2004	90
15494733	L-Tyrosine	Ren XR	Focal adhesion kinase in netrin-1 signaling.	Nature neuroscience	2004	77
15534001	L-Tyrosine	Williams CC	The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone.	The Journal of cell biology	2004	102
15542430	L-Tyrosine	Li YM	Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis.	Cancer cell	2004	150
15568026	L-Tyrosine	Sedy JR	B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator.	Nature immunology	2005	156
15604253	L-Tyrosine	Kosaka T	Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications.	Cancer research	2004	253
15681531	L-Tyrosine	Marchetti A	EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment.	Journal of clinical oncology 	2005	158
15690056	L-Tyrosine	Reed CC	Decorin prevents metastatic spreading of breast cancer.	Oncogene	2005	68
15705894	L-Tyrosine	Yang J	Novel roles of unphosphorylated STAT3 in oncogenesis and transcriptional regulation.	Cancer research	2005	135
15710947	L-Tyrosine	Han SW	Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib.	Journal of clinical oncology 	2005	141
15720813	L-Tyrosine	Hoelzinger DB	Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets.	Neoplasia	2005	99
15741570	L-Tyrosine	Shigematsu H	Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers.	Journal of the National Cancer Institute	2005	483
15749926	L-Tyrosine	Xu C	Basic fibroblast growth factor supports undifferentiated human embryonic stem cell growth without conditioned medium.	Stem cells	2005	76
15753357	L-Tyrosine	Shigematsu H	Somatic mutations of the HER2 kinase domain in lung adenocarcinomas.	Cancer research	2005	151
15753462	L-Tyrosine	Herbst RS	Phase I/II trial evaluating the anti-vascular endothelial growth factor monoclonal antibody bevacizumab in combination with the HER-1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib for patients with recurrent non-small-cell lung cancer.	Journal of clinical oncology 	2005	88
15771581	L-Tyrosine	Berg LJ	Tec family kinases in T lymphocyte development and function.	Annual review of immunology	2005	116
15830281	L-Tyrosine	Llovet JM	Updated treatment approach to hepatocellular carcinoma.	Journal of gastroenterology	2005	129
15831234	L-Tyrosine	Giannini C	Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme.	Neuro-oncology	2005	169
15870198	L-Tyrosine	Zhang Q	STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes.	Proceedings of the National Academy of Sciences of the United States of America	2005	76
15895073	L-Tyrosine	Chiarle R	Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target.	Nature medicine	2005	134
15902258	L-Tyrosine	Choi MH	Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II.	Nature	2005	105
15918149	L-Tyrosine	Roberts LR	Hepatocellular carcinoma: molecular pathways and new therapeutic targets.	Seminars in liver disease	2005	67
15920544	L-Tyrosine	Bhargava R	EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations.	Modern pathology 	2005	81
15930355	L-Tyrosine	Antonescu CR	Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation.	Clinical cancer research 	2005	163
15987685	L-Tyrosine	Keilhack H	Diverse biochemical properties of Shp2 mutants. Implications for disease phenotypes.	The Journal of biological chemistry	2005	100
16043829	L-Tyrosine	Herbst RS	TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer.	Journal of clinical oncology 	2005	284
16049312	L-Tyrosine	Pan Q	Rapid polymerase chain reaction-based detection of epidermal growth factor receptor gene mutations in lung adenocarcinomas.	The Journal of molecular diagnostics 	2005	76
16080193	L-Tyrosine	Hiscox S	Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation.	International journal of cancer	2006	77
16082245	L-Tyrosine	Miettinen M	KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation.	Applied immunohistochemistry & molecular morphology 	2005	90
16110317	L-Tyrosine	Wu XR	Urothelial tumorigenesis: a tale of divergent pathways.	Nature reviews. Cancer	2005	190
16170173	L-Tyrosine	Philip PA	Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer.	Journal of clinical oncology 	2005	95
16170353	L-Tyrosine	Ota H	Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells.	Oncogene	2006	121
16203990	L-Tyrosine	Borrello MG	Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene.	Proceedings of the National Academy of Sciences of the United States of America	2005	71
16230383	L-Tyrosine	Baird K	Gene expression profiling of human sarcomas: insights into sarcoma biology.	Cancer research	2005	89
16288224	L-Tyrosine	Natarajan M	HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells.	Oncogene	2006	69
16288295	L-Tyrosine	Cheng JQ	The Akt/PKB pathway: molecular target for cancer drug discovery.	Oncogene	2005	127
16452222	L-Tyrosine	Konecny GE	Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells.	Cancer research	2006	223
16452232	L-Tyrosine	Burgess T	Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors.	Cancer research	2006	67
16493428	L-Tyrosine	Koretzky GA	SLP76 and SLP65: complex regulation of signalling in lymphocytes and beyond.	Nature reviews. Immunology	2006	81
16507911	L-Tyrosine	Trevino JG	Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model.	The American journal of pathology	2006	71
16540667	L-Tyrosine	Alvarez JV	Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor.	Cancer research	2006	66
16551858	L-Tyrosine	Wardelmann E	Polyclonal evolution of multiple secondary KIT mutations in gastrointestinal stromal tumors under treatment with imatinib mesylate.	Clinical cancer research 	2006	62
16557260	L-Tyrosine	Monroe JG	ITAM-mediated tonic signalling through pre-BCR and BCR complexes.	Nature reviews. Immunology	2006	97
16557282	L-Tyrosine	Ostman A	Protein-tyrosine phosphatases and cancer.	Nature reviews. Cancer	2006	173
16585512	L-Tyrosine	Vajkoczy P	Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival.	Proceedings of the National Academy of Sciences of the United States of America	2006	76
16648858	L-Tyrosine	Ferby I	Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation.	Nature medicine	2006	95
16651418	L-Tyrosine	Cabodi S	p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.	Cancer research	2006	65
16682498	L-Tyrosine	Meresse B	Reprogramming of CTLs into natural killer-like cells in celiac disease.	The Journal of experimental medicine	2006	68
16682621	L-Tyrosine	Xin L	Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor.	Proceedings of the National Academy of Sciences of the United States of America	2006	60
16683005	L-Tyrosine	Nahta R	Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer.	Nature clinical practice. Oncology	2006	233
16740687	L-Tyrosine	Song L	Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival.	Cancer research	2006	79
16740702	L-Tyrosine	Srinivasan D	Activation of Abl tyrosine kinases promotes invasion of aggressive breast cancer cells.	Cancer research	2006	86
16778220	L-Tyrosine	Naresh A	The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cells.	Cancer research	2006	76
16828580	L-Tyrosine	Borzychowski AM	Inflammation and pre-eclampsia.	Seminars in fetal & neonatal medicine	2006	93
16835231	L-Tyrosine	Seidler DG	Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation.	The Journal of biological chemistry	2006	67
16908937	L-Tyrosine	Abou-Alfa GK	Phase II study of sorafenib in patients with advanced hepatocellular carcinoma.	Journal of clinical oncology 	2006	269
16959784	L-Tyrosine	Misra S	Hyaluronan constitutively regulates activation of multiple receptor tyrosine kinases in epithelial and carcinoma cells.	The Journal of biological chemistry	2006	60
17043651	L-Tyrosine	Iwamaru A	A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo.	Oncogene	2007	101
17045208	L-Tyrosine	Guo Z	Regulation of androgen receptor activity by tyrosine phosphorylation.	Cancer cell	2006	149
17047074	L-Tyrosine	Morgillo F	Heterodimerization of insulin-like growth factor receptor/epidermal growth factor receptor and induction of survivin expression counteract the antitumor action of erlotinib.	Cancer research	2006	104
17055279	L-Tyrosine	Chu Y	Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?	Neurobiology of disease	2007	101
17079491	L-Tyrosine	Johnson PT	Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid.	Proceedings of the National Academy of Sciences of the United States of America	2006	66
17080188	L-Tyrosine	Conti-Fine BM	Myasthenia gravis: past, present, and future.	The Journal of clinical investigation	2006	90
17090188	L-Tyrosine	Miettinen M	Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis.	Archives of pathology & laboratory medicine	2006	282
17124058	L-Tyrosine	Small D	FLT3 mutations: biology and treatment.	Hematology. American Society of Hematology. Education Program	2006	64
17175059	L-Tyrosine	Luppi F	Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation.	Lung cancer	2007	62
17177598	L-Tyrosine	Lee JC	Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain.	PLoS medicine	2006	96
17178882	L-Tyrosine	Liu L	Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.	Cancer research	2006	298
17183644	L-Tyrosine	Zaleskas VM	Molecular pathogenesis and therapy of polycythemia induced in mice by JAK2 V617F.	PloS one	2006	76
17239630	L-Tyrosine	de Gorter DJ	Bruton's tyrosine kinase and phospholipase Cgamma2 mediate chemokine-controlled B cell migration and homing.	Immunity	2007	64
17295177	L-Tyrosine	Villanueva A	Genomics and signaling pathways in hepatocellular carcinoma.	Seminars in liver disease	2007	156
17304354	L-Tyrosine	Piccaluga PP	Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets.	The Journal of clinical investigation	2007	72
17308108	L-Tyrosine	Sawada K	c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion.	Cancer research	2007	92
17317726	L-Tyrosine	Thamilselvan V	FAK association with multiple signal proteins mediates pressure-induced colon cancer cell adhesion via a Src-dependent PI3K/Akt pathway.	FASEB journal 	2007	60
17318191	L-Tyrosine	Coluccia AM	Bcr-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation.	The EMBO journal	2007	71
17322912	L-Tyrosine	Peschard P	From Tpr-Met to Met, tumorigenesis and tubes.	Oncogene	2007	61
17325667	L-Tyrosine	Mahadevan D	A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors.	Oncogene	2007	77
17332337	L-Tyrosine	Lutterbach B	Lung cancer cell lines harboring MET gene amplification are dependent on Met for growth and survival.	Cancer research	2007	95
17363602	L-Tyrosine	Shor AC	Dasatinib inhibits migration and invasion in diverse human sarcoma cell lines and induces apoptosis in bone sarcoma cells dependent on SRC kinase for survival.	Cancer research	2007	82
17426060	L-Tyrosine	Fizazi K	The role of Src in prostate cancer.	Annals of oncology 	2007	60
17431114	L-Tyrosine	Liu TJ	Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo.	Molecular cancer therapeutics	2007	59
17440062	L-Tyrosine	Balakrishnan A	Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma.	Cancer research	2007	58
17440088	L-Tyrosine	Galliher AJ	Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion.	Cancer research	2007	98
17470685	L-Tyrosine	Strumberg D	Safety, pharmacokinetics, and preliminary antitumor activity of sorafenib: a review of four phase I trials in patients with advanced refractory solid tumors.	The oncologist	2007	97
17483331	L-Tyrosine	Ostrander JH	Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells.	Cancer research	2007	62
17494887	L-Tyrosine	Kaneshiro Y	Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats.	Journal of the American Society of Nephrology 	2007	65
17498648	L-Tyrosine	Lee SB	Loss of LRRK2/PARK8 induces degeneration of dopaminergic neurons in Drosophila.	Biochemical and biophysical research communications	2007	61
17519389	L-Tyrosine	Amin HM	Pathobiology of ALK+ anaplastic large-cell lymphoma.	Blood	2007	65
17530017	L-Tyrosine	Nahta R	Trastuzumab: triumphs and tribulations.	Oncogene	2007	82
17558857	L-Tyrosine	Guarino M	The role of epithelial-mesenchymal transition in cancer pathology.	Pathology	2007	233
17565975	L-Tyrosine	Jarvius M	In situ detection of phosphorylated platelet-derived growth factor receptor beta using a generalized proximity ligation method.	Molecular & cellular proteomics 	2007	70
17586681	L-Tyrosine	Redmond DE Jr	Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2007	103
17623837	L-Tyrosine	Thomas MB	Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma.	Cancer	2007	71
17625570	L-Tyrosine	Soda M	Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.	Nature	2007	1116
17627510	L-Tyrosine	Maiese K	Mechanistic insights into diabetes mellitus and oxidative stress.	Current medicinal chemistry	2007	63
17644065	L-Tyrosine	Ling Y	Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cells.	Biochemical and biophysical research communications	2007	58
17646646	L-Tyrosine	Huang PH	Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma.	Proceedings of the National Academy of Sciences of the United States of America	2007	149
17667967	L-Tyrosine	Pasini B	Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD.	European journal of human genetics 	2008	87
17785413	L-Tyrosine	Tward AD	Distinct pathways of genomic progression to benign and malignant tumors of the liver.	Proceedings of the National Academy of Sciences of the United States of America	2007	71
17855663	L-Tyrosine	Pathak AK	Ursolic acid inhibits STAT3 activation pathway leading to suppression of proliferation and chemosensitization of human multiple myeloma cells.	Molecular cancer research 	2007	56
17888036	L-Tyrosine	Mitsudomi T	Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer.	Cancer science	2007	129
17894407	L-Tyrosine	De Luca A	The role of the EGFR signaling in tumor microenvironment.	Journal of cellular physiology	2008	96
17906625	L-Tyrosine	Cortina C	EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells.	Nature genetics	2007	85
17923684	L-Tyrosine	Garg P	Neph1 cooperates with nephrin to transduce a signal that induces actin polymerization.	Molecular and cellular biology	2007	61
17943726	L-Tyrosine	Matsui J	E7080, a novel inhibitor that targets multiple kinases, has potent antitumor activities against stem cell factor producing human small cell lung cancer H146, based on angiogenesis inhibition.	International journal of cancer	2008	54
17965226	L-Tyrosine	Amiel J	Hirschsprung disease, associated syndromes and genetics: a review.	Journal of medical genetics	2008	168
17965322	L-Tyrosine	Bacher U	Prognostic relevance of FLT3-TKD mutations in AML: the combination matters--an analysis of 3082 patients.	Blood	2008	50
17981673	L-Tyrosine	Bhola NE	Crosstalk between G-protein-coupled receptors and epidermal growth factor receptor in cancer.	Frontiers in bioscience 	2008	54
17984313	L-Tyrosine	Hexner EO	Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders.	Blood	2008	75
18056992	L-Tyrosine	Sidera K	A critical role for HSP90 in cancer cell invasion involves interaction with the extracellular domain of HER-2.	The Journal of biological chemistry	2008	53
18060032	L-Tyrosine	Gao SP	Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas.	The Journal of clinical investigation	2007	209
18076015	L-Tyrosine	Dematteo RP	Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST).	Cancer	2008	105
18079969	L-Tyrosine	Brantley-Sieders DM	The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.	The Journal of clinical investigation	2008	95
18093986	L-Tyrosine	Adya R	Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.	Cardiovascular research	2008	74
18172262	L-Tyrosine	Hutterer M	Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme.	Clinical cancer research 	2008	79
18192401	L-Tyrosine	Ohnishi N	Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse.	Proceedings of the National Academy of Sciences of the United States of America	2008	172
18204462	L-Tyrosine	Fujikado N	Dcir deficiency causes development of autoimmune diseases in mice due to excess expansion of dendritic cells.	Nature medicine	2008	60
18219225	L-Tyrosine	Flaherty KT	Pilot study of DCE-MRI to predict progression-free survival with sorafenib therapy in renal cell carcinoma.	Cancer biology & therapy	2008	50
18223323	L-Tyrosine	Espinosa I	A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors.	The American journal of surgical pathology	2008	86
18224294	L-Tyrosine	Bessette DC	PRL PTPs: mediators and markers of cancer progression.	Cancer metastasis reviews	2008	63
18228120	L-Tyrosine	Wagner KU	Jak2/Stat5 signaling in mammogenesis, breast cancer initiation and progression.	Journal of mammary gland biology and neoplasia	2008	57
18236164	L-Tyrosine	Barr S	Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions.	Clinical & experimental metastasis	2008	73
18264713	L-Tyrosine	Dickson DW	Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease.	Acta neuropathologica	2008	68
18285558	L-Tyrosine	Ali TK	Peroxynitrite mediates retinal neurodegeneration by inhibiting nerve growth factor survival signaling in experimental and human diabetes.	Diabetes	2008	63
18288131	L-Tyrosine	Renneville A	Cooperating gene mutations in acute myeloid leukemia: a review of the literature.	Leukemia	2008	62
18291115	L-Tyrosine	Lafky JM	Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer.	Biochimica et biophysica acta	2008	78
18297114	L-Tyrosine	Wheeler DL	Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members.	Oncogene	2008	168
18303429	L-Tyrosine	Marks JL	Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma.	Journal of thoracic oncology 	2008	75
18312355	L-Tyrosine	Lasota J	Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours.	Histopathology	2008	74
18316611	L-Tyrosine	Shattuck DL	Met receptor contributes to trastuzumab resistance of Her2-overexpressing breast cancer cells.	Cancer research	2008	119
18326860	L-Tyrosine	Gong P	TLR4 signaling is coupled to SRC family kinase activation, tyrosine phosphorylation of zonula adherens proteins, and opening of the paracellular pathway in human lung microvascular endothelia.	The Journal of biological chemistry	2008	56
18339872	L-Tyrosine	Zhang YX	AXL is a potential target for therapeutic intervention in breast cancer progression.	Cancer research	2008	69
18362333	L-Tyrosine	Diehn M	Identification of noninvasive imaging surrogates for brain tumor gene-expression modules.	Proceedings of the National Academy of Sciences of the United States of America	2008	102
18395971	L-Tyrosine	Zeng ZS	c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases.	Cancer letters	2008	55
18413800	L-Tyrosine	Godin-Heymann N	The T790M "gatekeeper" mutation in EGFR mediates resistance to low concentrations of an irreversible EGFR inhibitor.	Molecular cancer therapeutics	2008	60
18431473	L-Tyrosine	Curtin JF	Treg depletion inhibits efficacy of cancer immunotherapy: implications for clinical trials.	PloS one	2008	51
18437168	L-Tyrosine	Ladanyi M	Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond.	Modern pathology 	2008	80
18450603	L-Tyrosine	Marcucci G	MicroRNA expression in cytogenetically normal acute myeloid leukemia.	The New England journal of medicine	2008	149
18451159	L-Tyrosine	Park SI	Targeting SRC family kinases inhibits growth and lymph node metastases of prostate cancer in an orthotopic nude mouse model.	Cancer research	2008	103
18454307	L-Tyrosine	Sundvall M	Role of ErbB4 in breast cancer.	Journal of mammary gland biology and neoplasia	2008	50
18469855	L-Tyrosine	Osipo C	ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a gamma-secretase inhibitor.	Oncogene	2008	62
18483213	L-Tyrosine	Abdulghani J	Stat3 promotes metastatic progression of prostate cancer.	The American journal of pathology	2008	75
18483389	L-Tyrosine	Agaram NP	Molecular characterization of pediatric gastrointestinal stromal tumors.	Clinical cancer research 	2008	58
18487549	L-Tyrosine	Finn RS	Targeting Src in breast cancer.	Annals of oncology 	2008	62
18492751	L-Tyrosine	Liu Z	Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers.	The Journal of clinical endocrinology and metabolism	2008	109
18508592	L-Tyrosine	Buxade M	The Mnks: MAP kinase-interacting kinases (MAP kinase signal-integrating kinases).	Frontiers in bioscience 	2008	51
18519975	L-Tyrosine	Achen MG	Molecular control of lymphatic metastasis.	Annals of the New York Academy of Sciences	2008	55
18559524	L-Tyrosine	Hilberg F	BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy.	Cancer research	2008	140
18568074	L-Tyrosine	Guix M	Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins.	The Journal of clinical investigation	2008	177
18599154	L-Tyrosine	Rho JK	Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line.	Lung cancer	2009	64
18612155	L-Tyrosine	Kulke MH	Activity of sunitinib in patients with advanced neuroendocrine tumors.	Journal of clinical oncology 	2008	114
18620091	L-Tyrosine	Wagh PK	Met-related receptor tyrosine kinase Ron in tumor growth and metastasis.	Advances in cancer research	2008	58
18661552	L-Tyrosine	Kim YJ	Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action.	Glia	2009	52
18684881	L-Tyrosine	Metcalfe DD	Mast cells and mastocytosis.	Blood	2008	88
18696232	L-Tyrosine	Thomson S	Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy.	Clinical & experimental metastasis	2008	73
18718806	L-Tyrosine	Sabbah M	Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.	Drug resistance updates 	2008	99
18772882	L-Tyrosine	Lehembre F	NCAM-induced focal adhesion assembly: a functional switch upon loss of E-cadherin.	The EMBO journal	2008	53
18800267	L-Tyrosine	Burgess AW	EGFR family: structure physiology signalling and therapeutic targets.	Growth factors	2008	73
18818206	L-Tyrosine	Nasser MW	Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1.	The Journal of biological chemistry	2008	137
18823985	L-Tyrosine	Taura K	Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis.	Gastroenterology	2008	67
18836087	L-Tyrosine	Cappuzzo F	MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients.	Annals of oncology 	2009	90
18922892	L-Tyrosine	Joshi B	Phosphorylated caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion.	Cancer research	2008	77
18927285	L-Tyrosine	Fichtner I	Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers.	Clinical cancer research 	2008	93
18927303	L-Tyrosine	Takeuchi K	Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts.	Clinical cancer research 	2008	121
18955454	L-Tyrosine	Di Leo A	Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer.	Journal of clinical oncology 	2008	92
18990089	L-Tyrosine	Carén H	High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours.	The Biochemical journal	2008	66
19006193	L-Tyrosine	Kordower JH	Transplanted dopaminergic neurons develop PD pathologic changes: a second case report.	Movement disorders 	2008	72
19011564	L-Tyrosine	Liegl B	Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes.	The American journal of surgical pathology	2009	46
19039322	L-Tyrosine	Remsing Rix LL	Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells.	Leukemia	2009	63
19064915	L-Tyrosine	Soda M	A mouse model for EML4-ALK-positive lung cancer.	Proceedings of the National Academy of Sciences of the United States of America	2008	131
19074879	L-Tyrosine	Migliore C	MicroRNAs impair MET-mediated invasive growth.	Cancer research	2008	63
19136975	L-Tyrosine	Scott SA	Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness.	Nature chemical biology	2009	110
19144521	L-Tyrosine	Matozaki T	Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway.	Trends in cell biology	2009	104
19147653	L-Tyrosine	Oudit GY	Cardiac regulation by phosphoinositide 3-kinases and PTEN.	Cardiovascular research	2009	61
19157632	L-Tyrosine	Kim JE	Epidermal growth factor receptor tyrosine kinase inhibitors as a first-line therapy for never-smokers with adenocarcinoma of the lung having asymptomatic synchronous brain metastasis.	Lung cancer	2009	48
19182515	L-Tyrosine	Acevedo VD	Paths of FGFR-driven tumorigenesis.	Cell cycle	2009	48
19188609	L-Tyrosine	De Felice FG	Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers.	Proceedings of the National Academy of Sciences of the United States of America	2009	144
19234440	L-Tyrosine	Inamura K	EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset.	Modern pathology 	2009	107
19236704	L-Tyrosine	Klintworth GK	Corneal dystrophies.	Orphanet journal of rare diseases	2009	77
19238210	L-Tyrosine	Gandhi J	Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines.	PloS one	2009	75
19238633	L-Tyrosine	Kalikaki A	Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC.	British journal of cancer	2008	50
19276373	L-Tyrosine	Iorio MV	microRNA-205 regulates HER3 in human breast cancer.	Cancer research	2009	114
19276677	L-Tyrosine	Wheeler DL	Epidermal growth factor receptor cooperates with Src family kinases in acquired resistance to cetuximab.	Cancer biology & therapy	2009	57
19346299	L-Tyrosine	Ross JS	The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine.	The oncologist	2009	218
19364815	L-Tyrosine	Pedersen K	A naturally occurring HER2 carboxy-terminal fragment promotes mammary tumor growth and metastasis.	Molecular and cellular biology	2009	47
19435801	L-Tyrosine	Tomar A	A FAK-p120RasGAP-p190RhoGAP complex regulates polarity in migrating cells.	Journal of cell science	2009	54
19449109	L-Tyrosine	Thomas M	The role of the Angiopoietins in vascular morphogenesis.	Angiogenesis	2009	87
19459784	L-Tyrosine	Palmer RH	Anaplastic lymphoma kinase: signalling in development and disease.	The Biochemical journal	2009	109
19470474	L-Tyrosine	Mullighan CG	JAK mutations in high-risk childhood acute lymphoblastic leukemia.	Proceedings of the National Academy of Sciences of the United States of America	2009	161
19487814	L-Tyrosine	Zhao YY	Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration.	The Journal of clinical investigation	2009	99
19561643	L-Tyrosine	Enomoto M	Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling.	Oncogene	2009	50
19581523	L-Tyrosine	Wheeler DL	The role of Src in solid tumors.	The oncologist	2009	80
19584155	L-Tyrosine	Schmid K	EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases.	Clinical cancer research 	2009	74
19595306	L-Tyrosine	Jiang BH	PI3K/PTEN signaling in angiogenesis and tumorigenesis.	Advances in cancer research	2009	123
19597153	L-Tyrosine	Seike M	MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers.	Proceedings of the National Academy of Sciences of the United States of America	2009	160
19617568	L-Tyrosine	Ponzo MG	Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer.	Proceedings of the National Academy of Sciences of the United States of America	2009	82
19620627	L-Tyrosine	Trageser D	Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function.	The Journal of experimental medicine	2009	50
19620785	L-Tyrosine	Taulli R	The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation.	The Journal of clinical investigation	2009	103
19633047	L-Tyrosine	Kataoka Y	Association between gain-of-function mutations in PIK3CA and resistance to HER2-targeted agents in HER2-amplified breast cancer cell lines.	Annals of oncology 	2010	61
19648928	L-Tyrosine	Lim E	Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers.	Nature medicine	2009	480
19654408	L-Tyrosine	Zarrinkar PP	AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML).	Blood	2009	128
19671734	L-Tyrosine	Mitra D	An oncogenic isoform of HER2 associated with locally disseminated breast cancer and trastuzumab resistance.	Molecular cancer therapeutics	2009	50
19711116	L-Tyrosine	Jellinger KA	Formation and development of Lewy pathology: a critical update.	Journal of neurology	2009	49
19718025	L-Tyrosine	Prickett TD	Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4.	Nature genetics	2009	131
19758803	L-Tyrosine	Lai AZ	Crosstalk in Met receptor oncogenesis.	Trends in cell biology	2009	68
19759520	L-Tyrosine	Regales L	Dual targeting of EGFR can overcome a major drug resistance mutation in mouse models of EGFR mutant lung cancer.	The Journal of clinical investigation	2009	119
19765683	L-Tyrosine	Pasutto F	Heterozygous NTF4 mutations impairing neurotrophin-4 signaling in patients with primary open-angle glaucoma.	American journal of human genetics	2009	47
19768731	L-Tyrosine	Haller F	Localization- and mutation-dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co-expressed miRNAs located at 14q32.31.	The Journal of pathology	2010	50
19773371	L-Tyrosine	Hoftijzer H	Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma.	European journal of endocrinology	2009	49
19786658	L-Tyrosine	Johnston S	Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor-positive metastatic breast cancer.	Journal of clinical oncology 	2009	201
19802008	L-Tyrosine	O'Connell MP	The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma.	Oncogene	2010	74
19805051	L-Tyrosine	Sos ML	Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer.	Proceedings of the National Academy of Sciences of the United States of America	2009	92
19808973	L-Tyrosine	Qian F	Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.	Cancer research	2009	73
19826113	L-Tyrosine	Matulonis UA	Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancer.	Journal of clinical oncology 	2009	58
19855133	L-Tyrosine	Chen L	Tyrosine and serine phosphorylation of alpha-synuclein have opposing effects on neurotoxicity and soluble oligomer formation.	The Journal of clinical investigation	2009	58
19858324	L-Tyrosine	Kubagawa H	Identity of the elusive IgM Fc receptor (FcmuR) in humans.	The Journal of experimental medicine	2009	51
19880500	L-Tyrosine	Li K	A noncoding antisense RNA in tie-1 locus regulates tie-1 function in vivo.	Blood	2010	49
19887545	L-Tyrosine	Hirai H	Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents.	Molecular cancer therapeutics	2009	103
19901108	L-Tyrosine	Makishima H	Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies.	Journal of clinical oncology 	2009	61
19922469	L-Tyrosine	Mitsudomi T	Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer.	The FEBS journal	2010	111
19934298	L-Tyrosine	Wells SA Jr	Targeting the RET pathway in thyroid cancer.	Clinical cancer research 	2009	47
20008298	L-Tyrosine	Santos FP	Phase 2 study of CEP-701, an orally available JAK2 inhibitor, in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis.	Blood	2010	63
20018914	L-Tyrosine	Ghosh AK	Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression.	Blood	2010	64
20022659	L-Tyrosine	Mao C	KRAS mutations and resistance to EGFR-TKIs treatment in patients with non-small cell lung cancer: a meta-analysis of 22 studies.	Lung cancer	2010	81
20049846	L-Tyrosine	Guarino M	Src signaling in cancer invasion.	Journal of cellular physiology	2010	131
20054396	L-Tyrosine	Davis RE	Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.	Nature	2010	344
20068094	L-Tyrosine	Manara MC	NVP-BEZ235 as a new therapeutic option for sarcomas.	Clinical cancer research 	2010	55
20068149	L-Tyrosine	Novosyadlyy R	Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes.	Cancer research	2010	96
20072652	L-Tyrosine	Lin L	A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells.	Neoplasia	2010	54
20081860	L-Tyrosine	Morin RD	Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin.	Nature genetics	2010	394
20103629	L-Tyrosine	Huang D	Sunitinib acts primarily on tumor endothelium rather than tumor cells to inhibit the growth of renal cell carcinoma.	Cancer research	2010	63
20108024	L-Tyrosine	Suda K	Biological and clinical significance of KRAS mutations in lung cancer: an oncogenic driver that contrasts with EGFR mutation.	Cancer metastasis reviews	2010	47
20110609	L-Tyrosine	Kim W	Interneuronal transfer of human tau between Lamprey central neurons in situ.	Journal of Alzheimer's disease 	2010	47
20124232	L-Tyrosine	Rosenbloom J	Narrative review: fibrotic diseases: cellular and molecular mechanisms and novel therapies.	Annals of internal medicine	2010	70
20130650	L-Tyrosine	Naka K	TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia.	Nature	2010	152
20145116	L-Tyrosine	Leppänen VM	Structural determinants of growth factor binding and specificity by VEGF receptor 2.	Proceedings of the National Academy of Sciences of the United States of America	2010	46
20145120	L-Tyrosine	Holland SJ	R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer.	Cancer research	2010	121
20145208	L-Tyrosine	Sehat B	SUMOylation mediates the nuclear translocation and signaling of the IGF-1 receptor.	Science signaling	2010	72
20146086	L-Tyrosine	Clarke JL	High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancer.	Journal of neuro-oncology	2010	57
20152177	L-Tyrosine	Du D	The tight junction protein, occludin, regulates the directional migration of epithelial cells.	Developmental cell	2010	52
20165865	L-Tyrosine	Liegl-Atzwanger B	Gastrointestinal stromal tumors.	Virchows Archiv 	2010	50
20167603	L-Tyrosine	Guo X	DYRK1A and DYRK3 promote cell survival through phosphorylation and activation of SIRT1.	The Journal of biological chemistry	2010	75
20179713	L-Tyrosine	Pasquale EB	Eph receptors and ephrins in cancer: bidirectional signalling and beyond.	Nature reviews. Cancer	2010	319
20197548	L-Tyrosine	Akada H	Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera-like disease.	Blood	2010	86
20303742	L-Tyrosine	Orian-Rousseau V	CD44, a therapeutic target for metastasising tumours.	European journal of cancer	2010	116
20333297	L-Tyrosine	Mahajan K	Ack1 mediated AKT/PKB tyrosine 176 phosphorylation regulates its activation.	PloS one	2010	48
20368553	L-Tyrosine	Escudier B	Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival.	Journal of clinical oncology 	2010	165
20371662	L-Tyrosine	Robinson BG	Vandetanib (100 mg) in patients with locally advanced or metastatic hereditary medullary thyroid cancer.	The Journal of clinical endocrinology and metabolism	2010	44
20399956	L-Tyrosine	Grossmann KS	The tyrosine phosphatase Shp2 in development and cancer.	Advances in cancer research	2010	60
20458050	L-Tyrosine	Batchelor TT	Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma.	Journal of clinical oncology 	2010	148
20460524	L-Tyrosine	Dey JH	Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis.	Cancer research	2010	55
20479403	L-Tyrosine	Sequist LV	Neratinib, an irreversible pan-ErbB receptor tyrosine kinase inhibitor: results of a phase II trial in patients with advanced non-small-cell lung cancer.	Journal of clinical oncology 	2010	103
20489150	L-Tyrosine	Benedettini E	Met activation in non-small cell lung cancer is associated with de novo resistance to EGFR inhibitors and the development of brain metastasis.	The American journal of pathology	2010	47
20497720	L-Tyrosine	Xie HR	SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease.	Chinese medical journal	2010	82
20501798	L-Tyrosine	O'Brien NA	Activated phosphoinositide 3-kinase/AKT signaling confers resistance to trastuzumab but not lapatinib.	Molecular cancer therapeutics	2010	88
20501804	L-Tyrosine	Hammers HJ	Reversible epithelial to mesenchymal transition and acquired resistance to sunitinib in patients with renal cell carcinoma: evidence from a xenograft study.	Molecular cancer therapeutics	2010	56
20515495	L-Tyrosine	Krakstad C	Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics.	Molecular cancer	2010	72
20570559	L-Tyrosine	Herbst RS	Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC): a double-blind, randomised, phase 3 trial.	The Lancet. Oncology	2010	106
20571069	L-Tyrosine	Hirai H	MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo.	Molecular cancer therapeutics	2010	292
20573926	L-Tyrosine	Maemondo M	Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR.	The New England journal of medicine	2010	1115
20585556	L-Tyrosine	Harmon B	Role of Abl kinase and the Wave2 signaling complex in HIV-1 entry at a post-hemifusion step.	PLoS pathogens	2010	42
20627894	L-Tyrosine	Eichler AF	EGFR mutation status and survival after diagnosis of brain metastasis in nonsmall cell lung cancer.	Neuro-oncology	2010	57
20633936	L-Tyrosine	Gershon MD	Developmental determinants of the independence and complexity of the enteric nervous system.	Trends in neurosciences	2010	42
20644162	L-Tyrosine	Lechner MG	Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells.	Journal of immunology	2010	155
20702778	L-Tyrosine	Hudecek M	The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor.	Blood	2010	71
20713723	L-Tyrosine	Yao Z	TGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer.	Proceedings of the National Academy of Sciences of the United States of America	2010	110
20716591	L-Tyrosine	Sathornsumetee S	Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma.	Neuro-oncology	2010	52
20716670	L-Tyrosine	Mimeault M	Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies.	Pharmacological reviews	2010	48
20799954	L-Tyrosine	Shen Q	Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion.	Molecular cancer	2010	55
20823226	L-Tyrosine	Ko HS	Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function.	Proceedings of the National Academy of Sciences of the United States of America	2010	75
20824720	L-Tyrosine	da Cunha Santos G	Molecular predictors of outcome in a phase 3 study of gemcitabine and erlotinib therapy in patients with advanced pancreatic cancer: National Cancer Institute of Canada Clinical Trials Group Study PA.3.	Cancer	2010	44
20825314	L-Tyrosine	Baratz KH	E2-2 protein and Fuchs's corneal dystrophy.	The New England journal of medicine	2010	75
20844577	L-Tyrosine	Eierhoff T	The epidermal growth factor receptor (EGFR) promotes uptake of influenza A viruses (IAV) into host cells.	PLoS pathogens	2010	71
20856865	L-Tyrosine	Lebouvier T	Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms.	PloS one	2010	67
20858715	L-Tyrosine	Rankin EB	AXL is an essential factor and therapeutic target for metastatic ovarian cancer.	Cancer research	2010	53
20859283	L-Tyrosine	Seruga B	Drug resistance in metastatic castration-resistant prostate cancer.	Nature reviews. Clinical oncology	2011	74
20861192	L-Tyrosine	Hochgräfe F	Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells.	Cancer research	2010	58
20872043	L-Tyrosine	Neyns B	Phase II study of sunitinib malate in patients with recurrent high-grade glioma.	Journal of neuro-oncology	2011	44
20887192	L-Tyrosine	da Cunha Santos G	EGFR mutations and lung cancer.	Annual review of pathology	2011	72
20889717	L-Tyrosine	Ozawa T	PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas.	Genes & development	2010	61
20922806	L-Tyrosine	Song X	Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma.	Cancer	2011	35
20942957	L-Tyrosine	Shapiro NI	The association of endothelial cell signaling, severity of illness, and organ dysfunction in sepsis.	Critical care	2010	51
20952518	L-Tyrosine	Borthakur G	Phase I study of sorafenib in patients with refractory or relapsed acute leukemias.	Haematologica	2011	47
20971703	L-Tyrosine	Oser M	Specific tyrosine phosphorylation sites on cortactin regulate Nck1-dependent actin polymerization in invadopodia.	Journal of cell science	2010	55
21042280	L-Tyrosine	Montero JC	P-Rex1 participates in Neuregulin-ErbB signal transduction and its expression correlates with patient outcome in breast cancer.	Oncogene	2011	38
21051724	L-Tyrosine	Chen X	Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma.	Investigative ophthalmology & visual science	2011	37
21057535	L-Tyrosine	Vuoriluoto K	Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer.	Oncogene	2011	153
21062933	L-Tyrosine	Suda K	Reciprocal and complementary role of MET amplification and EGFR T790M mutation in acquired resistance to kinase inhibitors in lung cancer.	Clinical cancer research 	2010	55
21072204	L-Tyrosine	Kompier LC	FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy.	PloS one	2010	66
21102440	L-Tyrosine	da Costa Martins PA	MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling.	Nature cell biology	2010	83
21126318	L-Tyrosine	Becker W	Activation, regulation, and inhibition of DYRK1A.	The FEBS journal	2011	36
21151131	L-Tyrosine	Griffiths DS	LIF-independent JAK signalling to chromatin in embryonic stem cells uncovered from an adult stem cell disease.	Nature cell biology	2011	38
21152424	L-Tyrosine	Ware KE	Rapidly acquired resistance to EGFR tyrosine kinase inhibitors in NSCLC cell lines through de-repression of FGFR2 and FGFR3 expression.	PloS one	2010	54
21156283	L-Tyrosine	Rui L	Cooperative epigenetic modulation by cancer amplicon genes.	Cancer cell	2010	87
21163703	L-Tyrosine	De Roock W	KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer.	The Lancet. Oncology	2011	145
21168239	L-Tyrosine	Chung JH	Clinical and molecular evidences of epithelial to mesenchymal transition in acquired resistance to EGFR-TKIs.	Lung cancer	2011	45
21199531	L-Tyrosine	Nakamura T	Hepatocyte growth factor twenty years on: Much more than a growth factor.	Journal of gastroenterology and hepatology	2011	90
21204711	L-Tyrosine	Gutierrez C	HER2: biology, detection, and clinical implications.	Archives of pathology & laboratory medicine	2011	57
21205925	L-Tyrosine	Chen KF	Activation of phosphatidylinositol 3-kinase/Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells.	The Journal of pharmacology and experimental therapeutics	2011	69
21220474	L-Tyrosine	Donev IS	Transient PI3K inhibition induces apoptosis and overcomes HGF-mediated resistance to EGFR-TKIs in EGFR mutant lung cancer.	Clinical cancer research 	2011	38
21220499	L-Tyrosine	Nagai T	Sorafenib inhibits the hepatocyte growth factor-mediated epithelial mesenchymal transition in hepatocellular carcinoma.	Molecular cancer therapeutics	2011	39
21225626	L-Tyrosine	Sun S	Head neck squamous cell carcinoma c-Met⁺ cells display cancer stem cell properties and are responsible for cisplatin-resistance and metastasis.	International journal of cancer	2011	37
21233313	L-Tyrosine	Nelson EA	The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors.	Blood	2011	85
21237299	L-Tyrosine	Greten TF	Myeloid derived suppressor cells in human diseases.	International immunopharmacology	2011	112
21252716	L-Tyrosine	Travis WD	International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.	Journal of thoracic oncology 	2011	680
21258250	L-Tyrosine	Ludovini V	Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer.	Journal of thoracic oncology 	2011	51
21288922	L-Tyrosine	Shaw AT	Targeting anaplastic lymphoma kinase in lung cancer.	Clinical cancer research 	2011	51
21299849	L-Tyrosine	Quentmeier H	BCR-ABL1-independent PI3Kinase activation causing imatinib-resistance.	Journal of hematology & oncology	2011	39
21303969	L-Tyrosine	Ramalingam SS	Lung cancer: New biological insights and recent therapeutic advances.	CA	2011	99
21317930	L-Tyrosine	Mudduluru G	Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer.	Oncogene	2011	75
21325052	L-Tyrosine	Sun Q	Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth.	Proceedings of the National Academy of Sciences of the United States of America	2011	150
21358673	L-Tyrosine	Weigelt B	PIK3CA mutation, but not PTEN loss of function, determines the sensitivity of breast cancer cells to mTOR inhibitory drugs.	Oncogene	2011	69
21364762	L-Tyrosine	Erdman LK	Combinations of host biomarkers predict mortality among Ugandan children with severe malaria: a retrospective case-control study.	PloS one	2011	51
21368164	L-Tyrosine	Chakrabarty A	Feedback upregulation of HER3 (ErbB3) expression and activity attenuates antitumor effect of PI3K inhibitors.	Proceedings of the National Academy of Sciences of the United States of America	2012	122
21383697	L-Tyrosine	Oneyama C	MicroRNA-mediated downregulation of mTOR/FGFR3 controls tumor growth induced by Src-related oncogenic pathways.	Oncogene	2011	44
21408136	L-Tyrosine	Gopal U	A novel extracellular Hsp90 mediated co-receptor function for LRP1 regulates EphA2 dependent glioblastoma cell invasion.	PloS one	2011	42
21411864	L-Tyrosine	Chappell WH	Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health.	Oncotarget	2011	179
21412928	L-Tyrosine	Paulson V	High-resolution array CGH identifies common mechanisms that drive embryonal rhabdomyosarcoma pathogenesis.	Genes, chromosomes & cancer	2011	36
21430269	L-Tyrosine	Sequist LV	Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors.	Science translational medicine	2011	712
21439312	L-Tyrosine	Larsen AK	Targeting EGFR and VEGF(R) pathway cross-talk in tumor survival and angiogenesis.	Pharmacology & therapeutics	2011	36
21487037	L-Tyrosine	Gentile A	Ror1 is a pseudokinase that is crucial for Met-driven tumorigenesis.	Cancer research	2011	45
21501518	L-Tyrosine	Howe EN	Targets of miR-200c mediate suppression of cell motility and anoikis resistance.	Breast cancer research 	2011	75
21565214	L-Tyrosine	Tugues S	Vascular endothelial growth factors and receptors: anti-angiogenic therapy in the treatment of cancer.	Molecular aspects of medicine	2011	50
21573178	L-Tyrosine	Querings S	Benchmarking of mutation diagnostics in clinical lung cancer specimens.	PloS one	2011	37
21575866	L-Tyrosine	Sakamoto H	CH5424802, a selective ALK inhibitor capable of blocking the resistant gatekeeper mutant.	Cancer cell	2011	130
21576635	L-Tyrosine	Peck AR	Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure.	Journal of clinical oncology 	2011	38
21628563	L-Tyrosine	Li Y	c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype.	Proceedings of the National Academy of Sciences of the United States of America	2011	86
21642685	L-Tyrosine	Carvajal RD	KIT as a therapeutic target in metastatic melanoma.	JAMA	2011	120
21642981	L-Tyrosine	Joffre C	A direct role for Met endocytosis in tumorigenesis.	Nature cell biology	2011	63
21653320	L-Tyrosine	Wang X	A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells.	Blood	2011	111
21655094	L-Tyrosine	Han W	EGFR tyrosine kinase inhibitors activate autophagy as a cytoprotective response in human lung cancer cells.	PloS one	2011	66
21665146	L-Tyrosine	Schmid MC	Receptor tyrosine kinases and TLR/IL1Rs unexpectedly activate myeloid cell PI3kγ, a single convergent point promoting tumor inflammation and progression.	Cancer cell	2011	77
21690468	L-Tyrosine	Guo J	Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification.	Journal of clinical oncology 	2011	97
21711246	L-Tyrosine	Koch S	Signal transduction by vascular endothelial growth factor receptors.	The Biochemical journal	2011	203
21720997	L-Tyrosine	Kim HR	Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement.	Cancer	2012	37
21743492	L-Tyrosine	Quintavalle C	miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ.	Oncogene	2012	58
21752724	L-Tyrosine	Chu E	An update on the current and emerging targeted agents in metastatic colorectal cancer.	Clinical colorectal cancer	2012	39
21764376	L-Tyrosine	Yasuda H	EGFR exon 20 insertion mutations in non-small-cell lung cancer: preclinical data and clinical implications.	The Lancet. Oncology	2012	93
21768463	L-Tyrosine	Sequist LV	Randomized phase II study of erlotinib plus tivantinib versus erlotinib plus placebo in previously treated non-small-cell lung cancer.	Journal of clinical oncology 	2011	135
21788562	L-Tyrosine	Zhou Q	Relative abundance of EGFR mutations predicts benefit from gefitinib treatment for advanced non-small-cell lung cancer.	Journal of clinical oncology 	2011	64
21791426	L-Tyrosine	Chomel JC	Leukemic stem cell persistence in chronic myeloid leukemia patients with sustained undetectable molecular residual disease.	Blood	2011	43
21814823	L-Tyrosine	Pevzner A	Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis.	Journal of neurology	2012	39
21831840	L-Tyrosine	Hwang CI	Wild-type p53 controls cell motility and invasion by dual regulation of MET expression.	Proceedings of the National Academy of Sciences of the United States of America	2011	47
21852385	L-Tyrosine	Wang M	EGF receptor inhibition radiosensitizes NSCLC cells by inducing senescence in cells sustaining DNA double-strand breaks.	Cancer research	2011	37
21885862	L-Tyrosine	Taeger J	Targeting FGFR/PDGFR/VEGFR impairs tumor growth, angiogenesis, and metastasis by effects on tumor cells, endothelial cells, and pericytes in pancreatic cancer.	Molecular cancer therapeutics	2011	35
21898375	L-Tyrosine	Molina AM	Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma.	Cancer	2012	35
21908557	L-Tyrosine	Fox EM	A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer.	Cancer research	2011	58
21911423	L-Tyrosine	Hurtz C	BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia.	The Journal of experimental medicine	2011	47
21926191	L-Tyrosine	Yakes FM	Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth.	Molecular cancer therapeutics	2011	173
21926387	L-Tyrosine	Travis WD	International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary.	Proceedings of the American Thoracic Society	2011	83
21931021	L-Tyrosine	Paugh BS	Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma.	Journal of clinical oncology 	2011	75
21933749	L-Tyrosine	Shaw AT	Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis.	The Lancet. Oncology	2011	230
21975932	L-Tyrosine	Jin X	EGFR-AKT-Smad signaling promotes formation of glioma stem-like cells and tumor angiogenesis by ID3-driven cytokine induction.	Cancer research	2011	45
21985784	L-Tyrosine	Ebi H	Receptor tyrosine kinases exert dominant control over PI3K signaling in human KRAS mutant colorectal cancers.	The Journal of clinical investigation	2011	69
22015057	L-Tyrosine	Garcia-Donas J	Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study.	The Lancet. Oncology	2011	64
22057914	L-Tyrosine	Cheng Y	MK-2206, a novel allosteric inhibitor of Akt, synergizes with gefitinib against malignant glioma via modulating both autophagy and apoptosis.	Molecular cancer therapeutics	2012	40
22059152	L-Tyrosine	Guo D	An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway.	Cancer discovery	2011	70
22080864	L-Tyrosine	Feng H	Activation of Rac1 by Src-dependent phosphorylation of Dock180(Y1811) mediates PDGFRα-stimulated glioma tumorigenesis in mice and humans.	The Journal of clinical investigation	2011	39
22084170	L-Tyrosine	Kreahling JM	MK1775, a selective Wee1 inhibitor, shows single-agent antitumor activity against sarcoma cells.	Molecular cancer therapeutics	2012	42
22095627	L-Tyrosine	Tanaka A	Hyperoxia-induced LC3B interacts with the Fas apoptotic pathway in epithelial cell death.	American journal of respiratory cell and molecular biology	2012	38
22116549	L-Tyrosine	Gupta M	Regulation of STAT3 by histone deacetylase-3 in diffuse large B-cell lymphoma: implications for therapy.	Leukemia	2012	32
22130231	L-Tyrosine	Takahashi S	Vascular endothelial growth factor (VEGF), VEGF receptors and their inhibitors for antiangiogenic tumor therapy.	Biological & pharmaceutical bulletin	2011	48
22137795	L-Tyrosine	Snuderl M	Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma.	Cancer cell	2011	200
22140546	L-Tyrosine	Li C	Spectrum of oncogenic driver mutations in lung adenocarcinomas from East Asian never smokers.	PloS one	2011	59
22144665	L-Tyrosine	Ying W	Ganetespib, a unique triazolone-containing Hsp90 inhibitor, exhibits potent antitumor activity and a superior safety profile for cancer therapy.	Molecular cancer therapeutics	2012	64
22157681	L-Tyrosine	Garofalo M	EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers.	Nature medicine	2011	120
22160019	L-Tyrosine	Burger JA	Nurture versus nature: the microenvironment in chronic lymphocytic leukemia.	Hematology. American Society of Hematology. Education Program	2011	44
22161825	L-Tyrosine	Eccles SA	The epidermal growth factor receptor/Erb-B/HER family in normal and malignant breast biology.	The International journal of developmental biology	2011	41
22167408	L-Tyrosine	Jamal-Hanjani M	Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of epidermal growth factor receptor-mutant non-small cell lung cancer metastatic to the brain.	Clinical cancer research 	2012	37
22170610	L-Tyrosine	Png KJ	A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells.	Nature	2011	151
22173954	L-Tyrosine	Xie M	Activation of Notch-1 enhances epithelial-mesenchymal transition in gefitinib-acquired resistant lung cancer cells.	Journal of cellular biochemistry	2012	45
22178589	L-Tyrosine	Andersen JB	Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors.	Gastroenterology	2012	86
22180308	L-Tyrosine	Tai WT	Dovitinib induces apoptosis and overcomes sorafenib resistance in hepatocellular carcinoma through SHP-1-mediated inhibition of STAT3.	Molecular cancer therapeutics	2012	36
22180443	L-Tyrosine	Ponader S	The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo.	Blood	2012	171
22184391	L-Tyrosine	van Gaal JC	Anaplastic lymphoma kinase aberrations in rhabdomyosarcoma: clinical and prognostic implications.	Journal of clinical oncology 	2012	35
22207735	L-Tyrosine	Yuan H	Activation of stress response gene SIRT1 by BCR-ABL promotes leukemogenesis.	Blood	2012	53
22228822	L-Tyrosine	Kim Y	The EGFR T790M mutation in acquired resistance to an irreversible second-generation EGFR inhibitor.	Molecular cancer therapeutics	2012	36
22238366	L-Tyrosine	Gozgit JM	Ponatinib (AP24534), a multitargeted pan-FGFR inhibitor with activity in multiple FGFR-amplified or mutated cancer models.	Molecular cancer therapeutics	2012	71
22238368	L-Tyrosine	Chen CT	MET activation mediates resistance to lapatinib inhibition of HER2-amplified gastric cancer cells.	Molecular cancer therapeutics	2012	49
22248929	L-Tyrosine	Garrett JT	Will PI3K pathway inhibitors be effective as single agents in patients with cancer?	Oncotarget	2011	35
22257651	L-Tyrosine	Ou SH	Second-generation irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs): a better mousetrap? A review of the clinical evidence.	Critical reviews in oncology/hematology	2012	32
22257673	L-Tyrosine	Baselga J	Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial.	Lancet	2012	236
22261334	L-Tyrosine	Han W	Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locations.	Cancer letters	2012	70
22279054	L-Tyrosine	de Rooij MF	The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia.	Blood	2012	134
22282308	L-Tyrosine	Cheng L	Molecular pathology of lung cancer: key to personalized medicine.	Modern pathology 	2012	45
22285168	L-Tyrosine	Rosell R	Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.	The Lancet. Oncology	2012	1030
22289988	L-Tyrosine	Renneville A	Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association.	Leukemia	2012	30
22311673	L-Tyrosine	Little SE	Receptor tyrosine kinase genes amplified in glioblastoma exhibit a mutual exclusivity in variable proportions reflective of individual tumor heterogeneity.	Cancer research	2012	33
22323597	L-Tyrosine	Szerlip NJ	Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response.	Proceedings of the National Academy of Sciences of the United States of America	2012	141
22327623	L-Tyrosine	Takeuchi K	RET, ROS1 and ALK fusions in lung cancer.	Nature medicine	2012	277
22327624	L-Tyrosine	Kohno T	KIF5B-RET fusions in lung adenocarcinoma.	Nature medicine	2012	189
22362000	L-Tyrosine	Hoellenriegel J	Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration.	Leukemia	2012	46
22368270	L-Tyrosine	Man CH	Sorafenib treatment of FLT3-ITD(+) acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation.	Blood	2012	62
22370318	L-Tyrosine	Lee JS	Vandetanib Versus placebo in patients with advanced non-small-cell lung cancer after prior therapy with an epidermal growth factor receptor tyrosine kinase inhibitor: a randomized, double-blind phase III trial (ZEPHYR).	Journal of clinical oncology 	2012	74
22371878	L-Tyrosine	Khoury HJ	Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure.	Blood	2012	61
22390767	L-Tyrosine	Prud'homme GJ	Cancer stem cells and novel targets for antitumor strategies.	Current pharmaceutical design	2012	36
22393126	L-Tyrosine	Hamerlik P	Autocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth.	The Journal of experimental medicine	2012	105
22407829	L-Tyrosine	Perez-Moreno P	Squamous cell carcinoma of the lung: molecular subtypes and therapeutic opportunities.	Clinical cancer research 	2012	51
22434142	L-Tyrosine	Gorbatyuk MS	Glucose regulated protein 78 diminishes α-synuclein neurotoxicity in a rat model of Parkinson disease.	Molecular therapy 	2012	40
22436374	L-Tyrosine	Chen G	Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab.	BMC medicine	2012	36
22458527	L-Tyrosine	Troiani T	Targeting EGFR in pancreatic cancer treatment.	Current drug targets	2012	33
22461643	L-Tyrosine	Stern HM	Improving treatment of HER2-positive cancers: opportunities and challenges.	Science translational medicine	2012	44
22529104	L-Tyrosine	Pignatelli J	Hic-5 promotes invadopodia formation and invasion during TGF-β-induced epithelial-mesenchymal transition.	The Journal of cell biology	2012	59
22535374	L-Tyrosine	De Boeck A	Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression through paracrine neuregulin 1/HER3 signalling.	Gut	2013	37
22553347	L-Tyrosine	Sjödahl G	A molecular taxonomy for urothelial carcinoma.	Clinical cancer research 	2012	92
22566605	L-Tyrosine	Blum W	Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia.	Blood	2012	47
22573349	L-Tyrosine	Griffioen AW	Rapid angiogenesis onset after discontinuation of sunitinib treatment of renal cell carcinoma patients.	Clinical cancer research 	2012	40
22585576	L-Tyrosine	Felcht M	Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling.	The Journal of clinical investigation	2012	101
22589274	L-Tyrosine	Kelber JA	KRas induces a Src/PEAK1/ErbB2 kinase amplification loop that drives metastatic growth and therapy resistance in pancreatic cancer.	Cancer research	2012	33
22589483	L-Tyrosine	Matthay KK	Promising therapeutic targets in neuroblastoma.	Clinical cancer research 	2012	44
22609131	L-Tyrosine	Capurso C	From excess adiposity to insulin resistance: the role of free fatty acids.	Vascular pharmacology	2012	41
22617245	L-Tyrosine	Yasuda H	Preclinical rationale for use of the clinically available multitargeted tyrosine kinase inhibitor crizotinib in ROS1-translocated lung cancer.	Journal of thoracic oncology 	2012	34
22624718	L-Tyrosine	Lapalombella R	Tetraspanin CD37 directly mediates transduction of survival and apoptotic signals.	Cancer cell	2012	31
22635005	L-Tyrosine	Peinado H	Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET.	Nature medicine	2012	678
22641068	L-Tyrosine	Buurman R	Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.	Gastroenterology	2012	52
22641215	L-Tyrosine	Tobin LA	Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias.	Oncogene	2013	30
22652764	L-Tyrosine	Nagathihalli NS	Src-mediated regulation of E-cadherin and EMT in pancreatic cancer.	Frontiers in bioscience	2012	30
22677429	L-Tyrosine	Park SJ	Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 mutation.	Lung cancer	2012	63
22683780	L-Tyrosine	Kentsis A	Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia.	Nature medicine	2012	53
22688339	L-Tyrosine	Dinh T	Mechanisms involved in the development and healing of diabetic foot ulceration.	Diabetes	2012	38
22689860	L-Tyrosine	Tai YT	Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma.	Blood	2012	48
22705009	L-Tyrosine	Ma S	Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.	Gastroenterology	2012	30
22710920	L-Tyrosine	Wang JZ	Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration.	Journal of Alzheimer's disease 	2013	68
22711876	L-Tyrosine	Shaik S	SCF(β-TRCP) suppresses angiogenesis and thyroid cancer cell migration by promoting ubiquitination and destruction of VEGF receptor 2.	The Journal of experimental medicine	2012	32
22733536	L-Tyrosine	Heon S	The impact of initial gefitinib or erlotinib versus chemotherapy on central nervous system progression in advanced non-small cell lung cancer with EGFR mutations.	Clinical cancer research 	2012	36
22738912	L-Tyrosine	Yaqoob U	Neuropilin-1 stimulates tumor growth by increasing fibronectin fibril assembly in the tumor microenvironment.	Cancer research	2012	36
22751098	L-Tyrosine	Zhang Z	Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer.	Nature genetics	2012	298
22761469	L-Tyrosine	Arcila ME	Prevalence, clinicopathologic associations, and molecular spectrum of ERBB2 (HER2) tyrosine kinase mutations in lung adenocarcinomas.	Clinical cancer research 	2012	62
22763448	L-Tyrosine	Wilson TR	Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors.	Nature	2012	365
22806307	L-Tyrosine	Togashi Y	Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer.	Cancer chemotherapy and pharmacology	2012	42
22825000	L-Tyrosine	Thunnissen E	EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations.	Virchows Archiv 	2012	42
22826274	L-Tyrosine	Bai H	Influence of chemotherapy on EGFR mutation status among patients with non-small-cell lung cancer.	Journal of clinical oncology 	2012	65
22833179	L-Tyrosine	Toh HC	Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma.	Cancer	2013	26
22844075	L-Tyrosine	Nakagawa T	Combined therapy with mutant-selective EGFR inhibitor and Met kinase inhibitor for overcoming erlotinib resistance in EGFR-mutant lung cancer.	Molecular cancer therapeutics	2012	31
22874768	L-Tyrosine	Harbinski F	Rescue screens with secreted proteins reveal compensatory potential of receptor tyrosine kinases in driving cancer growth.	Cancer discovery	2012	34
22875912	L-Tyrosine	Wiestner A	Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia.	Blood	2012	40
22878749	L-Tyrosine	Goldberg SB	A phase I study of erlotinib and hydroxychloroquine in advanced non-small-cell lung cancer.	Journal of thoracic oncology 	2012	32
22890323	L-Tyrosine	Linger RM	Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer.	Oncogene	2013	44
22891040	L-Tyrosine	Kim SM	Activation of IL-6R/JAK1/STAT3 signaling induces de novo resistance to irreversible EGFR inhibitors in non-small cell lung cancer with T790M resistance mutation.	Molecular cancer therapeutics	2012	38
22891351	L-Tyrosine	Couto JP	STAT3 negatively regulates thyroid tumorigenesis.	Proceedings of the National Academy of Sciences of the United States of America	2012	43
22895193	L-Tyrosine	Seshagiri S	Recurrent R-spondin fusions in colon cancer.	Nature	2012	250
22897846	L-Tyrosine	Tamagnone L	Emerging role of semaphorins as major regulatory signals and potential therapeutic targets in cancer.	Cancer cell	2012	41
22897847	L-Tyrosine	Roberts KG	Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia.	Cancer cell	2012	159
22898678	L-Tyrosine	Leboulleux S	Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial.	The Lancet. Oncology	2012	62
22899358	L-Tyrosine	Fujita Y	Highly sensitive detection of EGFR T790M mutation using colony hybridization predicts favorable prognosis of patients with lung cancer harboring activating EGFR mutation.	Journal of thoracic oncology 	2012	33
22906415	L-Tyrosine	Crews LA	Selective elimination of leukemia stem cells: hitting a moving target.	Cancer letters	2013	29
22916121	L-Tyrosine	Petty A	A small molecule agonist of EphA2 receptor tyrosine kinase inhibits tumor cell migration in vitro and prostate cancer metastasis in vivo.	PloS one	2012	35
22961666	L-Tyrosine	Byers LA	Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1.	Cancer discovery	2012	95
22965961	L-Tyrosine	Schmoll HJ	Cediranib with mFOLFOX6 versus bevacizumab with mFOLFOX6 as first-line treatment for patients with advanced colorectal cancer: a double-blind, randomized phase III study (HORIZON III).	Journal of clinical oncology 	2012	49
22967996	L-Tyrosine	Awada A	Safety and efficacy of neratinib (HKI-272) plus vinorelbine in the treatment of patients with ErbB2-positive metastatic breast cancer pretreated with anti-HER2 therapy.	Annals of oncology 	2013	27
22975686	L-Tyrosine	Rushworth SA	BTK inhibitor ibrutinib is cytotoxic to myeloma and potently enhances bortezomib and lenalidomide activities through NF-κB.	Cellular signalling	2013	33
22996586	L-Tyrosine	Yan Y	MicroRNA-10a is involved in the metastatic process by regulating Eph tyrosine kinase receptor A4-mediated epithelial-mesenchymal transition and adhesion in hepatoma cells.	Hepatology	2013	42
23027128	L-Tyrosine	Zheng Y	Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT.	Oncogene	2013	25
23041612	L-Tyrosine	Zhang S	The onco-embryonic antigen ROR1 is expressed by a variety of human cancers.	The American journal of pathology	2012	36
23045577	L-Tyrosine	Advani RH	Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed/refractory B-cell malignancies.	Journal of clinical oncology 	2013	210
23052255	L-Tyrosine	Suehara Y	Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions.	Clinical cancer research 	2012	39
23084121	L-Tyrosine	Nielsen DL	Efficacy of HER2-targeted therapy in metastatic breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors.	Breast	2013	29
23085539	L-Tyrosine	McCubrey JA	Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance.	Oncotarget	2012	105
23093673	L-Tyrosine	Son M	C1q limits dendritic cell differentiation and activation by engaging LAIR-1.	Proceedings of the National Academy of Sciences of the United States of America	2012	33
23113752	L-Tyrosine	Savvides P	Phase II trial of sorafenib in patients with advanced anaplastic carcinoma of the thyroid.	Thyroid 	2013	35
23136191	L-Tyrosine	Spoerke JM	Phosphoinositide 3-kinase (PI3K) pathway alterations are associated with histologic subtypes and are predictive of sensitivity to PI3K inhibitors in lung cancer preclinical models.	Clinical cancer research 	2012	46
23154552	L-Tyrosine	Weickhardt AJ	Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancer.	Journal of thoracic oncology 	2012	97
23159595	L-Tyrosine	Spencer DH	Detection of FLT3 internal tandem duplication in targeted, short-read-length, next-generation sequencing data.	The Journal of molecular diagnostics 	2013	34
23169517	L-Tyrosine	Smith DC	Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial.	Journal of clinical oncology 	2013	120
23172555	L-Tyrosine	Ellison G	EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples.	Journal of clinical pathology	2013	58
23209031	L-Tyrosine	Gerdes CA	GA201 (RG7160): a novel, humanized, glycoengineered anti-EGFR antibody with enhanced ADCC and superior in vivo efficacy compared with cetuximab.	Clinical cancer research 	2013	31
23238013	L-Tyrosine	Binda E	The EphA2 receptor drives self-renewal and tumorigenicity in stem-like tumor-propagating cells from human glioblastomas.	Cancer cell	2012	45
23242808	L-Tyrosine	Girotti MR	Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanoma.	Cancer discovery	2013	106
23245941	L-Tyrosine	Rosenbluh J	β-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis.	Cell	2012	165
23246963	L-Tyrosine	Montero JC	Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancer.	Oncogene	2014	29
23258844	L-Tyrosine	Kim KH	Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells.	Neuro-oncology	2013	32
23275034	L-Tyrosine	Ward KK	Inhibition of focal adhesion kinase (FAK) activity prevents anchorage-independent ovarian carcinoma cell growth and tumor progression.	Clinical & experimental metastasis	2013	29
23281850	L-Tyrosine	Wade A	Proteoglycans and their roles in brain cancer.	The FEBS journal	2013	27
23299311	L-Tyrosine	Zhang B	Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-β-catenin signaling.	Blood	2013	70
23318457	L-Tyrosine	Sia D	Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies.	Oncogene	2013	49
23325080	L-Tyrosine	Tang J	Role of epidermal growth factor receptor in acute and chronic kidney injury.	Kidney international	2013	29
23328547	L-Tyrosine	Oxnard GR	Natural history and molecular characteristics of lung cancers harboring EGFR exon 20 insertions.	Journal of thoracic oncology 	2013	31
23333150	L-Tyrosine	Goff DJ	A Pan-BCL2 inhibitor renders bone-marrow-resident human leukemia stem cells sensitive to tyrosine kinase inhibition.	Cell stem cell	2013	54
23333754	L-Tyrosine	Sullivan DP	Poliovirus receptor (CD155) regulates a step in transendothelial migration between PECAM and CD99.	The American journal of pathology	2013	26
23334327	L-Tyrosine	Do TV	Aurora kinase A mediates epithelial ovarian cancer cell migration and adhesion.	Oncogene	2014	35
23334668	L-Tyrosine	Holmfeldt L	The genomic landscape of hypodiploid acute lymphoblastic leukemia.	Nature genetics	2013	131
23344264	L-Tyrosine	Yeh P	DNA-Mutation Inventory to Refine and Enhance Cancer Treatment (DIRECT): a catalog of clinically relevant cancer mutations to enable genome-directed anticancer therapy.	Clinical cancer research 	2013	37
23362162	L-Tyrosine	Tuononen K	Comparison of targeted next-generation sequencing (NGS) and real-time PCR in the detection of EGFR, KRAS, and BRAF mutations on formalin-fixed, paraffin-embedded tumor material of non-small cell lung carcinoma-superiority of NGS.	Genes, chromosomes & cancer	2013	35
23362324	L-Tyrosine	Zhu AX	Efficacy, safety, pharmacokinetics, and biomarkers of cediranib monotherapy in advanced hepatocellular carcinoma: a phase II study.	Clinical cancer research 	2013	25
23370315	L-Tyrosine	Hirsch FR	Epidermal growth factor receptor inhibition in lung cancer: status 2012.	Journal of thoracic oncology 	2013	28
23371856	L-Tyrosine	Arcila ME	EGFR exon 20 insertion mutations in lung adenocarcinomas: prevalence, molecular heterogeneity, and clinicopathologic characteristics.	Molecular cancer therapeutics	2013	48
23375101	L-Tyrosine	Rapraeger AC	Synstatin: a selective inhibitor of the syndecan-1-coupled IGF1R-αvβ3 integrin complex in tumorigenesis and angiogenesis.	The FEBS journal	2013	26
23391309	L-Tyrosine	Chong JJ	Progenitor cells identified by PDGFR-alpha expression in the developing and diseased human heart.	Stem cells and development	2013	35
23400594	L-Tyrosine	Casetti L	Differential contributions of STAT5A and STAT5B to stress protection and tyrosine kinase inhibitor resistance of chronic myeloid leukemia stem/progenitor cells.	Cancer research	2013	29
23401433	L-Tyrosine	Li T	Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies.	Journal of clinical oncology 	2013	97
23401451	L-Tyrosine	Ohashi K	Epidermal growth factor receptor tyrosine kinase inhibitor-resistant disease.	Journal of clinical oncology 	2013	113
23407558	L-Tyrosine	Yu HA	Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors.	Journal of thoracic oncology 	2013	57
23410976	L-Tyrosine	Day BW	EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiforme.	Cancer cell	2013	44
23418360	L-Tyrosine	Du WW	MicroRNA miR-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling.	Journal of cell science	2013	44
23437362	L-Tyrosine	Soares HP	Different patterns of Akt and ERK feedback activation in response to rapamycin, active-site mTOR inhibitors and metformin in pancreatic cancer cells.	PloS one	2013	45
23441129	L-Tyrosine	Walters DM	Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib.	Neoplasia	2013	28
23465663	L-Tyrosine	Pieper K	B-cell biology and development.	The Journal of allergy and clinical immunology	2013	48
23470965	L-Tyrosine	Yu HA	Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers.	Clinical cancer research 	2013	343
23484006	L-Tyrosine	Navis AC	Effects of dual targeting of tumor cells and stroma in human glioblastoma xenografts with a tyrosine kinase inhibitor against c-MET and VEGFR2.	PloS one	2013	28
23487751	L-Tyrosine	Franco MC	Nitration of Hsp90 induces cell death.	Proceedings of the National Academy of Sciences of the United States of America	2013	41
23502220	L-Tyrosine	Hochhaus A	Nilotinib is associated with a reduced incidence of BCR-ABL mutations vs imatinib in patients with newly diagnosed chronic myeloid leukemia in chronic phase.	Blood	2013	29
23509284	L-Tyrosine	Knight JF	Met synergizes with p53 loss to induce mammary tumors that possess features of claudin-low breast cancer.	Proceedings of the National Academy of Sciences of the United States of America	2013	28
23516327	L-Tyrosine	Frisch SM	Mechanisms that link the oncogenic epithelial-mesenchymal transition to suppression of anoikis.	Journal of cell science	2013	66
23521885	L-Tyrosine	Abram CL	Distinct roles for neutrophils and dendritic cells in inflammation and autoimmunity in motheaten mice.	Immunity	2013	35
23529165	L-Tyrosine	Craici IM	Podocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective study.	Hypertension	2013	28
23533263	L-Tyrosine	Akhavan D	De-repression of PDGFRβ transcription promotes acquired resistance to EGFR tyrosine kinase inhibitors in glioblastoma patients.	Cancer discovery	2013	28
23536707	L-Tyrosine	Terai H	Activation of the FGF2-FGFR1 autocrine pathway: a novel mechanism of acquired resistance to gefitinib in NSCLC.	Molecular cancer research 	2013	44
23542356	L-Tyrosine	Shien K	Acquired resistance to EGFR inhibitors is associated with a manifestation of stem cell-like properties in cancer cells.	Cancer research	2013	72
23550148	L-Tyrosine	Killian JK	Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor.	Cancer discovery	2013	78
23551194	L-Tyrosine	Lindeman NI	Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.	Archives of pathology & laboratory medicine	2013	80
23552377	L-Tyrosine	Lindeman NI	Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.	Journal of thoracic oncology 	2013	147
23552693	L-Tyrosine	Beaty BT	β1 integrin regulates Arg to promote invadopodial maturation and matrix degradation.	Molecular biology of the cell	2013	47
23552883	L-Tyrosine	Mitamura T	Downregulation of miRNA-31 induces taxane resistance in ovarian cancer cells through increase of receptor tyrosine kinase MET.	Oncogenesis	2013	34
23562183	L-Tyrosine	Lindeman NI	Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.	The Journal of molecular diagnostics 	2013	80
23584089	L-Tyrosine	Sadanandam A	A colorectal cancer classification system that associates cellular phenotype and responses to therapy.	Nature medicine	2013	205
23610448	L-Tyrosine	Guerin E	A model of postsurgical advanced metastatic breast cancer more accurately replicates the clinical efficacy of antiangiogenic drugs.	Cancer research	2013	25
23619944	L-Tyrosine	Peled N	Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer.	Cellular oncology	2013	27
23620405	L-Tyrosine	Hudecek M	Receptor affinity and extracellular domain modifications affect tumor recognition by ROR1-specific chimeric antigen receptor T cells.	Clinical cancer research 	2013	105
23623056	L-Tyrosine	Joensuu H	Gastrointestinal stromal tumour.	Lancet	2013	73
23624919	L-Tyrosine	Vultur A	MEK inhibition affects STAT3 signaling and invasion in human melanoma cell lines.	Oncogene	2014	23
23630186	L-Tyrosine	Gassenmaier M	CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis.	Stem cells	2013	27
23633458	L-Tyrosine	von Roemeling CA	Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinoma.	Clinical cancer research 	2013	49
23637631	L-Tyrosine	Giacomini CP	Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer types.	PLoS genetics	2013	30
23639648	L-Tyrosine	Miettinen M	Gastrointestinal stromal tumors.	Gastroenterology clinics of North America	2013	36
23644467	L-Tyrosine	Zhang K	The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis.	Nature cell biology	2013	95
23650389	L-Tyrosine	Acunzo M	Cross-talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2.	Proceedings of the National Academy of Sciences of the United States of America	2013	40
23661005	L-Tyrosine	Hage C	The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer.	Cell death & disease	2013	39
23677068	L-Tyrosine	Sekido Y	Molecular pathogenesis of malignant mesothelioma.	Carcinogenesis	2013	39
23684459	L-Tyrosine	Kim E	Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells.	Cancer cell	2013	152
23684620	L-Tyrosine	Han J	Gas6/Axl mediates tumor cell apoptosis, migration and invasion and predicts the clinical outcome of osteosarcoma patients.	Biochemical and biophysical research communications	2013	31
23690424	L-Tyrosine	Siu LL	Phase III randomized, placebo-controlled study of cetuximab plus brivanib alaninate versus cetuximab plus placebo in patients with metastatic, chemotherapy-refractory, wild-type K-RAS colorectal carcinoma: the NCIC Clinical Trials Group and AGITG CO.20 Trial.	Journal of clinical oncology 	2013	37
23695170	L-Tyrosine	Morgillo F	Synergistic effects of metformin treatment in combination with gefitinib, a selective EGFR tyrosine kinase inhibitor, in LKB1 wild-type NSCLC cell lines.	Clinical cancer research 	2013	32
23719267	L-Tyrosine	Davies KD	Molecular pathways: ROS1 fusion proteins in cancer.	Clinical cancer research 	2013	54
23719833	L-Tyrosine	Graham GG	The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings.	Inflammopharmacology	2013	37
23729403	L-Tyrosine	Kutluk Cenik B	BIBF 1120 (nintedanib), a triple angiokinase inhibitor, induces hypoxia but not EMT and blocks progression of preclinical models of lung and pancreatic cancer.	Molecular cancer therapeutics	2013	26
23732477	L-Tyrosine	Belov AA	Molecular mechanisms of fibroblast growth factor signaling in physiology and pathology.	Cold Spring Harbor perspectives in biology	2013	36
23732879	L-Tyrosine	Robicsek O	Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients.	Molecular psychiatry	2013	50
23743928	L-Tyrosine	Selinger CI	Testing for ALK rearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situ hybridization.	Modern pathology 	2013	33
23771907	L-Tyrosine	Cui B	Targeting ROR1 inhibits epithelial-mesenchymal transition and metastasis.	Cancer research	2013	33
23798385	L-Tyrosine	Buraschi S	Decorin causes autophagy in endothelial cells via Peg3.	Proceedings of the National Academy of Sciences of the United States of America	2013	51
23805317	L-Tyrosine	Garofalo M	MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer.	PloS one	2013	34
23831709	L-Tyrosine	Spiess C	Bispecific antibodies with natural architecture produced by co-culture of bacteria expressing two distinct half-antibodies.	Nature biotechnology	2013	50
23836557	L-Tyrosine	Yang G	A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenström macroglobulinemia.	Blood	2013	42
23862974	L-Tyrosine	Sanna-Cherchi S	Mutations in DSTYK and dominant urinary tract malformations.	The New England journal of medicine	2013	28
23872583	L-Tyrosine	Kanda R	Erlotinib resistance in lung cancer cells mediated by integrin β1/Src/Akt-driven bypass signaling.	Cancer research	2013	33
23896413	L-Tyrosine	Gotlib J	The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment.	Blood	2013	38
23913134	L-Tyrosine	Minami J	Histone deacetylase 3 as a novel therapeutic target in multiple myeloma.	Leukemia	2014	24
23921085	L-Tyrosine	Meyer AS	The receptor AXL diversifies EGFR signaling and limits the response to EGFR-targeted inhibitors in triple-negative breast cancer cells.	Science signaling	2013	67
23927790	L-Tyrosine	Kim HR	Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping.	Journal of experimental & clinical cancer research 	2013	28
23928062	L-Tyrosine	Burger JA	B cell receptor signaling in chronic lymphocytic leukemia.	Trends in immunology	2013	52
23931927	L-Tyrosine	Gridelli C	ALK inhibitors in the treatment of advanced NSCLC.	Cancer treatment reviews	2014	39
23933118	L-Tyrosine	Thakker RV	Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4).	Molecular and cellular endocrinology	2014	46
23970380	L-Tyrosine	Walker CJ	Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias.	Blood	2013	40
24009080	L-Tyrosine	Siemens H	Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness.	Oncotarget	2013	51
24019536	L-Tyrosine	Jacquemet G	RCP-driven α5β1 recycling suppresses Rac and promotes RhoA activity via the RacGAP1-IQGAP1 complex.	The Journal of cell biology	2013	33
24019545	L-Tyrosine	Motzer RJ	Tivozanib versus sorafenib as initial targeted therapy for patients with metastatic renal cell carcinoma: results from a phase III trial.	Journal of clinical oncology 	2013	59
24026012	L-Tyrosine	Giles KM	Axl mediates acquired resistance of head and neck cancer cells to the epidermal growth factor receptor inhibitor erlotinib.	Molecular cancer therapeutics	2013	33
24045150	L-Tyrosine	Giordano S	Met as a therapeutic target in HCC: facts and hopes.	Journal of hepatology	2014	29
24053309	L-Tyrosine	Nguyen DP	Inflammation and prostate cancer: the role of interleukin 6 (IL-6).	BJU international	2014	39
24054705	L-Tyrosine	Goffin JR	Epidermal growth factor receptor: pathway, therapies, and pipeline.	Clinical therapeutics	2013	25
24065147	L-Tyrosine	Niederst MJ	Bypass mechanisms of resistance to receptor tyrosine kinase inhibition in lung cancer.	Science signaling	2013	61
24082147	L-Tyrosine	Wang Y	STAT3 activation in response to IL-6 is prolonged by the binding of IL-6 receptor to EGF receptor.	Proceedings of the National Academy of Sciences of the United States of America	2013	38
24096486	L-Tyrosine	Ouyang H	microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-β actions.	Oncogene	2014	36
24105277	L-Tyrosine	Hata A	Rebiopsy of non-small cell lung cancer patients with acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor: Comparison between T790M mutation-positive and mutation-negative populations.	Cancer	2013	46
24122810	L-Tyrosine	Arai Y	Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma.	Hepatology	2014	45
24165158	L-Tyrosine	Rho JK	MET and AXL inhibitor NPS-1034 exerts efficacy against lung cancer cells resistant to EGFR kinase inhibitors because of MET or AXL activation.	Cancer research	2014	30
24170546	L-Tyrosine	Dunne PD	AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer.	Clinical cancer research 	2014	29
24190997	L-Tyrosine	Batchelor TT	Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation.	Proceedings of the National Academy of Sciences of the United States of America	2013	94
24199193	L-Tyrosine	Kamran MZ	Role of STAT3 in cancer metastasis and translational advances.	BioMed research international	2013	49
24199791	L-Tyrosine	Ahmad A	Inhibition of Hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs.	Journal of hematology & oncology	2013	36
24216507	L-Tyrosine	Chen X	Induction of myelodysplasia by myeloid-derived suppressor cells.	The Journal of clinical investigation	2013	42
24233839	L-Tyrosine	Lee HJ	Gas6/Axl pathway promotes tumor invasion through the transcriptional activation of Slug in hepatocellular carcinoma.	Carcinogenesis	2014	21
24242861	L-Tyrosine	Rosenberg JE	A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma.	Investigational new drugs	2014	43
24248375	L-Tyrosine	Drake JM	Metastatic castration-resistant prostate cancer reveals intrapatient similarity and interpatient heterogeneity of therapeutic kinase targets.	Proceedings of the National Academy of Sciences of the United States of America	2013	31
24258346	L-Tyrosine	Kitamura K	MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells.	Molecular cancer therapeutics	2014	40
24263190	L-Tyrosine	Goel HL	VEGF targets the tumour cell.	Nature reviews. Cancer	2013	182
24270740	L-Tyrosine	Cheng S	BTK inhibition targets in vivo CLL proliferation through its effects on B-cell receptor signaling activity.	Leukemia	2014	45
24276851	L-Tyrosine	Girnita L	Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulation.	Cellular and molecular life sciences 	2014	31
24279329	L-Tyrosine	Schedin-Weiss S	The role of protein glycosylation in Alzheimer disease.	The FEBS journal	2014	35
24297891	L-Tyrosine	Huijbers MG	MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4.	Proceedings of the National Academy of Sciences of the United States of America	2013	29
24302556	L-Tyrosine	Malchers F	Cell-autonomous and non-cell-autonomous mechanisms of transformation by amplified FGFR1 in lung cancer.	Cancer discovery	2014	24
24315443	L-Tyrosine	Miller JD	Human iPSC-based modeling of late-onset disease via progerin-induced aging.	Cell stem cell	2013	146
24323036	L-Tyrosine	Rousselot P	Loss of major molecular response as a trigger for restarting tyrosine kinase inhibitor therapy in patients with chronic-phase chronic myelogenous leukemia who have stopped imatinib after durable undetectable disease.	Journal of clinical oncology 	2014	41
24323901	L-Tyrosine	Touil Y	Colon cancer cells escape 5FU chemotherapy-induced cell death by entering stemness and quiescence associated with the c-Yes/YAP axis.	Clinical cancer research 	2014	40
24332241	L-Tyrosine	O'Brien S	Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial.	The Lancet. Oncology	2014	104
24334603	L-Tyrosine	Shi X	Gambogic acid induces apoptosis in imatinib-resistant chronic myeloid leukemia cells via inducing proteasome inhibition and caspase-dependent Bcr-Abl downregulation.	Clinical cancer research 	2014	31
24345756	L-Tyrosine	Dickinson RE	The evolution of cellular deficiency in GATA2 mutation.	Blood	2014	50
24355409	L-Tyrosine	Gelsomino F	Targeting the MET gene for the treatment of non-small-cell lung cancer.	Critical reviews in oncology/hematology	2014	21
24360619	L-Tyrosine	Figueroa-Magalhães MC	Treatment of HER2-positive breast cancer.	Breast	2014	29
24368849	L-Tyrosine	Mathew LK	miR-218 opposes a critical RTK-HIF pathway in mesenchymal glioblastoma.	Proceedings of the National Academy of Sciences of the United States of America	2014	26
24378644	L-Tyrosine	Siegelin MD	Epidermal growth factor receptor mutations in lung adenocarcinoma.	Laboratory investigation; a journal of technical methods and pathology	2014	47
24379393	L-Tyrosine	Atay S	Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion.	Proceedings of the National Academy of Sciences of the United States of America	2014	40
24379439	L-Tyrosine	Steinkamp MP	erbB3 is an active tyrosine kinase capable of homo- and heterointeractions.	Molecular and cellular biology	2014	27
24384849	L-Tyrosine	Corless CL	Gastrointestinal stromal tumors: what do we know now?	Modern pathology 	2014	25
24388873	L-Tyrosine	Siveen KS	Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors.	Biochimica et biophysica acta	2014	100
24403067	L-Tyrosine	Neill T	Decorin induces mitophagy in breast carcinoma cells via peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) and mitostatin.	The Journal of biological chemistry	2014	23
24412932	L-Tyrosine	Mahul-Mellier AL	c-Abl phosphorylates α-synuclein and regulates its degradation: implication for α-synuclein clearance and contribution to the pathogenesis of Parkinson's disease.	Human molecular genetics	2014	30
24436047	L-Tyrosine	Shern JF	Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors.	Cancer discovery	2014	96
24436048	L-Tyrosine	Will M	Rapid induction of apoptosis by PI3K inhibitors is dependent upon their transient inhibition of RAS-ERK signaling.	Cancer discovery	2014	45
24440599	L-Tyrosine	Kats LM	Proto-oncogenic role of mutant IDH2 in leukemia initiation and maintenance.	Cell stem cell	2014	44
24440911	L-Tyrosine	Zhang Y	Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B, and glioblastoma.	Cell death and differentiation	2014	21
24441398	L-Tyrosine	Esposito CL	Multifunctional aptamer-miRNA conjugates for targeted cancer therapy.	Molecular therapy 	2014	34
24443522	L-Tyrosine	Yang JJ	Lung cancers with concomitant EGFR mutations and ALK rearrangements: diverse responses to EGFR-TKI and crizotinib in relation to diverse receptors phosphorylation.	Clinical cancer research 	2014	32
24456475	L-Tyrosine	Warth A	ROS1 expression and translocations in non-small-cell lung cancer: clinicopathological analysis of 1478 cases.	Histopathology	2014	20
24472739	L-Tyrosine	Goyal A	Decorin activates AMPK, an energy sensor kinase, to induce autophagy in endothelial cells.	Matrix biology 	2014	22
24493829	L-Tyrosine	Costa C	The impact of EGFR T790M mutations and BIM mRNA expression on outcome in patients with EGFR-mutant NSCLC treated with erlotinib or chemotherapy in the randomized phase III EURTAC trial.	Clinical cancer research 	2014	55
24503127	L-Tyrosine	Gao Q	Activating mutations in PTPN3 promote cholangiocarcinoma cell proliferation and migration and are associated with tumor recurrence in patients.	Gastroenterology	2014	26
24525236	L-Tyrosine	Puissant A	SYK is a critical regulator of FLT3 in acute myeloid leukemia.	Cancer cell	2014	36
24535670	L-Tyrosine	de Bruin EC	Reduced NF1 expression confers resistance to EGFR inhibition in lung cancer.	Cancer discovery	2014	42
24556663	L-Tyrosine	Wollin L	Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis.	The Journal of pharmacology and experimental therapeutics	2014	49
24561444	L-Tyrosine	Mulligan LM	RET revisited: expanding the oncogenic portfolio.	Nature reviews. Cancer	2014	68
24563076	L-Tyrosine	Ross JS	New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing.	The oncologist	2014	61
24604288	L-Tyrosine	Hu X	Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple-negative breast cancer.	International journal of cancer	2014	30
24621885	L-Tyrosine	Zhang Y	MicroRNA-608 and microRNA-34a regulate chordoma malignancy by targeting EGFR, Bcl-xL and MET.	PloS one	2014	24
24626858	L-Tyrosine	Nagatsuma AK	Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma.	Gastric cancer 	2015	27
24633157	L-Tyrosine	Behjati S	Recurrent PTPRB and PLCG1 mutations in angiosarcoma.	Nature genetics	2014	38
24644001	L-Tyrosine	Li L	Metformin sensitizes EGFR-TKI-resistant human lung cancer cells in vitro and in vivo through inhibition of IL-6 signaling and EMT reversal.	Clinical cancer research 	2014	54
24657661	L-Tyrosine	Corrado C	Exosome-mediated crosstalk between chronic myelogenous leukemia cells and human bone marrow stromal cells triggers an interleukin 8-dependent survival of leukemia cells.	Cancer letters	2014	40
24658326	L-Tyrosine	Knubel KH	MerTK inhibition is a novel therapeutic approach for glioblastoma multiforme.	Oncotarget	2014	22
24659631	L-Tyrosine	Herman SE	Ibrutinib inhibits BCR and NF-κB signaling and reduces tumor proliferation in tissue-resident cells of patients with CLL.	Blood	2014	46
24662820	L-Tyrosine	Beristain AG	PKA signaling drives mammary tumorigenesis through Src.	Oncogene	2015	17
24685132	L-Tyrosine	Sun C	Intrinsic resistance to MEK inhibition in KRAS mutant lung and colon cancer through transcriptional induction of ERBB3.	Cell reports	2014	51
24705251	L-Tyrosine	Wu G	The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma.	Nature genetics	2014	141
24718867	L-Tyrosine	Patwardhan PP	Sustained inhibition of receptor tyrosine kinases and macrophage depletion by PLX3397 and rapamycin as a potential new approach for the treatment of MPNSTs.	Clinical cancer research 	2014	20
24727677	L-Tyrosine	Spirin PV	Silencing AML1-ETO gene expression leads to simultaneous activation of both pro-apoptotic and proliferation signaling.	Leukemia	2014	21
24737315	L-Tyrosine	Poluzzi C	Endorepellin evokes autophagy in endothelial cells.	The Journal of biological chemistry	2014	21
24743704	L-Tyrosine	Li S	Coexistence of EGFR with KRAS, or BRAF, or PIK3CA somatic mutations in lung cancer: a comprehensive mutation profiling from 5125 Chinese cohorts.	British journal of cancer	2014	29
24747441	L-Tyrosine	Seguin L	An integrin β₃-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition.	Nature cell biology	2014	77
24768581	L-Tyrosine	Kuiper JL	Incidence of T790M mutation in (sequential) rebiopsies in EGFR-mutated NSCLC-patients.	Lung cancer	2014	28
24771645	L-Tyrosine	Wynes MW	FGFR1 mRNA and protein expression, not gene copy number, predict FGFR TKI sensitivity across all lung cancer histologies.	Clinical cancer research 	2014	46
24800946	L-Tyrosine	Takahashi N	Serum levels of hepatocyte growth factor and epiregulin are associated with the prognosis on anti-EGFR antibody treatment in KRAS wild-type metastatic colorectal cancer.	British journal of cancer	2014	22
24813888	L-Tyrosine	Pirazzoli V	Acquired resistance of EGFR-mutant lung adenocarcinomas to afatinib plus cetuximab is associated with activation of mTORC1.	Cell reports	2014	23
24815784	L-Tyrosine	Reiss KA	Harnessing the power of the immune system via blockade of PD-1 and PD-L1: a promising new anticancer strategy.	Immunotherapy	2014	20
24821329	L-Tyrosine	Di Ieva A	Aggressive pituitary adenomas--diagnosis and emerging treatments.	Nature reviews. Endocrinology	2014	24
24827131	L-Tyrosine	Choueiri TK	A phase I study of cabozantinib (XL184) in patients with renal cell cancer.	Annals of oncology 	2014	26
24829205	L-Tyrosine	Wodarz D	Kinetics of CLL cells in tissues and blood during therapy with the BTK inhibitor ibrutinib.	Blood	2014	23
24831979	L-Tyrosine	Gregorc V	Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial.	The Lancet. Oncology	2014	44
24837095	L-Tyrosine	Graham RP	Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma.	Human pathology	2014	28
24850843	L-Tyrosine	Wang R	FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer.	Clinical cancer research 	2014	31
24856188	L-Tyrosine	Stenman G	Diagnostic and therapeutic implications of new molecular biomarkers in salivary gland cancers.	Oral oncology	2014	25
24867389	L-Tyrosine	Simbolo M	Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups.	Oncotarget	2014	33
24869598	L-Tyrosine	Woyach JA	Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib.	The New England journal of medicine	2014	164
24886126	L-Tyrosine	Ma J	Targeting of erbB3 receptor to overcome resistance in cancer treatment.	Molecular cancer	2014	31
24893891	L-Tyrosine	Cross DA	AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer.	Cancer discovery	2014	219
24913799	L-Tyrosine	Van Emburgh BO	Acquired resistance to EGFR-targeted therapies in colorectal cancer.	Molecular oncology	2014	24
24919575	L-Tyrosine	Yoshida T	Tyrosine phosphoproteomics identifies both codrivers and cotargeting strategies for T790M-related EGFR-TKI resistance in non-small cell lung cancer.	Clinical cancer research 	2014	31
24939055	L-Tyrosine	Qu Y	Antitumor activity of selective MEK1/2 inhibitor AZD6244 in combination with PI3K/mTOR inhibitor BEZ235 in gefitinib-resistant NSCLC xenograft models.	Journal of experimental & clinical cancer research 	2014	24
24957147	L-Tyrosine	Gallipoli P	JAK2/STAT5 inhibition by nilotinib with ruxolitinib contributes to the elimination of CML CD34+ cells in vitro and in vivo.	Blood	2014	24
24973425	L-Tyrosine	Zhang Z	Functional genetic approach identifies MET, HER3, IGF1R, INSR pathways as determinants of lapatinib unresponsiveness in HER2-positive gastric cancer.	Clinical cancer research 	2014	24
24991953	L-Tyrosine	Mei L	Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases.	Neuron	2014	88
25049327	L-Tyrosine	Roberts KG	Outcomes of children with BCR-ABL1–like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual disease.	Journal of clinical oncology 	2014	41
25056203	L-Tyrosine	Zhang H	ROR1 expression correlated with poor clinical outcome in human ovarian cancer.	Scientific reports	2014	24
25066121	L-Tyrosine	Porporato PE	A mitochondrial switch promotes tumor metastasis.	Cell reports	2014	80
25073158	L-Tyrosine	Chou RH	EGFR modulates DNA synthesis and repair through Tyr phosphorylation of histone H4.	Developmental cell	2014	23
25082755	L-Tyrosine	Chiron D	Cell-cycle reprogramming for PI3K inhibition overrides a relapse-specific C481S BTK mutation revealed by longitudinal functional genomics in mantle cell lymphoma.	Cancer discovery	2014	41
25086175	L-Tyrosine	Ferris RL	Too much of a good thing? Tim-3 and TCR signaling in T cell exhaustion.	Journal of immunology	2014	31
25092144	L-Tyrosine	Gerloff D	NF-κB/STAT5/miR-155 network targets PU.1 in FLT3-ITD-driven acute myeloid leukemia.	Leukemia	2015	27
25098269	L-Tyrosine	Sulzmaier FJ	FAK in cancer: mechanistic findings and clinical applications.	Nature reviews. Cancer	2014	170
25121748	L-Tyrosine	Xu W	Ebola virus VP24 targets a unique NLS binding site on karyopherin alpha 5 to selectively compete with nuclear import of phosphorylated STAT1.	Cell host & microbe	2014	50
25125655	L-Tyrosine	Arasada RR	EGFR blockade enriches for lung cancer stem-like cells through Notch3-dependent signaling.	Cancer research	2014	23
25125659	L-Tyrosine	Wilson C	AXL inhibition sensitizes mesenchymal cancer cells to antimitotic drugs.	Cancer research	2014	28
25129481	L-Tyrosine	Xing L	Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition.	Nature medicine	2014	58
25134459	L-Tyrosine	Eiring AM	Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia.	Leukemia	2015	29
25136066	L-Tyrosine	Brand TM	AXL mediates resistance to cetuximab therapy.	Cancer research	2014	33
25138588	L-Tyrosine	Kamel S	Ibrutinib inhibits collagen-mediated but not ADP-mediated platelet aggregation.	Leukemia	2015	31
25150798	L-Tyrosine	Burger JA	Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study.	The Lancet. Oncology	2014	66
25173427	L-Tyrosine	Lovly CM	Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancer.	Nature medicine	2014	65
25175099	L-Tyrosine	Seto T	Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 study.	The Lancet. Oncology	2014	95
25178641	L-Tyrosine	Millis SZ	Molecular profiling of infiltrating urothelial carcinoma of bladder and nonbladder origin.	Clinical genitourinary cancer	2015	15
25180601	L-Tyrosine	Shen J	Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculature.	The Journal of clinical investigation	2014	31
25186177	L-Tyrosine	Wan X	Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases.	Science translational medicine	2014	26
25187556	L-Tyrosine	Rankin EB	Direct regulation of GAS6/AXL signaling by HIF promotes renal metastasis through SRC and MET.	Proceedings of the National Academy of Sciences of the United States of America	2014	44
25189416	L-Tyrosine	Cheng S	Functional characterization of BTK(C481S) mutation that confers ibrutinib resistance: exploration of alternative kinase inhibitors.	Leukemia	2015	24
25193870	L-Tyrosine	Degryse S	JAK3 mutants transform hematopoietic cells through JAK1 activation, causing T-cell acute lymphoblastic leukemia in a mouse model.	Blood	2014	27
25193986	L-Tyrosine	Zhang JX	MiR-29c mediates epithelial-to-mesenchymal transition in human colorectal carcinoma metastasis via PTP4A and GNA13 regulation of β-catenin signaling.	Annals of oncology 	2014	22
25202833	L-Tyrosine	Hsueh AJ	Intraovarian control of early folliculogenesis.	Endocrine reviews	2015	25
25207766	L-Tyrosine	Roberts KG	Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.	The New England journal of medicine	2014	178
25209362	L-Tyrosine	Nikiforov YE	Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay.	Cancer	2014	62
25209439	L-Tyrosine	Henry C	Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling.	Journal of cancer research and clinical oncology	2015	16
25225437	L-Tyrosine	Smith MR	Cabozantinib in chemotherapy-pretreated metastatic castration-resistant prostate cancer: results of a phase II nonrandomized expansion study.	Journal of clinical oncology 	2014	27
25228534	L-Tyrosine	Katayama R	Two novel ALK mutations mediate acquired resistance to the next-generation ALK inhibitor alectinib.	Clinical cancer research 	2014	56
25242553	L-Tyrosine	Kariolis MS	An engineered Axl 'decoy receptor' effectively silences the Gas6-Axl signaling axis.	Nature chemical biology	2014	23
25247337	L-Tyrosine	Hoffknecht P	Efficacy of the irreversible ErbB family blocker afatinib in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-pretreated non-small-cell lung cancer patients with brain metastases or leptomeningeal disease.	Journal of thoracic oncology 	2015	42
25249658	L-Tyrosine	Gonzalez DM	Signaling mechanisms of the epithelial-mesenchymal transition.	Science signaling	2014	170
25250573	L-Tyrosine	Stanford JC	Efferocytosis produces a prometastatic landscape during postpartum mammary gland involution.	The Journal of clinical investigation	2014	24
25251599	L-Tyrosine	Reichl P	Axl activates autocrine transforming growth factor-β signaling in hepatocellular carcinoma.	Hepatology	2015	26
25263564	L-Tyrosine	Toso A	Enhancing chemotherapy efficacy in Pten-deficient prostate tumors by activating the senescence-associated antitumor immunity.	Cell reports	2014	38
25311215	L-Tyrosine	Leighl NB	Molecular testing for selection of patients with lung cancer for epidermal growth factor receptor and anaplastic lymphoma kinase tyrosine kinase inhibitors: American Society of Clinical Oncology endorsement of the College of American Pathologists/International Association for the study of lung cancer/association for molecular pathology guideline.	Journal of clinical oncology 	2014	49
25319834	L-Tyrosine	Lee JC	Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour.	The Journal of pathology	2015	15
25332238	L-Tyrosine	Abu-Thuraia A	Axl phosphorylates Elmo scaffold proteins to promote Rac activation and cell invasion.	Molecular and cellular biology	2015	21
25344523	L-Tyrosine	Da Roit F	Ibrutinib interferes with the cell-mediated anti-tumor activities of therapeutic CD20 antibodies: implications for combination therapy.	Haematologica	2015	32
25344858	L-Tyrosine	Axelrod H	Axl as a mediator of cellular growth and survival.	Oncotarget	2014	26
25351743	L-Tyrosine	Katayama R	Cabozantinib overcomes crizotinib resistance in ROS1 fusion-positive cancer.	Clinical cancer research 	2015	25
25353071	L-Tyrosine	Dadu R	Efficacy and tolerability of vemurafenib in patients with BRAF(V600E) -positive papillary thyroid cancer: M.D. Anderson Cancer Center off label experience.	The Journal of clinical endocrinology and metabolism	2015	21
25369307	L-Tyrosine	Rizvi S	Cholangiocarcinoma: molecular pathways and therapeutic opportunities.	Seminars in liver disease	2014	31
25374165	L-Tyrosine	Lei YY	Mitogen-activated protein kinase signal transduction in solid tumors.	Asian Pacific journal of cancer prevention 	2014	21
25376790	L-Tyrosine	Hu X	Multicenter phase II study of apatinib in non-triple-negative metastatic breast cancer.	BMC cancer	2014	21
25381264	L-Tyrosine	Ciamporcero E	Combination strategy targeting VEGF and HGF/c-met in human renal cell carcinoma models.	Molecular cancer therapeutics	2015	19
25381426	L-Tyrosine	Jackson AM	Endothelial cell antibodies associated with novel targets and increased rejection.	Journal of the American Society of Nephrology 	2015	15
25403583	L-Tyrosine	Won JK	Concomitant ALK translocation and EGFR mutation in lung cancer: a comparison of direct sequencing and sensitive assays and the impact on responsiveness to tyrosine kinase inhibitor.	Annals of oncology 	2015	19
25405368	L-Tyrosine	Chiyomaru T	Dual regulation of receptor tyrosine kinase genes EGFR and c-Met by the tumor-suppressive microRNA-23b/27b cluster in bladder cancer.	International journal of oncology	2015	25
25411317	L-Tyrosine	Zhang S	Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy.	Proceedings of the National Academy of Sciences of the United States of America	2014	38
25420417	L-Tyrosine	Geng R	Apatinib for the treatment of gastric cancer.	Expert opinion on pharmacotherapy	2015	17
25456362	L-Tyrosine	Jänne PA	Dacomitinib as first-line treatment in patients with clinically or molecularly selected advanced non-small-cell lung cancer: a multicentre, open-label, phase 2 trial.	The Lancet. Oncology	2014	20
25468223	L-Tyrosine	Cohen AL	Glioma biology and molecular markers.	Cancer treatment and research	2015	30
25474488	L-Tyrosine	Su J	MiR-143 and MiR-145 regulate IGF1R to suppress cell proliferation in colorectal cancer.	PloS one	2014	23
25492965	L-Tyrosine	Haskins JW	Neuregulin 1-activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration.	Science signaling	2014	29
25500121	L-Tyrosine	Girotti MR	Paradox-breaking RAF inhibitors that also target SRC are effective in drug-resistant BRAF mutant melanoma.	Cancer cell	2015	45
25502142	L-Tyrosine	Müller J	Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma.	Nature communications	2014	69
25542448	L-Tyrosine	Miao B	EPHA2 is a mediator of vemurafenib resistance and a novel therapeutic target in melanoma.	Cancer discovery	2015	17
25544636	L-Tyrosine	Schwartz S	Feedback suppression of PI3Kα signaling in PTEN-mutated tumors is relieved by selective inhibition of PI3Kβ.	Cancer cell	2015	48
25572173	L-Tyrosine	Ran L	Combined inhibition of MAP kinase and KIT signaling synergistically destabilizes ETV1 and suppresses GIST tumor growth.	Cancer discovery	2015	22
25583177	L-Tyrosine	Beuselinck B	Molecular subtypes of clear cell renal cell carcinoma are associated with sunitinib response in the metastatic setting.	Clinical cancer research 	2015	18
25628918	L-Tyrosine	Huang J	MicroRNA regulation and therapeutic targeting of survivin in cancer.	American journal of cancer research	2015	15
25655556	L-Tyrosine	Dothel G	Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome.	Gastroenterology	2015	21
25658601	L-Tyrosine	Bertaux-Skeirik N	CD44 plays a functional role in Helicobacter pylori-induced epithelial cell proliferation.	PLoS pathogens	2015	25
25670642	L-Tyrosine	Wang HB	Neuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cells.	Nature communications	2015	21
25707398	L-Tyrosine	van Bon BW	Disruptive de novo mutations of DYRK1A lead to a syndromic form of autism and ID.	Molecular psychiatry	2016	31
25731159	L-Tyrosine	Taniguchi K	A gp130-Src-YAP module links inflammation to epithelial regeneration.	Nature	2015	84
25742700	L-Tyrosine	Alinari L	Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation.	Blood	2015	20
25758528	L-Tyrosine	Niederst MJ	RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer.	Nature communications	2015	67
25759025	L-Tyrosine	Geng H	Self-enforcing feedback activation between BCL6 and pre-B cell receptor signaling defines a distinct subtype of acute lymphoblastic leukemia.	Cancer cell	2015	23
25760142	L-Tyrosine	Bae SY	Targeting the degradation of AXL receptor tyrosine kinase to overcome resistance in gefitinib-resistant non-small cell lung cancer.	Oncotarget	2015	16
25767293	L-Tyrosine	Brand TM	AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma.	Clinical cancer research 	2015	18
25786175	L-Tyrosine	Lee J	Epigenetic modification and antibody-dependent expansion of memory-like NK cells in human cytomegalovirus-infected individuals.	Immunity	2015	86
25792358	L-Tyrosine	Collins VP	Pilocytic astrocytoma: pathology, molecular mechanisms and markers.	Acta neuropathologica	2015	17
25797245	L-Tyrosine	Chiron D	Biological rational for sequential targeting of Bruton tyrosine kinase and Bcl-2 to overcome CD40-induced ABT-199 resistance in mantle cell lymphoma.	Oncotarget	2015	19
25799995	L-Tyrosine	Chen Z	Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia.	Nature	2015	30
25801750	L-Tyrosine	Lin C	Programmed Death-Ligand 1 Expression Predicts Tyrosine Kinase Inhibitor Response and Better Prognosis in a Cohort of Patients With Epidermal Growth Factor Receptor Mutation-Positive Lung Adenocarcinoma.	Clinical lung cancer	2015	18
25807554	L-Tyrosine	Tang MC	Chloroquine enhances gefitinib cytotoxicity in gefitinib-resistant nonsmall cell lung cancer cells.	PloS one	2015	17
25814448	L-Tyrosine	Tsai CF	Large-scale determination of absolute phosphorylation stoichiometries in human cells by motif-targeting quantitative proteomics.	Nature communications	2015	19
25829398	L-Tyrosine	Cervantes-Gomez F	Pharmacological and Protein Profiling Suggests Venetoclax (ABT-199) as Optimal Partner with Ibrutinib in Chronic Lymphocytic Leukemia.	Clinical cancer research 	2015	37
25838351	L-Tyrosine	Hing ZA	Selinexor is effective in acquired resistance to ibrutinib and synergizes with ibrutinib in chronic lymphocytic leukemia.	Blood	2015	16
25846096	L-Tyrosine	Oser MG	Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin.	The Lancet. Oncology	2015	62
25846554	L-Tyrosine	Pailler E	High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer.	Annals of oncology 	2015	28
25852056	L-Tyrosine	Thol F	How I treat refractory and early relapsed acute myeloid leukemia.	Blood	2015	22
25853747	L-Tyrosine	Treon SP	Ibrutinib in previously treated Waldenström's macroglobulinemia.	The New England journal of medicine	2015	88
25855404	L-Tyrosine	Furnari FB	Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma.	Nature reviews. Cancer	2015	51
25861727	L-Tyrosine	Costa PM	MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma.	Journal of controlled release 	2015	22
25863279	L-Tyrosine	Gómez-Gálvez Y	Potential of the cannabinoid CB(2) receptor as a pharmacological target against inflammation in Parkinson's disease.	Progress in neuro-psychopharmacology & biological psychiatry	2016	18
25865556	L-Tyrosine	Han T	PTPN11/Shp2 overexpression enhances liver cancer progression and predicts poor prognosis of patients.	Journal of hepatology	2015	19
25866791	L-Tyrosine	Brahmkhatri VP	Insulin-like growth factor system in cancer: novel targeted therapies.	BioMed research international	2015	21
25873174	L-Tyrosine	Crescenzo R	Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma.	Cancer cell	2015	54
25873175	L-Tyrosine	Elkabets M	AXL mediates resistance to PI3Kα inhibition by activating the EGFR/PKC/mTOR axis in head and neck and esophageal squamous cell carcinomas.	Cancer cell	2015	42
25882375	L-Tyrosine	Ali SM	Prospective comprehensive genomic profiling of advanced gastric carcinoma cases reveals frequent clinically relevant genomic alterations and new routes for targeted therapies.	The oncologist	2015	18
25882755	L-Tyrosine	Watanabe M	Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non-Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCR.	Clinical cancer research 	2015	50
25887320	L-Tyrosine	Ho-Yen CM	The clinical and functional significance of c-Met in breast cancer: a review.	Breast cancer research 	2015	25
25895031	L-Tyrosine	Tang Y	The association between PD-L1 and EGFR status and the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs.	Oncotarget	2015	45
25899785	L-Tyrosine	Kris MG	Targeting HER2 aberrations as actionable drivers in lung cancers: phase II trial of the pan-HER tyrosine kinase inhibitor dacomitinib in patients with HER2-mutant or amplified tumors.	Annals of oncology 	2015	27
25917266	L-Tyrosine	Malinowska-Ozdowy K	KRAS and CREBBP mutations: a relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia.	Leukemia	2015	17
25918719	L-Tyrosine	Tai YL	Emerging roles of focal adhesion kinase in cancer.	BioMed research international	2015	28
25925741	L-Tyrosine	Dong S	The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.	Journal of hematology & oncology	2015	26
25928165	L-Tyrosine	Hirano T	Long noncoding RNA, CCDC26, controls myeloid leukemia cell growth through regulation of KIT expression.	Molecular cancer	2015	18
25937177	L-Tyrosine	Cuadrado A	Structural and functional characterization of Nrf2 degradation by glycogen synthase kinase 3/β-TrCP.	Free radical biology & medicine	2015	16
25939061	L-Tyrosine	Thress KS	Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M.	Nature medicine	2015	164
25971889	L-Tyrosine	Cao HH	Quercetin inhibits HGF/c-Met signaling and HGF-stimulated melanoma cell migration and invasion.	Molecular cancer	2015	20
25972157	L-Tyrosine	Liu TM	Hypermorphic mutation of phospholipase C, γ2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activation.	Blood	2015	21
25979927	L-Tyrosine	Politi K	Lung cancer in the era of precision medicine.	Clinical cancer research 	2015	15
26006010	L-Tyrosine	Bradshaw JM	Prolonged and tunable residence time using reversible covalent kinase inhibitors.	Nature chemical biology	2015	33
26015511	L-Tyrosine	Göke F	FGFR1 Expression Levels Predict BGJ398 Sensitivity of FGFR1-Dependent Head and Neck Squamous Cell Cancers.	Clinical cancer research 	2015	16
26032687	L-Tyrosine	Liffers K	Histone Deacetylase Inhibitors Resensitize EGFR/EGFRvIII-Overexpressing, Erlotinib-Resistant Glioblastoma Cells to Tyrosine Kinase Inhibition.	Targeted oncology	2016	11
26051236	L-Tyrosine	Yang JC	Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6.	The Lancet. Oncology	2015	57
26058079	L-Tyrosine	Stratikopoulos EE	Kinase and BET Inhibitors Together Clamp Inhibition of PI3K Signaling and Overcome Resistance to Therapy.	Cancer cell	2015	32
26072676	L-Tyrosine	Rangarajan S	Novel Mechanisms for the Antifibrotic Action of Nintedanib.	American journal of respiratory cell and molecular biology	2016	18
26153496	L-Tyrosine	Yoshioka H	A randomized, double-blind, placebo-controlled, phase III trial of erlotinib with or without a c-Met inhibitor tivantinib (ARQ 197) in Asian patients with previously treated stage IIIB/IV nonsquamous nonsmall-cell lung cancer harboring wild-type epidermal growth factor receptor (ATTENTION study).	Annals of oncology 	2015	18
26160838	L-Tyrosine	Cheng N	Long non-coding RNA UCA1 induces non-T790M acquired resistance to EGFR-TKIs by activating the AKT/mTOR pathway in EGFR-mutant non-small cell lung cancer.	Oncotarget	2015	28
26168295	L-Tyrosine	Burggraaf J	Detection of colorectal polyps in humans using an intravenously administered fluorescent peptide targeted against c-Met.	Nature medicine	2015	31
26181354	L-Tyrosine	Yu HA	Acquired Resistance of EGFR-Mutant Lung Cancer to a T790M-Specific EGFR Inhibitor: Emergence of a Third Mutation (C797S) in the EGFR Tyrosine Kinase Domain.	JAMA oncology	2015	32
26182302	L-Tyrosine	Ross JS	Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Site: New Routes to Targeted Therapies.	JAMA oncology	2015	24
26182309	L-Tyrosine	Maddocks KJ	Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia.	JAMA oncology	2015	55
26186743	L-Tyrosine	Yeung AW	Role of indoleamine 2,3-dioxygenase in health and disease.	Clinical science	2015	20
26193078	L-Tyrosine	Ten Hacken E	Microenvironment interactions and B-cell receptor signaling in Chronic Lymphocytic Leukemia: Implications for disease pathogenesis and treatment.	Biochimica et biophysica acta	2016	26
26199389	L-Tyrosine	Scala S	Molecular Pathways: Targeting the CXCR4-CXCL12 Axis--Untapped Potential in the Tumor Microenvironment.	Clinical cancer research 	2015	19
26201448	L-Tyrosine	Khella HWZ	miR-221/222 Are Involved in Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma.	Molecular therapy 	2015	15
26206560	L-Tyrosine	Kirane A	Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis.	Cancer research	2015	17
26243863	L-Tyrosine	Kavuri SM	HER2 activating mutations are targets for colorectal cancer treatment.	Cancer discovery	2015	26
26261265	L-Tyrosine	Qian BZ	FLT1 signaling in metastasis-associated macrophages activates an inflammatory signature that promotes breast cancer metastasis.	The Journal of experimental medicine	2015	21
26269204	L-Tyrosine	Planchard D	EGFR-independent mechanisms of acquired resistance to AZD9291 in EGFR T790M-positive NSCLC patients.	Annals of oncology 	2015	45
26282169	L-Tyrosine	Soucheray M	Intratumoral Heterogeneity in EGFR-Mutant NSCLC Results in Divergent Resistance Mechanisms in Response to EGFR Tyrosine Kinase Inhibition.	Cancer research	2015	19
26282175	L-Tyrosine	Guo G	Ligand-Independent EGFR Signaling.	Cancer research	2015	22
26283684	L-Tyrosine	Dunne PD	EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal Cancer.	Clinical cancer research 	2016	13
26286024	L-Tyrosine	Ramsdale R	The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanoma.	Science signaling	2015	18
26297432	L-Tyrosine	Bora-Singhal N	Gli1-Mediated Regulation of Sox2 Facilitates Self-Renewal of Stem-Like Cells and Confers Resistance to EGFR Inhibitors in Non-Small Cell Lung Cancer.	Neoplasia	2015	19
26305508	L-Tyrosine	Lu C	Over-expression of ROR2 and Wnt5a cooperatively correlates with unfavorable prognosis in patients with non-small cell lung cancer.	Oncotarget	2015	18
26308162	L-Tyrosine	Russo A	A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives.	Oncotarget	2015	38
26324372	L-Tyrosine	Kelly K	Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial.	Journal of clinical oncology 	2015	24
26331539	L-Tyrosine	Prost S	Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists.	Nature	2015	29
26334838	L-Tyrosine	Ishii H	Digital PCR analysis of plasma cell-free DNA for non-invasive detection of drug resistance mechanisms in EGFR mutant NSCLC: Correlation with paired tumor samples.	Oncotarget	2015	19
26354436	L-Tyrosine	Narayana SK	The Interferon-induced Transmembrane Proteins, IFITM1, IFITM2, and IFITM3 Inhibit Hepatitis C Virus Entry.	The Journal of biological chemistry	2015	21
26364599	L-Tyrosine	Zhou L	Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma.	Oncogene	2016	39
26370354	L-Tyrosine	Tan CS	Treatment approaches for EGFR-inhibitor-resistant patients with non-small-cell lung cancer.	The Lancet. Oncology	2015	50
26387544	L-Tyrosine	Meads MB	Targeting PYK2 mediates microenvironment-specific cell death in multiple myeloma.	Oncogene	2016	11
26432786	L-Tyrosine	Sameni M	Cabozantinib (XL184) Inhibits Growth and Invasion of Preclinical TNBC Models.	Clinical cancer research 	2016	12
26444240	L-Tyrosine	Wiesner T	Alternative transcription initiation leads to expression of a novel ALK isoform in cancer.	Nature	2015	31
26446944	L-Tyrosine	Sundaresan TK	Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses.	Clinical cancer research 	2016	67
26473186	L-Tyrosine	Kim J	Invasive Bladder Cancer: Genomic Insights and Therapeutic Promise.	Clinical cancer research 	2015	21
26489445	L-Tyrosine	Kuboki Y	Comprehensive analyses using next-generation sequencing and immunohistochemistry enable precise treatment in advanced gastric cancer.	Annals of oncology 	2016	12
26536822	L-Tyrosine	Tarighat SS	The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation.	Leukemia	2016	18
26538619	L-Tyrosine	Stafford JH	Colony stimulating factor 1 receptor inhibition delays recurrence of glioblastoma after radiation by altering myeloid cell recruitment and polarization.	Neuro-oncology	2016	23
26545934	L-Tyrosine	Suzawa K	Antitumor effect of afatinib, as a human epidermal growth factor receptor 2-targeted therapy, in lung cancers harboring HER2 oncogene alterations.	Cancer science	2016	15
26554308	L-Tyrosine	Zhou J	Implication of epithelial-mesenchymal transition in IGF1R-induced resistance to EGFR-TKIs in advanced non-small cell lung cancer.	Oncotarget	2015	16
26563355	L-Tyrosine	Sartore-Bianchi A	Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer.	Journal of the National Cancer Institute	2016	13
26573073	L-Tyrosine	Melosky B	Pan Canadian Rash Trial: A Randomized Phase III Trial Evaluating the Impact of a Prophylactic Skin Treatment Regimen on Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-Induced Skin Toxicities in Patients With Metastatic Lung Cancer.	Journal of clinical oncology 	2016	12
26575700	L-Tyrosine	Tan H	miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer.	International journal of oncology	2016	10
26597162	L-Tyrosine	Hristova M	Airway epithelial dual oxidase 1 mediates allergen-induced IL-33 secretion and activation of type 2 immune responses.	The Journal of allergy and clinical immunology	2016	23
26616860	L-Tyrosine	Debruyne DN	ALK inhibitor resistance in ALK(F1174L)-driven neuroblastoma is associated with AXL activation and induction of EMT.	Oncogene	2016	16
26619122	L-Tyrosine	Hedberg ML	Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma.	The Journal of clinical investigation	2016	21
26620497	L-Tyrosine	Shea M	Management of advanced non-small cell lung cancers with known mutations or rearrangements: latest evidence and treatment approaches.	Therapeutic advances in respiratory disease	2016	21
26627015	L-Tyrosine	Wong SQ	UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell Carcinomas.	Cancer research	2015	27
26628631	L-Tyrosine	Wiestner A	The role of B-cell receptor inhibitors in the treatment of patients with chronic lymphocytic leukemia.	Haematologica	2015	18
26641137	L-Tyrosine	Byrd JC	Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia.	The New England journal of medicine	2016	58
26655421	L-Tyrosine	Chanan-Khan A	Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study.	The Lancet. Oncology	2016	28
26655502	L-Tyrosine	Matà R	IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.	Oncotarget	2016	11
26655835	L-Tyrosine	Guo X	Site-specific proteasome phosphorylation controls cell proliferation and tumorigenesis.	Nature cell biology	2016	14
26698910	L-Tyrosine	Shaw AT	Resensitization to Crizotinib by the Lorlatinib ALK Resistance Mutation L1198F.	The New England journal of medicine	2016	62
26701983	L-Tyrosine	Zhou X	Enhancer of Zeste Homolog 2 Inhibition Attenuates Renal Fibrosis by Maintaining Smad7 and Phosphatase and Tensin Homolog Expression.	Journal of the American Society of Nephrology 	2016	13
26716903	L-Tyrosine	Nanjo S	High efficacy of third generation EGFR inhibitor AZD9291 in a leptomeningeal carcinomatosis model with EGFR-mutant lung cancer cells.	Oncotarget	2016	12
26722841	L-Tyrosine	Heppner DE	Redox-dependent regulation of epidermal growth factor receptor signaling.	Redox biology	2016	12
26724471	L-Tyrosine	Lin JJ	Five-Year Survival in EGFR-Mutant Metastatic Lung Adenocarcinoma Treated with EGFR-TKIs.	Journal of thoracic oncology 	2016	24
26747862	L-Tyrosine	Olmos-Alonso A	Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathology.	Brain 	2016	43
26751586	L-Tyrosine	Fujita S	Transformation to SCLC after Treatment with the ALK Inhibitor Alectinib.	Journal of thoracic oncology 	2016	14
26763248	L-Tyrosine	Scaltriti M	Molecular Pathways: AXL, a Membrane Receptor Mediator of Resistance to Therapy.	Clinical cancer research 	2016	12
26768482	L-Tyrosine	Seki Y	Picoliter-Droplet Digital Polymerase Chain Reaction-Based Analysis of Cell-Free Plasma DNA to Assess EGFR Mutations in Lung Adenocarcinoma That Confer Resistance to Tyrosine-Kinase Inhibitors.	The oncologist	2016	14
26771488	L-Tyrosine	Freeman SA	Integrins Form an Expanding Diffusional Barrier that Coordinates Phagocytosis.	Cell	2016	17
26779812	L-Tyrosine	Du Y	Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors.	Nature medicine	2016	22
26786898	L-Tyrosine	Kwon O	Leptin signalling pathways in hypothalamic neurons.	Cellular and molecular life sciences 	2016	16
26789630	L-Tyrosine	Yoshida T	ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer.	PloS one	2016	17
26799287	L-Tyrosine	Del Re M	Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA.	Oncotarget	2017	13
26840022	L-Tyrosine	Pan W	KRAS mutation is a weak, but valid predictor for poor prognosis and treatment outcomes in NSCLC: A meta-analysis of 41 studies.	Oncotarget	2016	12
26852079	L-Tyrosine	van der Wekken AJ	Resistance mechanisms after tyrosine kinase inhibitors afatinib and crizotinib in non-small cell lung cancer, a review of the literature.	Critical reviews in oncology/hematology	2016	18
26855149	L-Tyrosine	Ambrogio C	Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma.	Nature medicine	2016	20
26855150	L-Tyrosine	Noll EM	CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma.	Nature medicine	2016	15
26859458	L-Tyrosine	Iacobucci I	Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia.	Cancer cell	2016	22
26861455	L-Tyrosine	Incio J	PlGF/VEGFR-1 Signaling Promotes Macrophage Polarization and Accelerated Tumor Progression in Obesity.	Clinical cancer research 	2016	18
26862733	L-Tyrosine	Wu SG	The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients.	Oncotarget	2016	29
26872634	L-Tyrosine	Schwab C	EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications.	Blood	2016	18
26873401	L-Tyrosine	Sawada G	Genomic Landscape of Esophageal Squamous Cell Carcinoma in a Japanese Population.	Gastroenterology	2016	35
26884585	L-Tyrosine	Li J	Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction.	Journal of clinical oncology 	2016	79
26916631	L-Tyrosine	Marchetti A	ALK Protein Analysis by IHC Staining after Recent Regulatory Changes: A Comparison of Two Widely Used Approaches, Revision of the Literature, and a New Testing Algorithm.	Journal of thoracic oncology 	2016	16
26936507	L-Tyrosine	Turro E	A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies.	Science translational medicine	2016	10
26957112	L-Tyrosine	Wu J	Acalabrutinib (ACP-196): a selective second-generation BTK inhibitor.	Journal of hematology & oncology	2016	15
26957481	L-Tyrosine	Grabiec AM	The role of airway macrophages in apoptotic cell clearance following acute and chronic lung inflammation.	Seminars in immunopathology	2016	11
26973209	L-Tyrosine	Imamura F	Monitoring of treatment responses and clonal evolution of tumor cells by circulating tumor DNA of heterogeneous mutant EGFR genes in lung cancer.	Lung cancer	2016	14
26980726	L-Tyrosine	Duployez N	Comprehensive mutational profiling of core binding factor acute myeloid leukemia.	Blood	2016	12
26989078	L-Tyrosine	Yang X	Quantification of mutant alleles in circulating tumor DNA can predict survival in lung cancer.	Oncotarget	2016	13
27002617	L-Tyrosine	Wang Y	Long non-coding RNA TUSC7 acts a molecular sponge for miR-10a and suppresses EMT in hepatocellular carcinoma.	Tumour biology 	2016	14
27013234	L-Tyrosine	Li P	αE-catenin inhibits a Src-YAP1 oncogenic module that couples tyrosine kinases and the effector of Hippo signaling pathway.	Genes & development	2016	15
27034374	L-Tyrosine	Chan PY	The TAM family receptor tyrosine kinase TYRO3 is a negative regulator of type 2 immunity.	Science	2016	14
27041571	L-Tyrosine	Zhang L	SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial-mesenchymal transition and invasion in mice and humans.	Oncogene	2016	13
27052656	L-Tyrosine	Chung JH	Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes.	Annals of oncology 	2016	10
27068398	L-Tyrosine	Dziadziuszko R	An Activating KIT Mutation Induces Crizotinib Resistance in ROS1-Positive Lung Cancer.	Journal of thoracic oncology 	2016	11
27071706	L-Tyrosine	Wang S	Third-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancer.	Journal of hematology & oncology	2016	52
27078022	L-Tyrosine	Awada A	Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial.	JAMA oncology	2016	11
27083334	L-Tyrosine	Park K	Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial.	The Lancet. Oncology	2016	78
27114609	L-Tyrosine	Getahun A	Continuous inhibitory signaling by both SHP-1 and SHIP-1 pathways is required to maintain unresponsiveness of anergic B cells.	The Journal of experimental medicine	2016	19
27127301	L-Tyrosine	Saba NS	Pathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphoma.	Blood	2016	13
27158780	L-Tyrosine	Campbell JD	Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas.	Nature genetics	2016	69
27198718	L-Tyrosine	Winqvist M	Real-world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: data from 95 consecutive patients treated in a compassionate use program. A study from the Swedish Chronic Lymphocytic Leukemia Group.	Haematologica	2016	11
27216193	L-Tyrosine	Moores SL	A Novel Bispecific Antibody Targeting EGFR and cMet Is Effective against EGFR Inhibitor-Resistant Lung Tumors.	Cancer research	2016	16
27225694	L-Tyrosine	Gainor JF	EGFR Mutations and ALK Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non-Small Cell Lung Cancer: A Retrospective Analysis.	Clinical cancer research 	2016	61
27229180	L-Tyrosine	Tan DS	The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation-Positive Non-Small Cell Lung Cancer: Status in 2016.	Journal of thoracic oncology 	2016	27
27237825	L-Tyrosine	Jiang T	EGFR TKIs plus WBRT Demonstrated No Survival Benefit Other Than That of TKIs Alone in Patients with NSCLC and EGFR Mutation and Brain Metastases.	Journal of thoracic oncology 	2016	11
27245147	L-Tyrosine	Katoh M	FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review).	International journal of molecular medicine	2016	14
27251275	L-Tyrosine	Mertins P	Proteogenomics connects somatic mutations to signalling in breast cancer.	Nature	2016	109
27257132	L-Tyrosine	Bersanelli M	L718Q Mutation as New Mechanism of Acquired Resistance to AZD9291 in EGFR-Mutated NSCLC.	Journal of thoracic oncology 	2016	13
27279544	L-Tyrosine	Choueiri TK	Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial.	The Lancet. Oncology	2016	53
27279912	L-Tyrosine	Wang C	Gas6/Axl Axis Contributes to Chemoresistance and Metastasis in Breast Cancer through Akt/GSK-3β/β-catenin Signaling.	Theranostics	2016	15
27281222	L-Tyrosine	Abraham SA	Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells.	Nature	2016	23
27323238	L-Tyrosine	Kobayashi Y	Not all epidermal growth factor receptor mutations in lung cancer are created equal: Perspectives for individualized treatment strategy.	Cancer science	2016	12
27343443	L-Tyrosine	Schrock AB	Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations.	Journal of thoracic oncology 	2016	13
27362227	L-Tyrosine	Chen YN	Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases.	Nature	2016	35
27368100	L-Tyrosine	Gao H	Multi-organ Site Metastatic Reactivation Mediated by Non-canonical Discoidin Domain Receptor 1 Signaling.	Cell	2016	15
27390349	L-Tyrosine	Gasparotto D	Quadruple-Negative GIST Is a Sentinel for Unrecognized Neurofibromatosis Type 1 Syndrome.	Clinical cancer research 	2017	9
27416909	L-Tyrosine	Eadie LN	The clinical significance of ABCB1 overexpression in predicting outcome of CML patients undergoing first-line imatinib treatment.	Leukemia	2017	7
27450722	L-Tyrosine	Shi P	Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment.	Cancer letters	2016	13
27461391	L-Tyrosine	Simons M	Mechanisms and regulation of endothelial VEGF receptor signalling.	Nature reviews. Molecular cell biology	2016	46
27468937	L-Tyrosine	Reckamp KL	A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and Plasma.	Journal of thoracic oncology 	2016	24
27468938	L-Tyrosine	Reck M	ctDNA Determination of EGFR Mutation Status in European and Japanese Patients with Advanced NSCLC: The ASSESS Study.	Journal of thoracic oncology 	2016	14
27470968	L-Tyrosine	Seifert AM	PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal Tumors.	Clinical cancer research 	2017	6
27479178	L-Tyrosine	Qorraj M	The PD-1/PD-L1 axis contributes to immune metabolic dysfunctions of monocytes in chronic lymphocytic leukemia.	Leukemia	2017	5
27492973	L-Tyrosine	Jin B	Anthelmintic Niclosamide Disrupts the Interplay of p65 and FOXM1/β-catenin and Eradicates Leukemia Stem Cells in Chronic Myelogenous Leukemia.	Clinical cancer research 	2017	7
27535981	L-Tyrosine	Amin NA	Cell-Intrinsic Determinants of Ibrutinib-Induced Apoptosis in Chronic Lymphocytic Leukemia.	Clinical cancer research 	2017	6
27542267	L-Tyrosine	Takahama T	Detection of the T790M mutation of EGFR in plasma of advanced non-small cell lung cancer patients with acquired resistance to tyrosine kinase inhibitors (West Japan oncology group 8014LTR study).	Oncotarget	2016	11
27595394	L-Tyrosine	Chen W	Targeting renal cell carcinoma with a HIF-2 antagonist.	Nature	2016	39
27601642	L-Tyrosine	Zhao X	TRiC subunits enhance BDNF axonal transport and rescue striatal atrophy in Huntington's disease.	Proceedings of the National Academy of Sciences of the United States of America	2016	10
27605552	L-Tyrosine	Carter BZ	Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cells.	Science translational medicine	2016	10
27613527	L-Tyrosine	Yu HA	A Phase 1/2 Trial of Ruxolitinib and Erlotinib in Patients with EGFR-Mutant Lung Adenocarcinomas with Acquired Resistance to Erlotinib.	Journal of thoracic oncology 	2017	5
27618553	L-Tyrosine	Vély F	Evidence of innate lymphoid cell redundancy in humans.	Nature immunology	2016	27
27633443	L-Tyrosine	Yue B	Linc00152 Functions as a Competing Endogenous RNA to Confer Oxaliplatin Resistance and Holds Prognostic Values in Colon Cancer.	Molecular therapy 	2016	22
27671334	L-Tyrosine	Balaji K	AXL Inhibition Suppresses the DNA Damage Response and Sensitizes Cells to PARP Inhibition in Multiple Cancers.	Molecular cancer research 	2017	8
27732970	L-Tyrosine	Dancsok AR	Advances in sarcoma diagnostics and treatment.	Oncotarget	2017	7
27765535	L-Tyrosine	Lee CK	Checkpoint Inhibitors in Metastatic EGFR-Mutated Non-Small Cell Lung Cancer-A Meta-Analysis.	Journal of thoracic oncology 	2017	33
27783593	L-Tyrosine	Dong L	Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment.	Nature	2016	22
27825616	L-Tyrosine	Yoh K	Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trial.	The Lancet. Respiratory medicine	2017	21
27840244	L-Tyrosine	Wang S	EAI045: The fourth-generation EGFR inhibitor overcoming T790M and C797S resistance.	Cancer letters	2017	10
27841873	L-Tyrosine	Guryanova OA	DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling.	Nature medicine	2016	16
27844272	L-Tyrosine	Duran I	Resistance to Targeted Therapies in Renal Cancer: The Importance of Changing the Mechanism of Action.	Targeted oncology	2017	7
27865871	L-Tyrosine	Rozenblum AB	Clinical Impact of Hybrid Capture-Based Next-Generation Sequencing on Changes in Treatment Decisions in Lung Cancer.	Journal of thoracic oncology 	2017	5
27890936	L-Tyrosine	Ilander M	Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia.	Leukemia	2017	9
27904138	L-Tyrosine	Yu J	Cirmtuzumab inhibits Wnt5a-induced Rac1 activation in chronic lymphocytic leukemia treated with ibrutinib.	Leukemia	2017	7
27908881	L-Tyrosine	Lee LY	Preclinical studies of gilteritinib, a next-generation FLT3 inhibitor.	Blood	2017	10
27923714	L-Tyrosine	Ho CC	Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib.	Journal of thoracic oncology 	2017	10
27987249	L-Tyrosine	Ornitz DM	Achondroplasia: Development, pathogenesis, and therapy.	Developmental dynamics 	2017	6
28007774	L-Tyrosine	D'Angelo SP	Combined KIT and CTLA-4 Blockade in Patients with Refractory GIST and Other Advanced Sarcomas: A Phase Ib Study of Dasatinib plus Ipilimumab.	Clinical cancer research 	2017	7
28011673	L-Tyrosine	Myklebust JH	Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.	Blood	2017	9
28017789	L-Tyrosine	Castellanos E	Driven by Mutations: The Predictive Value of Mutation Subtype in EGFR-Mutated Non-Small Cell Lung Cancer.	Journal of thoracic oncology 	2017	8
28034907	L-Tyrosine	Patel V	Comparison of Acalabrutinib, A Selective Bruton Tyrosine Kinase Inhibitor, with Ibrutinib in Chronic Lymphocytic Leukemia Cells.	Clinical cancer research 	2017	6
28064454	L-Tyrosine	Matsumoto K	Hepatocyte growth factor/MET in cancer progression and biomarker discovery.	Cancer science	2017	8
28067670	L-Tyrosine	Cai B	MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis.	The Journal of clinical investigation	2017	15
28073897	L-Tyrosine	Reguart N	Identification of ALK, ROS1, and RET Fusions by a Multiplexed mRNA-Based Assay in Formalin-Fixed, Paraffin-Embedded Samples from Advanced Non-Small-Cell Lung Cancer Patients.	Clinical chemistry	2017	7
28077173	L-Tyrosine	Liu X	Is CD47 an innate immune checkpoint for tumor evasion?	Journal of hematology & oncology	2017	8
28088512	L-Tyrosine	Lin JJ	ROS1 Fusions Rarely Overlap with Other Oncogenic Drivers in Non-Small Cell Lung Cancer.	Journal of thoracic oncology 	2017	9
28099915	L-Tyrosine	Huang WL	Liquid biopsy genotyping in lung cancer: ready for clinical utility?	Oncotarget	2017	7
28108460	L-Tyrosine	Zawistowski JS	Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacologic Targeting of the P-TEFb Complex.	Cancer discovery	2017	13
28109312	L-Tyrosine	Kelly SC	Locus coeruleus cellular and molecular pathology during the progression of Alzheimer's disease.	Acta neuropathologica communications	2017	10
28111464	L-Tyrosine	Deng J	Bruton's tyrosine kinase inhibition increases BCL-2 dependence and enhances sensitivity to venetoclax in chronic lymphocytic leukemia.	Leukemia	2017	8
28113019	L-Tyrosine	Magnuson WJ	Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis.	Journal of clinical oncology 	2017	15
28115513	L-Tyrosine	Onda K	Proton Pump Inhibitors Decrease Soluble fms-Like Tyrosine Kinase-1 and Soluble Endoglin Secretion, Decrease Hypertension, and Rescue Endothelial Dysfunction.	Hypertension	2017	6
28148299	L-Tyrosine	Shimozawa A	Propagation of pathological α-synuclein in marmoset brain.	Acta neuropathologica communications	2017	8
28167659	L-Tyrosine	Noy A	Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma.	Blood	2017	6
28167751	L-Tyrosine	Richard AS	AXL-dependent infection of human fetal endothelial cells distinguishes Zika virus from other pathogenic flaviviruses.	Proceedings of the National Academy of Sciences of the United States of America	2017	21
28199309	L-Tyrosine	Compagno M	Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells.	Nature	2017	14
28213007	L-Tyrosine	Sesumi Y	Effect of dasatinib on EMT-mediated-mechanism of resistance against EGFR inhibitors in lung cancer cells.	Lung cancer	2017	5
28271729	L-Tyrosine	Ahn MJ	EGFR TKI combination with immunotherapy in non-small cell lung cancer.	Expert opinion on drug safety	2017	10
28274957	L-Tyrosine	Hanker AB	An Acquired HER2T798I Gatekeeper Mutation Induces Resistance to Neratinib in a Patient with HER2 Mutant-Driven Breast Cancer.	Cancer discovery	2017	6
28306503	L-Tyrosine	Boeynaems S	Phase Separation of C9orf72 Dipeptide Repeats Perturbs Stress Granule Dynamics.	Molecular cell	2017	17
28405610	L-Tyrosine	Katewa A	Btk-specific inhibition blocks pathogenic plasma cell signatures and myeloid cell-associated damage in IFNα-driven lupus nephritis.	JCI insight	2017	5
28407039	L-Tyrosine	Haratani K	Tumor immune microenvironment and nivolumab efficacy in EGFR mutation-positive non-small-cell lung cancer based on T790M status after disease progression during EGFR-TKI treatment.	Annals of oncology 	2017	9
28498782	L-Tyrosine	Lee JK	Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas.	Journal of clinical oncology 	2017	11
28723893	L-Tyrosine	Manguso RT	In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target.	Nature	2017	16
12393461	Vincristine	Bharti AC	Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis.	Blood	2003	132
15016643	Vincristine	Pfreundschuh M	Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL.	Blood	2004	72
15933054	Vincristine	Farinha P	Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL).	Blood	2005	85
15955905	Vincristine	Sehn LH	Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia.	Journal of clinical oncology 	2005	144
16720851	Vincristine	Bernstein M	Ewing's sarcoma family of tumors: current management.	The oncologist	2006	82
17692808	Vincristine	Deng J	BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents.	Cancer cell	2007	183
17953712	Vincristine	Liu L	Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer.	Cancer science	2008	51
18226581	Vincristine	Pfreundschuh M	Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).	The Lancet. Oncology	2008	154
18378569	Vincristine	Wilson WH	Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers.	Journal of clinical oncology 	2008	58
18662969	Vincristine	Marcus R	Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma.	Journal of clinical oncology 	2008	91
18756521	Vincristine	Castillo J	HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases.	American journal of hematology	2008	51
19038878	Vincristine	Lenz G	Stromal gene signatures in large-B-cell lymphomas.	The New England journal of medicine	2008	349
19138562	Vincristine	Den Boer ML	A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study.	The Lancet. Oncology	2009	166
19706817	Vincristine	Choi WW	A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy.	Clinical cancer research 	2009	115
19901110	Vincristine	Wick W	NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.	Journal of clinical oncology 	2009	140
20160062	Vincristine	van den Bent MJ	IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group.	Clinical cancer research 	2010	93
20423999	Vincristine	Keating AK	Inhibition of Mer and Axl receptor tyrosine kinases in astrocytoma cells leads to increased apoptosis and improved chemosensitivity.	Molecular cancer therapeutics	2010	56
20660290	Vincristine	Schmitz N	Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group.	Blood	2010	55
21135273	Vincristine	Meyer PN	Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab.	Journal of clinical oncology 	2011	78
21189393	Vincristine	Ruan J	Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma.	Journal of clinical oncology 	2011	56
21482186	Vincristine	Peyrade F	Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial.	The Lancet. Oncology	2011	42
21960059	Vincristine	Nakatani F	miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy.	The Journal of pathology	2012	48
22173060	Vincristine	Trappe R	Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.	The Lancet. Oncology	2012	33
22665537	Vincristine	Green TM	Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.	Journal of clinical oncology 	2012	91
22851556	Vincristine	d'Amore F	Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01.	Journal of clinical oncology 	2012	55
22911837	Vincristine	Li ZM	Blood lymphocyte-to-monocyte ratio identifies high-risk patients in diffuse large B-cell lymphoma treated with R-CHOP.	PloS one	2012	36
23666744	Vincristine	Tan TZ	Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer.	EMBO molecular medicine	2013	37
24220563	Vincristine	Huang X	Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP.	Journal of clinical oncology 	2013	35
24336156	Vincristine	Tzankov A	Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.	Modern pathology 	2014	27
24506200	Vincristine	Perry AM	MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab.	British journal of haematology	2014	32
24831981	Vincristine	Vitolo U	Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial.	The Lancet. Oncology	2014	24
25499448	Vincristine	Sehn LH	Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity.	Blood	2015	50
25514302	Vincristine	Huang H	Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial.	JAMA	2014	22
26240231	Vincristine	Scott DW	Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies.	Journal of clinical oncology 	2015	26
26256760	Vincristine	Pastore A	Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.	The Lancet. Oncology	2015	40
27992268	Vincristine	Trappe RU	Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial.	Journal of clinical oncology 	2017	7
28259608	Vincristine	Ladenstein R	Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial.	The Lancet. Oncology	2017	8
10675335	L-Lysine	Martínez-Balbás MA	Regulation of E2F1 activity by acetylation.	The EMBO journal	2000	170
10949293	L-Lysine	Rea S	Regulation of chromatin structure by site-specific histone H3 methyltransferases.	Nature	2000	730
11242053	L-Lysine	Lachner M	Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins.	Nature	2001	774
11242054	L-Lysine	Bannister AJ	Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain.	Nature	2001	821
11484059	L-Lysine	Nielsen SJ	Rb targets histone H3 methylation and HP1 to promoters.	Nature	2001	255
12453418	L-Lysine	Milne TA	MLL targets SET domain methyltransferase activity to Hox gene promoters.	Molecular cell	2002	325
12867029	L-Lysine	Lehnertz B	Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin.	Current biology 	2003	353
14755719	L-Lysine	Zarranz JJ	The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.	Annals of neurology	2004	635
15235609	L-Lysine	Hamamoto R	SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells.	Nature cell biology	2004	170
15620353	L-Lysine	Shi Y	Histone demethylation mediated by the nuclear amine oxidase homolog LSD1.	Cell	2004	966
15620648	L-Lysine	Abbott DW	The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO.	Current biology 	2004	121
15988529	L-Lysine	Seligson DB	Global histone modification patterns predict risk of prostate cancer recurrence.	Nature	2005	273
16140033	L-Lysine	Shi YJ	Regulation of LSD1 histone demethylase activity by its associated factors.	Molecular cell	2005	263
16142732	L-Lysine	Brentano F	RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3.	Arthritis and rheumatism	2005	87
16222244	L-Lysine	Hirota T	Histone H3 serine 10 phosphorylation by Aurora B causes HP1 dissociation from heterochromatin.	Nature	2005	203
16441421	L-Lysine	Hamamoto R	Enhanced SMYD3 expression is essential for the growth of breast cancer cells.	Cancer science	2006	68
16603238	L-Lysine	Whetstine JR	Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases.	Cell	2006	312
16738054	L-Lysine	Shumaker DK	Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature aging.	Proceedings of the National Academy of Sciences of the United States of America	2006	199
17145880	L-Lysine	Kahl P	Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence.	Cancer research	2006	122
17277772	L-Lysine	Wissmann M	Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression.	Nature cell biology	2007	186
17363312	L-Lysine	Yamane K	PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation.	Molecular cell	2007	156
17611497	L-Lysine	Carpten JD	A transforming mutation in the pleckstrin homology domain of AKT1 in cancer.	Nature	2007	387
17687328	L-Lysine	Lan F	Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression.	Nature	2007	161
17719542	L-Lysine	Tanaka T	hCAS/CSE1L associates with chromatin and regulates expression of select p53 target genes.	Cell	2007	71
17851529	L-Lysine	Lan F	A histone H3 lysine 27 demethylase regulates animal posterior development.	Nature	2007	242
17923864	L-Lysine	Xiang Y	JMJD3 is a histone H3K27 demethylase.	Cell research	2007	66
17942719	L-Lysine	Huang HS	Prefrontal dysfunction in schizophrenia involves mixed-lineage leukemia 1-regulated histone methylation at GABAergic gene promoters.	The Journal of neuroscience 	2007	109
17967868	L-Lysine	Gupta A	The mammalian ortholog of Drosophila MOF that acetylates histone H4 lysine 16 is essential for embryogenesis and oncogenesis.	Molecular and cellular biology	2008	84
17994099	L-Lysine	Frescas D	JHDM1B/FBXL10 is a nucleolar protein that represses transcription of ribosomal RNA genes.	Nature	2007	77
18339804	L-Lysine	Shen Y	X-inactivation in female human embryonic stem cells is in a nonrandom pattern and prone to epigenetic alterations.	Proceedings of the National Academy of Sciences of the United States of America	2008	74
18446223	L-Lysine	Kondo Y	Downregulation of histone H3 lysine 9 methyltransferase G9a induces centrosome disruption and chromosome instability in cancer cells.	PloS one	2008	84
18480059	L-Lysine	Houston SI	Catalytic function of the PR-Set7 histone H4 lysine 20 monomethyltransferase is essential for mitotic entry and genomic stability.	The Journal of biological chemistry	2008	66
18579779	L-Lysine	Villeneuve LM	Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2008	106
18716620	L-Lysine	Song MS	The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network.	Nature	2008	144
18776137	L-Lysine	Miao F	Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation: an epigenetic study in diabetes.	Diabetes	2008	55
19112497	L-Lysine	Walsh MC	TRAF6 autoubiquitination-independent activation of the NFkappaB and MAPK pathways in response to IL-1 and RANKL.	PloS one	2008	63
19208907	L-Lysine	Brasacchio D	Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail.	Diabetes	2009	113
19223552	L-Lysine	Schulte JH	Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy.	Cancer research	2009	125
19340297	L-Lysine	Yang X	CDKN1C (p57) is a direct target of EZH2 and suppressed by multiple epigenetic mechanisms in breast cancer cells.	PloS one	2009	55
19349354	L-Lysine	Seligson DB	Global levels of histone modifications predict prognosis in different cancers.	The American journal of pathology	2009	117
19366799	L-Lysine	Elsheikh SE	Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome.	Cancer research	2009	83
19423649	L-Lysine	Komatsu S	Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma.	Carcinogenesis	2009	51
19577000	L-Lysine	Dekker FJ	Histone acetyl transferases as emerging drug targets.	Drug discovery today	2009	72
19805273	L-Lysine	Teesalu T	C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration.	Proceedings of the National Academy of Sciences of the United States of America	2009	116
19903865	L-Lysine	Chen S	Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells.	American journal of physiology. Endocrinology and metabolism	2010	50
20093773	L-Lysine	Jin S	c-Myb binds MLL through menin in human leukemia cells and is an important driver of MLL-associated leukemogenesis.	The Journal of clinical investigation	2010	49
20208519	L-Lysine	Chen D	Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses.	Nature	2010	51
20228790	L-Lysine	Metzger E	Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4.	Nature	2010	96
20571512	L-Lysine	Wilting RH	Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesis.	The EMBO journal	2010	65
20603076	L-Lysine	Lee JS	Negative regulation of hypoxic responses via induced Reptin methylation.	Molecular cell	2010	64
20736451	L-Lysine	Velichutina I	EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis.	Blood	2010	80
21115810	L-Lysine	Cho HS	Demethylation of RB regulator MYPT1 by histone demethylase LSD1 promotes cell cycle progression in cancer cells.	Cancer research	2011	47
21124902	L-Lysine	Cao F	An Ash2L/RbBP5 heterodimer stimulates the MLL1 methyltransferase activity through coordinated substrate interactions with the MLL1 SET domain.	PloS one	2010	42
21175789	L-Lysine	Tsang DP	Epigenetic regulation of signaling pathways in cancer: role of the histone methyltransferase EZH2.	Journal of gastroenterology and hepatology	2011	39
21310926	L-Lysine	He J	KDM2b/JHDM1b, an H3K36me2-specific demethylase, is required for initiation and maintenance of acute myeloid leukemia.	Blood	2011	50
21398221	L-Lysine	Jo SY	Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation.	Blood	2011	69
21400613	L-Lysine	Kauffman EC	Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer.	Molecular carcinogenesis	2011	47
21512140	L-Lysine	Cheng AS	EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.	Cancer research	2011	61
21565980	L-Lysine	Audrito V	Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network.	Cancer research	2011	39
21725364	L-Lysine	Niu X	The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C.	Oncogene	2012	48
21741597	L-Lysine	Bernt KM	MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L.	Cancer cell	2011	221
21764752	L-Lysine	Wang L	The leukemogenicity of AML1-ETO is dependent on site-specific lysine acetylation.	Science	2011	59
21837672	L-Lysine	Huqun	Enhancer of zeste homolog 2 is a novel prognostic biomarker in nonsmall cell lung cancer.	Cancer	2012	31
21890490	L-Lysine	Pereira F	KDM6B/JMJD3 histone demethylase is induced by vitamin D and modulates its effects in colon cancer cells.	Human molecular genetics	2011	36
21975933	L-Lysine	Wang J	Novel histone demethylase LSD1 inhibitors selectively target cancer cells with pluripotent stem cell properties.	Cancer research	2011	62
22099308	L-Lysine	Kuo AJ	NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming.	Molecular cell	2011	90
22190494	L-Lysine	Menssen A	The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop.	Proceedings of the National Academy of Sciences of the United States of America	2012	79
22370893	L-Lysine	Au SL	Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis.	Hepatology	2012	73
22391571	L-Lysine	Kalvik TV	Protein N-terminal acetyltransferases in cancer.	Oncogene	2013	34
22406531	L-Lysine	Dong C	G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer.	The Journal of clinical investigation	2012	125
22406747	L-Lysine	Schenk T	Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia.	Nature medicine	2012	134
22419068	L-Lysine	Van Aller GS	Smyd3 regulates cancer cell phenotypes and catalyzes histone H4 lysine 5 methylation.	Epigenetics	2012	39
22447389	L-Lysine	Willmann D	Impairment of prostate cancer cell growth by a selective and reversible lysine-specific demethylase 1 inhibitor.	International journal of cancer	2012	38
22536950	L-Lysine	Yuan Y	A small-molecule probe of the histone methyltransferase G9a induces cellular senescence in pancreatic adenocarcinoma.	ACS chemical biology	2012	40
22585859	L-Lysine	Bellail AC	A20 ubiquitin ligase-mediated polyubiquitination of RIP1 inhibits caspase-8 cleavage and TRAIL-induced apoptosis in glioblastoma.	Cancer discovery	2012	30
22683710	L-Lysine	Peña-Llopis S	BAP1 loss defines a new class of renal cell carcinoma.	Nature genetics	2012	184
22711031	L-Lysine	Crea F	EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis.	Cancer metastasis reviews	2012	44
22722849	L-Lysine	Barber MF	SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation.	Nature	2012	111
22766277	L-Lysine	Holm K	Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes.	Molecular oncology	2012	36
22797064	L-Lysine	Ezponda T	The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer.	Oncogene	2013	29
22824796	L-Lysine	Wang P	Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas.	Oncogene	2013	81
22948112	L-Lysine	Prud'homme GJ	Neuropilins are multifunctional coreceptors involved in tumor initiation, growth, metastasis and immunity.	Oncotarget	2012	43
23023262	L-Lysine	Knutson SK	A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells.	Nature chemical biology	2012	209
23221071	L-Lysine	Zhong Q	Epigenetic modification of Sod2 in the development of diabetic retinopathy and in the metabolic memory: role of histone methylation.	Investigative ophthalmology & visual science	2013	28
23236167	L-Lysine	Qi W	Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation.	Proceedings of the National Academy of Sciences of the United States of America	2012	158
23257913	L-Lysine	Shankar SR	G9a, a multipotent regulator of gene expression.	Epigenetics	2013	34
23273980	L-Lysine	Chocarro-Calvo A	Glucose-induced β-catenin acetylation enhances Wnt signaling in cancer.	Molecular cell	2013	32
23404370	L-Lysine	Reuss DE	Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations.	Acta neuropathologica	2013	26
23448461	L-Lysine	Valor LM	Lysine acetyltransferases CBP and p300 as therapeutic targets in cognitive and neurodegenerative disorders.	Current pharmaceutical design	2013	29
23487776	L-Lysine	Bae C	Xerocytosis is caused by mutations that alter the kinetics of the mechanosensitive channel PIEZO1.	Proceedings of the National Academy of Sciences of the United States of America	2013	69
23523103	L-Lysine	Zhao D	Lysine-5 acetylation negatively regulates lactate dehydrogenase A and is decreased in pancreatic cancer.	Cancer cell	2013	48
23633675	L-Lysine	Ding X	Epigenetic activation of AP1 promotes squamous cell carcinoma metastasis.	Science signaling	2013	27
23684752	L-Lysine	Amente S	The histone LSD1 demethylase in stemness and cancer transcription programs.	Biochimica et biophysica acta	2013	41
23764001	L-Lysine	Tiwari N	Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming.	Cancer cell	2013	95
23775793	L-Lysine	Menendez D	Diverse stresses dramatically alter genome-wide p53 binding and transactivation landscape in human cancer cells.	Nucleic acids research	2013	63
23863932	L-Lysine	Füllgrabe J	The histone H4 lysine 16 acetyltransferase hMOF regulates the outcome of autophagy.	Nature	2013	62
23889988	L-Lysine	Emdad L	AEG-1/MTDH/LYRIC: signaling pathways, downstream genes, interacting proteins, and regulation of tumor angiogenesis.	Advances in cancer research	2013	30
23900215	L-Lysine	Ding J	LSD1-mediated epigenetic modification contributes to proliferation and metastasis of colon cancer.	British journal of cancer	2013	31
23906982	L-Lysine	Eisinger-Mathason TS	Hypoxia-dependent modification of collagen networks promotes sarcoma metastasis.	Cancer discovery	2013	53
24025767	L-Lysine	Adorno M	Usp16 contributes to somatic stem-cell defects in Down's syndrome.	Nature	2013	30
24035499	L-Lysine	Hao R	Proteasomes activate aggresome disassembly and clearance by producing unanchored ubiquitin chains.	Molecular cell	2013	35
24136356	L-Lysine	Angulo I	Phosphoinositide 3-kinase δ gene mutation predisposes to respiratory infection and airway damage.	Science	2013	94
24165275	L-Lysine	Zhang J	Long non-coding RNA HOTAIR in carcinogenesis and metastasis.	Acta biochimica et biophysica Sinica	2014	42
24183969	L-Lysine	Garapaty-Rao S	Identification of EZH2 and EZH1 small molecule inhibitors with selective impact on diffuse large B cell lymphoma cell growth.	Chemistry & biology	2013	33
24200691	L-Lysine	Wagner KW	KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling.	The Journal of clinical investigation	2013	37
24345883	L-Lysine	Li Z	The polycomb group protein EZH2 is a novel therapeutic target in tongue cancer.	Oncotarget	2013	26
24491801	L-Lysine	Kim JH	UTX and MLL4 coordinately regulate transcriptional programs for cell proliferation and invasiveness in breast cancer cells.	Cancer research	2014	38
24496381	L-Lysine	Pastori C	BET bromodomain proteins are required for glioblastoma cell proliferation.	Epigenetics	2014	29
24516139	L-Lysine	Gonzalez ME	EZH2 expands breast stem cells through activation of NOTCH1 signaling.	Proceedings of the National Academy of Sciences of the United States of America	2014	43
24563539	L-Lysine	Knutson SK	Selective inhibition of EZH2 by EPZ-6438 leads to potent antitumor activity in EZH2-mutant non-Hodgkin lymphoma.	Molecular cancer therapeutics	2014	88
24647965	L-Lysine	Kazlauskaite A	Phosphorylation of Parkin at Serine65 is essential for activation: elaboration of a Miro1 substrate-based assay of Parkin E3 ligase activity.	Open biology	2014	37
24656132	L-Lysine	Cheng J	A role for H3K4 monomethylation in gene repression and partitioning of chromatin readers.	Molecular cell	2014	50
24667498	L-Lysine	Wang F	JMJD6 promotes colon carcinogenesis through negative regulation of p53 by hydroxylation.	PLoS biology	2014	23
24816405	L-Lysine	Kryczek I	IL-22(+)CD4(+) T cells promote colorectal cancer stemness via STAT3 transcription factor activation and induction of the methyltransferase DOT1L.	Immunity	2014	59
24821572	L-Lysine	Xie P	The covalent modifier Nedd8 is critical for the activation of Smurf1 ubiquitin ligase in tumorigenesis.	Nature communications	2014	24
24843002	L-Lysine	Carvalho S	SETD2 is required for DNA double-strand break repair and activation of the p53-mediated checkpoint.	eLife	2014	50
24844570	L-Lysine	Chiba T	Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma.	International journal of cancer	2015	16
24847881	L-Lysine	Mazur PK	SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer.	Nature	2014	64
24936451	L-Lysine	Phillips S	Cell-state transitions regulated by SLUG are critical for tissue regeneration and tumor initiation.	Stem cell reports	2014	25
24937458	L-Lysine	Yamamoto S	JARID1B is a luminal lineage-driving oncogene in breast cancer.	Cancer cell	2014	43
24963049	L-Lysine	Sankar S	Reversible LSD1 inhibition interferes with global EWS/ETS transcriptional activity and impedes Ewing sarcoma tumor growth.	Clinical cancer research 	2014	25
25111487	L-Lysine	McCabe MT	EZH2 as a potential target in cancer therapy.	Epigenomics	2014	28
25136132	L-Lysine	Barsyte-Lovejoy D	(R)-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cells.	Proceedings of the National Academy of Sciences of the United States of America	2014	36
25159818	L-Lysine	Soragni E	Epigenetic therapy for Friedreich ataxia.	Annals of neurology	2014	26
25176653	L-Lysine	Park DH	Activation of neuronal gene expression by the JMJD3 demethylase is required for postnatal and adult brain neurogenesis.	Cell reports	2014	26
25200183	L-Lysine	Ryu D	A SIRT7-dependent acetylation switch of GABPβ1 controls mitochondrial function.	Cell metabolism	2014	40
25280969	L-Lysine	Saloura V	WHSC1 promotes oncogenesis through regulation of NIMA-related kinase-7 in squamous cell carcinoma of the head and neck.	Molecular cancer research 	2015	16
25296254	L-Lysine	Skourti-Stathaki K	R-loops induce repressive chromatin marks over mammalian gene terminators.	Nature	2014	71
25341040	L-Lysine	Zhang Q	Polycomb protein EZH2 suppresses apoptosis by silencing the proapoptotic miR-31.	Cell death & disease	2014	24
25384215	L-Lysine	Zhao D	NOTCH-induced aldehyde dehydrogenase 1A1 deacetylation promotes breast cancer stem cells.	The Journal of clinical investigation	2014	27
25416779	L-Lysine	Groveman BR	Charge neutralization of the central lysine cluster in prion protein (PrP) promotes PrP(Sc)-like folding of recombinant PrP amyloids.	The Journal of biological chemistry	2015	16
25428914	L-Lysine	Zhang K	Long non-coding RNA HOTAIR promotes glioblastoma cell cycle progression in an EZH2 dependent manner.	Oncotarget	2015	53
25457180	L-Lysine	Bradley WD	EZH2 inhibitor efficacy in non-Hodgkin's lymphoma does not require suppression of H3K27 monomethylation.	Chemistry & biology	2014	36
25457206	L-Lysine	Page A	Alcohol directly stimulates epigenetic modifications in hepatic stellate cells.	Journal of hepatology	2015	16
25492968	L-Lysine	Penney J	Histone deacetylases in memory and cognition.	Science signaling	2014	27
25537518	L-Lysine	Liu L	Genetic alterations of histone lysine methyltransferases and their significance in breast cancer.	Oncotarget	2015	19
25556531	L-Lysine	Cohen TJ	An acetylation switch controls TDP-43 function and aggregation propensity.	Nature communications	2015	18
25574841	L-Lysine	Yuan B	Global transcriptional disturbances underlie Cornelia de Lange syndrome and related phenotypes.	The Journal of clinical investigation	2015	21
25582194	L-Lysine	Shakya A	Pluripotency transcription factor Oct4 mediates stepwise nucleosome demethylation and depletion.	Molecular and cellular biology	2015	15
25603177	L-Lysine	Hu Y	BRD4 inhibitor inhibits colorectal cancer growth and metastasis.	International journal of molecular sciences	2015	15
25611389	L-Lysine	Vishnubalaji R	Genome-wide mRNA and miRNA expression profiling reveal multiple regulatory networks in colorectal cancer.	Cell death & disease	2015	23
25629630	L-Lysine	Fillmore CM	EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors.	Nature	2015	59
25684206	L-Lysine	Laurent B	A specific LSD1/KDM1A isoform regulates neuronal differentiation through H3K9 demethylation.	Molecular cell	2015	45
25728682	L-Lysine	Kanu N	SETD2 loss-of-function promotes renal cancer branched evolution through replication stress and impaired DNA repair.	Oncogene	2015	24
25728775	L-Lysine	Arboleda VA	De novo nonsense mutations in KAT6A, a lysine acetyl-transferase gene, cause a syndrome including microcephaly and global developmental delay.	American journal of human genetics	2015	16
25825779	L-Lysine	Brown NG	RING E3 mechanism for ubiquitin ligation to a disordered substrate visualized for human anaphase-promoting complex.	Proceedings of the National Academy of Sciences of the United States of America	2015	21
25856009	L-Lysine	Theodoulou NH	Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition.	Journal of medicinal chemistry	2016	20
25982114	L-Lysine	Roe JS	BET Bromodomain Inhibition Suppresses the Function of Hematopoietic Transcription Factors in Acute Myeloid Leukemia.	Molecular cell	2015	67
25998713	L-Lysine	Rao RC	Hijacked in cancer: the KMT2 (MLL) family of methyltransferases.	Nature reviews. Cancer	2015	48
26027790	L-Lysine	Xu B	Targeting EZH2 and PRC2 dependence as novel anticancer therapy.	Experimental hematology	2015	17
26031919	L-Lysine	Cui S	The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell mice.	Blood	2015	17
26073078	L-Lysine	Ho TH	High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma.	Oncogene	2016	18
26101266	L-Lysine	Watson RL	Endothelial CD99 signals through soluble adenylyl cyclase and PKA to regulate leukocyte transendothelial migration.	The Journal of experimental medicine	2015	21
26172293	L-Lysine	Li H	LncRNA HOTAIR promotes human liver cancer stem cell malignant growth through downregulation of SETD2.	Oncotarget	2015	30
26175415	L-Lysine	Mohammad HP	A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC.	Cancer cell	2015	48
26199140	L-Lysine	Cho MH	DOT1L cooperates with the c-Myc-p300 complex to epigenetically derepress CDH1 transcription factors in breast cancer progression.	Nature communications	2015	20
26376677	L-Lysine	Li H	miR675 upregulates long noncoding RNA H19 through activating EGR1 in human liver cancer.	Oncotarget	2015	18
26399631	L-Lysine	Castel D	Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes.	Acta neuropathologica	2015	37
26469956	L-Lysine	Sun X	Long non-coding RNA HOTAIR regulates cyclin J via inhibition of microRNA-205 expression in bladder cancer.	Cell death & disease	2015	17
26503055	L-Lysine	Peng D	Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy.	Nature	2015	84
26560027	L-Lysine	Oldridge DA	Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.	Nature	2015	46
26567139	L-Lysine	Nagarsheth N	PRC2 Epigenetically Silences Th1-Type Chemokines to Suppress Effector T-Cell Trafficking in Colon Cancer.	Cancer research	2016	16
26645727	L-Lysine	Prieto-Granada CN	Loss of H3K27me3 Expression Is a Highly Sensitive Marker for Sporadic and Radiation-induced MPNST.	The American journal of surgical pathology	2016	14
26747897	L-Lysine	Li N	JARID1D Is a Suppressor and Prognostic Marker of Prostate Cancer Invasion and Metastasis.	Cancer research	2016	12
26748827	L-Lysine	Wienken M	MDM2 Associates with Polycomb Repressor Complex 2 and Enhances Stemness-Promoting Chromatin Modifications Independent of p53.	Molecular cell	2016	15
26755663	L-Lysine	Agarwal P	Genome-wide profiling of histone H3 lysine 27 and lysine 4 trimethylation in multiple myeloma reveals the importance of Polycomb gene targeting and highlights EZH2 as a potential therapeutic target.	Oncotarget	2016	13
26805763	L-Lysine	Sada M	Hypoxic stellate cells of pancreatic cancer stroma regulate extracellular matrix fiber organization and cancer cell motility.	Cancer letters	2016	10
26911690	L-Lysine	Song P	Parkin Modulates Endosomal Organization and Function of the Endo-Lysosomal Pathway.	The Journal of neuroscience 	2016	13
26917489	L-Lysine	Bamodu OA	Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.	BMC cancer	2016	12
26983694	L-Lysine	Kurozumi A	Regulation of the collagen cross-linking enzymes LOXL2 and PLOD2 by tumor-suppressive microRNA-26a/b in renal cell carcinoma.	International journal of oncology	2016	15
27135738	L-Lysine	Souroullas GP	An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation.	Nature medicine	2016	19
27154821	L-Lysine	Zhu L	ASH1L Links Histone H3 Lysine 36 Dimethylation to MLL Leukemia.	Cancer discovery	2016	11
27195672	L-Lysine	Li W	Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.	Cell death & disease	2016	21
27212032	L-Lysine	Cao C	Functional interaction of histone deacetylase 5 (HDAC5) and lysine-specific demethylase 1 (LSD1) promotes breast cancer progression.	Oncogene	2017	8
27214401	L-Lysine	Vinogradova M	An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells.	Nature chemical biology	2016	27
27270439	L-Lysine	Ramadoss S	Lysine demethylase KDM3A regulates breast cancer cell invasion and apoptosis by targeting histone and the non-histone protein p53.	Oncogene	2017	11
27292261	L-Lysine	da Motta LL	The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer.	Oncogene	2017	13
27335278	L-Lysine	Rau RE	DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia.	Blood	2016	12
27452519	L-Lysine	Rada M	Human EHMT2/G9a activates p53 through methylation-independent mechanism.	Oncogene	2017	6
27458201	L-Lysine	Cao J	An easy and efficient inducible CRISPR/Cas9 platform with improved specificity for multiple gene targeting.	Nucleic acids research	2016	15
27622505	L-Lysine	Bharaj P	The Matrix Protein of Nipah Virus Targets the E3-Ubiquitin Ligase TRIM6 to Inhibit the IKKε Kinase-Mediated Type-I IFN Antiviral Response.	PLoS pathogens	2016	10
27721406	L-Lysine	Zou M	Evolutionarily conserved dual lysine motif determines the non-chaperone function of secreted Hsp90alpha in tumour progression.	Oncogene	2017	6
27845892	L-Lysine	Si X	LncRNA H19 confers chemoresistance in ERα-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIK.	Oncotarget	2016	13
27852821	L-Lysine	Terashima M	MEG3 Long Noncoding RNA Contributes to the Epigenetic Regulation of Epithelial-Mesenchymal Transition in Lung Cancer Cell Lines.	The Journal of biological chemistry	2017	12
27926873	L-Lysine	Jozwik KM	FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3.	Cell reports	2016	11
27974677	L-Lysine	Han M	Histone demethylase lysine demethylase 5B in development and cancer.	Oncotarget	2017	6
28475860	L-Lysine	Butcher DT	CHARGE and Kabuki Syndromes: Gene-Specific DNA Methylation Signatures Identify Epigenetic Mechanisms Linking These Clinically Overlapping Conditions.	American journal of human genetics	2017	6
6583703	Pyruvic acid	Bulfield G	X chromosome-linked muscular dystrophy (mdx) in the mouse.	Proceedings of the National Academy of Sciences of the United States of America	1984	365
11790708	Pyruvic acid	Michelakis ED	Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage-gated potassium channels.	Circulation	2002	85
12942121	Pyruvic acid	Koukourakis MI	Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis.	British journal of cancer	2003	79
16766262	Pyruvic acid	Fantin VR	Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance.	Cancer cell	2006	367
17785433	Pyruvic acid	Kim JW	Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1.	Molecular and cellular biology	2007	162
18098322	Pyruvic acid	Gershwin ME	The causes of primary biliary cirrhosis: Convenient and inconvenient truths.	Hepatology	2008	90
18464261	Pyruvic acid	Wong TS	Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling.	International journal of cancer	2008	59
19185000	Pyruvic acid	Lleo A	Apotopes and the biliary specificity of primary biliary cirrhosis.	Hepatology	2009	61
19826036	Pyruvic acid	Yang C	Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling.	Cancer research	2009	138
19826085	Pyruvic acid	Harris T	Kinetics of hyperpolarized 13C1-pyruvate transport and metabolism in living human breast cancer cells.	Proceedings of the National Academy of Sciences of the United States of America	2009	60
20144215	Pyruvic acid	Zhou M	Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol.	Molecular cancer	2010	67
20228846	Pyruvic acid	Zhao F	Imatinib resistance associated with BCR-ABL upregulation is dependent on HIF-1alpha-induced metabolic reprograming.	Oncogene	2010	51
20978194	Pyruvic acid	Chen M	Turning on a fuel switch of cancer: hnRNP proteins regulate alternative splicing of pyruvate kinase mRNA.	Cancer research	2010	46
21732474	Pyruvic acid	Prigione A	Human induced pluripotent stem cells harbor homoplasmic and heteroplasmic mitochondrial DNA mutations while maintaining human embryonic stem cell-like metabolic reprogramming.	Stem cells	2011	42
21789790	Pyruvic acid	Bluemlein K	No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis.	Oncotarget	2011	72
22895557	Pyruvic acid	Sun Y	miR-124, miR-137 and miR-340 regulate colorectal cancer growth via inhibition of the Warburg effect.	Oncology reports	2012	35
22922757	Pyruvic acid	Anastasiou D	Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis.	Nature chemical biology	2012	151
23086999	Pyruvic acid	Keller KE	SAICAR stimulates pyruvate kinase isoform M2 and promotes cancer cell survival in glucose-limited conditions.	Science	2012	48
23204238	Pyruvic acid	Keshari KR	Hyperpolarized 13C-pyruvate magnetic resonance reveals rapid lactate export in metastatic renal cell carcinomas.	Cancer research	2013	28
23470539	Pyruvic acid	Zhao Y	Targeting cellular metabolism to improve cancer therapeutics.	Cell death & disease	2013	208
23685455	Pyruvic acid	Kaplon J	A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence.	Nature	2013	148
24077665	Pyruvic acid	Desai S	Tissue-specific isoform switch and DNA hypomethylation of the pyruvate kinase PKM gene in human cancers.	Oncotarget	2014	32
24120138	Pyruvic acid	Israelsen WJ	PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells.	Cell	2013	105
24316223	Pyruvic acid	Jiang Y	PKM2 regulates chromosome segregation and mitosis progression of tumor cells.	Molecular cell	2014	57
24361892	Pyruvic acid	Cheng P	Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1-RAGE and AKT pathways.	Biochemical and biophysical research communications	2014	20
24497069	Pyruvic acid	Feng W	Targeting unique metabolic properties of breast tumor initiating cells.	Stem cells	2014	34
24726384	Pyruvic acid	Xie H	Targeting lactate dehydrogenase--a inhibits tumorigenesis and tumor progression in mouse models of lung cancer and impacts tumor-initiating cells.	Cell metabolism	2014	83
24951766	Pyruvic acid	Ryan JJ	The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure.	Circulation research	2014	42
25313085	Pyruvic acid	Hamabe A	Role of pyruvate kinase M2 in transcriptional regulation leading to epithelial-mesenchymal transition.	Proceedings of the National Academy of Sciences of the United States of America	2014	30
25514599	Pyruvic acid	Liu WR	PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma.	Oncotarget	2015	16
25576919	Pyruvic acid	Chen Z	Co-expression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinoma.	Oncotarget	2015	19
25621950	Pyruvic acid	Fong MY	Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis.	Nature cell biology	2015	93
25818238	Pyruvic acid	Taniguchi K	MicroRNA-124 inhibits cancer cell growth through PTB1/PKM1/PKM2 feedback cascade in colorectal cancer.	Cancer letters	2015	25
25948776	Pyruvic acid	Luan W	PKM2 promotes glucose metabolism and cell growth in gliomas through a mechanism involving a let-7a/c-Myc/hnRNPA1 feedback loop.	Oncotarget	2015	17
26113084	Pyruvic acid	Rajeshkumar NV	Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function.	Cancer research	2015	18
26234680	Pyruvic acid	Calabretta S	Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells.	Oncogene	2016	18
26365179	Pyruvic acid	Dupuy F	PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer.	Cell metabolism	2015	51
26739387	Pyruvic acid	Azoitei N	PKM2 promotes tumor angiogenesis by regulating HIF-1α through NF-κB activation.	Molecular cancer	2016	14
26745603	Pyruvic acid	Tang R	MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in gastric cancer.	Oncotarget	2016	17
26876154	Pyruvic acid	He CL	Pyruvate Kinase M2 Activates mTORC1 by Phosphorylating AKT1S1.	Scientific reports	2016	13
27911861	Pyruvic acid	Zhu H	Pyruvate kinase M2 (PKM2) expression correlates with prognosis in solid cancers: a meta-analysis.	Oncotarget	2017	7
28183841	Pyruvic acid	Lee M	Mathematical modeling links Wnt signaling to emergent patterns of metabolism in colon cancer.	Molecular systems biology	2017	6
28196866	Pyruvic acid	Wang XX	SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy: SGLT2 PROTEIN INHIBITION DECREASES RENAL LIPID ACCUMULATION, INFLAMMATION, AND THE DEVELOPMENT OF NEPHROPATHY IN DIABETIC MICE.	The Journal of biological chemistry	2017	9
11919237	Docetaxel	Esteva FJ	Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer.	Journal of clinical oncology 	2002	99
16061678	Docetaxel	Li Y	Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells.	Cancer research	2005	95
16404427	Docetaxel	Arnould L	Trastuzumab-based treatment of HER2-positive breast cancer: an antibody-dependent cellular cytotoxicity mechanism?	British journal of cancer	2006	120
16606824	Docetaxel	Farokhzad OC	Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2006	334
17308271	Docetaxel	Beer TM	Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators.	Journal of clinical oncology 	2007	60
17606733	Docetaxel	Marangoni E	A new model of patient tumor-derived breast cancer xenografts for preclinical assays.	Clinical cancer research 	2007	119
17909051	Docetaxel	Loberg RD	Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo.	Cancer research	2007	91
18645028	Docetaxel	Meng Y	Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa.	Molecular cancer therapeutics	2008	60
18674639	Docetaxel	Chen Y	Targeting the androgen receptor pathway in prostate cancer.	Current opinion in pharmacology	2008	143
18824702	Docetaxel	Tolcher AW	Phase I and pharmacokinetic study of YM155, a small-molecule inhibitor of survivin.	Journal of clinical oncology 	2008	65
19147587	Docetaxel	Kim RH	Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis.	Cancer research	2009	73
19150933	Docetaxel	Corkery B	Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer.	Annals of oncology 	2009	74
19230702	Docetaxel	Catalano V	Gastric cancer.	Critical reviews in oncology/hematology	2009	100
19237188	Docetaxel	Boren T	MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy.	Gynecologic oncology	2009	50
19339269	Docetaxel	Attard G	Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer.	Cancer research	2009	174
19666588	Docetaxel	Creighton CJ	Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features.	Proceedings of the National Academy of Sciences of the United States of America	2009	438
19826044	Docetaxel	Gan L	Inhibition of the androgen receptor as a novel mechanism of taxol chemotherapy in prostate cancer.	Cancer research	2009	52
19917839	Docetaxel	Spielmann M	Trastuzumab for patients with axillary-node-positive breast cancer: results of the FNCLCC-PACS 04 trial.	Journal of clinical oncology 	2009	59
20100966	Docetaxel	Lynch TJ	Cetuximab and first-line taxane/carboplatin chemotherapy in advanced non-small-cell lung cancer: results of the randomized multicenter phase III trial BMS099.	Journal of clinical oncology 	2010	108
20308670	Docetaxel	Untch M	Neoadjuvant treatment with trastuzumab in HER2-positive breast cancer: results from the GeparQuattro study.	Journal of clinical oncology 	2010	97
20406831	Docetaxel	Riethdorf S	Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial.	Clinical cancer research 	2010	111
20498403	Docetaxel	Miles DW	Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer.	Journal of clinical oncology 	2010	205
20697801	Docetaxel	Huober J	Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study.	Breast cancer research and treatment	2010	52
20842666	Docetaxel	Zhang HL	Serum miRNA-21: elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy.	The Prostate	2011	89
21149267	Docetaxel	Jeyapalan Z	Expression of CD44 3'-untranslated region regulates endogenous microRNA functions in tumorigenesis and angiogenesis.	Nucleic acids research	2011	62
21197560	Docetaxel	Xu B	miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS.	Molecular and cellular biochemistry	2011	53
21233403	Docetaxel	Huang H	Specifically targeting angiopoietin-2 inhibits angiogenesis, Tie2-expressing monocyte infiltration, and tumor growth.	Clinical cancer research 	2011	43
21373875	Docetaxel	Glück S	TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab.	Breast cancer research and treatment	2012	62
21559013	Docetaxel	Lee HE	An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer.	British journal of cancer	2011	50
21612468	Docetaxel	de Bono JS	Abiraterone and increased survival in metastatic prostate cancer.	The New England journal of medicine	2011	837
21837479	Docetaxel	Loibl S	Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy.	Breast cancer research and treatment	2011	39
21918169	Docetaxel	Brunsvig PF	Telomerase peptide vaccination in NSCLC: a phase II trial in stage III patients vaccinated after chemoradiotherapy and an 8-year update on a phase I/II trial.	Clinical cancer research 	2011	40
21990397	Docetaxel	Brufsky AM	RIBBON-2: a randomized, double-blind, placebo-controlled, phase III trial evaluating the efficacy and safety of bevacizumab in combination with chemotherapy for second-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer.	Journal of clinical oncology 	2011	90
22112969	Docetaxel	Sonpavde G	Randomized phase II trial of docetaxel plus prednisone in combination with placebo or AT-101, an oral small molecule Bcl-2 family antagonist, as first-line therapy for metastatic castration-resistant prostate cancer.	Annals of oncology 	2012	37
22149875	Docetaxel	Baselga J	Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.	The New England journal of medicine	2012	444
22153890	Docetaxel	Gianni L	Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial.	The Lancet. Oncology	2012	275
22188813	Docetaxel	Maira SM	Identification and characterization of NVP-BKM120, an orally available pan-class I PI3-kinase inhibitor.	Molecular cancer therapeutics	2012	132
22257523	Docetaxel	Untch M	Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial.	The Lancet. Oncology	2012	74
22276821	Docetaxel	Bear HD	Bevacizumab added to neoadjuvant chemotherapy for breast cancer.	The New England journal of medicine	2012	104
22331954	Docetaxel	Bergh J	First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: results of a prospective, randomized phase III study.	Journal of clinical oncology 	2012	58
22377126	Docetaxel	Pierga JY	Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory HER2-positive breast cancer (BEVERLY-2): an open-label, single-arm phase 2 study.	The Lancet. Oncology	2012	31
22387005	Docetaxel	Shien K	Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy.	Lung cancer	2012	33
22454414	Docetaxel	Kelly WK	Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401.	Journal of clinical oncology 	2012	143
22558290	Docetaxel	Kirby BJ	Functional characterization of circulating tumor cells with a prostate-cancer-specific microfluidic device.	PloS one	2012	61
22884505	Docetaxel	Ismael G	Subcutaneous versus intravenous administration of (neo)adjuvant trastuzumab in patients with HER2-positive, clinical stage I-III breast cancer (HannaH study): a phase 3, open-label, multicentre, randomised trial.	The Lancet. Oncology	2012	43
22907596	Docetaxel	Pienta KJ	Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer.	Investigational new drugs	2013	46
22972611	Docetaxel	Sehdev V	The combination of alisertib, an investigational Aurora kinase A inhibitor, and docetaxel promotes cell death and reduces tumor growth in preclinical cell models of upper gastrointestinal adenocarcinomas.	Cancer	2013	26
23032615	Docetaxel	Mamounas EP	Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27.	Journal of clinical oncology 	2012	45
23041621	Docetaxel	Qiu M	Specific inhibition of Notch1 signaling enhances the antitumor efficacy of chemotherapy in triple negative breast cancer through reduction of cancer stem cells.	Cancer letters	2013	26
23200175	Docetaxel	Jänne PA	Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study.	The Lancet. Oncology	2013	181
23246022	Docetaxel	Mackey JR	Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial.	The Lancet. Oncology	2013	44
23340294	Docetaxel	Schott AF	Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors.	Clinical cancer research 	2013	44
23368632	Docetaxel	Chen J	Evaluation of characteristics of CD44+CD117+ ovarian cancer stem cells in three dimensional basement membrane extract scaffold versus two dimensional monocultures.	BMC cell biology	2013	26
23382472	Docetaxel	Hurvitz SA	Phase II randomized study of trastuzumab emtansine versus trastuzumab plus docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.	Journal of clinical oncology 	2013	80
23386691	Docetaxel	Shen H	Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector delivery.	Clinical cancer research 	2013	34
23422754	Docetaxel	Miles DW	Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer.	British journal of cancer	2013	38
23475636	Docetaxel	Swain SM	Cardiac tolerability of pertuzumab plus trastuzumab plus docetaxel in patients with HER2-positive metastatic breast cancer in CLEOPATRA: a randomized, double-blind, placebo-controlled phase III study.	The oncologist	2013	34
23576708	Docetaxel	Loriot Y	Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100).	Annals of oncology 	2013	72
23602601	Docetaxel	Swain SM	Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study.	The Lancet. Oncology	2013	161
23690416	Docetaxel	Bepler G	Randomized international phase III trial of ERCC1 and RRM1 expression-based chemotherapy versus gemcitabine/carboplatin in advanced non-small-cell lung cancer.	Journal of clinical oncology 	2013	40
23957948	Docetaxel	Sridhar SS	Castration-resistant prostate cancer: from new pathophysiology to new treatment.	European urology	2014	29
24002511	Docetaxel	von Minckwitz G	Response-guided neoadjuvant chemotherapy for breast cancer.	Journal of clinical oncology 	2013	38
24136883	Docetaxel	Gerber B	Neoadjuvant bevacizumab and anthracycline-taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44).	Annals of oncology 	2013	26
24149323	Docetaxel	Yan W	Epigenetic regulation of DACH1, a novel Wnt signaling component in colorectal cancer.	Epigenetics	2013	30
24200698	Docetaxel	van Soest RJ	Cross-resistance between taxanes and new hormonal agents abiraterone and enzalutamide may affect drug sequence choices in metastatic castration-resistant prostate cancer.	European journal of cancer	2013	38
24282274	Docetaxel	Fitzgerald JB	MM-141, an IGF-IR- and ErbB3-directed bispecific antibody, overcomes network adaptations that limit activity of IGF-IR inhibitors.	Molecular cancer therapeutics	2014	26
24309006	Docetaxel	Stewart DJ	Wnt signaling pathway in non-small cell lung cancer.	Journal of the National Cancer Institute	2014	94
24321502	Docetaxel	Heidenreich A	EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.	European urology	2014	203
24478320	Docetaxel	Sternberg CN	Improved outcomes in elderly patients with metastatic castration-resistant prostate cancer treated with the androgen receptor inhibitor enzalutamide: results from the phase III AFFIRM trial.	Annals of oncology 	2014	29
24616308	Docetaxel	Goldkorn A	Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer.	Journal of clinical oncology 	2014	50
24685829	Docetaxel	Swain SM	Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA.	Annals of oncology 	2014	22
24740322	Docetaxel	Liu C	Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration-resistant prostate cancer.	Clinical cancer research 	2014	61
24815864	Docetaxel	Palena C	Overexpression of the EMT driver brachyury in breast carcinomas: association with poor prognosis.	Journal of the National Cancer Institute	2014	25
24836273	Docetaxel	Sartor O	Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial.	The Lancet. Oncology	2014	58
24985346	Docetaxel	Ono M	Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells.	Science signaling	2014	105
25002723	Docetaxel	Harari PM	Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234.	Journal of clinical oncology 	2014	22
25018038	Docetaxel	Azad AA	Efficacy of enzalutamide following abiraterone acetate in chemotherapy-naive metastatic castration-resistant prostate cancer patients.	European urology	2015	26
25273343	Docetaxel	Gligorov J	Maintenance capecitabine and bevacizumab versus bevacizumab alone after initial first-line bevacizumab and docetaxel for patients with HER2-negative metastatic breast cancer (IMELDA): a randomised, open-label, phase 3 trial.	The Lancet. Oncology	2014	20
25301760	Docetaxel	James ND	Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019).	European urology	2015	36
25310895	Docetaxel	Chen D	MicroRNA-451 induces epithelial-mesenchymal transition in docetaxel-resistant lung adenocarcinoma cells by targeting proto-oncogene c-Myc.	European journal of cancer	2014	22
25359780	Docetaxel	Bhardwaj A	CXCL12/CXCR4 signaling counteracts docetaxel-induced microtubule stabilization via p21-activated kinase 4-dependent activation of LIM domain kinase 1.	Oncotarget	2014	20
25439694	Docetaxel	Hoskin P	Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial.	The Lancet. Oncology	2014	36
25693012	Docetaxel	Swain SM	Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer.	The New England journal of medicine	2015	175
25771365	Docetaxel	Vallabhajosula S	Radioimmunotherapy of Metastatic Prostate Cancer with ¹⁷⁷Lu-DOTAhuJ591 Anti Prostate Specific Membrane Antigen Specific Monoclonal Antibody.	Current radiopharmaceuticals	2016	15
25975632	Docetaxel	Earl HM	Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial.	The Lancet. Oncology	2015	25
26074382	Docetaxel	Attard G	Prostate cancer.	Lancet	2016	92
26077235	Docetaxel	Sparano JA	Long-Term Follow-Up of the E1199 Phase III Trial Evaluating the Role of Taxane and Schedule in Operable Breast Cancer.	Journal of clinical oncology 	2015	16
26117829	Docetaxel	Nakazawa M	Serial blood-based analysis of AR-V7 in men with advanced prostate cancer.	Annals of oncology 	2015	40
26181238	Docetaxel	Antonarakis ES	Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer.	JAMA oncology	2015	87
26196735	Docetaxel	Crawford ED	Treating Patients with Metastatic Castration Resistant Prostate Cancer: A Comprehensive Review of Available Therapies.	The Journal of urology	2015	24
26244877	Docetaxel	Sweeney CJ	Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer.	The New England journal of medicine	2015	132
26253814	Docetaxel	Prat A	Clinical implications of the intrinsic molecular subtypes of breast cancer.	Breast	2015	49
26510020	Docetaxel	Mateo J	DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.	The New England journal of medicine	2015	185
26847057	Docetaxel	Von Hoff DD	Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid Tumors.	Clinical cancer research 	2016	15
27400947	Docetaxel	Smith M	Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1.	Journal of clinical oncology 	2016	16
27591931	Docetaxel	Cornford P	EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer.	European urology	2017	44
27964843	Docetaxel	Luen SJ	Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of the CLEOPATRA study.	The Lancet. Oncology	2017	14
28133913	Docetaxel	Hanrahan K	The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer.	Molecular oncology	2017	8
28398846	Docetaxel	Blum JL	Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology).	Journal of clinical oncology 	2017	5
11006365	Gadolinium	Jacobs LD	Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group.	The New England journal of medicine	2000	142
15998902	Gadolinium	Galanis E	Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study.	Journal of clinical oncology 	2005	155
17267695	Gadolinium	Sadowski EA	Nephrogenic systemic fibrosis: risk factors and incidence estimation.	Radiology	2007	107
18272891	Gadolinium	Hauser SL	B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.	The New England journal of medicine	2008	394
19442942	Gadolinium	Carlsson M	Myocardium at risk after acute infarction in humans on cardiac magnetic resonance: quantitative assessment during follow-up and validation with single-photon emission computed tomography.	JACC. Cardiovascular imaging	2009	49
20035078	Gadolinium	Barr TL	Blood-brain barrier disruption in humans is independently associated with increased matrix metalloproteinase-9.	Stroke	2010	46
20163990	Gadolinium	Wynn D	Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta.	The Lancet. Neurology	2010	68
20818890	Gadolinium	Ho CY	Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.	The New England journal of medicine	2010	111
21372112	Gadolinium	Fleming JO	Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study.	Multiple sclerosis	2011	54
22047971	Gadolinium	Kappos L	Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial.	Lancet	2011	125
22160404	Gadolinium	La Gerche A	Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes.	European heart journal	2012	68
22847020	Gadolinium	Phuphanich S	Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma.	Cancer immunology, immunotherapy 	2013	76
22865271	Gadolinium	Thomsen HS	Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines.	European radiology	2013	39
23071146	Gadolinium	Dass S	Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy.	Circulation. Cardiovascular imaging	2012	60
23594591	Gadolinium	Robbers LF	Magnetic resonance imaging-defined areas of microvascular obstruction after acute myocardial infarction represent microvascular destruction and haemorrhage.	European heart journal	2013	27
24829362	Gadolinium	Chin CW	High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis.	European heart journal	2014	33
25388867	Gadolinium	Ferreira PF	In vivo cardiovascular magnetic resonance diffusion tensor imaging shows evidence of abnormal myocardial laminar orientations and mobility in hypertrophic cardiomyopathy.	Journal of cardiovascular magnetic resonance 	2014	27
26264658	Gadolinium	Zhou Z	MRI detection of breast cancer micrometastases with a fibronectin-targeting contrast agent.	Nature communications	2015	23
26700156	Gadolinium	Cao Y	Signal Change in the Dentate Nucleus on T1-Weighted MR Images After Multiple Administrations of Gadopentetate Dimeglumine Versus Gadobutrol.	AJR. American journal of roentgenology	2016	13
12759241	Bleomycin	McGuire JK	Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium.	The American journal of pathology	2003	87
14559807	Bleomycin	Quinn JE	BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis.	Cancer research	2003	99
15286810	Bleomycin	Phillips RJ	Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis.	The Journal of clinical investigation	2004	359
15618458	Bleomycin	Lawson WE	Characterization of fibroblast-specific protein 1 in pulmonary fibrosis.	American journal of respiratory and critical care medicine	2005	69
16327802	Bleomycin	Fichtner-Feigl S	IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis.	Nature medicine	2006	227
17178917	Bleomycin	Wang XM	Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis.	The Journal of experimental medicine	2006	142
17195235	Bleomycin	Distler JH	Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.	Arthritis and rheumatism	2007	68
17463394	Bleomycin	Xu J	Role of the SDF-1/CXCR4 axis in the pathogenesis of lung injury and fibrosis.	American journal of respiratory cell and molecular biology	2007	57
17569781	Bleomycin	Ortiz LA	Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury.	Proceedings of the National Academy of Sciences of the United States of America	2007	272
17916809	Bleomycin	Horan GS	Partial inhibition of integrin alpha(v)beta6 prevents pulmonary fibrosis without exacerbating inflammation.	American journal of respiratory and critical care medicine	2008	98
18162602	Bleomycin	Milam JE	PPAR-gamma agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis.	American journal of physiology. Lung cellular and molecular physiology	2008	64
18165226	Bleomycin	Gao F	Extracellular superoxide dismutase inhibits inflammation by preventing oxidative fragmentation of hyaluronan.	The Journal of biological chemistry	2008	64
18203815	Bleomycin	Tourkina E	Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo.	American journal of physiology. Lung cellular and molecular physiology	2008	61
19073610	Bleomycin	Kliment CR	Oxidative stress alters syndecan-1 distribution in lungs with pulmonary fibrosis.	The Journal of biological chemistry	2009	53
19104148	Bleomycin	Kim KK	Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis.	The Journal of clinical investigation	2009	158
19147812	Bleomycin	Xu MY	Lysophosphatidic acid induces alphavbeta6 integrin-mediated TGF-beta activation via the LPA2 receptor and the small G protein G alpha(q).	The American journal of pathology	2009	55
19433312	Bleomycin	Mehrad B	Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis.	The international journal of biochemistry & cell biology	2009	63
19497992	Bleomycin	Moodley Y	Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury.	The American journal of pathology	2009	85
19565505	Bleomycin	Ponticos M	Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen.	Arthritis and rheumatism	2009	61
19652365	Bleomycin	Scotton CJ	Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury.	The Journal of clinical investigation	2009	84
20201077	Bleomycin	Maurer B	MicroRNA-29, a key regulator of collagen expression in systemic sclerosis.	Arthritis and rheumatism	2010	126
20300636	Bleomycin	Murray LA	Serum amyloid P therapeutically attenuates murine bleomycin-induced pulmonary fibrosis via its effects on macrophages.	PloS one	2010	62
20971881	Bleomycin	Cushing L	miR-29 is a major regulator of genes associated with pulmonary fibrosis.	American journal of respiratory cell and molecular biology	2011	145
21044893	Bleomycin	Murray LA	TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P.	The international journal of biochemistry & cell biology	2011	88
21092408	Bleomycin	Murphy S	Human amnion epithelial cells prevent bleomycin-induced lung injury and preserve lung function.	Cell transplantation	2011	39
21169555	Bleomycin	Zhong Q	Role of endoplasmic reticulum stress in epithelial-mesenchymal transition of alveolar epithelial cells: effects of misfolded surfactant protein.	American journal of respiratory cell and molecular biology	2011	44
21370225	Bleomycin	Wei J	Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma?	Arthritis and rheumatism	2011	45
21420029	Bleomycin	Pandit KV	MicroRNAs in idiopathic pulmonary fibrosis.	Translational research 	2011	98
21680953	Bleomycin	Gibbons MA	Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis.	American journal of respiratory and critical care medicine	2011	107
21708929	Bleomycin	Li Y	Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44.	The Journal of experimental medicine	2011	97
21722364	Bleomycin	Tourkina E	Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide.	Fibrogenesis & tissue repair	2011	42
21871427	Bleomycin	Yamashita CM	Matrix metalloproteinase 3 is a mediator of pulmonary fibrosis.	The American journal of pathology	2011	37
21990376	Bleomycin	Schneider DJ	Cadherin-11 contributes to pulmonary fibrosis: potential role in TGF-β production and epithelial to mesenchymal transition.	FASEB journal 	2012	40
22095546	Bleomycin	Mackinnon AC	Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-3.	American journal of respiratory and critical care medicine	2012	52
22328737	Bleomycin	Beyer C	β-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis.	Annals of the rheumatic diseases	2012	45
22492165	Bleomycin	Lagares D	Inhibition of focal adhesion kinase prevents experimental lung fibrosis and myofibroblast formation.	Arthritis and rheumatism	2012	34
22815997	Bleomycin	Patel AS	Autophagy in idiopathic pulmonary fibrosis.	PloS one	2012	74
23141927	Bleomycin	Bhattacharyya S	Toll-like receptor 4 signaling augments transforming growth factor-β responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma.	The American journal of pathology	2013	41
23295467	Bleomycin	Slominski A	20S-hydroxyvitamin D3, noncalcemic product of CYP11A1 action on vitamin D3, exhibits potent antifibrogenic activity in vivo.	The Journal of clinical endocrinology and metabolism	2013	35
23457217	Bleomycin	Yang S	miR-145 regulates myofibroblast differentiation and lung fibrosis.	FASEB journal 	2013	38
23526221	Bleomycin	Aumiller V	WNT/β-catenin signaling induces IL-1β expression by alveolar epithelial cells in pulmonary fibrosis.	American journal of respiratory cell and molecular biology	2013	32
23657402	Bleomycin	Zhu H	MicroRNA-21 in scleroderma fibrosis and its function in TGF-β-regulated fibrosis-related genes expression.	Journal of clinical immunology	2013	28
23759512	Bleomycin	Tang X	Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis.	The American journal of pathology	2013	31
24172847	Bleomycin	Suwara MI	IL-1α released from damaged epithelial cells is sufficient and essential to trigger inflammatory responses in human lung fibroblasts.	Mucosal immunology	2014	31
24279830	Bleomycin	Das S	MicroRNA-326 regulates profibrotic functions of transforming growth factor-β in pulmonary fibrosis.	American journal of respiratory cell and molecular biology	2014	36
24706986	Bleomycin	Haak AJ	Targeting the myofibroblast genetic switch: inhibitors of myocardin-related transcription factor/serum response factor-regulated gene transcription prevent fibrosis in a murine model of skin injury.	The Journal of pharmacology and experimental therapeutics	2014	26
24740698	Bleomycin	Chrysanthopoulou A	Neutrophil extracellular traps promote differentiation and function of fibroblasts.	The Journal of pathology	2014	28
24920662	Bleomycin	Zhou Y	Chitinase 3-like 1 suppresses injury and promotes fibroproliferative responses in Mammalian lung fibrosis.	Science translational medicine	2014	29
25029475	Bleomycin	Bauer Y	A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis.	American journal of respiratory cell and molecular biology	2015	26
25180292	Bleomycin	Zerr P	Sirt1 regulates canonical TGF-β signalling to control fibroblast activation and tissue fibrosis.	Annals of the rheumatic diseases	2016	20
25385603	Bleomycin	Lee RH	TSG-6 as a biomarker to predict efficacy of human mesenchymal stem/progenitor cells (hMSCs) in modulating sterile inflammation in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2014	39
25533958	Bleomycin	Vaughan AE	Lineage-negative progenitors mobilize to regenerate lung epithelium after major injury.	Nature	2015	88
25959210	Bleomycin	Della Latta V	Bleomycin in the setting of lung fibrosis induction: From biological mechanisms to counteractions.	Pharmacological research	2015	28
25995225	Bleomycin	Reed NI	The αvβ1 integrin plays a critical in vivo role in tissue fibrosis.	Science translational medicine	2015	37
26436920	Bleomycin	Su S	miR-142-5p and miR-130a-3p are regulated by IL-4 and IL-13 and control profibrogenic macrophage program.	Nature communications	2015	22
26763945	Bleomycin	Zhao XK	Focal Adhesion Kinase Regulates Fibroblast Migration via Integrin beta-1 and Plays a Central Role in Fibrosis.	Scientific reports	2016	12
26849959	Bleomycin	Spanjer AI	TGF-β-induced profibrotic signaling is regulated in part by the WNT receptor Frizzled-8.	FASEB journal 	2016	13
26987798	Bleomycin	Li Y	Hyaluronan synthase 2 regulates fibroblast senescence in pulmonary fibrosis.	Matrix biology 	2016	10
28062404	Bleomycin	Manetti M	Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.	Annals of the rheumatic diseases	2017	6
7694152	D-Glutamic acid	Kaufman DL	Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes.	Nature	1993	184
7857653	D-Glutamic acid	Saido TC	Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques.	Neuron	1995	125
10774732	D-Glutamic acid	Man HY	Regulation of AMPA receptor-mediated synaptic transmission by clathrin-dependent receptor internalization.	Neuron	2000	155
12372652	D-Glutamic acid	Fatemi SH	Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices.	Biological psychiatry	2002	125
12388773	D-Glutamic acid	Fremeau RT Jr	The identification of vesicular glutamate transporter 3 suggests novel modes of signaling by glutamate.	Proceedings of the National Academy of Sciences of the United States of America	2002	138
12704387	D-Glutamic acid	Pollock PM	Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia.	Nature genetics	2003	89
14985749	D-Glutamic acid	Kawahara Y	Glutamate receptors: RNA editing and death of motor neurons.	Nature	2004	123
15124027	D-Glutamic acid	Talbot K	Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia.	The Journal of clinical investigation	2004	117
15217349	D-Glutamic acid	Bruijn LI	Unraveling the mechanisms involved in motor neuron degeneration in ALS.	Annual review of neuroscience	2004	340
15560956	D-Glutamic acid	Fatemi SH	GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum.	Schizophrenia research	2005	73
15563600	D-Glutamic acid	Colnot S	Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas.	Proceedings of the National Academy of Sciences of the United States of America	2004	79
15572176	D-Glutamic acid	Barbeito LH	A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis.	Brain research. Brain research reviews	2004	84
16429157	D-Glutamic acid	Ikeda Y	Spectrin mutations cause spinocerebellar ataxia type 5.	Nature genetics	2006	90
16452252	D-Glutamic acid	Nosyreva ED	Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome.	Journal of neurophysiology	2006	131
16964294	D-Glutamic acid	Zucman-Rossi J	Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas.	Oncogene	2007	62
17332361	D-Glutamic acid	Namkoong J	Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma.	Cancer research	2007	75
17726000	D-Glutamic acid	Tan HY	Dysfunctional and compensatory prefrontal cortical systems, genes and the pathogenesis of schizophrenia.	Cerebral cortex	2007	68
18077569	D-Glutamic acid	Lipsky RH	Brain-derived neurotrophic factor in neuronal survival and behavior-related plasticity.	Annals of the New York Academy of Sciences	2007	71
18282652	D-Glutamic acid	Turner BJ	Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.	Progress in neurobiology	2008	153
18326497	D-Glutamic acid	Lee SG	Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes.	The Journal of biological chemistry	2008	86
18469825	D-Glutamic acid	Savaskan NE	Small interfering RNA-mediated xCT silencing in gliomas inhibits neurodegeneration and alleviates brain edema.	Nature medicine	2008	61
18474609	D-Glutamic acid	Narayanan U	S6K1 phosphorylates and regulates fragile X mental retardation protein (FMRP) with the neuronal protein synthesis-dependent mammalian target of rapamycin (mTOR) signaling cascade.	The Journal of biological chemistry	2008	90
18838545	D-Glutamic acid	Hinson SR	Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2.	The Journal of experimental medicine	2008	71
19109228	D-Glutamic acid	Asnafi V	NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study.	Blood	2009	46
19191304	D-Glutamic acid	Rothstein JD	Current hypotheses for the underlying biology of amyotrophic lateral sclerosis.	Annals of neurology	2009	199
19706428	D-Glutamic acid	Mullins FM	STIM1 and calmodulin interact with Orai1 to induce Ca2+-dependent inactivation of CRAC channels.	Proceedings of the National Academy of Sciences of the United States of America	2009	90
20413653	D-Glutamic acid	Crews L	Molecular mechanisms of neurodegeneration in Alzheimer's disease.	Human molecular genetics	2010	111
20880507	D-Glutamic acid	Zhao Y	Targeting astrocytes for stroke therapy.	Neurotherapeutics 	2010	42
20884644	D-Glutamic acid	Geis C	Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition.	Brain 	2010	44
21084617	D-Glutamic acid	Osterweil EK	Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome.	The Journal of neuroscience 	2010	128
21666692	D-Glutamic acid	Chasman DI	Genome-wide association study reveals three susceptibility loci for common migraine in the general population.	Nature genetics	2011	78
21925173	D-Glutamic acid	Seifert G	Neuron-astrocyte signaling and epilepsy.	Experimental neurology	2013	29
22013185	D-Glutamic acid	Lancaster E	Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome.	Neurology	2011	50
22238332	D-Glutamic acid	Andronesi OC	Detection of 2-hydroxyglutarate in IDH-mutated glioma patients by in vivo spectral-editing and 2D correlation magnetic resonance spectroscopy.	Science translational medicine	2012	85
22275254	D-Glutamic acid	Rossi S	Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis.	Annals of neurology	2012	35
22339950	D-Glutamic acid	Duric V	Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects.	The international journal of neuropsychopharmacology	2013	53
22378043	D-Glutamic acid	McGill MR	The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation.	The Journal of clinical investigation	2012	139
22382129	D-Glutamic acid	Wang T	New perspectives on the biology of fragile X syndrome.	Current opinion in genetics & development	2012	39
22592998	D-Glutamic acid	Coulter DA	Astrocytic regulation of glutamate homeostasis in epilepsy.	Glia	2012	60
22891276	D-Glutamic acid	Kiel MJ	Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma.	The Journal of experimental medicine	2012	54
22930283	D-Glutamic acid	Grisham RN	BRAF mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer.	Cancer	2013	32
23237660	D-Glutamic acid	Belousov AB	Neuronal gap junctions: making and breaking connections during development and injury.	Trends in neurosciences	2013	30
23487788	D-Glutamic acid	Takeuchi K	Dysregulation of synaptic plasticity precedes appearance of morphological defects in a Pten conditional knockout mouse model of autism.	Proceedings of the National Academy of Sciences of the United States of America	2013	27
23523633	D-Glutamic acid	Iori V	Receptor for Advanced Glycation Endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures.	Neurobiology of disease	2013	28
23583108	D-Glutamic acid	Schobel SA	Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver.	Neuron	2013	103
23714777	D-Glutamic acid	Tong J	Expression of ALS-linked TDP-43 mutant in astrocytes causes non-cell-autonomous motor neuron death in rats.	The EMBO journal	2013	35
23793099	D-Glutamic acid	Tönjes M	BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1.	Nature medicine	2013	73
24126926	D-Glutamic acid	Kenny EM	Excess of rare novel loss-of-function variants in synaptic genes in schizophrenia and autism spectrum disorders.	Molecular psychiatry	2014	39
24469795	D-Glutamic acid	Morrison CD	Whole-genome sequencing identifies genomic heterogeneity at a nucleotide and chromosomal level in bladder cancer.	Proceedings of the National Academy of Sciences of the United States of America	2014	25
24662927	D-Glutamic acid	Nagy C	Astrocytic abnormalities and global DNA methylation patterns in depression and suicide.	Molecular psychiatry	2015	39
24865427	D-Glutamic acid	Liu G	Aldehyde dehydrogenase 1 defines and protects a nigrostriatal dopaminergic neuron subpopulation.	The Journal of clinical investigation	2014	20
24927875	D-Glutamic acid	Vucic S	Advances in treating amyotrophic lateral sclerosis: insights from pathophysiological studies.	Trends in neurosciences	2014	40
25100593	D-Glutamic acid	Kozak R	Reduction of brain kynurenic acid improves cognitive function.	The Journal of neuroscience 	2014	21
25225364	D-Glutamic acid	Chen R	Hominoid-specific enzyme GLUD2 promotes growth of IDH1R132H glioma.	Proceedings of the National Academy of Sciences of the United States of America	2014	25
25419706	D-Glutamic acid	Wetzel-Smith MK	A rare mutation in UNC5C predisposes to late-onset Alzheimer's disease and increases neuronal cell death.	Nature medicine	2014	26
25433904	D-Glutamic acid	MacDonald ML	Altered glutamate protein co-expression network topology linked to spine loss in the auditory cortex of schizophrenia.	Biological psychiatry	2015	19
25646370	D-Glutamic acid	Matsuo H	Genome-wide association study of clinically defined gout identifies multiple risk loci and its association with clinical subtypes.	Annals of the rheumatic diseases	2016	22
25673413	D-Glutamic acid	Locke AE	Genetic studies of body mass index yield new insights for obesity biology.	Nature	2015	564
25976297	D-Glutamic acid	Mantsch JR	Stress-Induced Reinstatement of Drug Seeking: 20 Years of Progress.	Neuropsychopharmacology 	2016	60
26098217	D-Glutamic acid	Ou J	Synaptic pathology and therapeutic repair in adult retinoschisis mouse by AAV-RS1 transfer.	The Journal of clinical investigation	2015	16
26265699	D-Glutamic acid	Karol SE	Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia.	Blood	2015	20
26384381	D-Glutamic acid	Hernández C	Topical Administration of GLP-1 Receptor Agonists Prevents Retinal Neurodegeneration in Experimental Diabetes.	Diabetes	2016	10
26439639	D-Glutamic acid	Gautier HO	Neuronal activity regulates remyelination via glutamate signalling to oligodendrocyte progenitors.	Nature communications	2015	16
27444795	D-Glutamic acid	Chung DW	Pathological Basis for Deficient Excitatory Drive to Cortical Parvalbumin Interneurons in Schizophrenia.	The American journal of psychiatry	2016	12
27629368	D-Glutamic acid	Haroon E	Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders.	Neuropsychopharmacology 	2017	7
27824355	D-Glutamic acid	Mechawar N	Neuropathology of mood disorders: do we see the stigmata of inflammation?	Translational psychiatry	2016	17
27908782	D-Glutamic acid	Raefsky SM	Adaptive responses of neuronal mitochondria to bioenergetic challenges: Roles in neuroplasticity and disease resistance.	Free radical biology & medicine	2017	16
28060739	D-Glutamic acid	Lu M	A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.	Oncotarget	2017	9
28100738	D-Glutamic acid	Mandolesi G	miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation.	The Journal of neuroscience 	2017	6
10318828	L-Lactic acid	Jonas JC	Chronic hyperglycemia triggers loss of pancreatic beta cell differentiation in an animal model of diabetes.	The Journal of biological chemistry	1999	100
10921872	L-Lactic acid	Kirk P	CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression.	The EMBO journal	2000	134
11299236	L-Lactic acid	Chen Z	Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice.	American journal of physiology. Heart and circulatory physiology	2001	90
11559017	L-Lactic acid	Brown DM	Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines.	Toxicology and applied pharmacology	2001	104
12682352	L-Lactic acid	Lee N	A major outbreak of severe acute respiratory syndrome in Hong Kong.	The New England journal of medicine	2003	245
16175178	L-Lactic acid	Cardone RA	The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis.	Nature reviews. Cancer	2005	162
16278308	L-Lactic acid	Gottfried E	Tumor-derived lactic acid modulates dendritic cell activation and antigen expression.	Blood	2006	75
17226902	L-Lactic acid	Foligne B	Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria.	World journal of gastroenterology	2007	88
18188595	L-Lactic acid	Pinheiro C	Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas.	Virchows Archiv 	2008	64
18304378	L-Lactic acid	Young CD	Sugar and fat - that's where it's at: metabolic changes in tumors.	Breast cancer research 	2008	53
18711745	L-Lactic acid	Junn E	Mitochondrial localization of DJ-1 leads to enhanced neuroprotection.	Journal of neuroscience research	2009	80
19033652	L-Lactic acid	Semenza GL	Tumor metabolism: cancer cells give and take lactate.	The Journal of clinical investigation	2008	82
19082467	L-Lactic acid	Yao Y	The expression of CRM1 is associated with prognosis in human osteosarcoma.	Oncology reports	2009	51
19213602	L-Lactic acid	Scher HI	Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data.	The Lancet. Oncology	2009	146
19224853	L-Lactic acid	Carreras J	High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma.	Journal of clinical oncology 	2009	51
19286567	L-Lactic acid	Amann T	GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis.	The American journal of pathology	2009	59
19628770	L-Lactic acid	Hou JM	Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy.	The American journal of pathology	2009	61
19668225	L-Lactic acid	Zhao YH	Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth.	Oncogene	2009	57
19815831	L-Lactic acid	van Beers EJ	Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease.	Haematologica	2009	50
20021214	L-Lactic acid	Kennedy KM	Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation.	Future oncology	2010	60
20100866	L-Lactic acid	Fogal V	Mitochondrial p32 protein is a critical regulator of tumor metabolism via maintenance of oxidative phosphorylation.	Molecular and cellular biology	2010	77
20118770	L-Lactic acid	Snuderl M	B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.	The American journal of surgical pathology	2010	54
20147742	L-Lactic acid	Coumans FA	All circulating EpCAM+CK+CD45- objects predict overall survival in castration-resistant prostate cancer.	Annals of oncology 	2010	63
20636790	L-Lactic acid	Pinheiro C	Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma.	Histopathology	2010	49
20864819	L-Lactic acid	Chiavarina B	HIF1-alpha functions as a tumor promoter in cancer associated fibroblasts, and as a tumor suppressor in breast cancer cells: Autophagy drives compartment-specific oncogenesis.	Cell cycle	2010	82
20952379	L-Lactic acid	Namavar Y	Clinical, neuroradiological and genetic findings in pontocerebellar hypoplasia.	Brain 	2011	36
20961996	L-Lactic acid	Qing G	Combinatorial regulation of neuroblastoma tumor progression by N-Myc and hypoxia inducible factor HIF-1alpha.	Cancer research	2010	46
21521946	L-Lactic acid	Witkiewicz AK	Molecular profiling of a lethal tumor microenvironment, as defined by stromal caveolin-1 status in breast cancers.	Cell cycle	2011	42
21550068	L-Lactic acid	Jarius S	Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.	Journal of the neurological sciences	2011	49
21558814	L-Lactic acid	Whitaker-Menezes D	Evidence for a stromal-epithelial "lactate shuttle" in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts.	Cell cycle	2011	117
21632858	L-Lactic acid	Koukourakis MI	Prognostic and predictive role of lactate dehydrogenase 5 expression in colorectal cancer patients treated with PTK787/ZK 222584 (vatalanib) antiangiogenic therapy.	Clinical cancer research 	2011	38
21804546	L-Lactic acid	Locasale JW	Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis.	Nature genetics	2011	271
21908873	L-Lactic acid	Ferraiuolo L	Dysregulation of astrocyte-motoneuron cross-talk in mutant superoxide dismutase 1-related amyotrophic lateral sclerosis.	Brain 	2011	40
22002575	L-Lactic acid	Li S	B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome.	Modern pathology 	2012	37
22124101	L-Lactic acid	Kim KB	BEAM: a randomized phase II study evaluating the activity of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced melanoma.	Journal of clinical oncology 	2012	52
22129993	L-Lactic acid	Balliet RM	Mitochondrial oxidative stress in cancer-associated fibroblasts drives lactate production, promoting breast cancer tumor growth: understanding the aging and cancer connection.	Cell cycle	2011	41
22130161	L-Lactic acid	Joseph RW	Correlation of NRAS mutations with clinical response to high-dose IL-2 in patients with advanced melanoma.	Journal of immunotherapy	2012	34
22180178	L-Lactic acid	Jakob JA	NRAS mutation status is an independent prognostic factor in metastatic melanoma.	Cancer	2012	112
22301554	L-Lactic acid	Crane JD	Massage therapy attenuates inflammatory signaling after exercise-induced muscle damage.	Science translational medicine	2012	41
22313602	L-Lactic acid	Witkiewicz AK	Using the "reverse Warburg effect" to identify high-risk breast cancer patients: stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers.	Cell cycle	2012	70
22492562	L-Lactic acid	Steenweg ME	Leukoencephalopathy with thalamus and brainstem involvement and high lactate 'LTBL' caused by EARS2 mutations.	Brain 	2012	59
22640478	L-Lactic acid	Ascierto PA	Sequencing of BRAF inhibitors and ipilimumab in patients with metastatic melanoma: a possible algorithm for clinical use.	Journal of translational medicine	2012	31
22828443	L-Lactic acid	Tamura H	Marrow stromal cells induce B7-H1 expression on myeloma cells, generating aggressive characteristics in multiple myeloma.	Leukemia	2013	40
22850421	L-Lactic acid	Fiaschi T	Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay.	Cancer research	2012	100
22874531	L-Lactic acid	Guido C	Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production.	Cell cycle	2012	50
22961700	L-Lactic acid	Yao F	LDHA is necessary for the tumorigenicity of esophageal squamous cell carcinoma.	Tumour biology 	2013	28
23043612	L-Lactic acid	Ho J	Importance of glycolysis and oxidative phosphorylation in advanced melanoma.	Molecular cancer	2012	33
23258846	L-Lactic acid	Miranda-Gonçalves V	Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets.	Neuro-oncology	2013	52
23295735	L-Lactic acid	Villamor N	NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome.	Leukemia	2013	28
23404405	L-Lactic acid	Rong Y	Lactate dehydrogenase A is overexpressed in pancreatic cancer and promotes the growth of pancreatic cancer cells.	Tumour biology 	2013	38
23574725	L-Lactic acid	Curry JM	Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer.	Cell cycle	2013	40
23643384	L-Lactic acid	Taft RJ	Mutations in DARS cause hypomyelination with brain stem and spinal cord involvement and leg spasticity.	American journal of human genetics	2013	38
23656776	L-Lactic acid	Fiaschi T	Carbonic anhydrase IX from cancer-associated fibroblasts drives epithelial-mesenchymal transition in prostate carcinoma cells.	Cell cycle	2013	29
23690483	L-Lactic acid	Besser MJ	Adoptive transfer of tumor-infiltrating lymphocytes in patients with metastatic melanoma: intent-to-treat analysis and efficacy after failure to prior immunotherapies.	Clinical cancer research 	2013	54
23913718	L-Lactic acid	Luke JJ	Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience.	Cancer	2013	39
24178759	L-Lactic acid	Maftouh M	Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia.	British journal of cancer	2014	23
24366912	L-Lactic acid	Chesnelong C	Lactate dehydrogenase A silencing in IDH mutant gliomas.	Neuro-oncology	2014	32
24449231	L-Lactic acid	Halabi S	Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancer.	Journal of clinical oncology 	2014	56
24486645	L-Lactic acid	Martinez-Outschoorn UE	Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth.	Seminars in cancer biology	2014	58
24634381	L-Lactic acid	Cui J	FOXM1 promotes the warburg effect and pancreatic cancer progression via transactivation of LDHA expression.	Clinical cancer research 	2014	28
24657625	L-Lactic acid	Hoque R	Lactate reduces liver and pancreatic injury in Toll-like receptor- and inflammasome-mediated inflammation via GPR81-mediated suppression of innate immunity.	Gastroenterology	2014	40
24695951	L-Lactic acid	Simeone E	Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma.	Cancer immunology, immunotherapy 	2014	33
24819450	L-Lactic acid	Trayhurn P	Hypoxia and adipocyte physiology: implications for adipose tissue dysfunction in obesity.	Annual review of nutrition	2014	31
24847880	L-Lactic acid	Madiraju AK	Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase.	Nature	2014	164
24885701	L-Lactic acid	Girgis H	Lactate dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma.	Molecular cancer	2014	26
25017943	L-Lactic acid	Sounni NE	Blocking lipid synthesis overcomes tumor regrowth and metastasis after antiangiogenic therapy withdrawal.	Cell metabolism	2014	34
25085000	L-Lactic acid	Idorn M	Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer.	Cancer immunology, immunotherapy 	2014	28
25136121	L-Lactic acid	Crane CA	Immune evasion mediated by tumor-derived lactate dehydrogenase induction of NKG2D ligands on myeloid cells in glioblastoma patients.	Proceedings of the National Academy of Sciences of the United States of America	2014	28
25273342	L-Lactic acid	von Minckwitz G	Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, randomised phase 3 trial.	The Lancet. Oncology	2014	28
25406319	L-Lactic acid	Tan Z	The monocarboxylate transporter 4 is required for glycolytic reprogramming and inflammatory response in macrophages.	The Journal of biological chemistry	2015	21
25456395	L-Lactic acid	Kim Y	Expression of lactate/H⁺ symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses.	Human pathology	2015	25
25676469	L-Lactic acid	Al Shammari B	The Extracellular Matrix Regulates Granuloma Necrosis in Tuberculosis.	The Journal of infectious diseases	2015	21
25749524	L-Lactic acid	Ono S	A direct plasma assay of circulating microRNA-210 of hypoxia can identify early systemic metastasis recurrence in melanoma patients.	Oncotarget	2015	15
25862517	L-Lactic acid	Simkens LH	Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group.	Lancet	2015	49
25917568	L-Lactic acid	Kondaveeti Y	Epithelial-mesenchymal transition induces similar metabolic alterations in two independent breast cancer cell lines.	Cancer letters	2015	20
25930027	L-Lactic acid	Stenmark KR	Metabolic reprogramming and inflammation act in concert to control vascular remodeling in hypoxic pulmonary hypertension.	Journal of applied physiology	2015	19
25997818	L-Lactic acid	Ramalingam S	A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1).	Annals of oncology 	2015	18
26018532	L-Lactic acid	Hanson J	Microvascular obstruction and endothelial activation are independently associated with the clinical manifestations of severe falciparum malaria in adults: an observational study.	BMC medicine	2015	19
26240224	L-Lactic acid	Palumbo A	Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group.	Journal of clinical oncology 	2015	80
26379078	L-Lactic acid	Punnoose EA	PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patients.	British journal of cancer	2015	17
26438120	L-Lactic acid	Scarisbrick JJ	Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model.	Journal of clinical oncology 	2015	18
26467665	L-Lactic acid	Tang LQ	Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma.	Journal of the National Cancer Institute	2016	23
26759242	L-Lactic acid	Lim SO	EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape.	Cancer research	2016	19
26775841	L-Lactic acid	Ju T	Targeting colorectal cancer cells by a novel sphingosine kinase 1 inhibitor PF-543.	Biochemical and biophysical research communications	2016	15
26787752	L-Lactic acid	Martens A	Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab.	Clinical cancer research 	2016	50
26794281	L-Lactic acid	Diem S	Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma.	British journal of cancer	2016	22
26811525	L-Lactic acid	Long GV	Overall Survival and Durable Responses in Patients With BRAF V600-Mutant Metastatic Melanoma Receiving Dabrafenib Combined With Trametinib.	Journal of clinical oncology 	2016	36
26876179	L-Lactic acid	Hong CS	MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4.	Cell reports	2016	15
26902416	L-Lactic acid	Xiao X	The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancer.	Scientific reports	2016	14
27134168	L-Lactic acid	Pisarsky L	Targeting Metabolic Symbiosis to Overcome Resistance to Anti-angiogenic Therapy.	Cell reports	2016	18
27178742	L-Lactic acid	Sade-Feldman M	Clinical Significance of Circulating CD33+CD11b+HLA-DR- Myeloid Cells in Patients with Stage IV Melanoma Treated with Ipilimumab.	Clinical cancer research 	2016	13
27591677	L-Lactic acid	Talasila KM	The angiogenic switch leads to a metabolic shift in human glioblastoma.	Neuro-oncology	2017	11
27688759	L-Lactic acid	Ferraiuolo L	Oligodendrocytes contribute to motor neuron death in ALS via SOD1-dependent mechanism.	Proceedings of the National Academy of Sciences of the United States of America	2016	11
27993896	L-Lactic acid	San-Millán I	Reexamining cancer metabolism: lactate production for carcinogenesis could be the purpose and explanation of the Warburg Effect.	Carcinogenesis	2017	7
28246332	L-Lactic acid	Carmona-Fontaine C	Metabolic origins of spatial organization in the tumor microenvironment.	Proceedings of the National Academy of Sciences of the United States of America	2017	7
28475671	L-Lactic acid	Long GV	Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study.	Annals of oncology 	2017	10
3282647	D-Glucose	Jain RK	Determinants of tumor blood flow: a review.	Cancer research	1988	237
3288530	D-Glucose	Ricordi C	Automated method for isolation of human pancreatic islets.	Diabetes	1988	215
6949641	D-Glucose	Tsuchiya S	Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester.	Cancer research	1982	187
9357784	D-Glucose	Turner JR	Physiological regulation of epithelial tight junctions is associated with myosin light-chain phosphorylation.	The American journal of physiology	1997	131
10449430	D-Glucose	Su CG	A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response.	The Journal of clinical investigation	1999	128
10571771	D-Glucose	Gilbert RE	The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?	Kidney international	1999	121
11022058	D-Glucose	Vila N	Proinflammatory cytokines and early neurological worsening in ischemic stroke.	Stroke	2000	110
11151758	D-Glucose	Weyer C	Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance.	Diabetologia	2000	137
11157411	D-Glucose	Geffken DF	Association between physical activity and markers of inflammation in a healthy elderly population.	American journal of epidemiology	2001	103
11287357	D-Glucose	Kern PA	Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance.	American journal of physiology. Endocrinology and metabolism	2001	300
11445252	D-Glucose	De Santi S	Hippocampal formation glucose metabolism and volume losses in MCI and AD.	Neurobiology of aging	2001	128
11673759	D-Glucose	Festa A	The relation of body fat mass and distribution to markers of chronic inflammation.	International journal of obesity and related metabolic disorders 	2001	115
11786564	D-Glucose	Bos R	Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography.	Journal of clinical oncology 	2002	92
11826410	D-Glucose	Pagano G	Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association.	Hepatology	2002	109
11861436	D-Glucose	Sacks DB	Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.	Clinical chemistry	2002	123
11916953	D-Glucose	Peila R	Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study.	Diabetes	2002	265
12021250	D-Glucose	Petersen KF	Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.	The Journal of clinical investigation	2002	172
12057982	D-Glucose	Rudd JH	Imaging atherosclerotic plaque inflammation with 18F-fluorodeoxyglucose positron emission tomography.	Circulation	2002	175
12086956	D-Glucose	Romeo G	Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes.	Diabetes	2002	89
12162730	D-Glucose	Abbott NJ	Astrocyte-endothelial interactions and blood-brain barrier permeability.	Journal of anatomy	2002	180
12203114	D-Glucose	Budanov AV	Identification of a novel stress-responsive gene Hi95 involved in regulation of cell viability.	Oncogene	2002	90
12589027	D-Glucose	Duan W	Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice.	Proceedings of the National Academy of Sciences of the United States of America	2003	116
12598526	D-Glucose	Bach D	Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity.	The Journal of biological chemistry	2003	187
12879249	D-Glucose	Rorsman P	Insulin granule dynamics in pancreatic beta cells.	Diabetologia	2003	159
12941770	D-Glucose	Butler AE	Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid.	Diabetes	2003	104
14670831	D-Glucose	Yan SF	Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond.	Circulation research	2003	82
15094078	D-Glucose	Hoyer S	Glucose metabolism and insulin receptor signal transduction in Alzheimer disease.	European journal of pharmacology	2004	75
15161755	D-Glucose	Butler AE	Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide (HIP Rat): a new model for type 2 diabetes.	Diabetes	2004	73
15197140	D-Glucose	Esposito K	Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus.	Circulation	2004	75
15199412	D-Glucose	Horie Y	Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas.	The Journal of clinical investigation	2004	165
15249677	D-Glucose	Liu F	O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease.	Proceedings of the National Academy of Sciences of the United States of America	2004	132
15272020	D-Glucose	Kamei Y	Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control.	The Journal of biological chemistry	2004	146
15292279	D-Glucose	Hull RL	Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes.	The Journal of clinical endocrinology and metabolism	2004	128
15353558	D-Glucose	Barata JT	Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells.	The Journal of experimental medicine	2004	87
15364812	D-Glucose	Ghanim H	Circulating mononuclear cells in the obese are in a proinflammatory state.	Circulation	2004	117
15653324	D-Glucose	Harrington LS	Restraining PI3K: mTOR signalling goes back to the membrane.	Trends in biochemical sciences	2005	127
15677538	D-Glucose	Vleugel MM	Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer.	Journal of clinical pathology	2005	71
15750215	D-Glucose	Steen E	Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?	Journal of Alzheimer's disease 	2005	298
15806154	D-Glucose	Buzzai M	The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation.	Oncogene	2005	114
15837624	D-Glucose	Shankar DB	The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia.	Cancer cell	2005	65
15842581	D-Glucose	Huang MA	One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study.	The American journal of gastroenterology	2005	83
15911795	D-Glucose	Enzinger C	Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects.	Neurology	2005	80
15932949	D-Glucose	Reiman EM	Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism.	Proceedings of the National Academy of Sciences of the United States of America	2005	124
16026270	D-Glucose	Caldwell RB	Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress.	Current drug targets	2005	65
16216937	D-Glucose	Jagust W	Central obesity and the aging brain.	Archives of neurology	2005	69
16284649	D-Glucose	Morino K	Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents.	The Journal of clinical investigation	2005	218
16306329	D-Glucose	Kristiansen OP	Interleukin-6 and diabetes: the good, the bad, or the indifferent?	Diabetes	2005	106
16388523	D-Glucose	Basaria S	Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy.	Cancer	2006	66
16463046	D-Glucose	Adiels M	Overproduction of large VLDL particles is driven by increased liver fat content in man.	Diabetologia	2006	110
16492903	D-Glucose	Nigro J	Insulin resistance and atherosclerosis.	Endocrine reviews	2006	63
16511589	D-Glucose	Lefebvre P	Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis.	The Journal of clinical investigation	2006	191
16550171	D-Glucose	Coucke PJ	Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome.	Nature genetics	2006	77
16567827	D-Glucose	Stefan N	Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans.	Diabetes care	2006	96
16627931	D-Glucose	Lester-Coll N	Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease.	Journal of Alzheimer's disease 	2006	109
16707446	D-Glucose	Gatenby RA	Acid-mediated tumor invasion: a multidisciplinary study.	Cancer research	2006	164
16731817	D-Glucose	Cancello R	Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity.	Diabetes	2006	112
16855264	D-Glucose	Florez JC	TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program.	The New England journal of medicine	2006	230
16861902	D-Glucose	Fu Y	Glucose regulated proteins in cancer progression, drug resistance and immunotherapy.	Cancer biology & therapy	2006	74
16873964	D-Glucose	de la Monte SM	Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease.	Journal of Alzheimer's disease 	2006	67
16912156	D-Glucose	Lee E	GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer.	Cancer research	2006	75
16970929	D-Glucose	Fülöp N	Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system.	Cardiovascular research	2007	56
17071576	D-Glucose	Cowey S	The metabolic syndrome: A high-risk state for cancer?	The American journal of pathology	2006	104
17077815	D-Glucose	Li Y	Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice.	Journal of cerebral blood flow and metabolism 	2007	65
17079810	D-Glucose	Mosconi L	Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease.	Journal of nuclear medicine 	2006	77
17088535	D-Glucose	Lee RH	Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice.	Proceedings of the National Academy of Sciences of the United States of America	2006	186
17141632	D-Glucose	Zhang W	PERK EIF2AK3 control of pancreatic beta cell differentiation and proliferation is required for postnatal glucose homeostasis.	Cell metabolism	2006	99
17167471	D-Glucose	Kahn SE	Mechanisms linking obesity to insulin resistance and type 2 diabetes.	Nature	2006	828
17200485	D-Glucose	Zhang Y	Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease.	Neurology	2007	156
17241871	D-Glucose	Shkoda A	Interleukin-10 blocked endoplasmic reticulum stress in intestinal epithelial cells: impact on chronic inflammation.	Gastroenterology	2007	73
17327434	D-Glucose	Thum T	Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes.	Diabetes	2007	103
17327884	D-Glucose	Capuron L	Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy.	Neuropsychopharmacology 	2007	67
17332274	D-Glucose	Frost RA	Protein kinase B/Akt: a nexus of growth factor and cytokine signaling in determining muscle mass.	Journal of applied physiology	2007	64
17344486	D-Glucose	Corcoran MP	Skeletal muscle lipid deposition and insulin resistance: effect of dietary fatty acids and exercise.	The American journal of clinical nutrition	2007	62
17374712	D-Glucose	Harman-Boehm I	Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity.	The Journal of clinical endocrinology and metabolism	2007	114
17472435	D-Glucose	Parikh H	TXNIP regulates peripheral glucose metabolism in humans.	PLoS medicine	2007	130
17493050	D-Glucose	Chang L	Structural and metabolic brain changes in the striatum associated with methamphetamine abuse.	Addiction	2007	139
17609686	D-Glucose	Cucullo L	Immortalized human brain endothelial cells and flow-based vascular modeling: a marriage of convenience for rational neurovascular studies.	Journal of cerebral blood flow and metabolism 	2008	51
17615265	D-Glucose	Karnieli O	Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation.	Stem cells	2007	73
17618858	D-Glucose	Klöting N	Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass.	Cell metabolism	2007	92
17624581	D-Glucose	Gillies RJ	Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis?	Journal of bioenergetics and biomembranes	2007	66
17640713	D-Glucose	Daneshmand S	Glucose-regulated protein GRP78 is up-regulated in prostate cancer and correlates with recurrence and survival.	Human pathology	2007	66
17640997	D-Glucose	Bozaoglu K	Chemerin is a novel adipokine associated with obesity and metabolic syndrome.	Endocrinology	2007	147
17646672	D-Glucose	Huang H	Dynamic FoxO transcription factors.	Journal of cell science	2007	344
17671651	D-Glucose	Lyssenko V	Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.	The Journal of clinical investigation	2007	204
17687336	D-Glucose	Gatenby RA	Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer.	British journal of cancer	2007	91
17726542	D-Glucose	Chandalia M	Insulin resistance and body fat distribution in South Asian men compared to Caucasian men.	PloS one	2007	58
17823655	D-Glucose	Son NH	Cardiomyocyte expression of PPARgamma leads to cardiac dysfunction in mice.	The Journal of clinical investigation	2007	101
17889646	D-Glucose	Dai C	Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis.	Cell	2007	300
17940659	D-Glucose	Dias WB	O-GlcNAc modification in diabetes and Alzheimer's disease.	Molecular bioSystems	2007	77
17942897	D-Glucose	Sato K	Autophagy is activated in colorectal cancer cells and contributes to the tolerance to nutrient deprivation.	Cancer research	2007	98
17977954	D-Glucose	Taksali SE	High visceral and low abdominal subcutaneous fat stores in the obese adolescent: a determinant of an adverse metabolic phenotype.	Diabetes	2008	76
17978280	D-Glucose	Calderwood SK	Extracellular heat shock proteins in cell signaling and immunity.	Annals of the New York Academy of Sciences	2007	66
18039092	D-Glucose	Waki H	Endocrine functions of adipose tissue.	Annual review of pathology	2007	83
18220694	D-Glucose	Ziyadeh FN	Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.	Current diabetes reviews	2008	91
18223655	D-Glucose	Danial NN	Dual role of proapoptotic BAD in insulin secretion and beta cell survival.	Nature medicine	2008	103
18371555	D-Glucose	Sluimer JC	Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis.	Journal of the American College of Cardiology	2008	75
18379722	D-Glucose	Hotta K	Variations in the FTO gene are associated with severe obesity in the Japanese.	Journal of human genetics	2008	66
18397542	D-Glucose	Trayhurn P	Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity?	The British journal of nutrition	2008	87
18474251	D-Glucose	Kotronen A	Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.	Gastroenterology	2008	56
18482745	D-Glucose	Zheng HC	Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.	Human pathology	2008	53
18515784	D-Glucose	Park TS	Ceramide is a cardiotoxin in lipotoxic cardiomyopathy.	Journal of lipid research	2008	101
18563385	D-Glucose	Di Marzo V	The endocannabinoid system in obesity and type 2 diabetes.	Diabetologia	2008	57
18577716	D-Glucose	Maciver NJ	Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival.	Journal of leukocyte biology	2008	109
18625459	D-Glucose	Landreth G	PPARgamma agonists as therapeutics for the treatment of Alzheimer's disease.	Neurotherapeutics 	2008	54
18689793	D-Glucose	Zhang QJ	Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice.	Cardiovascular research	2008	95
18701488	D-Glucose	Kotliarova S	Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulation.	Cancer research	2008	79
18768989	D-Glucose	Deng L	Hepatitis C virus infection induces apoptosis through a Bax-triggered, mitochondrion-mediated, caspase 3-dependent pathway.	Journal of virology	2008	56
18802479	D-Glucose	Skowera A	CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope.	The Journal of clinical investigation	2008	125
18834431	D-Glucose	Rahier J	Pancreatic beta-cell mass in European subjects with type 2 diabetes.	Diabetes, obesity & metabolism	2008	191
18852465	D-Glucose	Lewis EC	alpha1-Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice.	Proceedings of the National Academy of Sciences of the United States of America	2008	54
18984744	D-Glucose	Martin B	Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington's disease.	Diabetes	2009	64
19026743	D-Glucose	Zhao WQ	Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease.	Biochimica et biophysica acta	2009	59
19060908	D-Glucose	Lyssenko V	Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion.	Nature genetics	2009	179
19060909	D-Glucose	Bouatia-Naji N	A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk.	Nature genetics	2009	179
19075268	D-Glucose	Koschmieder S	Dysregulation of the C/EBPalpha differentiation pathway in human cancer.	Journal of clinical oncology 	2009	51
19076441	D-Glucose	Mosconi L	Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease.	Annals of the New York Academy of Sciences	2008	100
19141606	D-Glucose	Maratou E	Studies of insulin resistance in patients with clinical and subclinical hypothyroidism.	European journal of endocrinology	2009	56
19189073	D-Glucose	Yan SF	Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response.	Journal of molecular medicine	2009	54
19199892	D-Glucose	Crawford TN	Diabetic retinopathy and angiogenesis.	Current diabetes reviews	2009	73
19201187	D-Glucose	Tong X	The molecular determinants of de novo nucleotide biosynthesis in cancer cells.	Current opinion in genetics & development	2009	89
19273754	D-Glucose	Qin W	PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia.	Archives of neurology	2009	79
19276390	D-Glucose	Robey IF	Bicarbonate increases tumor pH and inhibits spontaneous metastases.	Cancer research	2009	160
19331544	D-Glucose	Gonzalez-Gronow M	GRP78: a multifunctional receptor on the cell surface.	Antioxidants & redox signaling	2009	71
19399017	D-Glucose	Fève B	The role of interleukins in insulin resistance and type 2 diabetes mellitus.	Nature reviews. Endocrinology	2009	48
19401422	D-Glucose	Capel F	Macrophages and adipocytes in human obesity: adipose tissue gene expression and insulin sensitivity during calorie restriction and weight stabilization.	Diabetes	2009	45
19451179	D-Glucose	Liu F	Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease.	Brain 	2009	68
19460373	D-Glucose	Sassone J	Huntington's disease: the current state of research with peripheral tissues.	Experimental neurology	2009	46
19478200	D-Glucose	Verschuren L	MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease.	Circulation research	2009	47
19541609	D-Glucose	Shackelford DB	mTOR and HIF-1alpha-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome.	Proceedings of the National Academy of Sciences of the United States of America	2009	78
19620249	D-Glucose	Vigneri P	Diabetes and cancer.	Endocrine-related cancer	2009	199
19629071	D-Glucose	Shackelford DB	The LKB1-AMPK pathway: metabolism and growth control in tumour suppression.	Nature reviews. Cancer	2009	446
19641507	D-Glucose	Danial NN	BAD: undertaker by night, candyman by day.	Oncogene	2008	98
19649631	D-Glucose	Haluska P	Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma.	Cancer chemotherapy and pharmacology	2010	46
19651814	D-Glucose	Kantartzis K	Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene.	Diabetes	2009	72
19670459	D-Glucose	Gastaldelli A	Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis.	Hepatology	2009	49
19723875	D-Glucose	Palmieri D	Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis.	Molecular cancer research 	2009	52
19774643	D-Glucose	Thibault R	Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: a transport deficiency.	Inflammatory bowel diseases	2010	49
19881548	D-Glucose	DeBerardinis RJ	Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer.	Oncogene	2010	311
19883376	D-Glucose	Wang F	Brd2 disruption in mice causes severe obesity without Type 2 diabetes.	The Biochemical journal	2009	46
19884662	D-Glucose	Melmed S	Acromegaly pathogenesis and treatment.	The Journal of clinical investigation	2009	78
19897009	D-Glucose	Saji M	The PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumors.	Molecular and cellular endocrinology	2010	47
19934006	D-Glucose	Oudit GY	Human recombinant ACE2 reduces the progression of diabetic nephropathy.	Diabetes	2010	71
19963098	D-Glucose	Gibbons JJ	Mammalian target of rapamycin: discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth.	Seminars in oncology	2009	81
20056746	D-Glucose	Krupa A	Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy.	Journal of the American Society of Nephrology 	2010	108
20065132	D-Glucose	Baker LD	Effects of aerobic exercise on mild cognitive impairment: a controlled trial.	Archives of neurology	2010	223
20065246	D-Glucose	Honea RA	Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease.	Neurology	2010	52
20086171	D-Glucose	Dang CV	Rethinking the Warburg effect with Myc micromanaging glutamine metabolism.	Cancer research	2010	126
20092409	D-Glucose	Jain SK	Low levels of hydrogen sulfide in the blood of diabetes patients and streptozotocin-treated rats causes vascular inflammation?	Antioxidants & redox signaling	2010	56
20165834	D-Glucose	Kanazawa I	Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus.	Osteoporosis international 	2011	44
20190804	D-Glucose	Caldwell SA	Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1.	Oncogene	2010	106
20206201	D-Glucose	Ralph SJ	The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.	Molecular aspects of medicine	2010	87
20215450	D-Glucose	Kayaniyil S	Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes.	Diabetes care	2010	67
20227367	D-Glucose	Godlewski J	MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells.	Molecular cell	2010	134
20308787	D-Glucose	Li Y	GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease.	Journal of Alzheimer's disease 	2010	65
20363910	D-Glucose	Baba Y	HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers.	The American journal of pathology	2010	44
20371626	D-Glucose	Solinas G	JNK1 and IKKbeta: molecular links between obesity and metabolic dysfunction.	FASEB journal 	2010	65
20375212	D-Glucose	Sell H	Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery.	The Journal of clinical endocrinology and metabolism	2010	51
20376506	D-Glucose	Nicolucci A	Epidemiological aspects of neoplasms in diabetes.	Acta diabetologica	2010	48
20489155	D-Glucose	Wang WX	miR-107 regulates granulin/progranulin with implications for traumatic brain injury and neurodegenerative disease.	The American journal of pathology	2010	61
20497976	D-Glucose	Widyantoro B	Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition.	Circulation	2010	85
20505657	D-Glucose	Kang YS	Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria.	Kidney international	2010	45
20512147	D-Glucose	Zhu H	Lin28a transgenic mice manifest size and puberty phenotypes identified in human genetic association studies.	Nature genetics	2010	103
20562852	D-Glucose	Marcheva B	Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes.	Nature	2010	345
20588114	D-Glucose	Dinarello CA	Role of IL-1beta in type 2 diabetes.	Current opinion in endocrinology, diabetes, and obesity	2010	83
20660625	D-Glucose	Bindom SM	Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice.	Diabetes	2010	43
20688814	D-Glucose	Villain N	Sequential relationships between grey matter and white matter atrophy and brain metabolic abnormalities in early Alzheimer's disease.	Brain 	2010	58
20692331	D-Glucose	Lu Y	Chronic alcohol-induced liver injury and oxidant stress are decreased in cytochrome P4502E1 knockout mice and restored in humanized cytochrome P4502E1 knock-in mice.	Free radical biology & medicine	2010	57
20739649	D-Glucose	Matsuzaki T	Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study.	Neurology	2010	89
20803499	D-Glucose	Santoro N	A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents.	Hepatology	2010	51
20816089	D-Glucose	Kim HS	Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis.	Cell metabolism	2010	128
20835230	D-Glucose	Masters SL	Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes.	Nature immunology	2010	307
20847408	D-Glucose	Valla J	Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE ε4 allele, the major late-onset Alzheimer's susceptibility gene.	Journal of Alzheimer's disease 	2010	57
20926834	D-Glucose	Zheng B	PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease.	Science translational medicine	2010	184
20937689	D-Glucose	Calori G	Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study.	Diabetes care	2011	65
21072170	D-Glucose	Wei J	PPARγ downregulation by TGFß in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesis.	PloS one	2010	44
21080476	D-Glucose	Lee M	Inverse association between adiposity and telomere length: The Fels Longitudinal Study.	American journal of human biology 	2011	36
21088486	D-Glucose	Cufí S	Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosis.	Cell cycle	2010	75
21109577	D-Glucose	Lawlor DA	Association between general and central adiposity in childhood, and change in these, with cardiovascular risk factors in adolescence: prospective cohort study.	BMJ	2010	78
21115858	D-Glucose	Duggan C	Associations of insulin resistance and adiponectin with mortality in women with breast cancer.	Journal of clinical oncology 	2011	65
21119005	D-Glucose	Lock R	Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation.	Molecular biology of the cell	2011	142
21241768	D-Glucose	Fröjdö S	Phosphoinositide 3-kinase as a novel functional target for the regulation of the insulin signaling pathway by SIRT1.	Molecular and cellular endocrinology	2011	38
21362136	D-Glucose	Wang A	Hyaluronan matrices in pathobiological processes.	The FEBS journal	2011	51
21435176	D-Glucose	Bosco D	Possible implications of insulin resistance and glucose metabolism in Alzheimer's disease pathogenesis.	Journal of cellular and molecular medicine	2011	45
21467168	D-Glucose	Dong D	A critical role for GRP78/BiP in the tumor microenvironment for neovascularization during tumor growth and metastasis.	Cancer research	2011	48
21481590	D-Glucose	Gurzov EN	Bcl-2 proteins in diabetes: mitochondrial pathways of β-cell death and dysfunction.	Trends in cell biology	2011	50
21499269	D-Glucose	Winer DA	B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies.	Nature medicine	2011	228
21516129	D-Glucose	Lee C	Fasting vs dietary restriction in cellular protection and cancer treatment: from model organisms to patients.	Oncogene	2011	74
21523780	D-Glucose	Dinarello CA	A clinical perspective of IL-1β as the gatekeeper of inflammation.	European journal of immunology	2011	164
21599535	D-Glucose	Leavens KF	Insulin signaling to hepatic lipid metabolism in health and disease.	Critical reviews in biochemistry and molecular biology	2011	41
21638209	D-Glucose	Samarakoon R	TGF-β1 → SMAD/p53/USF2 → PAI-1 transcriptional axis in ureteral obstruction-induced renal fibrosis.	Cell and tissue research	2012	39
21641545	D-Glucose	Kunkel SD	mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass.	Cell metabolism	2011	56
21670080	D-Glucose	Coloff JL	Akt-dependent glucose metabolism promotes Mcl-1 synthesis to maintain cell survival and resistance to Bcl-2 inhibition.	Cancer research	2011	50
21670386	D-Glucose	Lo RY	Longitudinal change of biomarkers in cognitive decline.	Archives of neurology	2011	66
21685543	D-Glucose	Ross AC	Vitamin D is linked to carotid intima-media thickness and immune reconstitution in HIV-positive individuals.	Antiviral therapy	2011	37
21737012	D-Glucose	Farb MG	Reduced adipose tissue inflammation represents an intermediate cardiometabolic phenotype in obesity.	Journal of the American College of Cardiology	2011	39
21745271	D-Glucose	Svegliati-Baroni G	Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.	Liver international 	2011	64
21778425	D-Glucose	Zhou S	Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction.	Circulation research	2011	49
21811634	D-Glucose	Caillou B	Tumor-associated macrophages (TAMs) form an interconnected cellular supportive network in anaplastic thyroid carcinoma.	PloS one	2011	36
21813778	D-Glucose	Westwell-Roper C	IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction.	Journal of immunology	2011	42
21829446	D-Glucose	Anand SS	Adipocyte hypertrophy, fatty liver and metabolic risk factors in South Asians: the Molecular Study of Health and Risk in Ethnic Groups (mol-SHARE).	PloS one	2011	36
21865645	D-Glucose	Ravassard P	A genetically engineered human pancreatic β cell line exhibiting glucose-inducible insulin secretion.	The Journal of clinical investigation	2011	90
21911743	D-Glucose	Eller K	Potential role of regulatory T cells in reversing obesity-linked insulin resistance and diabetic nephropathy.	Diabetes	2011	58
21933988	D-Glucose	Kowluru RA	Abrogation of MMP-9 gene protects against the development of retinopathy in diabetic mice by preventing mitochondrial damage.	Diabetes	2011	43
21968997	D-Glucose	Mauro C	NF-κB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration.	Nature cell biology	2011	76
21978918	D-Glucose	Qin Z	The use of THP-1 cells as a model for mimicking the function and regulation of monocytes and macrophages in the vasculature.	Atherosclerosis	2012	62
22008454	D-Glucose	Ryan AS	Exercise with calorie restriction improves insulin sensitivity and glycogen synthase activity in obese postmenopausal women with impaired glucose tolerance.	American journal of physiology. Endocrinology and metabolism	2012	32
22038520	D-Glucose	Rees MG	Cellular characterisation of the GCKR P446L variant associated with type 2 diabetes risk.	Diabetologia	2012	31
22056763	D-Glucose	Tailleux A	Roles of PPARs in NAFLD: potential therapeutic targets.	Biochimica et biophysica acta	2012	52
22096029	D-Glucose	Mor I	Control of glycolysis through regulation of PFK1: old friends and recent additions.	Cold Spring Harbor symposia on quantitative biology	2011	38
22162232	D-Glucose	Li D	Diabetes and pancreatic cancer.	Molecular carcinogenesis	2012	55
22162568	D-Glucose	Goodwin PJ	Insulin- and obesity-related variables in early-stage breast cancer: correlations and time course of prognostic associations.	Journal of clinical oncology 	2012	48
22162589	D-Glucose	Bendell JC	Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors.	Journal of clinical oncology 	2012	200
22169009	D-Glucose	Sanchez-Niño MD	Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy.	American journal of physiology. Renal physiology	2012	38
22191795	D-Glucose	de la Monte SM	Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease.	Drugs	2012	43
22213821	D-Glucose	Carter SF	Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG.	Journal of nuclear medicine 	2012	54
22226221	D-Glucose	Wronska A	Structural and biochemical characteristics of various white adipose tissue depots.	Acta physiologica	2012	64
22240811	D-Glucose	Kono T	PPAR-γ activation restores pancreatic islet SERCA2 levels and prevents β-cell dysfunction under conditions of hyperglycemic and cytokine stress.	Molecular endocrinology	2012	35
22245737	D-Glucose	Bulek AM	Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetes.	Nature immunology	2012	54
22265971	D-Glucose	Fei X	MicroRNA-195-5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulating GLUT3 expression.	FEBS letters	2012	37
22275356	D-Glucose	Lynch TP	Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis.	The Journal of biological chemistry	2012	70
22302938	D-Glucose	Krishnan J	Dietary obesity-associated Hif1α activation in adipocytes restricts fatty acid oxidation and energy expenditure via suppression of the Sirt2-NAD+ system.	Genes & development	2012	64
22315431	D-Glucose	Wei W	Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γ.	Proceedings of the National Academy of Sciences of the United States of America	2012	88
22328245	D-Glucose	Steinhäuser C	Astrocyte dysfunction in temporal lobe epilepsy: K+ channels and gap junction coupling.	Glia	2012	34
22330739	D-Glucose	Tiano JP	Importance of oestrogen receptors to preserve functional β-cell mass in diabetes.	Nature reviews. Endocrinology	2012	41
22343897	D-Glucose	Ichimura A	Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human.	Nature	2012	126
22351933	D-Glucose	Conley ME	Agammaglobulinemia and absent B lineage cells in a patient lacking the p85α subunit of PI3K.	The Journal of experimental medicine	2012	44
22355316	D-Glucose	Liang Y	Effect of canagliflozin on renal threshold for glucose, glycemia, and body weight in normal and diabetic animal models.	PloS one	2012	47
22414897	D-Glucose	Calkin AC	Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR.	Nature reviews. Molecular cell biology	2012	149
22426159	D-Glucose	Li Z	Glucose regulated protein 78: a critical link between tumor microenvironment and cancer hallmarks.	Biochimica et biophysica acta	2012	33
22452979	D-Glucose	McBrayer SK	Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapy.	Blood	2012	36
22466288	D-Glucose	Herman MA	A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism.	Nature	2012	138
22498478	D-Glucose	Kobayashi S	Suppression of autophagy is protective in high glucose-induced cardiomyocyte injury.	Autophagy	2012	31
22499789	D-Glucose	Kodama K	Expression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2012	45
22546860	D-Glucose	Benhamed F	The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans.	The Journal of clinical investigation	2012	92
22564993	D-Glucose	Bonanni B	Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial.	Journal of clinical oncology 	2012	66
22572877	D-Glucose	Cani PD	Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity.	Gut microbes	2012	81
22576210	D-Glucose	Ros S	Functional metabolic screen identifies 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 as an important regulator of prostate cancer cell survival.	Cancer discovery	2012	60
22661548	D-Glucose	Tan MJ	Emerging roles of angiopoietin-like 4 in human cancer.	Molecular cancer research 	2012	34
22751133	D-Glucose	Grkovic S	IGFBP-3 binds GRP78, stimulates autophagy and promotes the survival of breast cancer cells exposed to adverse microenvironments.	Oncogene	2013	26
22766017	D-Glucose	Baptissart M	Bile acids: from digestion to cancers.	Biochimie	2013	25
22796579	D-Glucose	Sparks JD	Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia.	Arteriosclerosis, thrombosis, and vascular biology	2012	31
22801498	D-Glucose	Lee Y	Oligodendroglia metabolically support axons and contribute to neurodegeneration.	Nature	2012	284
22806397	D-Glucose	Goldinger SM	Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8⁺ T-cell responses in melanoma patients.	European journal of immunology	2012	33
22883423	D-Glucose	Díaz-Prado S	Characterization of microRNA expression profiles in normal and osteoarthritic human chondrocytes.	BMC musculoskeletal disorders	2012	42
22923583	D-Glucose	Yi W	Phosphofructokinase 1 glycosylation regulates cell growth and metabolism.	Science	2012	132
22926856	D-Glucose	Bowerman M	Glucose metabolism and pancreatic defects in spinal muscular atrophy.	Annals of neurology	2012	35
22936011	D-Glucose	Craft S	Insulin and Alzheimer's disease: untangling the web.	Journal of Alzheimer's disease 	2013	42
22960655	D-Glucose	Aggarwal G	Adrenomedullin is up-regulated in patients with pancreatic cancer and causes insulin resistance in β cells and mice.	Gastroenterology	2012	31
22972646	D-Glucose	Lo RY	Vascular burden and Alzheimer disease pathologic progression.	Neurology	2012	50
22984531	D-Glucose	Safdie F	Fasting enhances the response of glioma to chemo- and radiotherapy.	PloS one	2012	33
22997257	D-Glucose	Yuen DA	eNOS deficiency predisposes podocytes to injury in diabetes.	Journal of the American Society of Nephrology 	2012	39
23151455	D-Glucose	Rodriguez OC	Dietary downregulation of mutant p53 levels via glucose restriction: mechanisms and implications for tumor therapy.	Cell cycle	2012	37
23183535	D-Glucose	Thatava T	Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells.	Molecular therapy 	2013	29
23187122	D-Glucose	Bradley D	Gastric bypass and banding equally improve insulin sensitivity and β cell function.	The Journal of clinical investigation	2012	55
23207292	D-Glucose	Djiogue S	Insulin resistance and cancer: the role of insulin and IGFs.	Endocrine-related cancer	2013	42
23219488	D-Glucose	Stengel A	Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity--correlation with body mass index.	Peptides	2013	62
23236214	D-Glucose	Brauer HA	Impact of tumor microenvironment and epithelial phenotypes on metabolism in breast cancer.	Clinical cancer research 	2013	38
23250986	D-Glucose	Spinetti G	Global remodeling of the vascular stem cell niche in bone marrow of diabetic patients: implication of the microRNA-155/FOXO3a signaling pathway.	Circulation research	2013	25
23274086	D-Glucose	Faubert B	AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo.	Cell metabolism	2013	183
23296339	D-Glucose	Liu CC	Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy.	Nature reviews. Neurology	2013	318
23305646	D-Glucose	Habegger KM	Fibroblast growth factor 21 mediates specific glucagon actions.	Diabetes	2013	31
23337530	D-Glucose	Ervinna N	Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice.	Endocrinology	2013	40
23342163	D-Glucose	Mortuza R	High glucose induced alteration of SIRTs in endothelial cells causes rapid aging in a p300 and FOXO regulated pathway.	PloS one	2013	40
23370525	D-Glucose	Goldfine AB	A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance.	Diabetologia	2013	34
23375680	D-Glucose	Barbieri M	Decreased carotid atherosclerotic process by control of daily acute glucose fluctuations in diabetic patients treated by DPP-IV inhibitors.	Atherosclerosis	2013	29
23388637	D-Glucose	Qian SW	BMP4-mediated brown fat-like changes in white adipose tissue alter glucose and energy homeostasis.	Proceedings of the National Academy of Sciences of the United States of America	2013	59
23396737	D-Glucose	Wong VW	Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study.	Annals of hepatology	2013	43
23439261	D-Glucose	Safar Zadeh E	The liver diseases of lipodystrophy: the long-term effect of leptin treatment.	Journal of hepatology	2013	26
23440242	D-Glucose	Ambrose M	Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions.	Blood	2013	39
23482247	D-Glucose	Basaranoglu M	Fructose as a key player in the development of fatty liver disease.	World journal of gastroenterology	2013	47
23539729	D-Glucose	Yoneda S	Predominance of β-cell neogenesis rather than replication in humans with an impaired glucose tolerance and newly diagnosed diabetes.	The Journal of clinical endocrinology and metabolism	2013	28
23562747	D-Glucose	Newman G	Leptin-cytokine crosstalk in breast cancer.	Molecular and cellular endocrinology	2014	32
23582329	D-Glucose	Lee YS	The fractalkine/CX3CR1 system regulates β cell function and insulin secretion.	Cell	2013	31
23599929	D-Glucose	Protas HD	Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease.	JAMA neurology	2013	31
23674815	D-Glucose	Clem BF	Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer.	Molecular cancer therapeutics	2013	45
23786764	D-Glucose	Supinski GS	Diaphragm weakness in mechanically ventilated critically ill patients.	Critical care	2013	32
23792151	D-Glucose	Hijmans BS	Zonation of glucose and fatty acid metabolism in the liver: mechanism and metabolic consequences.	Biochimie	2014	32
23813974	D-Glucose	Bochenek G	The large non-coding RNA ANRIL, which is associated with atherosclerosis, periodontitis and several forms of cancer, regulates ADIPOR1, VAMP3 and C11ORF10.	Human molecular genetics	2013	37
23823329	D-Glucose	Bouchonville M	Weight loss, exercise or both and cardiometabolic risk factors in obese older adults: results of a randomized controlled trial.	International journal of obesity	2014	30
23826303	D-Glucose	Wang X	Regional differences in islet distribution in the human pancreas--preferential beta-cell loss in the head region in patients with type 2 diabetes.	PloS one	2013	27
23832089	D-Glucose	Pajvani UB	Inhibition of Notch uncouples Akt activation from hepatic lipid accumulation by decreasing mTorc1 stability.	Nature medicine	2013	38
23852538	D-Glucose	Yao Y	A role for the endothelium in vascular calcification.	Circulation research	2013	44
23884882	D-Glucose	Fiori JL	Resveratrol prevents β-cell dedifferentiation in nonhuman primates given a high-fat/high-sugar diet.	Diabetes	2013	31
23886976	D-Glucose	Geurts L	Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.	Beneficial microbes	2014	46
23891854	D-Glucose	Anguizola J	Review: Glycation of human serum albumin.	Clinica chimica acta; international journal of clinical chemistry	2013	31
23897112	D-Glucose	Thambisetty M	Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging.	JAMA neurology	2013	39
23995067	D-Glucose	Flavahan WA	Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake.	Nature neuroscience	2013	83
24014835	D-Glucose	Jansen F	Endothelial microparticle-mediated transfer of MicroRNA-126 promotes vascular endothelial cell repair via SPRED1 and is abrogated in glucose-damaged endothelial microparticles.	Circulation	2013	77
24103379	D-Glucose	Murray PS	Psychosis in Alzheimer's disease.	Biological psychiatry	2014	24
24113348	D-Glucose	Liu J	Receptor for advanced glycation end-products promotes premature senescence of proximal tubular epithelial cells via activation of endoplasmic reticulum stress-dependent p21 signaling.	Cellular signalling	2014	23
24127133	D-Glucose	Winer DA	B Lymphocytes in obesity-related adipose tissue inflammation and insulin resistance.	Cellular and molecular life sciences 	2014	22
24141775	D-Glucose	Chen WT	GRP78 as a regulator of liver steatosis and cancer progression mediated by loss of the tumor suppressor PTEN.	Oncogene	2014	24
24153444	D-Glucose	Kerti L	Higher glucose levels associated with lower memory and reduced hippocampal microstructure.	Neurology	2013	33
24165795	D-Glucose	Lucas CL	Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency.	Nature immunology	2014	100
24166096	D-Glucose	Yan JW	The emerging role of miR-375 in cancer.	International journal of cancer	2014	38
24184209	D-Glucose	Ellis BC	CRNDE, a long non-coding RNA responsive to insulin/IGF signaling, regulates genes involved in central metabolism.	Biochimica et biophysica acta	2014	41
24204837	D-Glucose	Alvarez ML	Role of microRNA 1207-5P and its host gene, the long non-coding RNA Pvt1, as mediators of extracellular matrix accumulation in the kidney: implications for diabetic nephropathy.	PloS one	2013	25
24215793	D-Glucose	Mezza T	Insulin resistance alters islet morphology in nondiabetic humans.	Diabetes	2014	31
24222088	D-Glucose	Xu X	Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP.	Seminars in liver disease	2013	30
24222351	D-Glucose	Westwell-Roper CY	Resident macrophages mediate islet amyloid polypeptide-induced islet IL-1β production and β-cell dysfunction.	Diabetes	2014	28
24227685	D-Glucose	Shang L	β-cell dysfunction due to increased ER stress in a stem cell model of Wolfram syndrome.	Diabetes	2014	31
24233056	D-Glucose	Marselli L	Are we overestimating the loss of beta cells in type 2 diabetes?	Diabetologia	2014	23
24269021	D-Glucose	Johnson SC	Amyloid burden and neural function in people at risk for Alzheimer's Disease.	Neurobiology of aging	2014	35
24300239	D-Glucose	Dunn L	Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease.	Neurobiology of aging	2014	23
24388967	D-Glucose	Bryant KL	KRAS: feeding pancreatic cancer proliferation.	Trends in biochemical sciences	2014	99
24411018	D-Glucose	Morris JK	Impaired glycemia increases disease progression in mild cognitive impairment.	Neurobiology of aging	2014	23
24411942	D-Glucose	Roberts LD	β-Aminoisobutyric acid induces browning of white fat and hepatic β-oxidation and is inversely correlated with cardiometabolic risk factors.	Cell metabolism	2014	75
24462370	D-Glucose	Holmes MV	Causal effects of body mass index on cardiometabolic traits and events: a Mendelian randomization analysis.	American journal of human genetics	2014	42
24469106	D-Glucose	Parmenter TJ	Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis.	Cancer discovery	2014	54
24515116	D-Glucose	Stribl C	Mitochondrial dysfunction and decrease in body weight of a transgenic knock-in mouse model for TDP-43.	The Journal of biological chemistry	2014	22
24520123	D-Glucose	Dalmas E	T cell-derived IL-22 amplifies IL-1β-driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes.	Diabetes	2014	32
24531544	D-Glucose	Lien F	Metformin interferes with bile acid homeostasis through AMPK-FXR crosstalk.	The Journal of clinical investigation	2014	21
24568896	D-Glucose	Bhindi B	Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort.	European urology	2015	20
24570140	D-Glucose	Mortuza R	miR-195 regulates SIRT1-mediated changes in diabetic retinopathy.	Diabetologia	2014	27
24629563	D-Glucose	Yang SJ	Resveratrol ameliorates hepatic metaflammation and inhibits NLRP3 inflammasome activation.	Metabolism	2014	20
24654916	D-Glucose	Cipolla-Neto J	Melatonin, energy metabolism, and obesity: a review.	Journal of pineal research	2014	36
24662521	D-Glucose	Karnevi E	Tumour-educated macrophages display a mixed polarisation and enhance pancreatic cancer cell invasion.	Immunology and cell biology	2014	24
24662831	D-Glucose	Xiao L	Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy.	Oncogene	2014	30
24676639	D-Glucose	Fiorina P	Role of podocyte B7-1 in diabetic nephropathy.	Journal of the American Society of Nephrology 	2014	31
24703046	D-Glucose	Selvin E	Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study.	The lancet. Diabetes & endocrinology	2014	38
24723555	D-Glucose	Gaens KH	Nε-(carboxymethyl)lysine-receptor for advanced glycation end product axis is a key modulator of obesity-induced dysregulation of adipokine expression and insulin resistance.	Arteriosclerosis, thrombosis, and vascular biology	2014	25
24744147	D-Glucose	Olivier-Van Stichelen S	O-GlcNAcylation stabilizes β-catenin through direct competition with phosphorylation at threonine 41.	FASEB journal 	2014	23
24838911	D-Glucose	Liu Y	APOE genotype and neuroimaging markers of Alzheimer's disease: systematic review and meta-analysis.	Journal of neurology, neurosurgery, and psychiatry	2015	23
24846769	D-Glucose	Ghosh S	Elevated muscle TLR4 expression and metabolic endotoxemia in human aging.	The journals of gerontology. Series A, Biological sciences and medical sciences	2015	25
24925721	D-Glucose	Yoo TH	Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease.	Journal of the American Society of Nephrology 	2015	25
24930970	D-Glucose	Macintyre AN	The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function.	Cell metabolism	2014	137
24997364	D-Glucose	Slominski A	The role of melanogenesis in regulation of melanoma behavior: melanogenesis leads to stimulation of HIF-1α expression and HIF-dependent attendant pathways.	Archives of biochemistry and biophysics	2014	40
25002027	D-Glucose	Valencia T	Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis.	Cancer cell	2014	53
25035342	D-Glucose	Lim S	Links between ectopic fat and vascular disease in humans.	Arteriosclerosis, thrombosis, and vascular biology	2014	32
25036706	D-Glucose	Shigihara N	Human IAPP-induced pancreatic β cell toxicity and its regulation by autophagy.	The Journal of clinical investigation	2014	30
25038584	D-Glucose	Wahlström T	Impact of MYC in regulation of tumor cell metabolism.	Biochimica et biophysica acta	2015	36
25041791	D-Glucose	Philip PA	Dual blockade of epidermal growth factor receptor and insulin-like growth factor receptor-1 signaling in metastatic pancreatic cancer: phase Ib and randomized phase II trial of gemcitabine, erlotinib, and cixutumumab versus gemcitabine plus erlotinib (SWOG S0727).	Cancer	2014	27
25056438	D-Glucose	Chondronikola M	Brown adipose tissue improves whole-body glucose homeostasis and insulin sensitivity in humans.	Diabetes	2014	114
25062042	D-Glucose	Arnold N	Regulation of cardiac expression of the diabetic marker microRNA miR-29.	PloS one	2014	21
25102180	D-Glucose	Ng MC	Meta-analysis of genome-wide association studies in African Americans provides insights into the genetic architecture of type 2 diabetes.	PLoS genetics	2014	46
25165877	D-Glucose	Milosch N	Holo-APP and G-protein-mediated signaling are required for sAPPα-induced activation of the Akt survival pathway.	Cell death & disease	2014	21
25182023	D-Glucose	Ballak DB	IL-37 protects against obesity-induced inflammation and insulin resistance.	Nature communications	2014	27
25204974	D-Glucose	Carlsson PO	Preserved β-cell function in type 1 diabetes by mesenchymal stromal cells.	Diabetes	2015	22
25204977	D-Glucose	Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.	Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC.	Diabetes	2015	33
25211370	D-Glucose	Rezania A	Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells.	Nature biotechnology	2014	165
25239226	D-Glucose	Liu X	IL-1β induces IL-6 production in retinal Müller cells predominantly through the activation of p38 MAPK/NF-κB signaling pathway.	Experimental cell research	2015	17
25262344	D-Glucose	Swerdlow DI	HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.	Lancet	2015	82
25262977	D-Glucose	Hodgson K	Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections.	Immunology	2015	27
25284588	D-Glucose	Jiang L	Metabolic reprogramming during TGFβ1-induced epithelial-to-mesenchymal transition.	Oncogene	2015	26
25288136	D-Glucose	Coffee and Caffeine Genetics Consortium.	Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption.	Molecular psychiatry	2015	24
25304371	D-Glucose	Chen B	miR-22 as a prognostic factor targets glucose transporter protein type 1 in breast cancer.	Cancer letters	2015	21
25307742	D-Glucose	Haeusler RA	Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors.	Nature communications	2014	32
25324472	D-Glucose	Olivieri F	Age- and glycemia-related miR-126-3p levels in plasma and endothelial cells.	Aging	2014	22
25325735	D-Glucose	Balestrieri ML	Sirtuin 6 expression and inflammatory activity in diabetic atherosclerotic plaques: effects of incretin treatment.	Diabetes	2015	22
25336635	D-Glucose	Marsh SA	Protein O-GlcNAcylation and cardiovascular (patho)physiology.	The Journal of biological chemistry	2014	22
25336656	D-Glucose	Zhu Y	The emerging link between O-GlcNAc and Alzheimer disease.	The Journal of biological chemistry	2014	36
25341798	D-Glucose	McLaughlin T	T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans.	Arteriosclerosis, thrombosis, and vascular biology	2014	39
25362253	D-Glucose	Hasnain SZ	Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress.	Nature medicine	2014	31
25387570	D-Glucose	Menegazzo L	NETosis is induced by high glucose and associated with type 2 diabetes.	Acta diabetologica	2015	17
25448601	D-Glucose	Sekar S	Alzheimer's disease is associated with altered expression of genes involved in immune response and mitochondrial processes in astrocytes.	Neurobiology of aging	2015	25
25457209	D-Glucose	Zhou Y	Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2.	Journal of hepatology	2015	16
25512540	D-Glucose	Hung CL	A long noncoding RNA connects c-Myc to tumor metabolism.	Proceedings of the National Academy of Sciences of the United States of America	2014	47
25524916	D-Glucose	Palmer ND	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Diabetes	2015	18
25525878	D-Glucose	Mashimo T	Acetate is a bioenergetic substrate for human glioblastoma and brain metastases.	Cell	2014	120
25528771	D-Glucose	Shibuya K	Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells.	Oncotarget	2015	28
25563886	D-Glucose	Goos JA	Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver Metastasis.	Annals of surgery	2016	10
25584736	D-Glucose	Li T	Bile acids as metabolic regulators.	Current opinion in gastroenterology	2015	27
25587098	D-Glucose	Yan B	lncRNA-MIAT regulates microvascular dysfunction by functioning as a competing endogenous RNA.	Circulation research	2015	65
25625282	D-Glucose	Mahajan A	Identification and functional characterization of G6PC2 coding variants influencing glycemic traits define an effector transcript at the G6PC2-ABCB11 locus.	PLoS genetics	2015	33
25637831	D-Glucose	Satin LS	Pulsatile insulin secretion, impaired glucose tolerance and type 2 diabetes.	Molecular aspects of medicine	2015	19
25668019	D-Glucose	Valdearcos M	Hypothalamic inflammation in the control of metabolic function.	Annual review of physiology	2015	25
25678702	D-Glucose	Møller AB	Physical exercise increases autophagic signaling through ULK1 in human skeletal muscle.	Journal of applied physiology	2015	18
25697093	D-Glucose	Rutter GA	Pancreatic β-cell identity, glucose sensing and the control of insulin secretion.	The Biochemical journal	2015	40
25703085	D-Glucose	Francque S	PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis.	Journal of hepatology	2015	24
25732824	D-Glucose	Zhang D	Metabolic reprogramming of cancer-associated fibroblasts by IDH3α downregulation.	Cell reports	2015	27
25747274	D-Glucose	Monga SP	β-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis.	Gastroenterology	2015	58
25787249	D-Glucose	Puthanveetil P	Long non-coding RNA MALAT1 regulates hyperglycaemia induced inflammatory process in the endothelial cells.	Journal of cellular and molecular medicine	2015	32
25870263	D-Glucose	Shen L	Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP.	Proceedings of the National Academy of Sciences of the United States of America	2015	20
25887760	D-Glucose	Fu QF	Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.	Journal of hematology & oncology	2015	25
25911689	D-Glucose	Senkowski W	Three-Dimensional Cell Culture-Based Screening Identifies the Anthelmintic Drug Nitazoxanide as a Candidate for Treatment of Colorectal Cancer.	Molecular cancer therapeutics	2015	16
25919570	D-Glucose	Lin Y	MicroRNA-33b Inhibits Breast Cancer Metastasis by Targeting HMGA2, SALL4 and Twist1.	Scientific reports	2015	33
25956158	D-Glucose	Zadra G	Dissecting the Dual Role of AMPK in Cancer: From Experimental to Human Studies.	Molecular cancer research 	2015	24
25961460	D-Glucose	Fu X	MicroRNA-26a regulates insulin sensitivity and metabolism of glucose and lipids.	The Journal of clinical investigation	2015	24
26076035	D-Glucose	van der Meulen T	Urocortin3 mediates somatostatin-dependent negative feedback control of insulin secretion.	Nature medicine	2015	29
26179207	D-Glucose	Phan L	The cell cycle regulator 14-3-3σ opposes and reverses cancer metabolic reprogramming.	Nature communications	2015	19
26197299	D-Glucose	Flynn CR	Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery.	Nature communications	2015	19
26241401	D-Glucose	Mishra M	Epigenetic Modification of Mitochondrial DNA in the Development of Diabetic Retinopathy.	Investigative ophthalmology & visual science	2015	19
26355033	D-Glucose	Boden G	Excessive caloric intake acutely causes oxidative stress, GLUT4 carbonylation, and insulin resistance in healthy men.	Science translational medicine	2015	15
26373605	D-Glucose	Portelius E	Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.	Brain 	2015	34
26386349	D-Glucose	Munasinghe PE	Type-2 diabetes increases autophagy in the human heart through promotion of Beclin-1 mediated pathway.	International journal of cardiology	2016	12
26386558	D-Glucose	Ti D	LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b.	Journal of translational medicine	2015	22
26387865	D-Glucose	Altman BJ	MYC Disrupts the Circadian Clock and Metabolism in Cancer Cells.	Cell metabolism	2015	34
26394161	D-Glucose	Armstrong MJ	Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis.	Journal of hepatology	2016	18
26409295	D-Glucose	Dongiovanni P	Genetics of nonalcoholic fatty liver disease.	Metabolism	2016	14
26424786	D-Glucose	Wang XX	G Protein-Coupled Bile Acid Receptor TGR5 Activation Inhibits Kidney Disease in Obesity and Diabetes.	Journal of the American Society of Nephrology 	2016	11
26443705	D-Glucose	Zhang H	Tumor-selective proteotoxicity of verteporfin inhibits colon cancer progression independently of YAP1.	Science signaling	2015	24
26445512	D-Glucose	Kajimura S	Brown and Beige Fat: Physiological Roles beyond Heat Generation.	Cell metabolism	2015	88
26513002	D-Glucose	Martino J	Maternal Body Weight and Gestational Diabetes Differentially Influence Placental and Pregnancy Outcomes.	The Journal of clinical endocrinology and metabolism	2016	13
26523864	D-Glucose	Zhao E	Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction.	Nature immunology	2016	51
26556368	D-Glucose	Yki-Järvinen H	Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance.	Nutrients	2015	16
26598716	D-Glucose	Ranger TA	Is there an association between tendinopathy and diabetes mellitus? A systematic review with meta-analysis.	British journal of sports medicine	2016	12
26619117	D-Glucose	Denechaud PD	E2F1 mediates sustained lipogenesis and contributes to hepatic steatosis.	The Journal of clinical investigation	2016	13
26624892	D-Glucose	van de Bunt M	Transcript Expression Data from Human Islets Links Regulatory Signals from Genome-Wide Association Studies for Type 2 Diabetes and Glycemic Traits to Their Downstream Effectors.	PLoS genetics	2015	31
26628419	D-Glucose	Mita T	Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A).	Diabetes care	2016	21
26643952	D-Glucose	Soriano-Tárraga C	Epigenome-wide association study identifies TXNIP gene associated with type 2 diabetes mellitus and sustained hyperglycemia.	Human molecular genetics	2016	17
26694027	D-Glucose	Bennett BJ	Genetic Architecture of Atherosclerosis in Mice: A Systems Genetics Analysis of Common Inbred Strains.	PLoS genetics	2015	17
26704305	D-Glucose	Gwak H	Resveratrol triggers ER stress-mediated apoptosis by disrupting N-linked glycosylation of proteins in ovarian cancer cells.	Cancer letters	2016	11
26712688	D-Glucose	Iyengar NM	Systemic Correlates of White Adipose Tissue Inflammation in Early-Stage Breast Cancer.	Clinical cancer research 	2016	27
26718499	D-Glucose	Hanssen MJ	Short-term Cold Acclimation Recruits Brown Adipose Tissue in Obese Humans.	Diabetes	2016	20
26721390	D-Glucose	Lin AL	Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer's disease.	Journal of cerebral blood flow and metabolism 	2017	12
26724171	D-Glucose	Parks SK	Hypoxia optimises tumour growth by controlling nutrient import and acidic metabolite export.	Molecular aspects of medicine	2016	13
26773935	D-Glucose	Barron CC	Facilitative glucose transporters: Implications for cancer detection, prognosis and treatment.	Metabolism	2016	20
26813969	D-Glucose	Rodriguez-Vieitez E	Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease.	Brain 	2016	24
26824656	D-Glucose	Hu H	Phosphoinositide 3-Kinase Regulates Glycolysis through Mobilization of Aldolase from the Actin Cytoskeleton.	Cell	2016	30
26837280	D-Glucose	Bai X	MicroRNA-130b improves renal tubulointerstitial fibrosis via repression of Snail-induced epithelial-mesenchymal transition in diabetic nephropathy.	Scientific reports	2016	13
26853146	D-Glucose	Redis RS	Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2.	Molecular cell	2016	25
26942597	D-Glucose	Ariemma F	Low-Dose Bisphenol-A Impairs Adipogenesis and Generates Dysfunctional 3T3-L1 Adipocytes.	PloS one	2016	13
26947067	D-Glucose	Kung CP	The P72R Polymorphism of p53 Predisposes to Obesity and Metabolic Dysfunction.	Cell reports	2016	18
26950362	D-Glucose	Helman A	p16(Ink4a)-induced senescence of pancreatic beta cells enhances insulin secretion.	Nature medicine	2016	30
26962052	D-Glucose	Ossenkoppele R	Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.	Brain 	2016	82
26974308	D-Glucose	Joyal JS	Retinal lipid and glucose metabolism dictates angiogenesis through the lipid sensor Ffar1.	Nature medicine	2016	24
27027351	D-Glucose	D'Esposito V	Adipose microenvironment promotes triple negative breast cancer cell invasiveness and dissemination by producing CCL5.	Oncotarget	2016	12
27064285	D-Glucose	Dai C	Stress-impaired transcription factor expression and insulin secretion in transplanted human islets.	The Journal of clinical investigation	2016	10
27088857	D-Glucose	Lien EC	Glutathione biosynthesis is a metabolic vulnerability in PI(3)K/Akt-driven breast cancer.	Nature cell biology	2016	16
27088965	D-Glucose	Risacher SL	Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults.	JAMA neurology	2016	12
27162351	D-Glucose	Chen Z	Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort.	Proceedings of the National Academy of Sciences of the United States of America	2016	14
27256476	D-Glucose	Kusminski CM	Targeting adipose tissue in the treatment of obesity-associated diabetes.	Nature reviews. Drug discovery	2016	29
27343361	D-Glucose	Ferrer CM	O-GlcNAcylation in Cancer Biology: Linking Metabolism and Signaling.	Journal of molecular biology	2016	10
27345422	D-Glucose	Drucker DJ	The Cardiovascular Biology of Glucagon-like Peptide-1.	Cell metabolism	2016	25
27347932	D-Glucose	Laganà AS	Pleiotropic Actions of Peroxisome Proliferator-Activated Receptors (PPARs) in Dysregulated Metabolic Homeostasis, Inflammation and Cancer: Current Evidence and Future Perspectives.	International journal of molecular sciences	2016	12
27357347	D-Glucose	Smith R	18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers.	Brain 	2016	25
27557514	D-Glucose	Zou ZW	LncRNA ANRIL is up-regulated in nasopharyngeal carcinoma and promotes the cancer progression via increasing proliferation, reprograming cell glucose metabolism and inducing side-population stem-like cancer cells.	Oncotarget	2016	17
27557534	D-Glucose	Lien EC	Metabolic Reprogramming by the PI3K-Akt-mTOR Pathway in Cancer.	Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer	2016	11
27571186	D-Glucose	Dumesic DA	Hyperandrogenism Accompanies Increased Intra-Abdominal Fat Storage in Normal Weight Polycystic Ovary Syndrome Women.	The Journal of clinical endocrinology and metabolism	2016	11
27636730	D-Glucose	Gross B	PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD.	Nature reviews. Endocrinology	2017	26
27814523	D-Glucose	Li P	Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance.	Cell	2016	16
27864352	D-Glucose	Lawlor N	Single-cell transcriptomes identify human islet cell signatures and reveal cell-type-specific expression changes in type 2 diabetes.	Genome research	2017	12
27928162	D-Glucose	Hashimoto N	Role of miRNAs in the pathogenesis and susceptibility of diabetes mellitus.	Journal of human genetics	2017	6
27941246	D-Glucose	Ediger BN	LIM domain-binding 1 maintains the terminally differentiated state of pancreatic β cells.	The Journal of clinical investigation	2017	8
27964927	D-Glucose	Li X	Long noncoding RNA MALAT1 regulates renal tubular epithelial pyroptosis by modulated miR-23c targeting of ELAVL1 in diabetic nephropathy.	Experimental cell research	2017	5
28039838	D-Glucose	Gómez-Sámano MÁ	Fibroblast growth factor 21 and its novel association with oxidative stress.	Redox biology	2017	7
28065883	D-Glucose	Rawal S	Down-regulation of proangiogenic microRNA-126 and microRNA-132 are early modulators of diabetic cardiac microangiopathy.	Cardiovascular research	2017	7
28215845	D-Glucose	Chakravarthy H	Converting Adult Pancreatic Islet α Cells into β Cells by Targeting Both Dnmt1 and Arx.	Cell metabolism	2017	5
28351381	D-Glucose	von Ahrens D	The role of stromal cancer-associated fibroblasts in pancreatic cancer.	Journal of hematology & oncology	2017	10
28398233	D-Glucose	Colldén G	Therapeutic Potential of Targeting the Ghrelin Pathway.	International journal of molecular sciences	2017	5
28559417	D-Glucose	Kleinberger G	The FTD-like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism.	The EMBO journal	2017	6
7830766	Dopamine	Tomac A	Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo.	Nature	1995	117
9429233	Dopamine	Thompson J	D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele.	Pharmacogenetics	1997	114
10648446	Dopamine	Sabatini U	Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study.	Brain 	2000	98
10689037	Dopamine	Swainson R	Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication.	Neuropsychologia	2000	102
11689280	Dopamine	Weinstock M	Alterations induced by gestational stress in brain morphology and behaviour of the offspring.	Progress in neurobiology	2001	104
11739566	Dopamine	Stefanis L	Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death.	The Journal of neuroscience 	2001	136
12461550	Dopamine	Lotharius J	Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein.	Nature reviews. Neuroscience	2002	167
12628165	Dopamine	Staropoli JF	Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity.	Neuron	2003	110
14593166	Dopamine	Dawson TM	Molecular pathways of neurodegeneration in Parkinson's disease.	Science	2003	362
15457404	Dopamine	Chen J	Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain.	American journal of human genetics	2004	370
15502874	Dopamine	Shendelman S	DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation.	PLoS biology	2004	142
15576511	Dopamine	Lo Bianco C	Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease.	Proceedings of the National Academy of Sciences of the United States of America	2004	75
15777250	Dopamine	Nagatsu T	Inflammatory process in Parkinson's disease: role for cytokines.	Current pharmaceutical design	2005	72
15950014	Dopamine	Madras BK	The dopamine transporter and attention-deficit/hyperactivity disorder.	Biological psychiatry	2005	76
16930158	Dopamine	Koob GF	The neurobiology of addiction: a neuroadaptational view relevant for diagnosis.	Addiction	2006	108
17279544	Dopamine	Nakabeppu Y	Oxidative damage in nucleic acids and Parkinson's disease.	Journal of neuroscience research	2007	63
17679637	Dopamine	Shaw P	Polymorphisms of the dopamine D4 receptor, clinical outcome, and cortical structure in attention-deficit/hyperactivity disorder.	Archives of general psychiatry	2007	63
17761882	Dopamine	Kim J	A MicroRNA feedback circuit in midbrain dopamine neurons.	Science	2007	367
18391962	Dopamine	Kordower JH	Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease.	Nature medicine	2008	358
18497887	Dopamine	Tan HY	Genetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humans.	The Journal of clinical investigation	2008	55
18620336	Dopamine	Durstewitz D	The dual-state theory of prefrontal cortex dopamine function with relevance to catechol-o-methyltransferase genotypes and schizophrenia.	Biological psychiatry	2008	119
18702696	Dopamine	Fleming SM	Olfactory deficits in mice overexpressing human wildtype alpha-synuclein.	The European journal of neuroscience	2008	51
19104149	Dopamine	Brochard V	Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease.	The Journal of clinical investigation	2009	191
19230552	Dopamine	Braak H	Neuroanatomy and pathology of sporadic Parkinson's disease.	Advances in anatomy, embryology, and cell biology	2009	59
19244517	Dopamine	Joshi PR	Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease.	The Journal of neuroscience 	2009	59
19385059	Dopamine	Cannon JR	A highly reproducible rotenone model of Parkinson's disease.	Neurobiology of disease	2009	110
19661443	Dopamine	Gaskill PJ	Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuse.	The American journal of pathology	2009	45
19694908	Dopamine	Kitada T	Absence of nigral degeneration in aged parkin/DJ-1/PINK1 triple knockout mice.	Journal of neurochemistry	2009	58
19903734	Dopamine	Tong J	Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.	Brain 	2010	42
20082990	Dopamine	Ouchi Y	Neuroinflammation in the living brain of Parkinson's disease.	Parkinsonism & related disorders	2009	51
20356854	Dopamine	Samaranch L	PINK1-linked parkinsonism is associated with Lewy body pathology.	Brain 	2010	47
20534649	Dopamine	Garcia-Reitböck P	SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease.	Brain 	2010	66
20846908	Dopamine	Iranzo A	Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study corrected.	The Lancet. Neurology	2010	50
21048129	Dopamine	Xie Y	BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice.	The Journal of neuroscience 	2010	65
21112253	Dopamine	Kurian MA	Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study.	The Lancet. Neurology	2011	44
21150907	Dopamine	Moyer RA	Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse.	Neuropsychopharmacology 	2011	48
21246604	Dopamine	de la Fuente-Fernández R	Age-specific progression of nigrostriatal dysfunction in Parkinson's disease.	Annals of neurology	2011	39
21383264	Dopamine	Alia-Klein N	Gene x disease interaction on orbitofrontal gray matter in cocaine addiction.	Archives of general psychiatry	2011	39
21712347	Dopamine	Decressac M	GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease.	Brain 	2011	43
21877920	Dopamine	Sánchez-Danés A	Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and induced pluripotent stem cells.	Human gene therapy	2012	34
21898597	Dopamine	Yarnall A	The interplay of cholinergic function, attention, and falls in Parkinson's disease.	Movement disorders 	2011	40
22036874	Dopamine	Eisenhofer G	Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status.	European journal of cancer	2012	46
22166436	Dopamine	Phani S	Neurodegeneration and inflammation in Parkinson's disease.	Parkinsonism & related disorders	2012	42
22182688	Dopamine	Decressac M	Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons.	Neurobiology of disease	2012	54
22315428	Dopamine	Lundblad M	Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons.	Proceedings of the National Academy of Sciences of the United States of America	2012	71
22350713	Dopamine	Chesselet MF	A progressive mouse model of Parkinson's disease: the Thy1-aSyn ("Line 61") mice.	Neurotherapeutics 	2012	47
22539846	Dopamine	Groman SM	Dysregulation of D₂-mediated dopamine transmission in monkeys after chronic escalating methamphetamine exposure.	The Journal of neuroscience 	2012	33
22785313	Dopamine	Lim BK	Anhedonia requires MC4R-mediated synaptic adaptations in nucleus accumbens.	Nature	2012	93
22992525	Dopamine	Lemos JC	Severe stress switches CRF action in the nucleus accumbens from appetitive to aversive.	Nature	2012	59
23395371	Dopamine	MacLeod DA	RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk.	Neuron	2013	138
23562390	Dopamine	Iranzo A	Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study.	The Lancet. Neurology	2013	62
23610405	Dopamine	Decressac M	TFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicity.	Proceedings of the National Academy of Sciences of the United States of America	2013	126
23636255	Dopamine	Fisher BE	Treadmill exercise elevates striatal dopamine D2 receptor binding potential in patients with early Parkinson's disease.	Neuroreport	2013	27
23766857	Dopamine	Ariga H	Neuroprotective function of DJ-1 in Parkinson's disease.	Oxidative medicine and cellular longevity	2013	44
23918355	Dopamine	Lee MO	Inhibition of pluripotent stem cell-derived teratoma formation by small molecules.	Proceedings of the National Academy of Sciences of the United States of America	2013	46
24082145	Dopamine	Janezic S	Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model.	Proceedings of the National Academy of Sciences of the United States of America	2013	51
24658464	Dopamine	Li J	Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastoma.	Oncotarget	2014	23
24896179	Dopamine	Bingol B	The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy.	Nature	2014	120
24910427	Dopamine	Hallett PJ	Long-term health of dopaminergic neuron transplants in Parkinson's disease patients.	Cell reports	2014	25
24920625	Dopamine	Pifl C	Is Parkinson's disease a vesicular dopamine storage disorder? Evidence from a study in isolated synaptic vesicles of human and nonhuman primate striatum.	The Journal of neuroscience 	2014	31
25403878	Dopamine	Le Grand JN	Neural stem cells in Parkinson's disease: a role for neurogenesis defects in onset and progression.	Cellular and molecular life sciences 	2015	17
25555215	Dopamine	Wang L	Differentiation of hypothalamic-like neurons from human pluripotent stem cells.	The Journal of clinical investigation	2015	16
25556834	Dopamine	Lee JH	Reinstating aberrant mTORC1 activity in Huntington's disease mice improves disease phenotypes.	Neuron	2015	24
26093169	Dopamine	Paumier KL	Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration.	Neurobiology of disease	2015	41
26601965	Dopamine	Alam Q	Inflammatory Process in Alzheimer's and Parkinson's Diseases: Central Role of Cytokines.	Current pharmaceutical design	2016	16
26721587	Dopamine	Toledo JB	Pathological α-synuclein distribution in subjects with coincident Alzheimer's and Lewy body pathology.	Acta neuropathologica	2016	18
26839413	Dopamine	Mazzulli JR	α-Synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models.	Proceedings of the National Academy of Sciences of the United States of America	2016	25
26858591	Dopamine	Collier TJ	Is Alpha-Synuclein Loss-of-Function a Contributor to Parkinsonian Pathology? Evidence from Non-human Primates.	Frontiers in neuroscience	2016	15
26905200	Dopamine	Fernandes HJ	ER Stress and Autophagic Perturbations Lead to Elevated Extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-Derived Dopamine Neurons.	Stem cell reports	2016	27
27300435	Dopamine	Dolma S	Inhibition of Dopamine Receptor D4 Impedes Autophagic Flux, Proliferation, and Survival of Glioblastoma Stem Cells.	Cancer cell	2016	18
27413154	Dopamine	Aflaki E	A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism.	The Journal of neuroscience 	2016	15
27445146	Dopamine	Mazzulli JR	Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.	The Journal of neuroscience 	2016	13
27514754	Dopamine	Würth R	Phenotypical and Pharmacological Characterization of Stem-Like Cells in Human Pituitary Adenomas.	Molecular neurobiology	2017	5
28180961	Dopamine	Doppler K	Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.	Acta neuropathologica	2017	8
28398344	Dopamine	Rivetti di Val Cervo P	Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson's disease model.	Nature biotechnology	2017	11
8799830	Biotin	Iborra FJ	Active RNA polymerases are localized within discrete transcription "factories' in human nuclei.	Journal of cell science	1996	122
10397265	Biotin	Chang SS	Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.	Cancer research	1999	123
18495537	Biotin	Bartolazzi A	Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study.	The Lancet. Oncology	2008	53
19509156	Biotin	Yamamichi N	Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development.	Clinical cancer research 	2009	66
19903735	Biotin	Walker AK	Protein disulphide isomerase protects against protein aggregation and is S-nitrosylated in amyotrophic lateral sclerosis.	Brain 	2010	45
20463395	Biotin	Bossy B	S-Nitrosylation of DRP1 does not affect enzymatic activity and is not specific to Alzheimer's disease.	Journal of Alzheimer's disease 	2010	56
26234674	Biotin	Phatak P	Overexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1.	Oncogene	2016	15
7531702	L-Cysteine	Tewari M	Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product.	The Journal of biological chemistry	1995	121
7768953	L-Cysteine	Mu FT	EEA1, an early endosome-associated protein. EEA1 is a conserved alpha-helical peripheral membrane protein flanked by cysteine "fingers" and contains a calmodulin-binding IQ motif.	The Journal of biological chemistry	1995	210
8681377	L-Cysteine	Muzio M	FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex.	Cell	1996	479
9600969	L-Cysteine	Babic AM	CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth.	Proceedings of the National Academy of Sciences of the United States of America	1998	113
9811737	L-Cysteine	Cocchi F	The ectodomain of a novel member of the immunoglobulin subfamily related to the poliovirus receptor has the attributes of a bona fide receptor for herpes simplex virus types 1 and 2 in human cells.	Journal of virology	1998	135
10027396	L-Cysteine	Nör JE	Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression.	The American journal of pathology	1999	129
10458605	L-Cysteine	Bromberg JF	Stat3 as an oncogene.	Cell	1999	799
10728374	L-Cysteine	Saraste A	Morphologic and biochemical hallmarks of apoptosis.	Cardiovascular research	2000	147
11067861	L-Cysteine	Zheng T	Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema.	The Journal of clinical investigation	2000	161
11113131	L-Cysteine	Park CH	Hepcidin, a urinary antimicrobial peptide synthesized in the liver.	The Journal of biological chemistry	2001	352
11574398	L-Cysteine	Savage DB	Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans.	Diabetes	2001	106
11714645	L-Cysteine	Rabkin E	Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves.	Circulation	2001	148
12353035	L-Cysteine	Chun HJ	Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency.	Nature	2002	141
12639996	L-Cysteine	Sukhova GK	Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice.	The Journal of clinical investigation	2003	94
15094120	L-Cysteine	Bellail AC	Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion.	The international journal of biochemistry & cell biology	2004	124
15178558	L-Cysteine	Liu J	Lysosomal cysteine proteases in atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2004	83
16046058	L-Cysteine	Liaudet-Coopman E	Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis.	Cancer letters	2006	73
16207929	L-Cysteine	Young SG	Prelamin A, Zmpste24, misshapen cell nuclei, and progeria--new evidence suggesting that protein farnesylation could be important for disease pathogenesis.	Journal of lipid research	2005	88
16362181	L-Cysteine	Büki A	All roads lead to disconnection?--Traumatic axonal injury revisited.	Acta neurochirurgica	2006	121
16481467	L-Cysteine	Gocheva V	Distinct roles for cysteine cathepsin genes in multistage tumorigenesis.	Genes & development	2006	129
16722814	L-Cysteine	Gradishar WJ	Albumin-bound paclitaxel: a next-generation taxane.	Expert opinion on pharmacotherapy	2006	95
16818644	L-Cysteine	Rofstad EK	Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice.	Cancer research	2006	147
17235047	L-Cysteine	Infante JR	Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma.	Journal of clinical oncology 	2007	118
17245112	L-Cysteine	Gocheva V	Cysteine cathepsins and the cutting edge of cancer invasion.	Cell cycle	2007	96
17311556	L-Cysteine	Vasiljeva O	Emerging roles of cysteine cathepsins in disease and their potential as drug targets.	Current pharmaceutical design	2007	90
17420353	L-Cysteine	Jaffer FA	Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor.	Circulation	2007	76
17545618	L-Cysteine	DeAlmeida VI	The soluble wnt receptor Frizzled8CRD-hFc inhibits the growth of teratocarcinomas in vivo.	Cancer research	2007	62
17720813	L-Cysteine	Kelleher ZT	NOS2 regulation of NF-kappaB by S-nitrosylation of p65.	The Journal of biological chemistry	2007	64
17893322	L-Cysteine	Atcha FA	A unique DNA binding domain converts T-cell factors into strong Wnt effectors.	Molecular and cellular biology	2007	57
18003920	L-Cysteine	Fang J	S-nitrosylation of peroxiredoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson's disease.	Proceedings of the National Academy of Sciences of the United States of America	2007	75
19065049	L-Cysteine	Park YM	CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima.	The Journal of clinical investigation	2009	118
19342591	L-Cysteine	Cho DH	S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury.	Science	2009	300
19381019	L-Cysteine	Qing J	Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice.	The Journal of clinical investigation	2009	66
19539236	L-Cysteine	Chabriat H	Cadasil.	The Lancet. Neurology	2009	135
19567589	L-Cysteine	Lucio-Eterovic AK	Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy.	Clinical cancer research 	2009	75
20170166	L-Cysteine	Rauser S	Classification of HER2 receptor status in breast cancer tissues by MALDI imaging mass spectrometry.	Journal of proteome research	2010	48
20213804	L-Cysteine	Sonnylal S	Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis.	Arthritis and rheumatism	2010	57
21124317	L-Cysteine	Wang K	Integrative genomics identifies LMO1 as a neuroblastoma oncogene.	Nature	2011	95
21308479	L-Cysteine	Arvatz G	The heparanase system and tumor metastasis: is heparanase the seed and soil?	Cancer metastasis reviews	2011	39
21442631	L-Cysteine	Schrader J	Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells.	Hepatology	2011	81
21536738	L-Cysteine	Shochat C	Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias.	The Journal of experimental medicine	2011	98
21734079	L-Cysteine	Lamkanfi M	Modulation of inflammasome pathways by bacterial and viral pathogens.	Journal of immunology	2011	64
21820099	L-Cysteine	Nosková L	Mutations in DNAJC5, encoding cysteine-string protein alpha, cause autosomal-dominant adult-onset neuronal ceroid lipofuscinosis.	American journal of human genetics	2011	79
21969517	L-Cysteine	Von Hoff DD	Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial.	Journal of clinical oncology 	2011	260
22045338	L-Cysteine	Lynes EM	Palmitoylated TMX and calnexin target to the mitochondria-associated membrane.	The EMBO journal	2012	50
22048958	L-Cysteine	Maue RA	A novel mouse model of Niemann-Pick type C disease carrying a D1005G-Npc1 mutation comparable to commonly observed human mutations.	Human molecular genetics	2012	32
22056874	L-Cysteine	Harris LG	Increased vascularity and spontaneous metastasis of breast cancer by hedgehog signaling mediated upregulation of cyr61.	Oncogene	2012	35
22093547	L-Cysteine	Victor BC	Inhibition of cathepsin B activity attenuates extracellular matrix degradation and inflammatory breast cancer invasion.	Breast cancer research 	2011	36
22128301	L-Cysteine	Liu X	Iniparib nonselectively modifies cysteine-containing proteins in tumor cells and is not a bona fide PARP inhibitor.	Clinical cancer research 	2012	41
22193716	L-Cysteine	Cohen TJ	Redox signalling directly regulates TDP-43 via cysteine oxidation and disulphide cross-linking.	The EMBO journal	2012	35
22266111	L-Cysteine	Withana NP	Cathepsin B inhibition limits bone metastasis in breast cancer.	Cancer research	2012	44
22348534	L-Cysteine	Yoo NJ	Somatic mutations of the KEAP1 gene in common solid cancers.	Histopathology	2012	37
22388478	L-Cysteine	Shang YC	Prevention of β-amyloid degeneration of microglia by erythropoietin depends on Wnt1, the PI 3-K/mTOR pathway, Bad, and Bcl-xL.	Aging	2012	46
22657837	L-Cysteine	Nakamura T	Emerging role of protein-protein transnitrosylation in cell signaling pathways.	Antioxidants & redox signaling	2013	34
23016862	L-Cysteine	Voronkov A	Wnt/beta-catenin signaling and small molecule inhibitors.	Current pharmaceutical design	2013	55
23174564	L-Cysteine	Goldsmith EC	Cellular mechanisms of tissue fibrosis. 2. Contributory pathways leading to myocardial fibrosis: moving beyond collagen expression.	American journal of physiology. Cell physiology	2013	35
23203246	L-Cysteine	Cho SY	Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer.	Journal of nuclear medicine 	2012	68
23333463	L-Cysteine	Wei Z	STAT3 interacts with Skp2/p27/p21 pathway to regulate the motility and invasion of gastric cancer cells.	Cellular signalling	2013	29
23649698	L-Cysteine	Monet-Leprêtre M	Abnormal recruitment of extracellular matrix proteins by excess Notch3 ECD: a new pathomechanism in CADASIL.	Brain 	2013	25
23788041	L-Cysteine	Bullock MD	Pleiotropic actions of miR-21 highlight the critical role of deregulated stromal microRNAs during colorectal cancer progression.	Cell death & disease	2013	31
24078004	L-Cysteine	Zhao H	MiR-25 promotes gastric cancer cells growth and motility by targeting RECK.	Molecular and cellular biochemistry	2014	27
24675529	L-Cysteine	Nagaraju GP	Molecular mechanisms underlying the divergent roles of SPARC in human carcinogenesis.	Carcinogenesis	2014	26
24681256	L-Cysteine	Levonen AL	Redox regulation of antioxidants, autophagy, and the response to stress: implications for electrophile therapeutics.	Free radical biology & medicine	2014	49
24683721	L-Cysteine	Thota R	Treatment of metastatic pancreatic adenocarcinoma: a review.	Oncology	2014	37
24726192	L-Cysteine	Liu Y	Hydrogen sulfide maintains mesenchymal stem cell function and bone homeostasis via regulation of Ca(2+) channel sulfhydration.	Cell stem cell	2014	31
25205735	L-Cysteine	Kao L	Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy.	Journal of the American Society of Nephrology 	2015	25
25823923	L-Cysteine	Qin L	WNT5A promotes stemness characteristics in nasopharyngeal carcinoma cells leading to metastasis and tumorigenesis.	Oncotarget	2015	23
26069305	L-Cysteine	Rowe SP	¹⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer.	Journal of nuclear medicine 	2015	36
26169969	L-Cysteine	Hidalgo M	SPARC Expression Did Not Predict Efficacy of nab-Paclitaxel plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase III MPACT Trial.	Clinical cancer research 	2015	30
26805760	L-Cysteine	Zhang L	Unraveling the roles of Atg4 proteases from autophagy modulation to targeted cancer therapy.	Cancer letters	2016	10
26908579	L-Cysteine	Bornholdt ZA	Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies.	mBio	2016	15
26996066	L-Cysteine	Li S	MCP-1-induced ERK/GSK-3β/Snail signaling facilitates the epithelial-mesenchymal transition and promotes the migration of MCF-7 human breast carcinoma cells.	Cellular & molecular immunology	2017	5
27066895	L-Cysteine	Vince JE	The intersection of cell death and inflammasome activation.	Cellular and molecular life sciences 	2016	17
27465842	L-Cysteine	Chen CY	CCN1 Promotes VEGF Production in Osteoblasts and Induces Endothelial Progenitor Cell Angiogenesis by Inhibiting miR-126 Expression in Rheumatoid Arthritis.	Journal of bone and mineral research 	2017	7
27626662	L-Cysteine	Yan D	STAT3 and STAT6 Signaling Pathways Synergize to Promote Cathepsin Secretion from Macrophages via IRE1α Activation.	Cell reports	2016	11
28262504	L-Cysteine	Dong Z	Mitochondrial Ca2+ Uniporter Is a Mitochondrial Luminal Redox Sensor that Augments MCU Channel Activity.	Molecular cell	2017	14
11470825	24,25-Dihydroxyvitamin D	Pálmer HG	Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling.	The Journal of cell biology	2001	183
15905882	24,25-Dihydroxyvitamin D	Høyer-Hansen M	Vitamin D analog EB1089 triggers dramatic lysosomal changes and Beclin 1-mediated autophagic cell death.	Cell death and differentiation	2005	72
16180015	24,25-Dihydroxyvitamin D	Anderson MG	Expression of VDR and CYP24A1 mRNA in human tumors.	Cancer chemotherapy and pharmacology	2006	64
16197570	24,25-Dihydroxyvitamin D	Zittermann A	Putting cardiovascular disease and vitamin D insufficiency into perspective.	The British journal of nutrition	2005	75
17641030	24,25-Dihydroxyvitamin D	Chen S	Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation.	Journal of immunology	2007	188
18343778	24,25-Dihydroxyvitamin D	Zhang J	CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases.	American journal of clinical pathology	2008	65
18525004	24,25-Dihydroxyvitamin D	Tan X	Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling.	Journal of the American Society of Nephrology 	2008	66
19437538	24,25-Dihydroxyvitamin D	Mohri T	MicroRNA regulates human vitamin D receptor.	International journal of cancer	2009	58
19508330	24,25-Dihydroxyvitamin D	Fibbi B	Chronic inflammation in the pathogenesis of benign prostatic hyperplasia.	International journal of andrology	2010	42
19701245	24,25-Dihydroxyvitamin D	Kaler P	Macrophage-derived IL-1beta stimulates Wnt signaling and growth of colon cancer cells: a crosstalk interrupted by vitamin D3.	Oncogene	2009	67
19770375	24,25-Dihydroxyvitamin D	Newton-Bishop JA	Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma.	Journal of clinical oncology 	2009	79
20020487	24,25-Dihydroxyvitamin D	Janjetovic Z	20,23-dihydroxyvitamin D3, novel P450scc product, stimulates differentiation and inhibits proliferation and NF-kappaB activity in human keratinocytes.	Journal of cellular physiology	2010	44
20831823	24,25-Dihydroxyvitamin D	Lopes N	Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions.	BMC cancer	2010	48
21292298	24,25-Dihydroxyvitamin D	Brożyna AA	Expression of vitamin D receptor decreases during progression of pigmented skin lesions.	Human pathology	2011	42
21325459	24,25-Dihydroxyvitamin D	Yiu YF	Vitamin D deficiency is associated with depletion of circulating endothelial progenitor cells and endothelial dysfunction in patients with type 2 diabetes.	The Journal of clinical endocrinology and metabolism	2011	35
21840998	24,25-Dihydroxyvitamin D	Wong KE	Targeted expression of human vitamin D receptor in adipocytes decreases energy expenditure and induces obesity in mice.	The Journal of biological chemistry	2011	38
21947295	24,25-Dihydroxyvitamin D	Chen S	Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy.	Circulation	2011	63
22085499	24,25-Dihydroxyvitamin D	Welsh J	Cellular and molecular effects of vitamin D on carcinogenesis.	Archives of biochemistry and biophysics	2012	38
22328083	24,25-Dihydroxyvitamin D	Alvarez-Díaz S	MicroRNA-22 is induced by vitamin D and contributes to its antiproliferative, antimigratory and gene regulatory effects in colon cancer cells.	Human molecular genetics	2012	42
22362918	24,25-Dihydroxyvitamin D	Soilu-Hänninen M	A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis.	Journal of neurology, neurosurgery, and psychiatry	2012	40
22411958	24,25-Dihydroxyvitamin D	Disanto G	The evidence for a role of B cells in multiple sclerosis.	Neurology	2012	35
22498493	24,25-Dihydroxyvitamin D	Bristol ML	Dual functions of autophagy in the response of breast tumor cells to radiation: cytoprotective autophagy with radiation alone and cytotoxic autophagy in radiosensitization by vitamin D 3.	Autophagy	2012	33
22683847	24,25-Dihydroxyvitamin D	Slominski AT	In vivo evidence for a novel pathway of vitamin D₃ metabolism initiated by P450scc and modified by CYP27B1.	FASEB journal 	2012	87
22710573	24,25-Dihydroxyvitamin D	Majumdar A	Hepatic stem cells and transforming growth factor β in hepatocellular carcinoma.	Nature reviews. Gastroenterology & hepatology	2012	32
22993313	24,25-Dihydroxyvitamin D	Slominski AT	Novel vitamin D hydroxyderivatives inhibit melanoma growth and show differential effects on normal melanocytes.	Anticancer research	2012	37
22995334	24,25-Dihydroxyvitamin D	Brożyna AA	Expression of the vitamin D-activating enzyme 1α-hydroxylase (CYP27B1) decreases during melanoma progression.	Human pathology	2013	26
23297354	24,25-Dihydroxyvitamin D	Nebert DW	Human cytochromes P450 in health and disease.	Philosophical transactions of the Royal Society of London. Series B, Biological sciences	2013	57
23749111	24,25-Dihydroxyvitamin D	D'Orazio J	UV radiation and the skin.	International journal of molecular sciences	2013	71
23762029	24,25-Dihydroxyvitamin D	Verway M	Vitamin D induces interleukin-1β expression: paracrine macrophage epithelial signaling controls M. tuberculosis infection.	PLoS pathogens	2013	33
23905916	24,25-Dihydroxyvitamin D	Kiss M	The role of lipid-activated nuclear receptors in shaping macrophage and dendritic cell function: From physiology to pathology.	The Journal of allergy and clinical immunology	2013	35
23945234	24,25-Dihydroxyvitamin D	Liu W	Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis.	The Journal of clinical investigation	2013	54
24108316	24,25-Dihydroxyvitamin D	Ceglia L	A randomized study on the effect of vitamin D₃ supplementation on skeletal muscle morphology and vitamin D receptor concentration in older women.	The Journal of clinical endocrinology and metabolism	2013	36
24625454	24,25-Dihydroxyvitamin D	Vaidya R	Prognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP era.	Annals of oncology 	2014	21
25002714	24,25-Dihydroxyvitamin D	Zgaga L	Plasma vitamin D concentration influences survival outcome after a diagnosis of colorectal cancer.	Journal of clinical oncology 	2014	23
25080448	24,25-Dihydroxyvitamin D	Wu S	Intestinal epithelial vitamin D receptor deletion leads to defective autophagy in colitis.	Gut	2015	41
25259922	24,25-Dihydroxyvitamin D	Sherman MH	Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy.	Cell	2014	124
25591978	24,25-Dihydroxyvitamin D	Song M	Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status.	Gut	2016	28
26000280	24,25-Dihydroxyvitamin D	Mozos I	Links between Vitamin D Deficiency and Cardiovascular Diseases.	BioMed research international	2015	22
26130323	24,25-Dihydroxyvitamin D	Bashir M	Effects of high doses of vitamin D3 on mucosa-associated gut microbiome vary between regions of the human gastrointestinal tract.	European journal of nutrition	2016	14
26218741	24,25-Dihydroxyvitamin D	Sun J	VDR/vitamin D receptor regulates autophagic activity through ATG16L1.	Autophagy	2016	11
26453697	24,25-Dihydroxyvitamin D	Henderson CM	Measurement by a Novel LC-MS/MS Methodology Reveals Similar Serum Concentrations of Vitamin D-Binding Protein in Blacks and Whites.	Clinical chemistry	2016	25
27053631	24,25-Dihydroxyvitamin D	Ferrer-Mayorga G	Vitamin D receptor expression and associated gene signature in tumour stromal fibroblasts predict clinical outcome in colorectal cancer.	Gut	2017	5
28242709	24,25-Dihydroxyvitamin D	Tavera-Mendoza LE	Vitamin D receptor regulates autophagy in the normal mammary gland and in luminal breast cancer cells.	Proceedings of the National Academy of Sciences of the United States of America	2017	6
11297957	Bilirubin	Imbert-Bismut F	Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study.	Lancet	2001	233
16778155	Bilirubin	Terai S	Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy.	Stem cells	2006	106
16879391	Bilirubin	Durnez A	The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin.	Histopathology	2006	70
17291602	Bilirubin	Geier A	Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration.	Biochimica et biophysica acta	2007	65
17947486	Bilirubin	Plummer R	Phase 1 and pharmacokinetic study of lexatumumab in patients with advanced cancers.	Clinical cancer research 	2007	70
18509182	Bilirubin	Brunner TB	Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer.	Journal of clinical oncology 	2008	51
20066715	Bilirubin	Carr BI	Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study.	Cancer	2010	46
20525993	Bilirubin	Saglio G	Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia.	The New England journal of medicine	2010	288
21618574	Bilirubin	Sangro B	Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation.	Hepatology	2011	117
21748296	Bilirubin	El-Khoueiry AB	SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma.	Investigational new drugs	2012	39
22278680	Bilirubin	Sancho-Bru P	Liver progenitor cell markers correlate with liver damage and predict short-term mortality in patients with alcoholic hepatitis.	Hepatology	2012	44
22357140	Bilirubin	Kantarjian H	Inotuzumab ozogamicin, an anti-CD22-calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study.	The Lancet. Oncology	2012	70
23315099	Bilirubin	Haas M	Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy.	Journal of cancer research and clinical oncology	2013	34
26095784	Bilirubin	Zhu AX	Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial.	The Lancet. Oncology	2015	58
26235536	Bilirubin	Thakurdas SM	Jagged1 heterozygosity in mice results in a congenital cholangiopathy which is reversed by concomitant deletion of one copy of Poglut1 (Rumi).	Hepatology	2016	12
26332545	Bilirubin	Tefferi A	A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis.	The New England journal of medicine	2015	39
26838806	Bilirubin	Zhang Y	Bcl2 is a critical regulator of bile acid homeostasis by dictating Shp and lncRNA H19 function.	Scientific reports	2016	17
27108243	Bilirubin	Sartore-Bianchi A	Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial.	The Lancet. Oncology	2016	45
27677712	Bilirubin	Vitale A	Personalized treatment of patients with very early hepatocellular carcinoma.	Journal of hepatology	2017	7
28813164	Bilirubin	Ott PA	Pembrolizumab in Patients With Extensive-Stage Small-Cell Lung Cancer: Results From the Phase Ib KEYNOTE-028 Study.	Journal of clinical oncology 	2017	8
9111868	Sulfate	Naor D	CD44: structure, function, and association with the malignant process.	Advances in cancer research	1997	194
12435733	Sulfate	Mongiat M	Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan.	The Journal of biological chemistry	2003	84
16024626	Sulfate	Capurro MI	Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling.	Cancer research	2005	117
16322790	Sulfate	Li QZ	Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays.	The Journal of clinical investigation	2005	81
16452201	Sulfate	Zetser A	Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation.	Cancer research	2006	83
17339423	Sulfate	Mahtouk K	Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma.	Blood	2007	65
17347152	Sulfate	Yang Y	Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis.	The Journal of biological chemistry	2007	97
17573668	Sulfate	Campadelli-Fiume G	The multipartite system that mediates entry of herpes simplex virus into the cell.	Reviews in medical virology	2007	60
17613235	Sulfate	Rosenberg GA	Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia.	Neurosurgical focus	2007	78
17635638	Sulfate	Vreys V	Mammalian heparanase: what is the message?	Journal of cellular and molecular medicine	2007	83
17923576	Sulfate	Rehm M	Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia.	Circulation	2007	107
18812315	Sulfate	Purushothaman A	Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma.	The Journal of biological chemistry	2008	67
19360105	Sulfate	Zcharia E	Newly generated heparanase knock-out mice unravel co-regulation of heparanase and matrix metalloproteinases.	PloS one	2009	51
19466598	Sulfate	Iozzo RV	Basement membrane proteoglycans: modulators Par Excellence of cancer growth and angiogenesis.	Molecules and cells	2009	70
20097882	Sulfate	Purushothaman A	Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis.	Blood	2010	80
20385007	Sulfate	Valayannopoulos V	Mucopolysaccharidosis VI.	Orphanet journal of rare diseases	2010	43
20840586	Sulfate	Barash U	Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis.	The FEBS journal	2010	71
22133879	Sulfate	Sakai K	Human dental pulp-derived stem cells promote locomotor recovery after complete transection of the rat spinal cord by multiple neuro-regenerative mechanisms.	The Journal of clinical investigation	2012	71
22406535	Sulfate	Said N	RhoGDI2 suppresses lung metastasis in mice by reducing tumor versican expression and macrophage infiltration.	The Journal of clinical investigation	2012	41
22573479	Sulfate	Ibrahim SA	Targeting of syndecan-1 by microRNA miR-10b promotes breast cancer cell motility and invasiveness via a Rho-GTPase- and E-cadherin-dependent mechanism.	International journal of cancer	2012	34
22820644	Sulfate	Schmidt EP	The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis.	Nature medicine	2012	99
23374281	Sulfate	Ramani VC	The heparanase/syndecan-1 axis in cancer: mechanisms and therapies.	The FEBS journal	2013	49
23665161	Sulfate	Hendriksz CJ	Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA.	Molecular genetics and metabolism	2013	28
23792691	Sulfate	Biroccio A	TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells.	Nature cell biology	2013	27
24441045	Sulfate	Webber JP	Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes.	Oncogene	2015	70
24447621	Sulfate	Naziruddin B	Evidence for instant blood-mediated inflammatory reaction in clinical autologous islet transplantation.	American journal of transplantation 	2014	25
24768844	Sulfate	Urban S	Strategies to inhibit entry of HBV and HDV into hepatocytes.	Gastroenterology	2014	43
25063530	Sulfate	Wang X	Tumor necrosis factor-α- and interleukin-1β-dependent matrix metalloproteinase-3 expression in nucleus pulposus cells requires cooperative signaling via syndecan 4 and mitogen-activated protein kinase-NF-κB axis: implications in inflammatory disc disease.	The American journal of pathology	2014	20
25282103	Sulfate	Wood AR	Defining the role of common variation in the genomic and biological architecture of adult human height.	Nature genetics	2014	348
25849134	Sulfate	Caruana I	Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes.	Nature medicine	2015	51
25912399	Sulfate	Hadigal SR	Heparanase is a host enzyme required for herpes simplex virus-1 release from cells.	Nature communications	2015	18
25943787	Sulfate	Simon AY	Dengue virus binding and replication by platelets.	Blood	2015	15
26926788	Sulfate	Jung O	Heparanase-induced shedding of syndecan-1/CD138 in myeloma and endothelial cells activates VEGFR2 and an invasive phenotype: prevention by novel synstatins.	Oncogenesis	2016	10
27758044	Sulfate	Sanderson RD	Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy.	The FEBS journal	2017	14
11007475	Cytidine	Revy P	Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2).	Cell	2000	433
12732658	Cytidine	Okazaki IM	Constitutive expression of AID leads to tumorigenesis.	The Journal of experimental medicine	2003	132
15383579	Cytidine	He B	CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10.	Journal of immunology	2004	93
16547227	Cytidine	He B	HIV-1 envelope triggers polyclonal Ig class switch recombination through a CD40-independent mechanism involving BAFF and C-type lectin receptors.	Journal of immunology	2006	96
16729314	Cytidine	Bonvin M	Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication.	Hepatology	2006	87
17259987	Cytidine	Xu W	Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPI.	Nature immunology	2007	87
18066064	Cytidine	Pasqualucci L	AID is required for germinal center-derived lymphomagenesis.	Nature genetics	2008	135
18678733	Cytidine	Takizawa M	AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development.	The Journal of experimental medicine	2008	71
18820687	Cytidine	Nowarski R	Hypermutation by intersegmental transfer of APOBEC3G cytidine deaminase.	Nature structural & molecular biology	2008	58
19941823	Cytidine	Robbiani DF	AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations.	Molecular cell	2009	100
20728581	Cytidine	Frasca D	Age effects on B cells and humoral immunity in humans.	Ageing research reviews	2011	48
22108206	Cytidine	Perros F	Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension.	American journal of respiratory and critical care medicine	2012	49
22260300	Cytidine	Magrath I	Epidemiology: clues to the pathogenesis of Burkitt lymphoma.	British journal of haematology	2012	31
23995783	Cytidine	Weizman N	Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminase.	Oncogene	2014	45
24843014	Cytidine	Richardson SR	APOBEC3A deaminates transiently exposed single-strand DNA during LINE-1 retrotransposition.	eLife	2014	35
25355878	Cytidine	Warren CJ	APOBEC3A functions as a restriction factor of human papillomavirus.	Journal of virology	2015	38
25483777	Cytidine	Qian J	B cell super-enhancers and regulatory clusters recruit AID tumorigenic activity.	Cell	2014	71
25898173	Cytidine	Sharma S	APOBEC3A cytidine deaminase induces RNA editing in monocytes and macrophages.	Nature communications	2015	26
26255562	Cytidine	Nagathihalli NS	Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer.	Gastroenterology	2015	16
26258849	Cytidine	Chan K	An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers.	Nature genetics	2015	49
26296954	Cytidine	Issa JJ	Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study.	The Lancet. Oncology	2015	36
26638776	Cytidine	Kasar S	Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution.	Nature communications	2015	22
26779602	Cytidine	Minnich M	Multifunctional role of the transcription factor Blimp-1 in coordinating plasma cell differentiation.	Nature immunology	2016	36
27007129	Cytidine	Ciccolini J	Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective.	Cancer chemotherapy and pharmacology	2016	14
27149507	Cytidine	Sharma S	Transient overexpression of exogenous APOBEC3A causes C-to-U RNA editing of thousands of genes.	RNA biology	2017	7
27798611	Cytidine	Hess GT	Directed evolution using dCas9-targeted somatic hypermutation in mammalian cells.	Nature methods	2016	27
9121257	Ethanol	Poynard T	Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.	Lancet	1997	421
15313862	Ethanol	St John MA	Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma.	Archives of otolaryngology--head & neck surgery	2004	83
15578509	Ethanol	Lin SM	Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm.	Gastroenterology	2004	104
15717022	Ethanol	Blennow K	Cerebrospinal fluid protein biomarkers for Alzheimer's disease.	NeuroRx 	2004	92
15784178	Ethanol	Dumitrescu RG	Understanding breast cancer risk -- where do we stand in 2005?	Journal of cellular and molecular medicine	2005	85
15956766	Ethanol	Sulik KK	Genesis of alcohol-induced craniofacial dysmorphism.	Experimental biology and medicine	2005	70
16151628	Ethanol	Elsharkawy AM	The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis.	Apoptosis 	2005	98
16182404	Ethanol	Bräu N	Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy.	Journal of hepatology	2006	91
16488803	Ethanol	Fentiman IS	Male breast cancer.	Lancet	2006	88
16489089	Ethanol	Desai N	Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel.	Clinical cancer research 	2006	196
17663417	Ethanol	Bioulac-Sage P	Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry.	Hepatology	2007	88
17998146	Ethanol	Schmitz KJ	Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection.	Journal of hepatology	2008	66
18045675	Ethanol	Albano E	Oxidative mechanisms in the pathogenesis of alcoholic liver disease.	Molecular aspects of medicine	2008	55
18162065	Ethanol	Tang Y	Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease.	Alcoholism, clinical and experimental research	2008	99
18304676	Ethanol	Llovet JM	Novel advancements in the management of hepatocellular carcinoma in 2008.	Journal of hepatology	2008	202
18360824	Ethanol	Hafkamp HC	Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas.	International journal of cancer	2008	73
18382230	Ethanol	Kempermann G	The contribution of failing adult hippocampal neurogenesis to psychiatric disorders.	Current opinion in psychiatry	2008	77
18393390	Ethanol	Straub BK	Differential pattern of lipid droplet-associated proteins and de novo perilipin expression in hepatocyte steatogenesis.	Hepatology	2008	58
18433021	Ethanol	Ladeiro Y	MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.	Hepatology	2008	198
18486742	Ethanol	Argiris A	Head and neck cancer.	Lancet	2008	325
18666317	Ethanol	Gomaa AI	Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis.	World journal of gastroenterology	2008	139
18940959	Ethanol	Crews FT	Mechanisms of neurodegeneration and regeneration in alcoholism.	Alcohol and alcoholism	2009	165
19124685	Ethanol	Ernst C	Alternative splicing, methylation state, and expression profile of tropomyosin-related kinase B in the frontal cortex of suicide completers.	Archives of general psychiatry	2009	52
19362087	Ethanol	Fortunato F	Impaired autolysosome formation correlates with Lamp-2 depletion: role of apoptosis, autophagy, and necrosis in pancreatitis.	Gastroenterology	2009	69
19519716	Ethanol	Ouko LA	Effect of alcohol consumption on CpG methylation in the differentially methylated regions of H19 and IG-DMR in male gametes: implications for fetal alcohol spectrum disorders.	Alcoholism, clinical and experimental research	2009	69
19534673	Ethanol	Heymann F	Monocytes and macrophages as cellular targets in liver fibrosis.	Inflammation & allergy drug targets	2009	54
19581569	Ethanol	Treutlein J	Genome-wide association study of alcohol dependence.	Archives of general psychiatry	2009	142
19584139	Ethanol	Choi JY	Association between global DNA hypomethylation in leukocytes and risk of breast cancer.	Carcinogenesis	2009	87
19668381	Ethanol	Lin B	Integrated expression profiling and ChIP-seq analyses of the growth inhibition response program of the androgen receptor.	PloS one	2009	46
20238398	Ethanol	Szabo G	Alcoholic liver disease and the gut-liver axis.	World journal of gastroenterology	2010	101
20339361	Ethanol	Preis SR	Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study.	Obesity	2010	85
20451455	Ethanol	Marur S	HPV-associated head and neck cancer: a virus-related cancer epidemic.	The Lancet. Oncology	2010	313
20639898	Ethanol	Whittaker S	The role of signaling pathways in the development and treatment of hepatocellular carcinoma.	Oncogene	2010	208
20664081	Ethanol	Malhi H	Hepatocyte death: a clear and present danger.	Physiological reviews	2010	108
20684021	Ethanol	Rotman Y	The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease.	Hepatology	2010	96
20837529	Ethanol	Oh JY	Anti-inflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury.	Proceedings of the National Academy of Sciences of the United States of America	2010	60
20953207	Ethanol	Severi T	Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets.	Acta pharmacologica Sinica	2010	48
21091952	Ethanol	Kalaria RN	Vascular basis for brain degeneration: faltering controls and risk factors for dementia.	Nutrition reviews	2010	60
21128245	Ethanol	Ertle J	Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis.	International journal of cancer	2011	78
21160525	Ethanol	Leemans CR	The molecular biology of head and neck cancer.	Nature reviews. Cancer	2011	525
21242260	Ethanol	Cui R	Common variant in 6q26-q27 is associated with distal colon cancer in an Asian population.	Gut	2011	61
21358359	Ethanol	Omalu B	Emerging histomorphologic phenotypes of chronic traumatic encephalopathy in American athletes.	Neurosurgery	2011	76
21397320	Ethanol	Braganza JM	Chronic pancreatitis.	Lancet	2011	93
21488075	Ethanol	Trépo E	Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C.	Hepatology	2011	55
21521424	Ethanol	Taqi MM	Prodynorphin CpG-SNPs associated with alcohol dependence: elevated methylation in the brain of human alcoholics.	Addiction biology	2011	49
21721028	Ethanol	Marabita F	Genetic variation in the interleukin-28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection.	Hepatology	2011	39
21734388	Ethanol	Watson AJ	Colon cancer: a civilization disorder.	Digestive diseases	2011	39
22044102	Ethanol	Omalu B	Chronic traumatic encephalopathy in an Iraqi war veteran with posttraumatic stress disorder who committed suicide.	Neurosurgical focus	2011	54
22162228	Ethanol	Klein AP	Genetic susceptibility to pancreatic cancer.	Molecular carcinogenesis	2012	46
22320924	Ethanol	Gao B	Hepatoprotective and anti-inflammatory cytokines in alcoholic liver disease.	Journal of gastroenterology and hepatology	2012	51
22430805	Ethanol	Langevin SM	Peripheral blood DNA methylation profiles are indicative of head and neck squamous cell carcinoma: an epigenome-wide association study.	Epigenetics	2012	32
22521198	Ethanol	Leclercq S	Role of intestinal permeability and inflammation in the biological and behavioral control of alcohol-dependent subjects.	Brain, behavior, and immunity	2012	37
22765916	Ethanol	Redies C	Cadherins and neuropsychiatric disorders.	Brain research	2012	63
22841474	Ethanol	Meng F	Epigenetic regulation of miR-34a expression in alcoholic liver injury.	The American journal of pathology	2012	41
23142622	Ethanol	Aravinthan A	Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease.	Journal of hepatology	2013	31
23143602	Ethanol	Whitcomb DC	Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis.	Nature genetics	2012	48
23349641	Ethanol	Oksenberg N	Function and regulation of AUTS2, a gene implicated in autism and human evolution.	PLoS genetics	2013	29
23532958	Ethanol	Bertola A	Chronic plus binge ethanol feeding synergistically induces neutrophil infiltration and liver injury in mice: a critical role for E-selectin.	Hepatology	2013	77
23544014	Ethanol	Nickels S	Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors.	PLoS genetics	2013	45
23665288	Ethanol	Pais R	A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver.	Journal of hepatology	2013	67
23689081	Ethanol	Szabo G	MicroRNAs in liver disease.	Nature reviews. Gastroenterology & hepatology	2013	117
23867237	Ethanol	Vetreno RP	Increased receptor for advanced glycation end product expression in the human alcoholic prefrontal cortex is linked to adolescent drinking.	Neurobiology of disease	2013	45
23921128	Ethanol	Chen CL	Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells.	The Journal of clinical investigation	2013	46
24122827	Ethanol	Chen L	Epigenetic regulation of connective tissue growth factor by MicroRNA-214 delivery in exosomes from mouse or human hepatic stellate cells.	Hepatology	2014	37
24400890	Ethanol	McDaniel K	The functional role of microRNAs in alcoholic liver injury.	Journal of cellular and molecular medicine	2014	34
24445574	Ethanol	Singal AG	The effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma: a meta-analysis.	The American journal of gastroenterology	2014	46
24492484	Ethanol	Thapaliya S	Alcohol-induced autophagy contributes to loss in skeletal muscle mass.	Autophagy	2014	27
24586787	Ethanol	Kietzman HW	The teratogenic effects of prenatal ethanol exposure are exacerbated by Sonic Hedgehog or GLI2 haploinsufficiency in the mouse.	PloS one	2014	28
24629538	Ethanol	Leclercq S	Role of inflammatory pathways, blood mononuclear cells, and gut-derived bacterial products in alcohol dependence.	Biological psychiatry	2014	26
24638984	Ethanol	Giannelli G	Transforming growth factor-β as a therapeutic target in hepatocellular carcinoma.	Cancer research	2014	50
24670651	Ethanol	Song Y	Identification of genomic alterations in oesophageal squamous cell cancer.	Nature	2014	180
24705689	Ethanol	Muñoz M	Involvement of substance P and the NK-1 receptor in human pathology.	Amino acids	2014	23
24726381	Ethanol	Hashimoto-Torii K	Roles of heat shock factor 1 in neuronal response to fetal environmental risks and its relevance to brain disorders.	Neuron	2014	27
25011450	Ethanol	Holmes MV	Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data.	BMJ	2014	89
25390655	Ethanol	Willeit P	Leucocyte telomere length and risk of type 2 diabetes mellitus: new prospective cohort study and literature-based meta-analysis.	PloS one	2014	29
25439690	Ethanol	Ndiaye C	HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis.	The Lancet. Oncology	2014	73
25561778	Ethanol	Stojsavljević S	Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.	World journal of gastroenterology	2014	32
25645722	Ethanol	Villanueva A	DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma.	Hepatology	2015	26
25672924	Ethanol	Wang R	Effects of vascular risk factors and APOE ε4 on white matter integrity and cognitive decline.	Neurology	2015	20
25733647	Ethanol	Ekelund U	Physical activity and all-cause mortality across levels of overall and abdominal adiposity in European men and women: the European Prospective Investigation into Cancer and Nutrition Study (EPIC).	The American journal of clinical nutrition	2015	54
25747273	Ethanol	Lee JH	Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma.	Gastroenterology	2015	42
25880521	Ethanol	Alexander BT	Fetal programming and cardiovascular pathology.	Comprehensive Physiology	2015	17
25886648	Ethanol	Dare S	Relationship between smoking and obesity: a cross-sectional study of 499,504 middle-aged adults in the UK general population.	PloS one	2015	17
25930080	Ethanol	Roh YS	TLR2 and TLR9 contribute to alcohol-mediated liver injury through induction of CXCL1 and neutrophil infiltration.	American journal of physiology. Gastrointestinal and liver physiology	2015	17
26376349	Ethanol	Ohashi S	Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma.	Gastroenterology	2015	39
26582088	Ethanol	Uthaya Kumar DB	TLR4 Signaling via NANOG Cooperates With STAT3 to Activate Twist1 and Promote Formation of Tumor-Initiating Stem-Like Cells in Livers of Mice.	Gastroenterology	2016	11
26724859	Ethanol	Chen CL	NANOG Metabolically Reprograms Tumor-Initiating Stem-like Cells through Tumorigenic Changes in Oxidative Phosphorylation and Fatty Acid Metabolism.	Cell metabolism	2016	15
26763658	Ethanol	Wang F	DNA co-methylation modules in postmortem prefrontal cortex tissues of European Australians with alcohol use disorders.	Scientific reports	2016	10
26769846	Ethanol	Wang S	Increased hepatic receptor interacting protein kinase 3 expression due to impaired proteasomal functions contributes to alcohol-induced steatosis and liver injury.	Oncotarget	2016	11
26844476	Ethanol	Jamali R	Prediction of Nonalcoholic Fatty Liver Disease Via a Novel Panel of Serum Adipokines.	Medicine	2016	12
26850495	Ethanol	Mancina RM	The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.	Gastroenterology	2016	26
27431356	Ethanol	O'Donnell MJ	Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study.	Lancet	2016	48
27639178	Ethanol	Eguchi A	Extracellular vesicles released by hepatocytes from gastric infusion model of alcoholic liver disease contain a MicroRNA barcode that can be detected in blood.	Hepatology	2017	8
28118842	Ethanol	Coleman LG Jr	Microglial-derived miRNA let-7 and HMGB1 contribute to ethanol-induced neurotoxicity via TLR7.	Journal of neuroinflammation	2017	10
28530644	Ethanol	Yang AM	Intestinal fungi contribute to development of alcoholic liver disease.	The Journal of clinical investigation	2017	9
10766168	Sulfite	Ueki T	Hypermethylation of multiple genes in pancreatic adenocarcinoma.	Cancer research	2000	90
11984524	Sulfite	Hawkins N	CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability.	Gastroenterology	2002	97
16174854	Sulfite	Shen L	MGMT promoter methylation and field defect in sporadic colorectal cancer.	Journal of the National Cancer Institute	2005	157
16645207	Sulfite	Ogino S	Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis.	The Journal of molecular diagnostics 	2006	156
16951683	Sulfite	Chan TL	Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer.	Nature genetics	2006	68
17408664	Sulfite	Park IY	Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein.	Gastroenterology	2007	73
17875690	Sulfite	Taylor KH	Ultradeep bisulfite sequencing analysis of DNA methylation patterns in multiple gene promoters by 454 sequencing.	Cancer research	2007	77
17947713	Sulfite	Lu Q	Demethylation of CD40LG on the inactive X in T cells from women with lupus.	Journal of immunology	2007	91
18045775	Sulfite	Al-Mahdawi S	The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues.	Human molecular genetics	2008	90
18221536	Sulfite	Roll JD	DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines.	Molecular cancer	2008	54
19084528	Sulfite	Yu J	Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.	Gastroenterology	2009	53
19221000	Sulfite	Majid S	BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer.	Carcinogenesis	2009	60
19491193	Sulfite	Koga Y	Genome-wide screen of promoter methylation identifies novel markers in melanoma.	Genome research	2009	73
19535783	Sulfite	Melotte V	N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.	Journal of the National Cancer Institute	2009	50
19877066	Sulfite	Hashimoto K	DNA demethylation at specific CpG sites in the IL1B promoter in response to inflammatory cytokines in human articular chondrocytes.	Arthritis and rheumatism	2009	47
19897574	Sulfite	Kanduri M	Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia.	Blood	2010	46
19950268	Sulfite	Karouzakis E	DNA hypomethylation in rheumatoid arthritis synovial fibroblasts.	Arthritis and rheumatism	2009	55
20696752	Sulfite	Ceppi P	Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer.	Molecular cancer research 	2010	92
21350001	Sulfite	Li D	Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer.	Clinical cancer research 	2011	94
21772049	Sulfite	Kalac M	HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL.	Blood	2011	37
21969817	Sulfite	He Y	Hypomethylation of the hsa-miR-191 locus causes high expression of hsa-mir-191 and promotes the epithelial-to-mesenchymal transition in hepatocellular carcinoma.	Neoplasia	2011	37
22233696	Sulfite	Kimura T	A novel pit pattern identifies the precursor of colorectal cancer derived from sessile serrated adenoma.	The American journal of gastroenterology	2012	32
22589488	Sulfite	Mahapatra S	Global methylation profiling for risk prediction of prostate cancer.	Clinical cancer research 	2012	39
22689435	Sulfite	Neumann O	Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.	Hepatology	2012	42
22876840	Sulfite	Liu XH	MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5.	BMC cancer	2012	51
23056401	Sulfite	Takahashi M	The clinical significance of MiR-148a as a predictive biomarker in patients with advanced colorectal cancer.	PloS one	2012	46
24098911	Sulfite	Lu KH	Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression.	BMC cancer	2013	80
24448211	Sulfite	Zhubi A	Increased binding of MeCP2 to the GAD1 and RELN promoters may be mediated by an enrichment of 5-hmC in autism spectrum disorder (ASD) cerebellum.	Translational psychiatry	2014	45
24500968	Sulfite	Nones K	Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling.	International journal of cancer	2014	29
24504172	Sulfite	Kim HC	Collagen triple helix repeat containing 1 (CTHRC1) acts via ERK-dependent induction of MMP9 to promote invasion of colorectal cancer cells.	Oncotarget	2014	26
24806409	Sulfite	Liu EY	C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD.	Acta neuropathologica	2014	42
24929637	Sulfite	Dempster EL	Genome-wide methylomic analysis of monozygotic twins discordant for adolescent depression.	Biological psychiatry	2014	31
25608619	Sulfite	Zhang Z	microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma.	Molecular cancer	2015	20
25613496	Sulfite	Hu L	Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma.	Journal of experimental & clinical cancer research 	2015	52
25641194	Sulfite	Zhuo H	The aberrant expression of MEG3 regulated by UHRF1 predicts the prognosis of hepatocellular carcinoma.	Molecular carcinogenesis	2016	33
25663388	Sulfite	Steponaitiene R	Epigenetic silencing of miR-137 is a frequent event in gastric carcinogenesis.	Molecular carcinogenesis	2016	16
25822089	Sulfite	Liao J	Targeted disruption of DNMT1, DNMT3A and DNMT3B in human embryonic stem cells.	Nature genetics	2015	71
25996590	Sulfite	Janssen BG	Placental mitochondrial methylation and exposure to airborne particulate matter in the early life environment: An ENVIRONAGE birth cohort study.	Epigenetics	2015	25
26012557	Sulfite	Andoh-Noda T	Differentiation of multipotent neural stem cells derived from Rett syndrome patients is biased toward the astrocytic lineage.	Molecular brain	2015	18
26206665	Sulfite	Wang K	MDGA2 is a novel tumour suppressor cooperating with DMAP1 in gastric cancer and is associated with disease outcome.	Gut	2016	10
26437030	Sulfite	Kretzmer H	DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control.	Nature genetics	2015	29
26680004	Sulfite	Chen K	Loss of 5-hydroxymethylcytosine is linked to gene body hypermethylation in kidney cancer.	Cell research	2016	13
26707824	Sulfite	Fang S	Long noncoding RNA-HOTAIR affects chemoresistance by regulating HOXA1 methylation in small cell lung cancer cells.	Laboratory investigation; a journal of technical methods and pathology	2016	13
26923874	Sulfite	Johann PD	Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes.	Cancer cell	2016	31
26977886	Sulfite	Chun HE	Genome-Wide Profiles of Extra-cranial Malignant Rhabdoid Tumors Reveal Heterogeneity and Dysregulated Developmental Pathways.	Cancer cell	2016	14
28024084	Sulfite	Kim Y	Targeting the histone methyltransferase G9a activates imprinted genes and improves survival of a mouse model of Prader-Willi syndrome.	Nature medicine	2017	5
28215704	Sulfite	Spencer DH	CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression.	Cell	2017	12
8194005	Cisplatin	Mandard AM	Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations.	Cancer	1994	246
9053482	Cisplatin	-	International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group.	Journal of clinical oncology 	1997	198
9176490	Cisplatin	Heise C	ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents.	Nature medicine	1997	133
9704716	Cisplatin	Pegram MD	Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment.	Journal of clinical oncology 	1998	115
9927204	Cisplatin	Blandino G	Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy.	Oncogene	1999	97
10446958	Cisplatin	Yuan SS	BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo.	Cancer research	1999	142
10606224	Cisplatin	Brown JM	The hypoxic cell: a target for selective cancer therapy--eighteenth Bruce F. Cain Memorial Award lecture.	Cancer research	1999	111
12637505	Cisplatin	Mansouri A	Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells.	The Journal of biological chemistry	2003	85
14645242	Cisplatin	Dan HC	Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP).	The Journal of biological chemistry	2004	122
14702041	Cisplatin	Katayama H	Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53.	Nature genetics	2004	159
15208673	Cisplatin	Altomare DA	AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth.	Oncogene	2004	113
15469940	Cisplatin	Liu Q	Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215.	The Journal of biological chemistry	2004	85
15811630	Cisplatin	Albertella MR	The overexpression of specialized DNA polymerases in cancer.	DNA repair	2005	75
16289418	Cisplatin	Sieghart W	Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy.	Journal of hepatology	2006	62
16314626	Cisplatin	Burtness B	Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study.	Journal of clinical oncology 	2005	171
16357177	Cisplatin	Nawrocki ST	Bortezomib sensitizes pancreatic cancer cells to endoplasmic reticulum stress-mediated apoptosis.	Cancer research	2005	95
16951222	Cisplatin	Sok JC	Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting.	Clinical cancer research 	2006	141
17227995	Cisplatin	Lewis IJ	Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup.	Journal of the National Cancer Institute	2007	64
17671210	Cisplatin	Jacquemont C	Proteasome function is required for DNA damage response and fanconi anemia pathway activation.	Cancer research	2007	73
17923843	Cisplatin	Li SD	Tumor-targeted delivery of siRNA by self-assembled nanoparticles.	Molecular therapy 	2008	95
17947225	Cisplatin	Rosell R	Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer.	Annals of oncology 	2008	61
18206965	Cisplatin	Lim ST	Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation.	Molecular cell	2008	151
18316592	Cisplatin	Ohta T	Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth.	Cancer research	2008	174
18469852	Cisplatin	Chekenya M	The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling.	Oncogene	2008	54
18495226	Cisplatin	Gotlieb WH	In vitro metformin anti-neoplastic activity in epithelial ovarian cancer.	Gynecologic oncology	2008	67
18509321	Cisplatin	Zhou H	Urinary exosomal transcription factors, a new class of biomarkers for renal disease.	Kidney international	2008	53
18519691	Cisplatin	Zhang S	Identification and characterization of ovarian cancer-initiating cells from primary human tumors.	Cancer research	2008	391
18594319	Cisplatin	Ramlau R	A phase II study of Tg4010 (Mva-Muc1-Il2) in association with chemotherapy in patients with stage III/IV Non-small cell lung cancer.	Journal of thoracic oncology 	2008	52
18728788	Cisplatin	Levina V	Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties.	PloS one	2008	140
19360350	Cisplatin	Fujii H	Sphere-forming stem-like cell populations with drug resistance in human sarcoma cell lines.	International journal of oncology	2009	50
19584296	Cisplatin	Arumugam T	Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer.	Cancer research	2009	241
19706487	Cisplatin	Sayan AE	SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer.	Proceedings of the National Academy of Sciences of the United States of America	2009	48
19802016	Cisplatin	Abedini MR	Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-induced, p53-dependent ubiquitination of FLICE-like inhibitory protein.	Oncogene	2010	42
19881547	Cisplatin	Tesniere A	Immunogenic death of colon cancer cells treated with oxaliplatin.	Oncogene	2010	142
20049901	Cisplatin	Morigi M	Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury.	Stem cells	2010	51
20068070	Cisplatin	Kwok JM	FOXM1 confers acquired cisplatin resistance in breast cancer cells.	Molecular cancer research 	2010	72
20074550	Cisplatin	Teng Y	Wnt/beta-catenin signaling regulates cancer stem cells in lung cancer A549 cells.	Biochemical and biophysical research communications	2010	67
20099276	Cisplatin	Pogribny IP	Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin.	International journal of cancer	2010	94
20107315	Cisplatin	Hirai H	MK-1775, a small molecule Wee1 inhibitor, enhances anti-tumor efficacy of various DNA-damaging agents, including 5-fluorouracil.	Cancer biology & therapy	2010	65
20215556	Cisplatin	Sikora AG	Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma in vivo and synergizes with chemotherapy.	Clinical cancer research 	2010	43
20371173	Cisplatin	Guo L	Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.	European journal of cancer	2010	48
20670951	Cisplatin	Harrington KJ	Phase I/II study of oncolytic HSV GM-CSF in combination with radiotherapy and cisplatin in untreated stage III/IV squamous cell cancer of the head and neck.	Clinical cancer research 	2010	60
20697079	Cisplatin	Rischin D	Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial.	Journal of clinical oncology 	2010	136
20943634	Cisplatin	Chan AT	Nasopharyngeal carcinoma.	Annals of oncology 	2010	48
20947521	Cisplatin	Hall CA	Hippo pathway effector Yap is an ovarian cancer oncogene.	Cancer research	2010	71
21124918	Cisplatin	Leung EL	Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.	PloS one	2010	115
21151176	Cisplatin	Martins I	Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress.	Oncogene	2011	67
21205897	Cisplatin	Ren D	Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism.	Proceedings of the National Academy of Sciences of the United States of America	2011	118
21224400	Cisplatin	Ye G	MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance.	Journal of cell science	2011	40
21257722	Cisplatin	Dickson MA	A phase I clinical trial of safingol in combination with cisplatin in advanced solid tumors.	Clinical cancer research 	2011	39
21325880	Cisplatin	O'Donovan TR	Induction of autophagy by drug-resistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics.	Autophagy	2011	78
21327457	Cisplatin	Yang Z	Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation.	Annals of surgical oncology	2011	221
21334406	Cisplatin	Chen X	Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations.	Journal of hepatology	2011	38
21425153	Cisplatin	Hsu HS	Chemoresistance of lung cancer stemlike cells depends on activation of Hsp27.	Cancer	2011	40
21532889	Cisplatin	Rattan R	Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo.	Neoplasia	2011	85
21550168	Cisplatin	Noguchi S	MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells.	Cancer letters	2011	38
21684283	Cisplatin	Tan IB	Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy.	Gastroenterology	2011	73
21702042	Cisplatin	Vinall RL	MiR-34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53-Rb pathway status.	International journal of cancer	2012	31
21725369	Cisplatin	Sun L	MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1.	Oncogene	2012	79
21726833	Cisplatin	Lee TK	CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation.	Cell stem cell	2011	148
21782914	Cisplatin	Op de Beeck K	Apoptosis in acquired and genetic hearing impairment: the programmed death of the hair cell.	Hearing research	2011	37
21903745	Cisplatin	Curran WJ Jr	Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.	Journal of the National Cancer Institute	2011	174
21909139	Cisplatin	Yue P	Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells.	Oncogene	2012	43
22019520	Cisplatin	Quoix E	Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial.	The Lancet. Oncology	2011	73
22112324	Cisplatin	Kim CH	miRNA signature associated with outcome of gastric cancer patients following chemotherapy.	BMC medical genomics	2011	39
22178121	Cisplatin	Lee NY	Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial.	The Lancet. Oncology	2012	61
22193543	Cisplatin	Donzelli S	MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function.	Cell death and differentiation	2012	43
22249249	Cisplatin	Zeller C	Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling.	Oncogene	2012	61
22278418	Cisplatin	Chen G	Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents.	The Journal of clinical endocrinology and metabolism	2012	37
22302096	Cisplatin	Sehdev V	The aurora kinase A inhibitor MLN8237 enhances cisplatin-induced cell death in esophageal adenocarcinoma cells.	Molecular cancer therapeutics	2012	38
22308459	Cisplatin	Meirelles K	Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance.	Proceedings of the National Academy of Sciences of the United States of America	2012	39
22406827	Cisplatin	Guo XL	Targeting autophagy potentiates chemotherapy-induced apoptosis and proliferation inhibition in hepatocarcinoma cells.	Cancer letters	2012	44
22429801	Cisplatin	Haslehurst AM	EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer.	BMC cancer	2012	64
22431999	Cisplatin	Bruno S	Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury.	PloS one	2012	135
22465665	Cisplatin	Fu X	Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells.	FEBS letters	2012	50
22473169	Cisplatin	Rossi A	Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data.	Journal of clinical oncology 	2012	46
22473773	Cisplatin	Shan J	Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma.	Hepatology	2012	74
22498306	Cisplatin	Cheng W	MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells.	The FEBS journal	2012	64
22576688	Cisplatin	Wang Y	Long non-coding RNA UCA1a(CUDR) promotes proliferation and tumorigenesis of bladder cancer.	International journal of oncology	2012	46
22590557	Cisplatin	Wilkerson MD	Differential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylation.	PloS one	2012	50
22647982	Cisplatin	Zhou C	Monitoring autophagic flux by an improved tandem fluorescent-tagged LC3 (mTagRFP-mWasabi-LC3) reveals that high-dose rapamycin impairs autophagic flux in cancer cells.	Autophagy	2012	43
22778317	Cisplatin	Gridelli C	First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer: the TORCH randomized trial.	Journal of clinical oncology 	2012	64
22847005	Cisplatin	Bourguignon LY	Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.	The Journal of biological chemistry	2012	64
22928012	Cisplatin	Lohberger B	Aldehyde dehydrogenase 1, a potential marker for cancer stem cells in human sarcoma.	PloS one	2012	31
22987153	Cisplatin	Karanja KK	DNA2 and EXO1 in replication-coupled, homology-directed repair and in the interplay between HDR and the FA/BRCA network.	Cell cycle	2012	33
23071587	Cisplatin	Gout S	Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma.	PloS one	2012	33
23251001	Cisplatin	Kimple RJ	Development and characterization of HPV-positive and HPV-negative head and neck squamous cell carcinoma tumorgrafts.	Clinical cancer research 	2013	31
23372675	Cisplatin	Zhao G	MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma.	PloS one	2013	66
23449973	Cisplatin	Fortier AM	Keratin 8 and 18 loss in epithelial cancer cells increases collective cell migration and cisplatin sensitivity through claudin1 up-regulation.	The Journal of biological chemistry	2013	41
23461856	Cisplatin	Ma L	Cancer stem-like cell properties are regulated by EGFR/AKT/β-catenin signaling and preferentially inhibited by gefitinib in nasopharyngeal carcinoma.	The FEBS journal	2013	26
23483142	Cisplatin	Xu Y	miR-101 inhibits autophagy and enhances cisplatin-induced apoptosis in hepatocellular carcinoma cells.	Oncology reports	2013	39
23542177	Cisplatin	Mao B	SIRT1 regulates YAP2-mediated cell proliferation and chemoresistance in hepatocellular carcinoma.	Oncogene	2014	30
23548269	Cisplatin	Huntoon CJ	ATR inhibition broadly sensitizes ovarian cancer cells to chemotherapy independent of BRCA status.	Cancer research	2013	38
23563269	Cisplatin	Murtaza M	Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA.	Nature	2013	320
23610451	Cisplatin	Listerman I	The major reverse transcriptase-incompetent splice variant of the human telomerase protein inhibits telomerase activity but protects from apoptosis.	Cancer research	2013	32
23783243	Cisplatin	Shelton LM	Role of Nrf2 in protection against acute kidney injury.	Kidney international	2013	28
23816960	Cisplatin	Sequist LV	Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations.	Journal of clinical oncology 	2013	472
23816967	Cisplatin	Yang JC	Symptom control and quality of life in LUX-Lung 3: a phase III study of afatinib or cisplatin/pemetrexed in patients with advanced lung adenocarcinoma with EGFR mutations.	Journal of clinical oncology 	2013	59
23845449	Cisplatin	Vélayoudom-Céphise FL	Are G3 ENETS neuroendocrine neoplasms heterogeneous?	Endocrine-related cancer	2013	31
23967051	Cisplatin	Yasuda K	Ovarian cancer stem cells are enriched in side population and aldehyde dehydrogenase bright overlapping population.	PloS one	2013	29
24068565	Cisplatin	Cao W	miR-34a regulates cisplatin-induce gastric cancer cell death by modulating PI3K/AKT/survivin pathway.	Tumour biology 	2014	21
24081734	Cisplatin	Fassnacht M	Update in adrenocortical carcinoma.	The Journal of clinical endocrinology and metabolism	2013	50
24099915	Cisplatin	Dong Z	MicroRNA-31 inhibits cisplatin-induced apoptosis in non-small cell lung cancer cells by regulating the drug transporter ABCB9.	Cancer letters	2014	24
24165223	Cisplatin	Sun XP	Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer.	The FEBS journal	2014	20
24318570	Cisplatin	Liu SY	High aldehyde dehydrogenase activity identifies cancer stem cells in human cervical cancer.	Oncotarget	2013	29
24407244	Cisplatin	Zhang P	Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer.	Cell death & disease	2014	24
24439929	Cisplatin	Wu YL	Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial.	The Lancet. Oncology	2014	282
24495516	Cisplatin	Xia JT	MicroRNA-362 induces cell proliferation and apoptosis resistance in gastric cancer by activation of NF-κB signaling.	Journal of translational medicine	2014	23
24554720	Cisplatin	Joshi PM	Ovarian cancer-associated mutations disable catalytic activity of CDK12, a kinase that promotes homologous recombination repair and resistance to cisplatin and poly(ADP-ribose) polymerase inhibitors.	The Journal of biological chemistry	2014	24
24626199	Cisplatin	Karanja KK	Preventing over-resection by DNA2 helicase/nuclease suppresses repair defects in Fanconi anemia cells.	Cell cycle	2014	22
24668391	Cisplatin	Tsuburaya A	Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.	The British journal of surgery	2014	23
24669930	Cisplatin	He C	Nanoscale metal-organic frameworks for the co-delivery of cisplatin and pooled siRNAs to enhance therapeutic efficacy in drug-resistant ovarian cancer cells.	Journal of the American Chemical Society	2014	31
24720540	Cisplatin	Guo S	Co-delivery of cisplatin and rapamycin for enhanced anticancer therapy through synergistic effects and microenvironment modulation.	ACS nano	2014	22
24848258	Cisplatin	Shapiro IM	Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship.	Science translational medicine	2014	44
24947926	Cisplatin	Yoon C	CD44 expression denotes a subpopulation of gastric cancer cells in which Hedgehog signaling promotes chemotherapy resistance.	Clinical cancer research 	2014	26
24960601	Cisplatin	Choi W	Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer.	Nature reviews. Urology	2014	40
24965569	Cisplatin	Iveson T	Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study.	The Lancet. Oncology	2014	76
24989332	Cisplatin	Hassan R	Phase 1 study of the antimesothelin immunotoxin SS1P in combination with pemetrexed and cisplatin for front-line therapy of pleural mesothelioma and correlation of tumor response with serum mesothelin, megakaryocyte potentiating factor, and cancer antigen 125.	Cancer	2014	41
25104095	Cisplatin	Bryant C	Chk1 inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers.	BMC cancer	2014	23
25110412	Cisplatin	Grossi V	p38α MAPK pathway: a key factor in colorectal cancer therapy and chemoresistance.	World journal of gastroenterology	2014	30
25228385	Cisplatin	Tan X	miR-638 mediated regulation of BRCA1 affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancer.	Breast cancer research 	2014	30
25231400	Cisplatin	Hassan R	Phase II clinical trial of amatuximab, a chimeric antimesothelin antibody with pemetrexed and cisplatin in advanced unresectable pleural mesothelioma.	Clinical cancer research 	2014	31
25234467	Cisplatin	Guo J	MicroRNA-217 functions as a tumour suppressor gene and correlates with cell resistance to cisplatin in lung cancer.	Molecules and cells	2014	20
25249556	Cisplatin	Yu G	Pseudogene PTENP1 functions as a competing endogenous RNA to suppress clear-cell renal cell carcinoma progression.	Molecular cancer therapeutics	2014	44
25428916	Cisplatin	Desiderio V	Increased fucosylation has a pivotal role in invasive and metastatic properties of head and neck cancer stem cells.	Oncotarget	2015	19
25432176	Cisplatin	Kolev VN	PI3K/mTOR dual inhibitor VS-5584 preferentially targets cancer stem cells.	Cancer research	2015	42
25537512	Cisplatin	Chiu WT	FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells.	Oncotarget	2015	35
25589191	Cisplatin	Yang JC	Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials.	The Lancet. Oncology	2015	226
25596659	Cisplatin	Giralt J	Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial.	The Lancet. Oncology	2015	25
25596660	Cisplatin	Mesía R	Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial.	The Lancet. Oncology	2015	20
25607838	Cisplatin	Morigi M	Sirtuin 3-dependent mitochondrial dynamic improvements protect against acute kidney injury.	The Journal of clinical investigation	2015	35
25609015	Cisplatin	Litchfield K	Whole-exome sequencing reveals the mutational spectrum of testicular germ cell tumours.	Nature communications	2015	18
25658419	Cisplatin	Xu J	β-Catenin is required for the tumorigenic behavior of triple-negative breast cancer cells.	PloS one	2015	18
25682441	Cisplatin	Fuse N	Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients.	Gastric cancer 	2016	21
25701171	Cisplatin	Paz-Ares L	Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study.	The Lancet. Oncology	2015	31
25721211	Cisplatin	Zhao Z	miR-15b regulates cisplatin resistance and metastasis by targeting PEBP4 in human lung adenocarcinoma cells.	Cancer gene therapy	2015	15
25831546	Cisplatin	Srivastava AK	Enhanced expression of DNA polymerase eta contributes to cisplatin resistance of ovarian cancer stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2015	30
25832687	Cisplatin	Tan T	Concurrent chemo-radiation with or without induction gemcitabine, Carboplatin, and Paclitaxel: a randomized, phase 2/3 trial in locally advanced nasopharyngeal carcinoma.	International journal of radiation oncology, biology, physics	2015	35
25867064	Cisplatin	Zhu X	miR-186 regulation of Twist1 and ovarian cancer sensitivity to cisplatin.	Oncogene	2016	28
25868979	Cisplatin	Canino C	A STAT3-NFkB/DDIT3/CEBPβ axis modulates ALDH1A3 expression in chemoresistant cell subpopulations.	Oncotarget	2015	15
25871967	Cisplatin	Li X	MicroRNA-449a inhibits proliferation and induces apoptosis by directly repressing E2F3 in gastric cancer.	Cellular physiology and biochemistry 	2015	16
25972604	Cisplatin	Challagundla KB	Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy.	Journal of the National Cancer Institute	2015	50
25995442	Cisplatin	Liu G	Augmentation of response to chemotherapy by microRNA-506 through regulation of RAD51 in serous ovarian cancers.	Journal of the National Cancer Institute	2015	24
26020117	Cisplatin	Cioffi M	Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancer.	Scientific reports	2015	22
26026166	Cisplatin	Tanaka K	miR-27 is associated with chemoresistance in esophageal cancer through transformation of normal fibroblasts to cancer-associated fibroblasts.	Carcinogenesis	2015	20
26045340	Cisplatin	Thatcher N	Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial.	The Lancet. Oncology	2015	69
26178914	Cisplatin	Balermpas P	CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG).	International journal of cancer	2016	27
26201611	Cisplatin	Wu HM	Hypoxia-induced autophagy mediates cisplatin resistance in lung cancer cells.	Scientific reports	2015	18
26325371	Cisplatin	Liu M	RY-2f, an isoflavone analog, overcomes cisplatin resistance to inhibit ovarian tumorigenesis via targeting the PI3K/AKT/mTOR signaling pathway.	Oncotarget	2015	15
26462739	Cisplatin	Pariente R	Melatonin sensitizes human cervical cancer HeLa cells to cisplatin-induced cytotoxicity and apoptosis: effects on oxidative stress and DNA fragmentation.	Journal of pineal research	2016	17
26497652	Cisplatin	Teschendorff AE	HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer.	Genome medicine	2015	26
26517239	Cisplatin	Vendetti FP	The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in vivo.	Oncotarget	2015	26
26598537	Cisplatin	Cierna Z	Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors.	Annals of oncology 	2016	16
26654944	Cisplatin	Choi EJ	FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells.	Oncotarget	2016	12
26756568	Cisplatin	Zhou XL	High expression of long non-coding RNA AFAP1-AS1 predicts chemoradioresistance and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.	Molecular carcinogenesis	2016	16
26799420	Cisplatin	Su X	Overexpression of TRIM14 promotes tongue squamous cell carcinoma aggressiveness by activating the NF-κB signaling pathway.	Oncotarget	2016	12
26801672	Cisplatin	Liu S	NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer.	Tumour biology 	2016	10
26822397	Cisplatin	Fujitani K	Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial.	The Lancet. Oncology	2016	32
26909612	Cisplatin	Zhu X	miR-194 inhibits the proliferation, invasion, migration, and enhances the chemosensitivity of non-small cell lung cancer cells by targeting forkhead box A1 protein.	Oncotarget	2016	14
26989074	Cisplatin	Shen H	MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer.	Oncotarget	2016	11
27013395	Cisplatin	Morrow CJ	Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study.	Annals of oncology 	2016	14
27199349	Cisplatin	Langsch S	miR-29b Mediates NF-κB Signaling in KRAS-Induced Non-Small Cell Lung Cancers.	Cancer research	2016	14
27287412	Cisplatin	Shintani Y	IL-6 Secreted from Cancer-Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial-Mesenchymal Transition Signaling.	Journal of thoracic oncology 	2016	17
27381626	Cisplatin	Ter Brugge P	Mechanisms of Therapy Resistance in Patient-Derived Xenograft Models of BRCA1-Deficient Breast Cancer.	Journal of the National Cancer Institute	2016	11
27440269	Cisplatin	Lok BH	PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer.	Clinical cancer research 	2017	13
27591936	Cisplatin	Pan J	Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells.	Cancer letters	2016	20
27609068	Cisplatin	Wang Y	Long non-coding RNA LINC00161 sensitises osteosarcoma cells to cisplatin-induced apoptosis by regulating the miR-645-IFIT2 axis.	Cancer letters	2016	18
27776843	Cisplatin	Al-Batran SE	Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial.	The Lancet. Oncology	2016	17
27875524	Cisplatin	Li X	microRNA-137 promotes apoptosis in ovarian cancer cells via the regulation of XIAP.	British journal of cancer	2017	8
27888811	Cisplatin	Hientz K	The role of p53 in cancer drug resistance and targeted chemotherapy.	Oncotarget	2017	18
27911863	Cisplatin	Wang Q	Correlation of long non-coding RNA H19 expression with cisplatin-resistance and clinical outcome in lung adenocarcinoma.	Oncotarget	2017	8
27935869	Cisplatin	Dai Y	The involvement of Bcl-2 family proteins in AKT-regulated cell survival in cisplatin resistant epithelial ovarian cancer.	Oncotarget	2017	6
28027578	Cisplatin	Li D	Long noncoding RNA HULC modulates the phosphorylation of YB-1 through serving as a scaffold of extracellular signal-regulated kinase and YB-1 to enhance hepatocarcinogenesis.	Hepatology	2017	17
28163000	Cisplatin	Cunningham D	Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2-3 trial.	The Lancet. Oncology	2017	7
28192397	Cisplatin	Shi ZM	Downregulation of miR-218 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling.	Oncogene	2017	10
28196596	Cisplatin	Gardner EE	Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis.	Cancer cell	2017	14
28240761	Cisplatin	Elia G	Hepatocellular carcinoma and CXCR3 chemokines: a narrative review.	La Clinica terapeutica	2017	6
10567338	Etoposide	Masumoto J	ASC, a novel 22-kDa protein, aggregates during apoptosis of human promyelocytic leukemia HL-60 cells.	The Journal of biological chemistry	1999	117
12773551	Etoposide	Zhu WG	Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21(Cip1) promoter.	Molecular and cellular biology	2003	77
14612912	Etoposide	Robey RW	Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity.	British journal of cancer	2003	89
16569192	Etoposide	Fu X	Regulation of apoptosis by a prostate-specific and prostate cancer-associated noncoding gene, PCGEM1.	DNA and cell biology	2006	70
17310986	Etoposide	Lue H	Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity.	Oncogene	2007	89
17533374	Etoposide	Maxwell PJ	HIF-1 and NF-kappaB-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells.	Oncogene	2007	67
18559509	Etoposide	Wang L	Kaposi's sarcoma-associated herpesvirus confers a survival advantage to endothelial cells.	Cancer research	2008	61
18663354	Etoposide	Tagscherer KE	Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins.	Oncogene	2008	63
19118018	Etoposide	Ara T	Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cells.	Cancer research	2009	56
20625515	Etoposide	Song J	Characterization of side populations in HNSCC: highly invasive, chemoresistant and abnormal Wnt signaling.	PloS one	2010	45
21212465	Etoposide	Leontieva OV	DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence.	Aging	2010	96
21555371	Etoposide	Asiedu MK	TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype.	Cancer research	2011	76
22328513	Etoposide	Singh R	Downregulation of BCL2 by miRNAs augments drug-induced apoptosis--a combined computational and experimental approach.	Journal of cell science	2012	33
23437304	Etoposide	Wu CW	MicroRNA-18a attenuates DNA damage repair through suppressing the expression of ataxia telangiectasia mutated in colorectal cancer.	PloS one	2013	29
23512991	Etoposide	Batey MA	Preclinical evaluation of a novel ATM inhibitor, KU59403, in vitro and in vivo in p53 functional and dysfunctional models of human cancer.	Molecular cancer therapeutics	2013	32
23851503	Etoposide	Huang CK	Autocrine/paracrine mechanism of interleukin-17B receptor promotes breast tumorigenesis through NF-κB-mediated antiapoptotic pathway.	Oncogene	2014	22
25605014	Etoposide	Kirk JS	Top2a identifies and provides epigenetic rationale for novel combination therapeutic strategies for aggressive prostate cancer.	Oncotarget	2015	16
25639871	Etoposide	Seviour EG	Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer.	Oncogene	2016	14
25675296	Etoposide	Moriwaki K	Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death.	Cell death & disease	2015	18
12045200	Sirolimus	Goncharova EA	Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM).	The Journal of biological chemistry	2002	125
12782577	Sirolimus	Choe G	Analysis of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma patients in vivo.	Cancer research	2003	109
12901945	Sirolimus	Huang S	Targeting mTOR signaling for cancer therapy.	Current opinion in pharmacology	2003	80
14744976	Sirolimus	Virmani R	Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?	Circulation	2004	131
15156201	Sirolimus	Majumder PK	mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways.	Nature medicine	2004	282
15501954	Sirolimus	Zhou X	Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers.	Clinical cancer research 	2004	90
15641016	Sirolimus	Foulstone E	Insulin-like growth factor ligands, receptors, and binding proteins in cancer.	The Journal of pathology	2005	67
15647370	Sirolimus	Kang S	Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic.	Proceedings of the National Academy of Sciences of the United States of America	2005	218
15723049	Sirolimus	Ohanna M	Atrophy of S6K1(-/-) skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control.	Nature cell biology	2005	105
15833867	Sirolimus	Takeuchi H	Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors.	Cancer research	2005	163
15916903	Sirolimus	Fuchs BC	Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime?	Seminars in cancer biology	2005	131
15955899	Sirolimus	Chan S	Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer.	Journal of clinical oncology 	2005	105
16075055	Sirolimus	Shiojima I	Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure.	The Journal of clinical investigation	2005	271
16203860	Sirolimus	Yu WH	Macroautophagy--a novel Beta-amyloid peptide-generating pathway activated in Alzheimer's disease.	The Journal of cell biology	2005	237
16267020	Sirolimus	Amornphimoltham P	Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck.	Cancer research	2005	78
16341243	Sirolimus	Thomas GV	Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer.	Nature medicine	2006	169
16489002	Sirolimus	Klos KS	ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells.	Cancer research	2006	61
16585191	Sirolimus	Wang L	Immortalization of primary endothelial cells by the K1 protein of Kaposi's sarcoma-associated herpesvirus.	Cancer research	2006	66
16714284	Sirolimus	Cao Y	Autophagy is disrupted in a knock-in mouse model of juvenile neuronal ceroid lipofuscinosis.	The Journal of biological chemistry	2006	79
16740688	Sirolimus	Del Bufalo D	Antiangiogenic potential of the Mammalian target of rapamycin inhibitor temsirolimus.	Cancer research	2006	63
16799564	Sirolimus	Androutsellis-Theotokis A	Notch signalling regulates stem cell numbers in vitro and in vivo.	Nature	2006	271
16849518	Sirolimus	Koumenis C	"Translating" tumor hypoxia: unfolded protein response (UPR)-dependent and UPR-independent pathways.	Molecular cancer research 	2006	71
16904612	Sirolimus	Sodhi A	The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor.	Cancer cell	2006	65
16904613	Sirolimus	Phung TL	Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin.	Cancer cell	2006	152
16912159	Sirolimus	Wang MY	Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells.	Cancer research	2006	100
16959574	Sirolimus	Inoki K	TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth.	Cell	2006	372
17010674	Sirolimus	Wei G	Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance.	Cancer cell	2006	149
17031397	Sirolimus	Duran I	A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas.	British journal of cancer	2006	76
17047067	Sirolimus	Cao C	Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells.	Cancer research	2006	97
17172425	Sirolimus	Kuo PL	Plumbagin induces G2-M arrest and autophagy by inhibiting the AKT/mammalian target of rapamycin pathway in breast cancer cells.	Molecular cancer therapeutics	2006	75
17273556	Sirolimus	Le Bacquer O	Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2.	The Journal of clinical investigation	2007	97
17275731	Sirolimus	Tsang CK	Targeting mammalian target of rapamycin (mTOR) for health and diseases.	Drug discovery today	2007	109
17360704	Sirolimus	Roux PP	RAS/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation.	The Journal of biological chemistry	2007	222
17361185	Sirolimus	Wilker EW	14-3-3sigma controls mitotic translation to facilitate cytokinesis.	Nature	2007	80
17363557	Sirolimus	Mabuchi S	RAD001 (Everolimus) delays tumor onset and progression in a transgenic mouse model of ovarian cancer.	Cancer research	2007	59
17395690	Sirolimus	Aoki H	Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways.	Molecular pharmacology	2007	130
17440983	Sirolimus	Pantuck AJ	Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy.	Cancer	2007	85
17465001	Sirolimus	Pazienza V	The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms.	Hepatology	2007	64
17546049	Sirolimus	Bauer S	KIT oncogenic signaling mechanisms in imatinib-resistant gastrointestinal stromal tumor: PI3-kinase/AKT is a crucial survival pathway.	Oncogene	2007	60
17671177	Sirolimus	Ma L	Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer.	Cancer research	2007	58
17699757	Sirolimus	Armengol G	4E-binding protein 1: a key molecular "funnel factor" in human cancer with clinical implications.	Cancer research	2007	87
17804702	Sirolimus	Fan QW	A dual phosphoinositide-3-kinase alpha/mTOR inhibitor cooperates with blockade of epidermal growth factor receptor in PTEN-mutant glioma.	Cancer research	2007	66
17913600	Sirolimus	Swiech L	Role of mTOR in physiology and pathology of the nervous system.	Biochimica et biophysica acta	2008	99
18080139	Sirolimus	Martignoni G	PEComas: the past, the present and the future.	Virchows Archiv 	2008	93
18089801	Sirolimus	Masri J	mTORC2 activity is elevated in gliomas and promotes growth and cell motility via overexpression of rictor.	Cancer research	2007	92
18276609	Sirolimus	Tang G	Autophagy induced by Alexander disease-mutant GFAP accumulation is regulated by p38/MAPK and mTOR signaling pathways.	Human molecular genetics	2008	53
18342602	Sirolimus	Ozcan U	Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis.	Molecular cell	2008	165
18356598	Sirolimus	Zhou D	Human immunodeficiency virus type-1 infection inhibits autophagy.	AIDS	2008	66
18367868	Sirolimus	Mammucari C	Downstream of Akt: FoxO3 and mTOR in the regulation of autophagy in skeletal muscle.	Autophagy	2008	76
18393362	Sirolimus	Yin XM	Autophagy in the liver.	Hepatology	2008	76
18424697	Sirolimus	Basu S	Cutting edge: Foxp3-mediated induction of pim 2 allows human T regulatory cells to preferentially expand in rapamycin.	Journal of immunology	2008	57
18583310	Sirolimus	Yung HW	Evidence of placental translation inhibition and endoplasmic reticulum stress in the etiology of human intrauterine growth restriction.	The American journal of pathology	2008	96
18653228	Sirolimus	Motzer RJ	Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial.	Lancet	2008	689
18669866	Sirolimus	Perrone F	PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients.	Annals of oncology 	2009	114
18679422	Sirolimus	Zhuang D	C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells.	Oncogene	2008	56
18684977	Sirolimus	Golovina TN	CD28 costimulation is essential for human T regulatory expansion and function.	Journal of immunology	2008	55
18722121	Sirolimus	Carrière A	Oncogenic MAPK signaling stimulates mTORC1 activity by promoting RSK-mediated raptor phosphorylation.	Current biology 	2008	119
18725989	Sirolimus	Kinkade CW	Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model.	The Journal of clinical investigation	2008	158
18768809	Sirolimus	Fujishita T	Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in ApcDelta716 mice.	Proceedings of the National Academy of Sciences of the United States of America	2008	57
18787170	Sirolimus	Mao JH	FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression.	Science	2008	138
18846101	Sirolimus	Wouters BG	Hypoxia signalling through mTOR and the unfolded protein response in cancer.	Nature reviews. Cancer	2008	247
18922904	Sirolimus	Buck E	Feedback mechanisms promote cooperativity for small molecule inhibitors of epidermal and insulin-like growth factor receptors.	Cancer research	2008	82
18929564	Sirolimus	Villanueva A	Pivotal role of mTOR signaling in hepatocellular carcinoma.	Gastroenterology	2008	186
19029981	Sirolimus	Engelman JA	Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers.	Nature medicine	2008	484
19033662	Sirolimus	Lu Z	The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells.	The Journal of clinical investigation	2008	117
19055754	Sirolimus	Marty B	Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells.	Breast cancer research 	2008	63
19185849	Sirolimus	Guertin DA	mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice.	Cancer cell	2009	149
19211884	Sirolimus	Zhou J	Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice.	The Journal of neuroscience 	2009	149
19223493	Sirolimus	Yu G	Overexpression of phosphorylated mammalian target of rapamycin predicts lymph node metastasis and prognosis of chinese patients with gastric cancer.	Clinical cancer research 	2009	51
19246562	Sirolimus	Cullion K	Targeting the Notch1 and mTOR pathways in a mouse T-ALL model.	Blood	2009	50
19261747	Sirolimus	Puzio-Kuter AM	Inactivation of p53 and Pten promotes invasive bladder cancer.	Genes & development	2009	98
19264150	Sirolimus	Foster DA	Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells.	Biochimica et biophysica acta	2009	78
19282848	Sirolimus	Dankort D	Braf(V600E) cooperates with Pten loss to induce metastatic melanoma.	Nature genetics	2009	324
19326431	Sirolimus	Narayanan NK	Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice.	International journal of cancer	2009	60
19357233	Sirolimus	Trendelenburg AU	Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size.	American journal of physiology. Cell physiology	2009	168
19372546	Sirolimus	Breuleux M	Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K/mTOR inhibition.	Molecular cancer therapeutics	2009	75
19420259	Sirolimus	Di Nardo A	Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner.	The Journal of neuroscience 	2009	63
19451225	Sirolimus	James MF	NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth.	Molecular and cellular biology	2009	69
19451229	Sirolimus	López-Lago MA	Loss of the tumor suppressor gene NF2, encoding merlin, constitutively activates integrin-dependent mTORC1 signaling.	Molecular and cellular biology	2009	47
19501590	Sirolimus	Mueller MT	Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer.	Gastroenterology	2009	81
19535919	Sirolimus	Zhu H	Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells.	Autophagy	2009	113
19543393	Sirolimus	Strauss L	Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin.	PloS one	2009	59
19589955	Sirolimus	Mayhew DL	Translational signaling responses preceding resistance training-mediated myofiber hypertrophy in young and old humans.	Journal of applied physiology	2009	57
19625624	Sirolimus	Guo D	The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis.	Proceedings of the National Academy of Sciences of the United States of America	2009	84
19641186	Sirolimus	Gupta M	Inhibition of histone deacetylase overcomes rapamycin-mediated resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling through mTORC2.	Blood	2009	58
19644473	Sirolimus	Liu P	Targeting the phosphoinositide 3-kinase pathway in cancer.	Nature reviews. Drug discovery	2009	563
19665249	Sirolimus	Newell P	Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo.	Journal of hepatology	2009	52
19773376	Sirolimus	Kim KW	Combined Bcl-2/mammalian target of rapamycin inhibition leads to enhanced radiosensitization via induction of apoptosis and autophagy in non-small cell lung tumor xenograft model.	Clinical cancer research 	2009	47
19789349	Sirolimus	Konstantinidou G	Dual phosphoinositide 3-kinase/mammalian target of rapamycin blockade is an effective radiosensitizing strategy for the treatment of non-small cell lung cancer harboring K-RAS mutations.	Cancer research	2009	56
19796751	Sirolimus	Rini BI	Resistance to targeted therapy in renal-cell carcinoma.	The Lancet. Oncology	2009	134
19843504	Sirolimus	Hudon V	Renal tumour suppressor function of the Birt-Hogg-Dubé syndrome gene product folliculin.	Journal of medical genetics	2010	47
19860903	Sirolimus	Yuan R	Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy.	Journal of hematology & oncology	2009	61
19864570	Sirolimus	Spencer B	Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases.	The Journal of neuroscience 	2009	171
19917848	Sirolimus	Missiaglia E	Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway.	Journal of clinical oncology 	2010	97
19920197	Sirolimus	Fu L	Perifosine inhibits mammalian target of rapamycin signaling through facilitating degradation of major components in the mTOR axis and induces autophagy.	Cancer research	2009	53
19995915	Sirolimus	Julien LA	mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling.	Molecular and cellular biology	2010	141
20008935	Sirolimus	Olive V	miR-19 is a key oncogenic component of mir-17-92.	Genes & development	2009	235
20009104	Sirolimus	Guo D	EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy.	Science signaling	2009	82
20042677	Sirolimus	Deng L	A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis.	The American journal of pathology	2010	57
20053782	Sirolimus	Koduru S	Notch-1 inhibition by Withaferin-A: a therapeutic target against colon carcinogenesis.	Molecular cancer therapeutics	2010	44
20080688	Sirolimus	Hung KE	Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment.	Proceedings of the National Academy of Sciences of the United States of America	2010	80
20081105	Sirolimus	Nagaraja AK	A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer.	Molecular endocrinology	2010	77
20146692	Sirolimus	Orlova KA	The tuberous sclerosis complex.	Annals of the New York Academy of Sciences	2010	102
20157535	Sirolimus	Armour SM	Inhibition of mammalian S6 kinase by resveratrol suppresses autophagy.	Aging	2009	65
20160026	Sirolimus	Pang X	Celastrol suppresses angiogenesis-mediated tumor growth through inhibition of AKT/mammalian target of rapamycin pathway.	Cancer research	2010	44
20174468	Sirolimus	Crews L	Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy.	PloS one	2010	92
20190810	Sirolimus	Sato T	Single amino-acid changes that confer constitutive activation of mTOR are discovered in human cancer.	Oncogene	2010	64
20231677	Sirolimus	Doi T	Multicenter phase II study of everolimus in patients with previously treated metastatic gastric cancer.	Journal of clinical oncology 	2010	56
20371718	Sirolimus	Cirstea D	Dual inhibition of akt/mammalian target of rapamycin pathway by nanoparticle albumin-bound-rapamycin and perifosine induces antitumor activity in multiple myeloma.	Molecular cancer therapeutics	2010	48
20399811	Sirolimus	Martelli AM	The emerging role of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in normal myelopoiesis and leukemogenesis.	Biochimica et biophysica acta	2010	41
20421047	Sirolimus	Johnson SM	Novel expression patterns of PI3K/Akt/mTOR signaling pathway components in colorectal cancer.	Journal of the American College of Surgeons	2010	44
20434451	Sirolimus	Mujumdar N	Triptolide induces cell death in pancreatic cancer cells by apoptotic and autophagic pathways.	Gastroenterology	2010	41
20453062	Sirolimus	Aguado C	Laforin, the most common protein mutated in Lafora disease, regulates autophagy.	Human molecular genetics	2010	54
20460539	Sirolimus	Giovannetti E	MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity.	Cancer research	2010	122
20473305	Sirolimus	Yoshida T	Rtp801, a suppressor of mTOR signaling, is an essential mediator of cigarette smoke-induced pulmonary injury and emphysema.	Nature medicine	2010	61
20484036	Sirolimus	Doghman M	Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors.	Cancer research	2010	66
20491627	Sirolimus	Zhou H	The complexes of mammalian target of rapamycin.	Current protein & peptide science	2010	42
20498714	Sirolimus	Squarize CH	Accelerated wound healing by mTOR activation in genetically defined mouse models.	PloS one	2010	40
20501828	Sirolimus	Fornari F	MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells.	Cancer research	2010	129
20563248	Sirolimus	Molina JR	Invasive glioblastoma cells acquire stemness and increased Akt activation.	Neoplasia	2010	62
20574048	Sirolimus	Isakson P	Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein.	Blood	2010	69
20581392	Sirolimus	Walz G	Everolimus in patients with autosomal dominant polycystic kidney disease.	The New England journal of medicine	2010	134
20587533	Sirolimus	Voss V	The pan-Bcl-2 inhibitor (-)-gossypol triggers autophagic cell death in malignant glioma.	Molecular cancer research 	2010	49
20615870	Sirolimus	Abe N	Mammalian target of rapamycin (mTOR) activation increases axonal growth capacity of injured peripheral nerves.	The Journal of biological chemistry	2010	52
20630061	Sirolimus	Javle MM	Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies.	BMC cancer	2010	41
20634405	Sirolimus	Li X	The epidermal growth factor receptor antibody cetuximab induces autophagy in cancer cells by downregulating HIF-1alpha and Bcl-2 and activating the beclin 1/hVps34 complex.	Cancer research	2010	60
20661303	Sirolimus	Van Grol J	HIV-1 inhibits autophagy in bystander macrophage/monocytic cells through Src-Akt and STAT3.	PloS one	2010	46
20664473	Sirolimus	Boudreaux JP	The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and Cecum.	Pancreas	2010	58
20668162	Sirolimus	Goodman CA	A phosphatidylinositol 3-kinase/protein kinase B-independent activation of mammalian target of rapamycin signaling is sufficient to induce skeletal muscle hypertrophy.	Molecular biology of the cell	2010	42
20668229	Sirolimus	Green AS	The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation.	Blood	2010	53
20686178	Sirolimus	Andersen JN	Pathway-based identification of biomarkers for targeted therapeutics: personalized oncology with PI3K pathway inhibitors.	Science translational medicine	2010	57
20857497	Sirolimus	Sunayama J	Crosstalk between the PI3K/mTOR and MEK/ERK pathways involved in the maintenance of self-renewal and tumorigenicity of glioblastoma stem-like cells.	Stem cells	2010	61
20978191	Sirolimus	Zhang F	mTOR complex component Rictor interacts with PKCzeta and regulates cancer cell metastasis.	Cancer research	2010	49
21047224	Sirolimus	Krueger DA	Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis.	The New England journal of medicine	2010	226
21071439	Sirolimus	Carriere A	ERK1/2 phosphorylate Raptor to promote Ras-dependent activation of mTOR complex 1 (mTORC1).	The Journal of biological chemistry	2011	72
21099108	Sirolimus	Badell IR	LFA-1-specific therapy prolongs allograft survival in rhesus macaques.	The Journal of clinical investigation	2010	53
21145759	Sirolimus	Procaccini C	An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness.	Immunity	2010	96
21187475	Sirolimus	Gedaly R	PI-103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking Ras/Raf/MAPK and PI3K/AKT/mTOR pathways.	Anticancer research	2010	45
21228155	Sirolimus	Rieker C	Nucleolar disruption in dopaminergic neurons leads to oxidative damage and parkinsonism through repression of mammalian target of rapamycin signaling.	The Journal of neuroscience 	2011	42
21253593	Sirolimus	Golovina TN	Retinoic acid and rapamycin differentially affect and synergistically promote the ex vivo expansion of natural human T regulatory cells.	PloS one	2011	48
21289267	Sirolimus	Liu R	The Akt-specific inhibitor MK2206 selectively inhibits thyroid cancer cells harboring mutations that can activate the PI3K/Akt pathway.	The Journal of clinical endocrinology and metabolism	2011	36
21289308	Sirolimus	Yoshimi A	Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins.	Blood	2011	35
21339483	Sirolimus	Grundmann S	MicroRNA-100 regulates neovascularization by suppression of mammalian target of rapamycin in endothelial and vascular smooth muscle cells.	Circulation	2011	48
21339740	Sirolimus	Kim EK	Selective activation of Akt1 by mammalian target of rapamycin complex 2 regulates cancer cell migration, invasion, and metastasis.	Oncogene	2011	41
21346035	Sirolimus	Finley DS	Tumor biology and prognostic factors in renal cell carcinoma.	The oncologist	2011	39
21362200	Sirolimus	Sanchez CG	Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer.	Breast cancer research 	2011	49
21430067	Sirolimus	Gulhati P	mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways.	Cancer research	2011	165
21562229	Sirolimus	Burks TN	Losartan restores skeletal muscle remodeling and protects against disuse atrophy in sarcopenia.	Science translational medicine	2011	58
21707707	Sirolimus	Sun CH	Activation of the PI3K/Akt/mTOR pathway correlates with tumour progression and reduced survival in patients with urothelial carcinoma of the urinary bladder.	Histopathology	2011	38
21730275	Sirolimus	Morrow PK	Phase I/II study of trastuzumab in combination with everolimus (RAD001) in patients with HER2-overexpressing metastatic breast cancer who progressed on trastuzumab-based therapy.	Journal of clinical oncology 	2011	65
21750201	Sirolimus	Naing A	Phase I trial of cixutumumab combined with temsirolimus in patients with advanced cancer.	Clinical cancer research 	2011	44
21795477	Sirolimus	Uesugi A	The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer.	Cancer research	2011	74
21841310	Sirolimus	Shuda M	Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator.	The Journal of clinical investigation	2011	100
21862872	Sirolimus	Liu B	Potent anti-proliferative effects of metformin on trastuzumab-resistant breast cancer cells via inhibition of erbB2/IGF-1 receptor interactions.	Cell cycle	2011	41
21876152	Sirolimus	Ilic N	PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axis.	Proceedings of the National Academy of Sciences of the United States of America	2011	86
21878679	Sirolimus	Chan JC	AKT promotes rRNA synthesis and cooperates with c-MYC to stimulate ribosome biogenesis in cancer.	Science signaling	2011	41
21907282	Sirolimus	Carson RP	Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin.	Neurobiology of disease	2012	57
21952069	Sirolimus	Coppin C	Targeted therapy for advanced renal cell cancer (RCC): a Cochrane systematic review of published randomised trials.	BJU international	2011	55
21975930	Sirolimus	Patel V	Decreased lymphangiogenesis and lymph node metastasis by mTOR inhibition in head and neck cancer.	Cancer research	2011	52
21993994	Sirolimus	Ho C	AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathways.	Hepatology	2012	55
22025691	Sirolimus	Goto J	Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex.	Proceedings of the National Academy of Sciences of the United States of America	2011	61
22067397	Sirolimus	Chawla SP	Phase II study of the mammalian target of rapamycin inhibitor ridaforolimus in patients with advanced bone and soft tissue sarcomas.	Journal of clinical oncology 	2012	59
22119496	Sirolimus	Pavel ME	Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study.	Lancet	2011	163
22171948	Sirolimus	Deng W	Role and therapeutic potential of PI3K-mTOR signaling in de novo resistance to BRAF inhibition.	Pigment cell & melanoma research	2012	36
22193387	Sirolimus	Cinà DP	Inhibition of MTOR disrupts autophagic flux in podocytes.	Journal of the American Society of Nephrology 	2012	39
22215754	Sirolimus	Anderson KC	The 39th David A. Karnofsky Lecture: bench-to-bedside translation of targeted therapies in multiple myeloma.	Journal of clinical oncology 	2012	42
22234835	Sirolimus	Fang Y	MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.	Hepatology	2012	103
22310280	Sirolimus	Serrano I	Role of the integrin-linked kinase (ILK)/Rictor complex in TGFβ-1-induced epithelial-mesenchymal transition (EMT).	Oncogene	2013	36
22355189	Sirolimus	Sun Y	Inhibition of autophagy ameliorates acute lung injury caused by avian influenza A H5N1 infection.	Science signaling	2012	50
22397650	Sirolimus	Gerlinger M	Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.	The New England journal of medicine	2012	1714
22402744	Sirolimus	Weeraratne SD	Pleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastoma.	Acta neuropathologica	2012	57
22408430	Sirolimus	Pópulo H	The mTOR signalling pathway in human cancer.	International journal of molecular sciences	2012	128
22409888	Sirolimus	Molinolo AA	mTOR as a molecular target in HPV-associated oral and cervical squamous carcinomas.	Clinical cancer research 	2012	38
22431589	Sirolimus	Suh SS	MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme.	Proceedings of the National Academy of Sciences of the United States of America	2012	41
22457330	Sirolimus	Menon S	Chronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice.	Science signaling	2012	51
22473468	Sirolimus	Song MS	The functions and regulation of the PTEN tumour suppressor.	Nature reviews. Molecular cell biology	2012	494
22473959	Sirolimus	Lee K	Vital roles of mTOR complex 2 in Notch-driven thymocyte differentiation and leukemia.	The Journal of experimental medicine	2012	43
22488882	Sirolimus	Goebbels S	Genetic disruption of Pten in a novel mouse model of tomaculous neuropathy.	EMBO molecular medicine	2012	44
22565002	Sirolimus	Bachelot T	Randomized phase II trial of everolimus in combination with tamoxifen in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer with prior exposure to aromatase inhibitors: a GINECO study.	Journal of clinical oncology 	2012	132
22585904	Sirolimus	Baird TD	Eukaryotic initiation factor 2 phosphorylation and translational control in metabolism.	Advances in nutrition	2012	119
22605338	Sirolimus	Wang Y	Anticancer peptidylarginine deiminase (PAD) inhibitors regulate the autophagy flux and the mammalian target of rapamycin complex 1 activity.	The Journal of biological chemistry	2012	49
22622204	Sirolimus	Han J	Curcumin induces autophagy to protect vascular endothelial cell survival from oxidative stress damage.	Autophagy	2012	38
22674982	Sirolimus	Shrivastava S	Hepatitis C virus upregulates Beclin1 for induction of autophagy and activates mTOR signaling.	Journal of virology	2012	48
22685175	Sirolimus	Tasian SK	Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia.	Blood	2012	50
22711699	Sirolimus	Winbanks CE	Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin.	The Journal of cell biology	2012	32
22729223	Sirolimus	Lee JH	De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly.	Nature genetics	2012	135
22729283	Sirolimus	Xian L	Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells.	Nature medicine	2012	106
22773827	Sirolimus	Fukuda A	Growth-dependent podocyte failure causes glomerulosclerosis.	Journal of the American Society of Nephrology 	2012	43
22826565	Sirolimus	Zeng Z	Targeting of mTORC1/2 by the mTOR kinase inhibitor PP242 induces apoptosis in AML cells under conditions mimicking the bone marrow microenvironment.	Blood	2012	38
22859719	Sirolimus	Sun ZJ	Chemopreventive and chemotherapeutic actions of mTOR inhibitor in genetically defined head and neck squamous cell carcinoma mouse model.	Clinical cancer research 	2012	41
22872574	Sirolimus	Roberts PJ	Combined PI3K/mTOR and MEK inhibition provides broad antitumor activity in faithful murine cancer models.	Clinical cancer research 	2012	65
22885411	Sirolimus	Romagnoli A	ESX-1 dependent impairment of autophagic flux by Mycobacterium tuberculosis in human dendritic cells.	Autophagy	2012	64
22904304	Sirolimus	Procaccini C	Leptin-induced mTOR activation defines a specific molecular and transcriptional signature controlling CD4+ effector T cell responses.	Journal of immunology	2012	30
22907434	Sirolimus	Du W	ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer.	Oncogene	2013	27
22919032	Sirolimus	McInturff AM	Mammalian target of rapamycin regulates neutrophil extracellular trap formation via induction of hypoxia-inducible factor 1 α.	Blood	2012	50
22923433	Sirolimus	Iyer G	Genome sequencing identifies a basis for everolimus sensitivity.	Science	2012	174
22958932	Sirolimus	Iglesias-Bartolome R	mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis.	Cell stem cell	2012	91
22980985	Sirolimus	Lu P	Long-distance growth and connectivity of neural stem cells after severe spinal cord injury.	Cell	2012	147
22983984	Sirolimus	Iwaya T	Downregulation of miR-144 is associated with colorectal cancer progression via activation of mTOR signaling pathway.	Carcinogenesis	2012	50
22994652	Sirolimus	Welker MW	Recurrent hepatocellular carcinoma after liver transplantation - an emerging clinical challenge.	Transplant international 	2013	35
22994804	Sirolimus	Akimova T	Differing effects of rapamycin or calcineurin inhibitor on T-regulatory cells in pediatric liver and kidney transplant recipients.	American journal of transplantation 	2012	32
23026799	Sirolimus	Zou Z	Aurora kinase A inhibition-induced autophagy triggers drug resistance in breast cancer cells.	Autophagy	2012	45
23123587	Sirolimus	Reith RM	Loss of Tsc2 in Purkinje cells is associated with autistic-like behavior in a mouse model of tuberous sclerosis complex.	Neurobiology of disease	2013	42
23150676	Sirolimus	Jansson N	Activation of placental mTOR signaling and amino acid transporters in obese women giving birth to large babies.	The Journal of clinical endocrinology and metabolism	2013	50
23152448	Sirolimus	Kaul A	Pediatric glioma-associated KIAA1549:BRAF expression regulates neuroglial cell growth in a cell type-specific and mTOR-dependent manner.	Genes & development	2012	33
23155049	Sirolimus	Avrahami L	Inhibition of glycogen synthase kinase-3 ameliorates β-amyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the Alzheimer disease mouse model: in vivo and in vitro studies.	The Journal of biological chemistry	2013	43
23173671	Sirolimus	Cui L	MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.	BMC cancer	2012	31
23233719	Sirolimus	Wolff AC	Randomized phase III placebo-controlled trial of letrozole plus oral temsirolimus as first-line endocrine therapy in postmenopausal women with locally advanced or metastatic breast cancer.	Journal of clinical oncology 	2013	61
23271044	Sirolimus	Chiarini F	A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia.	Oncotarget	2012	35
23319457	Sirolimus	Figlin RA	Targeting PI3K and mTORC2 in metastatic renal cell carcinoma: new strategies for overcoming resistance to VEGFR and mTORC1 inhibitors.	International journal of cancer	2013	29
23325216	Sirolimus	Johnson SC	mTOR is a key modulator of ageing and age-related disease.	Nature	2013	329
23431193	Sirolimus	Posch C	Combined targeting of MEK and PI3K/mTOR effector pathways is necessary to effectively inhibit NRAS mutant melanoma in vitro and in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2013	70
23542178	Sirolimus	Ducker GS	Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors.	Oncogene	2014	31
23554977	Sirolimus	Lau MT	Fibroblast growth factor 2 induces E-cadherin down-regulation via PI3K/Akt/mTOR and MAPK/ERK signaling in ovarian cancer cells.	PloS one	2013	26
23570274	Sirolimus	Theoharides TC	Focal brain inflammation and autism.	Journal of neuroinflammation	2013	30
23582881	Sirolimus	Templeton AJ	Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08).	European urology	2013	27
23624914	Sirolimus	Ye Q	ERK and AKT signaling cooperate to translationally regulate survivin expression for metastatic progression of colorectal cancer.	Oncogene	2014	47
23671130	Sirolimus	Sun J	Metastasis suppressor, NDRG1, mediates its activity through signaling pathways and molecular motors.	Carcinogenesis	2013	25
23686362	Sirolimus	Sandri M	Signalling pathways regulating muscle mass in ageing skeletal muscle: the role of the IGF1-Akt-mTOR-FoxO pathway.	Biogerontology	2013	55
23708729	Sirolimus	Ryter SW	Autophagy: a critical regulator of cellular metabolism and homeostasis.	Molecules and cells	2013	53
23778311	Sirolimus	McCubrey JA	Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention.	Leukemia	2014	41
23818547	Sirolimus	Lu J	Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation.	Blood	2013	36
23818640	Sirolimus	Meckes DG Jr	Modulation of B-cell exosome proteins by gamma herpesvirus infection.	Proceedings of the National Academy of Sciences of the United States of America	2013	57
23856247	Sirolimus	Cai J	miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer.	Cancer research	2013	44
23897774	Sirolimus	Caza TN	HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE.	Annals of the rheumatic diseases	2014	22
23902785	Sirolimus	Op den Kamp CM	Nuclear transcription factor κ B activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexia.	The American journal of clinical nutrition	2013	27
23903756	Sirolimus	Elkabets M	mTORC1 inhibition is required for sensitivity to PI3K p110α inhibitors in PIK3CA-mutant breast cancer.	Science translational medicine	2013	76
23929677	Sirolimus	Sinha RA	Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice.	Hepatology	2014	48
23953116	Sirolimus	Thedieck K	Inhibition of mTORC1 by astrin and stress granules prevents apoptosis in cancer cells.	Cell	2013	52
24011086	Sirolimus	Tsubaki M	Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines.	Journal of experimental & clinical cancer research 	2013	27
24056770	Sirolimus	Canaud G	AKT2 is essential to maintain podocyte viability and function during chronic kidney disease.	Nature medicine	2013	46
24059496	Sirolimus	Sarkar S	Regulation of autophagy by mTOR-dependent and mTOR-independent pathways: autophagy dysfunction in neurodegenerative diseases and therapeutic application of autophagy enhancers.	Biochemical Society transactions	2013	69
24077167	Sirolimus	Liu R	Ten-eleven translocation-2 (TET2) is a master regulator of smooth muscle cell plasticity.	Circulation	2013	29
24092929	Sirolimus	Yamahara K	Obesity-mediated autophagy insufficiency exacerbates proteinuria-induced tubulointerstitial lesions.	Journal of the American Society of Nephrology 	2013	43
24161930	Sirolimus	Liu P	Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis.	Nature cell biology	2013	72
24174532	Sirolimus	Li M	Suppression of lysosome function induces autophagy via a feedback down-regulation of MTOR complex 1 (MTORC1) activity.	The Journal of biological chemistry	2013	46
24185040	Sirolimus	Francipane MG	Selective targeting of human colon cancer stem-like cells by the mTOR inhibitor Torin-1.	Oncotarget	2013	29
24270418	Sirolimus	Liu SC	Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance.	The Journal of clinical investigation	2013	29
24311635	Sirolimus	Kahn J	The mTORC1/mTORC2 inhibitor AZD2014 enhances the radiosensitivity of glioblastoma stem-like cells.	Neuro-oncology	2014	23
24333502	Sirolimus	Polivka J Jr	Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway.	Pharmacology & therapeutics	2014	89
24336570	Sirolimus	Johnson BE	Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma.	Science	2014	244
24367027	Sirolimus	Takasaka N	Autophagy induction by SIRT6 through attenuation of insulin-like growth factor signaling is involved in the regulation of human bronchial epithelial cell senescence.	Journal of immunology	2014	33
24393708	Sirolimus	Francipane MG	mTOR pathway in colorectal cancer: an update.	Oncotarget	2014	31
24401568	Sirolimus	Liu B	Hepatitis B virus X protein inhibits autophagic degradation by impairing lysosomal maturation.	Autophagy	2014	29
24440717	Sirolimus	Janku F	Assessing PIK3CA and PTEN in early-phase trials with PI3K/AKT/mTOR inhibitors.	Cell reports	2014	59
24445654	Sirolimus	Chang L	Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy.	Cancer metastasis reviews	2014	21
24469833	Sirolimus	Mathews Griner LA	High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells.	Proceedings of the National Academy of Sciences of the United States of America	2014	73
24470531	Sirolimus	Farid M	Malignant peripheral nerve sheath tumors.	The oncologist	2014	23
24470557	Sirolimus	Wen PY	Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02.	Neuro-oncology	2014	30
24474794	Sirolimus	Liu X	Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK.	Proceedings of the National Academy of Sciences of the United States of America	2014	68
24480319	Sirolimus	Santoni M	Emerging strategies to overcome the resistance to current mTOR inhibitors in renal cell carcinoma.	Biochimica et biophysica acta	2014	21
24481312	Sirolimus	Fruman DA	PI3K and cancer: lessons, challenges and opportunities.	Nature reviews. Drug discovery	2014	313
24481845	Sirolimus	Sciarretta S	Mammalian target of rapamycin signaling in cardiac physiology and disease.	Circulation research	2014	87
24534455	Sirolimus	Martinet W	mTOR inhibition: a promising strategy for stabilization of atherosclerotic plaques.	Atherosclerosis	2014	29
24603303	Sirolimus	Shimizu K	ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer.	British journal of cancer	2014	25
24603327	Sirolimus	Ma J	Methamphetamine induces autophagy as a pro-survival response against apoptotic endothelial cell death through the Kappa opioid receptor.	Cell death & disease	2014	21
24615500	Sirolimus	Rugo HS	Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2.	Annals of oncology 	2014	24
24631838	Sirolimus	Grabiner BC	A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity.	Cancer discovery	2014	83
24700142	Sirolimus	Yang N	SOX2 promotes the migration and invasion of laryngeal cancer cells by induction of MMP-2 via the PI3K/Akt/mTOR pathway.	Oncology reports	2014	20
24713927	Sirolimus	Gu Y	MLN4924, an NAE inhibitor, suppresses AKT and mTOR signaling via upregulation of REDD1 in human myeloma cells.	Blood	2014	22
24728411	Sirolimus	Ota KT	REDD1 is essential for stress-induced synaptic loss and depressive behavior.	Nature medicine	2014	50
24777052	Sirolimus	Ocana A	Activation of the PI3K/mTOR/AKT pathway and survival in solid tumors: systematic review and meta-analysis.	PloS one	2014	36
24791855	Sirolimus	Weisberg E	Identification of Wee1 as a novel therapeutic target for mutant RAS-driven acute leukemia and other malignancies.	Leukemia	2015	18
24841777	Sirolimus	Albiges L	A systematic review of sequencing and combinations of systemic therapy in metastatic renal cancer.	European urology	2015	30
24899720	Sirolimus	Caccamo A	Genetic reduction of mammalian target of rapamycin ameliorates Alzheimer's disease-like cognitive and pathological deficits by restoring hippocampal gene expression signature.	The Journal of neuroscience 	2014	34
24910242	Sirolimus	Umemura A	Liver damage, inflammation, and enhanced tumorigenesis after persistent mTORC1 inhibition.	Cell metabolism	2014	27
24930972	Sirolimus	Zhang P	Lipin-1 regulates autophagy clearance and intersects with statin drug effects in skeletal muscle.	Cell metabolism	2014	29
24931163	Sirolimus	Dodd KM	mTORC1 drives HIF-1α and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3.	Oncogene	2015	24
24947615	Sirolimus	Park HW	Hepatoprotective role of Sestrin2 against chronic ER stress.	Nature communications	2014	26
24954509	Sirolimus	Chou SD	HSF1 regulation of β-catenin in mammary cancer cells through control of HuR/elavL1 expression.	Oncogene	2015	21
25082895	Sirolimus	Cornu M	Hepatic mTORC1 controls locomotor activity, body temperature, and lipid metabolism through FGF21.	Proceedings of the National Academy of Sciences of the United States of America	2014	34
25086744	Sirolimus	Li H	PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer.	Archives of gynecology and obstetrics	2014	23
25099355	Sirolimus	Lu L	Critical role of all-trans retinoic acid in stabilizing human natural regulatory T cells under inflammatory conditions.	Proceedings of the National Academy of Sciences of the United States of America	2014	33
25175012	Sirolimus	Zhu L	TSC1 controls macrophage polarization to prevent inflammatory disease.	Nature communications	2014	40
25295501	Sirolimus	Wagle N	Response and acquired resistance to everolimus in anaplastic thyroid cancer.	The New England journal of medicine	2014	76
25311365	Sirolimus	Oguro-Ando A	Increased CYFIP1 dosage alters cellular and dendritic morphology and dysregulates mTOR.	Molecular psychiatry	2015	15
25341517	Sirolimus	Johnson SC	Modulating mTOR in aging and health.	Interdisciplinary topics in gerontology	2015	26
25444920	Sirolimus	Zheng B	Pre-clinical evaluation of AZD-2014, a novel mTORC1/2 dual inhibitor, against renal cell carcinoma.	Cancer letters	2015	21
25446280	Sirolimus	Wagner LM	Phase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: a report from the Children's Oncology Group.	Pediatric blood & cancer	2015	18
25450580	Sirolimus	Xu K	mTOR signaling in tumorigenesis.	Biochimica et biophysica acta	2014	34
25477072	Sirolimus	Gao B	Translational control by oncogenic signaling pathways.	Biochimica et biophysica acta	2015	15
25512523	Sirolimus	Perry JA	Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma.	Proceedings of the National Academy of Sciences of the United States of America	2014	62
25526733	Sirolimus	Ma DJ	A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K.	Neuro-oncology	2015	18
25531317	Sirolimus	Siu MK	Transforming growth factor-β promotes prostate bone metastasis through induction of microRNA-96 and activation of the mTOR pathway.	Oncogene	2015	19
25534823	Sirolimus	Kaul A	Akt- or MEK-mediated mTOR inhibition suppresses Nf1 optic glioma growth.	Neuro-oncology	2015	17
25540204	Sirolimus	Campbell GR	Autophagy induction by histone deacetylase inhibitors inhibits HIV type 1.	The Journal of biological chemistry	2015	17
25557953	Sirolimus	Cornella H	Unique genomic profile of fibrolamellar hepatocellular carcinoma.	Gastroenterology	2015	20
25561726	Sirolimus	Marchand B	Glycogen synthase kinase-3 (GSK3) inhibition induces prosurvival autophagic signals in human pancreatic cancer cells.	The Journal of biological chemistry	2015	22
25593290	Sirolimus	Ranchoux B	Endothelial-to-mesenchymal transition in pulmonary hypertension.	Circulation	2015	57
25601637	Sirolimus	Kong B	A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signalling.	Gut	2016	14
25645581	Sirolimus	Tramutola A	Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.	Journal of neurochemistry	2015	25
25653352	Sirolimus	Fields J	HIV-1 Tat alters neuronal autophagy by modulating autophagosome fusion to the lysosome: implications for HIV-associated neurocognitive disorders.	The Journal of neuroscience 	2015	19
25657110	Sirolimus	Cao Y	Fibronectin promotes cell proliferation and invasion through mTOR signaling pathway activation in gallbladder cancer.	Cancer letters	2015	19
25688110	Sirolimus	Cargnello M	The expanding role of mTOR in cancer cell growth and proliferation.	Mutagenesis	2015	23
25739910	Sirolimus	Mercado N	Accelerated ageing of the lung in COPD: new concepts.	Thorax	2015	33
25749036	Sirolimus	Yang H	FBXW7 suppresses epithelial-mesenchymal transition, stemness and metastatic potential of cholangiocarcinoma cells.	Oncotarget	2015	21
25791428	Sirolimus	Tang Z	mTor mediates tau localization and secretion: Implication for Alzheimer's disease.	Biochimica et biophysica acta	2015	19
25813405	Sirolimus	Wang Y	CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling.	Cancer letters	2015	45
25834401	Sirolimus	Li JP	The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.	Drug design, development and therapy	2015	20
25877892	Sirolimus	McGranahan N	Clonal status of actionable driver events and the timing of mutational processes in cancer evolution.	Science translational medicine	2015	78
26018084	Sirolimus	Nakashima M	Somatic Mutations in the MTOR gene cause focal cortical dysplasia type IIb.	Annals of neurology	2015	26
26124089	Sirolimus	Caino MC	PI3K therapy reprograms mitochondrial trafficking to fuel tumor cell invasion.	Proceedings of the National Academy of Sciences of the United States of America	2015	32
26134657	Sirolimus	Du K	Pten Deletion Promotes Regrowth of Corticospinal Tract Axons 1 Year after Spinal Cord Injury.	The Journal of neuroscience 	2015	21
26156073	Sirolimus	Bissler JJ	Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial.	Nephrology, dialysis, transplantation 	2016	28
26253360	Sirolimus	Chang L	Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance.	Critical reviews in oncology/hematology	2015	18
26277543	Sirolimus	Hsieh AL	MYC and metabolism on the path to cancer.	Seminars in cell & developmental biology	2015	31
26280535	Sirolimus	Herranz N	mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype.	Nature cell biology	2015	48
26311737	Sirolimus	Tsai JP	Licochalcone A induces autophagy through PI3K/Akt/mTOR inactivation and autophagy suppression enhances Licochalcone A-induced apoptosis of human cervical cancer cells.	Oncotarget	2015	22
26339054	Sirolimus	Thaa B	Differential Phosphatidylinositol-3-Kinase-Akt-mTOR Activation by Semliki Forest and Chikungunya Viruses Is Dependent on nsP3 and Connected to Replication Complex Internalization.	Journal of virology	2015	20
26364551	Sirolimus	Powles T	A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer.	European urology	2016	13
26364608	Sirolimus	Coarfa C	Comprehensive proteomic profiling identifies the androgen receptor axis and other signaling pathways as targets of microRNAs suppressed in metastatic prostate cancer.	Oncogene	2016	21
26389641	Sirolimus	Park YY	Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma.	Hepatology	2016	14
26476289	Sirolimus	Li L	Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans.	Journal of hepatology	2016	12
26540343	Sirolimus	Ji J	LINC00152 promotes proliferation in hepatocellular carcinoma by targeting EpCAM via the mTOR signaling pathway.	Oncotarget	2015	33
26563133	Sirolimus	Brunstein CG	Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect.	Blood	2016	46
26565512	Sirolimus	Qiang L	Autophagy positively regulates DNA damage recognition by nucleotide excision repair.	Autophagy	2016	12
26721400	Sirolimus	Agarwal S	Inhibition of Hif1α prevents both trauma-induced and genetic heterotopic ossification.	Proceedings of the National Academy of Sciences of the United States of America	2016	16
26735353	Sirolimus	Bournet B	Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities.	European journal of cancer	2016	19
26818518	Sirolimus	Gentry EG	Rho Kinase Inhibition as a Therapeutic for Progressive Supranuclear Palsy and Corticobasal Degeneration.	The Journal of neuroscience 	2016	10
26878385	Sirolimus	Garros-Regulez L	mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance.	Expert opinion on therapeutic targets	2016	14
26884601	Sirolimus	Viel S	TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway.	Science signaling	2016	24
26929424	Sirolimus	Kempf E	KRAS oncogene in lung cancer: focus on molecularly driven clinical trials.	European respiratory review 	2016	12
27074878	Sirolimus	Scioli MG	Combined treatment with platelet-rich plasma and insulin favours chondrogenic and osteogenic differentiation of human adipose-derived stem cells in three-dimensional collagen scaffolds.	Journal of tissue engineering and regenerative medicine	2017	5
27098600	Sirolimus	Zou M	Autophagy inhibition of hsa-miR-19a-3p/19b-3p by targeting TGF-β R II during TGF-β1-induced fibrogenesis in human cardiac fibroblasts.	Scientific reports	2016	13
27159400	Sirolimus	Mirzaa GM	Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism.	JAMA neurology	2016	14
27221134	Sirolimus	Elkaim E	Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: A cohort study.	The Journal of allergy and clinical immunology	2016	18
27226234	Sirolimus	Henske EP	Tuberous sclerosis complex.	Nature reviews. Disease primers	2016	22
27260250	Sirolimus	Li Q	Autophagy and Alzheimer's Disease.	Cellular and molecular neurobiology	2017	9
27465917	Sirolimus	Mao Y	IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells.	Blood	2016	16
27503005	Sirolimus	Statz CM	mTOR Inhibitors in Castration-Resistant Prostate Cancer: A Systematic Review.	Targeted oncology	2017	7
27511728	Sirolimus	Siska PJ	Suppression of Glut1 and Glucose Metabolism by Decreased Akt/mTORC1 Signaling Drives T Cell Impairment in B Cell Leukemia.	Journal of immunology	2016	14
27597759	Sirolimus	Sargent G	PEX2 is the E3 ubiquitin ligase required for pexophagy during starvation.	The Journal of cell biology	2016	13
27628078	Sirolimus	McCormack FX	Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management.	American journal of respiratory and critical care medicine	2016	13
27663511	Sirolimus	Riedl A	Comparison of cancer cells in 2D vs 3D culture reveals differences in AKT-mTOR-S6K signaling and drug responses.	Journal of cell science	2017	8
27671674	Sirolimus	Clark CA	Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma.	Cancer research	2016	18
27751729	Sirolimus	Hsieh JJ	Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma.	European urology	2017	13
27777238	Sirolimus	Tasian SK	Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia.	Blood	2017	15
27894091	Sirolimus	Lu XS	Preclinical study of cinobufagin as a promising anti-colorectal cancer agent.	Oncotarget	2017	11
28007498	Sirolimus	Kapahi P	Dietary restriction and lifespan: Lessons from invertebrate models.	Ageing research reviews	2017	9
28007903	Sirolimus	Zhu P	Autophagy activators suppress cystogenesis in an autosomal dominant polycystic kidney disease model.	Human molecular genetics	2017	6
28026112	Sirolimus	Wu J	Matrine induces Akt/mTOR signalling inhibition-mediated autophagy and apoptosis in acute myeloid leukaemia cells.	Journal of cellular and molecular medicine	2017	8
28027327	Sirolimus	Lefebvre C	Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis.	PLoS medicine	2016	20
28067669	Sirolimus	Brockhoff M	Targeting deregulated AMPK/mTORC1 pathways improves muscle function in myotonic dystrophy type I.	The Journal of clinical investigation	2017	6
28079894	Sirolimus	Jin F	MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy.	Cell death & disease	2017	16
28085563	Sirolimus	Sun A	The E3 ubiquitin ligase NEDD4 is an LC3-interactive protein and regulates autophagy.	Autophagy	2017	9
28094770	Sirolimus	Martin AR	Rapamycin-mediated mTOR inhibition uncouples HIV-1 latency reversal from cytokine-associated toxicity.	The Journal of clinical investigation	2017	9
28294596	Sirolimus	Bieri R	The Macrolide Toxin Mycolactone Promotes Bim-Dependent Apoptosis in Buruli Ulcer through Inhibition of mTOR.	ACS chemical biology	2017	6
28336668	Sirolimus	Castellano BM	Lysosomal cholesterol activates mTORC1 via an SLC38A9-Niemann-Pick C1 signaling complex.	Science	2017	17
28658205	Sirolimus	Zabala-Letona A	mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer.	Nature	2017	8
11139588	Tamoxifen	Campbell RA	Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance.	The Journal of biological chemistry	2001	191
12586780	Tamoxifen	Knowlden JM	Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells.	Endocrinology	2003	123
14555514	Tamoxifen	Girault I	Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas.	Clinical cancer research 	2003	80
15197194	Tamoxifen	Metcalfe K	Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.	Journal of clinical oncology 	2004	113
15756033	Tamoxifen	Cohen BD	Combination therapy enhances the inhibition of tumor growth with the fully human anti-type 1 insulin-like growth factor receptor monoclonal antibody CP-751,871.	Clinical cancer research 	2005	86
16088978	Tamoxifen	Kirkegaard T	AKT activation predicts outcome in breast cancer patients treated with tamoxifen.	The Journal of pathology	2005	76
16333527	Tamoxifen	Hiscox S	Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells.	Breast cancer research and treatment	2006	66
17200148	Tamoxifen	Coates AS	Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.	Journal of clinical oncology 	2007	182
17417639	Tamoxifen	Holst F	Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer.	Nature genetics	2007	77
18193062	Tamoxifen	Kouzine F	The functional response of upstream DNA to dynamic supercoiling in vivo.	Nature structural & molecular biology	2008	121
18458534	Tamoxifen	Mercier I	Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 downregulation and RB tumor suppressor functional inactivation: Implications for the response to hormonal therapy.	Cancer biology & therapy	2008	53
18676830	Tamoxifen	Stemke-Hale K	An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer.	Cancer research	2008	316
19005469	Tamoxifen	Hurtado A	Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen.	Nature	2008	102
19074892	Tamoxifen	Law JH	Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.	Cancer research	2008	118
19549922	Tamoxifen	Lin BC	Stimulating the GPR30 estrogen receptor with a novel tamoxifen analogue activates SF-1 and promotes endometrial cell proliferation.	Cancer research	2009	47
19685490	Tamoxifen	López-Knowles E	PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality.	International journal of cancer	2010	66
20215537	Tamoxifen	Cristofanilli M	Phase II, randomized trial to compare anastrozole combined with gefitinib or placebo in postmenopausal women with hormone receptor-positive metastatic breast cancer.	Clinical cancer research 	2010	40
21393507	Tamoxifen	Shi W	MicroRNA-301 mediates proliferation and invasion in human breast cancer.	Cancer research	2011	72
21559019	Tamoxifen	Jerevall PL	Prognostic utility of HOXB13:IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial.	British journal of cancer	2011	38
22232212	Tamoxifen	Lapinski PE	RASA1 maintains the lymphatic vasculature in a quiescent functional state in mice.	The Journal of clinical investigation	2012	32
22508479	Tamoxifen	Ward A	Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer.	Oncogene	2013	73
23143302	Tamoxifen	Nishio M	Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice.	The Journal of clinical investigation	2012	37
23589310	Tamoxifen	Khurana SS	The hyaluronic acid receptor CD44 coordinates normal and metaplastic gastric epithelial progenitor cell proliferation.	The Journal of biological chemistry	2013	32
24520391	Tamoxifen	Choi EJ	Novel brain arteriovenous malformation mouse models for type 1 hereditary hemorrhagic telangiectasia.	PloS one	2014	25
24746818	Tamoxifen	Luo X	Isolation and molecular characterization of circulating melanoma cells.	Cell reports	2014	32
25007959	Tamoxifen	Wei Y	Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells.	Breast cancer research and treatment	2014	39
25332252	Tamoxifen	Sestak I	Prediction of late distant recurrence after 5 years of endocrine treatment: a combined analysis of patients from the Austrian breast and colorectal cancer study group 8 and arimidex, tamoxifen alone or in combination randomized trials using the PAM50 risk of recurrence score.	Journal of clinical oncology 	2015	28
25433206	Tamoxifen	Huang B	Estrogen receptors in breast carcinogenesis and endocrine therapy.	Molecular and cellular endocrinology	2015	29
25935792	Tamoxifen	Gnant M	Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype.	Annals of oncology 	2015	15
25939896	Tamoxifen	Coates AS	Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.	Annals of oncology 	2015	194
26092816	Tamoxifen	Bernhard J	Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials.	The Lancet. Oncology	2015	21
26342236	Tamoxifen	Le Tourneau C	Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.	The Lancet. Oncology	2015	94
26494233	Tamoxifen	Hu JH	Postnatal Deletion of the Type II Transforming Growth Factor-β Receptor in Smooth Muscle Cells Causes Severe Aortopathy in Mice.	Arteriosclerosis, thrombosis, and vascular biology	2015	15
26538583	Tamoxifen	Tran KA	Endothelial β-Catenin Signaling Is Required for Maintaining Adult Blood-Brain Barrier Integrity and Central Nervous System Homeostasis.	Circulation	2016	11
26634606	Tamoxifen	Liu Q	Genetic lineage tracing identifies in situ Kit-expressing cardiomyocytes.	Cell research	2016	23
28063065	Tamoxifen	Zhang HY	Effects of long noncoding RNA-ROR on tamoxifen resistance of breast cancer cells by regulating microRNA-205.	Cancer chemotherapy and pharmacology	2017	8
28238593	Tamoxifen	Llombart-Cussac A	HER2-enriched subtype as a predictor of pathological complete response following trastuzumab and lapatinib without chemotherapy in early-stage HER2-positive breast cancer (PAMELA): an open-label, single-group, multicentre, phase 2 trial.	The Lancet. Oncology	2017	8
28355176	Tamoxifen	Shimokawa M	Visualization and targeting of LGR5+ human colon cancer stem cells.	Nature	2017	23
11246152	Creatine	Aksenov MY	Protein oxidation in the brain in Alzheimer's disease.	Neuroscience	2001	93
11524400	Creatine	Kamihata H	Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines.	Circulation	2001	146
11535563	Creatine	Choi KM	Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function.	Circulation	2001	87
11592034	Creatine	Brockington M	Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan.	American journal of human genetics	2001	112
14662268	Creatine	Vatta M	Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction.	Journal of the American College of Cardiology	2003	90
19726876	Creatine	Hayashi YK	Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy.	The Journal of clinical investigation	2009	96
20513521	Creatine	Busse WW	Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor alpha antibody, in a phase I study of subjects with mild asthma.	The Journal of allergy and clinical immunology	2010	47
20517938	Creatine	Malik V	Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy.	Annals of neurology	2010	72
21425469	Creatine	Cacchiarelli D	miRNAs as serum biomarkers for Duchenne muscular dystrophy.	EMBO molecular medicine	2011	70
21642241	Creatine	Kuwabara Y	Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage.	Circulation. Cardiovascular genetics	2011	110
23414587	Creatine	Ascierto PA	MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study.	The Lancet. Oncology	2013	147
23552962	Creatine	Zanou N	Skeletal muscle hypertrophy and regeneration: interplay between the myogenic regulatory factors (MRFs) and insulin-like growth factors (IGFs) pathways.	Cellular and molecular life sciences 	2013	34
23630012	Creatine	Nemazanyy I	Defects of Vps15 in skeletal muscles lead to autophagic vacuolar myopathy and lysosomal disease.	EMBO molecular medicine	2013	29
23681911	Creatine	Merritt EK	Heightened muscle inflammation susceptibility may impair regenerative capacity in aging humans.	Journal of applied physiology	2013	28
23868944	Creatine	Woo JS	Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.	Arteriosclerosis, thrombosis, and vascular biology	2013	31
24523439	Creatine	Rodon J	A phase I, multicenter, open-label, first-in-human, dose-escalation study of the oral smoothened inhibitor Sonidegib (LDE225) in patients with advanced solid tumors.	Clinical cancer research 	2014	45
24789910	Creatine	Alexander MS	MicroRNA-486-dependent modulation of DOCK3/PTEN/AKT signaling pathways improves muscular dystrophy-associated symptoms.	The Journal of clinical investigation	2014	24
27592805	Creatine	Kaufman HL	Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial.	The Lancet. Oncology	2016	81
10615135	Cytosine	Fuks F	DNA methyltransferase Dnmt1 associates with histone deacetylase activity.	Nature genetics	2000	229
10647011	Cytosine	Xu GL	Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene.	Nature	1999	236
11385577	Cytosine	Ogura Y	A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.	Nature	2001	997
15852235	Cytosine	Schmidt LS	Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dubé syndrome.	American journal of human genetics	2005	88
16423997	Cytosine	Jair KW	De novo CpG island methylation in human cancer cells.	Cancer research	2006	62
17878930	Cytosine	Siegmund KD	DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons.	PloS one	2007	139
17991895	Cytosine	Palii SS	DNA methylation inhibitor 5-Aza-2'-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B.	Molecular and cellular biology	2008	99
19047171	Cytosine	Jiang L	Global hypomethylation of genomic DNA in cancer-associated myofibroblasts.	Cancer research	2008	58
19234457	Cytosine	McGowan PO	Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse.	Nature neuroscience	2009	667
20886097	Cytosine	Bergbauer M	CpG-methylation regulates a class of Epstein-Barr virus promoters.	PLoS pathogens	2010	41
22090490	Cytosine	Chestnut BA	Epigenetic regulation of motor neuron cell death through DNA methylation.	The Journal of neuroscience 	2011	78
22722201	Cytosine	Stephens PJ	The landscape of cancer genes and mutational processes in breast cancer.	Nature	2012	500
22829908	Cytosine	Orr BA	Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma.	PloS one	2012	44
22902501	Cytosine	Doege CA	Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2.	Nature	2012	110
22980977	Cytosine	Lian CG	Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma.	Cell	2012	195
22999938	Cytosine	Hsu CH	TET1 suppresses cancer invasion by activating the tissue inhibitors of metalloproteinases.	Cell reports	2012	78
23396133	Cytosine	Kirby A	Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing.	Nature genetics	2013	45
25063673	Cytosine	Blanco S	Aberrant methylation of tRNAs links cellular stress to neuro-developmental disorders.	The EMBO journal	2014	71
25411794	Cytosine	Refsland EW	Natural polymorphisms in human APOBEC3H and HIV-1 Vif combine in primary T lymphocytes to affect viral G-to-A mutation levels and infectivity.	PLoS genetics	2014	27
25893293	Cytosine	Fan H	Hepatitis B virus X protein induces EpCAM expression via active DNA demethylation directed by RelA in complex with EZH2 and TET2.	Oncogene	2016	12
26091828	Cytosine	Swanton C	APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity.	Cancer discovery	2015	56
26199412	Cytosine	Kang J	Simultaneous deletion of the methylcytosine oxidases Tet1 and Tet3 increases transcriptome variability in early embryogenesis.	Proceedings of the National Academy of Sciences of the United States of America	2015	18
26420215	Cytosine	Leonard B	The PKC/NF-κB signaling pathway induces APOBEC3B expression in multiple human cancers.	Cancer research	2015	20
26436839	Cytosine	Okoye-Okafor UC	New IDH1 mutant inhibitors for treatment of acute myeloid leukemia.	Nature chemical biology	2015	25
26586431	Cytosine	Zhao Z	Combined Loss of Tet1 and Tet2 Promotes B Cell, but Not Myeloid Malignancies, in Mice.	Cell reports	2015	22
15099407	Acetaldehyde	Crabb DW	Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology.	The Proceedings of the Nutrition Society	2004	86
17920722	Acetaldehyde	Patel M	ALDH1A1 and ALDH3A1 expression in lung cancers: correlation with histologic type and potential precursors.	Lung cancer	2008	61
18573038	Acetaldehyde	Douville J	ALDH1 as a functional marker of cancer stem and progenitor cells.	Stem cells and development	2009	97
18591932	Acetaldehyde	Korkaya H	HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion.	Oncogene	2008	211
18790753	Acetaldehyde	Feldmann G	An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer.	Molecular cancer therapeutics	2008	89
19072981	Acetaldehyde	Chu P	Characterization of a subpopulation of colon cancer cells with stem cell-like properties.	International journal of cancer	2009	51
19188663	Acetaldehyde	Jones RJ	Circulating clonotypic B cells in classic Hodgkin lymphoma.	Blood	2009	56
19251410	Acetaldehyde	Chuthapisith S	Breast cancer chemoresistance: emerging importance of cancer stem cells.	Surgical oncology	2010	41
19258443	Acetaldehyde	Mullendore ME	Ligand-dependent Notch signaling is involved in tumor initiation and tumor maintenance in pancreatic cancer.	Clinical cancer research 	2009	67
19276181	Acetaldehyde	Jiang F	Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer.	Molecular cancer research 	2009	235
19509181	Acetaldehyde	Tanei T	Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.	Clinical cancer research 	2009	149
20010854	Acetaldehyde	Li T	ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome.	Laboratory investigation; a journal of technical methods and pathology	2010	111
20019840	Acetaldehyde	Vesuna F	Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression.	Neoplasia	2009	66
20028757	Acetaldehyde	Charafe-Jauffret E	Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer.	Clinical cancer research 	2010	238
20142235	Acetaldehyde	Su Y	Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer.	Cancer epidemiology, biomarkers & prevention 	2010	69
20309879	Acetaldehyde	Wang L	Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99-1 cells based on high aldehyde dehydrogenase activity.	International journal of cancer	2011	37
20422001	Acetaldehyde	Deng S	Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers.	PloS one	2010	153
20606680	Acetaldehyde	Lugli A	Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer.	British journal of cancer	2010	67
20716638	Acetaldehyde	Keysar SB	More than markers: biological significance of cancer stem cell-defining molecules.	Molecular cancer therapeutics	2010	65
20959469	Acetaldehyde	Todaro M	Tumorigenic and metastatic activity of human thyroid cancer stem cells.	Cancer research	2010	60
21224357	Acetaldehyde	Liu S	Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks.	Cancer research	2011	167
21280157	Acetaldehyde	Marcato P	Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.	Stem cells	2011	129
21281815	Acetaldehyde	Lindgren D	Isolation and characterization of progenitor-like cells from human renal proximal tubules.	The American journal of pathology	2011	60
21304586	Acetaldehyde	Chen C	Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma.	PloS one	2011	79
21304978	Acetaldehyde	Shankar S	Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition.	PloS one	2011	79
21552008	Acetaldehyde	Marcato P	Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform.	Cell cycle	2011	135
21695188	Acetaldehyde	Kim MP	ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.	PloS one	2011	105
21900397	Acetaldehyde	Lin L	STAT3 is necessary for proliferation and survival in colon cancer-initiating cells.	Cancer research	2011	70
22020330	Acetaldehyde	Canino C	SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells.	Oncogene	2012	33
22070916	Acetaldehyde	Zhang Z	The biology of head and neck cancer stem cells.	Oral oncology	2012	31
22162267	Acetaldehyde	Tang AL	UM-SCC-104: a new human papillomavirus-16-positive cancer stem cell-containing head and neck squamous cell carcinoma cell line.	Head & neck	2012	32
22262762	Acetaldehyde	Gerber JM	A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia.	Blood	2012	68
22438320	Acetaldehyde	Germann M	Stem-like cells with luminal progenitor phenotype survive castration in human prostate cancer.	Stem cells	2012	35
22730244	Acetaldehyde	Santini R	Hedgehog-GLI signaling drives self-renewal and tumorigenicity of human melanoma-initiating cells.	Stem cells	2012	43
22733132	Acetaldehyde	Gong C	Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem-like/progenitor cells.	Oncogene	2013	65
22846863	Acetaldehyde	Ji J	Clinical implications of cancer stem cell biology in hepatocellular carcinoma.	Seminars in oncology	2012	58
22887839	Acetaldehyde	Luo Y	ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets.	Stem cells	2012	72
22890301	Acetaldehyde	Ho PL	Normal and neoplastic urothelial stem cells: getting to the root of the problem.	Nature reviews. Urology	2012	39
23091114	Acetaldehyde	Duru N	HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells.	Clinical cancer research 	2012	47
23539445	Acetaldehyde	Xu C	β-Catenin/POU5F1/SOX2 transcription factor complex mediates IGF-I receptor signaling and predicts poor prognosis in lung adenocarcinoma.	Cancer research	2013	29
23586700	Acetaldehyde	Alamgeer M	Cancer stem cells in lung cancer: Evidence and controversies.	Respirology	2013	40
23762304	Acetaldehyde	Kuroda T	ALDH1-high ovarian cancer stem-like cells can be isolated from serous and clear cell adenocarcinoma cells, and ALDH1 high expression is associated with poor prognosis.	PloS one	2013	29
23975425	Acetaldehyde	Qian X	N-cadherin/FGFR promotes metastasis through epithelial-to-mesenchymal transition and stem/progenitor cell-like properties.	Oncogene	2014	33
24037726	Acetaldehyde	Hira A	Variant ALDH2 is associated with accelerated progression of bone marrow failure in Japanese Fanconi anemia patients.	Blood	2013	30
24043631	Acetaldehyde	Alam M	MUC1-C oncoprotein activates ERK→C/EBPβ signaling and induction of aldehyde dehydrogenase 1A1 in breast cancer cells.	The Journal of biological chemistry	2013	29
24116047	Acetaldehyde	Ueda K	Aldehyde dehydrogenase 1 identifies cells with cancer stem cell-like properties in a human renal cell carcinoma cell line.	PloS one	2013	31
24129237	Acetaldehyde	Suman S	Silencing NOTCH signaling causes growth arrest in both breast cancer stem cells and breast cancer cells.	British journal of cancer	2013	31
24201124	Acetaldehyde	Yang L	ALDH1A1 defines invasive cancer stem-like cells and predicts poor prognosis in patients with esophageal squamous cell carcinoma.	Modern pathology 	2014	25
24210755	Acetaldehyde	Ajani JA	ALDH-1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients.	Molecular oncology	2014	25
24511467	Acetaldehyde	Liu S	Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts.	Stem cell reports	2014	177
24615157	Acetaldehyde	Liu L	Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation.	International journal of cancer	2014	29
24652403	Acetaldehyde	Panni RZ	Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer.	Cancer immunology, immunotherapy 	2014	28
24681955	Acetaldehyde	Santini R	SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells.	Oncogene	2014	48
24709421	Acetaldehyde	Nör C	Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer.	Neoplasia	2014	37
24907115	Acetaldehyde	Shao C	Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathway.	Clinical cancer research 	2014	34
25106087	Acetaldehyde	Marcato P	Aldehyde dehydrogenase 1A3 influences breast cancer progression via differential retinoic acid signaling.	Molecular oncology	2015	19
25150980	Acetaldehyde	Shimoda M	Loss of the Timp gene family is sufficient for the acquisition of the CAF-like cell state.	Nature cell biology	2014	29
25151964	Acetaldehyde	Zhao D	VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.	Oncogene	2015	36
25155611	Acetaldehyde	Oberbeck N	Maternal aldehyde elimination during pregnancy preserves the fetal genome.	Molecular cell	2014	21
25163478	Acetaldehyde	Zambelli VO	Aldehyde dehydrogenase-2 regulates nociception in rodent models of acute inflammatory pain.	Science translational medicine	2014	22
25670168	Acetaldehyde	Cojoc M	Aldehyde Dehydrogenase Is Regulated by β-Catenin/TCF and Promotes Radioresistance in Prostate Cancer Progenitor Cells.	Cancer research	2015	30
25827713	Acetaldehyde	Thiagarajan PS	Development of a Fluorescent Reporter System to Delineate Cancer Stem Cells in Triple-Negative Breast Cancer.	Stem cells	2015	18
25979230	Acetaldehyde	James MI	Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy.	Cancer letters	2015	16
26421710	Acetaldehyde	Farnie G	High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.	Oncotarget	2015	30
26783961	Acetaldehyde	Tomita H	Aldehyde dehydrogenase 1A1 in stem cells and cancer.	Oncotarget	2016	47
27270422	Acetaldehyde	Lu J	MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1.	Oncogene	2017	8
27634934	Acetaldehyde	Keysar SB	Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.	Journal of the National Cancer Institute	2017	8
27888001	Acetaldehyde	Łuczaj W	Antioxidants and HNE in redox homeostasis.	Free radical biology & medicine	2017	6
15169807	Carboplatin	Johnson DH	Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer.	Journal of clinical oncology 	2004	314
15501983	Carboplatin	Mondesire WH	Targeting mammalian target of rapamycin synergistically enhances chemotherapy-induced cytotoxicity in breast cancer cells.	Clinical cancer research 	2004	91
16043828	Carboplatin	Eberhard DA	Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib.	Journal of clinical oncology 	2005	363
16782917	Carboplatin	Robert N	Randomized phase III study of trastuzumab, paclitaxel, and carboplatin compared with trastuzumab and paclitaxel in women with HER-2-overexpressing metastatic breast cancer.	Journal of clinical oncology 	2006	97
17140455	Carboplatin	Liu G	Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma.	Molecular cancer	2006	509
18264088	Carboplatin	Edwards SL	Resistance to therapy caused by intragenic deletion in BRCA2.	Nature	2008	233
18281656	Carboplatin	Edelman MJ	Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203.	Journal of clinical oncology 	2008	70
18316562	Carboplatin	Dowlati A	Cell adhesion molecules, vascular endothelial growth factor, and basic fibroblast growth factor in patients with non-small cell lung cancer treated with chemotherapy with or without bevacizumab--an Eastern Cooperative Oncology Group Study.	Clinical cancer research 	2008	82
18612151	Carboplatin	Hirsch FR	Increased EGFR gene copy number detected by fluorescent in situ hybridization predicts outcome in non-small-cell lung cancer patients treated with cetuximab and chemotherapy.	Journal of clinical oncology 	2008	70
19917840	Carboplatin	Kies MS	Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial.	Journal of clinical oncology 	2010	40
20085937	Carboplatin	Dahlberg SE	Clinical course of advanced non-small-cell lung cancer patients experiencing hypertension during treatment with bevacizumab in combination with carboplatin and paclitaxel on ECOG 4599.	Journal of clinical oncology 	2010	54
20100958	Carboplatin	Khambata-Ford S	Analysis of potential predictive markers of cetuximab benefit in BMS099, a phase III study of cetuximab and first-line taxane/carboplatin in advanced non-small-cell lung cancer.	Journal of clinical oncology 	2010	65
20952506	Carboplatin	Chen Z	Inhibition of ALK, PI3K/MEK, and HSP90 in murine lung adenocarcinoma induced by EML4-ALK fusion oncogene.	Cancer research	2010	71
21102589	Carboplatin	Gualberto A	Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab.	British journal of cancer	2011	37
21115860	Carboplatin	Valero V	Multicenter phase III randomized trial comparing docetaxel and trastuzumab with docetaxel, carboplatin, and trastuzumab as first-line chemotherapy for patients with HER2-gene-amplified metastatic breast cancer (BCIRG 007 study): two highly active therapeutic regimens.	Journal of clinical oncology 	2011	52
21618519	Carboplatin	Boyerinas B	Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1.	International journal of cancer	2012	43
21670455	Carboplatin	Fukuoka M	Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer in Asia (IPASS).	Journal of clinical oncology 	2011	326
22011650	Carboplatin	Thongprasert S	Health-related quality-of-life in a randomized phase III first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients from Asia with advanced NSCLC (IPASS).	Journal of thoracic oncology 	2011	35
22665533	Carboplatin	Carey LA	TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer.	Journal of clinical oncology 	2012	122
24336327	Carboplatin	Li A	SALL4 is a new target in endometrial cancer.	Oncogene	2015	19
24888810	Carboplatin	Langer CJ	Randomized, phase III trial of first-line figitumumab in combination with paclitaxel and carboplatin versus paclitaxel and carboplatin alone in patients with advanced non-small-cell lung cancer.	Journal of clinical oncology 	2014	45
25867061	Carboplatin	Xue J	MiRNA-621 sensitizes breast cancer to chemotherapy by suppressing FBXO11 and enhancing p53 activity.	Oncogene	2016	16
25893298	Carboplatin	He Y	Elevated CDCP1 predicts poor patient outcome and mediates ovarian clear cell carcinoma by promoting tumor spheroid formation, cell migration and chemoresistance.	Oncogene	2016	11
26025631	Carboplatin	Brozovic A	The miR-200 family differentially regulates sensitivity to paclitaxel and carboplatin in human ovarian carcinoma OVCAR-3 and MES-OV cells.	Molecular oncology	2015	15
26216383	Carboplatin	Dijkgraaf EM	A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer.	Annals of oncology 	2015	19
26928463	Carboplatin	Kumar A	Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer.	Nature medicine	2016	55
27569215	Carboplatin	Bliss SA	Mesenchymal Stem Cell-Derived Exosomes Stimulate Cycling Quiescence and Early Breast Cancer Dormancy in Bone Marrow.	Cancer research	2016	20
17439648	Curcumin	Bisht S	Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy.	Journal of nanobiotechnology	2007	146
20934487	Curcumin	Li YY	Increased expression of miRNA-146a in Alzheimer's disease transgenic mouse models.	Neuroscience letters	2011	36
22637745	Curcumin	Soubani O	Re-expression of miR-200 by novel approaches regulates the expression of PTEN and MT1-MMP in pancreatic cancer.	Carcinogenesis	2012	30
22952749	Curcumin	Bao B	Hypoxia induced aggressiveness of prostate cancer cells is linked with deregulated expression of VEGF, IL-6 and miRNAs that are attenuated by CDF.	PloS one	2012	43
22992310	Curcumin	Roy S	Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF.	Journal of hematology & oncology	2012	44
23548270	Curcumin	Yu CC	miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer.	Cancer research	2013	40
25667085	Curcumin	Picone P	Metformin increases APP expression and processing via oxidative stress, mitochondrial dysfunction and NF-κB activation: Use of insulin to attenuate metformin's effect.	Biochimica et biophysica acta	2015	16
25945832	Curcumin	Raninga PV	Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma.	Oncotarget	2015	18
26116834	Curcumin	Taverna S	Curcumin inhibits in vitro and in vivo chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21.	Oncotarget	2015	15
26703799	Curcumin	Suresh R	The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.	Advances in experimental medicine and biology	2016	14
27866850	Curcumin	Lim SO	Deubiquitination and Stabilization of PD-L1 by CSN5.	Cancer cell	2016	18
7540722	Nitric oxide	Giaid A	Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension.	The New England journal of medicine	1995	192
8816815	Nitric oxide	Topper JN	Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress.	Proceedings of the National Academy of Sciences of the United States of America	1996	141
9598824	Nitric oxide	Traub O	Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force.	Arteriosclerosis, thrombosis, and vascular biology	1998	172
10483914	Nitric oxide	Fawcett JW	The glial scar and central nervous system repair.	Brain research bulletin	1999	287
10556116	Nitric oxide	Jatakanon A	Neutrophilic inflammation in severe persistent asthma.	American journal of respiratory and critical care medicine	1999	142
10825356	Nitric oxide	Bitsch A	Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation.	Brain 	2000	130
11544106	Nitric oxide	Xie K	Interleukin-8 and human cancer biology.	Cytokine & growth factor reviews	2001	152
12154060	Nitric oxide	Gupta K	Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth.	Cancer research	2002	91
12183632	Nitric oxide	Gu Z	S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death.	Science	2002	227
12475801	Nitric oxide	Phan SH	The myofibroblast in pulmonary fibrosis.	Chest	2002	156
12518062	Nitric oxide	Hofseth LJ	Nitric oxide-induced cellular stress and p53 activation in chronic inflammation.	Proceedings of the National Academy of Sciences of the United States of America	2003	77
12639809	Nitric oxide	Maeda H	Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications.	International immunopharmacology	2003	83
12666098	Nitric oxide	Hunot S	Neuroinflammatory processes in Parkinson's disease.	Annals of neurology	2003	91
12846989	Nitric oxide	Hirsch EC	The role of glial reaction and inflammation in Parkinson's disease.	Annals of the New York Academy of Sciences	2003	85
15184672	Nitric oxide	Reynaert NL	Nitric oxide represses inhibitory kappaB kinase through S-nitrosylation.	Proceedings of the National Academy of Sciences of the United States of America	2004	92
15660333	Nitric oxide	Kanellis J	Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease.	Seminars in nephrology	2005	69
15690474	Nitric oxide	Sirica AE	Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy.	Hepatology	2005	98
15696076	Nitric oxide	Szefler SJ	Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.	The Journal of allergy and clinical immunology	2005	103
15728243	Nitric oxide	Barshes NR	Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts.	Journal of leukocyte biology	2005	91
15817707	Nitric oxide	Wesche DE	Leukocyte apoptosis and its significance in sepsis and shock.	Journal of leukocyte biology	2005	85
15950906	Nitric oxide	Lo HW	Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway.	Cancer cell	2005	173
16049344	Nitric oxide	Dekker RJ	Endothelial KLF2 links local arterial shear stress levels to the expression of vascular tone-regulating genes.	The American journal of pathology	2005	80
16192427	Nitric oxide	Amabile N	Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure.	Journal of the American Society of Nephrology 	2005	96
16288777	Nitric oxide	Jones SP	The ubiquitous role of nitric oxide in cardioprotection.	Journal of molecular and cellular cardiology	2006	123
16380428	Nitric oxide	Lowes MA	Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a).	Proceedings of the National Academy of Sciences of the United States of America	2005	102
16380482	Nitric oxide	Segal MS	Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes.	Diabetes	2006	69
16503465	Nitric oxide	Marks DJ	Defective acute inflammation in Crohn's disease: a clinical investigation.	Lancet	2006	107
16818701	Nitric oxide	Pantuck AJ	Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer.	Clinical cancer research 	2006	70
16963735	Nitric oxide	Yanagi Y	Measles virus: cellular receptors, tropism and pathogenesis.	The Journal of general virology	2006	69
16971655	Nitric oxide	Zhao HJ	Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice.	Journal of the American Society of Nephrology 	2006	111
17059358	Nitric oxide	Zariwala MA	Genetic defects in ciliary structure and function.	Annual review of physiology	2007	85
17101732	Nitric oxide	Serafini P	Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function.	The Journal of experimental medicine	2006	198
17379831	Nitric oxide	Suárez Y	Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells.	Circulation research	2007	222
17533181	Nitric oxide	Fung E	Delta-like 4 induces notch signaling in macrophages: implications for inflammation.	Circulation	2007	58
17577033	Nitric oxide	Filipazzi P	Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine.	Journal of clinical oncology 	2007	235
17592079	Nitric oxide	Sorrentino SA	Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.	Circulation	2007	88
17982277	Nitric oxide	Walter S	Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease.	Cellular physiology and biochemistry 	2007	103
18410513	Nitric oxide	Thirumangalakudi L	High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice.	Journal of neurochemistry	2008	68
18674538	Nitric oxide	Haile LA	Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.	Gastroenterology	2008	93
18803323	Nitric oxide	Jessen KR	Negative regulation of myelination: relevance for development, injury, and demyelinating disease.	Glia	2008	123
19234067	Nitric oxide	Fertuzinhos S	Selective depletion of molecularly defined cortical interneurons in human holoprosencephaly with severe striatal hypoplasia.	Cerebral cortex	2009	51
19289637	Nitric oxide	Greenstein AS	Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients.	Circulation	2009	125
19429441	Nitric oxide	Kerachian MA	Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action.	The Journal of steroid biochemistry and molecular biology	2009	52
19572148	Nitric oxide	Liu CY	Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14⁻/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer.	Journal of cancer research and clinical oncology	2010	84
19639676	Nitric oxide	Krüger M	Titin-based mechanical signalling in normal and failing myocardium.	Journal of molecular and cellular cardiology	2009	54
19714620	Nitric oxide	Takayama K	SIRT1 regulation of apoptosis of human chondrocytes.	Arthritis and rheumatism	2009	48
19883397	Nitric oxide	Bruns AF	Ligand-stimulated VEGFR2 signaling is regulated by co-ordinated trafficking and proteolysis.	Traffic	2010	46
19965817	Nitric oxide	Cherepanoff S	Bruch's membrane and choroidal macrophages in early and advanced age-related macular degeneration.	The British journal of ophthalmology	2010	57
20110409	Nitric oxide	Fijalkowska I	Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells.	The American journal of pathology	2010	76
20201076	Nitric oxide	Wang G	Markers of oxidative and nitrosative stress in systemic lupus erythematosus: correlation with disease activity.	Arthritis and rheumatism	2010	46
20385632	Nitric oxide	Elmahdy H	Human recombinant erythropoietin in asphyxia neonatorum: pilot trial.	Pediatrics	2010	40
20678595	Nitric oxide	Sitia S	From endothelial dysfunction to atherosclerosis.	Autoimmunity reviews	2010	52
20720216	Nitric oxide	Lam W	The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity.	Science translational medicine	2010	71
20923780	Nitric oxide	Kaur S	Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47.	The Journal of biological chemistry	2010	59
21036891	Nitric oxide	Guazzi M	PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study.	Circulation. Heart failure	2011	82
21300066	Nitric oxide	Grover M	Cellular changes in diabetic and idiopathic gastroparesis.	Gastroenterology	2011	78
21362471	Nitric oxide	Mukhopadhyay P	Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death.	Free radical biology & medicine	2011	35
21474820	Nitric oxide	Madhur MS	Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice.	Arteriosclerosis, thrombosis, and vascular biology	2011	60
21726807	Nitric oxide	Sarkar S	Complex inhibitory effects of nitric oxide on autophagy.	Molecular cell	2011	87
21768538	Nitric oxide	Wu W	Flow-Dependent Regulation of Kruppel-Like Factor 2 Is Mediated by MicroRNA-92a.	Circulation	2011	77
21852557	Nitric oxide	Rautou PE	Microparticles, vascular function, and atherothrombosis.	Circulation research	2011	70
21994414	Nitric oxide	Chen P	Tumor-associated macrophages promote angiogenesis and melanoma growth via adrenomedullin in a paracrine and autocrine manner.	Clinical cancer research 	2011	43
22184204	Nitric oxide	Knowles MR	Mutations of DNAH11 in patients with primary ciliary dyskinesia with normal ciliary ultrastructure.	Thorax	2012	45
22311128	Nitric oxide	Rao JS	Neuroinflammation and synaptic loss.	Neurochemical research	2012	36
22385633	Nitric oxide	Bossley CJ	Pediatric severe asthma is characterized by eosinophilia and remodeling without T(H)2 cytokines.	The Journal of allergy and clinical immunology	2012	45
22421969	Nitric oxide	Li W	Mesenchymal stem cells: a double-edged sword in regulating immune responses.	Cell death and differentiation	2012	60
22517765	Nitric oxide	Zimmerman MA	Butyrate suppresses colonic inflammation through HDAC1-dependent Fas upregulation and Fas-mediated apoptosis of T cells.	American journal of physiology. Gastrointestinal and liver physiology	2012	51
22936024	Nitric oxide	Tamoutounour S	CD64 distinguishes macrophages from dendritic cells in the gut and reveals the Th1-inducing role of mesenteric lymph node macrophages during colitis.	European journal of immunology	2012	113
23077543	Nitric oxide	Edin S	The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer.	PloS one	2012	98
23197572	Nitric oxide	Martin EA	Tadalafil alleviates muscle ischemia in patients with Becker muscular dystrophy.	Science translational medicine	2012	33
23271799	Nitric oxide	Ridnour LA	Molecular pathways: toll-like receptors in the tumor microenvironment--poor prognosis or new therapeutic opportunity.	Clinical cancer research 	2013	35
23306778	Nitric oxide	Muniyappa R	Role of insulin resistance in endothelial dysfunction.	Reviews in endocrine & metabolic disorders	2013	44
23349247	Nitric oxide	Riwanto M	Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling.	Circulation	2013	61
23547236	Nitric oxide	Dhande I	Proximal tubule angiotensin AT2 receptors mediate an anti-inflammatory response via interleukin-10: role in renoprotection in obese rats.	Hypertension	2013	26
23583836	Nitric oxide	Bosse K	Endothelial nitric oxide signaling regulates Notch1 in aortic valve disease.	Journal of molecular and cellular cardiology	2013	34
23684677	Nitric oxide	Paulus WJ	A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.	Journal of the American College of Cardiology	2013	257
23733335	Nitric oxide	Mussai F	Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment.	Blood	2013	31
23749634	Nitric oxide	Mattila JT	Microenvironments in tuberculous granulomas are delineated by distinct populations of macrophage subsets and expression of nitric oxide synthase and arginase isoforms.	Journal of immunology	2013	84
23825361	Nitric oxide	Ghebremariam YT	Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine.	Circulation	2013	27
23907995	Nitric oxide	Mendell JR	Eteplirsen for the treatment of Duchenne muscular dystrophy.	Annals of neurology	2013	128
23986401	Nitric oxide	Tian W	Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertension.	Science translational medicine	2013	37
24024753	Nitric oxide	Leigh MW	Standardizing nasal nitric oxide measurement as a test for primary ciliary dyskinesia.	Annals of the American Thoracic Society	2013	40
24088176	Nitric oxide	Arnold CE	A critical role for suppressor of cytokine signalling 3 in promoting M1 macrophage activation and function in vitro and in vivo.	Immunology	2014	22
24336068	Nitric oxide	Barsoum IB	A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells.	Cancer research	2014	66
24526691	Nitric oxide	Horio E	Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.	Arteriosclerosis, thrombosis, and vascular biology	2014	26
24549364	Nitric oxide	Mukherjee P	Development of nitric oxide synthase inhibitors for neurodegeneration and neuropathic pain.	Chemical Society reviews	2014	22
25001649	Nitric oxide	Iantorno M	Obesity, inflammation and endothelial dysfunction.	Journal of biological regulators and homeostatic agents	2014	25
25012134	Nitric oxide	Kumar S	Role of flow-sensitive microRNAs in endothelial dysfunction and atherosclerosis: mechanosensitive athero-miRs.	Arteriosclerosis, thrombosis, and vascular biology	2014	45
25351818	Nitric oxide	Bach LA	Endothelial cells and the IGF system.	Journal of molecular endocrinology	2015	20
25391251	Nitric oxide	Lee RJ	Bitter and sweet taste receptors in the respiratory epithelium in health and disease.	Journal of molecular medicine	2014	22
25575647	Nitric oxide	Teich AF	Synaptic therapy in Alzheimer's disease: a CREB-centric approach.	Neurotherapeutics 	2015	17
25631124	Nitric oxide	Cantoni C	TREM2 regulates microglial cell activation in response to demyelination in vivo.	Acta neuropathologica	2015	29
25737402	Nitric oxide	Li W	Intra-articular resveratrol injection prevents osteoarthritis progression in a mouse model by activating SIRT1 and thereby silencing HIF-2α.	Journal of orthopaedic research 	2015	17
25849745	Nitric oxide	Granados-Principal S	Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer.	Breast cancer research 	2015	30
26137590	Nitric oxide	Premer C	Allogeneic Mesenchymal Stem Cells Restore Endothelial Function in Heart Failure by Stimulating Endothelial Progenitor Cells.	EBioMedicine	2015	23
26289067	Nitric oxide	Gebhardt C	Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab.	Clinical cancer research 	2015	32
26732588	Nitric oxide	Kallaur AP	Genetic, Immune-Inflammatory, and Oxidative Stress Biomarkers as Predictors for Disability and Disease Progression in Multiple Sclerosis.	Molecular neurobiology	2017	8
26854724	Nitric oxide	Rasheed Z	MicroRNA-26a-5p regulates the expression of inducible nitric oxide synthase via activation of NF-κB pathway in human osteoarthritis chondrocytes.	Archives of biochemistry and biophysics	2016	12
26975422	Nitric oxide	Shiobara T	Dipeptidyl peptidase-4 is highly expressed in bronchial epithelial cells of untreated asthma and it increases cell proliferation along with fibronectin production in airway constitutive cells.	Respiratory research	2016	10
27301879	Nitric oxide	Thiele Orberg E	The myeloid immune signature of enterotoxigenic Bacteroides fragilis-induced murine colon tumorigenesis.	Mucosal immunology	2017	7
27732846	Nitric oxide	Van den Bossche J	Mitochondrial Dysfunction Prevents Repolarization of Inflammatory Macrophages.	Cell reports	2016	20
28108630	Nitric oxide	Cullis J	Macropinocytosis of Nab-paclitaxel Drives Macrophage Activation in Pancreatic Cancer.	Cancer immunology research	2017	7
28504669	Nitric oxide	Mishra BB	Nitric oxide prevents a pathogen-permissive granulocytic inflammation during tuberculosis.	Nature microbiology	2017	11
12384559	Plerixafor	Scotton CJ	Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer.	Cancer research	2002	118
15087398	Plerixafor	Tavor S	CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice.	Cancer research	2004	78
15548713	Plerixafor	Marchesi F	Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4.	Cancer research	2004	91
15574767	Plerixafor	Smith MC	CXCR4 regulates growth of both primary and metastatic breast cancer.	Cancer research	2004	213
16489019	Plerixafor	Yasumoto K	Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer.	Cancer research	2006	62
17119115	Plerixafor	Alsayed Y	Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma.	Blood	2007	116
17893878	Plerixafor	Kajiyama H	Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma.	International journal of cancer	2008	79
19588204	Plerixafor	Matsusue R	Hepatic stellate cells promote liver metastasis of colon cancer cells by the action of SDF-1/CXCR4 axis.	Annals of surgical oncology	2009	45
19641136	Plerixafor	Zabel BA	Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands.	Journal of immunology	2009	92
20631066	Plerixafor	Kozin SV	Recruitment of myeloid but not endothelial precursor cells facilitates tumor regrowth after local irradiation.	Cancer research	2010	82
21045835	Plerixafor	Singh S	CXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy.	British journal of cancer	2010	59
21349998	Plerixafor	Duda DG	CXCL12 (SDF1alpha)-CXCR4/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies?	Clinical cancer research 	2011	124
21618540	Plerixafor	Ping YF	The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling.	The Journal of pathology	2011	52
21742774	Plerixafor	Righi E	CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer.	Cancer research	2011	51
22045709	Plerixafor	Gourni E	PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agent.	Journal of nuclear medicine 	2011	38
22370645	Plerixafor	Jung MJ	Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells.	Oncogene	2013	54
22370717	Plerixafor	Schiraldi M	HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4.	The Journal of experimental medicine	2012	133
22648473	Plerixafor	Zhang Q	A microfluidic-based device for study of transendothelial invasion of tumor aggregates in realtime.	Lab on a chip	2012	31
22871210	Plerixafor	Zhang SS	CD133(+)CXCR4(+) colon cancer cells exhibit metastatic potential and predict poor prognosis of patients.	BMC medicine	2012	46
24157575	Plerixafor	Gatti M	Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity.	Toxicology	2013	27
25444927	Plerixafor	Guan G	The HIF-1α/CXCR4 pathway supports hypoxia-induced metastasis of human osteosarcoma cells.	Cancer letters	2015	16
26414794	Plerixafor	Izumi D	CXCL12/CXCR4 activation by cancer-associated fibroblasts promotes integrin β1 clustering and invasiveness in gastric cancer.	International journal of cancer	2016	11
26517945	Plerixafor	Fontanella R	A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion.	Cancer letters	2016	10
26851944	Plerixafor	Teng F	Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/CXCR4 axis.	Journal of hematology & oncology	2016	14
9887098	Hyaluronan	Yu Q	Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion.	Genes & development	1999	145
11731267	Hyaluronan	Csoka AB	The six hyaluronidase-like genes in the human and mouse genomes.	Matrix biology 	2001	112
12819017	Hyaluronan	de la Motte CA	Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid:polycytidylic acid: inter-alpha-trypsin inhibitor is crucial to structure and function.	The American journal of pathology	2003	93
15047232	Hyaluronan	Burleson KM	Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers.	Gynecologic oncology	2004	81
17079438	Hyaluronan	Götte M	Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective.	Cancer research	2006	100
19047049	Hyaluronan	Bourguignon LY	Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates beta-catenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells.	The Journal of biological chemistry	2009	51
19218337	Hyaluronan	Bharadwaj AG	Spontaneous metastasis of prostate cancer is promoted by excess hyaluronan synthesis and processing.	The American journal of pathology	2009	52
21278789	Hyaluronan	Kwak HJ	Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas.	Oncogene	2011	38
22753277	Hyaluronan	Auvinen P	Increased hyaluronan content and stromal cell CD44 associate with HER2 positivity and poor prognosis in human breast cancer.	International journal of cancer	2013	27
23085635	Hyaluronan	Vlahu CA	Damage of the endothelial glycocalyx in dialysis patients.	Journal of the American Society of Nephrology 	2012	34
23463525	Hyaluronan	Preston M	Digestion products of the PH20 hyaluronidase inhibit remyelination.	Annals of neurology	2013	26
24145190	Hyaluronan	Ju SY	Maintenance of the stemness in CD44(+) HCT-15 and HCT-116 human colon cancer cells requires miR-203 suppression.	Stem cell research	2014	21
25157350	Hyaluronan	Tolg C	Hyaluronan and RHAMM in wound repair and the "cancerization" of stromal tissues.	BioMed research international	2014	22
25387851	Hyaluronan	Tiainen S	High numbers of macrophages, especially M2-like (CD163-positive), correlate with hyaluronan accumulation and poor outcome in breast cancer.	Histopathology	2015	15
25778676	Hyaluronan	Becker BF	Degradation of the endothelial glycocalyx in clinical settings: searching for the sheddases.	British journal of clinical pharmacology	2015	27
26005723	Hyaluronan	Li L	Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells.	International journal of molecular medicine	2015	19
26485284	Hyaluronan	Cui Y	Therapeutic lymphangiogenesis ameliorates established acute lung allograft rejection.	The Journal of clinical investigation	2015	17
27694932	Hyaluronan	Liang J	Hyaluronan and TLR4 promote surfactant-protein-C-positive alveolar progenitor cell renewal and prevent severe pulmonary fibrosis in mice.	Nature medicine	2016	20
15709185	Gefitinib	Tokumo M	The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers.	Clinical cancer research 	2005	100
15939921	Gefitinib	Baselga J	Phase II and tumor pharmacodynamic study of gefitinib in patients with advanced breast cancer.	Journal of clinical oncology 	2005	83
16204011	Gefitinib	Bell DW	Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: molecular analysis of the IDEAL/INTACT gefitinib trials.	Journal of clinical oncology 	2005	123
16278407	Gefitinib	Lassman AB	Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01.	Clinical cancer research 	2005	68
16322287	Gefitinib	Haura EB	Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer.	Clinical cancer research 	2005	73
16785471	Gefitinib	Inoue A	Prospective phase II study of gefitinib for chemotherapy-naive patients with advanced non-small-cell lung cancer with epidermal growth factor receptor gene mutations.	Journal of clinical oncology 	2006	119
16906227	Gefitinib	Engelman JA	Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer.	The Journal of clinical investigation	2006	153
17047648	Gefitinib	Asahina H	A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations.	British journal of cancer	2006	68
17200208	Gefitinib	Zhang J	SRC-family kinases are activated in non-small cell lung cancer and promote the survival of epidermal growth factor receptor-dependent cell lines.	The American journal of pathology	2007	59
17440163	Gefitinib	Farnie G	Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways.	Journal of the National Cancer Institute	2007	101
17463250	Gefitinib	Engelman JA	MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.	Science	2007	1311
18381447	Gefitinib	Fuchs BC	Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells.	Cancer research	2008	94
18458038	Gefitinib	Sequist LV	First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations.	Journal of clinical oncology 	2008	246
18509184	Gefitinib	Yang CH	Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy.	Journal of clinical oncology 	2008	58
19276389	Gefitinib	Narayan M	Trastuzumab-induced HER reprogramming in "resistant" breast carcinoma cells.	Cancer research	2009	73
19435898	Gefitinib	Mukherjee B	EGFRvIII and DNA double-strand break repair: a molecular mechanism for radioresistance in glioblastoma.	Cancer research	2009	74
19447865	Gefitinib	Naumov GN	Combined vascular endothelial growth factor receptor and epidermal growth factor receptor (EGFR) blockade inhibits tumor growth in xenograft models of EGFR inhibitor resistance.	Clinical cancer research 	2009	61
19680293	Gefitinib	Gazdar AF	Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors.	Oncogene	2009	191
20351699	Gefitinib	Harris TJ	The molecular pathology of cancer.	Nature reviews. Clinical oncology	2010	58
21030498	Gefitinib	Heon S	Development of central nervous system metastases in patients with advanced non-small cell lung cancer and somatic EGFR mutations treated with gefitinib or erlotinib.	Clinical cancer research 	2010	50
21123652	Gefitinib	Tigno-Aranjuez JT	Inhibition of RIP2's tyrosine kinase activity limits NOD2-driven cytokine responses.	Genes & development	2010	49
21248303	Gefitinib	Janjigian YY	Phase I/II trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib.	Clinical cancer research 	2011	48
21597390	Gefitinib	Suda K	Epithelial to mesenchymal transition in an epidermal growth factor receptor-mutant lung cancer cell line with acquired resistance to erlotinib.	Journal of thoracic oncology 	2011	81
22281684	Gefitinib	Prahallad A	Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR.	Nature	2012	428
22414764	Gefitinib	Blivet-Van Eggelpoël MJ	Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells.	Journal of hepatology	2012	39
22586683	Gefitinib	Cheung HW	Amplification of CRKL induces transformation and epidermal growth factor receptor inhibitor resistance in human non-small cell lung cancers.	Cancer discovery	2011	49
22810899	Gefitinib	Johnson ML	Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinomas.	Cancer	2013	34
23154553	Gefitinib	D'Angelo SP	Distinct clinical course of EGFR-mutant resected lung cancers: results of testing of 1118 surgical specimens and effects of adjuvant gefitinib and erlotinib.	Journal of thoracic oncology 	2012	39
23307622	Gefitinib	Cufí S	Autophagy-related gene 12 (ATG12) is a novel determinant of primary resistance to HER2-targeted therapies: utility of transcriptome analysis of the autophagy interactome to guide breast cancer treatment.	Oncotarget	2012	33
23555954	Gefitinib	Chen G	miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells.	PloS one	2013	74
23816963	Gefitinib	Katakami N	LUX-Lung 4: a phase II trial of afatinib in patients with advanced non-small-cell lung cancer who progressed during prior treatment with erlotinib, gefitinib, or both.	Journal of clinical oncology 	2013	68
24108744	Gefitinib	Buonato JM	ERK1/2 blockade prevents epithelial-mesenchymal transition in lung cancer cells and promotes their sensitivity to EGFR inhibition.	Cancer research	2014	39
24486412	Gefitinib	Zhao D	Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells.	Cellular signalling	2014	25
24489728	Gefitinib	Murakami A	Hypoxia increases gefitinib-resistant lung cancer stem cells through the activation of insulin-like growth factor 1 receptor.	PloS one	2014	28
24983493	Gefitinib	Zhou JY	MicroRNA-34a overcomes HGF-mediated gefitinib resistance in EGFR mutant lung cancer cells partly by targeting MET.	Cancer letters	2014	21
25058005	Gefitinib	Shen H	Alteration in Mir-21/PTEN expression modulates gefitinib resistance in non-small cell lung cancer.	PloS one	2014	22
25294908	Gefitinib	Capelletti M	Identification of recurrent FGFR3-TACC3 fusion oncogenes from lung adenocarcinoma.	Clinical cancer research 	2014	27
25349974	Gefitinib	D'Incecco A	PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients.	British journal of cancer	2015	102
25359280	Gefitinib	Lin GN	Elevated neutrophil-to-lymphocyte ratio predicts poor outcome in patients with advanced non-small-cell lung cancer receiving first-line gefitinib or erlotinib treatment.	Asia-Pacific journal of clinical oncology	2017	14
25928246	Gefitinib	Wen W	Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancer.	Molecular cancer	2015	15
26537995	Gefitinib	Minguet J	Targeted therapies for treatment of non-small cell lung cancer--Recent advances and future perspectives.	International journal of cancer	2016	31
27435396	Gefitinib	Ballard P	Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases Activity.	Clinical cancer research 	2016	32
27663586	Gefitinib	Scarborough HA	AZ1366: An Inhibitor of Tankyrase and the Canonical Wnt Pathway that Limits the Persistence of Non-Small Cell Lung Cancer Cells Following EGFR Inhibition.	Clinical cancer research 	2017	5
28096505	Gefitinib	Gemmill RM	The neuropilin 2 isoform NRP2b uniquely supports TGFβ-mediated progression in lung cancer.	Science signaling	2017	6
18421051	Lapatinib	Lin NU	Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer.	Journal of clinical oncology 	2008	101
19047149	Lapatinib	Saxena NK	Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor.	Cancer research	2008	73
19179558	Lapatinib	Blackwell KL	Single-agent lapatinib for HER2-overexpressing advanced or metastatic breast cancer that progressed on first- or second-line trastuzumab-containing regimens.	Annals of oncology 	2009	51
19204209	Lapatinib	Sauter G	Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations.	Journal of clinical oncology 	2009	107
20730488	Lapatinib	Junttila TT	Trastuzumab-DM1 (T-DM1) retains all the mechanisms of action of trastuzumab and efficiently inhibits growth of lapatinib insensitive breast cancer.	Breast cancer research and treatment	2011	71
21245432	Lapatinib	Spraggs CF	HLA-DQA1*02:01 is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer.	Journal of clinical oncology 	2011	56
21342044	Lapatinib	Gajria D	HER2-amplified breast cancer: mechanisms of trastuzumab resistance and novel targeted therapies.	Expert review of anticancer therapy	2011	83
21499296	Lapatinib	Rexer BN	Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition.	Oncogene	2011	49
21699723	Lapatinib	Giuliano M	Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment.	Breast cancer research 	2011	46
21741829	Lapatinib	von Minckwitz G	Trastuzumab beyond progression: overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer.	European journal of cancer	2011	41
21847123	Lapatinib	Pandya K	Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence.	British journal of cancer	2011	46
22248472	Lapatinib	McDonagh CF	Antitumor activity of a novel bispecific antibody that targets the ErbB2/ErbB3 oncogenic unit and inhibits heregulin-induced activation of ErbB3.	Molecular cancer therapeutics	2012	79
22407832	Lapatinib	García-García C	Dual mTORC1/2 and HER2 blockade results in antitumor activity in preclinical models of breast cancer resistant to anti-HER2 therapy.	Clinical cancer research 	2012	54
22649126	Lapatinib	Krop IE	A phase II study of trastuzumab emtansine in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer who were previously treated with trastuzumab, lapatinib, an anthracycline, a taxane, and capecitabine.	Journal of clinical oncology 	2012	63
22689807	Lapatinib	Blackwell KL	Overall survival benefit with lapatinib in combination with trastuzumab for patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: final results from the EGF104900 Study.	Journal of clinical oncology 	2012	115
22745588	Lapatinib	Clark PA	Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibition.	Neoplasia	2012	45
23020162	Lapatinib	Verma S	Trastuzumab emtansine for HER2-positive advanced breast cancer.	The New England journal of medicine	2012	432
23071597	Lapatinib	Nowsheen S	Synthetic lethal interactions between EGFR and PARP inhibition in human triple negative breast cancer cells.	PloS one	2012	33
23149820	Lapatinib	Singh JK	Targeting CXCR1/2 significantly reduces breast cancer stem cell activity and increases the efficacy of inhibiting HER2 via HER2-dependent and -independent mechanisms.	Clinical cancer research 	2013	51
23220880	Lapatinib	Bose R	Activating HER2 mutations in HER2 gene amplification negative breast cancer.	Cancer discovery	2013	160
23940356	Lapatinib	Hanker AB	Mutant PIK3CA accelerates HER2-driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapies.	Proceedings of the National Academy of Sciences of the United States of America	2013	43
24080156	Lapatinib	Kümler I	A systematic review of dual targeting in HER2-positive breast cancer.	Cancer treatment reviews	2014	36
24097864	Lapatinib	Phillips GD	Dual targeting of HER2-positive cancer with trastuzumab emtansine and pertuzumab: critical role for neuregulin blockade in antitumor response to combination therapy.	Clinical cancer research 	2014	36
24222194	Lapatinib	Welslau M	Patient-reported outcomes from EMILIA, a randomized phase 3 study of trastuzumab emtansine (T-DM1) versus capecitabine and lapatinib in human epidermal growth factor receptor 2-positive locally advanced or metastatic breast cancer.	Cancer	2014	22
24656976	Lapatinib	Yan M	HER2 aberrations in cancer: implications for therapy.	Cancer treatment reviews	2014	45
24919460	Lapatinib	Balduzzi S	Trastuzumab-containing regimens for metastatic breast cancer.	The Cochrane database of systematic reviews	2014	27
25086636	Lapatinib	Müller V	Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial.	Breast cancer research and treatment	2014	29
25199759	Lapatinib	Loibl S	PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (her2) therapy in primary HER2-overexpressing breast cancer.	Journal of clinical oncology 	2014	47
25355722	Lapatinib	Krop IE	Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA.	Annals of oncology 	2015	24
25467182	Lapatinib	Scaltriti M	High HER2 expression correlates with response to the combination of lapatinib and trastuzumab.	Clinical cancer research 	2015	18
25605838	Lapatinib	Pivot X	CEREBEL (EGF111438): A Phase III, Randomized, Open-Label Study of Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer.	Journal of clinical oncology 	2015	23
25622903	Lapatinib	Zhang L	Heparanase mediates a novel mechanism in lapatinib-resistant brain metastatic breast cancer.	Neoplasia	2015	17
26204261	Lapatinib	Moasser MM	The Evolving Landscape of HER2 Targeting in Breast Cancer.	JAMA oncology	2015	15
26598744	Lapatinib	Piccart-Gebhart M	Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial.	Journal of clinical oncology 	2016	25
26647992	Lapatinib	Wang M	N-cadherin promotes epithelial-mesenchymal transition and cancer stem cell-like traits via ErbB signaling in prostate cancer cells.	International journal of oncology	2016	21
26920887	Lapatinib	Baselga J	Relationship between Tumor Biomarkers and Efficacy in EMILIA, a Phase III Study of Trastuzumab Emtansine in HER2-Positive Metastatic Breast Cancer.	Clinical cancer research 	2016	19
27034004	Lapatinib	Li W	Downregulation of LncRNA GAS5 causes trastuzumab resistance in breast cancer.	Oncotarget	2016	22
9267033	L-Glutamine	Davies SW	Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.	Cell	1997	464
9398841	L-Glutamine	White JK	Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion.	Nature genetics	1997	132
9519752	L-Glutamine	Mizutani M	Müller cell changes in human diabetic retinopathy.	Diabetes	1998	103
9620770	L-Glutamine	Cummings CJ	Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1.	Nature genetics	1998	178
9635424	L-Glutamine	Warrick JM	Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila.	Cell	1998	166
9768849	L-Glutamine	Jackson GR	Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons.	Neuron	1998	133
10200309	L-Glutamine	Scherzinger E	Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology.	Proceedings of the National Academy of Sciences of the United States of America	1999	168
10581028	L-Glutamine	Warrick JM	Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70.	Nature genetics	1999	215
10581038	L-Glutamine	Manley K	Msh2 deficiency prevents in vivo somatic instability of the CAG repeat in Huntington disease transgenic mice.	Nature genetics	1999	136
10684852	L-Glutamine	Arentz-Hansen H	The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase.	The Journal of experimental medicine	2000	122
11007884	L-Glutamine	Kegel KB	Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy.	The Journal of neuroscience 	2000	108
11081516	L-Glutamine	Fernandez-Funez P	Identification of genes that modify ataxin-1-induced neurodegeneration.	Nature	2000	173
11394998	L-Glutamine	Hara J	Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity.	Neuron	2001	282
12062094	L-Glutamine	Humbert S	The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt.	Developmental cell	2002	116
12191472	L-Glutamine	Lunkes A	Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions.	Molecular cell	2002	93
12223539	L-Glutamine	Wellington CL	Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease.	The Journal of neuroscience 	2002	85
14527432	L-Glutamine	Szebenyi G	Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport.	Neuron	2003	81
14978262	L-Glutamine	Lee WC	Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease.	Proceedings of the National Academy of Sciences of the United States of America	2004	99
15036808	L-Glutamine	Li SH	Huntingtin-protein interactions and the pathogenesis of Huntington's disease.	Trends in genetics 	2004	137
15152038	L-Glutamine	Chevalier-Larsen ES	Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy.	The Journal of neuroscience 	2004	72
15459747	L-Glutamine	Landles C	Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series.	EMBO reports	2004	94
15483602	L-Glutamine	Arrasate M	Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death.	Nature	2004	553
15811941	L-Glutamine	Harper SQ	RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model.	Proceedings of the National Academy of Sciences of the United States of America	2005	195
16076956	L-Glutamine	Slow EJ	Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions.	Proceedings of the National Academy of Sciences of the United States of America	2005	76
16122429	L-Glutamine	Tsuda H	The AXH domain of Ataxin-1 mediates neurodegeneration through its interaction with Gfi-1/Senseless proteins.	Cell	2005	77
16473015	L-Glutamine	Chang DT	Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons.	Neurobiology of disease	2006	75
16804541	L-Glutamine	Moseley ML	Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8.	Nature genetics	2006	132
17034350	L-Glutamine	Browne SE	Oxidative damage in Huntington's disease pathogenesis.	Antioxidants & redox signaling	2006	90
17041811	L-Glutamine	Borrell-Pagès M	Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies.	Cellular and molecular life sciences 	2006	62
17326147	L-Glutamine	Di Tommaso L	Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis.	Hepatology	2007	63
17687326	L-Glutamine	Bennett EJ	Global changes to the ubiquitin system in Huntington's disease.	Nature	2007	184
17984323	L-Glutamine	Filimonenko M	Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease.	The Journal of cell biology	2007	198
18177721	L-Glutamine	DeBerardinis RJ	The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.	Cell metabolism	2008	950
18337722	L-Glutamine	Lim J	Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1.	Nature	2008	130
18466116	L-Glutamine	Imarisio S	Huntington's disease: from pathology and genetics to potential therapies.	The Biochemical journal	2008	113
18550760	L-Glutamine	Gray M	Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice.	The Journal of neuroscience 	2008	194
18638556	L-Glutamine	Heng MY	Rodent genetic models of Huntington disease.	Neurobiology of disease	2008	62
18758459	L-Glutamine	Lee Y	miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis.	Nature neuroscience	2008	70
19118166	L-Glutamine	Packer AN	The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease.	The Journal of neuroscience 	2008	226
19334076	L-Glutamine	Drouet V	Sustained effects of nonallele-specific Huntingtin silencing.	Annals of neurology	2009	78
19487684	L-Glutamine	Nekooki-Machida Y	Distinct conformations of in vitro and in vivo amyloids of huntingtin-exon1 show different cytotoxicity.	Proceedings of the National Academy of Sciences of the United States of America	2009	81
19608102	L-Glutamine	van der Burg JM	Beyond the brain: widespread pathology in Huntington's disease.	The Lancet. Neurology	2009	76
20236390	L-Glutamine	Han I	Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features.	Journal of neurochemistry	2010	41
20383138	L-Glutamine	Martinez-Vicente M	Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease.	Nature neuroscience	2010	194
20670829	L-Glutamine	Miller JP	Matrix metalloproteinases are modifiers of huntingtin proteolysis and toxicity in Huntington's disease.	Neuron	2010	54
20955683	L-Glutamine	Jose C	Choosing between glycolysis and oxidative phosphorylation: a tumor's dilemma?	Biochimica et biophysica acta	2011	78
21163446	L-Glutamine	Ross CA	Huntington's disease: from molecular pathogenesis to clinical treatment.	The Lancet. Neurology	2011	293
21610160	L-Glutamine	Ross OA	Ataxin-2 repeat-length variation and neurodegeneration.	Human molecular genetics	2011	49
21852960	L-Glutamine	Kung HN	Glutamine synthetase is a genetic determinant of cell type-specific glutamine independence in breast epithelia.	PLoS genetics	2011	76
22271347	L-Glutamine	D'Ambrosio R	A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis.	Hepatology	2012	44
22383888	L-Glutamine	Bañez-Coronel M	A pathogenic mechanism in Huntington's disease involves small CAG-repeated RNAs with neurotoxic activity.	PLoS genetics	2012	50
22446390	L-Glutamine	Costa V	Shaping the role of mitochondria in the pathogenesis of Huntington's disease.	The EMBO journal	2012	37
22508507	L-Glutamine	Orr HT	Cell biology of spinocerebellar ataxia.	The Journal of cell biology	2012	47
22590724	L-Glutamine	Jia H	Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease.	Neurobiology of disease	2012	40
22613578	L-Glutamine	Juopperi TA	Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells.	Molecular brain	2012	72
22684686	L-Glutamine	Seidel K	Brain pathology of spinocerebellar ataxias.	Acta neuropathologica	2012	53
22748967	L-Glutamine	An MC	Genetic correction of Huntington's disease phenotypes in induced pluripotent stem cells.	Cell stem cell	2012	96
23160193	L-Glutamine	Kwan W	Mutant huntingtin impairs immune cell migration in Huntington disease.	The Journal of clinical investigation	2012	37
23172909	L-Glutamine	Farg MA	Ataxin-2 interacts with FUS and intermediate-length polyglutamine expansions enhance FUS-related pathology in amyotrophic lateral sclerosis.	Human molecular genetics	2013	25
23222885	L-Glutamine	Wang AM	Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation.	Nature chemical biology	2013	58
23499005	L-Glutamine	Reid MA	The B55α subunit of PP2A drives a p53-dependent metabolic adaptation to glutamine deprivation.	Molecular cell	2013	39
23898200	L-Glutamine	Caron NS	Polyglutamine domain flexibility mediates the proximity between flanking sequences in huntingtin.	Proceedings of the National Academy of Sciences of the United States of America	2013	28
24501367	L-Glutamine	Sosunov AA	Phenotypic heterogeneity and plasticity of isocortical and hippocampal astrocytes in the human brain.	The Journal of neuroscience 	2014	29
24584051	L-Glutamine	Crotti A	Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors.	Nature neuroscience	2014	57
24656866	L-Glutamine	Zhang X	Mutations in QARS, encoding glutaminyl-tRNA synthetase, cause progressive microcephaly, cerebral-cerebellar atrophy, and intractable seizures.	American journal of human genetics	2014	24
24840975	L-Glutamine	Deng H	The role of FUS gene variants in neurodegenerative diseases.	Nature reviews. Neurology	2014	36
25248380	L-Glutamine	Friemel J	Intratumor heterogeneity in hepatocellular carcinoma.	Clinical cancer research 	2015	35
26139106	L-Glutamine	Hernandez-Davies JE	Vemurafenib resistance reprograms melanoma cells towards glutamine dependence.	Journal of translational medicine	2015	19
26164081	L-Glutamine	Cohen R	Targeting cancer cell metabolism in pancreatic adenocarcinoma.	Oncotarget	2015	31
26590344	L-Glutamine	Bañez-Coronel M	RAN Translation in Huntington Disease.	Neuron	2015	39
26938440	L-Glutamine	Saudou F	The Biology of Huntingtin.	Neuron	2016	37
27018801	L-Glutamine	Tuttle MD	Solid-state NMR structure of a pathogenic fibril of full-length human α-synuclein.	Nature structural & molecular biology	2016	61
27617932	L-Glutamine	Pan M	Regional glutamine deficiency in tumours promotes dedifferentiation through inhibition of histone demethylation.	Nature cell biology	2016	19
28333144	L-Glutamine	Jones VC	Aberrant iPSC-derived human astrocytes in Alzheimer's disease.	Cell death & disease	2017	8
28405022	L-Glutamine	Becker LA	Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice.	Nature	2017	23
7666531	L-Threonine	Jowett JB	The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle.	Journal of virology	1995	205
9334355	L-Threonine	Serra R	Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis.	The Journal of cell biology	1997	117
9488451	L-Threonine	Weaver BK	Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1.	Molecular and cellular biology	1998	106
11237521	L-Threonine	Simpson L	PTEN: life as a tumor suppressor.	Experimental cell research	2001	134
11319750	L-Threonine	Miyazono K	Divergence and convergence of TGF-beta/BMP signaling.	Journal of cellular physiology	2001	89
11381269	L-Threonine	Howe JR	Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis.	Nature genetics	2001	154
11518967	L-Threonine	Dhanasekaran SM	Delineation of prognostic biomarkers in prostate cancer.	Nature	2001	372
11555628	L-Threonine	Altafaj X	Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome.	Human molecular genetics	2001	87
11686294	L-Threonine	Lawlor MA	PKB/Akt: a key mediator of cell proliferation, survival and insulin responses?	Journal of cell science	2001	231
11894098	L-Threonine	Kobayashi K	RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems.	Nature	2002	230
11956073	L-Threonine	Zhuang L	Cholesterol-rich lipid rafts mediate akt-regulated survival in prostate cancer cells.	Cancer research	2002	81
12019169	L-Threonine	Han H	Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray.	Cancer research	2002	96
12068308	L-Threonine	Davies H	Mutations of the BRAF gene in human cancer.	Nature	2002	2142
12244302	L-Threonine	Liang J	PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest.	Nature medicine	2002	251
12244303	L-Threonine	Viglietto G	Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer.	Nature medicine	2002	158
12466190	L-Threonine	Chang H	Genetic analysis of the mammalian transforming growth factor-beta superfamily.	Endocrine reviews	2002	150
12485160	L-Threonine	Miyazawa K	Two major Smad pathways in TGF-beta superfamily signalling.	Genes to cells 	2002	120
12684414	L-Threonine	Gritsko TM	Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer.	Clinical cancer research 	2003	86
12796778	L-Threonine	Toyo-oka K	14-3-3epsilon is important for neuronal migration by binding to NUDEL: a molecular explanation for Miller-Dieker syndrome.	Nature genetics	2003	102
12855641	L-Threonine	Kamai T	Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer.	Clinical cancer research 	2003	102
12884918	L-Threonine	Katayama H	The Aurora kinases: role in cell transformation and tumorigenesis.	Cancer metastasis reviews	2003	100
12971829	L-Threonine	Dittmer J	The biology of the Ets1 proto-oncogene.	Molecular cancer	2003	130
14500344	L-Threonine	Hingorani SR	Suppression of BRAF(V599E) in human melanoma abrogates transformation.	Cancer research	2003	107
14532286	L-Threonine	Chan FK	A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses.	The Journal of biological chemistry	2003	134
14647146	L-Threonine	Schlieman MG	Incidence, mechanism and prognostic value of activated AKT in pancreas cancer.	British journal of cancer	2003	80
14695152	L-Threonine	Omholt K	NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.	Clinical cancer research 	2003	88
15000151	L-Threonine	Byrd JC	Mucins and mucin binding proteins in colorectal cancer.	Cancer metastasis reviews	2004	110
15208680	L-Threonine	Karasarides M	B-RAF is a therapeutic target in melanoma.	Oncogene	2004	100
15735123	L-Threonine	Dai DL	Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases.	Journal of clinical oncology 	2005	79
15806160	L-Threonine	Sutherland BW	Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells.	Oncogene	2005	67
15833840	L-Threonine	Clark DE	The serine/threonine protein kinase, p90 ribosomal S6 kinase, is an important regulator of prostate cancer cell proliferation.	Cancer research	2005	67
15867923	L-Threonine	Wulf G	Phosphorylation-specific prolyl isomerization: is there an underlying theme?	Nature cell biology	2005	84
15871923	L-Threonine	Miyazono K	BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk.	Cytokine & growth factor reviews	2005	210
15940637	L-Threonine	Kobayashi S	Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells.	Gastroenterology	2005	73
16354698	L-Threonine	Evdokimova V	Akt-mediated YB-1 phosphorylation activates translation of silent mRNA species.	Molecular and cellular biology	2006	73
16672981	L-Threonine	Clark IE	Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin.	Nature	2006	504
16904831	L-Threonine	Pardali K	Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer.	Biochimica et biophysica acta	2007	176
17182864	L-Threonine	Shiojima I	Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway.	Genes & development	2006	115
17406652	L-Threonine	Choi Y	Minocycline attenuates neuronal cell death and improves cognitive impairment in Alzheimer's disease models.	Neuropsychopharmacology 	2007	64
17572487	L-Threonine	Gwack Y	Signalling to transcription: store-operated Ca2+ entry and NFAT activation in lymphocytes.	Cell calcium	2007	94
17676035	L-Threonine	Ji H	LKB1 modulates lung cancer differentiation and metastasis.	Nature	2007	327
17849476	L-Threonine	Leivonen SK	Transforming growth factor-beta signaling in cancer invasion and metastasis.	International journal of cancer	2007	59
18588945	L-Threonine	Eichhorn PJ	Protein phosphatase 2A regulatory subunits and cancer.	Biochimica et biophysica acta	2009	174
18806775	L-Threonine	Wang Z	Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy.	Nature	2008	93
19001320	L-Threonine	Di Nicolantonio F	Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer.	Journal of clinical oncology 	2008	425
19061640	L-Threonine	Su Y	APC is essential for targeting phosphorylated beta-catenin to the SCFbeta-TrCP ubiquitin ligase.	Molecular cell	2008	60
19075230	L-Threonine	Rychahou PG	Akt2 overexpression plays a critical role in the establishment of colorectal cancer metastasis.	Proceedings of the National Academy of Sciences of the United States of America	2008	65
19110052	L-Threonine	Chin YR	Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer.	Cellular signalling	2009	75
19270695	L-Threonine	Gao D	Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction.	Nature cell biology	2009	108
19296504	L-Threonine	Shaw LM	Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.	Annals of neurology	2009	591
19372583	L-Threonine	Boisvert-Adamo K	Mcl-1 is required for melanoma cell resistance to anoikis.	Molecular cancer research 	2009	52
19401561	L-Threonine	Roccaro AM	MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma.	Blood	2009	95
19458359	L-Threonine	Tamburini J	Protein synthesis is resistant to rapamycin and constitutes a promising therapeutic target in acute myeloid leukemia.	Blood	2009	54
19762341	L-Threonine	Miyazono K	Bone morphogenetic protein receptors and signal transduction.	Journal of biochemistry	2010	240
20080624	L-Threonine	Hu H	ATM is down-regulated by N-Myc-regulated microRNA-421.	Proceedings of the National Academy of Sciences of the United States of America	2010	78
20166984	L-Threonine	Falasca M	PI3K/Akt signalling pathway specific inhibitors: a novel strategy to sensitize cancer cells to anti-cancer drugs.	Current pharmaceutical design	2010	40
20188563	L-Threonine	Walsh DW	Extracellular BMP-antagonist regulation in development and disease: tied up in knots.	Trends in cell biology	2010	59
20203304	L-Threonine	Zu Y	SIRT1 promotes proliferation and prevents senescence through targeting LKB1 in primary porcine aortic endothelial cells.	Circulation research	2010	59
20508036	L-Threonine	Rakovic A	Effect of endogenous mutant and wild-type PINK1 on Parkin in fibroblasts from Parkinson disease patients.	Human molecular genetics	2010	41
20533398	L-Threonine	Trembley JH	Emergence of protein kinase CK2 as a key target in cancer therapy.	BioFactors	2010	47
20562913	L-Threonine	Gan Y	Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.	Oncogene	2010	78
20580720	L-Threonine	Lee G	Phosphoinositide 3-kinase signaling mediates beta-catenin activation in intestinal epithelial stem and progenitor cells in colitis.	Gastroenterology	2010	57
20593312	L-Threonine	Glass DJ	PI3 kinase regulation of skeletal muscle hypertrophy and atrophy.	Current topics in microbiology and immunology	2010	69
20679220	L-Threonine	Ueda T	Combined deficiency for MAP kinase-interacting kinase 1 and 2 (Mnk1 and Mnk2) delays tumor development.	Proceedings of the National Academy of Sciences of the United States of America	2010	51
20818844	L-Threonine	Flaherty KT	Inhibition of mutated, activated BRAF in metastatic melanoma.	The New England journal of medicine	2010	991
21211617	L-Threonine	Thiel C	NEK1 mutations cause short-rib polydactyly syndrome type majewski.	American journal of human genetics	2011	57
21245096	L-Threonine	Murakami H	LATS2 is a tumor suppressor gene of malignant mesothelioma.	Cancer research	2011	51
21266350	L-Threonine	Wang X	Phosphorylation regulates c-Myc's oncogenic activity in the mammary gland.	Cancer research	2011	51
21430779	L-Threonine	Ceol CJ	The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset.	Nature	2011	145
21482786	L-Threonine	Ong CC	Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells.	Proceedings of the National Academy of Sciences of the United States of America	2011	68
21629263	L-Threonine	Mu Y	TRAF6 ubiquitinates TGFβ type I receptor to promote its cleavage and nuclear translocation in cancer.	Nature communications	2011	53
21638088	L-Threonine	Capper D	Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody.	Acta neuropathologica	2011	79
21643690	L-Threonine	Heldin CH	Role of Smads in TGFβ signaling.	Cell and tissue research	2012	75
21682951	L-Threonine	Lee TH	Peptidyl-prolyl cis-trans isomerase Pin1 in ageing, cancer and Alzheimer disease.	Expert reviews in molecular medicine	2011	43
21706049	L-Threonine	Gu Y	Altered LKB1/CREB-regulated transcription co-activator (CRTC) signaling axis promotes esophageal cancer cell migration and invasion.	Oncogene	2012	32
21742770	L-Threonine	Babij C	STK33 kinase activity is nonessential in KRAS-dependent cancer cells.	Cancer research	2011	42
21743487	L-Threonine	Thomas M	The proto-oncogene Pim-1 is a target of miR-33a.	Oncogene	2012	45
21852578	L-Threonine	Arima K	Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo-Nishimura syndrome.	Proceedings of the National Academy of Sciences of the United States of America	2011	51
21908616	L-Threonine	Guo JP	IKBKE protein activates Akt independent of phosphatidylinositol 3-kinase/PDK1/mTORC2 and the pleckstrin homology domain to sustain malignant transformation.	The Journal of biological chemistry	2011	45
22025163	L-Threonine	Yap TA	First-in-man clinical trial of the oral pan-AKT inhibitor MK-2206 in patients with advanced solid tumors.	Journal of clinical oncology 	2011	175
22101766	L-Threonine	Robinson DR	Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer.	Nature medicine	2011	107
22371497	L-Threonine	Fong JJ	β-N-Acetylglucosamine (O-GlcNAc) is a novel regulator of mitosis-specific phosphorylations on histone H3.	The Journal of biological chemistry	2012	40
22842228	L-Threonine	Krauthammer M	Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma.	Nature genetics	2012	315
23041284	L-Threonine	Lin Y	Reciprocal regulation of Akt and Oct4 promotes the self-renewal and survival of embryonal carcinoma cells.	Molecular cell	2012	54
23063362	L-Threonine	Almeida S	Induced pluripotent stem cell models of progranulin-deficient frontotemporal dementia uncover specific reversible neuronal defects.	Cell reports	2012	43
23087057	L-Threonine	Kalev P	Loss of PPP2R2A inhibits homologous recombination DNA repair and predicts tumor sensitivity to PARP inhibition.	Cancer research	2012	33
23447565	L-Threonine	Haq R	BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition.	Proceedings of the National Academy of Sciences of the United States of America	2013	59
23562540	L-Threonine	Cruchaga C	GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.	Neuron	2013	88
23639323	L-Threonine	Perrotti D	Protein phosphatase 2A: a target for anticancer therapy.	The Lancet. Oncology	2013	92
23737503	L-Threonine	Lim S	Targeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function.	Proceedings of the National Academy of Sciences of the United States of America	2013	30
24121667	L-Threonine	Liang Q	CDK5 is essential for TGF-β1-induced epithelial-mesenchymal transition and breast cancer progression.	Scientific reports	2013	30
24632603	L-Threonine	Goldenson B	The aurora kinases in cell cycle and leukemia.	Oncogene	2015	39
24642468	L-Threonine	Li J	Neutrophil AKT2 regulates heterotypic cell-cell interactions during vascular inflammation.	The Journal of clinical investigation	2014	25
24771982	L-Threonine	Yang Y	Functional roles of p38 mitogen-activated protein kinase in macrophage-mediated inflammatory responses.	Mediators of inflammation	2014	43
24818585	L-Threonine	Kester MI	Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers.	JAMA neurology	2014	28
25042806	L-Threonine	Goodwin JM	An AMPK-independent signaling pathway downstream of the LKB1 tumor suppressor controls Snail1 and metastatic potential.	Molecular cell	2014	32
25057166	L-Threonine	Missiaglia E	Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features.	Annals of oncology 	2014	51
25355599	L-Threonine	Chai J	MicroRNA-455 inhibits proliferation and invasion of colorectal cancer by targeting RAF proto-oncogene serine/threonine-protein kinase.	Tumour biology 	2015	17
25395505	L-Threonine	Knipe RS	The Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosis.	Pharmacological reviews	2015	18
25404613	L-Threonine	Zannini L	CHK2 kinase in the DNA damage response and beyond.	Journal of molecular cell biology	2014	33
25500543	L-Threonine	Lemieux E	Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.	Oncogene	2015	34
25684140	L-Threonine	Zhao D	Cytoplasmic p27 promotes epithelial-mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation.	Oncogene	2015	20
25690731	L-Threonine	Kim EK	Compromised MAPK signaling in human diseases: an update.	Archives of toxicology	2015	50
25749412	L-Threonine	Warfel NA	PIM kinase (and Akt) biology and signaling in tumors.	Pharmacology & therapeutics	2015	29
25981171	L-Threonine	Datta D	Altered expression of CDC42 signaling pathway components in cortical layer 3 pyramidal cells in schizophrenia.	Biological psychiatry	2015	24
26073081	L-Threonine	Fedorenko IV	Fibronectin induction abrogates the BRAF inhibitor response of BRAF V600E/PTEN-null melanoma cells.	Oncogene	2016	14
26147946	L-Threonine	Sutphen CL	Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age.	JAMA neurology	2015	41
26366630	L-Threonine	Kester MI	Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease.	JAMA neurology	2015	33
26687681	L-Threonine	Liu CC	Cul3-KLHL20 Ubiquitin Ligase Governs the Turnover of ULK1 and VPS34 Complexes to Control Autophagy Termination.	Molecular cell	2016	26
26815163	L-Threonine	Åkerström T	Activating mutations in CTNNB1 in aldosterone producing adenomas.	Scientific reports	2016	15
26836182	L-Threonine	Melah KE	Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease.	Journal of Alzheimer's disease 	2016	10
26859459	L-Threonine	Kim SH	Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-κB-dependent Manner.	Cancer cell	2016	26
27107696	L-Threonine	Rang Z	miR-542-3p suppresses invasion and metastasis by targeting the proto-oncogene serine/threonine protein kinase, PIM1, in melanoma.	Biochemical and biophysical research communications	2016	13
27487218	L-Threonine	Strilic B	Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis.	Nature	2016	19
27497832	L-Threonine	Wani WY	O-GlcNAcylation and neurodegeneration.	Brain research bulletin	2017	7
27612668	L-Threonine	McCubrey JA	Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity-Diverse effects on cell growth, metabolism and cancer.	Biochimica et biophysica acta	2016	19
27999438	L-Threonine	Weinlich R	Necroptosis in development, inflammation and disease.	Nature reviews. Molecular cell biology	2017	29
2195544	L-Serine	Westermark P	Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation.	Proceedings of the National Academy of Sciences of the United States of America	1990	160
9407038	L-Serine	Siliciano JD	DNA damage induces phosphorylation of the amino terminus of p53.	Genes & development	1997	199
10442635	L-Serine	Bowden ET	An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation.	Oncogene	1999	112
10477620	L-Serine	Jobin C	Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity.	Journal of immunology	1999	121
10611961	L-Serine	Bamburg JR	Proteins of the ADF/cofilin family: essential regulators of actin dynamics.	Annual review of cell and developmental biology	1999	301
10712992	L-Serine	Segura-Valdez L	Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD.	Chest	2000	126
10949579	L-Serine	Andreasen PA	The plasminogen activation system in tumor growth, invasion, and metastasis.	Cellular and molecular life sciences 	2000	193
11294823	L-Serine	Yousef GM	The new human tissue kallikrein gene family: structure, function, and association to disease.	Endocrine reviews	2001	94
11479199	L-Serine	Magee JA	Expression profiling reveals hepsin overexpression in prostate cancer.	Cancer research	2001	101
12525533	L-Serine	Balk SP	Biology of prostate-specific antigen.	Journal of clinical oncology 	2003	91
12615961	L-Serine	Doble BW	GSK-3: tricks of the trade for a multi-tasking kinase.	Journal of cell science	2003	603
12784997	L-Serine	Sidenius N	The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy.	Cancer metastasis reviews	2003	86
14754404	L-Serine	Duffy MJ	The urokinase plasminogen activator system: role in malignancy.	Current pharmaceutical design	2004	90
15800615	L-Serine	Esashi F	CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair.	Nature	2005	142
15841311	L-Serine	Danø K	Plasminogen activation and cancer.	Thrombosis and haemostasis	2005	86
15854913	L-Serine	Guse A	Phosphorylation of ZEN-4/MKLP1 by aurora B regulates completion of cytokinesis.	Current biology 	2005	79
16096270	L-Serine	Zabel BA	Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades.	The Journal of biological chemistry	2005	70
16226704	L-Serine	She QB	The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells.	Cancer cell	2005	133
16377621	L-Serine	Grau S	The role of human HtrA1 in arthritic disease.	The Journal of biological chemistry	2006	64
17259299	L-Serine	Rajput AB	Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers.	Journal of clinical pathology	2007	59
17317136	L-Serine	Itoh S	Negative regulation of TGF-beta receptor/Smad signal transduction.	Current opinion in cell biology	2007	108
17573418	L-Serine	Shaw JL	Distribution of 15 human kallikreins in tissues and biological fluids.	Clinical chemistry	2007	69
17635716	L-Serine	Rau JC	Serpins in thrombosis, hemostasis and fibrinolysis.	Journal of thrombosis and haemostasis 	2007	68
17878380	L-Serine	Leaphart CL	A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair.	Journal of immunology	2007	113
17906618	L-Serine	Plun-Favreau H	The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1.	Nature cell biology	2007	151
18023328	L-Serine	Takahashi-Yanaga F	GSK-3beta regulates cyclin D1 expression: a new target for chemotherapy.	Cellular signalling	2008	82
18162327	L-Serine	Dass K	Evolving role of uPA/uPAR system in human cancers.	Cancer treatment reviews	2008	115
18408718	L-Serine	Finberg KE	Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA).	Nature genetics	2008	164
18505969	L-Serine	Setlur SR	Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer.	Journal of the National Cancer Institute	2008	110
18548086	L-Serine	Croucher DR	Revisiting the biological roles of PAI2 (SERPINB2) in cancer.	Nature reviews. Cancer	2008	50
19188682	L-Serine	Qatanani M	Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice.	The Journal of clinical investigation	2009	51
19221179	L-Serine	Yuan Z	Regulation of neuronal cell death by MST1-FOXO1 signaling.	The Journal of biological chemistry	2009	51
19386895	L-Serine	Sandilands A	Filaggrin in the frontline: role in skin barrier function and disease.	Journal of cell science	2009	101
19387015	L-Serine	Hara K	Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease.	The New England journal of medicine	2009	67
19409690	L-Serine	Tomlins SA	ETS gene fusions in prostate cancer: from discovery to daily clinical practice.	European urology	2009	102
19573808	L-Serine	Miao H	EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt.	Cancer cell	2009	121
19824918	L-Serine	Ghosh M	Trappin-2/Elafin: a novel innate anti-human immunodeficiency virus-1 molecule of the human female reproductive tract.	Immunology	2010	50
20140016	L-Serine	Wang J	Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma.	Oncogene	2010	46
20200349	L-Serine	Finberg KE	Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis.	Blood	2010	45
20346680	L-Serine	Moquin D	The molecular regulation of programmed necrotic cell injury.	Trends in biochemical sciences	2010	48
20926566	L-Serine	Matsuyama S	Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2.	Journal of virology	2010	42
21095632	L-Serine	Wang H	Glycogen synthase kinase 3: a point of convergence for the host inflammatory response.	Cytokine	2011	50
21098708	L-Serine	Ustach CV	A novel signaling axis of matriptase/PDGF-D/ß-PDGFR in human prostate cancer.	Cancer research	2010	41
21233335	L-Serine	Konicek BW	Therapeutic inhibition of MAP kinase interacting kinase blocks eukaryotic initiation factor 4E phosphorylation and suppresses outgrowth of experimental lung metastases.	Cancer research	2011	52
21255644	L-Serine	Mi W	O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy.	Biochimica et biophysica acta	2011	64
21255763	L-Serine	Belostotsky R	Mutations in the mitochondrial seryl-tRNA synthetase cause hyperuricemia, pulmonary hypertension, renal failure in infancy and alkalosis, HUPRA syndrome.	American journal of human genetics	2011	55
21538350	L-Serine	Thaiparambil JT	Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation.	International journal of cancer	2011	55
21577205	L-Serine	Maurer G	Raf kinases in cancer-roles and therapeutic opportunities.	Oncogene	2011	49
21593200	L-Serine	Zhao Y	Klotho depletion contributes to increased inflammation in kidney of the db/db mouse model of diabetes via RelA (serine)536 phosphorylation.	Diabetes	2011	44
21637291	L-Serine	Dagda RK	Mitochondrially localized PKA reverses mitochondrial pathology and dysfunction in a cellular model of Parkinson's disease.	Cell death and differentiation	2011	39
21668992	L-Serine	Lee HO	FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells.	BMC cancer	2011	48
21802835	L-Serine	Danila DC	TMPRSS2-ERG status in circulating tumor cells as a predictive biomarker of sensitivity in castration-resistant prostate cancer patients treated with abiraterone acetate.	European urology	2011	51
21813756	L-Serine	Tomlins SA	Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA.	Science translational medicine	2011	107
22080055	L-Serine	Hoogland AM	ERG immunohistochemistry is not predictive for PSA recurrence, local recurrence or overall survival after radical prostatectomy for prostate cancer.	Modern pathology 	2012	36
22323494	L-Serine	Brennen WN	Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy.	Molecular cancer therapeutics	2012	53
22325354	L-Serine	Yata K	Plk1 and CK2 act in concert to regulate Rad51 during DNA double strand break repair.	Molecular cell	2012	46
22476196	L-Serine	Bomfim TR	An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers.	The Journal of clinical investigation	2012	123
22476197	L-Serine	Talbot K	Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.	The Journal of clinical investigation	2012	269
22614006	L-Serine	Moleirinho S	KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals.	Oncogene	2013	43
22736790	L-Serine	Pettersson A	The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis.	Cancer epidemiology, biomarkers & prevention 	2012	80
22982943	L-Serine	Kubes P	Sterile inflammation in the liver.	Gastroenterology	2012	126
23024281	L-Serine	Karmakar M	Cutting edge: IL-1β processing during Pseudomonas aeruginosa infection is mediated by neutrophil serine proteases and is independent of NLRC4 and caspase-1.	Journal of immunology	2012	38
23045282	L-Serine	Hsu YL	Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/snail signaling pathway.	Oncogene	2013	28
23153585	L-Serine	Mizuno K	Signaling mechanisms and functional roles of cofilin phosphorylation and dephosphorylation.	Cellular signalling	2013	94
23201006	L-Serine	Tang L	The urokinase plasminogen activator system in breast cancer invasion and metastasis.	Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie	2013	32
23208492	L-Serine	Casar B	In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling.	Oncogene	2014	24
23277200	L-Serine	Barrett A	p130Cas: a key signalling node in health and disease.	Cellular signalling	2013	28
23297193	L-Serine	Blankman JL	ABHD12 controls brain lysophosphatidylserine pathways that are deregulated in a murine model of the neurodegenerative disease PHARC.	Proceedings of the National Academy of Sciences of the United States of America	2013	29
23306062	L-Serine	Laine A	Senescence sensitivity of breast cancer cells is defined by positive feedback loop between CIP2A and E2F1.	Cancer discovery	2013	32
23459660	L-Serine	Galloway SE	Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation.	PLoS pathogens	2013	66
23716601	L-Serine	Farrell AS	Pin1 regulates the dynamics of c-Myc DNA binding to facilitate target gene regulation and oncogenesis.	Molecular and cellular biology	2013	25
23728337	L-Serine	Feng H	EGFRvIII stimulates glioma growth and invasion through PKA-dependent serine phosphorylation of Dock180.	Oncogene	2014	25
24204027	L-Serine	Khanna A	Cancerous inhibitor of protein phosphatase 2A, an emerging human oncoprotein and a potential cancer therapy target.	Cancer research	2013	43
24419221	L-Serine	Mardinoglu A	Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease.	Nature communications	2014	65
24469043	L-Serine	Sales KU	Non-hematopoietic PAR-2 is essential for matriptase-driven pre-malignant progression and potentiation of ras-mediated squamous cell carcinogenesis.	Oncogene	2015	16
24488013	L-Serine	Miao H	EphA2 promotes infiltrative invasion of glioma stem cells in vivo through cross-talk with Akt and regulates stem cell properties.	Oncogene	2015	30
24505350	L-Serine	Nobili V	Role of docosahexaenoic acid treatment in improving liver histology in pediatric nonalcoholic fatty liver disease.	PloS one	2014	22
24519422	L-Serine	Sohn EH	Structural and biochemical analyses of choroidal thickness in human donor eyes.	Investigative ophthalmology & visual science	2014	21
24591637	L-Serine	Wang S	Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer.	Proceedings of the National Academy of Sciences of the United States of America	2014	32
24657168	L-Serine	Rao F	Inositol pyrophosphates mediate the DNA-PK/ATM-p53 cell death pathway by regulating CK2 phosphorylation of Tti1/Tel2.	Molecular cell	2014	24
24695853	L-Serine	Shi J	TNT003, an inhibitor of the serine protease C1s, prevents complement activation induced by cold agglutinins.	Blood	2014	20
24927563	L-Serine	Janghorban M	Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer.	Proceedings of the National Academy of Sciences of the United States of America	2014	31
25107476	L-Serine	Yarchoan M	Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer's disease and tauopathies.	Acta neuropathologica	2014	23
25220373	L-Serine	Marques RB	High Efficacy of Combination Therapy Using PI3K/AKT Inhibitors with Androgen Deprivation in Prostate Cancer Preclinical Models.	European urology	2015	17
25313073	L-Serine	Lefrançais E	Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells.	Proceedings of the National Academy of Sciences of the United States of America	2014	39
25457014	L-Serine	Loeb S	Active surveillance for prostate cancer: a systematic review of clinicopathologic variables and biomarkers for risk stratification.	European urology	2015	22
25468710	L-Serine	Abdel-Fatah TM	Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer.	Molecular oncology	2015	15
25497381	L-Serine	Koromilas AE	Roles of the translation initiation factor eIF2α serine 51 phosphorylation in cancer formation and treatment.	Biochimica et biophysica acta	2015	25
25561469	L-Serine	Liang K	Characterization of human cyclin-dependent kinase 12 (CDK12) and CDK13 complexes in C-terminal domain phosphorylation, gene transcription, and RNA processing.	Molecular and cellular biology	2015	23
25601544	L-Serine	Zhang L	NDR functions as a physiological YAP1 kinase in the intestinal epithelium.	Current biology 	2015	22
25646088	L-Serine	Artym VV	Dense fibrillar collagen is a potent inducer of invadopodia via a specific signaling network.	The Journal of cell biology	2015	17
25658204	L-Serine	Serasinghe MN	Mitochondrial division is requisite to RAS-induced transformation and targeted by oncogenic MAPK pathway inhibitors.	Molecular cell	2015	53
25698643	L-Serine	Prassas I	Unleashing the therapeutic potential of human kallikrein-related serine proteases.	Nature reviews. Drug discovery	2015	28
25855378	L-Serine	Virtakoivu R	Vimentin-ERK Signaling Uncouples Slug Gene Regulatory Function.	Cancer research	2015	21
25860938	L-Serine	Principe M	Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells.	Oncotarget	2015	24
25998963	L-Serine	Voskoboinik I	Perforin and granzymes: function, dysfunction and human pathology.	Nature reviews. Immunology	2015	50
26471730	L-Serine	Lai YC	Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1.	The EMBO journal	2015	34
26735014	L-Serine	Shu S	Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer.	Nature	2016	68
26811421	L-Serine	Moudry P	TOPBP1 regulates RAD51 phosphorylation and chromatin loading and determines PARP inhibitor sensitivity.	The Journal of cell biology	2016	12
26855967	L-Serine	In J	Enterohemorrhagic Escherichia coli reduce mucus and intermicrovillar bridges in human stem cell-derived colonoids.	Cellular and molecular gastroenterology and hepatology	2016	27
27247400	L-Serine	Li H	Envelope residue 375 substitutions in simian-human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques.	Proceedings of the National Academy of Sciences of the United States of America	2016	26
28061466	L-Serine	Tanase CP	Prostate cancer proteomics: Current trends and future perspectives for biomarker discovery.	Oncotarget	2017	7
28069606	L-Serine	Ivanov I	Proteolytic properties of single-chain factor XII: a mechanism for triggering contact activation.	Blood	2017	9
28279977	L-Serine	Pan CW	AKT-phosphorylated FOXO1 suppresses ERK activation and chemoresistance by disrupting IQGAP1-MAPK interaction.	The EMBO journal	2017	7
11830509	Celecoxib	Leahy KM	Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo.	Cancer research	2002	81
16806953	Celecoxib	Jung KH	Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus.	Neurobiology of disease	2006	66
19218449	Celecoxib	Hu M	Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast.	Proceedings of the National Academy of Sciences of the United States of America	2009	68
19822006	Celecoxib	Half E	Familial adenomatous polyposis.	Orphanet journal of rare diseases	2009	86
21115882	Celecoxib	Elmets CA	Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial.	Journal of the National Cancer Institute	2010	46
21345578	Celecoxib	Jendrossek V	Targeting apoptosis pathways by Celecoxib in cancer.	Cancer letters	2013	43
21443470	Celecoxib	Khan Z	Biology of Cox-2: an application in cancer therapeutics.	Current drug targets	2011	37
23001726	Celecoxib	Saito Y	The tumor suppressor microRNA-29c is downregulated and restored by celecoxib in human gastric cancer cells.	International journal of cancer	2013	25
25470039	Celecoxib	Kurtova AV	Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance.	Nature	2015	93
26261008	Celecoxib	Wang D	Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.	Gastroenterology	2015	26
27769779	Celecoxib	Gowda R	Synergistic inhibitory effects of Celecoxib and Plumbagin on melanoma tumor growth.	Cancer letters	2017	7
11110769	Angiotensin II	Frustaci A	Myocardial cell death in human diabetes.	Circulation research	2000	180
16280370	Angiotensin II	Ruiz-Ortega M	Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases.	Nephrology, dialysis, transplantation 	2006	71
18579813	Angiotensin II	Brooke BS	Angiotensin II blockade and aortic-root dilation in Marfan's syndrome.	The New England journal of medicine	2008	162
19050008	Angiotensin II	Sun Y	Myocardial repair/remodelling following infarction: roles of local factors.	Cardiovascular research	2009	60
20538689	Angiotensin II	Leask A	Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation.	Circulation research	2010	161
20679547	Angiotensin II	Zhong J	Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.	Circulation	2010	69
21298369	Angiotensin II	Osborn JW	Neural mechanisms of angiotensin II-salt hypertension: implications for therapies targeting neural control of the splanchnic circulation.	Current hypertension reports	2011	37
21839714	Angiotensin II	Nijenhuis T	Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.	The American journal of pathology	2011	46
21903938	Angiotensin II	Boon RA	MicroRNA-29 in aortic dilation: implications for aneurysm formation.	Circulation research	2011	90
22068875	Angiotensin II	Zhang W	Interleukin 6 underlies angiotensin II-induced hypertension and chronic renal damage.	Hypertension	2012	45
22760500	Angiotensin II	Adam O	Role of miR-21 in the pathogenesis of atrial fibrosis.	Basic research in cardiology	2012	44
24189039	Angiotensin II	Davis J	Myofibroblasts: trust your heart and let fate decide.	Journal of molecular and cellular cardiology	2014	52
24206662	Angiotensin II	Shibata S	Mineralocorticoid receptor phosphorylation regulates ligand binding and renal response to volume depletion and hyperkalemia.	Cell metabolism	2013	28
25201911	Angiotensin II	Zampetaki A	Role of miR-195 in aortic aneurysmal disease.	Circulation research	2014	24
25814687	Angiotensin II	Leask A	Getting to the heart of the matter: new insights into cardiac fibrosis.	Circulation research	2015	56
25898844	Angiotensin II	Lorenzen JM	Osteopontin is indispensible for AP1-mediated angiotensin II-related miR-21 transcription during cardiac fibrosis.	European heart journal	2015	23
26585673	Angiotensin II	Nagpal V	MiR-125b Is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis.	Circulation	2016	21
26974158	Angiotensin II	Zhang C	Matricellular protein CCN3 mitigates abdominal aortic aneurysm.	The Journal of clinical investigation	2016	13
27118293	Angiotensin II	Harvey A	Vascular Fibrosis in Aging and Hypertension: Molecular Mechanisms and Clinical Implications.	The Canadian journal of cardiology	2016	20
2673546	All-trans-retinoic acid	Chen PL	Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation.	Cell	1989	215
3520340	All-trans-retinoic acid	Bentley DL	A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells.	Nature	1986	257
8293467	All-trans-retinoic acid	Dyck JA	A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein.	Cell	1994	201
10617569	All-trans-retinoic acid	Perissi V	Molecular determinants of nuclear receptor-corepressor interaction.	Genes & development	1999	121
15003116	All-trans-retinoic acid	Sempere LF	Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation.	Genome biology	2004	524
17140406	All-trans-retinoic acid	Opitz B	IFNbeta induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein.	Cellular microbiology	2007	116
17273977	All-trans-retinoic acid	Pasutto F	Mutations in STRA6 cause a broad spectrum of malformations including anophthalmia, congenital heart defects, diaphragmatic hernia, alveolar capillary dysplasia, lung hypoplasia, and mental retardation.	American journal of human genetics	2007	106
17283129	All-trans-retinoic acid	Chen Y	Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis.	Cancer research	2007	120
17297439	All-trans-retinoic acid	Welch C	MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells.	Oncogene	2007	259
17314394	All-trans-retinoic acid	Freberg CT	Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract.	Molecular biology of the cell	2007	61
17534450	All-trans-retinoic acid	Rhodes DR	Molecular concepts analysis links tumors, pathways, mechanisms, and drugs.	Neoplasia	2007	68
18311793	All-trans-retinoic acid	Nguyen CQ	Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice.	Arthritis and rheumatism	2008	76
18820263	All-trans-retinoic acid	Annunziato F	The phenotype of human Th17 cells and their precursors, the cytokines that mediate their differentiation and the role of Th17 cells in inflammation.	International immunology	2008	52
18978796	All-trans-retinoic acid	Poeck H	5'-Triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma.	Nature medicine	2008	90
19345331	All-trans-retinoic acid	Huang S	ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome.	Cancer cell	2009	51
19451695	All-trans-retinoic acid	Payton JE	High throughput digital quantification of mRNA abundance in primary human acute myeloid leukemia samples.	The Journal of clinical investigation	2009	64
19570762	All-trans-retinoic acid	Iliev ID	Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells.	Gut	2009	101
19632232	All-trans-retinoic acid	Sakuraba A	Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn's disease.	Gastroenterology	2009	57
19844129	All-trans-retinoic acid	Zhao Y	Th17 immunity in patients with allergic asthma.	International archives of allergy and immunology	2010	58
19860663	All-trans-retinoic acid	Gorfu G	Role of beta7 integrins in intestinal lymphocyte homing and retention.	Current molecular medicine	2009	76
20592279	All-trans-retinoic acid	Honkanen J	IL-17 immunity in human type 1 diabetes.	Journal of immunology	2010	69
20638936	All-trans-retinoic acid	Takayama T	Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease.	Gastroenterology	2010	59
20706985	All-trans-retinoic acid	Ramirez JM	Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cells.	European journal of immunology	2010	47
20966922	All-trans-retinoic acid	de Thé H	Acute promyelocytic leukaemia: novel insights into the mechanisms of cure.	Nature reviews. Cancer	2010	115
21400475	All-trans-retinoic acid	van de Veerdonk FL	The anti-CD20 antibody rituximab reduces the Th17 cell response.	Arthritis and rheumatism	2011	37
21441909	All-trans-retinoic acid	Huh JR	Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity.	Nature	2011	139
21654831	All-trans-retinoic acid	Bovenschen HJ	Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin.	The Journal of investigative dermatology	2011	56
21772256	All-trans-retinoic acid	Hester ME	Rapid and efficient generation of functional motor neurons from human pluripotent stem cells using gene delivered transcription factor codes.	Molecular therapy 	2011	56
22493297	All-trans-retinoic acid	Wang XS	MicroRNA-29a and microRNA-142-3p are regulators of myeloid differentiation and acute myeloid leukemia.	Blood	2012	52
22539793	All-trans-retinoic acid	Bengsch B	Human Th17 cells express high levels of enzymatically active dipeptidylpeptidase IV (CD26).	Journal of immunology	2012	34
23221369	All-trans-retinoic acid	Yang QE	MicroRNAs 221 and 222 regulate the undifferentiated state in mammalian male germ cells.	Development	2013	28
23375374	All-trans-retinoic acid	Kittler R	A comprehensive nuclear receptor network for breast cancer cells.	Cell reports	2013	31
23380221	All-trans-retinoic acid	Grotenboer NS	Decoding asthma: translating genetic variation in IL33 and IL1RL1 into disease pathophysiology.	The Journal of allergy and clinical immunology	2013	29
23596287	All-trans-retinoic acid	Ivanov S	Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection.	Journal of virology	2013	33
23699600	All-trans-retinoic acid	Kaiser MF	Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myeloma.	Blood	2013	41
23769173	All-trans-retinoic acid	Yuan T	Human induced pluripotent stem cell-derived neural stem cells survive, migrate, differentiate, and improve neurologic function in a rat model of middle cerebral artery occlusion.	Stem cell research & therapy	2013	30
23863747	All-trans-retinoic acid	Guilhamon P	Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2.	Nature communications	2013	41
24360797	All-trans-retinoic acid	Hou J	Hepatic RIG-I predicts survival and interferon-α therapeutic response in hepatocellular carcinoma.	Cancer cell	2014	32
24833036	All-trans-retinoic acid	Israelow B	HepG2 cells mount an effective antiviral interferon-lambda based innate immune response to hepatitis C virus infection.	Hepatology	2014	23
25231870	All-trans-retinoic acid	Perry JR	Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche.	Nature	2014	93
25456015	All-trans-retinoic acid	Chen IY	Response of host inflammasomes to viral infection.	Trends in microbiology	2015	20
25700171	All-trans-retinoic acid	Devalla HD	Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology.	EMBO molecular medicine	2015	41
26690704	All-trans-retinoic acid	Egan CE	Toll-like receptor 4-mediated lymphocyte influx induces neonatal necrotizing enterocolitis.	The Journal of clinical investigation	2016	20
27590114	All-trans-retinoic acid	Bhattacharya N	Normalizing Microbiota-Induced Retinoic Acid Deficiency Stimulates Protective CD8(+) T Cell-Mediated Immunity in Colorectal Cancer.	Immunity	2016	11
28017614	All-trans-retinoic acid	Li Z	FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N6-Methyladenosine RNA Demethylase.	Cancer cell	2017	31
12623848	Imatinib	Branford S	Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis.	Blood	2003	115
14645423	Imatinib	Heinrich MC	Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor.	Journal of clinical oncology 	2003	377
14737178	Imatinib	Steelman LS	JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis.	Leukemia	2004	130
15781488	Imatinib	Blay JY	Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO.	Annals of oncology 	2005	131
16170379	Imatinib	Roman-Gomez J	Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemia.	Oncogene	2005	71
16286244	Imatinib	Neviani P	The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein.	Cancer cell	2005	159
16625094	Imatinib	Miettinen M	Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up.	The American journal of surgical pathology	2006	100
16954519	Imatinib	Heinrich MC	Molecular correlates of imatinib resistance in gastrointestinal stromal tumors.	Journal of clinical oncology 	2006	171
16981009	Imatinib	Paniagua RT	Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis.	The Journal of clinical investigation	2006	63
17114238	Imatinib	Puttini M	In vitro and in vivo activity of SKI-606, a novel Src-Abl inhibitor, against imatinib-resistant Bcr-Abl+ neoplastic cells.	Cancer research	2006	75
17138817	Imatinib	Hochhaus A	Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy.	Blood	2007	128
17185463	Imatinib	Cortes J	Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis.	Blood	2007	77
17189410	Imatinib	Soverini S	Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: by the GIMEMA Working Party on Chronic Myeloid Leukemia.	Clinical cancer research 	2006	109
17213283	Imatinib	Jørgensen HG	Nilotinib exerts equipotent antiproliferative effects to imatinib and does not induce apoptosis in CD34+ CML cells.	Blood	2007	84
17264298	Imatinib	Guilhot F	Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase.	Blood	2007	73
17284533	Imatinib	Venturini L	Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells.	Blood	2007	88
17414958	Imatinib	Szekanecz Z	Macrophages and their products in rheumatoid arthritis.	Current opinion in rheumatology	2007	80
17496200	Imatinib	O'Hare T	Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia.	Blood	2007	124
17496201	Imatinib	Ottmann O	Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: interim results of a phase 2 study.	Blood	2007	77
17710227	Imatinib	Shah NP	Sequential ABL kinase inhibitor therapy selects for compound drug-resistant BCR-ABL mutations with altered oncogenic potency.	The Journal of clinical investigation	2007	103
17907802	Imatinib	Swingler S	Apoptotic killing of HIV-1-infected macrophages is subverted by the viral envelope glycoprotein.	PLoS pathogens	2007	66
18401416	Imatinib	Hochhaus A	Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib.	Leukemia	2008	88
18550829	Imatinib	Tarn C	Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors.	Proceedings of the National Academy of Sciences of the United States of America	2008	71
18615679	Imatinib	Agaram NP	Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors.	Genes, chromosomes & cancer	2008	70
18772113	Imatinib	Dierks C	Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation.	Cancer cell	2008	143
18818703	Imatinib	Hu Y	beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia.	Leukemia	2009	65
18955458	Imatinib	Heinrich MC	Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor.	Journal of clinical oncology 	2008	132
19061839	Imatinib	Shah NP	Transient potent BCR-ABL inhibition is sufficient to commit chronic myeloid leukemia cells irreversibly to apoptosis.	Cancer cell	2008	87
19091943	Imatinib	Luo B	Highly parallel identification of essential genes in cancer cells.	Proceedings of the National Academy of Sciences of the United States of America	2008	214
19303137	Imatinib	Dematteo RP	Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial.	Lancet	2009	270
19363496	Imatinib	Fan AC	Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens.	Nature medicine	2009	48
19369233	Imatinib	Quintás-Cardama A	Delayed achievement of cytogenetic and molecular response is associated with increased risk of progression among patients with chronic myeloid leukemia in early chronic phase receiving high-dose or standard-dose imatinib therapy.	Blood	2009	52
19732723	Imatinib	Klemm L	The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia.	Cancer cell	2009	54
19878872	Imatinib	O'Hare T	AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance.	Cancer cell	2009	235
19965620	Imatinib	Huang Y	Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type.	Blood	2010	50
20103647	Imatinib	Puissant A	Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation.	Cancer research	2010	93
20124181	Imatinib	Gastrointestinal Stromal Tumor Meta-Analysis Group (MetaGIST).	Comparison of two doses of imatinib for the treatment of unresectable or metastatic gastrointestinal stromal tumors: a meta-analysis of 1,640 patients.	Journal of clinical oncology 	2010	89
20233975	Imatinib	Carette JE	Generation of iPSCs from cultured human malignant cells.	Blood	2010	75
20421539	Imatinib	White DL	Functional activity of the OCT-1 protein is predictive of long-term outcome in patients with chronic-phase chronic myeloid leukemia treated with imatinib.	Journal of clinical oncology 	2010	42
20660757	Imatinib	Gupta A	Autophagy inhibition and antimalarials promote cell death in gastrointestinal stromal tumor (GIST).	Proceedings of the National Academy of Sciences of the United States of America	2010	64
21125679	Imatinib	Antonescu CR	The GIST paradigm: lessons for other kinase-driven cancers.	The Journal of pathology	2011	38
21157039	Imatinib	Corbin AS	Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity.	The Journal of clinical investigation	2011	189
21228332	Imatinib	Matutes E	Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification.	Blood	2011	41
21856226	Imatinib	Kantarjian HM	Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial.	The Lancet. Oncology	2011	99
22331945	Imatinib	Stacchiotti S	Phase II study of imatinib in advanced chordoma.	Journal of clinical oncology 	2012	35
22453568	Imatinib	Joensuu H	One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial.	JAMA	2012	151
22592606	Imatinib	Kumano K	Generation of induced pluripotent stem cells from primary chronic myelogenous leukemia patient samples.	Blood	2012	44
22614970	Imatinib	George S	Efficacy and safety of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of imatinib and sunitinib: a multicenter phase II trial.	Journal of clinical oncology 	2012	48
23099009	Imatinib	Robertson KA	Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial.	The Lancet. Oncology	2012	37
23177515	Imatinib	Demetri GD	Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial.	Lancet	2013	203
23505219	Imatinib	Cadamuro M	Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma.	Hepatology	2013	28
23704092	Imatinib	Ross DM	Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study.	Blood	2013	92
23775962	Imatinib	Hodi FS	Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin.	Journal of clinical oncology 	2013	51
24297946	Imatinib	Hehlmann R	Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib: results from the randomized CML-study IV.	Journal of clinical oncology 	2014	52
24577808	Imatinib	Gotlib J	World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.	American journal of hematology	2014	25
24638003	Imatinib	Corless CL	Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial.	Journal of clinical oncology 	2014	40
24711084	Imatinib	Prendergast GC	Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer.	Cancer immunology, immunotherapy 	2014	61
24789445	Imatinib	Pickard MR	Regulation of apoptosis by long non-coding RNA GAS5 in breast cancer cells: implications for chemotherapy.	Breast cancer research and treatment	2014	36
24925196	Imatinib	von Mehren M	Gastrointestinal stromal tumors, version 2.2014.	Journal of the National Comprehensive Cancer Network 	2014	26
25515961	Imatinib	Wang LS	MicroRNA-486 regulates normal erythropoiesis and enhances growth and modulates drug response in CML progenitors.	Blood	2015	29
25871397	Imatinib	Liao H	MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2.	Oncotarget	2015	18
27854515	Imatinib	Xiao Y	lncRNA UCA1 Contributes to Imatinib Resistance by Acting as a ceRNA Against miR-16 in Chronic Myeloid Leukemia Cells.	DNA and cell biology	2017	6
28095277	Imatinib	Etienne G	Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid Leukemia.	Journal of clinical oncology 	2017	14
28329763	Imatinib	Wylie AA	The allosteric inhibitor ABL001 enables dual targeting of BCR-ABL1.	Nature	2017	6
12531805	Sunitinib	O'Farrell AM	SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo.	Blood	2003	170
17512858	Sunitinib	Rubin BP	Gastrointestinal stromal tumour.	Lancet	2007	93
19064974	Sunitinib	Golshayan AR	Metastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy.	Journal of clinical oncology 	2009	51
20103651	Sunitinib	Huang D	Interleukin-8 mediates resistance to antiangiogenic agent sunitinib in renal cell carcinoma.	Cancer research	2010	114
20339913	Sunitinib	Barrios CH	Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer.	Breast cancer research and treatment	2010	50
20368560	Sunitinib	Hainsworth JD	Phase II trial of bevacizumab and everolimus in patients with advanced renal cell carcinoma.	Journal of clinical oncology 	2010	49
20881001	Sunitinib	Amato RJ	Vaccination of metastatic renal cancer patients with MVA-5T4: a randomized, double-blind, placebo-controlled phase III study.	Clinical cancer research 	2010	47
21527770	Sunitinib	Rini BI	Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib.	Journal of the National Cancer Institute	2011	122
21882181	Sunitinib	Kim JJ	Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and clinical outcome in metastatic clear cell renal cell carcinoma patients treated with sunitinib.	Cancer	2012	37
22308314	Sunitinib	Conley SJ	Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia.	Proceedings of the National Academy of Sciences of the United States of America	2012	160
23378344	Sunitinib	Hollier BG	FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer.	Cancer research	2013	75
25123505	Sunitinib	Mikami S	Expression of TNF-α and CD44 is implicated in poor prognosis, cancer cell invasion, metastasis and resistance to the sunitinib treatment in clear cell renal cell carcinomas.	International journal of cancer	2015	22
25361735	Sunitinib	Huang H	VEGF suppresses T-lymphocyte infiltration in the tumor microenvironment through inhibition of NF-κB-induced endothelial activation.	FASEB journal 	2015	22
25538263	Sunitinib	Choueiri TK	Correlation of PD-L1 tumor expression and treatment outcomes in patients with renal cell carcinoma receiving sunitinib or pazopanib: results from COMPARZ, a randomized controlled trial.	Clinical cancer research 	2015	34
26626617	Sunitinib	Tannir NM	Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non-Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial.	European urology	2016	26
27297795	Sunitinib	Oppermann S	High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells.	Blood	2016	11
27487138	Sunitinib	Goto Y	The microRNA signature of patients with sunitinib failure: regulation of UHRF1 pathways by microRNA-101 in renal cell carcinoma.	Oncotarget	2016	15
28199818	Sunitinib	Choueiri TK	Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial.	Journal of clinical oncology 	2017	15
15956649	Erlotinib	Haas-Kogan DA	Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib.	Journal of the National Cancer Institute	2005	137
16230409	Erlotinib	Thomson S	Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition.	Cancer research	2005	205
16361555	Erlotinib	Yauch RL	Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients.	Clinical cancer research 	2005	171
16609043	Erlotinib	Sarkaria JN	Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response.	Clinical cancer research 	2006	112
16730237	Erlotinib	Ji H	The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies.	Cancer cell	2006	130
17452677	Erlotinib	Moore MJ	Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group.	Journal of clinical oncology 	2007	876
18281673	Erlotinib	Eberhard DA	Biomarkers of response to epidermal growth factor receptor inhibitors in Non-Small-Cell Lung Cancer Working Group: standardization for use in the clinical trial setting.	Journal of clinical oncology 	2008	72
18452692	Erlotinib	Molina JR	Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.	Mayo Clinic proceedings	2008	411
19238632	Erlotinib	Tang Z	Dual MET-EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer.	British journal of cancer	2008	59
19452131	Erlotinib	Li T	Skin toxicities associated with epidermal growth factor receptor inhibitors.	Targeted oncology	2009	52
20595147	Erlotinib	Porta R	Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation.	The European respiratory journal	2011	68
20603615	Erlotinib	Ye X	An anti-Axl monoclonal antibody attenuates xenograft tumor growth and enhances the effect of multiple anticancer therapies.	Oncogene	2010	71
20959484	Erlotinib	Yamamoto C	Loss of PTEN expression by blocking nuclear translocation of EGR1 in gefitinib-resistant lung cancer cells harboring epidermal growth factor receptor-activating mutations.	Cancer research	2010	43
21045158	Erlotinib	Shultz JC	Alternative splicing of caspase 9 is modulated by the phosphoinositide 3-kinase/Akt pathway via phosphorylation of SRp30a.	Cancer research	2010	46
21130517	Erlotinib	Brevet M	Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitors.	Lung cancer	2011	40
21430781	Erlotinib	Bivona TG	FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR.	Nature	2011	112
21576636	Erlotinib	Spigel DR	Randomized, double-blind, placebo-controlled, phase II trial of sorafenib and erlotinib or erlotinib alone in previously treated advanced non-small-cell lung cancer.	Journal of clinical oncology 	2011	44
21865399	Erlotinib	Grommes C	"Pulsatile" high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer.	Neuro-oncology	2011	74
22180495	Erlotinib	Yang H	Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer.	Cancer research	2012	58
22440336	Erlotinib	Scagliotti GV	Rationale and design of MARQUEE: a phase III, randomized, double-blind study of tivantinib plus erlotinib versus placebo plus erlotinib in previously treated patients with locally advanced or metastatic, nonsquamous, non-small-cell lung cancer.	Clinical lung cancer	2012	47
22753918	Erlotinib	Ramalingam SS	Randomized phase II study of dacomitinib (PF-00299804), an irreversible pan-human epidermal growth factor receptor inhibitor, versus erlotinib in patients with advanced non-small-cell lung cancer.	Journal of clinical oncology 	2012	66
23341526	Erlotinib	Welsh JW	Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer.	Journal of clinical oncology 	2013	87
23341531	Erlotinib	Herman JM	Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final results.	Journal of clinical oncology 	2013	36
23460709	Erlotinib	Martins RG	Cisplatin and radiotherapy with or without erlotinib in locally advanced squamous cell carcinoma of the head and neck: a randomized phase II trial.	Journal of clinical oncology 	2013	34
23894143	Erlotinib	Li R	Niclosamide overcomes acquired resistance to erlotinib through suppression of STAT3 in non-small cell lung cancer.	Molecular cancer therapeutics	2013	41
23994953	Erlotinib	Vazquez-Martin A	IGF-1R/epithelial-to-mesenchymal transition (EMT) crosstalk suppresses the erlotinib-sensitizing effect of EGFR exon 19 deletion mutations.	Scientific reports	2013	27
24550739	Erlotinib	Borad MJ	Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma.	PLoS genetics	2014	59
24687921	Erlotinib	Koeppen H	Biomarker analyses from a placebo-controlled phase II study evaluating erlotinib±onartuzumab in advanced non-small cell lung cancer: MET expression levels are predictive of patient benefit.	Clinical cancer research 	2014	31
24773774	Erlotinib	Weber B	Detection of EGFR mutations in plasma and biopsies from non-small cell lung cancer patients by allele-specific PCR assays.	BMC cancer	2014	32
25009014	Erlotinib	Azuma K	Association of PD-L1 overexpression with activating EGFR mutations in surgically resected nonsmall-cell lung cancer.	Annals of oncology 	2014	91
25031274	Erlotinib	Lee SM	Randomized trial of erlotinib plus whole-brain radiotherapy for NSCLC patients with multiple brain metastases.	Journal of the National Cancer Institute	2014	26
25137181	Erlotinib	Marchetti A	Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: toward a real-time liquid biopsy for treatment.	PloS one	2014	44
25149530	Erlotinib	Xu J	MiR-497 downregulation contributes to the malignancy of pancreatic cancer and associates with a poor prognosis.	Oncotarget	2014	24
25714397	Erlotinib	Stahlhut C	Combinatorial Action of MicroRNAs let-7 and miR-34 Effectively Synergizes with Erlotinib to Suppress Non-small Cell Lung Cancer Cell Proliferation.	Cell cycle	2015	23
26309190	Erlotinib	Hata A	Spatiotemporal T790M Heterogeneity in Individual Patients with EGFR-Mutant Non-Small-Cell Lung Cancer after Acquired Resistance to EGFR-TKI.	Journal of thoracic oncology 	2015	17
26540028	Erlotinib	William WN Jr	Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial.	JAMA oncology	2016	13
26720423	Erlotinib	Park K	First-Line Erlotinib Therapy Until and Beyond Response Evaluation Criteria in Solid Tumors Progression in Asian Patients With Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer: The ASPIRATION Study.	JAMA oncology	2016	28
26802155	Erlotinib	Carter CA	Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancer.	Annals of oncology 	2016	14
26891683	Erlotinib	Ramirez M	Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells.	Nature communications	2016	23
27281561	Erlotinib	Yanagita M	A Prospective Evaluation of Circulating Tumor Cells and Cell-Free DNA in EGFR-Mutant Non-Small Cell Lung Cancer Patients Treated with Erlotinib on a Phase II Trial.	Clinical cancer research 	2016	19
27409162	Erlotinib	Hsu PC	YAP promotes erlotinib resistance in human non-small cell lung cancer cells.	Oncotarget	2016	12
28061471	Erlotinib	Li L	Transformation to small-cell carcinoma as an acquired resistance mechanism to AZD9291: A case report.	Oncotarget	2017	6
9661897	Paclitaxel	Baselga J	Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts.	Cancer research	1998	130
11248153	Paclitaxel	Slamon DJ	Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.	The New England journal of medicine	2001	1772
15914550	Paclitaxel	Rouzier R	Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer.	Proceedings of the National Academy of Sciences of the United States of America	2005	77
16322248	Paclitaxel	Isakoff SJ	Breast cancer-associated PIK3CA mutations are oncogenic in mammary epithelial cells.	Cancer research	2005	174
16585214	Paclitaxel	Kelly MG	TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer.	Cancer research	2006	135
16809727	Paclitaxel	Perez EA	HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial.	Journal of clinical oncology 	2006	87
17538177	Paclitaxel	Gerstner ER	Increased permeability of the blood-brain barrier to chemotherapy in metastatic brain tumors: establishing a treatment paradigm.	Journal of clinical oncology 	2007	58
17611683	Paclitaxel	Kajiyama H	Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells.	International journal of oncology	2007	127
17965935	Paclitaxel	Zhou J	NF-kappaB pathway inhibitors preferentially inhibit breast cancer stem-like cells.	Breast cancer research and treatment	2008	55
18366788	Paclitaxel	Fillmore CM	Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy.	Breast cancer research 	2008	368
18676833	Paclitaxel	Ding Q	Down-regulation of myeloid cell leukemia-1 through inhibiting Erk/Pin 1 pathway by sorafenib facilitates chemosensitization in breast cancer.	Cancer research	2008	53
18758960	Paclitaxel	Tsang WP	Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3.	Apoptosis 	2008	65
18824714	Paclitaxel	Schneider BP	Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100.	Journal of clinical oncology 	2008	171
19491198	Paclitaxel	Walker SR	Reciprocal effects of STAT5 and STAT3 in breast cancer.	Molecular cancer research 	2009	53
19748175	Paclitaxel	Zhang Q	A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy.	Cancer letters	2010	56
19826413	Paclitaxel	Szajnik M	TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer.	Oncogene	2009	55
20530690	Paclitaxel	Carr JR	FoxM1 mediates resistance to herceptin and paclitaxel.	Cancer research	2010	71
20697084	Paclitaxel	Perez EA	HER2 and chromosome 17 effect on patient outcome in the N9831 adjuvant trastuzumab trial.	Journal of clinical oncology 	2010	53
20807808	Paclitaxel	Zhu ML	Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancer.	Cancer research	2010	87
21109570	Paclitaxel	Tamura K	FcγR2A and 3A polymorphisms predict clinical outcome of trastuzumab in both neoadjuvant and metastatic settings in patients with HER2-positive breast cancer.	Annals of oncology 	2011	47
21270667	Paclitaxel	Zhang JG	MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.	Journal of thoracic oncology 	2011	54
21354697	Paclitaxel	Li J	miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression.	Cancer letters	2011	36
21788566	Paclitaxel	Untch M	Pathologic complete response after neoadjuvant chemotherapy plus trastuzumab predicts favorable survival in human epidermal growth factor receptor 2-overexpressing breast cancer: results from the TECHNO trial of the AGO and GBG study groups.	Journal of clinical oncology 	2011	77
22184370	Paclitaxel	Karlan BY	Randomized, double-blind, placebo-controlled phase II study of AMG 386 combined with weekly paclitaxel in patients with recurrent ovarian cancer.	Journal of clinical oncology 	2012	61
22768203	Paclitaxel	Singh S	Chemoresistance in prostate cancer cells is regulated by miRNAs and Hedgehog pathway.	PloS one	2012	35
22987084	Paclitaxel	Romond EH	Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal growth factor receptor 2-positive breast cancer.	Journal of clinical oncology 	2012	72
23074172	Paclitaxel	Cittelly DM	Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel.	Molecular cancer therapeutics	2012	39
23359505	Paclitaxel	Sevko A	Antitumor effect of paclitaxel is mediated by inhibition of myeloid-derived suppressor cells and chronic inflammation in the spontaneous melanoma model.	Journal of immunology	2013	31
23391723	Paclitaxel	Bhola NE	TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer.	The Journal of clinical investigation	2013	106
23514751	Paclitaxel	Khongkow M	SIRT6 modulates paclitaxel and epirubicin resistance and survival in breast cancer.	Carcinogenesis	2013	29
23750239	Paclitaxel	Gao J	MiR-26a inhibits proliferation and migration of breast cancer through repression of MCL-1.	PloS one	2013	34
23849556	Paclitaxel	Heinemann V	Tumour-stroma interactions in pancreatic ductal adenocarcinoma: rationale and current evidence for new therapeutic strategies.	Cancer treatment reviews	2014	30
23871962	Paclitaxel	Swaminathan SK	CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer.	Journal of controlled release 	2013	27
24063698	Paclitaxel	Dent RA	Phase I trial of the oral PARP inhibitor olaparib in combination with paclitaxel for first- or second-line treatment of patients with metastatic triple-negative breast cancer.	Breast cancer research 	2013	34
24095300	Paclitaxel	Robidoux A	Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial.	The Lancet. Oncology	2013	61
24122958	Paclitaxel	Huang D	miRNA27a is a biomarker for predicting chemosensitivity and prognosis in metastatic or recurrent gastric cancer.	Journal of cellular biochemistry	2014	26
24360787	Paclitaxel	Earl HM	Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2×2 factorial randomised phase 3 trial.	The Lancet. Oncology	2014	23
24599932	Paclitaxel	Abraham JE	Replication of genetic polymorphisms reported to be associated with taxane-related sensory neuropathy in patients with early breast cancer treated with Paclitaxel.	Clinical cancer research 	2014	22
24669015	Paclitaxel	Gonzalez-Angulo AM	Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer†.	Annals of oncology 	2014	22
24868024	Paclitaxel	Satoh T	Lapatinib plus paclitaxel versus paclitaxel alone in the second-line treatment of HER2-amplified advanced gastric cancer in Asian populations: TyTAN--a randomized, phase III study.	Journal of clinical oncology 	2014	99
25104330	Paclitaxel	Stoeck A	Discovery of biomarkers predictive of GSI response in triple-negative breast cancer and adenoid cystic carcinoma.	Cancer discovery	2014	29
25130998	Paclitaxel	de Azambuja E	Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response.	The Lancet. Oncology	2014	50
25153722	Paclitaxel	Konno Y	MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells.	Oncotarget	2014	53
25240821	Paclitaxel	Wilke H	Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial.	The Lancet. Oncology	2014	246
25344740	Paclitaxel	Savai R	Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension.	Nature medicine	2014	26
25595279	Paclitaxel	Gonzalez-Villasana V	Rac1/Pak1/p38/MMP-2 Axis Regulates Angiogenesis in Ovarian Cancer.	Clinical cancer research 	2015	19
25605244	Paclitaxel	Yang Q	MiR-125b regulates epithelial-mesenchymal transition via targeting Sema4C in paclitaxel-resistant breast cancer cells.	Oncotarget	2015	27
25818419	Paclitaxel	Jiang L	Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response.	Biomaterials	2015	20
25918279	Paclitaxel	Heestand GM	Approach to patients with pancreatic cancer without detectable metastases.	Journal of clinical oncology 	2015	16
26092818	Paclitaxel	Hurvitz SA	Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial.	The Lancet. Oncology	2015	47
26181252	Paclitaxel	Salgado R	Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab: A Secondary Analysis of the NeoALTTO Trial.	JAMA oncology	2015	46
26469139	Paclitaxel	Perez EA	Association of Stromal Tumor-Infiltrating Lymphocytes With Recurrence-Free Survival in the N9831 Adjuvant Trial in Patients With Early-Stage HER2-Positive Breast Cancer.	JAMA oncology	2016	16
26578779	Paclitaxel	Tolaney SM	Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients.	Proceedings of the National Academy of Sciences of the United States of America	2015	32
26830752	Paclitaxel	Kamisawa T	Pancreatic cancer.	Lancet	2016	93
26869049	Paclitaxel	Untch M	Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto-GBG 69): a randomised, phase 3 trial.	The Lancet. Oncology	2016	26
26883251	Paclitaxel	Chen YM	Linc-ROR induces epithelial-mesenchymal transition and contributes to drug resistance and invasion of breast cancer cells.	Tumour biology 	2016	11
26908167	Paclitaxel	Ring BZ	Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients.	BMC cancer	2016	11
26979998	Paclitaxel	Zhang H	Dorsal Root Ganglion Infiltration by Macrophages Contributes to Paclitaxel Chemotherapy-Induced Peripheral Neuropathy.	The journal of pain 	2016	17
27021436	Paclitaxel	Au Yeung CL	Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1.	Nature communications	2016	58
27556950	Paclitaxel	Jordan NV	HER2 expression identifies dynamic functional states within circulating breast cancer cells.	Nature	2016	23
27635089	Paclitaxel	Zhang J	Efficacy of Anti-mesothelin Immunotoxin RG7787 plus Nab-Paclitaxel against Mesothelioma Patient-Derived Xenografts and Mesothelin as a Biomarker of Tumor Response.	Clinical cancer research 	2017	6
27803006	Paclitaxel	Martín M	A randomized adaptive phase II/III study of buparlisib, a pan-class I PI3K inhibitor, combined with paclitaxel for the treatment of HER2- advanced breast cancer (BELLE-4).	Annals of oncology 	2017	8
27887917	Paclitaxel	Jeong JY	MicroRNA-136 inhibits cancer stem cell activity and enhances the anti-tumor effect of paclitaxel against chemoresistant ovarian cancer cells by targeting Notch3.	Cancer letters	2017	9
28135148	Paclitaxel	Symmans WF	Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype.	Journal of clinical oncology 	2017	11
28209618	Paclitaxel	Chen MW	The STAT3-miRNA-92-Wnt Signaling Pathway Regulates Spheroid Formation and Malignant Progression in Ovarian Cancer.	Cancer research	2017	7
28296507	Paclitaxel	Shen CJ	LncRNA PVT1 epigenetically silences miR-195 and modulates EMT and chemoresistance in cervical cancer cells.	Journal of drug targeting	2017	7
28406482	Paclitaxel	Wang L	Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer via enhancing TRIB1/HDAC activity.	Cell death & disease	2017	6
28428276	Paclitaxel	Wen D	Micellar Delivery of miR-34a Modulator Rubone and Paclitaxel in Resistant Prostate Cancer.	Cancer research	2017	5
28679654	Paclitaxel	Karagiannis GS	Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism.	Science translational medicine	2017	7
18165647	Sorafenib	Choueiri TK	Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma.	Journal of clinical oncology 	2008	89
18955566	Sorafenib	Zeng Z	Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML.	Blood	2009	150
19726678	Sorafenib	Bai S	MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib.	The Journal of biological chemistry	2009	157
20347499	Sorafenib	Shimizu S	The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma.	Journal of hepatology	2010	87
20616044	Sorafenib	Wüstehube J	Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling.	Proceedings of the National Academy of Sciences of the United States of America	2010	47
21263155	Sorafenib	Sato T	FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivo.	Blood	2011	61
21325076	Sorafenib	Ma XH	Measurements of tumor cell autophagy predict invasiveness, resistance to chemotherapy, and survival in melanoma.	Clinical cancer research 	2011	67
21352471	Sorafenib	Meng F	Functional analysis of microRNAs in human hepatocellular cancer stem cells.	Journal of cellular and molecular medicine	2012	41
21368833	Sorafenib	Inuzuka H	SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction.	Nature	2011	195
21538283	Sorafenib	Nault JC	Genetics of hepatobiliary carcinogenesis.	Seminars in liver disease	2011	50
21816126	Sorafenib	Sangro B	Radioembolization for hepatocellular carcinoma.	Journal of hepatology	2012	62
22067401	Sorafenib	Oberholzer PA	RAS mutations are associated with the development of cutaneous squamous cell tumors in patients treated with RAF inhibitors.	Journal of clinical oncology 	2012	81
22322234	Sorafenib	Lachenmayer A	Combination therapy for hepatocellular carcinoma: additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib.	Journal of hepatology	2012	44
22504140	Sorafenib	Metzelder SK	High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses.	Leukemia	2012	40
22890726	Sorafenib	Arao T	FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma.	Hepatology	2013	25
23471579	Sorafenib	Xia H	MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.	Hepatology	2013	89
23835194	Sorafenib	Pez F	Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs.	Journal of hepatology	2013	56
23958557	Sorafenib	Govaere O	Keratin 19: a key role player in the invasion of human hepatocellular carcinomas.	Gut	2014	53
23980090	Sorafenib	Llovet JM	Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: results from the randomized phase III BRISK-PS study.	Journal of clinical oncology 	2013	107
24700742	Sorafenib	Xiang Q	Cabozantinib suppresses tumor growth and metastasis in hepatocellular carcinoma by a dual blockade of VEGFR2 and MET.	Clinical cancer research 	2014	26
25053293	Sorafenib	Fernando J	A mesenchymal-like phenotype and expression of CD44 predict lack of apoptotic response to sorafenib in liver tumor cells.	International journal of cancer	2015	23
25216638	Sorafenib	Rudalska R	In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer.	Nature medicine	2014	43
25633810	Sorafenib	Ohta K	MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A.	Oncotarget	2015	34
25938543	Sorafenib	Dai W	By reducing hexokinase 2, resveratrol induces apoptosis in HCC cells addicted to aerobic glycolysis and inhibits tumor growth in mice.	Oncotarget	2015	24
26045065	Sorafenib	Liu K	miR-494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN.	Oncology reports	2015	25
26154152	Sorafenib	Won C	Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma.	Hepatology	2015	21
26311740	Sorafenib	He C	MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.	Oncotarget	2015	22
26314551	Sorafenib	Ross JS	The distribution of BRAF gene fusions in solid tumors and response to targeted therapy.	International journal of cancer	2016	21
26364606	Sorafenib	Mandal R	Stamping out RAF and MEK1/2 to inhibit the ERK1/2 pathway: an emerging threat to anticancer therapy.	Oncogene	2016	13
26514126	Sorafenib	Lou G	Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma.	Journal of hematology & oncology	2015	38
26566875	Sorafenib	Diamond EL	Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms.	Cancer discovery	2016	28
26592953	Sorafenib	Govaere O	Laminin-332 sustains chemoresistance and quiescence as part of the human hepatic cancer stem cell niche.	Journal of hepatology	2016	13
27100895	Sorafenib	Zhang PF	Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling.	Cell death & disease	2016	15
27399335	Sorafenib	Tong J	FBW7 mutations mediate resistance of colorectal cancer to targeted therapies by blocking Mcl-1 degradation.	Oncogene	2017	13
27849562	Sorafenib	Bollard J	Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma.	Gut	2017	8
28177886	Sorafenib	Zhang X	Transarterial chemoembolization (TACE) combined with sorafenib versus TACE for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis.	Oncotarget	2017	7
28423574	Sorafenib	Cheng Y	Synergistic anti-tumor efficacy of sorafenib and fluvastatin in hepatocellular carcinoma.	Oncotarget	2017	5
16230377	Dasatinib	Nam S	Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells.	Cancer research	2005	132
16469872	Dasatinib	Copland M	Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction.	Blood	2006	149
17268817	Dasatinib	Finn RS	Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/"triple-negative" breast cancer cell lines growing in vitro.	Breast cancer research and treatment	2007	117
19363292	Dasatinib	Bellodi C	Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells.	The Journal of clinical investigation	2009	156
19447874	Dasatinib	Tatarov O	SRC family kinase activity is up-regulated in hormone-refractory prostate cancer.	Clinical cancer research 	2009	47
19690143	Dasatinib	Lu KV	Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients.	Cancer research	2009	60
20190765	Dasatinib	Li J	A chemical and phosphoproteomic characterization of dasatinib action in lung cancer.	Nature chemical biology	2010	95
20215510	Dasatinib	Choi YL	LYN is a mediator of epithelial-mesenchymal transition and a target of dasatinib in breast cancer.	Cancer research	2010	53
20303350	Dasatinib	Morton JP	Dasatinib inhibits the development of metastases in a mouse model of pancreatic ductal adenocarcinoma.	Gastroenterology	2010	46
20855820	Dasatinib	Johnson FM	Phase II study of dasatinib in patients with advanced non-small-cell lung cancer.	Journal of clinical oncology 	2010	60
21282564	Dasatinib	Baker AM	The role of lysyl oxidase in SRC-dependent proliferation and metastasis of colorectal cancer.	Journal of the National Cancer Institute	2011	43
21297102	Dasatinib	Li Q	3D models of epithelial-mesenchymal transition in breast cancer metastasis: high-throughput screening assay development, validation, and pilot screen.	Journal of biomolecular screening	2011	36
21423210	Dasatinib	Dulak AM	HGF-independent potentiation of EGFR action by c-Met.	Oncogene	2011	45
21523734	Dasatinib	Kluger HM	A phase 2 trial of dasatinib in advanced melanoma.	Cancer	2011	40
21768775	Dasatinib	Martinez-Outschoorn UE	Understanding the metabolic basis of drug resistance: therapeutic induction of the Warburg effect kills cancer cells.	Cell cycle	2011	42
22184410	Dasatinib	Hamilton A	Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival.	Blood	2012	88
22586301	Dasatinib	Chan CM	Targeted inhibition of Src kinase with dasatinib blocks thyroid cancer growth and metastasis.	Clinical cancer research 	2012	31
23947765	Dasatinib	Gomez-Casal R	Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes.	Molecular cancer	2013	46
26001294	Dasatinib	Srivastava K	p63 drives invasion in keratinocytes expressing HPV16 E6/E7 genes through regulation of Src-FAK signalling.	Oncotarget	2017	6
26321221	Dasatinib	Churchman ML	Efficacy of Retinoids in IKZF1-Mutated BCR-ABL1 Acute Lymphoblastic Leukemia.	Cancer cell	2015	26
10550418	Creatinine	Meyer TW	Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria.	Diabetologia	1999	111
11260414	Creatinine	Kambham N	Obesity-related glomerulopathy: an emerging epidemic.	Kidney international	2001	169
12081572	Creatinine	Rastaldi MP	Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies.	Kidney international	2002	89
12709468	Creatinine	Imai Y	Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome.	JAMA	2003	106
15327410	Creatinine	Szczech LA	The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection.	Kidney international	2004	81
15809451	Creatinine	Greipp PR	International staging system for multiple myeloma.	Journal of clinical oncology 	2005	372
16528543	Creatinine	Mishra J	Kidney NGAL is a novel early marker of acute injury following transplantation.	Pediatric nephrology	2006	75
16827865	Creatinine	Parikh CR	Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation.	American journal of transplantation 	2006	115
17021608	Creatinine	Zhou H	Exosomal Fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury.	Kidney international	2006	78
17785705	Creatinine	Lipton A	Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone metastases.	Journal of clinical oncology 	2007	69
17874137	Creatinine	Hirsch R	NGAL is an early predictive biomarker of contrast-induced nephropathy in children.	Pediatric nephrology	2007	104
18076931	Creatinine	Thompson RH	Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy.	The Journal of urology	2008	96
19237632	Creatinine	Fizazi K	Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates.	Journal of clinical oncology 	2009	108
19720929	Creatinine	Jensen HK	Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma.	Journal of clinical oncology 	2009	105
20383145	Creatinine	Chambers JC	Genetic loci influencing kidney function and chronic kidney disease.	Nature genetics	2010	90
20485332	Creatinine	Garin EH	Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis.	Kidney international	2010	42
20525986	Creatinine	Shah RV	Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure.	European journal of heart failure	2010	55
20581391	Creatinine	Serra AL	Sirolimus and kidney growth in autosomal dominant polycystic kidney disease.	The New England journal of medicine	2010	129
21309006	Creatinine	Hsieh C	Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring.	Arthritis care & research	2011	49
21368745	Creatinine	Trachtman H	A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis.	Kidney international	2011	68
21482744	Creatinine	Peralta CA	Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality.	JAMA	2011	102
22194591	Creatinine	Udy AA	Subtherapeutic initial β-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations.	Chest	2012	49
22240130	Creatinine	Nickolas TL	Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study.	Journal of the American College of Cardiology	2012	75
22311920	Creatinine	Ferguson MA	Established and emerging markers of kidney function.	Clinical chemistry	2012	30
22328173	Creatinine	Brunner HI	Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritis.	Arthritis and rheumatism	2012	32
22344503	Creatinine	Chapman AB	Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease.	Clinical journal of the American Society of Nephrology 	2012	83
22403278	Creatinine	Bomback AS	Eculizumab for dense deposit disease and C3 glomerulonephritis.	Clinical journal of the American Society of Nephrology 	2012	72
23121377	Creatinine	Torres VE	Tolvaptan in patients with autosomal dominant polycystic kidney disease.	The New England journal of medicine	2012	217
23233713	Creatinine	San Miguel JF	Persistent overall survival benefit and no increased risk of second malignancies with bortezomib-melphalan-prednisone versus melphalan-prednisone in patients with previously untreated multiple myeloma.	Journal of clinical oncology 	2013	30
23411786	Creatinine	Parekh DJ	Tolerance of the human kidney to isolated controlled ischemia.	Journal of the American Society of Nephrology 	2013	32
23618405	Creatinine	Zhou Y	Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro.	Stem cell research & therapy	2013	95
23667695	Creatinine	Wen MS	Decrease in irisin in patients with chronic kidney disease.	PloS one	2013	28
23886566	Creatinine	Sharma SG	The modern spectrum of renal biopsy findings in patients with diabetes.	Clinical journal of the American Society of Nephrology 	2013	31
24067879	Creatinine	Gane EJ	Telbivudine improves renal function in patients with chronic hepatitis B.	Gastroenterology	2014	29
24211404	Creatinine	Zubiri I	Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis.	Journal of proteomics	2014	32
24429405	Creatinine	Sinha A	Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children.	Kidney international	2014	22
24596084	Creatinine	Kawamura T	A multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy in patients with immunoglobulin A nephropathy.	Nephrology, dialysis, transplantation 	2014	21
24623144	Creatinine	Wise AF	Human mesenchymal stem cells alter macrophage phenotype and promote regeneration via homing to the kidney following ischemia-reperfusion injury.	American journal of physiology. Renal physiology	2014	23
24652789	Creatinine	Lu JL	Association of body mass index with outcomes in patients with CKD.	Journal of the American Society of Nephrology 	2014	43
24819981	Creatinine	Semba RD	Resveratrol levels and all-cause mortality in older community-dwelling adults.	JAMA internal medicine	2014	23
25054777	Creatinine	Freedman BI	APOL1 associations with nephropathy, atherosclerosis, and all-cause mortality in African Americans with type 2 diabetes.	Kidney international	2015	30
25063425	Creatinine	An Y	Renal histologic changes and the outcome in patients with diabetic nephropathy.	Nephrology, dialysis, transplantation 	2015	17
25145934	Creatinine	Lai JY	MicroRNA-21 in glomerular injury.	Journal of the American Society of Nephrology 	2015	27
25195004	Creatinine	Wasung ME	Biomarkers of renal function, which and when?	Clinica chimica acta; international journal of clinical chemistry	2015	31
25311702	Creatinine	Liu KD	Urine neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease and death in CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study.	American journal of kidney diseases 	2015	18
25530108	Creatinine	Le Quintrec M	Eculizumab for treatment of rapidly progressive C3 glomerulopathy.	American journal of kidney diseases 	2015	21
25855775	Creatinine	Zhang WR	Plasma IL-6 and IL-10 Concentrations Predict AKI and Long-Term Mortality in Adults after Cardiac Surgery.	Journal of the American Society of Nephrology 	2015	18
26015453	Creatinine	Schwartzman M	Podocyte-Specific Deletion of Yes-Associated Protein Causes FSGS and Progressive Renal Failure.	Journal of the American Society of Nephrology 	2016	10
26038526	Creatinine	Hodgin JB	Glomerular Aging and Focal Global Glomerulosclerosis: A Podometric Perspective.	Journal of the American Society of Nephrology 	2015	35
26040904	Creatinine	Solé C	miR-29c in urinary exosomes as predictor of early renal fibrosis in lupus nephritis.	Nephrology, dialysis, transplantation 	2015	25
26181658	Creatinine	Pardanani A	Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis: A Randomized Clinical Trial.	JAMA oncology	2015	18
26566060	Creatinine	Freedman BI	APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors.	Transplantation	2016	26
26912543	Creatinine	Torres VE	Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage: Results from the TEMPO 3:4 Trial.	Clinical journal of the American Society of Nephrology 	2016	13
27339817	Creatinine	Leung JC	Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients.	Hepatology	2017	9
28255002	Creatinine	Aubert O	Antibody-Mediated Rejection Due to Preexisting versus De Novo Donor-Specific Antibodies in Kidney Allograft Recipients.	Journal of the American Society of Nephrology 	2017	5
28286957	Creatinine	Chen H	Combined Clinical Phenotype and Lipidomic Analysis Reveals the Impact of Chronic Kidney Disease on Lipid Metabolism.	Journal of proteome research	2017	8
18985363	Isocitric acid	Balss J	Analysis of the IDH1 codon 132 mutation in brain tumors.	Acta neuropathologica	2008	234
19636000	Isocitric acid	Sanson M	Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.	Journal of clinical oncology 	2009	197
19805672	Isocitric acid	Weller M	Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network.	Journal of clinical oncology 	2009	142
19903171	Isocitric acid	Capper D	Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors.	Brain pathology	2010	89
20410924	Isocitric acid	Pardanani A	IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms.	Leukemia	2010	43
20805365	Isocitric acid	Schnittger S	IDH1 mutations are detected in 6.6% of 1414 AML patients and are associated with intermediate risk karyotype and unfavorable prognosis in adults younger than 60 years and unmutated NPM1 status.	Blood	2010	43
21163902	Isocitric acid	Christensen BC	DNA methylation, isocitrate dehydrogenase mutation, and survival in glioma.	Journal of the National Cancer Institute	2011	92
21446051	Isocitric acid	Huse JT	Molecular subclassification of diffuse gliomas: seeing order in the chaos.	Glia	2011	77
21596855	Isocitric acid	Green CL	The prognostic significance of IDH2 mutations in AML depends on the location of the mutation.	Blood	2011	50
22034964	Isocitric acid	SongTao Q	IDH mutations predict longer survival and response to temozolomide in secondary glioblastoma.	Cancer science	2012	39
22166263	Isocitric acid	Luchman HA	An in vivo patient-derived model of endogenous IDH1-mutant glioma.	Neuro-oncology	2012	47
22180306	Isocitric acid	Borger DR	Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping.	The oncologist	2012	142
22343889	Isocitric acid	Turcan S	IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype.	Nature	2012	444
22688054	Isocitric acid	Müller T	Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas.	The American journal of pathology	2012	31
23104868	Isocitric acid	Kannan K	Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma.	Oncotarget	2012	60
23204232	Isocitric acid	Jin G	Disruption of wild-type IDH1 suppresses D-2-hydroxyglutarate production in IDH1-mutated gliomas.	Cancer research	2013	35
23264629	Isocitric acid	Ward PS	The potential for isocitrate dehydrogenase mutations to produce 2-hydroxyglutarate depends on allele specificity and subcellular compartmentalization.	The Journal of biological chemistry	2013	40
23558169	Isocitric acid	Rohle D	An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells.	Science	2013	275
23558173	Isocitric acid	Wang F	Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation.	Science	2013	176
23801749	Isocitric acid	Hughes LA	The CpG island methylator phenotype: what's in a name?	Cancer research	2013	45
23904111	Isocitric acid	Wiestler B	ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis.	Acta neuropathologica	2013	51
23999439	Isocitric acid	Andronesi OC	Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate.	The Journal of clinical investigation	2013	32
24478380	Isocitric acid	Borger DR	Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinoma.	Clinical cancer research 	2014	24
24510240	Isocitric acid	Molenaar RJ	The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone.	Neuro-oncology	2014	26
25043045	Isocitric acid	Saha SK	Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer.	Nature	2014	66
25081751	Isocitric acid	Chan AK	TERT promoter mutations contribute to subset prognostication of lower-grade gliomas.	Modern pathology 	2015	21
25135958	Isocitric acid	Bao ZS	RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas.	Genome research	2014	41
25182153	Isocitric acid	Shim EH	L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancer.	Cancer discovery	2014	45
25701198	Isocitric acid	Olar A	IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas.	Acta neuropathologica	2015	21
25783747	Isocitric acid	Weller M	Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups.	Acta neuropathologica	2015	28
26188014	Isocitric acid	Waitkus MS	Isocitrate dehydrogenase mutations in gliomas.	Neuro-oncology	2016	25
26268241	Isocitric acid	Wang C	IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma.	Blood	2015	24
26534967	Isocitric acid	Andronesi OC	Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate.	Clinical cancer research 	2016	14
26691210	Isocitric acid	de la Fuente MI	Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma.	Neuro-oncology	2016	22
26945349	Isocitric acid	Chen JR	Isocitrate Dehydrogenase (IDH)1/2 Mutations as Prognostic Markers in Patients With Glioblastomas.	Medicine	2016	13
26948350	Isocitric acid	Masui K	Molecular classification of gliomas.	Handbook of clinical neurology	2016	14
27005468	Isocitric acid	Dang L	IDH mutations in cancer and progress toward development of targeted therapeutics.	Annals of oncology 	2016	26
27353503	Isocitric acid	Zhang B	Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas.	Neuro-oncology	2017	8
27370400	Isocitric acid	Garber ST	Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies.	Neuro-oncology	2016	11
27522058	Isocitric acid	Sosulski ML	Sirtuin 3 Deregulation Promotes Pulmonary Fibrosis.	The journals of gerontology. Series A, Biological sciences and medical sciences	2017	9
27820599	Isocitric acid	Miroshnikova YA	Tissue mechanics promote IDH1-dependent HIF1α-tenascin C feedback to regulate glioblastoma aggression.	Nature cell biology	2016	12
28043904	Isocitric acid	Sia D	Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis.	Gastroenterology	2017	17
28124097	Isocitric acid	Pusch S	Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivo.	Acta neuropathologica	2017	7
28148839	Isocitric acid	Sulkowski PL	2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity.	Science translational medicine	2017	18
28193778	Isocitric acid	Yen K	AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations.	Cancer discovery	2017	14
28360267	Isocitric acid	Venteicher AS	Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq.	Science	2017	29
28588019	Isocitric acid	Amatangelo MD	Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response.	Blood	2017	10
11309634	Pteroyl-D-glutamic acid	Watanabe T	Molecular predictors of survival after adjuvant chemotherapy for colon cancer.	The New England journal of medicine	2001	177
15175435	Pteroyl-D-glutamic acid	Hurwitz H	Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.	The New England journal of medicine	2004	1926
15908660	Pteroyl-D-glutamic acid	Hurwitz HI	Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer.	Journal of clinical oncology 	2005	117
15998951	Pteroyl-D-glutamic acid	Ince WL	Association of k-ras, b-raf, and p53 status with the treatment effect of bevacizumab.	Journal of the National Cancer Institute	2005	70
16365183	Pteroyl-D-glutamic acid	Jubb AM	Impact of vascular endothelial growth factor-A expression, thrombospondin-2 expression, and microvessel density on the treatment effect of bevacizumab in metastatic colorectal cancer.	Journal of clinical oncology 	2006	106
16809730	Pteroyl-D-glutamic acid	Toffoli G	The role of UGT1A1*28 polymorphism in the pharmacodynamics and pharmacokinetics of irinotecan in patients with metastatic colorectal cancer.	Journal of clinical oncology 	2006	67
20498393	Pteroyl-D-glutamic acid	Sargent DJ	Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.	Journal of clinical oncology 	2010	237
20921462	Pteroyl-D-glutamic acid	Peeters M	Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer.	Journal of clinical oncology 	2010	193
20921465	Pteroyl-D-glutamic acid	Douillard JY	Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study.	Journal of clinical oncology 	2010	370
21502544	Pteroyl-D-glutamic acid	Van Cutsem E	Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status.	Journal of clinical oncology 	2011	383
21641636	Pteroyl-D-glutamic acid	Maughan TS	Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial.	Lancet	2011	219
22147942	Pteroyl-D-glutamic acid	Ogino S	Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803.	Clinical cancer research 	2012	87
22949147	Pteroyl-D-glutamic acid	Van Cutsem E	Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen.	Journal of clinical oncology 	2012	212
22965965	Pteroyl-D-glutamic acid	Hoff PM	Cediranib plus FOLFOX/CAPOX versus placebo plus FOLFOX/CAPOX in patients with previously untreated metastatic colorectal cancer: a randomized, double-blind, phase III study (HORIZON II).	Journal of clinical oncology 	2012	37
23045248	Pteroyl-D-glutamic acid	Gavin PG	Mutation profiling and microsatellite instability in stage II and III colon cancer: an assessment of their prognostic and oxaliplatin predictive value.	Clinical cancer research 	2012	60
23569301	Pteroyl-D-glutamic acid	Ye LC	Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases.	Journal of clinical oncology 	2013	55
24019539	Pteroyl-D-glutamic acid	Sinicrope FA	Prognostic impact of deficient DNA mismatch repair in patients with stage III colon cancer from a randomized trial of FOLFOX-based adjuvant chemotherapy.	Journal of clinical oncology 	2013	43
24024839	Pteroyl-D-glutamic acid	Douillard JY	Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer.	The New England journal of medicine	2013	432
24687833	Pteroyl-D-glutamic acid	Schwartzberg LS	PEAK: a randomized, multicenter phase II study of panitumumab plus modified fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) or bevacizumab plus mFOLFOX6 in patients with previously untreated, unresectable, wild-type KRAS exon 2 metastatic colorectal cancer.	Journal of clinical oncology 	2014	117
24859205	Pteroyl-D-glutamic acid	Shiovitz S	CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer.	Gastroenterology	2014	31
24928083	Pteroyl-D-glutamic acid	Taieb J	Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial.	The Lancet. Oncology	2014	28
25337750	Pteroyl-D-glutamic acid	Loupakis F	Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.	The New England journal of medicine	2014	110
25361982	Pteroyl-D-glutamic acid	Klingbiel D	Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial.	Annals of oncology 	2015	20
25543664	Pteroyl-D-glutamic acid	Sun Z	Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.	World journal of surgical oncology	2014	22
25605843	Pteroyl-D-glutamic acid	Van Cutsem E	Fluorouracil, leucovorin, and irinotecan plus cetuximab treatment and RAS mutations in colorectal cancer.	Journal of clinical oncology 	2015	88
25877855	Pteroyl-D-glutamic acid	Tabernero J	Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study.	The Lancet. Oncology	2015	92
26189067	Pteroyl-D-glutamic acid	Rödel C	Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.	The Lancet. Oncology	2015	41
26338525	Pteroyl-D-glutamic acid	Cremolini C	FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study.	The Lancet. Oncology	2015	55
27055731	Pteroyl-D-glutamic acid	Nywening TM	Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial.	The Lancet. Oncology	2016	40
27575024	Pteroyl-D-glutamic acid	Stintzing S	FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial.	The Lancet. Oncology	2016	19
15269313	Irinotecan	Cunningham D	Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.	The New England journal of medicine	2004	932
15677699	Irinotecan	Chung KY	Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.	Journal of clinical oncology 	2005	204
17050875	Irinotecan	Lenz HJ	Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines.	Journal of clinical oncology 	2006	92
17060484	Irinotecan	Rubbia-Brandt L	Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery.	Annals of oncology 	2007	62
17947719	Irinotecan	Vredenburgh JJ	Bevacizumab plus irinotecan in recurrent glioblastoma multiforme.	Journal of clinical oncology 	2007	340
18182667	Irinotecan	Sathornsumetee S	Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan.	Journal of clinical oncology 	2008	79
18390971	Irinotecan	Sobrero AF	EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer.	Journal of clinical oncology 	2008	175
18560594	Irinotecan	Dylla SJ	Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy.	PloS one	2008	174
18842611	Irinotecan	Scartozzi M	Arterial hypertension correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumab.	Annals of oncology 	2009	79
19164213	Irinotecan	Bibeau F	Impact of Fc{gamma}RIIa-Fc{gamma}RIIIa polymorphisms and KRAS mutations on the clinical outcome of patients with metastatic colorectal cancer treated with cetuximab plus irinotecan.	Journal of clinical oncology 	2009	129
19217207	Irinotecan	Costantino E	TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptotis in human colorectal carcinoma cells.	Cancer letters	2009	47
19332770	Irinotecan	Quant EC	Role of a second chemotherapy in recurrent malignant glioma patients who progress on bevacizumab.	Neuro-oncology	2009	51
19366826	Irinotecan	Prenen H	PIK3CA mutations are not a major determinant of resistance to the epidermal growth factor receptor inhibitor cetuximab in metastatic colorectal cancer.	Clinical cancer research 	2009	86
19603018	Irinotecan	Loupakis F	KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer.	British journal of cancer	2009	139
19664991	Irinotecan	Hoey T	DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency.	Cell stem cell	2009	110
19738126	Irinotecan	Jacobs B	Amphiregulin and epiregulin mRNA expression in primary tumors predicts outcome in metastatic colorectal cancer treated with cetuximab.	Journal of clinical oncology 	2009	87
20167811	Irinotecan	de Groot JF	Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice.	Neuro-oncology	2010	166
20177422	Irinotecan	Graziano F	Genetic modulation of the Let-7 microRNA binding to KRAS 3'-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab-irinotecan.	The pharmacogenomics journal	2010	41
20332776	Irinotecan	Fang DD	Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery.	British journal of cancer	2010	41
20530282	Irinotecan	McLeod HL	Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741.	Journal of clinical oncology 	2010	50
22825584	Irinotecan	Julien S	Characterization of a large panel of patient-derived tumor xenografts representing the clinical heterogeneity of human colorectal cancer.	Clinical cancer research 	2012	77
23081779	Irinotecan	Kobayashi S	LGR5-positive colon cancer stem cells interconvert with drug-resistant LGR5-negative cells and are capable of tumor reconstitution.	Stem cells	2012	38
23168366	Irinotecan	Bennouna J	Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.	The Lancet. Oncology	2013	205
23725851	Irinotecan	Seymour MT	Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial.	The Lancet. Oncology	2013	74
23881988	Irinotecan	Hurwitz HI	Efficacy and safety of bevacizumab in metastatic colorectal cancer: pooled analysis from seven randomized controlled trials.	The oncologist	2013	31
24119443	Irinotecan	Kjersem JB	Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first-line oxaliplatin-based treatment.	Molecular oncology	2014	33
24138831	Irinotecan	Loupakis F	FOLFOXIRI plus bevacizumab as first-line treatment in BRAF mutant metastatic colorectal cancer.	European journal of cancer	2014	22
24585723	Irinotecan	Goldstein J	Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H).	Annals of oncology 	2014	32
24717919	Irinotecan	Primrose J	Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial.	The Lancet. Oncology	2014	46
24934408	Irinotecan	Al-Ahmadie H	Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy.	Cancer discovery	2014	32
25589621	Irinotecan	Yaeger R	Pilot trial of combined BRAF and EGFR inhibition in BRAF-mutant metastatic colorectal cancer patients.	Clinical cancer research 	2015	47
26541320	Irinotecan	Goldstein DA	Metastatic Colorectal Cancer: A Systematic Review of the Value of Current Therapies.	Clinical colorectal cancer	2016	11
26989027	Irinotecan	Hsu HC	Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patients.	Oncotarget	2016	19
10344734	Decitabine	Toyota M	Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification.	Cancer research	1999	104
10811911	Decitabine	Ferguson AT	High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer.	Proceedings of the National Academy of Sciences of the United States of America	2000	111
11196646	Decitabine	Soengas MS	Inactivation of the apoptosis effector Apaf-1 in malignant melanoma.	Nature	2001	164
12006535	Decitabine	Soria JC	Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.	Clinical cancer research 	2002	90
12839967	Decitabine	Sato N	Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays.	Cancer research	2003	99
16007195	Decitabine	Niwa Y	Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma.	Oncogene	2005	93
16247458	Decitabine	Ying J	Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation.	Oncogene	2006	69
16449975	Decitabine	Veeck J	Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis.	Oncogene	2006	81
16763620	Decitabine	Mann J	Regulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: implications for wound healing and fibrogenesis.	Cell death and differentiation	2007	64
17079474	Decitabine	Wehbe H	Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression.	Cancer research	2006	60
17145863	Decitabine	Muthusamy V	Epigenetic silencing of novel tumor suppressors in malignant melanoma.	Cancer research	2006	64
17241887	Decitabine	Isomoto H	Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing.	Gastroenterology	2007	66
17875710	Decitabine	Iorio MV	MicroRNA signatures in human ovarian cancer.	Cancer research	2007	470
17948228	Decitabine	Lehmann U	Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer.	The Journal of pathology	2008	136
18286529	Decitabine	Feng W	Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.	Cancer	2008	64
18430739	Decitabine	Fujii S	Enhancer of zeste homologue 2 (EZH2) down-regulates RUNX3 by increasing histone H3 methylation.	The Journal of biological chemistry	2008	67
19109157	Decitabine	Lal G	Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation.	Journal of immunology	2009	145
19407485	Decitabine	Lee KH	Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer.	Pancreatology 	2009	65
19503096	Decitabine	Saito Y	Chromatin remodeling at Alu repeats by epigenetic treatment activates silenced microRNA-512-5p with downregulation of Mcl-1 in human gastric cancer cells.	Oncogene	2009	54
20126405	Decitabine	Hollenbach PW	A comparison of azacitidine and decitabine activities in acute myeloid leukemia cell lines.	PloS one	2010	75
21349819	Decitabine	Suh SO	MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer.	Carcinogenesis	2011	64
21368160	Decitabine	Sproul D	Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer.	Proceedings of the National Academy of Sciences of the United States of America	2011	57
21703189	Decitabine	Alpini G	Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer.	Journal of hepatology	2011	41
21747116	Decitabine	Stefanska B	Definition of the landscape of promoter DNA hypomethylation in liver cancer.	Cancer research	2011	57
21960261	Decitabine	Tsai KW	Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer.	International journal of cancer	2011	59
22002305	Decitabine	Ramachandran I	Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.	Oncogene	2012	35
22237753	Decitabine	Sun CY	Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation.	Kidney international	2012	35
22821729	Decitabine	Wang F	SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer.	The Journal of pathology	2013	38
23079745	Decitabine	Kim JK	Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b.	Hepatology	2013	68
23297133	Decitabine	Klco JM	Genomic impact of transient low-dose decitabine treatment on primary AML cells.	Blood	2013	51
23318422	Decitabine	Xiang Y	MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine.	Oncogene	2014	49
23408834	Decitabine	Heuck CJ	Myeloma is characterized by stage-specific alterations in DNA methylation that occur early during myelomagenesis.	Journal of immunology	2013	25
24030154	Decitabine	Steinhart L	Smac mimetic and demethylating agents synergistically trigger cell death in acute myeloid leukemia cells and overcome apoptosis resistance by inducing necroptosis.	Cell death & disease	2013	25
24045501	Decitabine	Traina F	Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms.	Leukemia	2014	58
24077826	Decitabine	Turcan S	Efficient induction of differentiation and growth inhibition in IDH1 mutant glioma cells by the DNMT Inhibitor Decitabine.	Oncotarget	2013	49
24283360	Decitabine	Naito Y	MicroRNA-143 regulates collagen type III expression in stromal fibroblasts of scirrhous type gastric cancer.	Cancer science	2014	20
24301681	Decitabine	Watson CJ	Hypoxia-induced epigenetic modifications are associated with cardiac tissue fibrosis and the development of a myofibroblast-like phenotype.	Human molecular genetics	2014	40
24481854	Decitabine	Li Z	DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer.	Gastric cancer 	2015	59
24484870	Decitabine	Ufkin ML	miR-125a regulates cell cycle, proliferation, and apoptosis by targeting the ErbB pathway in acute myeloid leukemia.	Leukemia research	2014	22
24535937	Decitabine	Odunsi K	Epigenetic potentiation of NY-ESO-1 vaccine therapy in human ovarian cancer.	Cancer immunology research	2014	31
24622842	Decitabine	Roy DM	Driver mutations of cancer epigenomes.	Protein & cell	2014	28
25210796	Decitabine	Yan F	Restoration of miR-101 suppresses lung tumorigenesis through inhibition of DNMT3a-dependent DNA methylation.	Cell death & disease	2014	23
25822018	Decitabine	Meldi K	Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemia.	The Journal of clinical investigation	2015	25
26859457	Decitabine	Grandin M	Structural Decoding of the Netrin-1/UNC5 Interaction and its Therapeutical Implications in Cancers.	Cancer cell	2016	13
26934121	Decitabine	Dong P	Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression.	Oncotarget	2016	11
27623509	Decitabine	Lucarini V	Combining Type I Interferons and 5-Aza-2'-Deoxycitidine to Improve Anti-Tumor Response against Melanoma.	The Journal of investigative dermatology	2017	7
16024630	Bortezomib	Qin JZ	Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells.	Cancer research	2005	90
16166592	Bortezomib	Pérez-Galán P	The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status.	Blood	2006	134
16357160	Bortezomib	Nawrocki ST	Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells.	Cancer research	2005	84
16397231	Bortezomib	Roccaro AM	Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells.	Cancer research	2006	62
16507771	Bortezomib	Obeng EA	Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells.	Blood	2006	284
17164350	Bortezomib	Bhardwaj A	Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells.	Blood	2007	93
17227835	Bortezomib	Pérez-Galán P	The BH3-mimetic GX15-070 synergizes with bortezomib in mantle cell lymphoma by enhancing Noxa-mediated activation of Bak.	Blood	2007	69
17371942	Bortezomib	Giuliani N	The proteasome inhibitor bortezomib affects osteoblast differentiation in vitro and in vivo in multiple myeloma patients.	Blood	2007	58
17525289	Bortezomib	Davenport EL	Heat shock protein inhibition is associated with activation of the unfolded protein response pathway in myeloma plasma cells.	Blood	2007	80
17545623	Bortezomib	Gomez-Bougie P	Noxa up-regulation and Mcl-1 cleavage are associated to apoptosis induction by bortezomib in multiple myeloma.	Cancer research	2007	81
17906076	Bortezomib	Tai YT	Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu.	Blood	2008	99
18006697	Bortezomib	Chauhan D	Combination of proteasome inhibitors bortezomib and NPI-0052 trigger in vivo synergistic cytotoxicity in multiple myeloma.	Blood	2008	63
18042711	Bortezomib	Nikiforov MA	Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition.	Proceedings of the National Academy of Sciences of the United States of America	2007	74
18057228	Bortezomib	Piva R	CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib.	Blood	2008	53
18818117	Bortezomib	McConkey DJ	Mechanisms of proteasome inhibitor action and resistance in cancer.	Drug resistance updates 	2008	83
19050304	Bortezomib	Kuhn DJ	Targeted inhibition of the immunoproteasome is a potent strategy against models of multiple myeloma that overcomes resistance to conventional drugs and nonspecific proteasome inhibitors.	Blood	2009	56
19308771	Bortezomib	Berg M	Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells.	Cytotherapy	2009	75
19380866	Bortezomib	Dunleavy K	Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma.	Blood	2009	111
20022965	Bortezomib	Armstrong JL	Regulation of endoplasmic reticulum stress-induced cell death by ATF4 in neuroectodermal tumor cells.	The Journal of biological chemistry	2010	50
20233973	Bortezomib	Dasmahapatra G	The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo.	Blood	2010	48
20388793	Bortezomib	Grisendi G	Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy.	Cancer research	2010	53
20555361	Bortezomib	Ri M	Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress.	Leukemia	2010	55
20729919	Bortezomib	Chen KF	CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells.	Oncogene	2010	49
21626033	Bortezomib	Sayers TJ	Targeting the extrinsic apoptosis signaling pathway for cancer therapy.	Cancer immunology, immunotherapy 	2011	40
21900099	Bortezomib	Bladé J	Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach.	Journal of clinical oncology 	2011	44
22057347	Bortezomib	D'Arcy P	Inhibition of proteasome deubiquitinating activity as a new cancer therapy.	Nature medicine	2011	108
22538852	Bortezomib	Mimura N	Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma.	Blood	2012	94
22685174	Bortezomib	Fang J	Cytotoxic effects of bortezomib in myelodysplastic syndrome/acute myeloid leukemia depend on autophagy-mediated lysosomal degradation of TRAF6 and repression of PSMA1.	Blood	2012	38
23151137	Bortezomib	Zhao Y	Cullin-RING Ligases as attractive anti-cancer targets.	Current pharmaceutical design	2013	50
23588715	Bortezomib	Tai YT	CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications.	Leukemia	2014	69
23916134	Bortezomib	Brüning A	Nelfinavir and bortezomib inhibit mTOR activity via ATF4-mediated sestrin-2 regulation.	Molecular oncology	2013	28
24029229	Bortezomib	Leung-Hagesteijn C	Xbp1s-negative tumor B cells and pre-plasmablasts mediate therapeutic proteasome inhibitor resistance in multiple myeloma.	Cancer cell	2013	82
24055414	Bortezomib	Dimopoulos M	Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study.	The Lancet. Oncology	2013	49
24091729	Bortezomib	Amodio N	miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells.	Cell cycle	2013	31
24171104	Bortezomib	Wiita AP	Global cellular response to chemotherapy-induced apoptosis.	eLife	2013	27
24928860	Bortezomib	Wang J	Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells.	Blood	2014	48
25670156	Bortezomib	Niewerth D	Molecular basis of resistance to proteasome inhibitors in hematological malignancies.	Drug resistance updates 	2015	25
25889583	Bortezomib	Verbrugge SE	Proteasome inhibitors as experimental therapeutics of autoimmune diseases.	Arthritis research & therapy	2015	17
26258847	Bortezomib	Ungewickell A	Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2.	Nature genetics	2015	33
27016342	Bortezomib	Ramani VC	Chemotherapy induces expression and release of heparanase leading to changes associated with an aggressive tumor phenotype.	Matrix biology 	2016	12
27857131	Bortezomib	Qin Y	Epigenetic silencing of miR-137 induces drug resistance and chromosomal instability by targeting AURKA in multiple myeloma.	Leukemia	2017	6
27926488	Bortezomib	Zeng D	Blocking EZH2 methylation transferase activity by GSK126 decreases stem cell-like myeloma cells.	Oncotarget	2017	6
28186131	Bortezomib	Viziteu E	RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma.	Leukemia	2017	5
7732003	Cholesterol	Stemme S	T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein.	Proceedings of the National Academy of Sciences of the United States of America	1995	147
8035924	Cholesterol	Breteler MM	Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study.	Neurology	1994	143
9218423	Cholesterol	Sullivan PM	Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis.	The Journal of biological chemistry	1997	145
9761744	Cholesterol	Ilangumaran S	Effects of cholesterol depletion by cyclodextrin on the sphingolipid microdomains of the plasma membrane.	The Biochemical journal	1998	122
10079097	Cholesterol	Gosling J	MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B.	The Journal of clinical investigation	1999	117
10430941	Cholesterol	Trigatti B	Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology.	Proceedings of the National Academy of Sciences of the United States of America	1999	114
10559883	Cholesterol	Kobayashi T	Late endosomal membranes rich in lysobisphosphatidic acid regulate cholesterol transport.	Nature cell biology	1999	162
11149950	Cholesterol	Laffitte BA	LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes.	Proceedings of the National Academy of Sciences of the United States of America	2001	139
11238037	Cholesterol	Sugiyama S	Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes.	The American journal of pathology	2001	102
11440984	Cholesterol	Vasa M	Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease.	Circulation research	2001	431
11683410	Cholesterol	Bell SE	Differential gene expression during capillary morphogenesis in 3D collagen matrices: regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling.	Journal of cell science	2001	111
11705484	Cholesterol	Tounian P	Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study.	Lancet	2001	107
11790787	Cholesterol	Joseph SB	Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors.	The Journal of biological chemistry	2002	141
12297848	Cholesterol	Forns X	Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model.	Hepatology	2002	175
12527752	Cholesterol	Prior IA	Direct visualization of Ras proteins in spatially distinct cell surface microdomains.	The Journal of cell biology	2003	224
12658281	Cholesterol	Puglielli L	Alzheimer's disease: the cholesterol connection.	Nature neuroscience	2003	163
15023877	Cholesterol	Hsue PY	Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection.	Circulation	2004	155
15071184	Cholesterol	Sleat DE	Genetic evidence for nonredundant functional cooperativity between NPC1 and NPC2 in lipid transport.	Proceedings of the National Academy of Sciences of the United States of America	2004	93
15142859	Cholesterol	Burke AP	Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study.	Arteriosclerosis, thrombosis, and vascular biology	2004	94
15314690	Cholesterol	Zheng L	Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.	The Journal of clinical investigation	2004	172
15699278	Cholesterol	Desvarieux M	Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST).	Circulation	2005	116
15998837	Cholesterol	Nishimoto N	Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease.	Blood	2005	128
16000557	Cholesterol	Titus MA	Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer.	Clinical cancer research 	2005	146
16079201	Cholesterol	Malek G	Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration.	Proceedings of the National Academy of Sciences of the United States of America	2005	82
16631505	Cholesterol	Virmani R	Pathology of the vulnerable plaque.	Journal of the American College of Cardiology	2006	329
16707575	Cholesterol	Corcoran RB	Oxysterols stimulate Sonic hedgehog signal transduction and proliferation of medulloblastoma cells.	Proceedings of the National Academy of Sciences of the United States of America	2006	84
17495599	Cholesterol	Lara-Castro C	Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease.	Current opinion in lipidology	2007	63
17522380	Cholesterol	Lutgens SP	Cathepsin cysteine proteases in cardiovascular disease.	FASEB journal 	2007	71
17940007	Cholesterol	DiFiglia M	Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits.	Proceedings of the National Academy of Sciences of the United States of America	2007	129
18160725	Cholesterol	Packard RR	Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction.	Clinical chemistry	2008	191
18193043	Cholesterol	Willer CJ	Newly identified loci that influence lipid concentrations and risk of coronary artery disease.	Nature genetics	2008	608
18223541	Cholesterol	Williams KJ	Rapid regression of atherosclerosis: insights from the clinical and experimental literature.	Nature clinical practice. Cardiovascular medicine	2008	70
18321997	Cholesterol	Waldo SW	Heterogeneity of human macrophages in culture and in atherosclerotic plaques.	The American journal of pathology	2008	71
18440684	Cholesterol	Foster MC	Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study.	American journal of kidney diseases 	2008	62
18480203	Cholesterol	Zethelius B	Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.	The New England journal of medicine	2008	186
18617650	Cholesterol	Murphy AJ	High-density lipoprotein reduces the human monocyte inflammatory response.	Arteriosclerosis, thrombosis, and vascular biology	2008	90
18782619	Cholesterol	Hong C	Coordination of inflammation and metabolism by PPAR and LXR nuclear receptors.	Current opinion in genetics & development	2008	66
18797930	Cholesterol	Sima AV	Vascular endothelium in atherosclerosis.	Cell and tissue research	2009	49
19074428	Cholesterol	Vetrivel KS	Alzheimer disease Abeta production in the absence of S-palmitoylation-dependent targeting of BACE1 to lipid rafts.	The Journal of biological chemistry	2009	48
19221221	Cholesterol	McGillicuddy FC	Inflammation impairs reverse cholesterol transport in vivo.	Circulation	2009	118
19360495	Cholesterol	Esquirol Y	Shift work and metabolic syndrome: respective impacts of job strain, physical activity, and dietary rhythms.	Chronobiology international	2009	58
19651157	Cholesterol	Nuutinen T	Clusterin: a forgotten player in Alzheimer's disease.	Brain research reviews	2009	86
19698799	Cholesterol	Curcio CA	Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins.	Progress in retinal and eye research	2009	89
19797256	Cholesterol	Curcio CA	Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration.	Journal of lipid research	2010	57
19887621	Cholesterol	Yamaguchi H	Lipid rafts and caveolin-1 are required for invadopodia formation and extracellular matrix degradation by human breast cancer cells.	Cancer research	2009	49
19952353	Cholesterol	Crowe SM	The macrophage: the intersection between HIV infection and atherosclerosis.	Journal of leukocyte biology	2010	46
20035627	Cholesterol	Salminen A	ER stress in Alzheimer's disease: a novel neuronal trigger for inflammation and Alzheimer's pathology.	Journal of neuroinflammation	2009	75
20300641	Cholesterol	Rajab A	Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations.	PLoS genetics	2010	61
20335529	Cholesterol	Gleissner CA	CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages.	Journal of immunology	2010	50
20847045	Cholesterol	Lewis TL	Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease.	The Journal of biological chemistry	2010	46
20854368	Cholesterol	Zlokovic BV	Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid β-peptide elimination from the brain.	Journal of neurochemistry	2010	67
21343302	Cholesterol	Zhu H	Polymerase transcriptase release factor (PTRF) anchors MG53 protein to cell injury site for initiation of membrane repair.	The Journal of biological chemistry	2011	38
21386088	Cholesterol	Jones TH	Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study).	Diabetes care	2011	76
21392724	Cholesterol	Otvos JD	Clinical implications of discordance between low-density lipoprotein cholesterol and particle number.	Journal of clinical lipidology	2011	51
21399642	Cholesterol	Huang R	Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma.	Nature structural & molecular biology	2011	62
21414625	Cholesterol	Recio-Mayoral A	Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease--a cross-sectional study of predialysis, dialysis and kidney-transplantation patients.	Atherosclerosis	2011	39
21480318	Cholesterol	Bitetto D	Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C.	Hepatology	2011	41
21482781	Cholesterol	Feig JE	HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells.	Proceedings of the National Academy of Sciences of the United States of America	2011	94
21527913	Cholesterol	Verweij FJ	LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF-κB activation.	The EMBO journal	2011	53
21601592	Cholesterol	McLaren JE	Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy.	Progress in lipid research	2011	53
21690377	Cholesterol	Ding JD	Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration.	Proceedings of the National Academy of Sciences of the United States of America	2011	64
21818333	Cholesterol	Shiels PG	Accelerated telomere attrition is associated with relative household income, diet and inflammation in the pSoBid cohort.	PloS one	2011	39
21866103	Cholesterol	Carette JE	Ebola virus entry requires the cholesterol transporter Niemann-Pick C1.	Nature	2011	321
21900234	Cholesterol	Bate C	Amyloid-β-induced synapse damage is mediated via cross-linkage of cellular prion proteins.	The Journal of biological chemistry	2011	40
22009537	Cholesterol	Park JK	miR-221 silencing blocks hepatocellular carcinoma and promotes survival.	Cancer research	2011	59
22356914	Cholesterol	Oh J	Endoplasmic reticulum stress controls M2 macrophage differentiation and foam cell formation.	The Journal of biological chemistry	2012	63
22437840	Cholesterol	Ordonez MP	Disruption and therapeutic rescue of autophagy in a human neuronal model of Niemann Pick type C1.	Human molecular genetics	2012	31
22467316	Cholesterol	Lacolley P	The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles.	Cardiovascular research	2012	104
22508243	Cholesterol	Savard C	Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis.	Hepatology	2013	56
22587332	Cholesterol	Gao W	Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease.	Lipids in health and disease	2012	47
22820288	Cholesterol	Hsu SH	Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver.	The Journal of clinical investigation	2012	184
22835784	Cholesterol	van Echten-Deckert G	Sphingolipids: critical players in Alzheimer's disease.	Progress in lipid research	2012	36
22872701	Cholesterol	Elrick MJ	Impaired proteolysis underlies autophagic dysfunction in Niemann-Pick type C disease.	Human molecular genetics	2012	33
23035117	Cholesterol	Xu M	δ-Tocopherol reduces lipid accumulation in Niemann-Pick type C1 and Wolman cholesterol storage disorders.	The Journal of biological chemistry	2012	37
23312047	Cholesterol	Superko HR	High-density lipoprotein subclasses and their relationship to cardiovascular disease.	Journal of clinical lipidology	2012	30
23332012	Cholesterol	Longenecker CT	Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals.	HIV medicine	2013	56
23485521	Cholesterol	Bernstein DL	Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease.	Journal of hepatology	2013	47
23585901	Cholesterol	Suzuki T	A randomized controlled trial of multicomponent exercise in older adults with mild cognitive impairment.	PloS one	2013	29
23663738	Cholesterol	Nagareddy PR	Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis.	Cell metabolism	2013	71
23885072	Cholesterol	Paul D	Morphological and biochemical characterization of the membranous hepatitis C virus replication compartment.	Journal of virology	2013	70
23918283	Cholesterol	Appelqvist H	The lysosome: from waste bag to potential therapeutic target.	Journal of molecular cell biology	2013	115
23966867	Cholesterol	Liu CT	Genome-wide association of body fat distribution in African ancestry populations suggests new loci.	PLoS genetics	2013	38
23995233	Cholesterol	Freigang S	Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1α and sterile vascular inflammation in atherosclerosis.	Nature immunology	2013	56
24060386	Cholesterol	Danilo C	Scavenger receptor class B type I regulates cellular cholesterol metabolism and cell signaling associated with breast cancer development.	Breast cancer research 	2013	26
24077434	Cholesterol	Shinto L	A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease.	Journal of Alzheimer's disease 	2014	20
24366527	Cholesterol	McKee AC	The neuropathology of sport.	Acta neuropathologica	2014	56
24504735	Cholesterol	Du F	MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice.	Arteriosclerosis, thrombosis, and vascular biology	2014	31
24507774	Cholesterol	Peloso GM	Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks.	American journal of human genetics	2014	80
24507775	Cholesterol	Lange LA	Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol.	American journal of human genetics	2014	67
24602293	Cholesterol	Gacci M	Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis.	BJU international	2015	23
24606897	Cholesterol	Yue S	Cholesteryl ester accumulation induced by PTEN loss and PI3K/AKT activation underlies human prostate cancer aggressiveness.	Cell metabolism	2014	91
24608080	Cholesterol	Zhang M	MicroRNA-27a/b regulates cellular cholesterol efflux, influx and esterification/hydrolysis in THP-1 macrophages.	Atherosclerosis	2014	29
24664998	Cholesterol	Vance JE	Niemann-Pick C disease and mobilization of lysosomal cholesterol by cyclodextrin.	Journal of lipid research	2014	24
24907980	Cholesterol	Vitali C	HDL and cholesterol handling in the brain.	Cardiovascular research	2014	27
24925270	Cholesterol	Casas R	The effects of the mediterranean diet on biomarkers of vascular wall inflammation and plaque vulnerability in subjects with high risk for cardiovascular disease. A randomized trial.	PloS one	2014	29
25101658	Cholesterol	Strong A	Sortilin and lipoprotein metabolism: making sense out of complexity.	Current opinion in lipidology	2014	20
25341796	Cholesterol	Roche-Molina M	Induction of sustained hypercholesterolemia by single adeno-associated virus-mediated gene transfer of mutant hPCSK9.	Arteriosclerosis, thrombosis, and vascular biology	2015	22
25414253	Cholesterol	Foks AC	Treating atherosclerosis with regulatory T cells.	Arteriosclerosis, thrombosis, and vascular biology	2015	28
25487149	Cholesterol	Do R	Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction.	Nature	2015	114
25980762	Cholesterol	Dongiovanni P	Statin use and non-alcoholic steatohepatitis in at risk individuals.	Journal of hepatology	2015	25
25991857	Cholesterol	Toomey CB	Regulation of age-related macular degeneration-like pathology by complement factor H.	Proceedings of the National Academy of Sciences of the United States of America	2015	19
26131930	Cholesterol	Joshi PK	Directional dominance on stature and cognition in diverse human populations.	Nature	2015	29
26200341	Cholesterol	Zhao L	Lanosterol reverses protein aggregation in cataracts.	Nature	2015	29
26333678	Cholesterol	Giunzioni I	Local effects of human PCSK9 on the atherosclerotic lesion.	The Journal of pathology	2016	14
26493158	Cholesterol	Chistiakov DA	Macrophage-mediated cholesterol handling in atherosclerosis.	Journal of cellular and molecular medicine	2016	15
26564908	Cholesterol	Tambini MD	ApoE4 upregulates the activity of mitochondria-associated ER membranes.	EMBO reports	2016	18
26607793	Cholesterol	Wang C	CD5L/AIM Regulates Lipid Biosynthesis and Restrains Th17 Cell Pathogenicity.	Cell	2015	33
26662987	Cholesterol	Novák J	Mechanistic Role of MicroRNAs in Coupling Lipid Metabolism and Atherosclerosis.	Advances in experimental medicine and biology	2015	22
26892965	Cholesterol	Ketelhuth DF	Adaptive Response of T and B Cells in Atherosclerosis.	Circulation research	2016	15
26982734	Cholesterol	Yang W	Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism.	Nature	2016	40
27077736	Cholesterol	Salvoza NC	Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease.	PloS one	2016	12
27277824	Cholesterol	Mahley RW	Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders.	Journal of molecular medicine	2016	24
27328938	Cholesterol	Muralidharan R	Folate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migration.	Journal of nanobiotechnology	2016	12
27540175	Cholesterol	Franzén O	Cardiometabolic risk loci share downstream cis- and trans-gene regulation across tissues and diseases.	Science	2016	25
27640307	Cholesterol	Harel T	Recurrent De Novo and Biallelic Variation of ATAD3A, Encoding a Mitochondrial Membrane Protein, Results in Distinct Neurological Syndromes.	American journal of human genetics	2016	14
27841877	Cholesterol	Lotta LA	Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance.	Nature genetics	2017	27
27889186	Cholesterol	Kettner NM	Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis.	Cancer cell	2016	21
28212521	Cholesterol	Camaré C	Angiogenesis in the atherosclerotic plaque.	Redox biology	2017	5
28334899	Cholesterol	Spracklen CN	Association analyses of East Asian individuals and trans-ancestry analyses with European individuals reveal new loci associated with cholesterol and triglyceride levels.	Human molecular genetics	2017	7
28596373	Cholesterol	Wang Y	Mitochondrial Oxidative Stress Promotes Atherosclerosis and Neutrophil Extracellular Traps in Aged Mice.	Arteriosclerosis, thrombosis, and vascular biology	2017	6
15126355	Doxycycline	Stephen RL	Activation of peroxisome proliferator-activated receptor delta stimulates the proliferation of human breast and prostate cancer cell lines.	Cancer research	2004	71
15668323	Doxycycline	Lappalainen U	Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung.	American journal of respiratory cell and molecular biology	2005	99
16322224	Doxycycline	Baumann P	CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis.	Cancer research	2005	87
16572121	Doxycycline	Ngo VN	A loss-of-function RNA interference screen for molecular targets in cancer.	Nature	2006	211
17678629	Doxycycline	Raffetto JD	Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.	Biochemical pharmacology	2008	164
18806273	Doxycycline	Pello R	Mitochondrial DNA background modulates the assembly kinetics of OXPHOS complexes in a cellular model of mitochondrial disease.	Human molecular genetics	2008	50
19177017	Doxycycline	Wiederschain D	Single-vector inducible lentiviral RNAi system for oncology target validation.	Cell cycle	2009	124
21518986	Doxycycline	Vergadi E	Early macrophage recruitment and alternative activation are critical for the later development of hypoxia-induced pulmonary hypertension.	Circulation	2011	50
21804090	Doxycycline	Zhu L	Activation of RhoA in podocytes induces focal segmental glomerulosclerosis.	Journal of the American Society of Nephrology 	2011	40
22105174	Doxycycline	Chakravarty D	Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation.	The Journal of clinical investigation	2011	67
22158040	Doxycycline	Hsu TI	Sp1 expression regulates lung tumor progression.	Oncogene	2012	37
22615765	Doxycycline	Chen S	SOX2 gene regulates the transcriptional network of oncogenes and affects tumorigenesis of human lung cancer cells.	PloS one	2012	49
23218253	Doxycycline	Fitting S	Synaptic dysfunction in the hippocampus accompanies learning and memory deficits in human immunodeficiency virus type-1 Tat transgenic mice.	Biological psychiatry	2013	54
24889938	Doxycycline	Sun Y	Estrogen promotes stemness and invasiveness of ER-positive breast cancer cells through Gli1 activation.	Molecular cancer	2014	35
25600873	Doxycycline	de Vries NA	Prolonged Ezh2 Depletion in Glioblastoma Causes a Robust Switch in Cell Fate Resulting in Tumor Progression.	Cell reports	2015	19
25965570	Doxycycline	Shirai CL	Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo.	Cancer cell	2015	34
25996154	Doxycycline	Ong CW	Neutrophil-Derived MMP-8 Drives AMPK-Dependent Matrix Destruction in Human Pulmonary Tuberculosis.	PLoS pathogens	2015	28
26087310	Doxycycline	De Luca A	Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells.	Oncotarget	2015	37
26091037	Doxycycline	Dow LE	Apc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer.	Cell	2015	80
26197969	Doxycycline	Walker AK	Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43.	Acta neuropathologica	2015	24
26517688	Doxycycline	Zhuang C	Tetracycline-inducible shRNA targeting long non-coding RNA PVT1 inhibits cell growth and induces apoptosis in bladder cancer cells.	Oncotarget	2015	28
27015551	Doxycycline	Li J	shRNA targeting long non-coding RNA CCAT2 controlled by tetracycline-inducible system inhibits progression of bladder cancer cells.	Oncotarget	2016	11
28039467	Doxycycline	Bonuccelli G	Targeting cancer stem cell propagation with palbociclib, a CDK4/6 inhibitor: Telomerase drives tumor cell heterogeneity.	Oncotarget	2017	11
12941837	Gemcitabine	Maloney EK	An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation.	Cancer research	2003	81
15897578	Gemcitabine	Berberat PO	Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment.	Clinical cancer research 	2005	67
16258101	Gemcitabine	Kindler HL	Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer.	Journal of clinical oncology 	2005	107
16622265	Gemcitabine	Zhu AX	Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma.	Journal of clinical oncology 	2006	75
16762633	Gemcitabine	Meng F	Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines.	Gastroenterology	2006	296
17131328	Gemcitabine	Nakahira S	Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancer.	International journal of cancer	2007	59
17332349	Gemcitabine	Feldmann G	Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers.	Cancer research	2007	242
17404099	Gemcitabine	Nomi T	Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer.	Clinical cancer research 	2007	211
18245495	Gemcitabine	Hwang RF	Cancer-associated stromal fibroblasts promote pancreatic tumor progression.	Cancer research	2008	289
18316569	Gemcitabine	Laheru D	Allogeneic granulocyte macrophage colony-stimulating factor-secreting tumor immunotherapy alone or in sequence with cyclophosphamide for metastatic pancreatic cancer: a pilot study of safety, feasibility, and immune activation.	Clinical cancer research 	2008	106
18413796	Gemcitabine	Melisi D	LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis.	Molecular cancer therapeutics	2008	93
18829536	Gemcitabine	Ramachandran V	Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival.	Cancer research	2008	51
19174553	Gemcitabine	Jimeno A	A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development.	Molecular cancer therapeutics	2009	104
19366899	Gemcitabine	Beltran PJ	AMG 479, a fully human anti-insulin-like growth factor receptor type I monoclonal antibody, inhibits the growth and survival of pancreatic carcinoma cells.	Molecular cancer therapeutics	2009	52
19435867	Gemcitabine	Moriyama T	MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance.	Molecular cancer therapeutics	2009	118
19549912	Gemcitabine	Banerjee S	Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer.	Cancer research	2009	48
19654003	Gemcitabine	Crawford M	MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer.	Biochemical and biophysical research communications	2009	60
19654291	Gemcitabine	Li Y	Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells.	Cancer research	2009	252
19730150	Gemcitabine	Park JK	Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma.	Pancreas	2009	87
20501833	Gemcitabine	Morgan MA	Mechanism of radiosensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair.	Cancer research	2010	100
20606093	Gemcitabine	Philip PA	Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205.	Journal of clinical oncology 	2010	167
21078544	Gemcitabine	Arlt A	Targeting apoptosis pathways in pancreatic cancer.	Cancer letters	2013	27
21081113	Gemcitabine	Kikuta K	Pancreatic stellate cells promote epithelial-mesenchymal transition in pancreatic cancer cells.	Biochemical and biophysical research communications	2010	54
21106054	Gemcitabine	Zhang XJ	Dysregulation of miR-15a and miR-214 in human pancreatic cancer.	Journal of hematology & oncology	2010	57
21135251	Gemcitabine	Villarroel MC	Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer.	Molecular cancer therapeutics	2011	71
21148071	Gemcitabine	Dangi-Garimella S	Three-dimensional collagen I promotes gemcitabine resistance in pancreatic cancer through MT1-MMP-mediated expression of HMGA2.	Cancer research	2011	37
21177151	Gemcitabine	Bensouda Y	Treatment for metastatic nasopharyngeal carcinoma.	European annals of otorhinolaryngology, head and neck diseases	2011	46
21306953	Gemcitabine	Kindler HL	Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study.	The Lancet. Oncology	2011	101
21389100	Gemcitabine	Rajeshkumar NV	MK-1775, a potent Wee1 inhibitor, synergizes with gemcitabine to achieve tumor regressions, selectively in p53-deficient pancreatic cancer xenografts.	Clinical cancer research 	2011	71
21408027	Gemcitabine	Bao B	Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer.	PloS one	2011	73
21436454	Gemcitabine	Beatty GL	CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans.	Science	2011	405
21594619	Gemcitabine	Bodoky G	A phase II open-label randomized study to assess the efficacy and safety of selumetinib (AZD6244 ARRY-142886) versus capecitabine in patients with advanced or metastatic pancreatic cancer who have failed first-line gemcitabine therapy.	Investigational new drugs	2012	51
21709185	Gemcitabine	Crane CH	Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression.	Journal of clinical oncology 	2011	68
21903606	Gemcitabine	Stokes JB	Inhibition of focal adhesion kinase by PF-562,271 inhibits the growth and metastasis of pancreatic cancer concomitant with altering the tumor microenvironment.	Molecular cancer therapeutics	2011	57
22056140	Gemcitabine	Lonardo E	Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy.	Cell stem cell	2011	102
22072567	Gemcitabine	Wei D	Radiosensitization of human pancreatic cancer cells by MLN4924, an investigational NEDD8-activating enzyme inhibitor.	Cancer research	2012	52
22086681	Gemcitabine	Bao B	Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells.	Cancer prevention research	2012	101
22363658	Gemcitabine	Zhang G	DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma.	PloS one	2012	39
22510406	Gemcitabine	Hamada S	Pancreatic stellate cells enhance stem cell-like phenotypes in pancreatic cancer cells.	Biochemical and biophysical research communications	2012	46
22705007	Gemcitabine	Maréchal R	Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinoma.	Gastroenterology	2012	60
22811078	Gemcitabine	Wang L	First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE/IIE extranodal natural killer/T-cell lymphoma.	Cancer	2013	36
22825331	Gemcitabine	Prevo R	The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy.	Cancer biology & therapy	2012	57
23177026	Gemcitabine	Wang P	The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasL.	Molecular oncology	2013	38
23402593	Gemcitabine	Lee GY	Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer.	ACS nano	2013	47
23437065	Gemcitabine	Proctor E	Bmi1 enhances tumorigenicity and cancer stem cell function in pancreatic adenocarcinoma.	PloS one	2013	32
23547081	Gemcitabine	Ueno H	Randomized phase III study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: GEST study.	Journal of clinical oncology 	2013	89
23593991	Gemcitabine	Thompson R	The cancer therapeutic potential of Chk1 inhibitors: how mechanistic studies impact on clinical trial design.	British journal of clinical pharmacology	2013	35
24216611	Gemcitabine	Hamada S	MiR-365 induces gemcitabine resistance in pancreatic cancer cells by targeting the adaptor protein SHC1 and pro-apoptotic regulator BAX.	Cellular signalling	2014	25
24351397	Gemcitabine	Valle JW	Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials.	Annals of oncology 	2014	52
24859161	Gemcitabine	Li L	Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and β-catenin signaling in pancreatic ductal adenocarcinoma cells.	Gastroenterology	2014	29
24919854	Gemcitabine	Gelbert LM	Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine.	Investigational new drugs	2014	57
25034785	Gemcitabine	Zeuner A	Elimination of quiescent/slow-proliferating cancer stem cells by Bcl-XL inhibition in non-small cell lung cancer.	Cell death and differentiation	2014	27
25056373	Gemcitabine	Koido S	Treatment with chemotherapy and dendritic cells pulsed with multiple Wilms' tumor 1 (WT1)-specific MHC class I/II-restricted epitopes for pancreatic cancer.	Clinical cancer research 	2014	26
25117811	Gemcitabine	Hasegawa S	MicroRNA-1246 expression associated with CCNG2-mediated chemoresistance and stemness in pancreatic cancer.	British journal of cancer	2014	27
25156567	Gemcitabine	Franco J	CDK4/6 inhibitors have potent activity in combination with pathway selective therapeutic agents in models of pancreatic cancer.	Oncotarget	2014	31
25277192	Gemcitabine	Khan S	MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer.	Oncotarget	2014	33
25473894	Gemcitabine	Suzuki S	JNK suppression of chemotherapeutic agents-induced ROS confers chemoresistance on pancreatic cancer stem cells.	Oncotarget	2015	18
25609246	Gemcitabine	Fuchs CS	A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: the GAMMA trial.	Annals of oncology 	2015	25
25632066	Gemcitabine	Chen JS	A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer.	Annals of oncology 	2015	21
25638153	Gemcitabine	Ma J	Down-regulation of miR-223 reverses epithelial-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells.	Oncotarget	2015	29
25717063	Gemcitabine	Cioffi M	Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms.	Clinical cancer research 	2015	20
25834145	Gemcitabine	Duluc C	Pharmacological targeting of the protein synthesis mTOR/4E-BP1 pathway in cancer-associated fibroblasts abrogates pancreatic tumour chemoresistance.	EMBO molecular medicine	2015	20
25889214	Gemcitabine	Li Z	The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer.	Journal of translational medicine	2015	45
26036346	Gemcitabine	Tréhoux S	Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by targeting the MUC1 mucin in pancreatic cancer cells.	Biochimica et biophysica acta	2015	20
26077591	Gemcitabine	Miller BW	Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy.	EMBO molecular medicine	2015	33
26156960	Gemcitabine	Di Caro G	Dual prognostic significance of tumour-associated macrophages in human pancreatic adenocarcinoma treated or untreated with chemotherapy.	Gut	2016	16
26179201	Gemcitabine	Valle JW	Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial.	The Lancet. Oncology	2015	23
26527777	Gemcitabine	Catenacci DV	Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer.	Journal of clinical oncology 	2015	30
26540314	Gemcitabine	Leone F	Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study).	Cancer	2016	11
26546043	Gemcitabine	Tyagi N	p-21 activated kinase 4 (PAK4) maintains stem cell-like phenotypes in pancreatic cancer cells through activation of STAT3 signaling.	Cancer letters	2016	13
26666820	Gemcitabine	Wu ZH	MiRNA-21 induces epithelial to mesenchymal transition and gemcitabine resistance via the PTEN/AKT pathway in breast cancer.	Tumour biology 	2016	14
26817584	Gemcitabine	Liu Y	MiR-130a-3p regulates cell migration and invasion via inhibition of Smad4 in gemcitabine resistant hepatoma cells.	Journal of experimental & clinical cancer research 	2016	11
26828016	Gemcitabine	Fan P	MicroRNA-101-3p reverses gemcitabine resistance by inhibition of ribonucleotide reductase M1 in pancreatic cancer.	Cancer letters	2016	10
27216178	Gemcitabine	Schultz MJ	The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype.	Cancer research	2016	12
27669441	Gemcitabine	Richards KE	Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells.	Oncogene	2017	28
27742686	Gemcitabine	Ireland L	Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors.	Cancer research	2016	16
28034748	Gemcitabine	Zhang Y	MiR-216a decreases MALAT1 expression, induces G2/M arrest and apoptosis in pancreatic cancer cells.	Biochemical and biophysical research communications	2017	6
28381539	Gemcitabine	Vennin C	Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis.	Science translational medicine	2017	11
10446993	Doxorubicin	Chang BD	A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents.	Cancer research	1999	119
11119611	Doxorubicin	Rivas C	Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53.	Journal of virology	2001	103
11948130	Doxorubicin	Park JW	Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.	Clinical cancer research 	2002	106
15053878	Doxorubicin	Campbell KJ	Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B.	Molecular cell	2004	113
16170171	Doxorubicin	Hershman D	Racial disparities in treatment and survival among women with early-stage breast cancer.	Journal of clinical oncology 	2005	93
17415413	Doxorubicin	Biswas S	Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression.	The Journal of clinical investigation	2007	100
17823410	Doxorubicin	Corney DC	MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.	Cancer research	2007	223
17854227	Doxorubicin	Bagalkot V	Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer.	Nano letters	2007	126
17891174	Doxorubicin	Ma S	CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway.	Oncogene	2008	209
18039953	Doxorubicin	Nefedova Y	Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy.	Blood	2008	54
18424910	Doxorubicin	Akar U	Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells.	Autophagy	2008	71
18645025	Doxorubicin	Kovalchuk O	Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin.	Molecular cancer therapeutics	2008	147
19584283	Doxorubicin	Fornari F	MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.	Cancer research	2009	117
19840887	Doxorubicin	Fleming GF	Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: a Gynecologic Oncology Group study.	Gynecologic oncology	2010	43
20098429	Doxorubicin	Li Y	Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer.	Nature medicine	2010	94
20179989	Doxorubicin	Valle JW	A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction.	Investigational new drugs	2011	35
20388796	Doxorubicin	Yoo BK	Molecular mechanism of chemoresistance by astrocyte elevated gene-1.	Cancer research	2010	46
20460510	Doxorubicin	Adhikari AS	CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance.	Cancer research	2010	80
20495188	Doxorubicin	Horie T	Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway.	Cardiovascular research	2010	47
20668064	Doxorubicin	Zhang X	Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway.	Cancer research	2010	48
21055388	Doxorubicin	Henry JC	miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines.	Biochemical and biophysical research communications	2010	48
21527554	Doxorubicin	Chen J	Sirtuin 1 is upregulated in a subset of hepatocellular carcinomas where it is essential for telomere maintenance and tumor cell growth.	Cancer research	2011	42
21642992	Doxorubicin	Hung T	Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters.	Nature genetics	2011	323
22281424	Doxorubicin	Xiao Y	Multifunctional unimolecular micelles for cancer-targeted drug delivery and positron emission tomography imaging.	Biomaterials	2012	42
22521303	Doxorubicin	Bao L	Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298.	The American journal of pathology	2012	42
22698404	Doxorubicin	Jackson JG	p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer.	Cancer cell	2012	72
22817844	Doxorubicin	Liu Z	Novel HER2 aptamer selectively delivers cytotoxic drug to HER2-positive breast cancer cells in vitro.	Journal of translational medicine	2012	30
23251413	Doxorubicin	Corcoran C	Docetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomes.	PloS one	2012	72
23277563	Doxorubicin	Hirsch HA	Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth.	Proceedings of the National Academy of Sciences of the United States of America	2013	106
23349734	Doxorubicin	Godugu C	AlgiMatrix™ based 3D cell culture system as an in-vitro tumor model for anticancer studies.	PloS one	2013	33
23435381	Doxorubicin	Johnsson P	A pseudogene long-noncoding-RNA network regulates PTEN transcription and translation in human cells.	Nature structural & molecular biology	2013	141
23526568	Doxorubicin	Qu J	MicroRNA-195 chemosensitizes colon cancer cells to the chemotherapeutic drug doxorubicin by targeting the first binding site of BCL2L2 mRNA.	Journal of cellular physiology	2015	16
23715267	Doxorubicin	Pang B	Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin.	Nature communications	2013	46
23723074	Doxorubicin	Dong Y	Tumor suppressor functions of miR-133a in colorectal cancer.	Molecular cancer research 	2013	31
23801752	Doxorubicin	Oehme I	Histone deacetylase 10 promotes autophagy-mediated cell survival.	Proceedings of the National Academy of Sciences of the United States of America	2013	35
23955273	Doxorubicin	Clozel T	Mechanism-based epigenetic chemosensitization therapy of diffuse large B-cell lymphoma.	Cancer discovery	2013	34
24136231	Doxorubicin	Fan YH	USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis.	Cell death & disease	2013	30
24211739	Doxorubicin	Xu L	MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.	Journal of hepatology	2014	35
24577057	Doxorubicin	Liu Y	Lack of correlation of stem cell markers in breast cancer stem cells.	British journal of cancer	2014	24
25079333	Doxorubicin	Tavora B	Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy.	Nature	2014	21
25292190	Doxorubicin	Xu M	miR-382 inhibits osteosarcoma metastasis and relapse by targeting Y box-binding protein 1.	Molecular therapy 	2015	18
25368020	Doxorubicin	Park EY	Targeting of miR34a-NOTCH1 axis reduced breast cancer stemness and chemoresistance.	Cancer research	2014	38
25407491	Doxorubicin	Zhang Y	miR-103/107 modulates multidrug resistance in human gastric carcinoma by downregulating Cav-1.	Tumour biology 	2015	17
25445786	Doxorubicin	Kiran S	Sirtuin 7 promotes cellular survival following genomic stress by attenuation of DNA damage, SAPK activation and p53 response.	Experimental cell research	2015	17
25504623	Doxorubicin	Jiang T	Furin-mediated sequential delivery of anticancer cytokine and small-molecule drug shuttled by graphene.	Advanced materials	2015	21
25512109	Doxorubicin	Amornsupak K	Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells.	BMC cancer	2014	26
25789975	Doxorubicin	Hall JR	Long noncoding RNA lincRNA-p21 is the major mediator of UVB-induced and p53-dependent apoptosis in keratinocytes.	Cell death & disease	2015	16
25909227	Doxorubicin	Go H	MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.	Oncotarget	2015	20
25944566	Doxorubicin	Baker EK	BET inhibitors induce apoptosis through a MYC independent mechanism and synergise with CDK inhibitors to kill osteosarcoma cells.	Scientific reports	2015	22
26028030	Doxorubicin	Niu J	Induction of miRNA-181a by genotoxic treatments promotes chemotherapeutic resistance and metastasis in breast cancer.	Oncogene	2016	19
26552700	Doxorubicin	Picaud S	Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy.	Cancer research	2015	36
26781446	Doxorubicin	Shang C	Long noncoding RNA HOTAIR is a prognostic biomarker and inhibits chemosensitivity to doxorubicin in bladder transitional cell carcinoma.	Cancer chemotherapy and pharmacology	2016	13
26809111	Doxorubicin	Lencioni R	Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial.	Journal of hepatology	2016	54
26876203	Doxorubicin	Zhang ZM	Pygo2 activates MDR1 expression and mediates chemoresistance in breast cancer via the Wnt/β-catenin pathway.	Oncogene	2016	11
27286459	Doxorubicin	Murakami T	Effective molecular targeting of CDK4/6 and IGF-1R in a rare FUS-ERG fusion CDKN2A-deletion doxorubicin-resistant Ewing's sarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse model.	Oncotarget	2016	23
27479180	Doxorubicin	Quotti Tubi L	Protein kinase CK2 regulates AKT, NF-κB and STAT3 activation, stem cell viability and proliferation in acute myeloid leukemia.	Leukemia	2017	6
28126034	Doxorubicin	Xu J	Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer.	Journal of experimental & clinical cancer research 	2017	9
14998849	Oxaliplatin	Rubbia-Brandt L	Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.	Annals of oncology 	2004	141
16857785	Oxaliplatin	Yang AD	Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines.	Clinical cancer research 	2006	139
18272912	Oxaliplatin	Tol J	A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity.	Annals of oncology 	2008	57
19196673	Oxaliplatin	Tol J	Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer.	The New England journal of medicine	2009	301
19244128	Oxaliplatin	Dallas NA	Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition.	Cancer research	2009	149
19786657	Oxaliplatin	Chibaudel B	Can chemotherapy be discontinued in unresectable metastatic colorectal cancer? The GERCOR OPTIMOX2 Study.	Journal of clinical oncology 	2009	58
20648559	Oxaliplatin	Ning Y	Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models.	International journal of cancer	2011	87
21606427	Oxaliplatin	Aschele C	Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial.	Journal of clinical oncology 	2011	133
22172905	Oxaliplatin	Della Vittoria Scarpati G	A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.	International journal of radiation oncology, biology, physics	2012	43
22391039	Oxaliplatin	Ning Y	The CXCR2 antagonist, SCH-527123, shows antitumor activity and sensitizes cells to oxaliplatin in preclinical colon cancer models.	Molecular cancer therapeutics	2012	31
22473163	Oxaliplatin	Dewdney A	Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C).	Journal of clinical oncology 	2012	61
22698403	Oxaliplatin	O'Brien CA	ID1 and ID3 regulate the self-renewal capacity of human colon cancer-initiating cells through p21.	Cancer cell	2012	62
23017669	Oxaliplatin	Foxtrot Collaborative Group	Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial.	The Lancet. Oncology	2012	42
23342249	Oxaliplatin	Fan F	Overexpression of snail induces epithelial-mesenchymal transition and a cancer stem cell-like phenotype in human colorectal cancer cells.	Cancer medicine	2012	58
23510984	Oxaliplatin	Cohn AL	A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer.	Annals of oncology 	2013	30
23574723	Oxaliplatin	Qian X	MicroRNA-143 inhibits tumor growth and angiogenesis and sensitizes chemosensitivity to oxaliplatin in colorectal cancers.	Cell cycle	2013	41
24225157	Oxaliplatin	Yamada Y	Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial.	The Lancet. Oncology	2013	37
24356622	Oxaliplatin	Peeters M	Final results from a randomized phase 3 study of FOLFIRI {+/-} panitumumab for second-line treatment of metastatic colorectal cancer.	Annals of oncology 	2014	23
25446103	Oxaliplatin	Wan LY	miR-320 enhances the sensitivity of human colon cancer cells to chemoradiotherapy in vitro by targeting FOXM1.	Biochemical and biophysical research communications	2015	16
25616665	Oxaliplatin	Zhang Y	MicroRNA-520g confers drug resistance by regulating p21 expression in colorectal cancer.	The Journal of biological chemistry	2015	22
25918287	Oxaliplatin	Dienstmann R	Personalizing colon cancer adjuvant therapy: selecting optimal treatments for individual patients.	Journal of clinical oncology 	2015	38
25924065	Oxaliplatin	Shalapour S	Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy.	Nature	2015	50
25938772	Oxaliplatin	Hu Y	Fibroblast-Derived Exosomes Contribute to Chemoresistance through Priming Cancer Stem Cells in Colorectal Cancer.	PloS one	2015	37
25943534	Oxaliplatin	Stewart R	Identification and Characterization of MEDI4736, an Antagonistic Anti-PD-L1 Monoclonal Antibody.	Cancer immunology research	2015	20
26474521	Oxaliplatin	Garcia-Aguilar J	Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.	The Lancet. Oncology	2015	20
26527776	Oxaliplatin	André T	Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study.	Journal of clinical oncology 	2015	32
26626800	Oxaliplatin	Shitara K	Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2 gastrectomy.	Gastric cancer 	2017	7
26831668	Oxaliplatin	Zhijun H	Pre-clinical characterization of 4SC-202, a novel class I HDAC inhibitor, against colorectal cancer cells.	Tumour biology 	2016	11
26872698	Oxaliplatin	Pfirschke C	Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy.	Immunity	2016	49
27856123	Oxaliplatin	Sunakawa Y	Prognostic Impact of Primary Tumor Location on Clinical Outcomes of Metastatic Colorectal Cancer Treated With Cetuximab Plus Oxaliplatin-Based Chemotherapy: A Subgroup Analysis of the JACCRO CC-05/06 Trials.	Clinical colorectal cancer	2017	5
12920149	Somatostatin	Reubi JC	Peptide receptors as molecular targets for cancer diagnosis and therapy.	Endocrine reviews	2003	137
16253899	Somatostatin	Oberg K	Endocrine tumours of the pancreas.	Best practice & research. Clinical gastroenterology	2005	76
20974464	Somatostatin	Yang Y	Increased interstitial white matter neuron density in the dorsolateral prefrontal cortex of people with schizophrenia.	Biological psychiatry	2011	36
21745723	Somatostatin	Konradi C	Hippocampal interneurons are abnormal in schizophrenia.	Schizophrenia research	2011	72
26087898	Somatostatin	Boora GK	Exome-level comparison of primary well-differentiated neuroendocrine tumors and their cell lines.	Cancer genetics	2015	18
26731483	Somatostatin	Rinke A	Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients with Metastatic Neuroendocrine Midgut Tumors (PROMID): Results of Long-Term Survival.	Neuroendocrinology	2017	25
26843617	Somatostatin	Lapa C	68GaPentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer--initial experience.	Oncotarget	2016	17
27941241	Somatostatin	Swisa A	PAX6 maintains β cell identity by repressing genes of alternative islet cell types.	The Journal of clinical investigation	2017	7
10700175	Fluorouracil	Scherf U	A gene expression database for the molecular pharmacology of cancer.	Nature genetics	2000	247
15774776	Fluorouracil	Ghadimi BM	Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy.	Journal of clinical oncology 	2005	67
16246976	Fluorouracil	Rödel C	Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.	Journal of clinical oncology 	2005	191
17906203	Fluorouracil	Collette L	Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group.	Journal of clinical oncology 	2007	71
19074875	Fluorouracil	Braun CJ	p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest.	Cancer research	2008	165
19276252	Fluorouracil	Sakamoto K	Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth.	Clinical cancer research 	2009	62
19439999	Fluorouracil	Takagi T	Decreased expression of microRNA-143 and -145 in human gastric cancers.	Oncology	2009	94
20081809	Fluorouracil	Ong CW	CD133 expression predicts for non-response to chemotherapy in colorectal cancer.	Modern pathology 	2010	44
20501503	Fluorouracil	Fariña-Sarasqueta A	The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients.	Annals of oncology 	2010	77
20585341	Fluorouracil	Boni V	Role of primary miRNA polymorphic variants in metastatic colon cancer patients treated with 5-fluorouracil and irinotecan.	The pharmacogenomics journal	2011	37
20737575	Fluorouracil	Zhang J	Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene Friend leukemia virus integration 1 gene.	Cancer	2011	41
21969819	Fluorouracil	Shibata T	NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer.	Neoplasia	2011	40
22072615	Fluorouracil	Nie J	microRNA-365, down-regulated in colon cancer, inhibits cell cycle progression and promotes apoptosis of colon cancer cells by probably targeting Cyclin D1 and Bcl-2.	Carcinogenesis	2012	57
22205702	Fluorouracil	Xiong H	Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition.	The Journal of biological chemistry	2012	72
22260991	Fluorouracil	Funkhouser WK Jr	Relevance, pathogenesis, and testing algorithm for mismatch repair-defective colorectal carcinomas: a report of the association for molecular pathology.	The Journal of molecular diagnostics 	2012	30
23167930	Fluorouracil	Svoboda M	MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.	Radiation oncology	2012	32
23744359	Fluorouracil	Karaayvaz M	miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer.	Cell death & disease	2013	37
23746666	Fluorouracil	Vermorken JB	Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.	The Lancet. Oncology	2013	69
24446491	Fluorouracil	Shin JY	High c-Kit expression identifies hematopoietic stem cells with impaired self-renewal and megakaryocytic bias.	The Journal of experimental medicine	2014	38
25820415	Fluorouracil	Kawai T	Keratin 19, a Cancer Stem Cell Marker in Human Hepatocellular Carcinoma.	Clinical cancer research 	2015	23
26031544	Fluorouracil	Kawakami H	Microsatellite instability testing and its role in the management of colorectal cancer.	Current treatment options in oncology	2015	24
26494468	Fluorouracil	Alam SK	DNA damage-induced ephrin-B2 reverse signaling promotes chemoresistance and drives EMT in colorectal carcinoma harboring mutant p53.	Cell death and differentiation	2016	11
26603945	Fluorouracil	Meulendijks D	Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data.	The Lancet. Oncology	2015	18
26673620	Fluorouracil	Wang L	MicroRNA-497 inhibits tumor growth and increases chemosensitivity to 5-fluorouracil treatment by targeting KSR1.	Oncotarget	2016	15
28114937	Fluorouracil	Zhang JX	Decreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf/MEK/ERK pathway.	Molecular cancer	2017	9
15041700	Temozolomide	Hegi ME	Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide.	Clinical cancer research 	2004	146
17404084	Temozolomide	Cahill DP	Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment.	Clinical cancer research 	2007	91
18082451	Temozolomide	Gorlia T	Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.	The Lancet. Oncology	2008	95
18565887	Temozolomide	Murat A	Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma.	Journal of clinical oncology 	2008	233
19088037	Temozolomide	Pallini R	Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme.	Clinical cancer research 	2008	95
19265662	Temozolomide	Bleau AM	PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells.	Cell stem cell	2009	239
20439646	Temozolomide	Stupp R	Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma.	Journal of clinical oncology 	2010	99
20935218	Temozolomide	Gaspar N	MGMT-independent temozolomide resistance in pediatric glioblastoma cells associated with a PI3-kinase-mediated HOX/stem cell gene signature.	Cancer research	2010	44
21737504	Temozolomide	Grossman SA	Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide.	Clinical cancer research 	2011	84
21768296	Temozolomide	Mitchell DA	Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans.	Blood	2011	45
21988793	Temozolomide	Beier D	Chemoresistance of glioblastoma cancer stem cells--much more complex than expected.	Molecular cancer	2011	80
22048237	Temozolomide	Kirkwood JM	Phase II, open-label, randomized trial of the MEK1/2 inhibitor selumetinib as monotherapy versus temozolomide in patients with advanced melanoma.	Clinical cancer research 	2012	77
22197930	Temozolomide	Stark MS	Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing.	Nature genetics	2011	74
22469979	Temozolomide	Wagner L	Smac mimetic sensitizes glioblastoma cells to Temozolomide-induced apoptosis in a RIP1- and NF-κB-dependent manner.	Oncogene	2013	28
22532597	Temozolomide	Kohsaka S	STAT3 inhibition overcomes temozolomide resistance in glioblastoma by downregulating MGMT expression.	Molecular cancer therapeutics	2012	31
23047041	Temozolomide	Triscott J	Disulfiram, a drug widely used to control alcoholism, suppresses the self-renewal of glioblastoma and over-rides resistance to temozolomide.	Oncotarget	2012	33
23370117	Temozolomide	Curtin NJ	Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.	Molecular aspects of medicine	2013	75
23792642	Temozolomide	Comincini S	microRNA-17 regulates the expression of ATG7 and modulates the autophagy process, improving the sensitivity to temozolomide and low-dose ionizing radiation treatments in human glioblastoma cells.	Cancer biology & therapy	2013	32
23908450	Temozolomide	Wieland A	Anticancer effects of niclosamide in human glioblastoma.	Clinical cancer research 	2013	30
24469053	Temozolomide	Zhang LH	TRIM24 promotes glioma progression and enhances chemoresistance through activation of the PI3K/Akt signaling pathway.	Oncogene	2015	16
24608791	Temozolomide	Auffinger B	Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy.	Cell death and differentiation	2014	58
24861879	Temozolomide	Shi Z	MiR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-Ras.	Neuro-oncology	2014	36
24980823	Temozolomide	Wang L	MiR-143 acts as a tumor suppressor by targeting N-RAS and enhances temozolomide-induced apoptosis in glioma.	Oncotarget	2014	43
24991839	Temozolomide	Rangwala R	Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma.	Autophagy	2014	73
25093489	Temozolomide	Han S	Exogenous IGFBP-2 promotes proliferation, invasion, and chemoresistance to temozolomide in glioma cells via the integrin β1-ERK pathway.	British journal of cancer	2014	26
25163906	Temozolomide	Stupp R	Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial.	The Lancet. Oncology	2014	126
25605243	Temozolomide	Wang Z	Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors.	Oncotarget	2015	18
25609769	Temozolomide	Suchorska B	Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBM.	Neurology	2015	17
25762461	Temozolomide	Nabors LB	Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study.	Neuro-oncology	2015	30
26846818	Temozolomide	Phillips AC	ABT-414, an Antibody-Drug Conjugate Targeting a Tumor-Selective EGFR Epitope.	Molecular cancer therapeutics	2016	15
27503138	Temozolomide	Arita H	A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas.	Acta neuropathologica communications	2016	12
27690220	Temozolomide	Kawaguchi K	Vemurafenib-resistant BRAF-V600E-mutated melanoma is regressed by MEK-targeting drug trametinib, but not cobimetinib in a patient-derived orthotopic xenograft (PDOX) mouse model.	Oncotarget	2016	26
28106277	Temozolomide	Kawaguchi K	Tumor-Targeting Salmonella typhimurium A1-R Sensitizes Melanoma With a BRAF-V600E Mutation to Vemurafenib in a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model.	Journal of cellular biochemistry	2017	15
28187000	Temozolomide	Chen W	MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression.	Oncotarget	2017	8
28622068	Temozolomide	Kawaguchi K	Salmonella typhimurium A1-R targeting of a chemotherapy-resistant BRAF-V600E melanoma in a patient-derived orthotopic xenograft (PDOX) model is enhanced in combination with either vemurafenib or temozolomide.	Cell cycle	2017	8
28668966	Temozolomide	Li H	Long Non-Coding RNA MALAT1 Decreases the Sensitivity of Resistant Glioblastoma Cell Lines to Temozolomide.	Cellular physiology and biochemistry 	2017	7
28844499	Temozolomide	Weller M	Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.	The Lancet. Oncology	2017	11
9508771	1-Phosphatidyl-D-myo-inositol	Honda K	Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion.	The Journal of cell biology	1998	102
10400993	1-Phosphatidyl-D-myo-inositol	Marsh DJ	PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome.	Human molecular genetics	1999	98
10749120	1-Phosphatidyl-D-myo-inositol	Zhong H	Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.	Cancer research	2000	317
11280739	1-Phosphatidyl-D-myo-inositol	Asselin E	XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.	Cancer research	2001	87
11358816	1-Phosphatidyl-D-myo-inositol	Brognard J	Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation.	Cancer research	2001	209
11404460	1-Phosphatidyl-D-myo-inositol	Lin HK	Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor.	Proceedings of the National Academy of Sciences of the United States of America	2001	102
11406568	1-Phosphatidyl-D-myo-inositol	Cuello M	Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2.	Cancer research	2001	88
11431323	1-Phosphatidyl-D-myo-inositol	Sonoda Y	Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma.	Cancer research	2001	90
11479209	1-Phosphatidyl-D-myo-inositol	Bachelder RE	Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells.	Cancer research	2001	106
11884591	1-Phosphatidyl-D-myo-inositol	Kops GJ	Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors.	Molecular and cellular biology	2002	107
12167664	1-Phosphatidyl-D-myo-inositol	Dan HC	Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin.	The Journal of biological chemistry	2002	100
12351634	1-Phosphatidyl-D-myo-inositol	Modur V	FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer.	The Journal of biological chemistry	2002	113
12682293	1-Phosphatidyl-D-myo-inositol	Sudhakar A	Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins.	Proceedings of the National Academy of Sciences of the United States of America	2003	111
12897778	1-Phosphatidyl-D-myo-inositol	Matsunaga T	Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia.	Nature medicine	2003	143
14769856	1-Phosphatidyl-D-myo-inositol	Liu H	Polarity and proliferation are controlled by distinct signaling pathways downstream of PI3-kinase in breast epithelial tumor cells.	The Journal of cell biology	2004	96
15059275	1-Phosphatidyl-D-myo-inositol	Hwang SY	IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-kappaB- and PI3-kinase/Akt-dependent pathways.	Arthritis research & therapy	2004	84
15143086	1-Phosphatidyl-D-myo-inositol	Chakravarti A	The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas.	Journal of clinical oncology 	2004	91
15231645	1-Phosphatidyl-D-myo-inositol	Yang L	Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt.	Cancer research	2004	142
15254419	1-Phosphatidyl-D-myo-inositol	Bachman KE	The PIK3CA gene is mutated with high frequency in human breast cancers.	Cancer biology & therapy	2004	183
15284297	1-Phosphatidyl-D-myo-inositol	Sharples EJ	Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion.	Journal of the American Society of Nephrology 	2004	82
15289301	1-Phosphatidyl-D-myo-inositol	Broderick DK	Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas.	Cancer research	2004	84
15494427	1-Phosphatidyl-D-myo-inositol	Yu JL	Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis.	Blood	2005	118
15766664	1-Phosphatidyl-D-myo-inositol	Kim RH	DJ-1, a novel regulator of the tumor suppressor PTEN.	Cancer cell	2005	133
15942189	1-Phosphatidyl-D-myo-inositol	Nawshad A	Transforming growth factor-beta signaling during epithelial-mesenchymal transformation: implications for embryogenesis and tumor metastasis.	Cells, tissues, organs	2005	95
15994075	1-Phosphatidyl-D-myo-inositol	Velho S	The prevalence of PIK3CA mutations in gastric and colon cancer.	European journal of cancer	2005	97
16168105	1-Phosphatidyl-D-myo-inositol	Wu G	Somatic mutation and gain of copy number of PIK3CA in human breast cancer.	Breast cancer research 	2005	66
16288007	1-Phosphatidyl-D-myo-inositol	García-Rostán G	Mutation of the PIK3CA gene in anaplastic thyroid cancer.	Cancer research	2005	84
16324768	1-Phosphatidyl-D-myo-inositol	Tang JM	Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis.	Lung cancer	2006	87
16339315	1-Phosphatidyl-D-myo-inositol	Zhao JJ	The oncogenic properties of mutant p110alpha and p110beta phosphatidylinositol 3-kinases in human mammary epithelial cells.	Proceedings of the National Academy of Sciences of the United States of America	2005	128
16543232	1-Phosphatidyl-D-myo-inositol	Misra UK	Activation and cross-talk between Akt, NF-kappaB, and unfolded protein response signaling in 1-LN prostate cancer cells consequent to ligation of cell surface-associated GRP78.	The Journal of biological chemistry	2006	73
16731745	1-Phosphatidyl-D-myo-inositol	Smalley KS	Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases.	Molecular cancer therapeutics	2006	150
16732316	1-Phosphatidyl-D-myo-inositol	Cheng JC	Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway.	Oncogene	2006	64
16912192	1-Phosphatidyl-D-myo-inositol	Chesler L	Inhibition of phosphatidylinositol 3-kinase destabilizes Mycn protein and blocks malignant progression in neuroblastoma.	Cancer research	2006	62
17068222	1-Phosphatidyl-D-myo-inositol	Ferretti C	Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts.	Human reproduction update	2007	98
17210696	1-Phosphatidyl-D-myo-inositol	Maroulakou IG	Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice.	Cancer research	2007	108
17234779	1-Phosphatidyl-D-myo-inositol	Tabe Y	Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cells.	Cancer research	2007	61
17332339	1-Phosphatidyl-D-myo-inositol	Campbell PM	K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling.	Cancer research	2007	79
17341655	1-Phosphatidyl-D-myo-inositol	Blanco-Aparicio C	PTEN, more than the AKT pathway.	Carcinogenesis	2007	120
17363567	1-Phosphatidyl-D-myo-inositol	Saxena NK	Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells.	Cancer research	2007	118
17403556	1-Phosphatidyl-D-myo-inositol	De Felice FG	Alzheimer's disease-type neuronal tau hyperphosphorylation induced by A beta oligomers.	Neurobiology of aging	2008	109
17452630	1-Phosphatidyl-D-myo-inositol	Saal LH	Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity.	Proceedings of the National Academy of Sciences of the United States of America	2007	184
17563745	1-Phosphatidyl-D-myo-inositol	Kikuno N	Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity.	Oncogene	2007	79
17692802	1-Phosphatidyl-D-myo-inositol	Brugge J	A new mutational AKTivation in the PI3K pathway.	Cancer cell	2007	92
17973573	1-Phosphatidyl-D-myo-inositol	Cragg MS	Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics.	PLoS medicine	2007	118
18299320	1-Phosphatidyl-D-myo-inositol	Havasi A	Hsp27 inhibits Bax activation and apoptosis via a phosphatidylinositol 3-kinase-dependent mechanism.	The Journal of biological chemistry	2008	53
18625725	1-Phosphatidyl-D-myo-inositol	Wang SE	Transforming growth factor beta engages TACE and ErbB3 to activate phosphatidylinositol-3 kinase/Akt in ErbB2-overexpressing breast cancer and desensitizes cells to trastuzumab.	Molecular and cellular biology	2008	65
18644989	1-Phosphatidyl-D-myo-inositol	Toulany M	Targeting of AKT1 enhances radiation toxicity of human tumor cells by inhibiting DNA-PKcs-dependent DNA double-strand break repair.	Molecular cancer therapeutics	2008	52
18757405	1-Phosphatidyl-D-myo-inositol	Yamamoto H	PIK3CA mutations and copy number gains in human lung cancers.	Cancer research	2008	145
18829572	1-Phosphatidyl-D-myo-inositol	Oda K	PIK3CA cooperates with other phosphatidylinositol 3'-kinase pathway mutations to effect oncogenic transformation.	Cancer research	2008	59
19147570	1-Phosphatidyl-D-myo-inositol	Mirzoeva OK	Basal subtype and MAPK/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to MEK inhibition.	Cancer research	2009	116
19176381	1-Phosphatidyl-D-myo-inositol	Almog N	Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype.	Cancer research	2009	73
19214224	1-Phosphatidyl-D-myo-inositol	Read RD	A drosophila model for EGFR-Ras and PI3K-dependent human glioma.	PLoS genetics	2009	54
19318560	1-Phosphatidyl-D-myo-inositol	Szczepanski MJ	Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack.	Cancer research	2009	64
19371598	1-Phosphatidyl-D-myo-inositol	Morselli E	Anti- and pro-tumor functions of autophagy.	Biochimica et biophysica acta	2009	93
19426212	1-Phosphatidyl-D-myo-inositol	Rudd CE	CD28 and CTLA-4 coreceptor expression and signal transduction.	Immunological reviews	2009	162
19435916	1-Phosphatidyl-D-myo-inositol	Hennessy BT	Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics.	Cancer research	2009	263
19568240	1-Phosphatidyl-D-myo-inositol	Meng XN	Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion.	British journal of cancer	2009	56
19789314	1-Phosphatidyl-D-myo-inositol	Platt FM	Spectrum of phosphatidylinositol 3-kinase pathway gene alterations in bladder cancer.	Clinical cancer research 	2009	71
20081861	1-Phosphatidyl-D-myo-inositol	Houghton AM	Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth.	Nature medicine	2010	120
20233997	1-Phosphatidyl-D-myo-inositol	Zhang J	Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth.	Journal of the National Cancer Institute	2010	74
20388916	1-Phosphatidyl-D-myo-inositol	Poliseno L	Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation.	Science signaling	2010	166
20471940	1-Phosphatidyl-D-myo-inositol	Chin YR	The actin-bundling protein palladin is an Akt1-specific substrate that regulates breast cancer cell migration.	Molecular cell	2010	55
20522708	1-Phosphatidyl-D-myo-inositol	Herman SE	Phosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals.	Blood	2010	160
21320503	1-Phosphatidyl-D-myo-inositol	Ke AW	CD151 amplifies signaling by integrin α6β1 to PI3K and induces the epithelial-mesenchymal transition in HCC cells.	Gastroenterology	2011	43
21628414	1-Phosphatidyl-D-myo-inositol	Kuchenbauer F	Comprehensive analysis of mammalian miRNA* species and their role in myeloid cells.	Blood	2011	38
21818118	1-Phosphatidyl-D-myo-inositol	Qiang L	HIF-1α is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway.	Cell death and differentiation	2012	59
21820331	1-Phosphatidyl-D-myo-inositol	Martínez-Martín N	T cell receptor internalization from the immunological synapse is mediated by TC21 and RhoG GTPase-dependent phagocytosis.	Immunity	2011	46
21951552	1-Phosphatidyl-D-myo-inositol	Debaisieux S	The ins and outs of HIV-1 Tat.	Traffic	2012	55
22002674	1-Phosphatidyl-D-myo-inositol	Florey O	Autophagy machinery mediates macroendocytic processing and entotic cell death by targeting single membranes.	Nature cell biology	2011	112
22065080	1-Phosphatidyl-D-myo-inositol	Koul D	Antitumor activity of NVP-BKM120--a selective pan class I PI3 kinase inhibitor showed differential forms of cell death based on p53 status of glioma cells.	Clinical cancer research 	2012	50
22133722	1-Phosphatidyl-D-myo-inositol	Roychowdhury S	Personalized oncology through integrative high-throughput sequencing: a pilot study.	Science translational medicine	2011	190
22195044	1-Phosphatidyl-D-myo-inositol	Mitroulis I	Neutrophil extracellular trap formation is associated with IL-1β and autophagy-related signaling in gout.	PloS one	2011	64
22494966	1-Phosphatidyl-D-myo-inositol	Torsvik A	Mesenchymal stem cell signaling in cancer progression.	Cancer treatment reviews	2013	27
22588880	1-Phosphatidyl-D-myo-inositol	Ni J	Functional characterization of an isoform-selective inhibitor of PI3K-p110β as a potential anticancer agent.	Cancer discovery	2012	56
22614243	1-Phosphatidyl-D-myo-inositol	Simioni C	Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia.	Leukemia	2012	30
22727489	1-Phosphatidyl-D-myo-inositol	Lai Y	The antimicrobial protein REG3A regulates keratinocyte proliferation and differentiation after skin injury.	Immunity	2012	33
22729222	1-Phosphatidyl-D-myo-inositol	Lindhurst MJ	Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA.	Nature genetics	2012	46
22936542	1-Phosphatidyl-D-myo-inositol	Rose DP	The cellular and molecular mechanisms by which insulin influences breast cancer risk and progression.	Endocrine-related cancer	2012	33
22969158	1-Phosphatidyl-D-myo-inositol	Hoshino D	Network analysis of the focal adhesion to invadopodia transition identifies a PI3K-PKCα invasive signaling axis.	Science signaling	2012	33
23112296	1-Phosphatidyl-D-myo-inositol	Wang RC	Akt-mediated regulation of autophagy and tumorigenesis through Beclin 1 phosphorylation.	Science	2012	167
23348690	1-Phosphatidyl-D-myo-inositol	Ha GH	TACC3 promotes epithelial-mesenchymal transition (EMT) through the activation of PI3K/Akt and ERK signaling pathways.	Cancer letters	2013	28
23420005	1-Phosphatidyl-D-myo-inositol	Fu LL	Beclin-1: autophagic regulator and therapeutic target in cancer.	The international journal of biochemistry & cell biology	2013	42
23643389	1-Phosphatidyl-D-myo-inositol	Hao Y	Gain of interaction with IRS1 by p110α-helical domain mutants is crucial for their oncogenic functions.	Cancer cell	2013	25
23838428	1-Phosphatidyl-D-myo-inositol	Beazley-Long N	VEGF-A165b is an endogenous neuroprotective splice isoform of vascular endothelial growth factor A in vivo and in vitro.	The American journal of pathology	2013	25
24067654	1-Phosphatidyl-D-myo-inositol	Tian Y	Adaptor complex AP2/PICALM, through interaction with LC3, targets Alzheimer's APP-CTF for terminal degradation via autophagy.	Proceedings of the National Academy of Sciences of the United States of America	2013	36
24417819	1-Phosphatidyl-D-myo-inositol	Avitzur Y	Mutations in tetratricopeptide repeat domain 7A result in a severe form of very early onset inflammatory bowel disease.	Gastroenterology	2014	27
24440701	1-Phosphatidyl-D-myo-inositol	Wang Y	MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA.	Biochemical and biophysical research communications	2014	24
24450858	1-Phosphatidyl-D-myo-inositol	Gopal AK	PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma.	The New England journal of medicine	2014	145
24533074	1-Phosphatidyl-D-myo-inositol	Wang L	PIK3CA mutations frequently coexist with EGFR/KRAS mutations in non-small cell lung cancer and suggest poor prognosis in EGFR/KRAS wildtype subgroup.	PloS one	2014	28
24607406	1-Phosphatidyl-D-myo-inositol	Todaro M	CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis.	Cell stem cell	2014	116
24615777	1-Phosphatidyl-D-myo-inositol	Brown JR	Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia.	Blood	2014	124
24703947	1-Phosphatidyl-D-myo-inositol	Wang H	Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3.	Molecular cell	2014	198
24867100	1-Phosphatidyl-D-myo-inositol	Wang F	MiRNA-181c inhibits EGFR-signaling-dependent MMP9 activation via suppressing Akt phosphorylation in glioblastoma.	Tumour biology 	2014	22
25001183	1-Phosphatidyl-D-myo-inositol	Hu J	microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.	European journal of cancer	2014	33
25183785	1-Phosphatidyl-D-myo-inositol	Rubashkin MG	Force engages vinculin and promotes tumor progression by enhancing PI3K activation of phosphatidylinositol (3,4,5)-triphosphate.	Cancer research	2014	41
25275521	1-Phosphatidyl-D-myo-inositol	McKnight NC	Beclin 1 is required for neuron viability and regulates endosome pathways via the UVRAG-VPS34 complex.	PLoS genetics	2014	21
25475121	1-Phosphatidyl-D-myo-inositol	Huang XP	MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.	The FEBS journal	2015	20
25544637	1-Phosphatidyl-D-myo-inositol	Costa C	Measurement of PIP3 levels reveals an unexpected role for p110β in early adaptive responses to p110α-specific inhibitors in luminal breast cancer.	Cancer cell	2015	46
25559818	1-Phosphatidyl-D-myo-inositol	Majewski IJ	PIK3CA mutations are associated with decreased benefit to neoadjuvant human epidermal growth factor receptor 2-targeted therapies in breast cancer.	Journal of clinical oncology 	2015	46
25650317	1-Phosphatidyl-D-myo-inositol	Ghosh JC	Adaptive mitochondrial reprogramming and resistance to PI3K therapy.	Journal of the National Cancer Institute	2015	27
26117819	1-Phosphatidyl-D-myo-inositol	Yap TA	Drugging PI3K in cancer: refining targets and therapeutic strategies.	Current opinion in pharmacology	2015	40
26926684	1-Phosphatidyl-D-myo-inositol	Desmedt C	Genomic Characterization of Primary Invasive Lobular Breast Cancer.	Journal of clinical oncology 	2016	18
28518139	1-Phosphatidyl-D-myo-inositol	Li N	MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer.	Cell death & disease	2017	10
